Citrus Sinensis ID: 011412
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 486 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFP7 | 493 | Probable receptor-like pr | yes | no | 0.967 | 0.953 | 0.75 | 0.0 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.907 | 0.9 | 0.759 | 0.0 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.726 | 0.860 | 0.606 | 1e-128 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.732 | 0.864 | 0.597 | 1e-125 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.779 | 0.974 | 0.566 | 1e-124 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.699 | 0.829 | 0.637 | 1e-123 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.722 | 0.888 | 0.570 | 1e-120 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.855 | 0.976 | 0.527 | 1e-119 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.648 | 0.809 | 0.603 | 1e-115 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.748 | 0.854 | 0.564 | 1e-115 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 729 bits (1883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/500 (75%), Positives = 405/500 (81%), Gaps = 30/500 (6%)
Query: 1 MGFDGENGKVKKASWDSSKSKA---KKKKKKVEDE-----VEVEEEEETGCWVKLRFFGS 52
MG D K +W S K K K KKK D+ E EE E +GCWVK RF
Sbjct: 1 MGLDAVKAK---GNWKSEKPKETENKNHKKKNGDDNKSRNEEEEEGEASGCWVKFRFMIG 57
Query: 53 CISSRSKVDSSVSG------TSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKL 106
CI S+S +D+S S T T ESKS N+ S DQP V S+TTTSNAES+SST +
Sbjct: 58 CIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVI 117
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
EEL ++S LRKFTFNDLKL+TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV
Sbjct: 118 SEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 177
Query: 167 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 226
AVKTLN DGLQGHKEWLAE+NFLG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHL
Sbjct: 178 AVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 237
Query: 227 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
FRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLDADYNAKLSDFGLA
Sbjct: 238 FRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLA 297
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
KD P+ KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRP
Sbjct: 298 KDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 357
Query: 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
NGEHNLVEWARPHL ++RRFYRL+DPRLEGHFSIKGAQK QLAA CLSRDPK RP MS+
Sbjct: 358 NGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSD 417
Query: 407 VVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ-----RSLS 461
VVEALKPLP+LKDMASSSYYFQTMQAER+ +NG G SRNGQ R+LS
Sbjct: 418 VVEALKPLPHLKDMASSSYYFQTMQAERL------KNGSGRSQGFGSRNGQHQPVFRTLS 471
Query: 462 IPNGSYASPYHHQFPHPSPK 481
P+GS SPY HQ P P PK
Sbjct: 472 SPHGS--SPYRHQIPSPKPK 489
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 695 bits (1794), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/449 (75%), Positives = 380/449 (84%), Gaps = 8/449 (1%)
Query: 37 EEEETGCWVKLRFFGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSN 96
EEE GCWVK R+ C SS S V++S++ +++ S+S S DQP V S+TTTSN
Sbjct: 42 EEEANGCWVKFRYIVCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSN 101
Query: 97 AESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 156
AES+ ST + EEL + S L+KF+F DLKLATRNFRPESLLGEGGFGCVFKGW+EENGTA
Sbjct: 102 AESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTA 161
Query: 157 PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 216
PVKPGTGLTVAVKTLN DGLQGHKEWLAE+N+LG+L+H NLVKL+GYCIEDDQRLLVYEF
Sbjct: 162 PVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEF 221
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLD +Y
Sbjct: 222 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEY 281
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
NAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLT
Sbjct: 282 NAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
Query: 337 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 396
GRRSMDKNRPNGEHNLVEWARPHL ++RRFYRL+DPRLEGHFS+KGAQK QLAA CLSR
Sbjct: 342 GRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSR 401
Query: 397 DPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG 456
D K RP MSEVVE LKPLP+LKDMAS+SYYFQTMQAER+ + + +G SRNG
Sbjct: 402 DSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERLKAGSGSGSGRGFG----SRNG 457
Query: 457 Q---RSLSIPNGSY-ASPYHHQFPHPSPK 481
Q R+LS P+G +SPY HQ P P PK
Sbjct: 458 QPVFRTLSSPHGQAGSSPYRHQIPSPKPK 486
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1177), Expect = e-128, Method: Compositional matrix adjust.
Identities = 225/371 (60%), Positives = 279/371 (75%), Gaps = 18/371 (4%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
G C+S++ K +SS G ST Y++K + +V S T E E
Sbjct: 1 MGICLSAQVKAESS--GASTKYDAKDIGSLGSKASSVSVRPSPRT------------EGE 46
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ + L+ F+F +LK ATRNFRP+S+LGEGGFGCVFKGWI+E +PGTGL +AVK
Sbjct: 47 ILQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVK 106
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN DG QGH+EWLAEVN+LG H +LVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR
Sbjct: 107 KLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRR 166
Query: 230 SL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
L PL W +R+K+ALGAAKGLAFLH R VIYRDFKTSNILLD++YNAKLSDFGLA
Sbjct: 167 GLYFQPLSWKLRLKVALGAAKGLAFLHSSETR-VIYRDFKTSNILLDSEYNAKLSDFGLA 225
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
KDGP GDK+HVSTRVMGT+GYAAPEY+ TGHLT++SDVYSFGVVLLE+L+GRR++DKNRP
Sbjct: 226 KDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRP 285
Query: 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
+GE NLVEWA+P+L +R+ +R+ID RL+ +S++ A K A L+ CL+ + K RP MSE
Sbjct: 286 SGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSE 345
Query: 407 VVEALKPLPNL 417
VV L+ + +L
Sbjct: 346 VVSHLEHIQSL 356
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 447 bits (1151), Expect = e-125, Method: Compositional matrix adjust.
Identities = 223/373 (59%), Positives = 275/373 (73%), Gaps = 17/373 (4%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
G C+S++ K S G S Y S ND+ + ++ I + + E E
Sbjct: 1 MGICLSAQIKAVSP--GASPKYMSSEANDSLGSKSSSVSIRTN-----------PRTEGE 47
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ + L+ FTF +LK ATRNFRP+S+LGEGGFG VFKGWI+E KPGTG+ +AVK
Sbjct: 48 ILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVK 107
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN DG QGH+EWLAEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR
Sbjct: 108 KLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRR 167
Query: 230 S---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
PL W++R+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLSDFGLA
Sbjct: 168 GSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLA 226
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
KDGP GDK+HVSTR+MGTYGYAAPEY+ TGHLT++SDVYS+GVVLLE+L+GRR++DKNRP
Sbjct: 227 KDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRP 286
Query: 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
GE LVEWARP L +R+ +R+ID RL+ +S++ A K A LA CL+ + K RP M+E
Sbjct: 287 PGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNE 346
Query: 407 VVEALKPLPNLKD 419
VV L+ + L +
Sbjct: 347 VVSHLEHIQTLNE 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 446 bits (1148), Expect = e-124, Method: Compositional matrix adjust.
Identities = 225/397 (56%), Positives = 286/397 (72%), Gaps = 18/397 (4%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
G C S+R K D + +ST SK SRD + S+ S S + E E
Sbjct: 1 MGGCFSNRIKTDIA---SSTWLSSKFL---SRD--------GSKGSSTASFSYMPRTEGE 46
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ + L+ F+ ++LK ATRNFRP+S++GEGGFGCVFKGWI+E+ AP KPGTG+ +AVK
Sbjct: 47 ILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVK 106
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN +G QGH+EWLAE+N+LG L H NLVKLIGYC+E++ RLLVYEFM RGSLENHLFRR
Sbjct: 107 RLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRR 166
Query: 230 SL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
PL W+ R+++ALGAA+GLAFLH A+ VIYRDFK SNILLD++YNAKLSDFGLA
Sbjct: 167 GTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLA 225
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+DGP GD +HVSTRVMGT GYAAPEY+ TGHL+ +SDVYSFGVVLLE+L+GRR++DKN+P
Sbjct: 226 RDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQP 285
Query: 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
GEHNLV+WARP+L +RR R++DPRL+G +S+ A K A LA C+S D K+RP M+E
Sbjct: 286 VGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNE 345
Query: 407 VVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRN 443
+V+ ++ L K+ + Q I SP N
Sbjct: 346 IVKTMEELHIQKEASKEQQNPQISIDNIINKSPQAVN 382
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1141), Expect = e-123, Method: Compositional matrix adjust.
Identities = 222/348 (63%), Positives = 268/348 (77%), Gaps = 8/348 (2%)
Query: 99 SNSSTSKLEEELKVA---SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 155
S+ ST + ++ + +++ FT +L+ T++FRP+ +LGEGGFG V+KG+I++N
Sbjct: 34 SDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLR 93
Query: 156 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215
+K L VAVK LN +GLQGH+EWL EVNFLG L H NLVKLIGYC EDD RLLVYE
Sbjct: 94 VGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYE 150
Query: 216 FMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
FM RGSLENHLFR++ PL WS RM IALGAAKGLAFLH AERPVIYRDFKTSNILLD+
Sbjct: 151 FMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDS 209
Query: 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334
DY AKLSDFGLAK GP+GD+THVSTRVMGTYGYAAPEYVMTGHLT+RSDVYSFGVVLLEM
Sbjct: 210 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEM 269
Query: 335 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 394
LTGR+S+DK RP+ E NLV+WARP L ++R+ ++IDPRLE +S++ AQKA LA +CL
Sbjct: 270 LTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCL 329
Query: 395 SRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 442
S++PKARPLMS+VVE L+PL D A +G P+ R
Sbjct: 330 SQNPKARPLMSDVVETLEPLQCTGDALIPCATTTAGAAFAMGGVPDYR 377
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 433 bits (1113), Expect = e-120, Method: Compositional matrix adjust.
Identities = 211/370 (57%), Positives = 267/370 (72%), Gaps = 19/370 (5%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEE 109
GSC SSR K D +G S+ S + AA K E E
Sbjct: 1 MGSCFSSRVKADIFHNGKSSDLYGLSLSSRKSSSTVAA---------------AQKTEGE 45
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ ++ ++ FTFN+LKLATRNFRP+S++GEGGFGCVFKGW++E+ P KPGTGL +AVK
Sbjct: 46 ILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVK 105
Query: 170 TLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
LN +G QGH+EWL E+N+LG L H NLVKLIGYC+ED+ RLLVYEFM +GSLENHLFRR
Sbjct: 106 KLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRR 165
Query: 230 SL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
PLPW +R+ +AL AAKGLAFLH + + VIYRD K SNILLDADYNAKLSDFGLA
Sbjct: 166 GAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLSDFGLA 224
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+DGP GD ++VSTRVMGTYGYAAPEY+ +GHL +RSDVYSFGV+LLE+L+G+R++D NRP
Sbjct: 225 RDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRP 284
Query: 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
E NLV+WARP+L +R+ ++D RL+ + + A + A +A CLS +PK+RP M +
Sbjct: 285 AKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQ 344
Query: 407 VVEALKPLPN 416
VV AL+ L +
Sbjct: 345 VVRALQQLQD 354
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 428 bits (1100), Expect = e-119, Method: Compositional matrix adjust.
Identities = 230/436 (52%), Positives = 293/436 (67%), Gaps = 20/436 (4%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNS-STSKLEE 108
G+C+ S +KVDSS + S S+ +S+ + S + S + S T + E
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEG 60
Query: 109 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
E+ + L+ FTFN+LK ATRNFRP+SLLGEGGFG VFKGWI+ KPG+G+ VAV
Sbjct: 61 EILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAV 120
Query: 169 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
K L +G QGHKEWL EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSLENHLFR
Sbjct: 121 KKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFR 180
Query: 229 R-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
R + PL W+IRMK+A+GAAKGL FLH+ A+ VIYRDFK +NILLDA++N+KLSDFGLAK
Sbjct: 181 RGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAK 239
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 347
GP GDKTHVST+VMGT+GYAAPEYV TG LT++SDVYSFGVVLLE+L+GRR++DK++
Sbjct: 240 AGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVG 299
Query: 348 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
E +LV+WA P+LG++R+ +R++D RL G + KGA AA LA CL+ D K RP MSEV
Sbjct: 300 MEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEV 359
Query: 408 VEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSY 467
+ L L + K +G+ + R GS+ + R SY
Sbjct: 360 LAKLDQLESTK------------PGTGVGNRQAQIDSPRGSNGSIVQKSPRRY-----SY 402
Query: 468 ASPYHHQFPHPSPKPN 483
P H P SP P
Sbjct: 403 DRPLLHITPGASPLPT 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1067), Expect = e-115, Method: Compositional matrix adjust.
Identities = 193/320 (60%), Positives = 248/320 (77%), Gaps = 5/320 (1%)
Query: 101 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160
++ K E E+ ++ ++ F+FN+LKLATRNFR +S++GEGGFGCVF+GW++E P K
Sbjct: 31 ATAHKTEGEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKS 90
Query: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG 220
+GL +AVK LN DG QGH+EWL E+N+LG L H NLVKLIGYC+ED+QRLLVYEFM +G
Sbjct: 91 SSGLVIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKG 150
Query: 221 SLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
SLENHLF + PL W +R+K+AL AAKGLAFLH + + VIYRD K SNILLD+D+
Sbjct: 151 SLENHLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDSDF 209
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
NAKLSDFGLA+DGP G++++VSTRVMGT+GYAAPEYV TGHL +RSDVYSFGVVLLE+L
Sbjct: 210 NAKLSDFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLC 269
Query: 337 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 396
GR+++D NRP E NLV+WARP+L RR+ ++D RL + +GA + A +A CLS
Sbjct: 270 GRQALDHNRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSF 329
Query: 397 DPKARPLMSEVVEALKPLPN 416
+PK+RP M +VV AL L +
Sbjct: 330 EPKSRPTMDQVVRALVQLQD 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1067), Expect = e-115, Method: Compositional matrix adjust.
Identities = 209/370 (56%), Positives = 272/370 (73%), Gaps = 6/370 (1%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYESKSTNDTSRDQ----PAAAVISSTTTSNAESNSSTSK 105
G+C+ S +KVD+S + S + +S+ P+ +S +T ++ T +
Sbjct: 1 MGNCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60
Query: 106 LEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 165
E E+ + L+ FTFN+LK AT+NFR ++LLGEGGFGCVFKGWI++ +PG+G+
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 166 VAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 225
VAVK L +G QGHKEWL EVN+LG L H NLV L+GYC E + RLLVYEFMP+GSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 226 LFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284
LFRR + PL W+IRMK+A+GAAKGL FLHE A+ VIYRDFK +NILLDAD+NAKLSDFG
Sbjct: 181 LFRRGAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFG 239
Query: 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344
LAK GP GD THVST+V+GT+GYAAPEYV TG LT++SDVYSFGVVLLE+++GRR+MD +
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNS 299
Query: 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404
E++LV+WA P+LG++R+ +R++D +L G + KGA AA LA CL+ D K RP M
Sbjct: 300 NGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKM 359
Query: 405 SEVVEALKPL 414
SEV+ L+ L
Sbjct: 360 SEVLVTLEQL 369
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 486 | ||||||
| 359473277 | 481 | PREDICTED: probable receptor-like protei | 0.979 | 0.989 | 0.887 | 0.0 | |
| 255558222 | 495 | Protein kinase APK1B, chloroplast precur | 0.995 | 0.977 | 0.874 | 0.0 | |
| 351722951 | 485 | serine/threonine protein kinase-like pro | 0.983 | 0.985 | 0.883 | 0.0 | |
| 356498172 | 491 | PREDICTED: probable receptor-like protei | 0.993 | 0.983 | 0.886 | 0.0 | |
| 147857978 | 495 | hypothetical protein VITISV_008843 [Viti | 0.979 | 0.961 | 0.855 | 0.0 | |
| 356567562 | 487 | PREDICTED: probable receptor-like protei | 0.991 | 0.989 | 0.899 | 0.0 | |
| 356526888 | 487 | PREDICTED: probable receptor-like protei | 0.991 | 0.989 | 0.899 | 0.0 | |
| 224100247 | 478 | predicted protein [Populus trichocarpa] | 0.977 | 0.993 | 0.860 | 0.0 | |
| 224100451 | 445 | predicted protein [Populus trichocarpa] | 0.909 | 0.993 | 0.930 | 0.0 | |
| 53689728 | 603 | serine/threonine protein kinase-like [So | 0.969 | 0.781 | 0.848 | 0.0 |
| >gi|359473277|ref|XP_003631281.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] gi|296086431|emb|CBI32020.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2296), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/491 (88%), Positives = 455/491 (92%), Gaps = 15/491 (3%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGC-WVKLRFFGSCISSRSK 59
MG G + KV+ SW+ KSK +KKK EEETGC WVKLRF SCISSRSK
Sbjct: 1 MGLGGNDVKVE--SWEVGKSKGRKKKDG--------GEEETGCCWVKLRFMASCISSRSK 50
Query: 60 VDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKF 119
VDSS+SGTSTHYE++STNDTSRDQP A V+SSTTTSNAESNSSTSKLEEELKVASRLRKF
Sbjct: 51 VDSSISGTSTHYENRSTNDTSRDQPVAPVVSSTTTSNAESNSSTSKLEEELKVASRLRKF 110
Query: 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+FNDLK+ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH
Sbjct: 111 SFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 170
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
KEWLAEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW+IRM
Sbjct: 171 KEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWAIRM 230
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVST
Sbjct: 231 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVST 290
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH
Sbjct: 291 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 350
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 419
LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK RPLMSEVVEALKPLPNLKD
Sbjct: 351 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLPNLKD 410
Query: 420 MASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG---QRSLSIPNGSYASPYH-HQF 475
MASSSYYFQTMQAERIGSSPN RNG+R Q G LSRNG QRSLSIPNGS+ASPYH +Q+
Sbjct: 411 MASSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYHQNQY 470
Query: 476 PHPSPKPNGKP 486
P+ SPKPNGKP
Sbjct: 471 PYQSPKPNGKP 481
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558222|ref|XP_002520138.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540630|gb|EEF42193.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2272), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/495 (87%), Positives = 451/495 (91%), Gaps = 11/495 (2%)
Query: 1 MGFDGENG-KVKKASWDSSKSKAKKKKKK-VEDEV------EVEEEEETGCWVKLRFFGS 52
MG E+G + K +SW+ K K + KKK+ V + +V EE ETGCW K RF GS
Sbjct: 1 MGLGSEDGNRAKASSWEVCKPKGRNKKKQDVSNSSGGASPGDVVEEAETGCWFKFRFIGS 60
Query: 53 CISSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKV 112
CISSRSKVDSSVSGTSTH ESKSTNDTSRDQP A ISSTTTSNAESNSSTSKLEEELK+
Sbjct: 61 CISSRSKVDSSVSGTSTHCESKSTNDTSRDQPTAPTISSTTTSNAESNSSTSKLEEELKI 120
Query: 113 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 172
ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN
Sbjct: 121 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 180
Query: 173 HDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 232
HDGLQGHKEWLAEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP
Sbjct: 181 HDGLQGHKEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 240
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG
Sbjct: 241 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 300
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRP GEHNL
Sbjct: 301 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPIGEHNL 360
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE LK
Sbjct: 361 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEVLK 420
Query: 413 PLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASP 470
PLPNLKDMASSSYYFQ+MQA++I SSPN ++ R QGG L RNG QRSLSIPNGS+ASP
Sbjct: 421 PLPNLKDMASSSYYFQSMQADKIASSPNAKSSNRTQGG-LLRNGQQQRSLSIPNGSHASP 479
Query: 471 YHHQFPHPSPKPNGK 485
YHHQ+P SPKPNGK
Sbjct: 480 YHHQYPFQSPKPNGK 494
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351722951|ref|NP_001235470.1| serine/threonine protein kinase-like protein [Glycine max] gi|223452506|gb|ACM89580.1| serine/threonine protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 865 bits (2235), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/491 (88%), Positives = 453/491 (92%), Gaps = 13/491 (2%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
MG ENGKV + SWD KSK +KKKK E E E GCWV+LRF GSCISSRSKV
Sbjct: 1 MGLGAENGKVVE-SWDVCKSKGRKKKKGDE-----GGEAEAGCWVRLRFIGSCISSRSKV 54
Query: 61 DSSVSG--TSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSS-TSKLEEELKVASRL 116
D+SVSG TSTHY ESKSTNDTSRDQP A +SSTTTSNAESNSS TSKLEEELK+ASRL
Sbjct: 55 DTSVSGSGTSTHYAESKSTNDTSRDQPTAPAVSSTTTSNAESNSSSTSKLEEELKIASRL 114
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
RKF+FN+LKLATRNFRPES LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL
Sbjct: 115 RKFSFNELKLATRNFRPESFLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 174
Query: 177 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 236
QGHKEWLAEVNFLGDLVH NLVKL+GYCIE+DQRLLVYEFMPRGSLENHLFRRS+PLPWS
Sbjct: 175 QGHKEWLAEVNFLGDLVHPNLVKLVGYCIEEDQRLLVYEFMPRGSLENHLFRRSIPLPWS 234
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTH
Sbjct: 235 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTH 294
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
VSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDK+RPNGEHNLVEWA
Sbjct: 295 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKHRPNGEHNLVEWA 354
Query: 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416
RPHLGERRRFYRLIDPRLEGHFS+KGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPN
Sbjct: 355 RPHLGERRRFYRLIDPRLEGHFSVKGAQKAALLAAHCLSRDPKARPLMSEVVEALKPLPN 414
Query: 417 LKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQ 474
LKDMASSSYYFQ MQA+RIG+SPNTRNG R QG L+RNG QRSLSIPNG+YASPYHHQ
Sbjct: 415 LKDMASSSYYFQAMQADRIGASPNTRNG-RMQGALLTRNGQQQRSLSIPNGTYASPYHHQ 473
Query: 475 FPHPSPKPNGK 485
FP PSPKPNGK
Sbjct: 474 FPQPSPKPNGK 484
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498172|ref|XP_003517927.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 863 bits (2231), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/492 (88%), Positives = 454/492 (92%), Gaps = 9/492 (1%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETG--CWVKLRFFGSCISSRS 58
MG GENGKV + SWD KSK +KKKK D EVEE E CWV+LRF GSCISSRS
Sbjct: 1 MGLGGENGKVVE-SWDVCKSKGGRKKKKKGDAEEVEEGAEAEAGCWVRLRFIGSCISSRS 59
Query: 59 KVDSSVS--GTSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASR 115
KVD+SVS G STHY ESKSTNDTSRDQP A +SSTTTSNAESNSSTSKLEEELK+ASR
Sbjct: 60 KVDTSVSASGISTHYAESKSTNDTSRDQPTAPAVSSTTTSNAESNSSTSKLEEELKIASR 119
Query: 116 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 175
LRKF+FNDLK ATRNFRPES LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG
Sbjct: 120 LRKFSFNDLKSATRNFRPESFLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 179
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
LQGHKEWLAEVNFLGDLVH NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRS+PLPW
Sbjct: 180 LQGHKEWLAEVNFLGDLVHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSMPLPW 239
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT
Sbjct: 240 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 299
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355
HVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDK+RPNGEHNLVEW
Sbjct: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKHRPNGEHNLVEW 359
Query: 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415
ARPHLGERRRFYRLIDPRLEGHFS+KGAQKAAQLAAHCLSRDPK+RPLMSEVVEALKPLP
Sbjct: 360 ARPHLGERRRFYRLIDPRLEGHFSVKGAQKAAQLAAHCLSRDPKSRPLMSEVVEALKPLP 419
Query: 416 NLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHH 473
+LKDMASSSYYFQ MQA+R G+SPNTRNG R QG L+RNG QRSLSIPNG+YASPYHH
Sbjct: 420 SLKDMASSSYYFQAMQADRFGASPNTRNG-RMQGALLTRNGQQQRSLSIPNGTYASPYHH 478
Query: 474 QFPHPSPKPNGK 485
QFP PSPKPNGK
Sbjct: 479 QFPQPSPKPNGK 490
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857978|emb|CAN82516.1| hypothetical protein VITISV_008843 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 862 bits (2228), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/505 (85%), Positives = 450/505 (89%), Gaps = 29/505 (5%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGC-WVKLRFFGSCISSRSK 59
MG G + KV+ SW+ KSK +KKK EEETGC WVKLRF SCISSRSK
Sbjct: 1 MGLGGNDVKVE--SWEVGKSKGRKKKDG--------GEEETGCCWVKLRFMASCISSRSK 50
Query: 60 VDSSVSGTSTHY--------ESKSTN------DTSRDQPAAAVISSTTTSNAESNSSTSK 105
VDSS+SGTSTHY E +S N RDQP A V+SSTTTSNAESNSSTSK
Sbjct: 51 VDSSISGTSTHYDLGVXFDVEPRSLNVFWCDFGLCRDQPVAPVVSSTTTSNAESNSSTSK 110
Query: 106 LEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 165
LEEELKVASRLRKF+FNDLK+ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT
Sbjct: 111 LEEELKVASRLRKFSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 170
Query: 166 VAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 225
VAVKTLNHDGLQGHKEWLAEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENH
Sbjct: 171 VAVKTLNHDGLQGHKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 230
Query: 226 LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
LFRR+LPLPW+IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGL
Sbjct: 231 LFRRALPLPWAIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGL 290
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR
Sbjct: 291 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 350
Query: 346 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405
PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK RPLMS
Sbjct: 351 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMS 410
Query: 406 EVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG---QRSLSI 462
EVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPN RNG+R Q G LSRNG QRSLSI
Sbjct: 411 EVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSI 470
Query: 463 PNGSYASPYH-HQFPHPSPKPNGKP 486
PNGS+ASPYH +Q+P+ SPKPNGKP
Sbjct: 471 PNGSHASPYHQNQYPYQSPKPNGKP 495
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567562|ref|XP_003551987.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 861 bits (2224), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/489 (89%), Positives = 456/489 (93%), Gaps = 7/489 (1%)
Query: 1 MGFDG-ENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSK 59
MG G ENGKV S D KSK +KKKKK + EVEE+EETGCW +LRF GSCISSRSK
Sbjct: 1 MGLGGAENGKVVVESLDVCKSKGRKKKKKED--GEVEEKEETGCWFRLRFIGSCISSRSK 58
Query: 60 VDSSVSGTSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRK 118
VDSSVSGTST+Y ESKST DTSRDQP V+SSTTTSNAESNSSTSKLEEE KV+SRLRK
Sbjct: 59 VDSSVSGTSTNYAESKSTIDTSRDQPTVPVVSSTTTSNAESNSSTSKLEEEFKVSSRLRK 118
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG
Sbjct: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
HKEWLAEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR
Sbjct: 179 HKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVS
Sbjct: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVS 298
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP
Sbjct: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 418
HLGERRRFYRLIDPRLEGHFSIKGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLK
Sbjct: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPKARPLMSEVVEALKPLPNLK 418
Query: 419 DMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFP 476
DMASSSYYFQTMQA+R +SPNTRNG R QG L+RNG QRSLSIP+G++ASPYHHQFP
Sbjct: 419 DMASSSYYFQTMQADRFSASPNTRNG-RTQGALLTRNGQQQRSLSIPHGTHASPYHHQFP 477
Query: 477 HPSPKPNGK 485
PSPKPNGK
Sbjct: 478 QPSPKPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526888|ref|XP_003532048.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2213), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/489 (89%), Positives = 455/489 (93%), Gaps = 7/489 (1%)
Query: 1 MGFDG-ENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSK 59
MG G ENGKV S D KSK +KKKKK + EVEEEEETGCW +LRF GSCISSRSK
Sbjct: 1 MGLGGAENGKVVVESLDVCKSKGRKKKKKED--GEVEEEEETGCWFRLRFIGSCISSRSK 58
Query: 60 VDSSVSGTSTHY-ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRK 118
VDSSVSGTST+Y ESKST DTSRDQP V+SSTTTSNAESNSSTSKLEEELKVASRLRK
Sbjct: 59 VDSSVSGTSTNYAESKSTIDTSRDQPTLRVVSSTTTSNAESNSSTSKLEEELKVASRLRK 118
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
F FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG
Sbjct: 119 FAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
HKEWLAEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR
Sbjct: 179 HKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YN+KLSDFGLAKDGPEGDKTHVS
Sbjct: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNSKLSDFGLAKDGPEGDKTHVS 298
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP
Sbjct: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 418
HLGERRRFY+LIDPRLEGHFSIKGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLK
Sbjct: 359 HLGERRRFYKLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPKARPLMSEVVEALKPLPNLK 418
Query: 419 DMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFP 476
DMASSSYYFQTMQA+R SPNTRNG R QG L+RNG QRSLSIP+G++ASPYHHQFP
Sbjct: 419 DMASSSYYFQTMQADRFSVSPNTRNG-RTQGALLTRNGQQQRSLSIPHGTHASPYHHQFP 477
Query: 477 HPSPKPNGK 485
PSPKPNGK
Sbjct: 478 QPSPKPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100247|ref|XP_002311801.1| predicted protein [Populus trichocarpa] gi|222851621|gb|EEE89168.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 838 bits (2165), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/489 (86%), Positives = 442/489 (90%), Gaps = 14/489 (2%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
MG E GKVK +SWD KSK +KKK + + GCWVKLR G CISSRSKV
Sbjct: 1 MGLGSEEGKVK-SSWDVCKSKERKKK----------DGTKAGCWVKLRLVGGCISSRSKV 49
Query: 61 DSSVSGTSTH-YESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKF 119
DSSVSGT ESKS NDTS DQPA V+SS+TTSN ESNSS SKLEEELKVASRLRKF
Sbjct: 50 DSSVSGTICESTESKSINDTSTDQPAVPVVSSSTTSNTESNSSLSKLEEELKVASRLRKF 109
Query: 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH
Sbjct: 110 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 169
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
KEWLAEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM
Sbjct: 170 KEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 229
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD PEGDKTHVST
Sbjct: 230 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEGDKTHVST 289
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARP+
Sbjct: 290 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPY 349
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 419
LGERRRFYRLIDPRL+GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV+ LKPLPNLKD
Sbjct: 350 LGERRRFYRLIDPRLQGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVDTLKPLPNLKD 409
Query: 420 MASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPH 477
MASSSYYFQTMQ +R+GSSPN +NG+R+Q G LSRNG QRS SIP+G +ASP+HHQ+PH
Sbjct: 410 MASSSYYFQTMQGDRVGSSPNAKNGVRSQAGLLSRNGHQQRSFSIPHGPHASPFHHQYPH 469
Query: 478 PSPKPNGKP 486
SPKP+GKP
Sbjct: 470 QSPKPSGKP 478
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100451|ref|XP_002311881.1| predicted protein [Populus trichocarpa] gi|222851701|gb|EEE89248.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2148), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/445 (93%), Positives = 426/445 (95%), Gaps = 3/445 (0%)
Query: 42 GCWVKLRFFGSCISSRSKVDSSVSGTSTH-YESKSTNDTSRDQPAAAVISSTTTSNAESN 100
GCWVKLRF GSCISSRSKVDSSVSGT ESKSTNDTS DQPAA V+S++TTSN ESN
Sbjct: 1 GCWVKLRFIGSCISSRSKVDSSVSGTICESTESKSTNDTSIDQPAALVVSTSTTSNTESN 60
Query: 101 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160
SSTSKLEEELKVASRLRKFTFNDLK ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP
Sbjct: 61 SSTSKLEEELKVASRLRKFTFNDLKFATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 120
Query: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG 220
GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEFMPRG
Sbjct: 121 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRG 180
Query: 221 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280
SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE ERPVIYRDFKTSNILLDADYNAKL
Sbjct: 181 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEETERPVIYRDFKTSNILLDADYNAKL 240
Query: 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 340
SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRS
Sbjct: 241 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRS 300
Query: 341 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 400
MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA
Sbjct: 301 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 360
Query: 401 RPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QR 458
RPLMSEVV ALKPLPNLKDMAS+SYYFQTMQAER+GSSPN RNG+R+Q G LSRNG QR
Sbjct: 361 RPLMSEVVNALKPLPNLKDMASTSYYFQTMQAERVGSSPNARNGVRSQAGLLSRNGHQQR 420
Query: 459 SLSIPNGSYASPYHHQFPHPSPKPN 483
SLSIP+GS+ASPYH+Q+PH SPKPN
Sbjct: 421 SLSIPHGSHASPYHYQYPHKSPKPN 445
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|53689728|gb|AAU89742.1| serine/threonine protein kinase-like [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 830 bits (2144), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/502 (84%), Positives = 444/502 (88%), Gaps = 31/502 (6%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
+G DGE G+ SWD KSK KKKK+ EEETGCW KL F GSCISSRSKV
Sbjct: 115 LGGDGEKGE----SWDVEKSKGKKKKEV--------TEEETGCWTKLWFIGSCISSRSKV 162
Query: 61 DSSVSGTSTHY--------------ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKL 106
DSS+SG STH ESKSTN TSRDQP A +ISSTTTSNAESNSSTSKL
Sbjct: 163 DSSISGISTHCDKSTYVLTSCIALAESKSTN-TSRDQPVAPIISSTTTSNAESNSSTSKL 221
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
EEELKV+SRLRKF FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV
Sbjct: 222 EEELKVSSRLRKFAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 281
Query: 167 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 226
AVKTLNHDGLQ W AEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL
Sbjct: 282 AVKTLNHDGLQVLSIWQAEVNFLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 341
Query: 227 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
FRRS+PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA
Sbjct: 342 FRRSMPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 401
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEM+TGRRSMDKNRP
Sbjct: 402 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMITGRRSMDKNRP 461
Query: 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
NGEHNLVEWARPHLGERRRFYRL+DPRLEGHFSIKGAQKAAQLAA CLSRDPKARP+MS+
Sbjct: 462 NGEHNLVEWARPHLGERRRFYRLVDPRLEGHFSIKGAQKAAQLAARCLSRDPKARPMMSD 521
Query: 407 VVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIP 463
VVEALKPLPNLKDMASSSYYFQTMQA+R+GSSP+T+NG+R Q GS SRNGQ RSLSIP
Sbjct: 522 VVEALKPLPNLKDMASSSYYFQTMQADRVGSSPSTKNGVRTQ-GSFSRNGQQHPRSLSIP 580
Query: 464 NGSYASPYHHQFPHPSPKPNGK 485
NGS+ASPYH QFP SPKPNGK
Sbjct: 581 NGSHASPYHQQFPQNSPKPNGK 602
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 486 | ||||||
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.888 | 0.876 | 0.752 | 1.1e-176 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.897 | 0.889 | 0.727 | 9.1e-171 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.757 | 0.812 | 0.8 | 8.4e-161 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.646 | 0.742 | 0.663 | 2.9e-112 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.600 | 0.712 | 0.720 | 3.6e-112 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.695 | 0.868 | 0.611 | 7.6e-112 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.635 | 0.782 | 0.632 | 3.9e-108 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.751 | 0.856 | 0.577 | 8.1e-108 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.707 | 0.807 | 0.582 | 2.5e-106 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.646 | 0.811 | 0.611 | 1.6e-104 |
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1716 (609.1 bits), Expect = 1.1e-176, P = 1.1e-176
Identities = 341/453 (75%), Positives = 365/453 (80%)
Query: 41 TGCWVKLRFF-G-----XXXXXXXXXXXXXXXXXTHYESKSTNDTSRDQPAAAVIXXXXX 94
+GCWVK RF G T ESKS N+ S DQP V
Sbjct: 46 SGCWVKFRFMIGCIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTT 105
Query: 95 XXXXXXXXXXKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENG 154
+ EEL ++S LRKFTFNDLKL+TRNFRPESLLGEGGFGCVFKGWIEENG
Sbjct: 106 SNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENG 165
Query: 155 TAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214
TAPVKPGTGLTVAVKTLN DGLQGHKEWLAE+NFLG+L+H NLVKL+GYCIEDDQRLLVY
Sbjct: 166 TAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVY 225
Query: 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLDA
Sbjct: 226 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDA 285
Query: 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334
DYNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEM
Sbjct: 286 DYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 345
Query: 335 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 394
LTGRRSMDKNRPNGEHNLVEWARPHL ++RRFYRL+DPRLEGHFSIKGAQK QLAA CL
Sbjct: 346 LTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCL 405
Query: 395 SRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGI-RAQGGSLS 453
SRDPK RP MS+VVEALKPLP+LKDMASSSYYFQTMQAER+ +NG R+QG S
Sbjct: 406 SRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTMQAERL------KNGSGRSQGFG-S 458
Query: 454 RNGQ-----RSLSIPNGSYASPYHHQFPHPSPK 481
RNGQ R+LS P+GS SPY HQ P P PK
Sbjct: 459 RNGQHQPVFRTLSSPHGS--SPYRHQIPSPKPK 489
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1660 (589.4 bits), Expect = 9.1e-171, P = 9.1e-171
Identities = 323/444 (72%), Positives = 354/444 (79%)
Query: 42 GCWVKLRFFGXXXXXXXXXXXXXXXXXTHYESKSTNDTSRDQPAAAVIXXXXXXXXXXXX 101
GCWVK R+ + S+S S DQP V
Sbjct: 47 GCWVKFRYIVCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESSL 106
Query: 102 XXXKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG 161
+ EEL + S L+KF+F DLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPG
Sbjct: 107 STPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG 166
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
TGLTVAVKTLN DGLQGHKEWLAE+N+LG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGS
Sbjct: 167 TGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 226
Query: 222 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
LENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLD +YNAKLS
Sbjct: 227 LENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLS 286
Query: 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 341
DFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSM
Sbjct: 287 DFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 346
Query: 342 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
DKNRPNGEHNLVEWARPHL ++RRFYRL+DPRLEGHFS+KGAQK QLAA CLSRD K R
Sbjct: 347 DKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIR 406
Query: 402 PLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ---R 458
P MSEVVE LKPLP+LKDMAS+SYYFQTMQAER+ + + +G R G SRNGQ R
Sbjct: 407 PKMSEVVEVLKPLPHLKDMASASYYFQTMQAERLKAGSGSGSG-RGFG---SRNGQPVFR 462
Query: 459 SLSIPNGSY-ASPYHHQFPHPSPK 481
+LS P+G +SPY HQ P P PK
Sbjct: 463 TLSSPHGQAGSSPYRHQIPSPKPK 486
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1566 (556.3 bits), Expect = 8.4e-161, P = 8.4e-161
Identities = 304/380 (80%), Positives = 335/380 (88%)
Query: 109 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
ELK +S+LR F FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV
Sbjct: 81 ELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 140
Query: 169 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
KTLN DGLQGHKEWLAE+NFLG+LVH +LVKL+GYC+E+DQRLLVYEFMPRGSLENHLFR
Sbjct: 141 KTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFR 200
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
R+LPLPWS+RMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLD +YNAKLSDFGLAKD
Sbjct: 201 RTLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 260
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348
P+ K+HVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLE+LTGRRS+DK+RPNG
Sbjct: 261 APDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNG 320
Query: 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
E NLVEW RPHL +++RFYRL+DPRLEGH+SIKGAQKA Q+AA CL+RD KARP MSEVV
Sbjct: 321 EQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVV 380
Query: 409 EALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGS-LSRNG--QRSLSIPNG 465
EALKPLPNLKD ASSS FQTMQ P +NG+R QGG +SRNG RSLS N
Sbjct: 381 EALKPLPNLKDFASSSSSFQTMQ-------PVAKNGVRTQGGGFVSRNGPPMRSLSSLNL 433
Query: 466 SYASPYHHQFPHPSPKPNGK 485
ASPY ++ SPKP GK
Sbjct: 434 PQASPY--RYARQSPKPKGK 451
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
Identities = 211/318 (66%), Positives = 255/318 (80%)
Query: 105 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
+ E E+ + L+ FTF +LK ATRNFRP+S+LGEGGFG VFKGWI+E KPGTG+
Sbjct: 54 RTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGV 113
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 224
+AVK LN DG QGH+EWLAEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLEN
Sbjct: 114 VIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLEN 173
Query: 225 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
HLFRR PL W++R+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLS
Sbjct: 174 HLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLS 232
Query: 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 341
DFGLAKDGP GDK+HVSTR+MGTYGYAAPEY+ TGHLT++SDVYS+GVVLLE+L+GRR++
Sbjct: 233 DFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAV 292
Query: 342 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
DKNRP GE LVEWARP L +R+ +R+ID RL+ +S++ A K A LA CL+ + K R
Sbjct: 293 DKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLR 352
Query: 402 PLMSEVVEALKPLPNLKD 419
P M+EVV L+ + L +
Sbjct: 353 PNMNEVVSHLEHIQTLNE 370
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
Identities = 214/297 (72%), Positives = 250/297 (84%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
FT +L+ T++FRP+ +LGEGGFG V+KG+I++N +K L VAVK LN +GLQG
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK---SLPVAVKVLNKEGLQG 113
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSI 237
H+EWL EVNFLG L H NLVKLIGYC EDD RLLVYEFM RGSLENHLFR++ PL WS
Sbjct: 114 HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSR 173
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
RM IALGAAKGLAFLH AERPVIYRDFKTSNILLD+DY AKLSDFGLAK GP+GD+THV
Sbjct: 174 RMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 232
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357
STRVMGTYGYAAPEYVMTGHLT+RSDVYSFGVVLLEMLTGR+S+DK RP+ E NLV+WAR
Sbjct: 233 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWAR 292
Query: 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
P L ++R+ ++IDPRLE +S++ AQKA LA +CLS++PKARPLMS+VVE L+PL
Sbjct: 293 PKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1104 (393.7 bits), Expect = 7.6e-112, P = 7.6e-112
Identities = 209/342 (61%), Positives = 265/342 (77%)
Query: 105 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
+ E E+ + L+ F+ ++LK ATRNFRP+S++GEGGFGCVFKGWI+E+ AP KPGTG+
Sbjct: 42 RTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGI 101
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 224
+AVK LN +G QGH+EWLAE+N+LG L H NLVKLIGYC+E++ RLLVYEFM RGSLEN
Sbjct: 102 VIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLEN 161
Query: 225 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
HLFRR PL W+ R+++ALGAA+GLAFLH A+ VIYRDFK SNILLD++YNAKLS
Sbjct: 162 HLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLS 220
Query: 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 341
DFGLA+DGP GD +HVSTRVMGT GYAAPEY+ TGHL+ +SDVYSFGVVLLE+L+GRR++
Sbjct: 221 DFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAI 280
Query: 342 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
DKN+P GEHNLV+WARP+L +RR R++DPRL+G +S+ A K A LA C+S D K+R
Sbjct: 281 DKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSR 340
Query: 402 PLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRN 443
P M+E+V+ ++ L K+ + Q I SP N
Sbjct: 341 PTMNEIVKTMEELHIQKEASKEQQNPQISIDNIINKSPQAVN 382
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1069 (381.4 bits), Expect = 3.9e-108, P = 3.9e-108
Identities = 198/313 (63%), Positives = 250/313 (79%)
Query: 105 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
K E E+ ++ ++ FTFN+LKLATRNFRP+S++GEGGFGCVFKGW++E+ P KPGTGL
Sbjct: 41 KTEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGL 100
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 224
+AVK LN +G QGH+EWL E+N+LG L H NLVKLIGYC+ED+ RLLVYEFM +GSLEN
Sbjct: 101 VIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLEN 160
Query: 225 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
HLFRR PLPW +R+ +AL AAKGLAFLH + + VIYRD K SNILLDADYNAKLS
Sbjct: 161 HLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLS 219
Query: 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 341
DFGLA+DGP GD ++VSTRVMGTYGYAAPEY+ +GHL +RSDVYSFGV+LLE+L+G+R++
Sbjct: 220 DFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRAL 279
Query: 342 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
D NRP E NLV+WARP+L +R+ ++D RL+ + + A + A +A CLS +PK+R
Sbjct: 280 DHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSR 339
Query: 402 PLMSEVVEALKPL 414
P M +VV AL+ L
Sbjct: 340 PTMDQVVRALQQL 352
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
Identities = 216/374 (57%), Positives = 267/374 (71%)
Query: 105 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 164
+ E E+ + L+ FTFN+LK ATRNFRP+SLLGEGGFG VFKGWI+ KPG+G+
Sbjct: 57 RTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGI 116
Query: 165 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 224
VAVK L +G QGHKEWL EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSLEN
Sbjct: 117 VVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLEN 176
Query: 225 HLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283
HLFRR PL W+IRMK+A+GAAKGL FLH+ A+ VIYRDFK +NILLDA++N+KLSDF
Sbjct: 177 HLFRRGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDF 235
Query: 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 343
GLAK GP GDKTHVST+VMGT+GYAAPEYV TG LT++SDVYSFGVVLLE+L+GRR++DK
Sbjct: 236 GLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDK 295
Query: 344 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 403
++ E +LV+WA P+LG++R+ +R++D RL G + KGA AA LA CL+ D K RP
Sbjct: 296 SKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPK 355
Query: 404 MSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSL-SI 462
MSEV+ L L + K QA+ SP NG Q + R L I
Sbjct: 356 MSEVLAKLDQLESTKPGTGVG----NRQAQI--DSPRGSNGSIVQKSPRRYSYDRPLLHI 409
Query: 463 PNGSYASPYHHQFP 476
G+ P H+ P
Sbjct: 410 TPGASPLPTHNHSP 423
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1052 (375.4 bits), Expect = 2.5e-106, P = 2.5e-106
Identities = 202/347 (58%), Positives = 256/347 (73%)
Query: 73 SKSTNDTSRDQ-PAAAVIXXXXXXXXXXXXXXXKLEEELKVASRLRKFTFNDLKLATRNF 131
SK ++ TSR P+ + E E+ + L+ FTFN+LK AT+NF
Sbjct: 27 SKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTEGEILSSPNLKAFTFNELKNATKNF 86
Query: 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 191
R ++LLGEGGFGCVFKGWI++ +PG+G+ VAVK L +G QGHKEWL EVN+LG
Sbjct: 87 RQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQGHKEWLTEVNYLGQ 146
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLA 250
L H NLV L+GYC E + RLLVYEFMP+GSLENHLFRR PL W+IRMK+A+GAAKGL
Sbjct: 147 LSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAVGAAKGLT 206
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
FLHE A+ VIYRDFK +NILLDAD+NAKLSDFGLAK GP GD THVST+V+GT+GYAAP
Sbjct: 207 FLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGTHGYAAP 265
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370
EYV TG LT++SDVYSFGVVLLE+++GRR+MD + E++LV+WA P+LG++R+ +R++
Sbjct: 266 EYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPYLGDKRKLFRIM 325
Query: 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 417
D +L G + KGA AA LA CL+ D K RP MSEV+ L+ L ++
Sbjct: 326 DTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESV 372
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 1.6e-104, P = 1.6e-104
Identities = 195/319 (61%), Positives = 249/319 (78%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
E EL + L+ FTFN+LK ATRNF+P S++GEGGFGCV+KGWI E +P KPG+G+ V
Sbjct: 60 EGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVV 119
Query: 167 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 226
AVK L +G QGHKEWL EV++LG L H+NLVKLIGYC+E ++RLLVYE+MP+GSLENHL
Sbjct: 120 AVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHL 179
Query: 227 FRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
FRR P+PW RMK+A AA+GL+FLHE VIYRDFK SNILLD D+NAKLSDFGL
Sbjct: 180 FRRGAEPIPWKTRMKVAFSAARGLSFLHEAK---VIYRDFKASNILLDVDFNAKLSDFGL 236
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
AK GP GD+THV+T+V+GT GYAAPEY+ TG LTS+SDVYSFGVVLLE+L+GR ++DK++
Sbjct: 237 AKAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSK 296
Query: 346 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405
E NLV+WA P+L +RR+ +R++D +L G + KGA AA +A CL+ +PK RP M+
Sbjct: 297 VGVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMA 356
Query: 406 EVVEALKPLP-NLKDMASS 423
+V+ L+ L + K M S+
Sbjct: 357 DVLSTLQQLETSSKKMGST 375
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LFP7 | Y5158_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.75 | 0.9670 | 0.9533 | yes | no |
| Q9SRH7 | Y3130_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7594 | 0.9074 | 0.9 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00028989001 | SubName- Full=Chromosome chr1 scaffold_46, whole genome shotgun sequence; (481 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 486 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-11 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 1e-53
Identities = 77/278 (27%), Positives = 116/278 (41%), Gaps = 66/278 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 195
LGEGGFG V+ ++ G VA+K + + E L E+ L L H
Sbjct: 1 LGEGGFGTVYLARDKKTGK---------KVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+VKL G +++ LV E+ GSL++ L L ++I L +GL +LH
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-- 109
Query: 256 AERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+I+RD K NILLD+D KL+DFGL+K ++GT Y APE ++
Sbjct: 110 -SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLL 166
Query: 315 -TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
G+ + +SD++S GV+L E+
Sbjct: 167 GKGYYSEKSDIWSLGVILYEL--------------------------------------- 187
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
+ L L +DP+ RP E++E L
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 8e-53
Identities = 89/281 (31%), Positives = 128/281 (45%), Gaps = 30/281 (10%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
LGEG FG V+KG ++ + VAVKTL D Q +E+L E + L
Sbjct: 4 GKKLGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+VKL+G C E++ +V E+M G L ++L + L S + AL A+G+ +L
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
+ I+RD N L+ + K+SDFGL++D + D + APE
Sbjct: 119 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPES 174
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL--GERRRFYRLI 370
+ G TS+SDV+SFGV+L E+ T P + E +L G R
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYLKNGYRLPQPPNC 228
Query: 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
P L L C + DP+ RP SE+VE L
Sbjct: 229 PPEL------------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 3e-52
Identities = 90/284 (31%), Positives = 128/284 (45%), Gaps = 33/284 (11%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 188
+ LG G FG V+K GTG VAVK L + + E+
Sbjct: 1 YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
L L H N+V+LI + D LV E+ G L R PL KIAL +G
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRG 110
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L +LH +I+RD K NILLD + K++DFGLAK + ++T V GT Y
Sbjct: 111 LEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYM 165
Query: 309 APEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE ++ G + DV+S GV+L E+LTG+ L + +
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIR 212
Query: 368 RLIDPRLEGHF--SIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R++ P LE G+++A L CL++DP RP E+++
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 3e-52
Identities = 93/282 (32%), Positives = 133/282 (47%), Gaps = 31/282 (10%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
LGEG FG V+KG ++ G + VAVKTL D Q +E+L E + L
Sbjct: 4 GKKLGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 251
H N+VKL+G C E++ ++V E+MP G L ++L R L S + AL A+G+ +
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
L + I+RD N L+ + K+SDFGL++D + D V + APE
Sbjct: 119 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPE 174
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL--GERRRFYRL 369
+ G TS+SDV+SFGV+L E+ T P + E +L G R
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYLKKGYRLPKPPN 228
Query: 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
P L +L C + DP+ RP SE+VE L
Sbjct: 229 CPPEL------------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 7e-51
Identities = 91/282 (32%), Positives = 134/282 (47%), Gaps = 37/282 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG FG V+KG ++ GT VAVKTL + +E+L E + + L H
Sbjct: 7 LGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V+L+G C + + +V E+MP G L + L + L +++AL AKG+ +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------RVMGTYGYAA 309
+ ++RD N L+ + K+SDFGL++D E D + M A
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------A 172
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
PE + G TS+SDV+SFGV+L E+ T P + E L + YRL
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLEDG---YRL 223
Query: 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
PR E + +L C + DP+ RP SE+VE L
Sbjct: 224 --PRPEN-----CPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-49
Identities = 94/295 (31%), Positives = 133/295 (45%), Gaps = 54/295 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHL 195
LGEG FG V+KG K G VAVKTL D + K++L E + L H
Sbjct: 3 LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------LPWSIRMKIALGAAK 247
N+V+L+G C E++ LV E+M G L ++L + L + A+ AK
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------RV 301
G+ +L + ++RD N L+ D K+SDFGL++D + D T R
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE---HNL-VEWAR 357
M APE + G TS+SDV+SFGV+L E+ T G L E
Sbjct: 174 M------APESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVL 217
Query: 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+L R+ YRL P + + +L C DP+ RP SE+VE L+
Sbjct: 218 EYL---RKGYRLPKPE---YCP----DELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 3e-47
Identities = 84/282 (29%), Positives = 124/282 (43%), Gaps = 35/282 (12%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 189
+ LGEG FG V+ TG VA+K + ++ +E L E+ L
Sbjct: 1 YEILEKLGEGSFGKVYLA---------RDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKG 248
L H N+V+L ++D+ LV E+ G L + L R L R
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSA 109
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L +LH + +++RD K NILLD D + KL+DFGLA+ G+K T V GT Y
Sbjct: 110 LEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYM 163
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFY 367
APE ++ D++S GV+L E+LTG+ P G+ L+E + + F
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGKPKPPF- 216
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
P E S +A L L +DP+ R E ++
Sbjct: 217 ----PPPEWDIS----PEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F +G+GGFG V+K K TG VA+K + + + ++ + E+ L
Sbjct: 2 FEILEKIGKGGFGEVYKAR--------HKR-TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
H N+VK G ++ D+ +V EF GSL++ L + L S + KGL
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH +I+RD K +NILL +D KL DFGL+ + + ++GT + AP
Sbjct: 113 YLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAP 166
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
E + ++D++S G+ +E+ G+
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 81/272 (29%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLV 193
LLG G FG V+ ++++ TG +AVK+ L+ D + + E+ L L
Sbjct: 7 LLGRGSFGSVYLA-LDKD--------TGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 194 HLNLVKLIGYCIEDDQR-LLVY-EFMPRGSLENHLFRRSLPLPWS-IRMKIALGAAKGLA 250
H N+V+ G ++++ L ++ E++ GSL + L ++ LP IR K +GLA
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIR-KYTRQILEGLA 115
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH +++RD K +NIL+D+D KL+DFG AK + + + V GT + AP
Sbjct: 116 YLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370
E + +D++S G ++EM TG+ P E A +G
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAALYKIG-----SSGE 221
Query: 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
P + H S ++A CL RDPK RP
Sbjct: 222 PPEIPEHLS----EEAKDFLRKCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-34
Identities = 72/205 (35%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHL 195
LGEG FG V + G TG VAVK+LNH G + H ++ E+ L L H
Sbjct: 12 LGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 196 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
N+VK G C + R L+ E++P GSL ++L R + + + KG+ +L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST--RVMGTYGYAAPE 311
+ I+RD NIL++++ K+SDFGLAK PE + + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLT 336
+ T +S SDV+SFGV L E+ T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 74/207 (35%), Positives = 108/207 (52%), Gaps = 21/207 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLV 193
L+G G FG V+KG E TG VA+K L + K + E++ L +L
Sbjct: 7 LIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+VK IG IE L ++ E+ GSL + ++ P P S+ +GLA+L
Sbjct: 58 HPNIVKYIG-SIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
HE+ VI+RD K +NIL D KL+DFG+A + K V+GT + APE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEV 170
Query: 313 V-MTGHLTSRSDVYSFGVVLLEMLTGR 338
+ M+G T+ SD++S G ++E+LTG
Sbjct: 171 IEMSGASTA-SDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 3e-30
Identities = 99/377 (26%), Positives = 146/377 (38%), Gaps = 44/377 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 186
++R LGEG FG V+ + VA+K L KE L E+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48
Query: 187 NFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIAL 243
L L H N+VKL + ++ LV E++ GSLE+ L R PL S + I
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAK----DGPEGDKTHVS 298
L +LH + +I+RD K NILLD D KL DFGLAK G +
Sbjct: 109 QILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 299 TRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355
+ +GT GY APE ++ + +S SD++S G+ L E+LTG + + + +
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-L 224
Query: 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-ALKPL 414
+ P S + A+ L L++DPK R S + L
Sbjct: 225 KIILELPTPSLASPLSPSNPELIS----KAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280
Query: 415 PNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQ---------GGSLSRNGQRSLSIPNG 465
LK+ S A S P + + + L + PNG
Sbjct: 281 LKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNG 340
Query: 466 SYASPYHHQFPHPSPKP 482
+SP++ S
Sbjct: 341 VSSSPHNSSSLLLSTAS 357
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 77/278 (27%), Positives = 123/278 (44%), Gaps = 30/278 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+G+G FG V+KG ++ VAVKT K +L E L H
Sbjct: 2 KIGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VKLIG C++ +V E +P GSL L ++ L ++++L AA G+ +L
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE- 110
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ I+RD N L+ + K+SDFG++++ G T + APE +
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374
G TS SDV+S+G++L E + + N + R + YR+ P+L
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERI---ESGYRMPAPQL 219
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ +L C + DP+ RP SE+ L+
Sbjct: 220 CPE-------EIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 84/293 (28%), Positives = 132/293 (45%), Gaps = 45/293 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LG+G FG V++G VK VA+KT+N + + E+L E + + +
Sbjct: 14 LGQGSFGMVYEG----LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--------FRRSLPLPWSIRM-KIALGAA 246
++V+L+G L+V E M +G L+++L L P + ++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
G+A+L A + ++RD N ++ D K+ DFG+ +D E D + +
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----E 362
+ APE + G T++SDV+SFGVVL EM T L E +P+ G E
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAE--QPYQGLSNEE 229
Query: 363 RRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413
+F +ID GH K +L C +PK RP E+V +LK
Sbjct: 230 VLKF--VID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 91/298 (30%), Positives = 135/298 (45%), Gaps = 28/298 (9%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVN 187
R + +LGEG FG V + P GTG VAVKTL + Q + W E+N
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H N+VK G C E + L+ E++P GSL ++L + L L + + A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQI 116
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGT 304
+G+A+LH + I+RD N+LLD D K+ DFGLAK PEG + + V
Sbjct: 117 CEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ A E + + SDV+SFGV L E+LT ++ P ++ + + R
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVR 232
Query: 365 ------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416
R RL P+ Q+ L +C + K RP ++ LK + +
Sbjct: 233 LIELLERGMRLPCPK-------NCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 28/209 (13%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
+ +G+G FG V G G VAVK L D +LAE + + L H
Sbjct: 12 ATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLH 253
NLV+L+G ++ + +V E+M +GSL ++L R + + ++ AL +G+ +L
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD---GPEGDKTHVSTRVMGTYGYAAP 310
E+ ++RD N+L+ D AK+SDFGLAK+ G + K V + AP
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAP 168
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLT-GR 338
E + +++SDV+SFG++L E+ + GR
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 75/210 (35%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDL 192
LG+G FG V V K TG A+K L + KE L E N L +
Sbjct: 1 LGKGSFGKVLL----------VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI 50
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR-SLPLPWSIRM--KIALGAAKG 248
H +VKL Y + +++L LV E+ P G L +HL + + +I L
Sbjct: 51 NHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA---- 105
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L +LH +IYRD K NILLDAD + KL+DFGLAK+ + +T GT Y
Sbjct: 106 LEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYL 160
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
APE ++ D +S GV+L EMLTG+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 70/215 (32%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGL-QGHKEWLAEVNFLGDLVH 194
LGEG FG VF G ++P VAVKTL K++ E L + H
Sbjct: 13 LGEGAFGKVFLGECYH-----LEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSL-------PLPWSIRMKI 241
N+VK G C E D ++V+E+M G L L L S ++I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A+ A G+ +L A + ++RD T N L+ D K+ DFG+++D D V
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
M + PE +M T+ SDV+SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 136 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLV 193
LG+G FG V +G W G + VAVK L D L ++L E + L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKV-------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFL 252
H NL++L G + ++V E P GSL + L + +L S A+ A G+ +L
Sbjct: 55 HENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST---RVMGTYGYAA 309
+ I+RD NILL +D K+ DFGL + P+ + +V +V + + A
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCA 168
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT 336
PE + T + SDV+ FGV L EM T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLVH 194
LGEG FG V+KG E G T +VA+KTL N + + +E+ E + DL H
Sbjct: 13 LGEGAFGKVYKG--ELTGPNERLSAT--SVAIKTLKENAEP-KVQQEFRQEAELMSDLQH 67
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRM 239
N+V L+G C ++ +++E++ G L L R S L S +
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
IA+ A G+ +L + ++RD N L+ K+SDFGL++D D V +
Sbjct: 128 HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334
+ + + PE ++ G T+ SD++SFGVVL E+
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 65/227 (28%), Positives = 114/227 (50%), Gaps = 25/227 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 194
LG G FG V+KG WI E VK + VA+K L + + +KE L E + + H
Sbjct: 15 LGSGAFGTVYKGVWIPEG--EKVK----IPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 248
++V+L+G C+ Q L+ + MP G L +++ L W +++ AKG
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
+++L E + +++RD N+L+ + K++DFGLAK +K + + +
Sbjct: 122 MSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 354
A E ++ T +SDV+S+GV + E++T G + + +L+E
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 33/276 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V+ G W+E+ VA+KT+ +G ++++ E + L H
Sbjct: 12 IGSGQFGLVWLGYWLEKR-----------KVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L G C E LV+EFM G L ++L + + + L +G+A+L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD N L+ + K+SDFG+ + + D+ ST +++PE
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSF 175
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
+S+SDV+SFGV++ E+ + ++ +NR N E +VE +RL PRL
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE-------TINAGFRLYKPRL- 225
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
+Q +L HC P+ RP S ++ L
Sbjct: 226 ------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 35/275 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLVH 194
+LG+G +G V+ G + VK V + T N + E L EV+ L L H
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVK-----QVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+N+V+ +G C++D+ + EF+P GS+ + L R PLP + K G+A+LH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDKTHVSTRVMGTYGYAAP 310
V++RD K +N++L + KL DFG A+ G G +++ + GT + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRFY 367
E + +SD++S G + EM TG+ SMD+ A ++G R
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----------AMFYIGAHRGLM 227
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
PRL FS A CL+RD RP
Sbjct: 228 ----PRLPDSFS----AAAIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 42/273 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
+G+G FG VFK V+ A+K ++ + +E + E L L
Sbjct: 8 IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLP----WSIRMKIALGAAKGL 249
+++ ++ + +V E+ G L L +R PLP W ++I LG L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
A LH + +++RD K+ N+ LDA N K+ D G+AK D T+ + ++GT Y +
Sbjct: 115 AHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLS 169
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
PE +SDV++ GVVL E TG+ D N + L+ + R
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI----------LKIIRG 216
Query: 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
+ P + +S Q+ AQL CL++D + RP
Sbjct: 217 VFPPVSQMYS----QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 131 FRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
F E LG G FG V++G W + VA+K L D L +++ EV L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWK-----------NRVRVAIKILKSDDLLKQQDFQKEVQAL 56
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGA 245
L H +L+ L C + ++ E M +GSL R + LP+ I M A
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL-AFLRSPEGQVLPVASLIDM--ACQV 113
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
A+G+A+L E + I+RD NIL+ D K++DFGLA+ E ++ Y
Sbjct: 114 AEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PY 168
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE G +++SDV+SFG++L EM T
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 90/278 (32%), Positives = 126/278 (45%), Gaps = 54/278 (19%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V+ G W NGT V AVKTL G + +L E + L H
Sbjct: 14 LGAGQFGEVWMGTW---NGTTKV--------AVKTLK-PGTMSPEAFLQEAQIMKKLRHD 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LV+L C E++ +V E+M +GSL + L + L LP + M A A+G+A+L
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYL 119
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTY 305
R I+RD NIL+ + K++DFGLA+ EG K +
Sbjct: 120 ES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK------- 169
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERR 364
+ APE G T +SDV+SFG++L E++T R P G N R L +
Sbjct: 170 -WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTN-----REVLEQVE 218
Query: 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
R YR+ PR ++ L C +DP+ RP
Sbjct: 219 RGYRM--PRPPNC-----PEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 84/285 (29%), Positives = 128/285 (44%), Gaps = 48/285 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGT-APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
LLG G FG V++G ++G VK V++ G + K+ E+ L L H
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS-IRM---KIALGAAKGLA 250
N+V+ +G E+D + E +P GSL L ++ P IR+ +I LG L
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLG----LE 116
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-----GTY 305
+LH+ R ++RD K +NIL+D + KL+DFG+AK V G+
Sbjct: 117 YLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSP 165
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ APE + G +D++S G +LEM TG+ P + V A +G +
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVA-AVFKIGRSK 218
Query: 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
P + H S +A CL RDP RP +E++E
Sbjct: 219 EL-----PPIPDHLS----DEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 29/229 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 188
N +G+G FG VF+ G P +P T VAVK L + ++ E
Sbjct: 6 NIEYVRDIGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAAL 61
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------ 230
+ + H N+VKL+G C L++E+M G L L RS
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 231 ---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
LPL + ++ IA A G+A+L +ER ++RD T N L+ + K++DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ D S + PE + T+ SDV+++GVVL E+ +
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 91/305 (29%), Positives = 141/305 (46%), Gaps = 45/305 (14%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDG 175
+ T ND+ + + E+++ G G +KG +NG V VK +N +
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFV---------VKEINDVNS 728
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
+ +E+ +G L H N+VKLIG C + L++E++ +L L L W
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSW 779
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
R KIA+G AK L FLH V+ + I++D L L+ G
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGL----L 832
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVE 354
T+ + Y APE T +T +SD+Y FG++L+E+LTG+ D G H ++VE
Sbjct: 833 CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE--FGVHGSIVE 890
Query: 355 WAR-----PHLGERRRFYRLIDPRLEGHFSIKGAQ--KAAQLAAHCLSRDPKARPLMSEV 407
WAR HL IDP + G S+ + + LA HC + DP ARP ++V
Sbjct: 891 WARYCYSDCHLD------MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944
Query: 408 VEALK 412
++ L+
Sbjct: 945 LKTLE 949
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 34/283 (12%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGD 191
E ++G G FG V +G ++ G + VA+KTL G + L E + +G
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEI------DVAIKTL-KAGSSDKQRLDFLTEASIMGQ 61
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+++L G + +++ E+M GSL+ L + + G A G+ +
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAA 309
L +E ++RD NIL++++ K+SDFGL++ + E T ++ + A
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTA 176
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-LGERRRFYR 368
PE + TS SDV+SFG+V+ E+++ GE + + + YR
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS----------YGERPYWDMSNQDVIKAVEDGYR 226
Query: 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
L P QL C +D RP S++V L
Sbjct: 227 LPPPM-------DCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 73/206 (35%), Positives = 106/206 (51%), Gaps = 21/206 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V KG K G + VAVKTL G KE+L E + + L H
Sbjct: 3 LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+V+LIG C + +LV E P G L +L +R +P S ++A A G+A+L E
Sbjct: 57 CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAMGMAYL--E 112
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG-----YAAP 310
++ V +RD N+LL + AK+SDFG+++ G + +T T G + AP
Sbjct: 113 SKHFV-HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAP 167
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + G +S+SDV+S+GV L E +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG G G V K +P TG +AVKT+ + K+ L E++ L
Sbjct: 9 LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+V G + + E+M GSL+ L +P I KIA+ KGL +LHE+
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM--------GTYGY 307
+I+RD K SNIL+++ KL DFG VS +++ GT Y
Sbjct: 120 --HKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
APE + + +SD++S G+ L+E+ TGR
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 74/280 (26%), Positives = 121/280 (43%), Gaps = 50/280 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV 193
+LG+G G V+K TG A+K ++ DG + K+ L E+ L
Sbjct: 7 KVLGQGSSGVVYKV---------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
+VK G ++ + +V E+M GSL + L ++ +P + IA KGL +LH
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAP 310
+R +I+RD K SN+L+++ K++DFG++K + + T V GT Y +P
Sbjct: 117 --TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSP 169
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370
E + + +D++S G+ LLE G+ F+ L+
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----------------FFELM 212
Query: 371 D-------PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARP 402
P L FS + + CL +DPK RP
Sbjct: 213 QAICDGPPPSLPAEEFS----PEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V G W + + VA+K + +G +++ E + L H
Sbjct: 12 LGSGQFGVVHLGKWRGK-----------IDVAIKMI-REGAMSEDDFIEEAKVMMKLSHP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
NLV+L G C + +V E+M G L N+L R L + + + + +L
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEY 312
I+RD N L+ D K+SDFGLA+ D D+ S +A PE
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKFPVKWAPPEV 172
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 372
+S+SDV+SFGV++ E+ + + + N E +VE G YRL P
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--SVSAG-----YRLYRP 223
Query: 373 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
+L + + C P+ RP +++ L
Sbjct: 224 KL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 80/295 (27%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 193
+LGEG FG V +G + ++ + +K VAVKT+ D +E+L+E + D
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 194 HLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIA 242
H N++KLIG C E +++ FM G L + L L LP +K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTHVST 299
+ A G+ +L + R I+RD N +L D ++DFGL+K GD + ++
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
+ + A E + TS+SDV++FGV + E+ T R H + ++
Sbjct: 177 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYL--- 228
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
R RL P + L C DPK RP +++ E L+ +
Sbjct: 229 ----RHGNRLKQPE-------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (250), Expect = 7e-24
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 64/297 (21%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 187
+ +G+G FG V+ + +G +K L++ + ++ L EV
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGK---------LYVLKEIDLSNMSEKEREDALNEVK 51
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSL---PLP----WSIRM 239
L L H N++K E+ +L V E+ G L + ++ P P +
Sbjct: 52 ILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
++ L L +LH R +++RD K NI L ++ KL DFG++K T
Sbjct: 111 QLCLA----LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKT 162
Query: 300 RVMGTYGYAAPE------YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
V GT Y +PE Y +SD++S G VL E+ T + + L
Sbjct: 163 VV-GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGENLLE---L- 211
Query: 354 EWARPHLGERRRFYRLID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
+++ P + +S + L + L +DP+ RP ++++
Sbjct: 212 ------------ALKILKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 71/216 (32%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E +P K + VAVK L L K++ E L +L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP----------------LPWSIRMK 240
+VK G C + D ++V+E+M G L N R P L S +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
IA A G+ +L A + ++RD T N L+ A+ K+ DFG+++D D V
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
M + PE +M T+ SDV+SFGV+L E+ T
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 73/217 (33%), Positives = 110/217 (50%), Gaps = 26/217 (11%)
Query: 136 LLGEGGFGCVFKGW---IEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGD 191
LG G FG V++G I G+ P++ VAVKTL Q KE+L E + + +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIR------VAVKTLRKGATDQEKKEFLKEAHLMSN 55
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-------FRRSLPLPWSIRMKIALG 244
H N+VKL+G C+ ++ + ++ E M G L ++L F L L + I L
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLD 114
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDGPEGDKTHVST 299
AKG +L + I+RD N L+ DAD K+ DFGLA+D + D
Sbjct: 115 VAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ + APE ++ G T++SDV+SFGV++ E+LT
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 84/300 (28%), Positives = 135/300 (45%), Gaps = 43/300 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 188
LGEG FG V + P V+ G L VAVK L D + + ++L EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------PL 233
L L N+++L+G C+++D ++ E+M G L L L L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 234 P---WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
P +S + +AL A G+ +L + ++RD T N L+ + K++DFG++++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE- 349
GD + R + + A E ++ G T+ SDV++FGV L E+L + K +P GE
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQPYGEL 245
Query: 350 --HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
++E A ++ R L P Q +L C SRD + RP S++
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPP-------CPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 7e-23
Identities = 72/213 (33%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R+ + LG+G FG V E P++ TG VAVK L H + +++ E+
Sbjct: 4 RHLKFIQQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58
Query: 189 LGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L L H N+VK G C +R LV E++P GSL ++L + L + A
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG--- 303
KG+ +L + ++RD T NIL++++ K+ DFGL K P+ DK + R G
Sbjct: 119 KGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESP 174
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ Y APE + + SDV+SFGVVL E+ T
Sbjct: 175 IFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 9e-23
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWL 183
L R LLG G FG V KG WI E + + VA+KT+ + G Q +E
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIP------VAIKTIQDRSGRQTFQEIT 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
+ +G L H +V+L+G C LV + P GSL +H+ + L + +
Sbjct: 58 DHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
AKG+ +L E +++R+ NILL +D +++DFG+A DK + +
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E ++ G T +SDV+S+GV + EM++
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 74/224 (33%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHL 195
LG G FG V++G V+ L VAVKTL Q ++L E + H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVE----LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIRMK----IALGAAKG 248
N+V+LIG E R ++ E M G L++ L R + P P S+ MK A AKG
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 249 LAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+L E I+RD N LL AK++DFG+A+D R M
Sbjct: 129 CKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 349
+ PE + G TS++DV+SFGV+L E+ + R N E
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 72/214 (33%), Positives = 106/214 (49%), Gaps = 37/214 (17%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V++G W N T PV AVKTL + K++LAE + L H
Sbjct: 14 LGAGQFGEVWEGLW---NNTTPV--------AVKTLKPGTMDP-KDFLAEAQIMKKLRHP 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
L++L C ++ +V E M GSL +L R+L LP I M A A G+A+L
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYL 119
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTY 305
+ I+RD N+L+ + K++DFGLA+ + EG K +
Sbjct: 120 EA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK------- 169
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 338
+ APE + + +SDV+SFG++L E++T GR
Sbjct: 170 -WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 66/207 (31%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV 193
LG+GGFG V A TG A K L+ L +G + L E L + V
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKV 50
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAF 251
+ + Y E L LV M G L+ H++ P P + + A GL
Sbjct: 51 SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
LH+ R ++YRD K N+LLD N ++SD GLA + G K GT GY APE
Sbjct: 111 LHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPE 164
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLTGR 338
+ D ++ G L EM+ GR
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 137 LGEGGFG----CVFKGWIEENG-TAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLG 190
LGEG FG C +G E G AP G + VAVK L D + ++L E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI--------- 241
L + N+++L+G C+ DD ++ E+M G L L +R + ++ I
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 242 --ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+ A G+ +L A ++RD T N L+ Y K++DFG++++ GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
R + + A E ++ G T+ SDV++FGV L EM T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 19/208 (9%)
Query: 136 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGDLV 193
++G+G FGCV+ G I+ +G + AVK+LN L+ +++L E + D
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQK-------IHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 194 HLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLA 250
H N++ L+G C+ + L+V +M G L N F RS +++ I G AKG+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYA 308
+L A + ++RD N +LD + K++DFGLA+D E H T +
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLT 336
A E + T T++SDV+SFGV+L E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN----HDGLQGHKEWLAEVNFLGDL 192
+GEG G VFK E TG TVA+K + G+ + L E+ L
Sbjct: 8 IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIP--NQALREIKALQAC 56
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H +VKL+ +LV E+MP L L PLP + KG+A++
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
H +++RD K +N+L+ AD K++DFGLA+ E + S +V T Y APE
Sbjct: 116 HANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE- 170
Query: 313 VMTG--HLTSRSDVYSFGVVLLEMLTGR 338
++ G D+++ G + E+L G
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 5e-22
Identities = 61/233 (26%), Positives = 94/233 (40%), Gaps = 39/233 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 186
+F+ ++GEG F V + T A+K L+ L + K E
Sbjct: 2 DFKFGKIIGEGSFSTVVLAK---------EKETNKEYAIKILDKRQLIKEKKVKYVKIEK 52
Query: 187 NFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIAL 243
L L H ++KL Y +D++ L V E+ P G L ++ SL R A
Sbjct: 53 EVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAE 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM- 302
L +LH + +I+RD K NILLD D + K++DFG AK +
Sbjct: 111 -ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 303 -----------------GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
GT Y +PE + SD+++ G ++ +MLTG+
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 5e-22
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 22/213 (10%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 186
+ LGEG +G V+K ++ G VA+K + +G+ L E+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGE---------IVALKKIRLDNEEEGIP--STALREI 49
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+ L +L H N+VKL+ + + LV+E+ L+ +L +R PL ++ I
Sbjct: 50 SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL 108
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GLA+ H +++RD K NIL++ D KL+DFGLA+ +T+ + V+ T
Sbjct: 109 RGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLW 163
Query: 307 YAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y APE ++ S + D++S G + EM+TG+
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 79/275 (28%), Positives = 113/275 (41%), Gaps = 30/275 (10%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 193
S LGEG G V K + TG+ A+KT+ D K+ L E+
Sbjct: 7 SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQILRELEINKSCK 57
Query: 194 HLNLVKLIGYCIEDDQRLL--VYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGAAKG 248
+VK G +++ + E+ GSL++ + +R + + KIA KG
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGY 307
L++LH R +I+RD K SNILL KL DFG++ + T GT Y
Sbjct: 118 LSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFY 169
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE + + SDV+S G+ LLE+ R P GE L
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELLSYIVNMPNP 226
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
L D E IK +++ CL +DP RP
Sbjct: 227 ELKD---EPGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E P + + VAVKTL K++ E L +L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------LPWSIRMKIAL 243
+VK G C+E D ++V+E+M G L N R P L S + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
A G+ +L A + ++RD T N L+ + K+ DFG+++D D V M
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ PE +M T+ SDV+S GVVL E+ T
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 8e-22
Identities = 81/284 (28%), Positives = 112/284 (39%), Gaps = 48/284 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQG-HKEWLAEVNFLGDLVH 194
+G G FG V+ V TG +AVK + D KE E+ L L H
Sbjct: 8 IGGGTFGKVYTA---------VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
NLVK G + ++ + E+ G+LE L L + L +GLA+LH
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV---MGTYGYAAPE 311
+++RD K +NI LD + KL DFG A T + V GT Y APE
Sbjct: 118 HG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSLAGTPAYMAPE 173
Query: 312 YVMTGHLTSR---SDVYSFGVVLLEMLTGRR---SMDKNRPNGEHNLVEWA---RPHLGE 362
+ G +D++S G V+LEM TG+R +D E+ G
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----------EFQIMFHVGAGH 223
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
+ + EG + CL DPK RP SE
Sbjct: 224 KPPIPDSLQLSPEGKDFLD----------RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 137 LGEGGFGCV-------FKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 188
LGEG FG V + + E+ + VAVK L D +++L EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIR 238
L L N+ +L+G C D ++ E+M G L L + S L +S
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ +A A G+ +L ++RD T N L+ +Y K++DFG++++ D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
R + A E V+ G T++SDV++FGV L E+LT
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 4e-21
Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 26/210 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG FG V +G TG VAVK + D + +L E + L H N
Sbjct: 14 IGEGEFGAVLQG-----------EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKN 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM-KIALGAAKGLAFLHEE 255
LV+L+G I + +V E M +G+L N L R L I++ + +L A+G+ +L
Sbjct: 61 LVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES- 118
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVM 314
+ +++RD NIL+ D AK+SDFGLA+ G G D + + + + APE +
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALK 170
Query: 315 TGHLTSRSDVYSFGVVLLEMLT-GRRSMDK 343
+S+SDV+S+GV+L E+ + GR K
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVNFLGDLVH 194
+GEG G V+K TG VA+K + L+ + L E+ + D H
Sbjct: 27 IGEGASGEVYKA---------TDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+V + D+ +V E+M GSL + + + + + + +GL +LH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ VI+RD K+ NILL D + KL+DFG A + S V+GT + APE V+
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE-VI 188
Query: 315 TGHL-TSRSDVYSFGVVLLEMLTG 337
+ D++S G++ +EM G
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 5e-21
Identities = 84/278 (30%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVH 194
LLG+G FG VFKG +++ VAVKT D Q K ++L+E L H
Sbjct: 2 LLGKGNFGEVFKGTLKDK----------TPVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+VKLIG C + +V E +P G + L ++ L +K AL AA G+A+L
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE- 110
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT-YGYAAPEYV 313
+ I+RD N L+ + K+SDFG+++ E D + S+ + + APE +
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEAL 166
Query: 314 MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
G +S SDV+S+G++L E S+ G N + AR + + YR+ P+
Sbjct: 167 NYGRYSSESDVWSYGILLWETF----SLGVCPYPGMTN--QQAREQV---EKGYRMSCPQ 217
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
K ++ C P+ RP SE+ + L
Sbjct: 218 -------KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-21
Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 37/286 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--------NHDGLQGH--KEWLAE 185
L+G+G +G V+ + N T TG +AVK + HD Q K +E
Sbjct: 8 LIGKGTYGRVY---LALNVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ L DL HLN+V+ +G+ ++ + E++P GS+ + R +
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQV 117
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+GLA+LH + +++RD K N+L+DAD K+SDFG++K + + + G+
Sbjct: 118 LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 306 GYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
+ APE + + +++ D++S G V+LEM GR RP + + A LG +
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIA-AMFKLGNK 227
Query: 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R P + S+ + A C + +P RP E+++
Sbjct: 228 RS-----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 66/215 (30%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E + P + VAVK L +++ E L L H +
Sbjct: 13 LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRMKI 241
+V+ G C E L+V+E+M G L N R P L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A A G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
M + PE ++ T+ SD++SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G V+K + TG VA+K + L+ E L E+ L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVAIKKIK---LRFESEGIPKTALREIKLLKE 54
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
L H N++KL+ L LV+EFM L + R LP S+ +GLA
Sbjct: 55 LNHPNIIKLLD-VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRVMGTYGY 307
F H +++RD K N+L++ + KL+DFGLA+ P TH V TR Y
Sbjct: 113 FCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WY 164
Query: 308 AAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 338
APE ++ ++ D++S G + E+L+ R
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 25/216 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLA--- 184
N+R LLG+G FG V+ TG +AVK + D KE A
Sbjct: 3 NWRRGKLLGQGAFGRVY---------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E+ L +L H +V+ G C+ DD+ L ++ E+MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTR 111
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRV 301
+G+ +LH +++RD K +NIL D+ N KL DFG +K T + + V
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-V 167
Query: 302 MGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLT 336
GT + +PE V++G R +DV+S G ++EMLT
Sbjct: 168 TGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 33/210 (15%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G +G V++G W + + LTVAVKTL D ++ E+L E + ++ H
Sbjct: 14 LGGGQYGEVYEGVWKKYS----------LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLH 253
NLV+L+G C + ++ EFM G+L ++L R + + + +A + + +L
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLE 121
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTYG 306
++ I+RD N L+ ++ K++DFGL++ G K +
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------- 170
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + + +SDV++FGV+L E+ T
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLVHL 195
LGEG FG V E P TG VAVK+L + H L E+ L +L H
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 196 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
N+VK G C ED L+ EF+P GSL+ +L R + ++K A+ KG+ +L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL- 125
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPE 311
R ++RD N+L+++++ K+ DFGL K E DK + + + + + APE
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLT 336
++ SDV+SFGV L E+LT
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 137 LGEGGFG----CVFKG---WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 188
LGEG FG C +G +++++ + V + VAVK L D + + ++L E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP----------WSIR 238
+ L N+++L+ CI D ++ E+M G L L R +S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ +A A G+ +L + ++RD T N L+ +Y K++DFG++++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
R + + + E ++ G T+ SDV++FGV L E+LT
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 75/299 (25%), Positives = 110/299 (36%), Gaps = 51/299 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDL 192
++GEG +G V K + TG VA+K + D K L EV L L
Sbjct: 7 GVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+V L + LV+E++ R LE LP P ++R + +A+
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVR-SYIWQLLQAIAY 115
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
H +I+RD K NIL+ KL DFG A+ + ++ V T Y APE
Sbjct: 116 CHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE 171
Query: 312 ----YVMTGHLTSRSDVYSFGVVLLEMLTGR----------------RSMDKNRPNGEHN 351
G DV++ G ++ E+L G + + P H
Sbjct: 172 LLVGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP--SHQ 226
Query: 352 LVEWARPHLGERRRFYRLIDPR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
+ + P +P LE + K + A CL DPK R E
Sbjct: 227 ELFSSNPRF----AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 76/293 (25%), Positives = 128/293 (43%), Gaps = 47/293 (16%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 185
L + + +G+G FG V G G VAVK + +D + +LAE
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAE 49
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 243
+ + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 50 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+ + +L ++RD N+L+ D AK+SDFGL K E T + ++
Sbjct: 110 DVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL-- 161
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
+ APE + +++SDV+SFG++L E+ + R V + R L +
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKD- 207
Query: 364 RRFYRLIDPRLEGHFSIKGAQKAA----QLAAHCLSRDPKARPLMSEVVEALK 412
+ PR+E + + + C D RP ++ E L+
Sbjct: 208 ------VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 165 TVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 223
VA+K ++ + Q E EV + H N+VK + D+ LV ++ GSL
Sbjct: 28 KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87
Query: 224 NHLFRRSLP---LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280
+ + S P L +I + KGL +LH + I+RD K NILL D + K+
Sbjct: 88 -DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKI 143
Query: 281 SDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEM 334
+DFG LA G V +GT + APE VM ++D++SFG+ +E+
Sbjct: 144 ADFGVSASLADGG--DRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIEL 200
Query: 335 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKA-AQLAAHC 393
TG K P L P P LE K K+ ++ + C
Sbjct: 201 ATGAAPYSKYPPMKVLMLTLQNDP-------------PSLETGADYKKYSKSFRKMISLC 247
Query: 394 LSRDPKARPLMSEVVE 409
L +DP RP E+++
Sbjct: 248 LQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 16/211 (7%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
+ ++G G FG VF+G ++ G V VA+KTL + + ++L+E + +G
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEV------AVAIKTLKPGYTEKQRQDFLSEASIMGQF 63
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G + +++ E+M G+L+ +L + + G A G+ +L
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAA 309
++ ++RD NIL++++ K+SDFGL++ D PEG T ++ + A
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTA 178
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
PE + TS SDV+SFG+V+ E+++ G R
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G + G +P T VA+KT+N ++ E+L E + + +
Sbjct: 14 LGQGSFGMVYEGIAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 244
++V+L+G + L++ E M RG L+++L RSL P +++A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 128 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ +PE + G T+ SDV+SFGVVL E+ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN---HDGLQGHKEWLAEV 186
+F ++G+G FG V +++ T A+K +N + L E
Sbjct: 1 HFELLRVIGKGAFGKVCI--VQKRDT-------KKMFAMKYMNKQKCVEKGSVRNVLNER 51
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L +L H LV L Y +D++ + LV + + G L HL ++ ++ I
Sbjct: 52 RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EI 109
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +I+RD K NILLD + ++DF +A T T GT
Sbjct: 110 VLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTP 163
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
GY APE + + D +S GV E L G+R +
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F LGEG +G V+K +E G VA+K + + +E + E++ L
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQ---------VVAIKVVPVEE--DLQEIIKEISILK 53
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
+VK G ++ +V E+ GS+ + + + L I KGL
Sbjct: 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH I+RD K NILL+ + AKL+DFG++ G D V+GT + AP
Sbjct: 114 YLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAP 168
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
E + +++D++S G+ +EM G+
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 71/227 (31%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-- 193
LGEG FG V K E G P TVAVK L D + K+ L DLV
Sbjct: 19 PLGEGAFGQVVKA--EAVGL--DNPNETSTVAVKMLKDDATE--KD-------LSDLVSE 65
Query: 194 ---------HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-------SLPLPWSI 237
H N++ L+G C ++ +V E+ G+L + L R S P
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 238 RMKI--------ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289
+ A A+G+ FL A + I+RD N+L+ D+ K++DFGLA+D
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 290 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
D +T + APE + T +SDV+SFGV+L E+ T
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 69/232 (29%), Positives = 106/232 (45%), Gaps = 33/232 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGLQGH-KEWLAEVN 187
N LGEG FG V K +K G T VAVK L + ++ L+E N
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFR-----LKGRAGYTTVAVKMLKENASSSELRDLLSEFN 55
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---------------FRRSLP 232
L + H +++KL G C +D LL+ E+ GSL + L R S
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 233 L------PWSIRMKI--ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284
L ++ I A ++G+ +L AE +++RD N+L+ K+SDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
L++D E D ++ + A E + T++SDV+SFGV+L E++T
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 9e-19
Identities = 81/293 (27%), Positives = 123/293 (41%), Gaps = 62/293 (21%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 181
LKL + LG G FG V+ G+ + VA+K+L G +
Sbjct: 6 ETLKLVKK-------LGAGQFGEVWMGYYNGH----------TKVAIKSLK-QGSMSPEA 47
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIR 238
+LAE N + L H LV+L + + ++ E+M GSL + L L + I
Sbjct: 48 FLAEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPE 291
M A A+G+AF+ + I+RD + +NIL+ K++DFGLA+ E
Sbjct: 107 M--AAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161
Query: 292 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-- 349
G K + + APE + G T +SDV+SFG++L E++T R N E
Sbjct: 162 GAKFPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
Query: 350 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
NL R YR+ P ++ +L C P+ RP
Sbjct: 214 QNL-----------ERGYRMPRPD-------NCPEELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 9e-19
Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 12/203 (5%)
Query: 136 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 193
+LG G FG V+KG W+ E T + VA+K LN G + + E++ E + +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIP------VAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H +LV+L+G C+ +L V + MP G L +++ + + + + AKG+ +L
Sbjct: 68 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
E R +++RD N+L+ + + K++DFGLA+ +K + + + A E +
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT 336
T +SDV+S+GV + E++T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F+ LG+G +G V+K + A+K ++ G KE VN +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ---------FYALKEVDL-GSMSQKEREDAVNEI 50
Query: 190 GDLVHLNLVKLIGY--CIEDDQRL-LVYEFMPRGSLENHLFRRSL---PLPWSIRMKIAL 243
L +N +I Y D +L +V E+ P G L + +R +P +I +
Sbjct: 51 RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+GL LHE + +++RD K++NILL A+ K+ D G++K K +++ +G
Sbjct: 111 QLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIG 163
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
T Y APE + +SD++S G +L EM T + AR R
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARSMQDLR 210
Query: 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
+ R P + +S Q L PK RP ++
Sbjct: 211 YKVQRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 31/286 (10%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
E ++G G FG V +G ++ G + VA+KTL + +++L+E + +G
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N++ L G + +++ EFM G+L++ L + + + G A G+ +L
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG---TYGYAA 309
+E ++RD NIL++++ K+SDFGL++ + T +G + A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368
PE + TS SDV+S+G+V+ E+++ G R N +E + YR
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----------QDYR 229
Query: 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
L P + QL C +D ARP ++V L +
Sbjct: 230 LPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 39/289 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 14 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------PLPWSIRMKIALGA 245
++V+L+G + L+V E M G L+++L RSL P P +++ I + A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPP-TLQEMIQMAA 126
Query: 246 --AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 127 EIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
+ APE + G T+ SD++SFGVVL E+ + L E L
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNE 228
Query: 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ ++D ++ L C +PK RP E+V LK
Sbjct: 229 QVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 73/284 (25%), Positives = 115/284 (40%), Gaps = 55/284 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGH-KEWL-AEVNFLGDLV 193
+G+G FG V K V+ G + K +++ + K+ L +EVN L +L
Sbjct: 8 IGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 194 HLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRS----LPLP----WSIRMKIAL 243
H N+V+ I+ + L V E+ G L L ++ + W I ++ L
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 244 GAAKGLAFLH--EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTHVS 298
L H + V++RD K +NI LDA+ N KL DFGLAK KT+V
Sbjct: 117 A----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV- 171
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
GT Y +PE + +SD++S G ++ E+ P AR
Sbjct: 172 ----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL-------SPPFT------ARN 214
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
L + R+ +S + ++ L+ DP RP
Sbjct: 215 QLQLASKIKEGKFRRIPYRYS----SELNEVIKSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 41/222 (18%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGHKE---WLA 184
+F LG G FG V V+ G+G A+K L+ + K+ L
Sbjct: 1 DDFEFIKTLGTGSFGRVML----------VRHKGSGKYYALKILSKAKIVKLKQVEHVLN 50
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM--- 239
E L + H LV L G +DD L LV E++P G L +HL + P P + R
Sbjct: 51 EKRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAA 108
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
++ L L +LH ++YRD K N+LLD+D K++DFG AK V
Sbjct: 109 QVVLA----LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKG 153
Query: 300 RVM---GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 337
R GT Y APE ++ G+ D ++ G+++ EML G
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+GEG FG V++G + VAVKT + +E +L E + H
Sbjct: 13 CIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
++VKLIG ++ +V E P G L ++L L + + + + LA+L
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ ++RD N+L+ + KL DFGL++ E + + +++ + APE +
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESIN 181
Query: 315 TGHLTSRSDVYSFGVVLLEML 335
TS SDV+ FGV + E+L
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 41/218 (18%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---------GLQGHKEWLAEV 186
+LG+G FG V A +K GT AVK L D K LA
Sbjct: 2 VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSI--RMKIA 242
L L+ C + RL V E++ G L H+ R P + +I
Sbjct: 53 GKHPFLTQLHS------CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIV 106
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRV 301
LG L FLHE R +IYRD K N+LLD++ + K++DFG+ K+G G T +
Sbjct: 107 LG----LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STF 156
Query: 302 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
GT Y APE +++ + D ++ GV+L EML G+
Sbjct: 157 CGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G V+K N TG VA+K + ++ KE + E+ L
Sbjct: 7 IGEGTYGQVYKA---RNKK------TGELVALKKIR---MENEKEGFPITAIREIKLLQK 54
Query: 192 LVHLNLVKLIGYCIEDDQR--LLVYEFMP---RGSLENHLFRRSLPLPWSIR--MKIALG 244
L H N+V+L + +V+E+M G L++ + + I+ MK L
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES---QIKCYMKQLL- 110
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+GL +LH +++RD K SNIL++ D KL+DFGLA+ + T + T
Sbjct: 111 --EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVIT 164
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y PE ++ D++S G +L E+ G+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 84/273 (30%), Positives = 126/273 (46%), Gaps = 45/273 (16%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V+ G W NG VAVKTL G + +L E + L H
Sbjct: 14 LGNGQFGEVWMGTW---NGNT--------KVAVKTLK-PGTMSPESFLEEAQIMKKLRHD 61
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
LV+L + ++ +V E+M +GSL + L R+L LP + M A A G+A++
Sbjct: 62 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYI 118
Query: 253 HEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAA 309
ER I+RD +++NIL+ K++DFGLA+ + + T R + + A
Sbjct: 119 ----ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT---ARQGAKFPIKWTA 171
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
PE + G T +SDV+SFG++L E++T R N R L + R YR+
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------REVLEQVERGYRM 222
Query: 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
P+ +L C +DP+ RP
Sbjct: 223 PCPQ-------DCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 31/275 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K + VA+K +N +G ++++ E + L H
Sbjct: 12 LGSGQFGVVHLG----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + +V EFM G L N+L +R L + + + +G+ +L +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
I+RD N L+ + K+SDFG+ + + D+ S+ ++ PE
Sbjct: 121 ---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 317 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 376
+S+SDV+SFGV++ E+ T + + + N E +VE R +RL P+L
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVE-------MISRGFRLYRPKLAS 227
Query: 377 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
+ + C P+ RP +E++ A+
Sbjct: 228 MTVYE-------VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 73/284 (25%), Positives = 120/284 (42%), Gaps = 55/284 (19%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 189
F +G+G FG V+K + T VA+K ++ + + E + E+ FL
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
+ K G ++ + ++ E+ GS + L + L + I GL
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGL 111
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYG 306
+LHEE I+RD K +NILL + + KL+DFG++ G T ++ +GT
Sbjct: 112 EYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPF 163
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRR 365
+ APE + ++D++S G+ +E+ G P + H + R
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKG------EPPLSDLHPM------------R 205
Query: 366 FYRLID----PRLEGH-FS--IKGAQKAAQLAAHCLSRDPKARP 402
LI P LEG+ FS K + CL++DPK RP
Sbjct: 206 VLFLIPKNNPPSLEGNKFSKPFKD------FVSLCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 66/206 (32%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDL-VH 194
LG G FG V +E K + VAVK L +E L +E+ + L H
Sbjct: 43 LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLH 253
N+V L+G C L++ E+ G L N L R R L + + AKG+AFL
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVMGTYGYAAP 310
A + I+RD N+LL K+ DFGLA+D D +V + R+ + AP
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARL--PVKWMAP 212
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLT 336
E + T SDV+S+G++L E+ +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 27/231 (11%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKE 181
+L L+ F E LGE FG ++KG + G + VA+KTL + + Q E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGE 53
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------- 230
+ E + + +L H N+V L+G ++ +++E++ +G L L RS
Sbjct: 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113
Query: 231 -----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
L + IA+ A G+ +L + +++D NIL+ + K+SD GL
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGL 170
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+++ D V + + + PE +M G +S SD++SFGVVL E+ +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 19/190 (10%)
Query: 161 GTGLTVAVKTL----NHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214
TG +AVK + N Q + E+ + L H ++++++G ED L
Sbjct: 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82
Query: 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
E+M GS+ +HL + ++ + +GL++LH E +I+RD K +N+L+D+
Sbjct: 83 EWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDS 138
Query: 275 D-YNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFG 328
+++DFG LA G + +++GT + APE V+ G RS DV+S G
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVG 195
Query: 329 VVLLEMLTGR 338
V++EM T +
Sbjct: 196 CVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 67/223 (30%), Positives = 101/223 (45%), Gaps = 37/223 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNH-----DGLQGHKEW 182
+ LGEG + V+K +E G VA+K L DG+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGR---------IVAIKKIKLGERKEAKDGI--NFTA 49
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIR--M 239
L E+ L +L H N++ L+ LV+EFM LE + +S+ L P I+ M
Sbjct: 50 LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYM 108
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH- 296
+ L +GL +LH +++RD K +N+L+ +D KL+DFGLA+ P TH
Sbjct: 109 LMTL---RGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ 162
Query: 297 VSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
V TR Y APE + H D++S G + E+L
Sbjct: 163 VVTRW-----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGD 191
E +LG G FG + +G ++ L VA+ TL G + +LAE LG
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRE------LPVAIHTL-RAGCSDKQRRGFLAEALTLGQ 62
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+V+L G + ++V E+M G+L++ L + L M + G A G+ +
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGDKTHVSTRVMGTYGYAAP 310
L +E +++ +L+++D K+S F L +D E T +S + +AAP
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL--WAAP 177
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
E + H +S SDV+SFG+V+ E+++ G R
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 130 NFRPESL-----LGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQG-HKEW 182
+ R E L LG G G V K VK TG +A K ++ K+
Sbjct: 1 DLRNEDLETISDLGAGNGGSVSK----------VKHIPTGTVMAKKVVHIGAKSSVRKQI 50
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L E+ + + +V G + ++ + EFM GSL+ ++++ P+P I KIA
Sbjct: 51 LRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIA 109
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRV 301
+ +GL +L+ +++RD K SNIL+++ KL DFG++ G+ + ++
Sbjct: 110 VAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTF 162
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
+GT Y +PE + G T +SDV+S G+ ++E+ G+
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 85/285 (29%), Positives = 131/285 (45%), Gaps = 45/285 (15%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
++ + R + LG+G FG V+ G W NGT VA+KTL G + +L
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTW---NGTT--------KVAIKTLK-PGTMMPEAFL 49
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 240
E + L H LV L + ++ +V EFM +GSL + L + L LP + M
Sbjct: 50 QEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM- 107
Query: 241 IALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A G+A++ ER I+RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 108 -AAQIADGMAYI----ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT---A 159
Query: 300 RVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357
R + + APE + G T +SDV+SFG++L E++T R N R
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---------R 210
Query: 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
L + R YR+ P+ + +L C +DP RP
Sbjct: 211 EVLEQVERGYRMPCPQ-------GCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 75/291 (25%), Positives = 118/291 (40%), Gaps = 32/291 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 188
N + + LG G FG VF + G V VK L E+ E++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEE----GGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIA 242
L H N+V+L+G C E + ++ E+ G L+ L + P P S + K+A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 243 LGA--AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
L A G+ L + ++RD N L+ + K+S L+KD + +
Sbjct: 122 LCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRN 177
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ + APE V +++SDV+SFGV++ E+ T E L
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------------QGELPFYGL 222
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
+ RL +LE + +L C + +PK RP SE+V AL
Sbjct: 223 SDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P L + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 52/222 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
LG+G FG V+ +E G VA+K + + W L EV L
Sbjct: 7 LGDGTFGSVYLARNKETGE---------LVAIKKMK----KKFYSWEECMNLREVKSLRK 53
Query: 192 L-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-----RRSLPLPWSIRMKIALGA 245
L H N+VKL E+D+ V+E+M E +L+ R+ P S+ I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQI 108
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDKTHVSTRV 301
+GLA +H+ +RD K N+L+ K++DFGLA++ P D +VSTR
Sbjct: 109 LQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTR- 162
Query: 302 MGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGR 338
Y APE + L S S D+++ G ++ E+ T R
Sbjct: 163 ----WYRAPEIL----LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V+K TGL A K + + + ++++ E++ L + H N
Sbjct: 13 LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V L +++ ++ EF G+L++ + L + + L FLH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD K NILL D + KL+DFG+ AK+ K +GT + APE V
Sbjct: 124 ---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVAC 177
Query: 316 GHLTS-----RSDVYSFGVVLLEMLTGR 338
++D++S G+ L+E+
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 77/302 (25%), Positives = 123/302 (40%), Gaps = 57/302 (18%)
Query: 124 LKLATRNFRPESLL------GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ 177
L+L P S L GEG G V TG VAVK ++ Q
Sbjct: 8 LQLVVDPGDPRSYLDNFVKIGEGSTGIV---------CIATDKSTGRQVAVKKMDLRKQQ 58
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
+ EV + D H N+V++ + D+ +V EF+ G+L + +
Sbjct: 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD--------IVTHT 110
Query: 238 RMK------IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAK 287
RM + L K L+FLH + VI+RD K+ +ILL +D KLSDFG ++K
Sbjct: 111 RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 347
+ P ++GT + APE + + D++S G++++EM+ G P
Sbjct: 168 EVPR------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP- 220
Query: 348 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
L +R + P+L+ K + + L RDP R +E+
Sbjct: 221 ------------LQAMKRIRDNLPPKLKNL--HKVSPRLRSFLDRMLVRDPAQRATAAEL 266
Query: 408 VE 409
+
Sbjct: 267 LN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VH 194
LGEG FG V + E G +P +TVAVK L + + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP---------------WSIRM 239
N++ L+G C ++ ++ E+ +G+L L R P P + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L R I+RD N+L+ D K++DFGLA+ + D ++
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFG+++ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 239
N++ L+G C +D ++ E+ +G+L +L R P L + +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 71/303 (23%), Positives = 125/303 (41%), Gaps = 58/303 (19%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLA 184
NF+ E +G+G F V+K +G VA+K + + K + L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDG---------RVVALKKVQIFEMMDAKARQDCLK 51
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE---NHLFRRSLPLP----WSI 237
E++ L L H N++K + IE+++ +V E G L H ++ +P W
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+++ L +H + +++RD K +N+ + A KL D GL + KT
Sbjct: 112 FVQLC----SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTA 162
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357
+ ++GT Y +PE + +SD++S G +L EM
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQS 204
Query: 358 PHLGERRRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
P G++ Y L P H+S ++ L + C++ DP+ RP +S V++
Sbjct: 205 PFYGDKMNLYSLCKKIEKCDYPPLPADHYS----EELRDLVSRCINPDPEKRPDISYVLQ 260
Query: 410 ALK 412
K
Sbjct: 261 VAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-----TLNHDGLQGHKEWLA----E 185
+L+G G FG V+ G + +G +AVK +++ + L E
Sbjct: 6 ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ L +L H N+V+ +G ++ D + E++P GS+ L ++
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVRNFVRQI 115
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR----- 300
KGL +LH R +I+RD K +NIL+D K+SDFG++K E + T
Sbjct: 116 LKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPS 171
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
+ G+ + APE V T ++D++S G +++EMLTG+
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 15/211 (7%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 188
+ E ++G G FG V G ++ G + VA+KTL + + ++L+E +
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREI------PVAIKTLKAGYTEKQRRDFLSEASI 58
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
+G H N++ L G + ++V E+M GSL+ L + + + G A G
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASG 118
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTY 305
+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T ++
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PI 173
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + TS SDV+S+G+V+ E+++
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 83/280 (29%), Positives = 129/280 (46%), Gaps = 45/280 (16%)
Query: 130 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 54
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 55 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 111
Query: 246 AKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A G+A++ ER ++RD + +NIL+ + K++DFGLA+ + + T R
Sbjct: 112 ASGMAYV----ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAK 164
Query: 305 Y--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
+ + APE + G T +SDV+SFG++L E+ T R N R L +
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQ 215
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
R YR+ P + + L C ++P+ RP
Sbjct: 216 VERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 193
+G G FG V+ N T VAVK +++ G Q +++W + EV FL L
Sbjct: 29 IGHGSFGAVY---FATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N ++ G +++ LV E+ GS + L PL I GA +GLA+LH
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
+I+RD K NILL KL+DFG A K+ + +GT + APE +
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVI 189
Query: 314 MT---GHLTSRSDVYSFGVVLLEM 334
+ G + DV+S G+ +E+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 69/209 (33%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGDLVH 194
+GEG +G VFK E TG VA+K + D K L E+ L L H
Sbjct: 9 IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
NLV LI ++L LV+E+ ++ N L + +P + KI + + F H
Sbjct: 60 PNLVNLI-EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVSTRVMGTYGYAAP 310
+ I+RD K NIL+ KL DFG A+ GP D T +V+TR Y AP
Sbjct: 118 KHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAP 169
Query: 311 EYVMTGHLT--SRSDVYSFGVVLLEMLTG 337
E ++ G DV++ G V E+LTG
Sbjct: 170 E-LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 77/241 (31%), Positives = 106/241 (43%), Gaps = 40/241 (16%)
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
L + + NDL+ +G G G V+K ++ G +AVK
Sbjct: 3 LTIDGQKYPADLNDLEN-------LGEIGSGTCGQVYKMRFKKTGH---------VMAVK 46
Query: 170 TLNHDGLQGHKEWLAEVNFLGDL-VHL------NLVKLIGYCIEDDQRLLVYEFMPRGSL 222
+ G +KE + L DL V L +VK GY I D + E M L
Sbjct: 47 QMRRTG---NKEENKRI--LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CL 100
Query: 223 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282
+ L R P+P I K+ + K L +L E+ VI+RD K SNILLDA N KL D
Sbjct: 101 DKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCD 158
Query: 283 FGLAKDGPEGD-KTHVSTRVMGTYGYAAPEYVMTGHLTS----RSDVYSFGVVLLEMLTG 337
FG++ G D K TR G Y APE + R+DV+S G+ L+E+ TG
Sbjct: 159 FGIS--GRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG 214
Query: 338 R 338
+
Sbjct: 215 Q 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 56/157 (35%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 204 CIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 257
C + + RL V EF+ G L H+ R R LP +S + +AL FLHE
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------FLHE--- 114
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTG 316
R +IYRD K N+LLDA+ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 317 HLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHN 351
D ++ GV++ EM+ GR D N + N
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 73/245 (29%), Positives = 100/245 (40%), Gaps = 57/245 (23%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 186
+F ++G G FG V+ TG A+K L + + AE
Sbjct: 2 DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAER 52
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MK 240
+ L D +VKL Y +D++ L LV E+MP G L N L R+ + + R +
Sbjct: 53 DILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV 111
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT----- 295
+AL + L F+H RD K NIL+DAD + KL+DFGL K +
Sbjct: 112 LALDSVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 296 -----------------HVSTRVM-----GTYGYAAPEYVMTGH-LTSRSDVYSFGVVLL 332
H RV GT Y APE V+ G D +S GV+L
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILY 221
Query: 333 EMLTG 337
EML G
Sbjct: 222 EMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V+ G+ N T VAVKTL G + +L E N + L H
Sbjct: 14 LGAGQFGEVWMGYYN-NST---------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 62
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLH 253
LV+L +++ ++ E+M +GSL + L + LP I + A+G+A++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 120
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTYG 306
+ I+RD + +N+L+ K++DFGLA+ EG K +
Sbjct: 121 R---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-------- 169
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + G T +SDV+SFG++L E++T
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 204 CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262
C + RL LV E++ G L H+ +R LP A L FLHE R +IY
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119
Query: 263 RDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 321
RD K N+LLDAD + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGEEYGFS 176
Query: 322 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 381
D ++ GV++ EM+ GR D N + N ++ + E+ R+ S+
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-------PIRIPRFLSV- 228
Query: 382 GAQKAAQLAAHCLSRDPKAR 401
KA+ + L++DPK R
Sbjct: 229 ---KASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 51/290 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----------LAE 185
LG G FGCV+K + NG +A+K +N K+ ++E
Sbjct: 7 HLGSGAFGCVYKVRKKNNG--------QNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58
Query: 186 VNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFM---PRGSLENHLFRRSLPLP----WSI 237
V + + L H N+V+ +E+D+ +V + + P G N L + W+I
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+++ L L +LH+E + +++RD +NI+L D ++DFGLAK K
Sbjct: 119 FVQMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL-- 170
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357
T V+GT Y+ PE V ++DV++FG +L +M T P N++ A
Sbjct: 171 -TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLA- 222
Query: 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
+ + +P EG +S + + CL+ D +ARP + +V
Sbjct: 223 -----TKIVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 76/282 (26%), Positives = 115/282 (40%), Gaps = 49/282 (17%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFL 189
++ L+G G +G V++G TG VA+K +N D + EV L
Sbjct: 3 YQRLELIGRGAYGAVYRG---------KHVPTGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 190 GDLVHL---NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK----I 241
L N+ K G RL ++ E+ GS+ R+L I K I
Sbjct: 54 SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVI 106
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
L ++H+ VI+RD K +NIL+ N KL DFG+A + ST V
Sbjct: 107 IREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFV 162
Query: 302 MGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
GT + APE + G +++D++S G+ + EM TG L+ ++P
Sbjct: 163 -GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-- 219
Query: 361 GERRRFYRLIDPRLEG-HFSIKGAQKAAQLAAHCLSRDPKAR 401
PRLE +S + + A CL +PK R
Sbjct: 220 -----------PRLEDNGYS----KLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-LAEVNF 188
NF+ LGEG + V+KG N T TG VA+K ++ D +G + E++
Sbjct: 1 NFKQLEKLGEGTYATVYKG---RNRT------TGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIRMKIALGA 245
+ +L H N+V+L +++ +LV+E+M + ++ H R +L L
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
KG+AF HE V++RD K N+L++ KL+DFGLA+ T + V T
Sbjct: 110 LKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TL 164
Query: 306 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y AP+ ++ S S D++S G ++ EM+TGR
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLN 196
G +G VF K TG A+K + + + L E + L
Sbjct: 4 GAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+VKL Y + + L LV E++P G L L L + L +LH
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS------TRVMGTYGYAA 309
+I+RD K NIL+D++ + KL+DFGL+K G + +++ R++GT Y A
Sbjct: 113 G---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 310 PEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
PE V+ G S++ D +S G +L E L G
Sbjct: 170 PE-VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 73/215 (33%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHD-----GLQGH----KEWLAEV 186
LG GGFG V VK T A+K + G Q H KE L E
Sbjct: 1 LGVGGFGRVEL----------VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC 50
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
N H +VKL Y D++ +Y E+ G L L R L ++ R IA
Sbjct: 51 N------HPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYTARFYIA- 100
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+LH R +IYRD K N+LLD++ KL DFG AK G KT G
Sbjct: 101 CVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCG 154
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE ++ D +S G++L E+LTGR
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 87/283 (30%), Positives = 128/283 (45%), Gaps = 58/283 (20%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNF 188
+LG+GG+G VF+ + + A TG A+K L + H + AE N
Sbjct: 2 KVLGKGGYGKVFQ--VRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP-----WSIRMKIA 242
L + H +V LI Y + +L L+ E++ G L HL R + + + + +A
Sbjct: 54 LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA 112
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRV 301
L LH++ +IYRD K NILLDA + KL+DFGL K+ EG TH
Sbjct: 113 LE------HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---F 160
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
GT Y APE +M +GH D +S G ++ +MLTG A P
Sbjct: 161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTG------------------APPFT 201
Query: 361 GERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKAR 401
E R+ + ID L+G ++ +A L L R+P +R
Sbjct: 202 AENRK--KTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVK----PGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFL 189
+LG+G FG VF V+ P G A+K L L+ E + L
Sbjct: 3 VLGQGSFGKVFL----------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL 52
Query: 190 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
++ H +VKL Y + + +L L+ +F+ G L L + + ++ +A A
Sbjct: 53 AEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALA 110
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L LH +IYRD K NILLD + + KL+DFGL+K+ + +K S GT Y
Sbjct: 111 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 309 APEYV-MTGHLTSRSDVYSFGVVLLEMLTG 337
APE V GH S +D +SFGV++ EMLTG
Sbjct: 166 APEVVNRRGHTQS-ADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 71/237 (29%), Positives = 102/237 (43%), Gaps = 43/237 (18%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-TLNHDGLQG-HKEWLA 184
R++ LGEG FG V+K + TG VA+K L H+ G L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITALR 56
Query: 185 EVNFLGDLVHLNLVKLIGYCIE-----DDQRLLVYEFMP------RGSLENHLFRRSLPL 233
E+ L L H N+V LI +E +R VY P G LEN + +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES- 115
Query: 234 PWSIR--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---- 287
I+ M L +G+ +LHE +++RD K +NIL+D K++DFGLA+
Sbjct: 116 --QIKCYMLQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 288 -----DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
G G T T ++ T Y PE ++ T+ D++ G V EM T R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRM-------------- 239
N++ L+G C +D ++ E+ +G+L +L RR + +S +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 83/282 (29%), Positives = 121/282 (42%), Gaps = 47/282 (16%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 187
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQ 52
Query: 188 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L + V+ V + Y E D LV M G L+ H++ ++ P + AA
Sbjct: 53 IL-EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAA 109
Query: 247 K---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+ GL LH E +YRD K NILLD + ++SD GLA PEG+ + RV G
Sbjct: 110 EILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-G 163
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
T GY APE + T D + G ++ EM+ G+ P G +
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ------------------SPFRGRK 205
Query: 364 RRFYR-LIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
+ R +D R+ E +S K +++A + L++DPK R
Sbjct: 206 EKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 82/276 (29%), Positives = 115/276 (41%), Gaps = 35/276 (12%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 187
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQ 52
Query: 188 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGA 245
L + V+ V + Y E D LV M G L+ H++ + A
Sbjct: 53 IL-EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
GL LH+E ++YRD K NILLD + ++SD GLA PEG + RV GT
Sbjct: 112 CCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTV 165
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
GY APE V T D ++ G +L EM+ G+ + + + VE
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------- 214
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
RL+ ++ +S K + A L L +DPK R
Sbjct: 215 --RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 67/260 (25%), Positives = 111/260 (42%), Gaps = 34/260 (13%)
Query: 162 TGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLI--GYCIEDDQRLLVYEF 216
TG VA+K L D + + + E L H N+V L+ G V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---D 273
+P +L L LP ++ L LA H + +++RD K NI++
Sbjct: 61 VPGRTLREVLAADG-ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116
Query: 274 ADYNAKLSDFGLAKDGP---EGDKTHVS--TRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 328
+AK+ DFG+ P + D ++ T V+GT Y APE + +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 329 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 388
++ LE LTG+R + G ++ E L + P + GH Q
Sbjct: 177 LIFLECLTGQRVVQ-----GA-SVAEILYQQLSPVD---VSLPPWIAGH-------PLGQ 220
Query: 389 LAAHCLSRDPKARPLMSEVV 408
+ L++DP+ R + +
Sbjct: 221 VLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHL 195
LG G FGCV KG + + VA+K L ++ + E + E + L +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+V++IG C E + +LV E G L L + + S +++ + G+ +L
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG- 113
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYV 313
+ ++RD N+LL + AK+SDFGL+K D ++ R G + + APE +
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT 336
+SRSDV+S+G+ + E +
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V+K +E TG+ A K ++ + ++++ E++ L H N
Sbjct: 13 LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+VKL+ ++ ++ EF G+++ + PL + + L +LHE
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
+I+RD K NIL D + KL+DFG++ + S +GT + APE VM
Sbjct: 124 ---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 178
Query: 317 HLTSR-----SDVYSFGVVLLEM 334
R +DV+S G+ L+EM
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 39/240 (16%)
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRM 239
L E+ L L H N++ + ++D+ L+ E+ G+L + + R+ +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+ +A ++++H+ +++RD KT NI L KL DFG++K G + ++
Sbjct: 107 LFQIVSA--VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAE 159
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV------ 353
V+GT Y +PE +SD+++ G VL E+LT +R+ D P NLV
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQG 216
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413
+ P + + + + L L +DP+ RP EV++
Sbjct: 217 NYT---------------PVVSVY-----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 65/224 (29%), Positives = 93/224 (41%), Gaps = 44/224 (19%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 194
++GEG +G V+K + TG VA+K ++ +E E N L H
Sbjct: 13 VIGEGTYGKVYKA-RHKK--------TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62
Query: 195 LNLVKLIG------YCIEDDQRLLVYEFMPRGSLEN-----HLFRRSLPLPWSIRMKIAL 243
N+ G DDQ LV E GS+ + + L W IA
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAY 117
Query: 244 ---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVS 298
+GLA+LHE VI+RD K NILL + KL DFG++ D G + +
Sbjct: 118 ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG-RRNTF 173
Query: 299 TRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG 337
GT + APE + +RSDV+S G+ +E+ G
Sbjct: 174 I---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 44/124 (35%), Positives = 73/124 (58%), Gaps = 7/124 (5%)
Query: 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274
E M GSL+ L +++ +P +I KI++ +GL +L E+ +++RD K SNIL+++
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNS 135
Query: 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334
KL DFG++ G D ++ +GT Y +PE + H T +SD++S G+ L+EM
Sbjct: 136 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
Query: 335 LTGR 338
GR
Sbjct: 192 AIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVH 194
LGEG FG V +G + ++ + L VAVKT+ +++L+E + + H
Sbjct: 7 LGEGEFGSVMEGQLNQDDSI-------LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 195 LNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIAL 243
N+++LIG C++ + +++ FM G L + L L LP + +K
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
A G+ +L + + I+RD N +L+ + N ++DFGL+K GD
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E + T++SDV+SFGV + E+ T
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 31/223 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVN 187
+ ++G G FG V + V +K + + + + A E
Sbjct: 1 KYEKIRVVGRGAFGIV---HLCRRKADQKL------VIIKQIPVEQMTKDERLAAQNECQ 51
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE-------NHLFRRSLPLPWSIRMK 240
L L H N+++ +ED ++V E+ P G+L N L L + +++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTHVST 299
+A LH + +++RD KT NILLD K+ DFG++K K+ T
Sbjct: 112 LA---------LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT 160
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342
V+GT Y +PE +SD+++ G VL E+ + +R+ +
Sbjct: 161 -VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 27/231 (11%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HK 180
++ L+T F E LGE FG V+KG + GTAP + VA+KTL D +G +
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHL--FGTAPGEQTQ--AVAIKTLK-DKAEGPLRE 53
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------- 230
E+ E L H N+V L+G ++ +++ + L L RS
Sbjct: 54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 231 -----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
L + + I A G+ FL + V+++D T N+L+ N K+SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
++ D + + + +PE +M G + SD++S+GVVL E+ +
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 26/220 (11%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 183
L F+ +LG G FG V+KG WI P + VA+K L + +KE L
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEIL 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWS 236
E + + + ++ +L+G C+ +L + + MP G L ++++ + L L W
Sbjct: 58 DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-LNWC 115
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
+++ AKG+ +L E R +++RD N+L+ + K++DFGLAK +K +
Sbjct: 116 VQI------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ + A E ++ T +SDV+S+GV + E++T
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 67/209 (32%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLV 193
LG+GGFG E VK TG A K L+ L+ G K L E L +
Sbjct: 1 LGKGGFG--------EVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGL 249
+V L Y E L LV M G L+ H++ R L + I + G+
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGI 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
LH ++YRD K N+LLD N +LSD GLA + +G T+ GT GY A
Sbjct: 109 LHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMA 162
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
PE + + D ++ G + EM+ GR
Sbjct: 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 39/276 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V G K VA+K + +G E++ E + L H
Sbjct: 12 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEK 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
LV+L G C + +V E+M G L N+L S +++ +G+A+L
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--- 117
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAPEYV 313
+ I+RD N L+D K+SDFGL++ D + S+ +G+ ++ PE +
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPPEVL 173
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 372
+ +S+SDV++FGV++ E+ + G+ ++ N E VE + + R YR P
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSE--TVE----KVSQGLRLYR---P 223
Query: 373 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
L ++K + C + RP +++
Sbjct: 224 HL-------ASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 71/220 (32%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH---------DGLQGHKE 181
FR ++LG G FG V A K TG A+K L + L K
Sbjct: 1 FRCLAVLGRGHFGKVL--------LAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKR 51
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
N H LV L C + + + V E+ G L H+ P R
Sbjct: 52 IFETAN---SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAV 104
Query: 241 I-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP-EGDKTHVS 298
A GL +LHE ++YRD K N+LLD + K++DFGL K+G GD+T S
Sbjct: 105 FYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--S 159
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 337
T GT + APE V+T +R+ D + GV++ EML G
Sbjct: 160 T-FCGTPEFLAPE-VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G FG V+K +E TG A K + + ++++ E+ L H
Sbjct: 20 LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHE 254
+VKL+G D + ++ EF P G+++ + R L P I++ I + L +LH
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV-ICRQMLEALQYLHS 128
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+I+RD K N+LL D + KL+DFG++ + + S +GT + APE VM
Sbjct: 129 ---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVM 183
Query: 315 TGHLTS-----RSDVYSFGVVLLEM 334
+ ++D++S G+ L+EM
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 8e-15
Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 195
+G G FG V G G + + V VK L +L EV +L H
Sbjct: 3 IGNGWFGKVLLGEAH-RGMSKAR------VVVKELRASATPDEQLLFLQEVQPYRELNHP 55
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 250
N+++ +G CIE LLV EF P G L+N+L + + ++A A GL
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLL 114
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH+ I+ D N L AD + K+ D+GLA + D + AP
Sbjct: 115 WLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171
Query: 311 EYV-------MTGHLTSRSDVYSFGVVLLEMLT 336
E V + T +S+++S GV + E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 8e-15
Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 34/283 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 195
+G+G FG VFKG +N T V VA+K ++ + + E + E+ L
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ K G ++D + ++ E++ GS + L PL + I KGL +LH E
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 120
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+ I+RD K +N+LL KL+DFG+A G D +GT + APE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
S++D++S G+ +E+ G + P L+ P P LE
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLE 222
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 418
G++S + + CL+++P RP E+++ + K
Sbjct: 223 GNYS----KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 193
+LG+G FG V + ++ G+ VAVK L D +E+L E + +
Sbjct: 6 MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 194 HLNLVKLIGYCIED--DQRL----LVYEFMPRGSLENHLFRRSL-----PLPWSIRMKIA 242
H N++KLIG + RL ++ FM G L L + LP ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ A G+ +L + + I+RD N +L+ + ++DFGL+K GD
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E + T+ SDV++FGV + E++T
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 193
+G G FG V+ VA+K +++ G Q +++W + EV FL L
Sbjct: 23 IGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N ++ G + + LV E+ GS + L PL I GA +GLA+LH
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
I+RD K NILL KL+DFG A + +GT + APE +
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSAS------LVSPANSFVGTPYWMAPEVI 183
Query: 314 MT---GHLTSRSDVYSFGVVLLEM 334
+ G + DV+S G+ +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 41/98 (41%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GT 304
A GL FLH + +IYRD K N++LDA+ + K++DFG+ K+ G KT TR GT
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGT 164
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342
Y APE + D ++FGV+L EML G+ D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 36/223 (16%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL 192
E ++GEG FG V + I+ K G + A+K L + H+++ E+ L L
Sbjct: 7 EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 193 -VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR---------- 238
H N++ L+G C + E+ P G+L + L R+S L P +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTS 118
Query: 239 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
++ A A G+ +L +E+ I+RD N+L+ + +K++DFGL++ G++
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEV 171
Query: 296 HVSTRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+V + MG + A E + T++SDV+SFGV+L E+++
Sbjct: 172 YVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267
D LV E++ G + L + LP + G+ LH+ R +I+RD K
Sbjct: 70 DYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKP 125
Query: 268 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 327
N+L+D + KL+DFGL+++G + + +GT Y APE ++ SD +S
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 328 GVVLLEMLTGRRSMDKNRP-----NGEHNLVEW 355
G V+ E L G P N + W
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 35/224 (15%)
Query: 131 FRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNF 188
LL EG FG +F G I+E KPG V VKT+ +H L E
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61
Query: 189 LGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIRMK-- 240
L L H N++ ++ CIED + ++Y +M G+L+ LF + L P ++ +
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQL 119
Query: 241 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPE-----G 292
+A+ A G+++LH+ R VI++D N ++D + K++D L++D P G
Sbjct: 120 VHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
D + + M A E ++ +S SDV+SFGV+L E++T
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 68/212 (32%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV 193
LG+GGFG V A TG A K LN L +G++ + E L V
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAK-V 50
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GL 249
H + + Y + L LV M G L H++ P + A+ GL
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMGTYG 306
LH+ R +IYRD K N+LLD D N ++SD GLA KDG K + GT G
Sbjct: 111 EHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPG 162
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
+ APE + D ++ GV L EM+ R
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
+G G FG VF G + + T VAVK+ K ++L E L H
Sbjct: 3 IGRGNFGEVFSGRLRADNTP---------VAVKSCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V+LIG C + +V E + G L L +++ AA G+ +L
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES- 112
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYAAPEYV 313
+ I+RD N L+ K+SDFG++++ E D + ST M + APE +
Sbjct: 113 --KHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT 336
G +S SDV+SFG++L E +
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 72/208 (34%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGDL 192
+G+G FG V + G AVK L + KE +AE N L ++
Sbjct: 3 IGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGAAKGL 249
H LV L Y + +L V +++ G L HL R RS P P R + A A L
Sbjct: 54 KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASAL 109
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+LH +IYRD K NILLD+ + L+DFGL K+G E KT ++ GT Y A
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE + D + G VL EML G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 50/297 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 186
NFR E +G G F V++ +G VA+K + L + + + E+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGV---------PVALKKVQIFDLMDAKARADCIKEI 53
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIAL 243
+ L L H N++K IED++ +V E G L H ++ +P K +
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
L +H R V++RD K +N+ + A KL D GL + KT + ++G
Sbjct: 114 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
T Y +PE + +SD++S G +L EM P G++
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDK 210
Query: 364 RRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
Y L P H+S ++ QL C++ DP+ RP ++ V + K
Sbjct: 211 MNLYSLCKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V+K G VA+K + + + E++ L + H N
Sbjct: 11 IGSGTYGDVYKARDIATGE---------LVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIAL---GAAKGLAF 251
+V G + D+ +V E+ GSL++ + R L +IA KGLA+
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-----QIAYVCRETLKGLAY 116
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYA 308
LHE I+RD K +NILL D + KL+DFG++ T + +GT +
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWM 168
Query: 309 APEYV---MTGHLTSRSDVYSFGVVLLEM 334
APE G + D+++ G+ +E+
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 80/281 (28%), Positives = 119/281 (42%), Gaps = 45/281 (16%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 187
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKR 52
Query: 188 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L + V+ V + Y E D LV M G L+ H++ ++ P + AA
Sbjct: 53 IL-EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFDEQRAIFYAA 109
Query: 247 K---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+ GL L E ++YRD K NILLD + ++SD GLA PEG+ V RV G
Sbjct: 110 ELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-G 163
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
T GY APE + T D + G ++ EM+ G+ K + V+
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREE------ 212
Query: 364 RRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
+D R+ + +S K ++ A + L+++PK R
Sbjct: 213 ------VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 55/233 (23%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 188
+ +G G +G V V TG VA+K +++ D L K L E+
Sbjct: 2 YELLKPIGSGAYGVVCSA---------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKL 52
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL------LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L L H N++ L+ + +V E M E L + I+
Sbjct: 53 LRHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELM-----ETDLHK-------VIKSPQP 99
Query: 243 LGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPE 291
L +GL +LH VI+RD K SNIL++++ + K+ DFGLA+ P+
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
Query: 292 GDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
D+ +V TR Y APE +++ +++ D++S G + E+LT +
Sbjct: 157 EDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 84/307 (27%), Positives = 119/307 (38%), Gaps = 65/307 (21%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLV 193
L+GEG +G V K +E TG VA+K + D K + E+ L L
Sbjct: 8 LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H NLV LI + LV+EF+ L + L + L S K +G+ F H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVSTRVMGTYGYAAP 310
+I+RD K NIL+ KL DFG A+ P T +V+TR Y AP
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAP 169
Query: 311 EYVMTGHLTSRS-DVYSFGVVLLEMLTG---------------------------RRSMD 342
E ++ R+ D+++ G ++ EMLTG +
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229
Query: 343 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
KN L E + +RF P+L G LA CL DP RP
Sbjct: 230 KNPLFAGMRLPE-VKEIEPLEKRF-----PKLSG--------LVLDLAKQCLRIDPDDRP 275
Query: 403 LMSEVVE 409
S+++
Sbjct: 276 SSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 37/91 (40%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
GL FLH+ + +IYRD K N+LLD D + K++DFG+ K+ G+ ++ GT Y
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
APE + D +SFGV+L EML G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 32/207 (15%)
Query: 204 CIEDDQRLL-VYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 257
C + + RL V E++ G L H+ R R LP +S + +AL +LHE
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE--- 114
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTG 316
R +IYRD K N+LLD++ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 317 HLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374
D ++ GV++ EM+ GR D + N + N ++ + E++ R+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IRI 224
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
S+ KAA + L++DPK R
Sbjct: 225 PRSLSV----KAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 126 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 183
L + +LG G FG V+KG WI P + VA+K L + + +KE L
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEIL 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E + + + +L+G C+ +L V + MP G L +++ + + +
Sbjct: 58 DEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCV 116
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPE--GDKTHV 297
AKG+++L E +++RD N+L+ + + K++DFGLA+ D E D V
Sbjct: 117 QIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ M A E ++ T +SDV+S+GV + E++T
Sbjct: 174 PIKWM------ALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 70/216 (32%), Positives = 105/216 (48%), Gaps = 35/216 (16%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 193
E LG G FG V+ ++ VAVKT+ G + +LAE N + L
Sbjct: 11 EKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVMKTLQ 59
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLA 250
H LVKL + + ++ EFM +GSL + L PLP I + A+G+A
Sbjct: 60 HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMA 116
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMG 303
F+ + R I+RD + +NIL+ A K++DFGLA+ EG K +
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK----- 168
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339
+ APE + G T +SDV+SFG++L+E++T R
Sbjct: 169 ---WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 185
NF+ +GEG +G V+K + TG VA+K + D G+ + E
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTA--IRE 49
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 242
++ L +L H N+VKL+ +++ LV+EF+ + F + P +P +
Sbjct: 50 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSYL 106
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+GLAF H + R V++RD K N+L++ + KL+DFGLA+ G T +
Sbjct: 107 FQLLQGLAFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEV 161
Query: 303 GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSM 341
T Y APE ++ + ++ D++S G + EM+T RR++
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 39/278 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG G G V+K + T +AVK + D ++ K+ ++E+ L
Sbjct: 9 LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
++ G +++ + EFM GSL+ ++R+ +P + +IA+ KGL +L
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLD--VYRK---IPEHVLGRIAVAVVKGLTYLWS- 113
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+++RD K SN+L++ KL DFG++ ++ +GT Y APE +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISG 167
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID---P 372
SDV+S G+ +E+ GR + + N + L + ++D P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKN---------QGSLMPLQLLQCIVDEDPP 218
Query: 373 RL-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
L G FS +K C+ + PK RP +++
Sbjct: 219 VLPVGQFS----EKFVHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 42/198 (21%)
Query: 225 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284
++ + L +P I KIA+ K L +LH + VI+RD K SN+L++ + KL DFG
Sbjct: 92 KVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 285 --------LAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLL 332
+AK G K Y APE + +SDV+S G+ ++
Sbjct: 150 ISGYLVDSVAKTIDAGCKP-----------YMAPERINPELNQKGYDVKSDVWSLGITMI 198
Query: 333 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL-EGHFSIKGAQKAAQLAA 391
E+ TGR D W P + ++ P+L FS +
Sbjct: 199 ELATGRFPYDS-----------WKTP-FQQLKQVVEEPSPQLPAEKFSP----EFQDFVN 242
Query: 392 HCLSRDPKARPLMSEVVE 409
CL ++ K RP E+++
Sbjct: 243 KCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 67/221 (30%), Positives = 97/221 (43%), Gaps = 47/221 (21%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG+G FG VF A +K GT A+K L D V + D V
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKD-----------VVLMDDDVEC 41
Query: 196 NLV--KLIG-----------YCI--EDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSI 237
+V +++ YC + V E++ G L H+ + LP
Sbjct: 42 TMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY 101
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+I G L FLH + ++YRD K NILLD D + K++DFG+ K+ GD
Sbjct: 102 AAEIICG----LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-- 152
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
+ GT Y APE ++ + D +SFGV+L EML G+
Sbjct: 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 30/220 (13%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL 192
+ ++GEG FG V K I+ K G + A+K + + H+++ E+ L L
Sbjct: 12 QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64
Query: 193 -VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA------LGA 245
H N++ L+G C L E+ P G+L + L R+S L IA L +
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 123
Query: 246 AKGLAFLHEEA-------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ L F + A ++ I+RD NIL+ +Y AK++DFGL++ G + +V
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 179
Query: 299 TRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 180 -KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 9e-14
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVH 194
++GEG FG V K I+ K G + A+K + + H+++ E+ L L H
Sbjct: 2 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 195 L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR------------ 238
N++ L+G C L E+ P G+L + L R+S L P
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL++ G + +V
Sbjct: 114 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV 166
Query: 298 STRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 167 K-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVN 187
+ + +G+G G V+ TA + TG VA+K +N Q KE + E+
Sbjct: 19 KKYTRFEKIGQGASGTVY--------TA-IDVATGQEVAIKQMNLQQ-QPKKELIINEIL 68
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ + H N+V + + D+ +V E++ GSL + + + + +
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--GQIAAVCRECLQ 126
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYG 306
L FLH VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT
Sbjct: 127 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPY 180
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ APE V + D++S G++ +EM+ G
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 48/141 (34%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
Y + D +L L+ +++ G L HL++R +R+ IA L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ---LGII 127
Query: 262 YRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVMT---G 316
YRD K NILLD++ + L+DFGL+K+ E ++ + GT Y APE + G
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGG 184
Query: 317 HLTSRSDVYSFGVVLLEMLTG 337
H D +S GV+ E+LTG
Sbjct: 185 H-DKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG G FG V KG + + TVAVK L +D E L E N + L +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEK-------TVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
+V++IG C E + +LV E G L L + +I ++ + G+ +L E
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVHQVSMGMKYLEE 113
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEY 312
++RD N+LL + AK+SDFGL+K D+ + + G + + APE
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 313 VMTGHLTSRSDVYSFGVVLLE 333
+ +S+SDV+SFGV++ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 186
N+R LLG+G FG V+ + V G L + + + KE A E+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCY-------DVDTGRELAAKQVQFDPESPETSKEVSALECEI 55
Query: 187 NFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
L +L H +V+ G C+ D ++ L ++ E+MP GS+++ L + L S+ K
Sbjct: 56 QLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTR 113
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-VM 302
+G+++LH +++RD K +NIL D+ N KL DFG +K + R V
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
GT + +PE + ++DV+S G ++EMLT +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 33/232 (14%)
Query: 117 RKFTFNDLKLATRNFR--PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
R + D ++A F+ PE L +G G FG V+ + + T V VA+
Sbjct: 5 RAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY--FARDVRTNEV-------VAI 55
Query: 169 KTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 225
K +++ G Q +++W + EV FL + H N ++ G + + LV E+ GS +
Sbjct: 56 KKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDL 114
Query: 226 LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
L PL I GA +GLA+LH +I+RD K NILL KL+DFG
Sbjct: 115 LEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGS 171
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 334
A + +GT + APE ++ G + DV+S G+ +E+
Sbjct: 172 ASIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 31/222 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 184
N+R LLG+G FG V+ + + TG +AVK + + + + KE A
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALEC 53
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E+ L +L+H +V+ G + +R L E MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYT 112
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------GPEGDKTH 296
+G+++LH +++RD K +NIL D+ N KL DFG +K G K+
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS- 168
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
V GT + +PE + ++D++S G ++EMLT +
Sbjct: 169 ----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 17/215 (7%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 183
+L +F S LG G G VFK KP +GL +A K ++ + + +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQII 51
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E+ L + +V G D + + E M GSL+ + +++ +P I K+++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSI 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
KGL +L E+ + +++RD K SNIL+++ KL DFG++ G D ++ +G
Sbjct: 111 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 164
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
T Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L FLH VIYRD K NILLDA+ + KL+DFG+ K+G T +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
APE + D ++ GV++ EM+ G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 70/274 (25%), Positives = 121/274 (44%), Gaps = 34/274 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 195
+G+G FG V+KG +N T V VA+K ++ + + E + E+ L
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
+ + G ++ + ++ E++ GS + L + PL + I KGL +LH E
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE 120
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+ I+RD K +N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 375
++D++S G+ +E+ G P L+ P P LE
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLE 222
Query: 376 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
G +S + + CL++DP+ RP E+++
Sbjct: 223 GQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 73/256 (28%), Positives = 100/256 (39%), Gaps = 58/256 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN-------FL 189
+G+GG+G VF K TG VA+K + L L EV L
Sbjct: 9 VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55
Query: 190 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMP----------RGSLENHLFRRSLPLPWSIR 238
LVKL+ Y +DD+ L L E++P G L R +
Sbjct: 56 TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM-----AE 109
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
M A+ A L ++H RD K N L+DA + KL+DFGL+K +
Sbjct: 110 MFEAVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA 356
V+G+ Y APE V+ G + D +S G +L E L G + PN NL W
Sbjct: 156 NSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK 214
Query: 357 ----RPHLGERRRFYR 368
RP + R
Sbjct: 215 ETLQRPVYDDPRFNLS 230
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 30/212 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 191
+GEG +G V+KG TG VA+K + L+ +E + E++ L +
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKE 55
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI---RMKIAL-GAAK 247
L H N+V L +++ + L++EF+ L+ +L SLP + +K L +
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKSYLYQILQ 112
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ F H R V++RD K N+L+D KL+DFGLA+ G V T + T Y
Sbjct: 113 GILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167
Query: 308 AAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
APE ++ S D++S G + EM T +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 75/284 (26%), Positives = 122/284 (42%), Gaps = 40/284 (14%)
Query: 133 PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-E 185
PE L +G+G FG VFKG +N T V VA+K ++ + + E + E
Sbjct: 2 PEELFTKLERIGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQE 52
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
+ L + K G ++ + ++ E++ GS + L R+ P +
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEI 110
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
KGL +LH E + I+RD K +N+LL + KL+DFG+A G D +GT
Sbjct: 111 LKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTP 165
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + S++D++S G+ +E+ G P L+ P
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP------- 218
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
P L G FS + + CL++DP RP E+++
Sbjct: 219 ------PTLTGEFS----KPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 74/235 (31%), Positives = 103/235 (43%), Gaps = 43/235 (18%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGL 176
FT DLK +G G FG V K + +GT +AVK D
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGT---------IMAVKRIRSTVDEK 44
Query: 177 QGHKEWLAEVNFLGDLVH-----LNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-----HL 226
+ K L ++ D+V +VK G + + E M SL+ +
Sbjct: 45 E-QKRLLMDL----DVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYE 98
Query: 227 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
+S+ +P I KIA+ K L +L EE + +I+RD K SNILLD + N KL DFG++
Sbjct: 99 VLKSV-IPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS 155
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEMLTGR 338
G D TR G Y APE + RSDV+S G+ L E+ TG+
Sbjct: 156 --GQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 133 PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---L 183
PE L +G G FG V+ N VA+K +++ G Q +++W +
Sbjct: 13 PEKLFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDII 63
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
EV FL L H N ++ G + + LV E+ GS + L PL +
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
GA +GLA+LH +I+RD K NILL KL DFG A + +G
Sbjct: 123 GALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXFVG 173
Query: 304 TYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 334
T + APE ++ G + DV+S G+ +E+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 38/91 (41%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
GL FLH + +IYRD K N++LD D + K++DFG+ K+ GD ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
APE + T D +SFGV+L EML G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 96/363 (26%), Positives = 143/363 (39%), Gaps = 68/363 (18%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V ++E T G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 249
H L L Y + RL V E+ G L HL R + +S GA L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSAL 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+LH +E+ V+YRD K N++LD D + K++DFGL K+G + T + GT Y A
Sbjct: 109 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 164
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
PE + D + GVV+ EM+ GR L+ L E RF R
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEIRFPRT 218
Query: 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPK---------ARPLMS---------EVVEAL 411
+ P +A L + L +DPK A+ +M + V
Sbjct: 219 LSP------------EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEK 266
Query: 412 KPLPNLKDMASSS----YYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSY 467
K +P K +S Y+ + A+ I +P ++ + +R P SY
Sbjct: 267 KLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDN-----ERRPHFPQFSY 321
Query: 468 ASP 470
++
Sbjct: 322 SAS 324
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 183
+L +F S LG G G V K KP +GL +A K ++ + + +
Sbjct: 1 ELKDDDFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQII 51
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E+ L + +V G D + + E M GSL+ + + + +P I K+++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSI 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
+GLA+L E+ + +++RD K SNIL+++ KL DFG++ G D ++ +G
Sbjct: 111 AVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 164
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
T Y +PE + H + +SD++S G+ L+E+ GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 30/227 (13%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
++G GGFG V+ K TG A+K L+ ++ + E L + + L
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIML 48
Query: 196 NLVKL--------IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+LV + Y +L + + M G L HL + + +R A
Sbjct: 49 SLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEII 107
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
GL +H R V+YRD K +NILLD + ++SD GLA D + K H S +GT+G
Sbjct: 108 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHG 160
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
Y APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 36/217 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 191
LG+G +G V+K + T VA+K + D + + A E+ FL +
Sbjct: 15 LGKGAYGIVWKA---------IDRRTKEVVALKKI-FDAFRNATD--AQRTFREIMFLQE 62
Query: 192 LV-HLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 245
L H N+VKL+ E+D+ + LV+E+M E L R ++ R I
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQL 116
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVM 302
K L ++H VI+RD K SNILL++D KL+DFGLA+ + E + V T +
Sbjct: 117 LKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 303 GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
T Y APE ++ ++ D++S G +L EML G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 50/145 (34%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 194 HLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H L +L C + RL V EF+ G L H+ ++S + A L FL
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFL 112
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 312
H+ + +IYRD K N+LLD + + KL+DFG+ K+G KT ++ GT Y APE
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEI 167
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTG 337
+ D ++ GV+L EML G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 161 GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFM 217
GTG A+K L + K+ E + L +L H +V ++ ++++ + EF+
Sbjct: 41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100
Query: 218 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277
G L HL R++ P + +LH + +IYRD K N+LLD +
Sbjct: 101 VGGELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGH 156
Query: 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 336
K++DFG AK P+ T + GT Y APE + + GH D ++ GV+L E +
Sbjct: 157 VKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIA 210
Query: 337 G 337
G
Sbjct: 211 G 211
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 85/275 (30%), Positives = 112/275 (40%), Gaps = 48/275 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V + E T G A+K L + + E + E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 249
H L L Y + RL V E+ G L HL R + R GA L
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIVSAL 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+LH R V+YRD K N++LD D + K++DFGL K+G T + GT Y A
Sbjct: 109 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRF 366
PE + D + GVV+ EM+ GR + D R L E L E RF
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELI---LMEEIRF 214
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
R + P +A L A L +DPK R
Sbjct: 215 PRTLSP------------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 21/183 (11%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
+G VAVK ++ Q + EV + D H N+V++ + ++ ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 222 LENHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278
L + + + L +IA + L +LH + VI+RD K+ +ILL D
Sbjct: 105 LTDIVSQTRLN-----EEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRV 156
Query: 279 KLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334
KLSDFG ++KD P+ ++GT + APE + + D++S G++++EM
Sbjct: 157 KLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 335 LTG 337
+ G
Sbjct: 211 VDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 64/258 (24%), Positives = 112/258 (43%), Gaps = 42/258 (16%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 221
TG VAVK ++ Q + EV + D H N+V + + D+ +V EF+ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 222 LENHLFRRSLPLPWSIRMK------IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275
L + + RM + L + L++LH + VI+RD K+ +ILL +D
Sbjct: 106 LTD--------IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSD 154
Query: 276 YNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 331
KLSDFG ++K+ P+ ++GT + APE + + D++S G+++
Sbjct: 155 GRIKLSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 208
Query: 332 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 391
+EM+ G + P L RR + PR++ + +
Sbjct: 209 IEMIDGEPPY-------------FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FLD 253
Query: 392 HCLSRDPKARPLMSEVVE 409
L R+P R E+++
Sbjct: 254 LMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 70/214 (32%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
FR +LG+GGFG V A TG A K L ++ K +N
Sbjct: 2 FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 191 DLVHLN--LVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +N V + Y E D LV M G L+ H++ ++ P + AA+
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAE 110
Query: 248 ---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
GL LH E ++YRD K NILLD + ++SD GLA + PEG+ + RV GT
Sbjct: 111 ITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GT 164
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
GY APE V T D + G ++ EM+ G+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 46/297 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGW-IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
NF+ E +G G F V++ + + +K V+ + ++ + E++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALK-------KVQIFEMMDAKARQDCVKEIDL 55
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGA 245
L L H N++K + IED++ +V E G L + ++ +P K +
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ +H R V++RD K +N+ + A KL D GL + KT + ++GT
Sbjct: 116 CSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTP 170
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
Y +PE + +SD++S G +L EM P G++
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDKMN 212
Query: 366 FYRLID-------PRLEG-HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+ L P L H+S +K +L + C+ DP RP + V + K +
Sbjct: 213 LFSLCQKIEQCDYPPLPTEHYS----EKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 184
N+R LLG G FG V+ + + TG +AVK + + D + KE A
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALEC 53
Query: 185 EVNFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKI 241
E+ L +L H +V+ G C+ D +++L ++ E+MP GS+++ L + L ++ +
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRY 111
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------GPEGDKT 295
+G+++LH +++RD K +NIL D+ N KL DFG +K G K+
Sbjct: 112 TRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
V GT + +PE + ++DV+S ++EMLT
Sbjct: 169 -----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 47/277 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVH 194
++G GGFG V+ K TG A+K L+ ++ + E LA L + +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLA----LNERIM 47
Query: 195 LNLVKL--------IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L+LV + Y +L + + M G L HL + + +R A
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEI 106
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
GL +H R V+YRD K +NILLD + ++SD GLA D + K H S +GT+
Sbjct: 107 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTH 159
Query: 306 GYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
GY APE + G S +D +S G +L ++L G +++ +H E
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----------EID 208
Query: 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
R + L FS + L L RD R
Sbjct: 209 RMTLTMAVELPDSFS----PELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 73/283 (25%), Positives = 120/283 (42%), Gaps = 51/283 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+GEG G V A VK +G VAVK ++ Q + EV + D H N
Sbjct: 28 IGEGSTGIVC--------IATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 250
+V++ + D+ +V EF+ G+L + + RM + L K L+
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLKALS 130
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 306
LH + VI+RD K+ +ILL D KLSDFG ++K+ P ++GT
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKSLVGTPY 181
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
+ APE + D++S G++++EM+ G P ++ R +L + +
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKN 238
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ P L+G L RDP R +E+++
Sbjct: 239 LHKVSPSLKGFLD------------RLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 27/162 (16%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHL-----FRRSLPLPWSI 237
E L ++ H +++L + E DQR L + E++P G L ++L F S L ++
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ AL +LH + ++YRD K NILLD + + KL+DFG AK K
Sbjct: 109 EIVCAL------EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRD 153
Query: 298 STRVM-GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 337
T + GT Y APE + GH + D ++ G+++ EML G
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 186
+F +LG+G FG V A K GT A+K L D + + + E
Sbjct: 1 DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMK 240
L + + C + RL V E++ G L H+ F+ + ++ +
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+ GL FLH R +IYRD K N++LD++ + K++DFG+ K E V+TR
Sbjct: 112 V------GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTR 159
Query: 301 VM-GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342
GT Y APE + D +++GV+L EML G+ D
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 35/94 (37%), Positives = 56/94 (59%), Gaps = 5/94 (5%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTY 305
+GL ++H V++RD K SN+LL+ + + K+ DFGLA+ PE D T T + T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 306 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y APE ++ +++ D++S G +L EML+ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 71/208 (34%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGD 191
++G+G FG V + +G AVK L + KE +AE N L +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKC---------YAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGL 249
+ H LV L Y + ++L V +F+ G L HL R RS P P + R A A L
Sbjct: 53 VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EIASAL 109
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+LH ++YRD K NILLD+ + L+DFGL K+G T +T GT Y A
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLA 164
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
PE + + D + G VL EML G
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 69/263 (26%), Positives = 118/263 (44%), Gaps = 50/263 (19%)
Query: 84 PAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFG 143
P+++ SS+++S + S S +K EL+ R+ + +G G G
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELE---RVNR------------------IGSGAGG 88
Query: 144 CVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLVHLNLVKLI 201
V+K + TG A+K + NH+ ++ E+ L D+ H N+VK
Sbjct: 89 TVYK---------VIHRPTGRLYALKVIYGNHED-TVRRQICREIEILRDVNHPNVVKCH 138
Query: 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
+ + ++ EFM GSLE L +A G+A+LH R ++
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHR---RHIV 190
Query: 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVMTGHLTS 320
+RD K SN+L+++ N K++DFG+++ + D + S +GT Y +PE + T
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHG 247
Query: 321 R-----SDVYSFGVVLLEMLTGR 338
D++S GV +LE GR
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 68/207 (32%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGD 191
++G+G FG V + +G+ AVK L + KE +AE N L +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGS---------FYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
L H LV L Y + ++L V +++ G L HL R L R A A +
Sbjct: 53 LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIG 110
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH +IYRD K NILLD+ + L+DFGL K+G E ++T ++ GT Y AP
Sbjct: 111 YLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAP 165
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTG 337
E + D + G VL EML G
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAE 185
F + +GEG +G V++ +G VA+K + DG+ L E
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISS--LRE 56
Query: 186 VNFLGDLVHLNLVKL---------------IGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230
+ L +L H N+V+L + YC +D LL + MP
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT----------- 103
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
P S + L +GL +LHE +I+RD K SN+LL K++DFGLA+
Sbjct: 104 -PFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLAR--T 157
Query: 291 EGDKTHVSTRVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLLEMLTGR 338
G T + T Y APE + T + T+ D+++ G +L E+L +
Sbjct: 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 45/219 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G V+K + TG VA+K + L+ E + E++ L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVALKKIR---LETEDEGVPSTAIREISLLKE 54
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA---- 246
L H N+V+L+ + + +L LV+EF+ L+ + S P L
Sbjct: 55 LNHPNIVRLLD-VVHSENKLYLVFEFL---DLDLKKYMDSSP-------LTGLDPPLIKS 103
Query: 247 ------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+G+A+ H V++RD K N+L+D + KL+DFGLA+ G T
Sbjct: 104 YLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTH 158
Query: 301 VMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ T Y APE ++ S D++S G + EM+ R
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 87/275 (31%), Positives = 115/275 (41%), Gaps = 48/275 (17%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V + E T G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAT-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 249
H L L Y + RL V E+ G L HL R + R GA L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---YGAEIVSAL 108
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYA 308
+LH V+YRD K N++LD D + K++DFGL K+G +G GT Y
Sbjct: 109 GYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYL 162
Query: 309 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRF 366
APE V+ + R+ D + GVV+ EM+ GR N +H L E L E RF
Sbjct: 163 APE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHEKLFELI---LMEEIRF 214
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
R + P +A L A L +DPK R
Sbjct: 215 PRTLSP------------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG+G +G V+ A T + +A+K + + + E+ L H
Sbjct: 15 VLGKGTYGIVY---------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA--KGLAFLH 253
N+V+ +G E+ + E +P GSL L + PL + + I +GL +LH
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 254 EEAERPVIYRDFKTSNILLDADYNA--KLSDFG----LAKDGPEGDKTHVSTRVMGTYGY 307
+ +++RD K N+L++ Y+ K+SDFG LA P + GT Y
Sbjct: 126 DNQ---IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQY 175
Query: 308 AAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGR 338
APE + G + +D++S G ++EM TG+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 47/229 (20%)
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAF 251
H ++V L G C+ D + ++V EF+ G L+ + R+S L PW + K+A A L++
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 252 LHEEAERPVIYRDFKTSNILL-----DADYNA--KLSDFGLAKDGPEGDKTHVSTR--VM 302
L ++ +++ + T NILL D + KLSD G+ V +R +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQECV 169
Query: 303 GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
+ APE V + +L+ +D +SFG L E+ NGE L + L
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----------NGEIPLKD---KTLA 216
Query: 362 ERRRFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVV 408
E+ RFY EG + ++ A L HC++ DP RP ++
Sbjct: 217 EKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 19/144 (13%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI----RMKIALGAAKGLAFLHEEAE 257
Y +DD+ L +V E+MP G L N + +P W+ + +AL A + F+H
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 315
RD K N+LLD + KL+DFG T V GT Y +PE + +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 316 --GHLTSRSDVYSFGVVLLEMLTG 337
G+ D +S GV L EML G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G V+K T T+A+K + L+ E + E++ L +
Sbjct: 10 IGEGTYGVVYKARDRV---------TNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAA 246
+ H N+V+L + + LV+E++ L+ H+ F ++ L + +I
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI----L 112
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+G+A+ H V++RD K N+L+D NA KL+DFGLA+ G T + T
Sbjct: 113 RGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTL 167
Query: 306 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ + H ++ D++S G + EM+ +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 56/172 (32%), Positives = 77/172 (44%), Gaps = 24/172 (13%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 302
A+G+ FL A R I+RD NILL + K+ DFGLA+D + D +V S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGSARL- 238
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
+ APE + T++SDV+SFGV+L E+ + S P + N R G
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQINEEFCQRLKDGT 294
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
R R P + + C DPK RP S +VE L L
Sbjct: 295 RMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G + +G P + V VK L +Q ++L E L H
Sbjct: 3 IGNGWFGKVILGEVN-SGYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKG 248
NL++ +G C E LLV EF P G L+ +L RS P P +++ ++A A G
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQ-RMACEIALG 112
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L LH+ I+ D N LL AD K+ D+GL+ + + D ++ +
Sbjct: 113 LLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI 169
Query: 309 APEYV--MTGHL-----TSRSDVYSFGVVLLEML 335
APE V + G+L T S+V+S GV + E+
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 65/191 (34%), Positives = 81/191 (42%), Gaps = 26/191 (13%)
Query: 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271
LV F+ G L +HL R R A + L L + VIYRD K NIL
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTA----ELLCALENLHKFNVIYRDLKPENIL 125
Query: 272 LDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 330
LD + L DFGL K + + DKT+ GT Y APE ++ T D ++ GV+
Sbjct: 126 LDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYLAPELLLGHGYTKAVDWWTLGVL 182
Query: 331 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 390
L EMLTG P + N+ E R L E RF D + A L
Sbjct: 183 LYEMLTGL------PPFYDENVNEMYRKILQEPLRFPDGFD------------RDAKDLL 224
Query: 391 AHCLSRDPKAR 401
LSRDP R
Sbjct: 225 IGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G VF + TG VA+K +N + + E+ + +L + N
Sbjct: 27 IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAAKGLAFLH 253
+V + + D+ +V E++ GSL + + + +IA + L FLH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-----EAQIAAVCRECLQALEFLH 132
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEY 312
VI+RD K+ N+LL D + KL+DFG A+ PE K + ++GT + APE
Sbjct: 133 ANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTG 337
V + D++S G++ +EM+ G
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 41/125 (32%), Positives = 57/125 (45%), Gaps = 4/125 (3%)
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
RS PLP + I + LA+LH R +I+RD KT NI LD NA L DFG A
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACK 234
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPN 347
T GT +PE + +++D++S G+VL EM ++ K +
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
Query: 348 GEHNL 352
L
Sbjct: 295 SSSQL 299
|
Length = 392 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 159 KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 218
KPG V +K G +G L E L ++ H +++++ + +V +P
Sbjct: 87 KPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LP 137
Query: 219 --RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
L +L +RS PLP + I +GL +LH A+R +I+RD KT NI ++
Sbjct: 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH--AQR-IIHRDVKTENIFINDVD 194
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ D G A+ P + + GT APE + S++D++S G+VL EML
Sbjct: 195 QVCIGDLGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
Query: 337 GRRSMDKNRPNGEHNLVEWARPHL 360
++ ++ P+ V+ HL
Sbjct: 252 YPSTIFEDPPSTPEEYVKSCHSHL 275
|
Length = 357 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 46/183 (25%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 166 VAVKTLNHDGLQGHKEWLA----EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFM 217
V ++T +GHK + E+ L + N++K+ G+ I+ L L+ E+
Sbjct: 46 VIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 218 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277
RG L L + L + ++ +A+ KGL L++ +P Y++ + + L+ +Y
Sbjct: 105 TRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYK 161
Query: 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEML 335
K+ GL K +V+ V Y + + + T + D+YS GVVL E+
Sbjct: 162 LKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
Query: 336 TGR 338
TG+
Sbjct: 217 TGK 219
|
Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 19/146 (13%)
Query: 204 CIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 257
C + RL V E++ G L + F+ + ++ + I GL FLH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHSKG- 121
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTG 316
+IYRD K N++LD++ + K++DFG+ K E V+T+ GT Y APE +
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 317 HLTSRSDVYSFGVVLLEMLTGRRSMD 342
D ++FGV+L EML G+ +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFL 189
+GEG +G V+K TG VA+K + L KE + E+ L
Sbjct: 13 GQIGEGTYGQVYKA---------RDKDTGELVALKKVR---LDNEKEGFPITAIREIKIL 60
Query: 190 GDLVHLNLVKLIGYCIEDDQRL----------LVYEFMPR---GSLENHLFRRSLPLPWS 236
L H N+V L + L LV+E+M G LE+ L S S
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
MK L +GL + H+ + ++RD K SNILL+ KL+DFGLA+ +
Sbjct: 121 F-MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ +V+ T Y PE ++ + DV+S G +L E+ T +
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 20/145 (13%)
Query: 203 YC-IEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEA 256
+C +DD+ L +V E+MP G L N + +P W + + +AL A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 165
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT- 315
RD K N+LLD + KL+DFG E T V GT Y +PE + +
Sbjct: 166 ------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 316 ---GHLTSRSDVYSFGVVLLEMLTG 337
G+ D +S GV L EML G
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G V+ + TG VA++ +N + + E+ + + + N
Sbjct: 28 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 136
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 190
Query: 316 GHLTSRSDVYSFGVVLLEMLTG 337
+ D++S G++ +EM+ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G+G G V+ + TG VA+K +N + + E+ + + + N
Sbjct: 27 IGQGASGTVYTA---------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALDFLHSNQ 135
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 136 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 189
Query: 316 GHLTSRSDVYSFGVVLLEMLTG 337
+ D++S G++ +EM+ G
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 62/252 (24%), Positives = 99/252 (39%), Gaps = 58/252 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGD 191
L+G+GG G V+ + P VA+K + D L K +L E D
Sbjct: 9 LIGKGGMGEVYLAY---------DPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAAD 58
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFR-----RSLPLPWSIR------ 238
L+H +V + Y I D VY MP G L + SL + +
Sbjct: 59 LIHPGIVPV--YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTH 296
+ I + ++H + V++RD K NILL + D+G A K E D
Sbjct: 116 LSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 297 VST--------------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT------ 336
+ +++GT Y APE ++ + +D+Y+ GV+L +MLT
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
Query: 337 ---GRRSMDKNR 345
GR+ ++
Sbjct: 233 RKKGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL ++H +I+RD K SNI ++ D K+ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 307 YAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 338
Y APE +M H D++S G ++ E+LTG+
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 10/139 (7%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
Y + D +L L+ +++ G L HL +R +++ L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLHKLG---II 127
Query: 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHL 318
YRD K NILLD++ + L+DFGL+K+ E D+ + GT Y AP+ V GH
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIVRGGDGGH- 185
Query: 319 TSRSDVYSFGVVLLEMLTG 337
D +S GV++ E+LTG
Sbjct: 186 DKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 74/282 (26%), Positives = 121/282 (42%), Gaps = 51/282 (18%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGDL 192
LG+G F ++KG ++ V PG ++V +K L H++ LA + + L
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H +LVKL G C+ D + ++V E++ G L+ L R + ++ +A A L +L
Sbjct: 59 SHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 253 HEEAERPVIYRDFKTSNILL-DADYN------AKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
++ +++ + NIL+ N KLSD G+ + R+
Sbjct: 118 EDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168
Query: 306 GYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
+ APE + G LT +D +SFG LLE+ + NGE L + E+
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICS----------NGEEPLSTLSS---SEK 215
Query: 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAA---HCLSRDPKARP 402
RFY+ + H A+LA C + DP RP
Sbjct: 216 ERFYQ------DQH--RLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 75/285 (26%), Positives = 118/285 (41%), Gaps = 45/285 (15%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIA 242
+E++ L H +VK DD+ LL+ E+ G L + +R LP+ ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
L + + L E R +++RD K++NI L KL DFG +K + V++
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
GT Y APE + ++D++S GV+L E+LT RP G
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLT------------------LHRPFKGP 274
Query: 363 RRR------FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV--EALKPL 414
+R Y DP F + L LS++P RP +++ E LK +
Sbjct: 275 SQREIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329
Query: 415 PNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRS 459
NL FQ + SP+ R I Q L +G+R+
Sbjct: 330 ANL---------FQDIVRHSETISPHDREEILRQ---LQESGERA 362
|
Length = 478 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 47/144 (32%), Positives = 67/144 (46%), Gaps = 19/144 (13%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEAE 257
Y +DD+ L +V E+MP G L N + +P W + + +AL A + F+H
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 315
RD K N+LLD + KL+DFG + T V GT Y +PE + +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 316 --GHLTSRSDVYSFGVVLLEMLTG 337
G+ D +S GV L EML G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH-------LFRRSLPLPWSI 237
EV L + H N+V E+ + +V E+ G L LF L W +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTH 296
+I+LG L +H+ R +++RD K+ NI L + AKL DFG+A+ D
Sbjct: 109 --QISLG----LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSME 157
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344
++ +GT Y +PE +++D++S G VL E+ T + + N
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 137 LGEGGFGCVFKGW--IEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLV 193
LGEG + VFKG + EN VA+K + + +G + EV+ L DL
Sbjct: 14 LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N+V L D LV+E++ + L+ ++ + +GLA+ H
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
R V++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ +
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 176
Query: 314 M-TGHLTSRSDVYSFGVVLLEMLTGR 338
+ + +++ D++ G + EM +GR
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWL 183
NF +LG G +G VF + + TG A+K L L H
Sbjct: 1 NFELLKVLGTGAYGKVF--LVRKVT----GHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM--- 239
E N L + + + Y + + +L L+ +++ G + HL++R +R
Sbjct: 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG 112
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
+I L L LH+ ++YRD K NILLD++ + L+DFGL+K+ +K +
Sbjct: 113 EIILA----LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 300 RVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLLEMLTG 337
GT Y APE + GH D +S G+++ E+LTG
Sbjct: 166 -FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 38/216 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGDLVH 194
+GEG +G VFK E T VA+K L+ D L E+ L +L H
Sbjct: 8 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMP----------RGSLENHLFRRSLPLPWSIRMKIALG 244
N+V+L D + LV+E+ G ++ + + +
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-----------FQ 107
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
KGLAF H V++RD K N+L++ + KL+DFGLA+ G + + T
Sbjct: 108 LLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVT 162
Query: 305 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRR 339
Y P+ + L S S D++S G + E+ R
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 53/184 (28%), Positives = 77/184 (41%), Gaps = 45/184 (24%)
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
L LH+ ++YRD K NILLDA + L DFGL+K +KT + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 309 APEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
APE ++ G+ T D +S GV++ EM G W+ + + ++
Sbjct: 164 APEVLLDEKGY-TKHVDFWSLGVLVFEMCCG-----------------WSPFYAEDTQQM 205
Query: 367 YRLID------PR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416
YR I P+ EG +KG L+R+P+ R LK P
Sbjct: 206 YRNIAFGKVRFPKNVLSDEGRQFVKG----------LLNRNPQHRLGAHRDAVELKEHPF 255
Query: 417 LKDM 420
D+
Sbjct: 256 FADI 259
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 50/288 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGDLVH 194
LG+G +G V+K +P TG+T+A+K + + L K + + E++ L V
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVS 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF 251
+V G + + E+M GSL+ L+ + +P + +I KGL F
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAP 310
L EE +I+RD K +N+L++ + KL DFG++ + KT++ G Y AP
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAP 170
Query: 311 EYVMTGHLTSR------SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
E + +G SDV+S G+ +LEM GR P N+
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFA---------- 217
Query: 365 RFYRLID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ ++D P L +S A A CL++ P RP ++++E
Sbjct: 218 QLSAIVDGDPPTLPSGYS----DDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 24/160 (15%)
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGL 249
N+V L Y + +D LV + G L +H+ + L +P W+ M +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDA---- 100
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYA 308
LH E ++ RD +NILLD + +L+ F + D V Y
Sbjct: 101 --LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348
APE T D +S G +L E+LTG +++ + P+G
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 33/219 (15%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 186
+ P + +G G +G V+K P +G VA+K++ N DGL + EV
Sbjct: 2 YEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLP--LSTVREV 50
Query: 187 NFLGDLVHL---NLVKLIGYC--IEDDQRL---LVYEFMPRGSLENHLFRRSLP-LPWSI 237
L L N+V+L+ C D+ LV+E + + L +L + P LP
Sbjct: 51 ALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAET 109
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ +GL FLH +++RD K NIL+ + KL+DFGLA+ +
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQM 162
Query: 298 S-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 335
+ T V+ T Y APE ++ + D++S G + EM
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 58/175 (33%), Positives = 79/175 (45%), Gaps = 10/175 (5%)
Query: 167 AVKTLNHDGLQGHKE---WLAEVN-FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL 222
AVK L + KE ++E N L ++ H LV L D+ V +++ G L
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83
Query: 223 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282
HL R L R A A L +LH ++YRD K NILLD+ + L+D
Sbjct: 84 FYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTD 139
Query: 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
FGL K+ E + T ++ GT Y APE + D + G VL EML G
Sbjct: 140 FGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 62/240 (25%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 187
++P +G G +G V + +G VA+K + H D K L E+
Sbjct: 6 RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR---------LLVYEFM---------PRGSLENHLFRR 229
L H N++ I D R +V + M L R
Sbjct: 57 ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY 111
Query: 230 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-- 287
L + + +GL ++H VI+RD K SN+L++ D ++ DFG+A+
Sbjct: 112 FL---YQL--------LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 288 -DGPEGDKT----HVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSM 341
P K +V+TR Y APE +++ + + D++S G + EML GRR +
Sbjct: 158 SSSPTEHKYFMTEYVATR-----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 64/207 (30%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 192
LLG+G FG V + E + G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAS-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H L L Y + RL V E++ G L HL R + R A L +
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDY 110
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
LH ++YRD K N++LD D + K++DFGL K+G T + GT Y APE
Sbjct: 111 LHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPE 165
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLTGR 338
+ D + GVV+ EM+ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 15/181 (8%)
Query: 162 TGLTVAVKTLNH--DGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMP 218
TG VA+K + K E+ L L H N++ L I + + V E +
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278
+ H S PL +GL ++H V++RD K SNIL++ + +
Sbjct: 93 --GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDL 147
Query: 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTG 337
K+ DFGLA+ +VSTR Y APE ++T D++S G + EML G
Sbjct: 148 KICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
Query: 338 R 338
+
Sbjct: 203 K 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL----- 183
+ + + +GEG +G VFK +NG G VA+K + +Q +E +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVR---VQTGEEGMPLSTI 49
Query: 184 ---AEVNFLGDLVHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LP 234
A + L H N+V+L C + + LV+E + + L +L + P +P
Sbjct: 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI---YSF 162
Query: 295 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
T V+ T Y APE ++ + D++S G + EM +
Sbjct: 163 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 49/151 (32%), Positives = 70/151 (46%), Gaps = 17/151 (11%)
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+H + +I+RD K++NILL ++ KL DFG +K V GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 371
+ ++D++S GV+L E+LT +R D GE N+ E L R D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-NMEEVMHKTLAGR------YD 263
Query: 372 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
P L S + ++ LS DPK RP
Sbjct: 264 P-LPPSIS----PEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 39/217 (17%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT----LNHDGLQGHKEWLAEVNFLG 190
+ +GEG +G V+K TG VA+K L+ +G+ L E+ L
Sbjct: 5 AEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLK 53
Query: 191 DLV---HLNLVKLIGYC--IEDDQRL---LVYEFMPR---GSLENHLFRRSLPLPWSIR- 238
L H N+V+L+ C D+ L LV+E + + L + LP P +I+
Sbjct: 54 QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLP-PETIKD 111
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
M+ L +G+ FLH +++RD K NIL+ +D K++DFGLA+
Sbjct: 112 LMRQLL---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMA 162
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334
T V+ T Y APE ++ + D++S G + E+
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG + VFKG + T VA+K + + +G + EV+ L +L H
Sbjct: 13 LGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V L + LV+E++ L+ +L + +GL++ H+
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK- 121
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM- 314
R +++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ ++
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 177
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGR 338
+ ++ D++ G +L EM TGR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL +LH +++RD K N+L++++ K+ DFGLA+ + H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 307 YAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE +M + H TS D++S G + E+L R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG + V+KG NG VA+K ++ +G + E + L L H
Sbjct: 13 LGEGSYATVYKGISRINGQ---------LVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 254
N+V L + V+E+M L ++ + L P+++R+ +GLA++H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG 121
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+ +++RD K N+L+ KL+DFGLA+ +T+ S V T Y P+ ++
Sbjct: 122 ---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 315 -TGHLTSRSDVYSFGVVLLEMLTGR 338
+S D++ G + +EML G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 61/260 (23%), Positives = 120/260 (46%), Gaps = 39/260 (15%)
Query: 91 STTTSNAESNSSTSKLEEELKVASRLRKFTFNDL-KLATRNFRPESLLGEGGFGCVFKGW 149
N++ + E+E K+ ND+ + ++++ +++G G FG V++
Sbjct: 34 KLDEEERSHNNNAGEDEDEEKMID-------NDINRSPNKSYKLGNIIGNGSFGVVYEA- 85
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY----CI 205
+ T VA+K + D ++E L + +L H+N++ L Y C
Sbjct: 86 --------ICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYYYTECF 133
Query: 206 EDDQRLL----VYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 259
+ +++ + V EF+P+ H R + LP + + + LA++H +
Sbjct: 134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--- 190
Query: 260 VIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGH 317
+ +RD K N+L+D + + KL DFG AK+ G + S + + Y APE ++ +
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATN 247
Query: 318 LTSRSDVYSFGVVLLEMLTG 337
T+ D++S G ++ EM+ G
Sbjct: 248 YTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 46/282 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
+GEG FG +E+G V +K +N + +E EV L ++ H
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYV---------IKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSIRMKIALGAAK 247
N+V+ E+ +V ++ G L LF L W +++ +AL
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL---- 114
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
+H+ R +++RD K+ NI L D KL DFG+A+ ++ +GT Y
Sbjct: 115 --KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYY 167
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
+PE ++SD+++ G VL EM T + + + NLV L R Y
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLV------LKIIRGSY 218
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
P + H+S +QL R+P+ RP ++ ++E
Sbjct: 219 ----PPVSSHYSYDLRNLVSQL----FKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 81/296 (27%), Positives = 125/296 (42%), Gaps = 52/296 (17%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F L+G G +G V+KG VK TG A+K ++ G + +E E+N L
Sbjct: 8 FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 57
Query: 191 DLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 240
H N+ G I+ DDQ LV EF GS+ + + +L W
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AY 115
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GL+ LH+ VI+RD K N+LL + KL DFG++ + D+T V R
Sbjct: 116 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRR 168
Query: 301 --VMGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+GT + APE + +SD++S G+ +EM G + P L+
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R PRL+ S K ++K CL ++ RP ++++
Sbjct: 229 P-------------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 26/145 (17%)
Query: 230 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289
S PL ++ + A+G+ FL A + I+RD N+LL AK+ DFGLA+D
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD- 261
Query: 290 PEGDKTHVSTRVMGT----YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
D +V V G + APE + T +SDV+S+G++L E+ S+ K+
Sbjct: 262 IMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGKS- 313
Query: 346 PNGEHNLVEWARPHLGERRRFYRLI 370
P + +FY+++
Sbjct: 314 ----------PYPGILVNSKFYKMV 328
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 53/170 (31%), Positives = 71/170 (41%), Gaps = 20/170 (11%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
AKG+ FL A R I+RD NILL + K+ DFGLA+D +
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGERR 364
+ APE + T +SDV+SFGV+L E+ S+ + G E+ R G R
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIF----SLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
R P + Q C +P RP SE+VE L L
Sbjct: 302 RAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 46/218 (21%)
Query: 139 EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGDLV 193
EG +G V++ TG VA+K L + KE L E+N L L
Sbjct: 15 EGTYGVVYRA---------RDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQ 62
Query: 194 HLNLVKL----IGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIR-----MKI 241
H N+V + +G + D+ +V E++ + +E P+ M
Sbjct: 63 HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM------KQPFLQSEVKCLMLQ 114
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
L G+A LH+ +++RD KTSN+LL+ K+ DFGLA+ G T++
Sbjct: 115 LL---SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQL 166
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
+ T Y APE ++ ++ D++S G + E+LT +
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHK-EWLAEVNFLGDLV 193
LGEG + V+KG + G VA+K L H+ +G + E + L DL
Sbjct: 13 LGEGSYATVYKGRSKLTGQL---------VALKEIRLEHE--EGAPFTAIREASLLKDLK 61
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRG---SLENHLFRRSLPLPWSIRM---KIAL-GAA 246
H N+V L LV+E++ +++ + M ++ L
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC--------GGGLSMHNVRLFLFQLL 113
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GLA+ H+ R V++RD K N+L+ KL+DFGLA+ KT+ + V T
Sbjct: 114 RGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLW 168
Query: 307 YAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGR 338
Y P+ ++ T + TS D++ G + EM TGR
Sbjct: 169 YRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 62/232 (26%)
Query: 138 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVH 194
G G +G V+K G A+K D Q + E+ L +L H
Sbjct: 9 GRGTYGRVYKAK-------RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 195 LNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLF----------RRSLP------LPWS 236
N+V L+ +E + L++++ E+ L+ R S+P L W
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DGP 290
I G+ +LH V++RD K +NIL+ + K+ D GLA+ + P
Sbjct: 117 I--------LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 291 -----EGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 336
+ D V+ T Y APE ++ H T D+++ G + E+LT
Sbjct: 166 LKPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 62/228 (27%), Positives = 90/228 (39%), Gaps = 26/228 (11%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LG G FG V A K VA+K + K+
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
+E L + H V L G ++ LV EF+ G L RR+ P +
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG--- 133
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR- 300
AA+ + ++YRD K N+LLD D K++DFG AK V TR
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRT 185
Query: 301 --VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
+ GT Y APE ++ +D ++ G+ + E+L G N P
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 137 LGEGGFGCVFKGW--IEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLV 193
LGEG + V+KG + +N VA+K + + +G + EV+ L DL
Sbjct: 14 LGEGTYATVYKGRSKLTDN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H N+V L + LV+E++ + L+ +L + +GL + H
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
R V++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ +
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176
Query: 314 M-TGHLTSRSDVYSFGVVLLEMLTGR 338
+ + +++ D++ G + EM TGR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 69/240 (28%), Positives = 101/240 (42%), Gaps = 46/240 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+G+G FG VFK A K T VA+K + ++ KE L E+ L
Sbjct: 20 IGQGTFGEVFK--------ARHKK-TKQIVALKKVL---MENEKEGFPITALREIKILQL 67
Query: 192 LVHLNLVKLIGYCIEDDQR--------LLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 240
L H N+V LI C LV+EF G L N + +L + MK
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV-MK 126
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVS 298
+ L GL ++H +++RD K +NIL+ D KL+DFGLA+ + K +
Sbjct: 127 MLL---NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
T + T Y PE + L R D++ G ++ EM T M N + L+
Sbjct: 181 TNRVVTLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
KGL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H T D++S G ++ EMLTG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 59/245 (24%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
DL + RP LG G G VF + V VAVK + Q K
Sbjct: 2 DLGSRYMDLRP---LGCGSNGLVF---------SAVDSDCDKRVAVKKIVLTDPQSVKHA 49
Query: 183 LAEVNFLGDLVHLNLVKL--------------IGYCIEDDQRLLVYEFMP--------RG 220
L E+ + L H N+VK+ +G E + +V E+M +G
Sbjct: 50 LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG 109
Query: 221 SL-ENH--LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DY 276
L E H LF L +GL ++H V++RD K +N+ ++ D
Sbjct: 110 PLSEEHARLFMYQL--------------LRGLKYIHSAN---VLHRDLKPANVFINTEDL 152
Query: 277 NAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLE 333
K+ DFGLA+ D K ++S ++ + Y +P +++ + T D+++ G + E
Sbjct: 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAE 211
Query: 334 MLTGR 338
MLTG+
Sbjct: 212 MLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 68/224 (30%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
F ++G G +G V+KG VK TG A+K ++ + +E E+N L
Sbjct: 18 FELVEVVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTEDE-EEEIKLEINMLK 67
Query: 191 DLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 240
H N+ G I+ DDQ LV EF GS+ + + +L W
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AY 125
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
I +GLA LH VI+RD K N+LL + KL DFG++ + D+T V R
Sbjct: 126 ICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRR 178
Query: 301 --VMGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTG 337
+GT + APE + RSD++S G+ +EM G
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
GL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ EMLTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 28/221 (12%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ P +G G +G V + T VA+K + + D K L E
Sbjct: 4 DTKYVPIKPIGRGAYGIV---------CSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE 54
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENH-LFRRSLPLPWSIR 238
+ L L H N++ + + R +VYE M + H + R S L
Sbjct: 55 IKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHC 110
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+GL ++H V++RD K SN+LL+A+ + K+ DFGLA+ +K
Sbjct: 111 QYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFM 165
Query: 299 TRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 338
T + T Y APE ++ T+ DV+S G + E+L +
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 67/221 (30%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLV-H 194
+G+G +G V+K +++G+ AVK L D + E + AE N L L H
Sbjct: 30 IGKGTYGKVYKVTNKKDGS---------LAAVKIL--DPISDVDEEIEAEYNILQSLPNH 78
Query: 195 LNLVKLIGYCIEDD-----QRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGAA 246
N+VK G + D Q LV E GS L L L ++ I GA
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV----- 301
GL LH +I+RD K +NILL + KL DFG++ STR+
Sbjct: 139 LGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQ-------LTSTRLRRNTS 188
Query: 302 MGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTG 337
+GT + APE + +R DV+S G+ +E+ G
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 67/259 (25%), Positives = 99/259 (38%), Gaps = 76/259 (29%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEV-- 186
+F ++G G FG V K TG A+K L + L+ KE +A V
Sbjct: 2 DFESIKVIGRGAFGEV---------RLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRA 50
Query: 187 --NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-- 241
+ L + + +VKL Y +D+ L L+ E++P G + L ++ R I
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 242 ---ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHV 297
A+ + L ++H RD K N+LLDA + KLSDFGL G K+H
Sbjct: 110 TILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHR 156
Query: 298 ST----------------------------------RVM-----GTYGYAAPEYVMTGHL 318
+ R + GT Y APE +
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216
Query: 319 TSRSDVYSFGVVLLEMLTG 337
D +S GV++ EML G
Sbjct: 217 NKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 24/167 (14%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
AKG++FL A + I+RD NILL K+ DFGLA+D V
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE + T SDV+S+G++L E+ + L P + +
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPGMPVDSK 325
Query: 366 FYRLIDPRLEGH--FSIKGA-QKAAQLAAHCLSRDPKARPLMSEVVE 409
FY++I EG+ S + A + + C DP RP ++V+
Sbjct: 326 FYKMIK---EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 68/217 (31%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGDLV- 193
+G+G +G VFK ++NG+ AVK L+ HD +E AE N L L
Sbjct: 26 IGKGTYGKVFKVLNKKNGS---------KAAVKILDPIHDI---DEEIEAEYNILKALSD 73
Query: 194 HLNLVKLIG-YCIED----DQRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGA 245
H N+VK G Y +D DQ LV E GS L +R + I I A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
GL LH I+RD K +NILL + KL DFG++ +GT
Sbjct: 134 LMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTP 188
Query: 306 GYAAPEYV-----MTGHLTSRSDVYSFGVVLLEMLTG 337
+ APE + + +R DV+S G+ +E+ G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 65/247 (26%), Positives = 92/247 (37%), Gaps = 55/247 (22%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAE 185
++F+ LLG+G G VF + GT + A+K L+ + + L E
Sbjct: 1 KHFKKIKLLGKGDVGRVF--LVRLKGTGKL-------FALKVLDKKEMIKRNKVKRVLTE 51
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 242
L L H L L + LV ++ P G L + P L +
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL--FRLLQRQPGKCLSEEV---AR 106
Query: 243 LGAAK---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------------ 287
AA+ L +LH ++YRD K NILL + LSDF L+K
Sbjct: 107 FYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 288 --DGPEGDKTH----------VSTRVM---GTYGYAAPEYVM-TGHLTSRSDVYSFGVVL 331
G + S R GT Y APE + GH S D ++ G++L
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILL 222
Query: 332 LEMLTGR 338
EML G
Sbjct: 223 YEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEW-LAEVNF 188
F ++GEG +G V K +E T VA+K + + + KE L E+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKM 53
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGA 245
L L N+V+L + LV+E++ + LE +P P +R I
Sbjct: 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI-YQL 109
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
K + + H+ +++RD K N+L+ + KL DFG A++ EG + T + T
Sbjct: 110 IKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATR 165
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
Y +PE ++ D++S G +L E+ G+
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 302
A+G+ FL A R I+RD NILL + K+ DFGLA+D + D +V R+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARL- 237
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T++SDV+SFGV+L E+ +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 61/258 (23%), Positives = 106/258 (41%), Gaps = 36/258 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 194
+G G FG V I TG+ V VK L + + E+L + + L H
Sbjct: 3 IGNGWFGKVLLSEI--------YTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH 54
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 248
N+++ +G C+E LLV+E+ G L+++L R S L + ++A A G
Sbjct: 55 PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAG 111
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
+ +H+ ++ D N L +D K+ D+G+ + D +
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 309 APEYV-------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
APE V +T T S+V++ GV L E+ +N +L + +
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELF-------ENAAQPYSHLSDREVLNHV 221
Query: 362 ERRRFYRLIDPRLEGHFS 379
+ + +L P+LE +S
Sbjct: 222 IKDQQVKLFKPQLELPYS 239
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 34/102 (33%), Positives = 59/102 (57%), Gaps = 9/102 (8%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGT 304
GL ++H V++RD K N+L++AD K+ DFGLA+ + P + + T + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 305 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNR 345
Y APE +++ +++ DV+S G +L E+L GR+ + K +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 40/280 (14%)
Query: 78 DTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLL 137
++ D P+ A S + + + + L A K +D LA +FR L
Sbjct: 103 ASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQA----KLKHDDEFLA--HFRVIDDL 156
Query: 138 GEGGFG----CVFKGWIEE-------NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV 186
G FG C + EE N T KP +A + E E+
Sbjct: 157 PAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLE--NEI 214
Query: 187 NFLGDLVHLNLVKL--------IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
LG L H N++K+ Y I +Y FM + + + PL R
Sbjct: 215 LALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQTR 270
Query: 239 --MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
MK L A + ++H+ + +I+RD K NI L+ D L DFG A E ++
Sbjct: 271 AIMKQLLCA---VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKEREA 323
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+GT +PE + +D++S G++LL+ML+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 74/304 (24%), Positives = 121/304 (39%), Gaps = 47/304 (15%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 188
++ + ++G+G +G V + + TG VA+K +N + + L E+
Sbjct: 2 YKIQEVIGKGSYGVV---------CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 189 LGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
L L H ++V++ + +R +V+E M S + + + + L
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLY 110
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVST 299
+ L ++H V +RD K NIL +AD K+ DFGLA+ D P T
Sbjct: 111 QLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP---TAIFWT 164
Query: 300 RVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH------N 351
+ T Y APE + T D++S G + E+LTG+ N H +
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLITD 222
Query: 352 LVEWARPHLGER------RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARP 402
L+ P R RR+ + + FS K A +L L+ DPK RP
Sbjct: 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282
Query: 403 LMSE 406
E
Sbjct: 283 TAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 185 EVNFLGDLVHLNLVKLI-GYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIA 242
E L L H N+V + ED +V F G L + L ++ LP + ++
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ A L +LHE+ +++RD KT N+ L K+ D G+A+ ++ +++ ++
Sbjct: 109 VQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLI 163
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
GT Y +PE +SDV++ G + EM T + + + N +LV
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLV--------- 211
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
YR+I+ +L + + +L A LS+ P+ RP + ++
Sbjct: 212 ----YRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 43/143 (30%), Positives = 62/143 (43%), Gaps = 11/143 (7%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261
Y +D L LV E+ P G L + L R + A+ + +H + +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIHSVHQMGYV 124
Query: 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY--VMTGHLT 319
+RD K N+L+D + KL+DFG A +K S +GT Y APE M G
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 320 SRSDV----YSFGVVLLEMLTGR 338
V +S GV+ EM+ GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 42/221 (19%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
++ +GEG F V K + G A+K + H + L +VN L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGK---------YYAIKCMKK-----HFKSLEQVNNLR 46
Query: 191 DLV-------HLNLVKLIGYCIEDDQ--RL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
++ H N+++LI + D + RL LV+E M +L + R PLP
Sbjct: 47 EIQALRRLSPHPNILRLIE-VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKS 104
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTH 296
K L +H + +RD K NIL+ D KL+DFG + P + +
Sbjct: 105 YMYQLLKSLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTE--Y 158
Query: 297 VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 336
+STR Y APE ++T G+ + D+++ G V E+L+
Sbjct: 159 ISTR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+GL ++H +I+RD K SN+ ++ D ++ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ H D++S G ++ E+L G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 51/204 (25%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG + V+KG + NG VA+K + +G + E + L L H
Sbjct: 13 LGEGSYATVYKGKSKVNGK---------LVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 254
N+V L + LV+E++ L ++ + L P ++++ + +GL+++H+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQ 121
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
R +++RD K N+L+ KL+DFGLA+ + +H + + T Y P+ ++
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 315 -TGHLTSRSDVYSFGVVLLEMLTG 337
+ ++ D++ G + +EM+ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 67/251 (26%), Positives = 97/251 (38%), Gaps = 63/251 (25%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F ++G G FG V K TG A+K L + KE +A +
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAE 51
Query: 190 GD-LVHLN---LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI--- 241
D LV + +VK+ Y +D + L L+ EF+P G + L ++ + + I
Sbjct: 52 RDILVEADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAET 110
Query: 242 --ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA------------- 286
A+ A L F+H RD K N+LLDA + KLSDFGL
Sbjct: 111 VLAIDAIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 287 --KDGPEGD------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 326
P D + ++ +GT Y APE M D +S
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 327 FGVVLLEMLTG 337
GV++ EML G
Sbjct: 222 LGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 39/220 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK----TLNHDGLQGHKEWLAEVNFLGDL 192
+GEG +G V+K TG VA+K ++ +G+ L E++ L L
Sbjct: 9 IGEGTYGKVYKA---------RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57
Query: 193 VHLN-LVKLIGYCIEDDQR-------LLVYEFMP---RGSLENHLFRRSLPLPWSIRMKI 241
+V+L+ +E + LV+E++ + ++++ PLP
Sbjct: 58 SESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDG--PEGDKTHVS 298
KG+A H+ V++RD K N+L+D K++D GL + P TH
Sbjct: 116 MYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-- 170
Query: 299 TRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 337
+ T Y APE ++ H ++ D++S G + EM
Sbjct: 171 --EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 66/252 (26%), Positives = 96/252 (38%), Gaps = 65/252 (25%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ----GHKEWLA 184
+F ++G G FG V K TG A+K L D L+ GH A
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIR--A 50
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA- 242
E + L + L +VK+ Y +D L L+ EF+P G + L ++ + IA
Sbjct: 51 ERDILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAE 109
Query: 243 ----LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--- 295
+ + L F+H RD K N+LLD+ + KLSDFGL + +T
Sbjct: 110 TVLAIDSIHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160
Query: 296 ------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 325
++ +GT Y APE M D +
Sbjct: 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220
Query: 326 SFGVVLLEMLTG 337
S GV++ EML G
Sbjct: 221 SLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V+K TG A+K + + + E+ + D H N
Sbjct: 17 IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 256
+V G + D+ + EF GSL++ ++ + PL S ++ +GL +LH +
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT- 315
+ ++RD K +NILL + + KL+DFG++ S +GT + APE
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVE 181
Query: 316 --GHLTSRSDVYSFGVVLLEM 334
G D+++ G+ +E+
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 23/172 (13%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 304
A+G+ FL A + ++RD N+LL K+ DFGLA+D D +VS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH-DSNYVSKGSTFLP 302
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ APE + T+ SDV+S+G++L E+ + L P +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS---------------LGGTPYPGMIVDS 347
Query: 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEALKP 413
FY I Q+ + C + +P+ RP +S++VE+L P
Sbjct: 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 183
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
APE ++ D++S G ++ EM+ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 137 LGEGGFGCVFKGWIEENGT----APVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGD 191
LGEG +G V K + G VK K G+ G H L E+ + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
+ H N++ L+ +E D LV + M L+ + R + L S I L GL
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGLNV 134
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--------DGPEGDKTHVSTRVMG 303
LH+ ++RD +NI +++ K++DFGLA+ D D+T M
Sbjct: 135 LHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 304 ----TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T Y APE +M D++S G + E+LTG+
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 116 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 175
LR+ +D +L R +G G +G V+K TG AVK + +
Sbjct: 3 LRRNPQHDYELIQR-------VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEP 46
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
E+ + + H N+V G + ++ + E+ GSL++ ++ + PL
Sbjct: 47 GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSE 105
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ +GLA+LH + + ++RD K +NILL + + KL+DFG+A
Sbjct: 106 LQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162
Query: 296 HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEM 334
S +GT + APE G D+++ G+ +E+
Sbjct: 163 RKS--FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 47/192 (24%), Positives = 76/192 (39%), Gaps = 25/192 (13%)
Query: 162 TGLTVAVKTLNHDGLQGHKEWL---AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 218
T VAVK +N D ++ E+ L H N++ + I D + +V M
Sbjct: 24 TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 219 RGSLENHLFRRSLP--LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
GS E+ L + P LP I L ++H + I+R K S+ILL D
Sbjct: 83 YGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDG 138
Query: 277 NAKLSDFGLAKDGPEGDKTHV--------STRVMGTYGYAAPEYV---MTGHLTSRSDVY 325
LS + + K S + + + +PE + + G+ +SD+Y
Sbjct: 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEVLQQNLQGY-NEKSDIY 194
Query: 326 SFGVVLLEMLTG 337
S G+ E+ G
Sbjct: 195 SVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 22/169 (13%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSI 237
E L + H N+V D +V E+ G L LF L W +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT 295
+M + G+ +HE + V++RD K+ NI L + KL DFG A+ P
Sbjct: 108 QMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GA 155
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344
+ T V GT Y PE ++SD++S G +L E+ T + N
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 51/185 (27%), Positives = 78/185 (42%), Gaps = 36/185 (19%)
Query: 198 VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLA 250
+ + Y +D+ L LV ++ G L L + LP + M IA+ + L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 306
++H RD K NIL+D + + +L+DFG L +DG T S+ +GT
Sbjct: 123 YVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPD 168
Query: 307 YAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
Y +PE + G D +S GV + EML G P +LVE +
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMN 222
Query: 362 ERRRF 366
+ RF
Sbjct: 223 HKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 60/208 (28%)
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 250
+VKL Y +D L V +++P G + + L F L + + A+ + +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL---------AKDGPEGDKTHVS--- 298
F+H RD K NIL+D D + KL+DFGL +K +GD
Sbjct: 122 FIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 299 ------------------------TRVM-----GTYGYAAPEYVM-TGHLTSRSDVYSFG 328
R + GT Y APE ++ TG+ T D +S G
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVG 231
Query: 329 VVLLEMLTGRRSMDKNRPNG-EHNLVEW 355
V+L EML G+ + P + ++ W
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEML------TGRRSMDK-NR---------PNGEHN 351
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 352 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 302
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 304
A G+ FL A + ++RD N+L+ K+ DFGLA+D D ++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYISKGSTFLP 304
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ APE + T+ SDV+SFG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG+G F +FKG E G T V +K L+ + + + + L H +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKT--EVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEE 255
LV G C+ D+ ++V E++ GSL+ +L + + S ++++ AK LA+ LH
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV----AKQLAWALHFL 116
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYAAPEYV 313
++ + + + N+LL + + K + K G V + + + PE +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 314 MTG-HLTSRSDVYSFGVVLLEMLTG 337
+L+ +D +SFG L E+ +G
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ LH +I+RD K SNI++ +D K+ DFGLA+ + T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYY 188
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
APE ++ D++S G ++ E++ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 66/264 (25%), Positives = 96/264 (36%), Gaps = 77/264 (29%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F ++G+G FG V K TG A+KTL + K+ LA V
Sbjct: 2 DFHTVKVIGKGAFGEV---------RLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAE 51
Query: 190 GDLVHLN----LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-- 242
D++ + +V L Y +D Q L L+ EF+P G L L + R +A
Sbjct: 52 RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC 110
Query: 243 ---LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-------------- 285
+ A L F+H RD K NIL+D + KLSDFGL
Sbjct: 111 VLAIEAVHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 286 -------AKDGPEGDKTHV-------------------STRVM-----GTYGYAAPEYVM 314
K+ + + + R+M GT Y APE +
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IF 220
Query: 315 TGHLTSRS-DVYSFGVVLLEMLTG 337
+ D +S G ++ E L G
Sbjct: 221 LQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 66/256 (25%), Positives = 99/256 (38%), Gaps = 73/256 (28%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL---AEVNFLGDLV 193
LG G FG V K T A+KTL + + AE + L +
Sbjct: 9 LGIGAFGEV---------CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAK 247
+ +VKL Y +D L V +++P G + + L R L + + +A+ +
Sbjct: 60 NEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-------------------KD 288
+ F+H RD K NIL+D D + KL+DFGL +D
Sbjct: 119 KMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169
Query: 289 GPE-------------GD----------KTH---VSTRVMGTYGYAAPEYVMTGHLTSRS 322
E GD K H ++ ++GT Y APE ++ T
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229
Query: 323 DVYSFGVVLLEMLTGR 338
D +S GV+L EML G+
Sbjct: 230 DWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 21/151 (13%)
Query: 203 YCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSI-RMKIALGAAKGLAFLHEEAERP 259
+C + +R L V E++ G L + LP + RM A L +LH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFA-ETVLALEYLHNYG--- 121
Query: 260 VIYRDFKTSNILLDADYNAKLSDFGLAKDG--------PEGD-----KTHVSTRVMGTYG 306
+++RD K N+L+ + + KL+DFGL+K G EG + + +V GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Y APE ++ D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 44/151 (29%), Positives = 65/151 (43%), Gaps = 30/151 (19%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI------RMKIALGAAKGLAFLHEE 255
Y +D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH-- 125
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 311
RD K N+LLD + + +L+DFG L DG T S +GT Y +PE
Sbjct: 126 -------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG-----TVQSNVAVGTPDYISPE 173
Query: 312 YVM-----TGHLTSRSDVYSFGVVLLEMLTG 337
+ G D +S GV + EML G
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 13/155 (8%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRM 239
E L L H +VK +E D ++ E+ L+ L ++L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
I L G+ ++H+ R +++RD K NI L + K+ DFG+++ ++T
Sbjct: 112 FIQL--LLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLAT 163
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334
GT Y +PE + S+SD++S G +L EM
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 43/221 (19%)
Query: 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 253
H++L + G C+ + ++V EF+ G L+ L + +P + ++ +A A L++L
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE 134
Query: 254 EEAERPVIYRDFKTSNILLD----ADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+ + +++ + NILL A+ + KLSD G++ ++ RV
Sbjct: 135 D---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE-----RV-ERIP 185
Query: 307 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
+ APE V G L++ +D +SFG LLE+ +GE L E E+ R
Sbjct: 186 WIAPECVPGGNSLSTAADKWSFGTTLLEICF----------DGEVPLKERTPS---EKER 232
Query: 366 FY----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
FY RL +P ++ A L + CL+ +P RP
Sbjct: 233 FYEKKHRLPEP---------SCKELATLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 30/151 (19%)
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLAFLHEE 255
Y +D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 311
RD K N+LLD + + +L+DFG + +DG T S+ +GT Y +PE
Sbjct: 126 -------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPE 173
Query: 312 YVMT-----GHLTSRSDVYSFGVVLLEMLTG 337
+ G D +S GV + EML G
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 12/160 (7%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKI 241
E + L + H ++++L G + L+ +PR + + + +R++ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAI--CDILAI 187
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
+ + +LHE +I+RD K NI ++ + L DFG A P +
Sbjct: 188 ERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGW 243
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 341
GT APE + D++S G+VL EM T S+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 61/206 (29%)
Query: 184 AEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHL-----FRRSLPLPWSI 237
AE + L + + +V+L Y +D D V +++P G + + L F L +
Sbjct: 50 AERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA 108
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL------------ 285
+ A+ + + F+H RD K NIL+D D + KL+DFGL
Sbjct: 109 ELTCAVESVHKMGFIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 286 --AKDGPEGDKTHVSTR-------------------------------VMGTYGYAAPEY 312
+ D D S ++GT Y APE
Sbjct: 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219
Query: 313 VMTGHLTSRSDVYSFGVVLLEMLTGR 338
++ T D +S GV+L EML G+
Sbjct: 220 LLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 33/115 (28%), Positives = 51/115 (44%), Gaps = 3/115 (2%)
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278
R L +L R PL + +A + ++H E +I+RD KT N+L++ +
Sbjct: 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDI 299
Query: 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 333
L DFG A T + GT APE + T D++S G+V+ E
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 21/136 (15%)
Query: 216 FMPRGSLENHLFRRSLP--LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273
FM GS N L + P + ++ I GA +GL +LH+ I+R+ K S+IL+
Sbjct: 80 FMAYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 274 ADYNAKLSD----FGLAKDGPEG----DKTHVSTRVMGTYGYAAPEYV---MTGHLTSRS 322
D LS + L ++G + D ST V+ + +PE + + G+ +S
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKS 191
Query: 323 DVYSFGVVLLEMLTGR 338
D+YS G+ E+ TGR
Sbjct: 192 DIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 10/97 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGDL 192
LG G FG V +E K +TVAVK L +E L +++LG+
Sbjct: 43 LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 97
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
H+N+V L+G C L++ E+ G L N L R+
Sbjct: 98 -HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 27/105 (25%), Positives = 47/105 (44%), Gaps = 11/105 (10%)
Query: 56 SRSKVDSSVSGTSTHYESKSTNDTSRDQPA-AAVISSTTTSNAESNSSTSKLEEELKVAS 114
SRS + SG+ E+ ++ D+ R + A + T+ +N + ++ KV
Sbjct: 45 SRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTY 104
Query: 115 RLRKFTFN----------DLKLATRNFRPESLLGEGGFGCVFKGW 149
L + D+ ++T+ F+ SLLGEG FG V + W
Sbjct: 105 ALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAW 149
|
Length = 467 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 26/171 (15%)
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMP----------RGSLENHLFRRSLP 232
E+ L +L H N++ L + R L++++ R S N ++ +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQ 104
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NAKLSDFGLAK- 287
LP S+ + G+ +LH V++RD K +NIL+ + K++D G A+
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
Query: 288 -DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 336
+ P + V+ T+ Y APE ++ H T D+++ G + E+LT
Sbjct: 162 FNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 21/215 (9%)
Query: 134 ESLLGEGGFGCVFK------GWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+ L+G GGFGCV++ I A ++ T+ ++TL ++ + + +A
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIY-DIDKIALWK 75
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL---ENHLFRRSLPLPWSIRMKIALG 244
+ ++ HL + K G C + + Y F+ L +F+R + I
Sbjct: 76 NIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKD 134
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGP--EGDKTHVS 298
L ++HE + + D K NI++D + + D+G+A G E K
Sbjct: 135 MLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 333
GT YA + +T R D+ S G +L+
Sbjct: 192 LH-RGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 486 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.56 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.99 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.78 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.71 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.7 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.64 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.49 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.44 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.43 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.31 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.29 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.22 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.19 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.09 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.08 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.06 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.01 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.98 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.81 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.74 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.69 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.68 | |
| PLN02236 | 344 | choline kinase | 97.44 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.34 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.24 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.99 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.93 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.91 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.86 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.81 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.79 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.74 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.69 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.66 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.62 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.58 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.43 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.41 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.09 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.93 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.87 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.75 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.58 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.52 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-54 Score=431.88 Aligned_cols=290 Identities=58% Similarity=0.993 Sum_probs=254.3
Q ss_pred cccccChhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC
Q 011412 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194 (486)
Q Consensus 115 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 194 (486)
....|++.++..++++|.....||+||||.||+|...+ |..||||++........++|.+|+.+|.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 35679999999999999999999999999999999864 46899998876554314669999999999999
Q ss_pred CCceEEEEEEEeCC-eeEEEEeecCCCChhHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 195 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 195 ~nIv~~~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
||+|+|+|||.+.+ ..+||+||+++|+|.++|..... .++|..+++|+.++|+||+|||.....+|||||||++||||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 99999999999988 59999999999999999987665 89999999999999999999999887789999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~ 352 (486)
|+++.+||+|||+|+..... .....+...||.+|+|||++..+..+.++|||||||+|+||+||+.+.+...+.....+
T Consensus 211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 99999999999999776541 11111111799999999999999999999999999999999999999987776677779
Q ss_pred HHhhhhhcccccccccccCCccC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 353 VEWARPHLGERRRFYRLIDPRLE-GHFSI-KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
.+|+.+.+.+. ++.+++|+.+. +.+.. .....+..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus 290 ~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 290 VEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 99997777665 88899999987 66664 577789999999999999999999999999965543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=422.22 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=212.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.+|...++||+|||+.||.+++.. +|+.||+|++.+... ...+.+.+||+|.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 579999999999999999999866 788999999986433 23467899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+.+++|||+|+|..++|..++. +.+++++..+..++.||+.||.|||+.+ |||||||..||||+++.+|||+||||
T Consensus 89 Ds~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred cCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccce
Confidence 9999999999999999999886 5678999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
|......... ..+.||||.|.|||++....++..+||||+|||||-||+|++||+...-.. ..........
T Consensus 165 At~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke------ty~~Ik~~~Y- 235 (592)
T KOG0575|consen 165 ATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE------TYNKIKLNEY- 235 (592)
T ss_pred eeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH------HHHHHHhcCc-
Confidence 9987654332 345899999999999999999999999999999999999999997643211 1111111100
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.++...+..+++||.++|+.||.+||++++|+.+
T Consensus 236 -----------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 -----------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -----------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1122335678999999999999999999999974
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-52 Score=396.60 Aligned_cols=254 Identities=27% Similarity=0.397 Sum_probs=211.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+.+.++.||+|..|+|||++++. |++.+|+|++.... ....+++.+|++++++.+|||||.+||.|..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~---------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKP---------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcC---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 345556789999999999999986 78899999995432 33457899999999999999999999999999
Q ss_pred C-eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 208 D-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 208 ~-~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
. .+.|+||||++|+|++++... +.+++....+|+.++++||.|||. .+ ||||||||+||||+..|.|||||||.
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence 8 499999999999999998554 579999999999999999999996 55 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--CCcchhHHhhhhhcccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP--NGEHNLVEWARPHLGER 363 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~ 363 (486)
++...+. ...+++||..|||||.+.+..|+.++||||||++|+||.+|+.||....+ .....+..+.. .+
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv---~~- 297 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV---DE- 297 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh---cC-
Confidence 9987554 35678999999999999999999999999999999999999999976522 11112222211 10
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
..|.+... .++.+++.|+..||++||.+||++.|++++-.
T Consensus 298 ------ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 298 ------PPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred ------CCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 11222222 35678999999999999999999999998643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=403.00 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=209.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-------HHHHHHHHHHHhcCCCCCceE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGDLVHLNLVK 199 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~ 199 (486)
..+.|.+.+.||+|+||.|-+|..+. ||+.||||+++...... ...+.+|+++|++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~---------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK---------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc---------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 45678899999999999999998765 88999999998654322 234679999999999999999
Q ss_pred EEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---C
Q 011412 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---Y 276 (486)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~---~ 276 (486)
++++|...+..||||||++||+|.+.+..++ .+.+.....+++|++.||.|||++| |+||||||+|||+..+ .
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcce
Confidence 9999999999999999999999999997654 5778888999999999999999999 9999999999999655 7
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCCCC-cchh
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL---TSRSDVYSFGVVLLEMLTGRRSMDKNRPNG-EHNL 352 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslGvil~elltG~~pf~~~~~~~-~~~~ 352 (486)
.+||+|||+|+....+. ...++|||+.|.|||++.+..+ ..++|||||||+||-+|+|.+||....... ....
T Consensus 317 llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ 393 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ 393 (475)
T ss_pred EEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence 89999999999876433 3566899999999999986543 448899999999999999999997654332 1111
Q ss_pred HHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
+ ...+..+ ........++++.+||.+||..||++||++.|+|++-+
T Consensus 394 I------~~G~y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 394 I------LKGRYAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred H------hcCcccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 1 1111111 11122345678999999999999999999999998654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-52 Score=398.19 Aligned_cols=203 Identities=32% Similarity=0.527 Sum_probs=182.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..+|.+.+.||.|+||+||+|+++. ++..||||.+.... ....+.+..|+.+|+.++|||||++++++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~---------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKK---------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEeEecc---------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 3578888999999999999999987 56799999998774 333456789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC------CcEE
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD------YNAK 279 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~------~~vk 279 (486)
.++.+|||||||.||+|.++|.+++ .+++..+..++.||+.||++||+++ ||||||||.||||+.. -.+|
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEE
Confidence 9999999999999999999997665 7999999999999999999999998 9999999999999764 4689
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~ 346 (486)
|+|||+|+.+..+. ...+.||++.|||||++..+.|+.|+|+||+|+|||+|++|+.||+..+.
T Consensus 156 IADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 156 IADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred ecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 99999999987543 34568999999999999999999999999999999999999999986544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-52 Score=395.11 Aligned_cols=262 Identities=29% Similarity=0.381 Sum_probs=213.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|+++++||+|+||+||.++.++ |++.||+|++++..... .+...+|..+|.+++||+||+++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d---------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD---------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc---------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 3589999999999999999998875 78899999998765433 35578999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
++.+.+|||+||+.||.|..+|.+. +.+++..+..++..|+.||.|||+++ ||||||||+|||||.+|+++|+|||
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence 9999999999999999999999655 47999999999999999999999999 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
|++....... ...++|||+.|||||++.+..|+..+|+|||||++||||+|.+||...+.. .+.......+.
T Consensus 171 L~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~k~ 242 (357)
T KOG0598|consen 171 LCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKGKL 242 (357)
T ss_pred cchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcCcC
Confidence 9996443322 234589999999999999999999999999999999999999999765322 12221221110
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCccCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 421 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 421 (486)
...+.-.+..+++|+.++|..||++|.-...=.+.++..+.+.++.
T Consensus 243 -----------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 243 -----------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred -----------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 0111112467899999999999999974222223355565555443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=402.87 Aligned_cols=255 Identities=35% Similarity=0.582 Sum_probs=210.2
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcE-EEEEEecCCCccc--HHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+.+.+.||.|+||+||+|.+. |.. ||||++....... .+.|.+|+.+|.+|+|||||+++|++...
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 334456999999999999995 445 9999998654322 45899999999999999999999999988
Q ss_pred C-eeEEEEeecCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEeecC
Q 011412 208 D-QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG 284 (486)
Q Consensus 208 ~-~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~vkl~DFG 284 (486)
. .++|||||+++|+|.++|.. ....+++..++.|+.||++||.|||++++ ||||||||+||||+.++ ++||+|||
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCc
Confidence 7 79999999999999999987 47789999999999999999999999774 99999999999999997 99999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
+++...... ...+...||+.|||||++. ...|+.|+||||||++||||+||+.||....+.. ....
T Consensus 190 lsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~~------- 257 (362)
T KOG0192|consen 190 LSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VASA------- 257 (362)
T ss_pred cceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHHH-------
Confidence 998765422 1233468999999999999 5699999999999999999999999998765411 1110
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
.+.......++..++..+..|+.+||..||..||++.+|+..|+.+..
T Consensus 258 ------v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 258 ------VVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ------HHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 000111222233356789999999999999999999999999986543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=378.86 Aligned_cols=266 Identities=26% Similarity=0.345 Sum_probs=213.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
+.|+.+.++|+|+||+||||++++ ||+.||||++..... ...+-.++||++|++|+|+|+|.++++|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 357788899999999999999987 899999999875432 222346899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
...++||+|||+. ++.+-|.+....++...+.+++.|++.|+.|+|+++ ||||||||+||||+.+|.+||||||+|
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhh
Confidence 9999999999977 666667777788999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc-----
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL----- 360 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~----- 360 (486)
+..... ....+..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|.+...-+....+......+
T Consensus 149 R~L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 149 RTLSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred HhhcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH
Confidence 987632 223567889999999999886 789999999999999999999999998876655444433222111
Q ss_pred ---ccccccccccCCcc------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 361 ---GERRRFYRLIDPRL------EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 361 ---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
....-|..+.-|.. +..++ .....+.+|+++||..||.+|++.++++.+
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111211111111 11121 233468899999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-52 Score=378.91 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=206.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEE-EEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIG-YCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~-~~~ 205 (486)
.+|+++++||+|.||.||++.+.. +|..||.|.+...... ....+..|+.+|++|+|||||++++ .|.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~---------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLL---------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeecc---------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 468888999999999999999876 6779999999865443 3456889999999999999999998 455
Q ss_pred eCCe-eEEEEeecCCCChhHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCcEEEcCCCcEEE
Q 011412 206 EDDQ-RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 206 ~~~~-~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~-~iiHrDLKp~NIll~~~~~vkl 280 (486)
++.. ++||||||.+|+|...|. +....+++..+++++.|++.||..+|++-++ -|+||||||.||||+.+|.|||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 5555 899999999999999885 3456799999999999999999999995422 3999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
+||||++.+..... .....+|||.||+||.+....|+.++||||+||++|||+.-++||.+.+ +.+.-. .+
T Consensus 170 GDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~-KI 240 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCK-KI 240 (375)
T ss_pred ccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHH-HH
Confidence 99999998765332 3456899999999999999999999999999999999999999998762 111111 01
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. +---+.++ ....+.++..||..|+..||..||+...++..+
T Consensus 241 ~------qgd~~~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 241 E------QGDYPPLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred H------cCCCCCCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 0 00001111 134467899999999999999999865555443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=392.37 Aligned_cols=255 Identities=26% Similarity=0.350 Sum_probs=212.9
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcC-CCCCceEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVKL 200 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~~ 200 (486)
+....+|.+++.||.|+|++||+|+.+. +++.||||++.+..... .+-+.+|-.+|.+| .||.|++|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~---------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKA---------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecC---------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 4456799999999999999999998876 78899999998654432 23467899999999 89999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
|..|+++..+|+|+||+++|+|.++|.+. +.|++.....++.||+.||+|||++| ||||||||+|||||.||++||
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikI 215 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKI 215 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEE
Confidence 99999999999999999999999999666 47999999999999999999999999 999999999999999999999
Q ss_pred eecCCCCCCCCCCcc---------e--eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 011412 281 SDFGLAKDGPEGDKT---------H--VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 349 (486)
Q Consensus 281 ~DFGla~~~~~~~~~---------~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~ 349 (486)
+|||.|+.+...... . ....++||..|.+||++..+..+..+|||+||||||+|+.|.+||.+.++...
T Consensus 216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli 295 (604)
T KOG0592|consen 216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI 295 (604)
T ss_pred eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence 999999876443221 1 12458999999999999999999999999999999999999999986544211
Q ss_pred chhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 350 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. .+++. +.-.|+..+++.+.+|++++|..||.+|+++.+|.++
T Consensus 296 F----------------qkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 F----------------QKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred H----------------HHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1 11111 1112333344789999999999999999999887664
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=361.18 Aligned_cols=240 Identities=28% Similarity=0.357 Sum_probs=206.1
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhcCCCCCceEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
..++|+.++.||.|+||.|.+++.+. +|..||+|+++....... +...+|..+|+.+.||+++++++.
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~---------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t 112 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKH---------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT 112 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEcc---------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe
Confidence 34689999999999999999999887 677999999987765443 346789999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
|.+.+.+||||||++||.|..+|++ .+.+++..+..++.||+.||+|||+++ |++|||||+|||||.+|.+||+||
T Consensus 113 ~~d~~~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 113 FKDNSNLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred eccCCeEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEec
Confidence 9999999999999999999999954 457999999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
|+|+..... .-+.|||+.|+|||++....|+.++|+|||||++|||+.|.+||...++. ......+...
T Consensus 189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~iY~KI~~~~ 257 (355)
T KOG0616|consen 189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QIYEKILEGK 257 (355)
T ss_pred cceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HHHHHHHhCc
Confidence 999986543 34579999999999999999999999999999999999999999876652 1111222222
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 402 (486)
.+ |+..+...+++|+.++|+.|-.+|-
T Consensus 258 v~------------fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 258 VK------------FPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred cc------------CCcccCHHHHHHHHHHHhhhhHhhh
Confidence 22 2333346789999999999999993
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=379.98 Aligned_cols=259 Identities=31% Similarity=0.439 Sum_probs=206.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|...+.||+|+||.||++.+.+ +|..+|||.+........+.+.+|+++|.+|+|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 356777899999999999999876 57799999998764333566899999999999999999999754444
Q ss_pred --eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeecCC
Q 011412 209 --QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGL 285 (486)
Q Consensus 209 --~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~vkl~DFGl 285 (486)
.++|+|||+++|+|.+++.+.+..+++..+..+++||++||+|||+++ ||||||||+||||+. ++.+||+|||+
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence 689999999999999999877668999999999999999999999988 999999999999999 79999999999
Q ss_pred CCCCCC-CCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 286 AKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 286 a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
++.... .........+.||+.|||||++..+ ....++|||||||++.||+||++||... . ....+......+.
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~---~~~~~~~~ig~~~ 239 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--F---EEAEALLLIGRED 239 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--c---chHHHHHHHhccC
Confidence 987653 1111123347899999999999853 3345999999999999999999999753 0 0111111111000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
..| .++...+.++.+++.+|+..||.+|||+.++|++....
T Consensus 240 ------~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 240 ------SLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred ------CCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 111 33334567899999999999999999999999876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=386.91 Aligned_cols=267 Identities=27% Similarity=0.358 Sum_probs=215.1
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHH--HHHHHHHHhcCC-CCCceEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGDLV-HLNLVKLIGY 203 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~nIv~~~~~ 203 (486)
..++|.+++.||.|+||.||+|+... +|..||||+++..... .++ -+||++.|++|+ |||||++.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~---------~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE---------TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC---------CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence 44678899999999999999998876 6778999999865433 333 368999999998 9999999999
Q ss_pred EEeCC-eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 204 CIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 204 ~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
+.+.+ .+|+||||| ..+|.+++..++..|++..+..|+.||++||+|+|.+| +.||||||+|||+.....|||+|
T Consensus 78 i~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred hhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecc
Confidence 99988 999999999 55999999988999999999999999999999999998 99999999999999888999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--hh
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PH 359 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~--~~ 359 (486)
||+||....... .+..+-|.+|+|||++. .+.|+.++||||+|||++|+.+-++.|.+....++...+--.. +.
T Consensus 154 FGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 154 FGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD 230 (538)
T ss_pred cccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence 999998754433 56678999999999875 6789999999999999999999999998876544332221111 00
Q ss_pred cccc-----------cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 360 LGER-----------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 360 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+. .++.....-.+..-++ .++.++.+||.+||+.||.+|||+.|++++-
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0000 0111111111222222 2567899999999999999999999999854
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=384.36 Aligned_cols=265 Identities=27% Similarity=0.384 Sum_probs=211.6
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~ 202 (486)
...++|++++.||+|+||.||+|+-++ ||..||+|++++.... ..+.++.|-.+|...++|+||+||.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~---------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY 208 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKD---------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY 208 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEcc---------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence 345799999999999999999998766 8899999999876543 3355788999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
.|++.+++||||||++||++..+|.+.+ .|++..+..++.+++.||..||+.| +|||||||+|+|||..|++||+|
T Consensus 209 sFQD~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 209 SFQDKEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred EecCCCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecc
Confidence 9999999999999999999999996654 7999999999999999999999999 99999999999999999999999
Q ss_pred cCCCCCCCC----------------------CCcc----ee-------------------eeeccccccccCccccccCC
Q 011412 283 FGLAKDGPE----------------------GDKT----HV-------------------STRVMGTYGYAAPEYVMTGH 317 (486)
Q Consensus 283 FGla~~~~~----------------------~~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~ 317 (486)
|||+.-... .+.. .. ....+|||.|||||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 999853211 0000 00 01268999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhccc
Q 011412 318 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 396 (486)
Q Consensus 318 ~~~~~DvwslGvil~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 396 (486)
|+..+|+|||||||||||.|.+||....+...- .++.|.. .+. +.. ......++.+||.+||.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-~l~----fP~----------~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-TLK----FPE----------EVDLSDEAKDLITRLLC- 428 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-hcc----CCC----------cCcccHHHHHHHHHHhc-
Confidence 999999999999999999999999887765432 2222221 111 000 11223689999999999
Q ss_pred CCCCCCCHHHHHHHhcCCCCCccC
Q 011412 397 DPKARPLMSEVVEALKPLPNLKDM 420 (486)
Q Consensus 397 dP~~RPs~~eil~~L~~~~~~~~~ 420 (486)
||..|.- .-=++.++.++.++.+
T Consensus 429 d~~~RLG-~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 429 DPENRLG-SKGAEEIKKHPFFKGV 451 (550)
T ss_pred CHHHhcC-cccHHHHhcCCccccC
Confidence 9999986 3333444455555444
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=382.30 Aligned_cols=269 Identities=25% Similarity=0.313 Sum_probs=216.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
....|+.++.||+|.||.||+|++.. ||+.||+|++..+.. ....-..+||.||++|+||||++|.+..
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~---------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLE---------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecc---------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence 34578889999999999999999876 788999999987653 3345678999999999999999999998
Q ss_pred EeC--CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 205 IED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 205 ~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
.+. ..+|||+|||+. +|.-++...+..|++.++..++.|++.||.|||.++ |+|||||.+|||||.+|.+||+|
T Consensus 186 t~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaD 261 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIAD 261 (560)
T ss_pred EecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecc
Confidence 876 689999999977 999999877889999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
||||+++...... ..+..+-|.+|+|||++.+ ..|+.++|+||.||||.||++|++.|++.........+-..+..-.
T Consensus 262 FGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 262 FGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred ccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 9999977554433 2556678999999999886 5899999999999999999999999998766554443332221111
Q ss_pred cc----cccc--cccCC------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 ER----RRFY--RLIDP------RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ~~----~~~~--~~~~~------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+. .++. ..+.+ .+.+. ...++..+.+|+..+|..||.+|.|+.++|+.
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 10 0111 11111 11111 11234567899999999999999999999863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=350.54 Aligned_cols=266 Identities=26% Similarity=0.385 Sum_probs=215.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.+|..++.||+|.||+||+|++.. ||+.||||+++...... ....++||+.|+.++|+||+.++++|-.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 467788899999999999999876 78899999998654321 2457899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+.+.||+||++. +|+..|..+...+....+..|+.++++||+|||.+. |+||||||.|+||+.+|.+||+|||+|
T Consensus 73 ~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 73 KSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred CCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccch
Confidence 9999999999955 999999888889999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-------- 357 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~-------- 357 (486)
+.....+.. .+..+-|.+|+|||.+.+ ..|+..+|+||.|||+.||+-|.+-|.+.+.-+....+-.+.
T Consensus 149 r~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 149 RFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred hccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence 987665443 233468999999998875 589999999999999999999998888765543333221111
Q ss_pred hhc---ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PHL---GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.+ .+..++...-.+.+.. +-..+..++.+|+.+||..||.+|++++|++++
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 1112222122222222 333455677999999999999999999999873
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=386.74 Aligned_cols=258 Identities=32% Similarity=0.474 Sum_probs=211.9
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+.+.+++.||+|-||.||+|.+... ..||+|.++... .....|.+|+++|++|+|+|||+++++|..
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCC----------CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 334455667899999999999999652 269999998753 334678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
++.+|||||||+.|+|.++|.. .+..+.....+.++.|||+||+||++++ +|||||..+||||+++..+||+||||
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccc
Confidence 8899999999999999999986 5677999999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
|+...++. ........-.+.|.|||.+..+.|+.++|||||||+||||+| |+.||....... +++ .+..
T Consensus 350 Ar~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~----~le~-- 419 (468)
T KOG0197|consen 350 ARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLE----LLER-- 419 (468)
T ss_pred ccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHH----HHhc--
Confidence 99544433 223333345779999999999999999999999999999999 888876543222 111 1111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
-+++-.| ..++..+.+||..||..+|++|||+..+...|+.+..
T Consensus 420 -GyRlp~P-------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 420 -GYRLPRP-------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred -cCcCCCC-------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 1222222 2356889999999999999999999999998876543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=379.58 Aligned_cols=254 Identities=27% Similarity=0.347 Sum_probs=210.5
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC----c-ccHHHHHHHHHHHhcCC-CCCceEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----L-QGHKEWLAEVNFLGDLV-HLNLVKL 200 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~-~~~~~~~~E~~~l~~l~-h~nIv~~ 200 (486)
....|.+.+.||+|+||.|++|++.. +|..||||++.... . ...+.+.+|+.+|+.++ ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL---------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc---------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 45689999999999999999999876 67899999887641 1 22345678999999998 9999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEE
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAK 279 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~vk 279 (486)
+.++.....+|+|||||.||+|.+++.+ .+.+.+..+..+++|++.||+|||+.+ |+||||||+||||+.+ +++|
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEE
Confidence 9999999999999999999999999987 668999999999999999999999998 9999999999999999 9999
Q ss_pred EeecCCCCCCC-CCCcceeeeeccccccccCccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 280 LSDFGLAKDGP-EGDKTHVSTRVMGTYGYAAPEYVMTGH-LT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 280 l~DFGla~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
|+|||++.... ... .....|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..... ...
T Consensus 162 l~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~ 232 (370)
T KOG0583|consen 162 LSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLY 232 (370)
T ss_pred EeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHH
Confidence 99999999874 222 345689999999999999877 85 7899999999999999999999863211 111
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
.........+. ..+. +.++..|+.+||..||.+|+++.+|+++-+-
T Consensus 233 ~ki~~~~~~~p--------~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~ 278 (370)
T KOG0583|consen 233 RKIRKGEFKIP--------SYLL---SPEARSLIEKMLVPDPSTRITLLEILEHPWF 278 (370)
T ss_pred HHHhcCCccCC--------CCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhChhh
Confidence 11111111111 1111 4678999999999999999999999965543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=382.23 Aligned_cols=269 Identities=26% Similarity=0.426 Sum_probs=219.1
Q ss_pred cChhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCC
Q 011412 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLN 196 (486)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n 196 (486)
....+|.+..+++.+...||+|.||+||+|+|.. .||||+++..... ..+.|.+|+.+|++-+|.|
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~N 449 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHEN 449 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhh
Confidence 3346666777788888999999999999999976 6999999877654 3467999999999999999
Q ss_pred ceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011412 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (486)
Q Consensus 197 Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 276 (486)
|+-+.|||..+.. .||+.+|+|-+|..+|+.....|.....+.|++||++||.|||.++ |||||||..||||.+++
T Consensus 450 IlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~ 525 (678)
T KOG0193|consen 450 ILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDL 525 (678)
T ss_pred heeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCC
Confidence 9999999988776 9999999999999999877788999999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~ 353 (486)
+|||+||||+................|...|||||+++. .+|+..+|||||||++|||+||..||.........
T Consensus 526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi--- 602 (678)
T KOG0193|consen 526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII--- 602 (678)
T ss_pred cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE---
Confidence 999999999987544433223334568899999999974 57999999999999999999999999733222111
Q ss_pred HhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
|. .+... ...|. .....++++.+.+|+..||..++++||.+.+|+..|+.+..
T Consensus 603 -fm---VGrG~---l~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 603 -FM---VGRGY---LMPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -EE---ecccc---cCccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11 11110 01111 11233567889999999999999999999999997776544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=378.96 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=213.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
..|.....||+|+-|.||.|.... +++.||||++........+-+++|+.+|+.++|+|||.+++.|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~---------~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKIS---------TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhcchhhhccccccceeeeeecc---------CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 467777899999999999998765 67789999998877666667899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
.+|+||||++||+|.+.+... .+++.++..|++++++||+|||.++ |||||||.+|||++.+|.+||+|||++..
T Consensus 344 eLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred eeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeec
Confidence 999999999999999988543 4899999999999999999999998 99999999999999999999999999988
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
...... ...+.+||++|||||++....|+.++||||||++++||+-|.+||-..++.....++...
T Consensus 419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n------------ 484 (550)
T KOG0578|consen 419 ISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN------------ 484 (550)
T ss_pred cccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc------------
Confidence 766543 345689999999999999999999999999999999999999999764443222221110
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
-.| .-..+...+..+++|+.+||+.|+.+|+++.|+|++
T Consensus 485 -g~P--~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 485 -GTP--KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -CCC--CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 001 111223345789999999999999999999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=360.85 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=212.5
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..++|++.+.||.|.-++||+|++.. +++.||||+++.+.... ...+.+|+..|+.++||||++++.+|.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 34689999999999999999999976 66799999998766544 477899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+..+|+||.||.+|++.+++... ...+++..+..|.+++++||.|||.+| .||||||+.||||+.+|.|||+|||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCce
Confidence 999999999999999999999643 445999999999999999999999999 9999999999999999999999999
Q ss_pred CCCCCCCCC-cceee-eeccccccccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 285 LAKDGPEGD-KTHVS-TRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 285 la~~~~~~~-~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
.+-...... ..... ..+.||++|||||++. ...|+.|+||||||++..||.+|..||....+... ....+
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tL 245 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTL 245 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHh
Confidence 876543332 22222 5578999999999965 45899999999999999999999999987654321 11111
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..... ......+..+-...+...++.++..||+.||.+|||+++++++
T Consensus 246 qn~pp--~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 246 QNDPP--TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCCCC--CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11111 0000111111222344578899999999999999999999964
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=369.50 Aligned_cols=248 Identities=28% Similarity=0.386 Sum_probs=211.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|.+.+.||+|+||.||||+.+. |.+.||+|.+.+.... ..+.+.+|++|++.|+|||||.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 467888899999999999998765 7889999999865443 24568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
..++|+|.|||.| +|..+|... ..++++.+..|+.|++.||.|||+.+ |+|||+||.||||+..|.+|+||||+|
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhh
Confidence 9999999999976 999999554 57999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
+.... .+.+.+++.||+.|||||++.++.|+..+|+||||||+|||++|++||.... +.+.....+.+
T Consensus 148 r~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d---- 215 (808)
T KOG0597|consen 148 RAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKD---- 215 (808)
T ss_pred hhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcC----
Confidence 98654 4556778999999999999999999999999999999999999999996432 11111212211
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.. .+...+..+..|+..+|.+||..|.+-.+++.+
T Consensus 216 -----~v~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 216 -----PVK---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -----CCC---CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 111 122456778999999999999999999998864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=367.80 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=213.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
..|..+++||+|.||.||+|.+.. +++.||+|++..+... ...++.+|+.+|.+++++||.++|+.+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeeeeecc---------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 357777899999999999998876 7889999999876543 346788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..++++||||.||++.+.|. .+..+.+..+.-++++++.||.|||.++ .+|||||+.||||..+|.+||+|||.+-
T Consensus 84 ~~LwiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred ccHHHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceee
Confidence 99999999999999999984 4445688888889999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
........ ..+++||+.|||||++....|+.++||||||++.+||++|.+|+....+.....+ +.
T Consensus 160 ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------Ip 224 (467)
T KOG0201|consen 160 QLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------IP 224 (467)
T ss_pred eeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------cc
Confidence 87654443 3568999999999999999999999999999999999999999987665221111 12
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+-..|.+.+. ++..+++|+..||..||+.||++.++|++
T Consensus 225 k~~PP~L~~~----~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 225 KSAPPRLDGD----FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCCccccc----cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2233444443 44678999999999999999999999964
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=373.24 Aligned_cols=265 Identities=30% Similarity=0.448 Sum_probs=205.6
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+.... +..++..||||++..... .....+.+|+.+|..+ +||||+++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGID----KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccC----CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 4568999999999999999999864211 123567899999975432 2235688999999999 899999999988
Q ss_pred EeC-CeeEEEEeecCCCChhHHHhhcC-----------------------------------------------------
Q 011412 205 IED-DQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 230 (486)
Q Consensus 205 ~~~-~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 230 (486)
... ..+++|||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 46889999999999999986431
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeecc
Q 011412 231 --------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302 (486)
Q Consensus 231 --------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 302 (486)
..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence 24778888999999999999999988 9999999999999999999999999998654322222222345
Q ss_pred ccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHH
Q 011412 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 381 (486)
Q Consensus 303 gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (486)
++..|||||++.+..++.++|||||||+||||++ |..||....... .+.. .+.+... .. .+..
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~----~~~~~~~------~~----~~~~ 301 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ----RLKDGTR------MR----APEN 301 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH----HHhcCCC------CC----CCCC
Confidence 6788999999999999999999999999999997 999997643211 1111 1111000 00 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 382 GAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 382 ~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 345788999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=376.07 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=210.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.-|++++-||.|+-|.|.+|++.. ||+.+|||++..... .....+.+||-+|+-|.||||+++|++|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~---------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE---------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhhhccc---------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 347888999999999999999877 899999999986621 11245789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
...++|+|+||++||.|+++|.+++ ++++..+.++++||+.|+.|||..+ |+||||||+|+|||..++|||+|||+
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccce
Confidence 9999999999999999999997665 7889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
|.....+. ...+-||++.|.|||++.+..|. .++||||.|||||.||||+.||++++. ..+..... ....
T Consensus 159 AsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV~---~G~f 229 (786)
T KOG0588|consen 159 ASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKVQ---RGVF 229 (786)
T ss_pred eecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHHH---cCcc
Confidence 98765543 34457999999999999999985 689999999999999999999985432 11111111 1000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
+++...+.++++||.+||..||.+|.++.||+++..
T Consensus 230 ------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 ------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 112233568999999999999999999999999764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=379.60 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=207.6
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcC-CCCCceEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVKL 200 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~~ 200 (486)
....++|.++++||+|.||+|+++..+. +++.||||+++++..-. .+..+.|.+|+... +||.++.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~---------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L 434 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKG---------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL 434 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcC---------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence 3456789999999999999999999876 77799999999876533 34577898888877 49999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
+.+|+..+++|+||||+.||++..++ +...+++..+..|+..|+.||+|||+++ |||||||.+|||||.+|++||
T Consensus 435 ~~~fQT~~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 435 FSCFQTKEHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred ccccccCCeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEe
Confidence 99999999999999999999965443 4457999999999999999999999999 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
+|||+++....... ...++|||+.|||||++.+..|+.++|+|||||+|||||.|..||.+++..+..+ ..+
T Consensus 510 ADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd------sI~ 581 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD------SIV 581 (694)
T ss_pred cccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHh
Confidence 99999998653322 3567999999999999999999999999999999999999999998765432211 111
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 404 (486)
.+ ...++...+.++..|++++|.++|.+|.-+
T Consensus 582 ~d------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 ND------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cC------------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 122344456789999999999999999865
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=355.36 Aligned_cols=269 Identities=28% Similarity=0.343 Sum_probs=215.9
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHH---HHHHHHHHHhcCCCCCceEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~nIv~~~~ 202 (486)
...++|++++.||.|.-|+||++.... ++..+|+|++.+......+ ++..|-+||..++||.++.||+
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa 144 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYA 144 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhh
Confidence 445678888999999999999999876 5679999999877655443 4567999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
.|..+...|||||||+||+|..+++++ +..+++..+..++.+++.||+|||-.| ||+|||||+||||.++|+|.|+
T Consensus 145 ~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLs 221 (459)
T KOG0610|consen 145 SFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLS 221 (459)
T ss_pred eeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEee
Confidence 999999999999999999999988754 567999999999999999999999999 9999999999999999999999
Q ss_pred ecCCCCCCCC---------------------------------CCcc---------------------eeeeeccccccc
Q 011412 282 DFGLAKDGPE---------------------------------GDKT---------------------HVSTRVMGTYGY 307 (486)
Q Consensus 282 DFGla~~~~~---------------------------------~~~~---------------------~~~~~~~gt~~y 307 (486)
||.|+..... .... .....++||-.|
T Consensus 222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY 301 (459)
T KOG0610|consen 222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY 301 (459)
T ss_pred eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence 9999753210 0000 012247899999
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHH
Q 011412 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA 387 (486)
Q Consensus 308 ~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (486)
+|||++.+...+.++|||+|||+|||||.|..||.+...... ....+.....| .+. ...+..++
T Consensus 302 lAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T------l~NIv~~~l~F--------p~~--~~vs~~ak 365 (459)
T KOG0610|consen 302 LAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET------LRNIVGQPLKF--------PEE--PEVSSAAK 365 (459)
T ss_pred ccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh------HHHHhcCCCcC--------CCC--CcchhHHH
Confidence 999999999999999999999999999999999987644321 11112221111 111 13356799
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhcCCCCCccCCC
Q 011412 388 QLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 422 (486)
Q Consensus 388 ~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 422 (486)
+||+++|.+||.+|.....=...++..+.++.+.+
T Consensus 366 DLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 366 DLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred HHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 99999999999999985555555566777766654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=372.85 Aligned_cols=242 Identities=29% Similarity=0.454 Sum_probs=204.0
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCee
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
...++-||.|+.|.||+|+.+ ++.||||+++.- -..+|+.|++|+|+||+.+.|+|.....+
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-----------netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-----------NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred hhhhhhhccCcccceeeeecc-----------CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 344578999999999999985 468999998632 23689999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|||||||..|-|...|. .+..+.......|..+||.||.|||.+. |||||||.-||||..+..|||+|||.++...
T Consensus 188 CIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred EEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999999994 4567889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.. .....++||..|||||++.+...+.|+|||||||+|||||||..||.+..... +.|. .-
T Consensus 264 ~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwG------------VG 324 (904)
T KOG4721|consen 264 DK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWG------------VG 324 (904)
T ss_pred hh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEe------------cc
Confidence 43 22345899999999999999999999999999999999999999997543321 1111 11
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
...+.-..+..++.-++-|+++||+..|..||++++|+.+|+.
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 1112223344567788999999999999999999999999874
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=347.39 Aligned_cols=268 Identities=24% Similarity=0.301 Sum_probs=212.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|+.+..|++|+||.||+|+++. |++.||+|+++.+.... --.-++||.+|.+++|||||.+-.+..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~---------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKK---------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCC---------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 3467788899999999999998875 78899999998654211 123579999999999999999999876
Q ss_pred eC--CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 206 ED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 206 ~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
.. +.+|||||||+. +|..++.....+|....+.-++.|++.||+|||... |+|||||++|+|++..|.+||+||
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEeccc
Confidence 53 679999999977 999999888889999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-----
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR----- 357 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~----- 357 (486)
|+|+.+.... ...+..+-|.+|+|||++.+ ..|+.++|+||+|||+.||+++++.|.+.......+.+-...
T Consensus 222 GLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 222 GLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE 299 (419)
T ss_pred chhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence 9999876543 23566788999999999875 579999999999999999999999998876554433322111
Q ss_pred ---hhcccc-----cccccccCCccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 ---PHLGER-----RRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ---~~~~~~-----~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.+.+. ..+....-..+...|... ..+...+|+..+|..||.+|.|+.+.|++
T Consensus 300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111110 011111111122223222 34667899999999999999999999874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=352.82 Aligned_cols=269 Identities=27% Similarity=0.344 Sum_probs=211.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEec--CCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
...|..++.||+|+||.|..|.+.. +|+.||||++. .......++..+|+++|+.++|+||+.+++++.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~---------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKR---------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred cceecccccccCcceeeEEEEEEcC---------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 4567778999999999999998876 77899999998 344444577899999999999999999999987
Q ss_pred e-----CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 206 E-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 206 ~-----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
. -..+|+|+|+| +.+|.+.|. .+..++...+..++.||++||+|+|+.+ |+||||||.|+|++.+..+||
T Consensus 92 p~~~~~f~DvYiV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred cccccccceeEEehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEe
Confidence 6 34679999999 668988884 4456999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
||||+|+...........+..+-|.+|+|||++. ...|+.++||||+||||.|||+|++.|.+........++......
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 9999999875432233356678899999999875 678999999999999999999999999887655444433322211
Q ss_pred ccc----------ccccccccCC----ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 360 LGE----------RRRFYRLIDP----RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 360 ~~~----------~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
-.+ .....+.+.. .+...|+ .....+.+|+.+||..||.+|+|+.|+|++-
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 100 0000011111 0111111 3346789999999999999999999999853
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=357.90 Aligned_cols=272 Identities=28% Similarity=0.439 Sum_probs=208.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCc-------cccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTA-------PVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVK 199 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~-------~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~ 199 (486)
.++|++.+.||+|+||.||+|.+...... ..+.+++..||||.+..... ....++.+|+++|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 35789999999999999999987553211 12334566899999976432 22456889999999999999999
Q ss_pred EEEEEEeCCeeEEEEeecCCCChhHHHhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011412 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (486)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 261 (486)
+++++.+.+..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885431 24677889999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh--CCC
Q 011412 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRR 339 (486)
Q Consensus 262 HrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--G~~ 339 (486)
||||||+|||++.++.+||+|||+++...............++..|||||++.+..++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999987654433333334556889999999988899999999999999999987 456
Q ss_pred CCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 340 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 340 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
||...... ................ . ....+..++..+.+|+.+||+.||.+||++.+|.+.|+
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~~~~---~----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQGRQ---V----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhcccc---c----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 77643321 1111111111100000 0 00011123467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.11 Aligned_cols=252 Identities=29% Similarity=0.406 Sum_probs=203.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.|++.+.||+|+||.||+|.+.. +|+.||||.+...... ....+.+|+.+|..++|+||+++++++.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec---------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 36778899999999999998876 6779999998754322 22357789999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
++..++|||||++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999888643 346899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++....... .....||..|||||++.+..++.++|||||||++|||++|+.||.............. ....
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~--- 219 (285)
T cd05631 149 AVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVKE--- 219 (285)
T ss_pred cEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hhhc---
Confidence 987543221 2345799999999999999999999999999999999999999976543211111100 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~ 410 (486)
....++...+..+.+|+.+||+.||.+||+ +.+++++
T Consensus 220 --------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 --------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 001122223467889999999999999997 7788764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=385.07 Aligned_cols=266 Identities=30% Similarity=0.445 Sum_probs=222.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
...+.+..+.||+|.||.||+|....-.. -.....||||.++..... ...+|.+|+++|+.|+|||||+|+|+|.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p----~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLP----GQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCC----CccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 34566777899999999999998765221 124457999999987665 5678999999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcC---------CC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRS---------LP----LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~---------~~----l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
.++.+|+|+|||..|+|.++|..+. .. ++..+.+.|+.|||.||.||-++. +|||||..+|+||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence 9999999999999999999996431 22 788999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 351 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~ 351 (486)
.++..|||+||||++..-..++.+...+-.-.++|||||.+..++|+.++|||||||+|||+++ |..||.+....+.
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-- 714 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-- 714 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--
Confidence 9999999999999999877777766555566889999999999999999999999999999999 8999987654332
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
++.... + ++ -.-+..++..++.||..||+.+|++||+++||-..|+....
T Consensus 715 -Ie~i~~----g----~l------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 -IECIRA----G----QL------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -HHHHHc----C----Cc------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 222211 0 01 11233567899999999999999999999999999976543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=352.68 Aligned_cols=267 Identities=23% Similarity=0.328 Sum_probs=204.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|++.+.||.|+||.||+|.+.. ++..||+|+++.... .....+.+|+.+++.++||||+++++++..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC---------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 479999999999999999998865 677999999875432 2234678999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||+++ +|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 76 RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred CeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCccee
Confidence 999999999975 999988776667899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh--------hh
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--------RP 358 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~--------~~ 358 (486)
........ .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+... .+
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 152 AKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred eccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 64332211 233568999999998865 56899999999999999999999999765432221111100 00
Q ss_pred hcccccccccccCCccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 359 HLGERRRFYRLIDPRLEGH----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.......+.....+..... .....+.++.+|+.+||+.||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0011111111111111000 001124568899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=367.60 Aligned_cols=263 Identities=27% Similarity=0.415 Sum_probs=205.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
.++|++.+.||+|+||.||+|.+... ....++..||||+++.... ...+.+.+|+.+|..+ +|||||+++++|.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 45788999999999999999975321 1123567899999975432 2335688999999999 8999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcC-------------------------------------------------------
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------- 230 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------- 230 (486)
..+..++|||||++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999986432
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011412 231 -------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (486)
Q Consensus 231 -------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~ 291 (486)
..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 24678889999999999999999988 99999999999999999999999999987544
Q ss_pred CCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 292 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
...........++..|+|||++.+..++.++|||||||++|||++ |..||....... ....... ... ...
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~---~~~ 337 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGY---RML 337 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCc---cCC
Confidence 332222222345678999999999999999999999999999998 888886542211 1111111 000 000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
.+...+.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus 338 -------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 -------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 011124578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=353.92 Aligned_cols=262 Identities=26% Similarity=0.349 Sum_probs=207.1
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------------cHHHHHHHHHHHh
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------GHKEWLAEVNFLG 190 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------------~~~~~~~E~~~l~ 190 (486)
....+.|++++.||+|.||.|-+|++.. +++.||||++.+.... ..+.+.+||.+|+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~---------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK 163 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEV---------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK 163 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecC---------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH
Confidence 4456789999999999999999999876 6779999999754321 1346889999999
Q ss_pred cCCCCCceEEEEEEEe--CCeeEEEEeecCCCChhHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 011412 191 DLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (486)
Q Consensus 191 ~l~h~nIv~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp 267 (486)
+|+|||||+|+.+..+ .+.+|||+|||..|.+.. . ....+ +.+.++++|+++++.||+|||.++ ||||||||
T Consensus 164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w-~-p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKP 238 (576)
T KOG0585|consen 164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW-C-PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKP 238 (576)
T ss_pred hcCCcCeeEEEEeecCcccCceEEEEEeccCCcccc-C-CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccch
Confidence 9999999999999876 468999999999998854 2 22334 899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEeecCCCCCCCCCCc---ceeeeeccccccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCC
Q 011412 268 SNILLDADYNAKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTGRRS 340 (486)
Q Consensus 268 ~NIll~~~~~vkl~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltG~~p 340 (486)
+|+||+.+|+|||+|||.+.....+.. ........||+.|||||.+.++. .+.+.||||+||+||.|+.|+.|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 999999999999999999886532211 11223368999999999987632 35689999999999999999999
Q ss_pred CCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 341 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
|.+..... . +..+++..+.-....+....+++||.+||.+||..|.+..+|..+.+....
T Consensus 319 F~~~~~~~------l----------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 319 FFDDFELE------L----------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cccchHHH------H----------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 97653211 1 112222222222222445789999999999999999999999988875443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=356.65 Aligned_cols=247 Identities=24% Similarity=0.312 Sum_probs=202.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 368899999999999999998865 577999999975422 22345788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+.+.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCc
Confidence 999999999999999999998654 46899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .......
T Consensus 148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~---~i~~~~~- 215 (291)
T cd05612 148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYE---KILAGKL- 215 (291)
T ss_pred chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCCc-
Confidence 9875432 123579999999999999999999999999999999999999997543211 111 0111100
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 411 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~L 411 (486)
.++...+..+.+|+.+||+.||.+||+ +.+++++.
T Consensus 216 -----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 216 -----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 111122457889999999999999995 78877654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=368.37 Aligned_cols=265 Identities=26% Similarity=0.394 Sum_probs=207.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|++...+. ..++..||||+++..... ....+.+|+.+|+.+ +|+|||+++++|
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGK----EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCc----ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34578999999999999999998754221 124568999999754322 235688999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC------------------------------------------------------
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------ 230 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------ 230 (486)
...+..++|||||++|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999985321
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcc
Q 011412 231 ---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295 (486)
Q Consensus 231 ---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~ 295 (486)
..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24678889999999999999999988 999999999999999999999999999875443222
Q ss_pred eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCcc
Q 011412 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374 (486)
Q Consensus 296 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (486)
.......++..|||||++.+..++.++|||||||++|||++ |+.||....... ...... ... ..+..
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~----~~~------~~~~~ 336 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMV----KRG------YQMSR 336 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHH----Hcc------cCccC
Confidence 22222345678999999998999999999999999999997 999997543211 111100 000 00001
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 375 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.. ..+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 337 ~~----~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 337 PD----FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1246789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=328.81 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=211.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++.+.||+|-||.||+|+.+. ++..||+|++.+.... ...++.+|++|-..|+||||+++|++|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred hhhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 4689999999999999999999877 5668999999765432 235688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
.+....||++||..+|+|.+.|.. ....+++.....++.|++.||.|+|.++ ||||||||+|+|++.++.+||+||
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence 999999999999999999999973 3456999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
|.+...... .....|||..|.+||.+.+..++..+|+|++|++.||++.|.+||....... .....
T Consensus 169 GwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYkrI------- 234 (281)
T KOG0580|consen 169 GWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYKRI------- 234 (281)
T ss_pred CceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHHHH-------
Confidence 998875432 2456899999999999999999999999999999999999999997643111 11000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
..++-. ++...+..+.+||.+||..+|.+|....|++++-+
T Consensus 235 ----~k~~~~----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 235 ----RKVDLK----FPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ----HHcccc----CCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 001111 11223467899999999999999999999998765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=360.87 Aligned_cols=243 Identities=30% Similarity=0.377 Sum_probs=198.1
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 211 (486)
+.||+|+||.||+|.+.. +|+.||||+++.... .....+.+|+.+|+.++||||+++++++...+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 469999999999998865 677999999975422 22345778999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011412 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (486)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~ 291 (486)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 72 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 72 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 999999999999988654 47899999999999999999999988 99999999999999999999999999976422
Q ss_pred CCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 011412 292 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 371 (486)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (486)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +... .....
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~---~~~~~-------- 211 (323)
T cd05571 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---ILMEE-------- 211 (323)
T ss_pred CCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHH---HHcCC--------
Confidence 211 1234679999999999999999999999999999999999999996532211 1110 01110
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011412 372 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 410 (486)
Q Consensus 372 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~ 410 (486)
. .++...+..+.+||.+||+.||++|| ++.+++++
T Consensus 212 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1 11122346789999999999999999 78888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=360.88 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=202.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.+|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+|.+++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 578899999999999999999865 677999999975422 23356889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+++..|+||||+.+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccC
Confidence 999999999999999999998654 46889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++...... ...+||+.|+|||++.+..++.++|||||||++|||++|..||....... .. .........
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~---~~i~~~~~~ 233 (329)
T PTZ00263 165 AKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IY---EKILAGRLK 233 (329)
T ss_pred ceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HH---HHHhcCCcC
Confidence 98754322 23579999999999999999999999999999999999999996543211 11 101111000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~ 410 (486)
++...+..+.+|+.+||+.||.+||+ +.+++.+
T Consensus 234 ------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 ------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11112356889999999999999996 5666654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=357.66 Aligned_cols=267 Identities=24% Similarity=0.345 Sum_probs=206.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++++.||+|+||.||++.+.. +|..||+|.+..... .....+.+|+++|+.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 4689999999999999999998875 677899999976432 223568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 99999999999999999998654 46899999999999999999999852 2999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc--
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR-- 364 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 364 (486)
....... .....||..|+|||++.+..++.++|||||||++|||++|+.||............. .+......
T Consensus 152 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~ 225 (331)
T cd06649 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGE 225 (331)
T ss_pred ccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCC
Confidence 8654322 234579999999999999999999999999999999999999996533211000000 00000000
Q ss_pred -----------------------------cccc-ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 365 -----------------------------RFYR-LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 365 -----------------------------~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.+.. +.............+.++.+|+.+||+.||++||++.+|+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000 00000000001123467899999999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=360.47 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=206.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++++.||+|+||.||+|.+.. +|+.||||+++.... .....+.+|+.+|..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 368899999999999999999875 577999999975422 23356788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
..+..||||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcC
Confidence 999999999999999999998544 46889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+... .
T Consensus 148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------~- 214 (333)
T cd05600 148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-------K- 214 (333)
T ss_pred Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-------c-
Confidence 986543 123457999999999999999999999999999999999999999764332111111000 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+............+..+.+|+.+||..+|.+||++.+++++.
T Consensus 215 --~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 215 --ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred --ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 00000000000012346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=350.86 Aligned_cols=268 Identities=23% Similarity=0.293 Sum_probs=204.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++.+.||+|+||.||+|++.. ++..||||++..... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 368899999999999999998865 577899999875432 223567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..++||||++++.|..+. .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 99999999999887665443 44557899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc------
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL------ 360 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~------ 360 (486)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......+
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 148 RNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred ccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 876433221 1234578999999999998899999999999999999999999997643321111111000000
Q ss_pred --ccccccccccCCccC------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 361 --GERRRFYRLIDPRLE------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 361 --~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.....+.....+... ..+....+..+.+|+.+||+.||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 00111234578999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=351.15 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=211.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHH---HHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..+|++.+.||+|.||.|-+|+... .|+.||||.++++......+ +.+||+||..|+||||+.+|.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~---------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHK---------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhcc---------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 3578888999999999999997754 68899999999887665443 67899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
...+.+.|||||..+|.|.+++.+++ .+++..+..+++||..|+.|+|.++ ++|||||.+|||||.++++||+|||
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccc
Confidence 99999999999999999999996654 7999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
|+..+.... ..+++||++.|.+||++.+..| ++.+|-|||||+||.|+.|..||++..-. .++... ...
T Consensus 199 LSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQI----s~G 268 (668)
T KOG0611|consen 199 LSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQI----SRG 268 (668)
T ss_pred hhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHHh----hcc
Confidence 998875433 3567999999999999999988 57899999999999999999999865321 111111 000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
....| ..+..+.-||++||..||++|.|+.+|..+.+
T Consensus 269 ----aYrEP--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 269 ----AYREP--------ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ----cccCC--------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 01111 12346789999999999999999999998875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=349.53 Aligned_cols=245 Identities=20% Similarity=0.319 Sum_probs=198.6
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEEEEe----C
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE----D 207 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~ 207 (486)
..||+|++|.||+|.+ +|..||||.++...... .+.+.+|+.+|.+++|||||++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEE-----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 5799999999999987 46789999998654433 3567799999999999999999999877 3
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
..+++|||||++|+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchH
Confidence 4688999999999999999654 4788999999999999999999984 5 889999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... +... ......
T Consensus 171 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~---i~~~~~ 239 (283)
T PHA02988 171 KILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDL---IINKNN 239 (283)
T ss_pred hhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHhcCC
Confidence 8653321 22468899999999876 689999999999999999999999997543211 1111 000000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
...++...+..+.+|+.+||+.||.+||++.|+++.|+.+.
T Consensus 240 ----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 ----------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ----------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 01112234567999999999999999999999999987553
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=345.52 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=208.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|++.+.||+|+||.||+|++.... ..+..||+|.++..... ....+.+|+.+|..++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPS------KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCC------CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 357889999999999999999876432 24678999999865332 23468899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..+|||||+++|+|.+++......+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||.+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999776667899999999999999999999988 999999999999999999999999987
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
......... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... +... +.+..
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~----~~~~~- 225 (266)
T cd05064 155 QEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKA----VEDGF- 225 (266)
T ss_pred ccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH----HHCCC-
Confidence 654322111 1112345678999999999999999999999999999775 999997543221 1111 11100
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
... .+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 226 -----~~~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -----RLP----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCC----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 001 1122356789999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=361.40 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=212.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|..++.+|+|+||.+++++++.+ +..|++|.+....... .+....|+.+++++.|||||.+++.|.+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~---------~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSD---------DKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccC---------CceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 4788899999999999999988774 4589999998665433 3457899999999999999999999999
Q ss_pred CCe-eEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 207 DDQ-RLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 207 ~~~-~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
++. ++|||+||+||+|.+.|.+. +..++++.+..|+.|++.||.|||+++ |+|||||+.|||++.++.|||+|||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchh
Confidence 888 99999999999999999755 478999999999999999999999888 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+|+....... ...+..||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+... ++....
T Consensus 152 laK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~------- 219 (426)
T KOG0589|consen 152 LAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKIN------- 219 (426)
T ss_pred hhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHh-------
Confidence 9998766542 2455789999999999999999999999999999999999999997654321 111111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.. ...++.....++..|+..||..+|..||++.++|..
T Consensus 220 ---~~~----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 ---RGL----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---hcc----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111 112233445789999999999999999999999976
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=372.06 Aligned_cols=262 Identities=24% Similarity=0.307 Sum_probs=210.3
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCceEEEE-E
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIG-Y 203 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~-~ 203 (486)
+...++++.+.|.+|||+.||+|.+.. .|..||+|++-..+....+.+.+||.+|+.|. |+|||.|++ .
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 345678888999999999999999875 33689999998777777788999999999997 999999999 3
Q ss_pred EEe------CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011412 204 CIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (486)
Q Consensus 204 ~~~------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 276 (486)
... .-+++|+||||.||.|-+++..+ ...|++..+++|+.|+++||++||... .+|||||||-+||||+.+|
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADG 183 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCC
Confidence 322 12568999999999999999744 345999999999999999999999987 7799999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceee-------eeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVS-------TRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~ 346 (486)
..||||||.|+........... -...-|+.|+|||++. +..++.|+|||||||+||-|+....||+....
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 9999999999754332211000 0134699999999874 77899999999999999999999999975422
Q ss_pred CCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011412 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 417 (486)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 417 (486)
. .+++....-.-....+..+.+||+.||+.||.+||++-+++..+-.+.+.
T Consensus 264 l--------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 L--------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred e--------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1 11111111111135678899999999999999999999999988766554
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=348.94 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=201.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 3679999999999999999998865 5779999999754322 23457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..++||||+. ++|.+++......++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcc
Confidence 999999999995 6888888776677899999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc---
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE--- 362 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--- 362 (486)
+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... .........+..
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 226 (303)
T cd07869 151 RAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNE 226 (303)
T ss_pred eeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCCh
Confidence 75432211 1233568999999998865 468999999999999999999999997543211 111100000000
Q ss_pred --ccccc--cccCCc-c----CCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 363 --RRRFY--RLIDPR-L----EGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 363 --~~~~~--~~~~~~-~----~~~~~~-----~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..... ....+. + ...+.. .....+.+|+.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000 000000 0 000000 012467899999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=352.79 Aligned_cols=257 Identities=28% Similarity=0.353 Sum_probs=201.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
+|++++.||+|+||.||+++.... ..+|..||+|++..... ...+.+..|+.+|..+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTG------HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEccc------CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 578899999999999999987542 23678999999874321 2234577899999999 599999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
..++.+++||||+++|+|.+++..+ ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999999999998654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
+++........ .....+||+.|||||++.+. .++.++|||||||+||||++|..||...........+ .....
T Consensus 151 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~--- 224 (332)
T cd05614 151 LSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRIL--- 224 (332)
T ss_pred CCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHh---
Confidence 99865332221 12346799999999998765 4789999999999999999999999754322111111 00000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
..++.+.. ..+..+.+|+.+||+.||++|| ++.+++++-
T Consensus 225 -----~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 225 -----KCDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred -----cCCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 01121222 2345688999999999999999 677777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=365.47 Aligned_cols=274 Identities=28% Similarity=0.439 Sum_probs=219.6
Q ss_pred cChhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCC
Q 011412 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHL 195 (486)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~ 195 (486)
+.-..|.+..++..+.++||+|+||.||+|.++..+.. ....||||..+... .....++++|+++|++++||
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~ 221 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHP 221 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCC
Confidence 34445566677888889999999999999998763221 01128999998633 34457899999999999999
Q ss_pred CceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011412 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 196 nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 275 (486)
|||++||++.....++||||+|.||+|.++|.+....++....+.++.+++.||+|||+++ +|||||..+|||++.+
T Consensus 222 NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 222 NVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKK 298 (474)
T ss_pred CEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCC
Confidence 9999999999999999999999999999999887778999999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcceeee-eccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 011412 276 YNAKLSDFGLAKDGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~ 353 (486)
+.+||+||||++.... ..... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+........
T Consensus 299 ~~vKISDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~-- 373 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA-- 373 (474)
T ss_pred CeEEeCccccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH--
Confidence 9999999999987541 11111 1135679999999999999999999999999999999 888997654321111
Q ss_pred HhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCcc
Q 011412 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 419 (486)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 419 (486)
+. ..+ ......+...+..+..++.+||..||++||+|.++.+.|+.+.....
T Consensus 374 -kI---~~~----------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 374 -KI---VKN----------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -HH---Hhc----------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11 010 11111222346788899999999999999999999999987755433
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=354.83 Aligned_cols=244 Identities=31% Similarity=0.375 Sum_probs=197.7
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 211 (486)
+.||+|+||.||++.+.. +|..||+|++..... .....+.+|+++++.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 469999999999998865 577999999975422 22345678999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011412 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (486)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~ 291 (486)
|||||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 72 lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 72 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 999999999999888554 46899999999999999999999988 99999999999999999999999999876432
Q ss_pred CCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 011412 292 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 371 (486)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (486)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .......
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~---~~~~~~~------- 212 (323)
T cd05595 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LILMEEI------- 212 (323)
T ss_pred CCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHhcCCC-------
Confidence 211 1234679999999999999999999999999999999999999996543211 100 0000000
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 372 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 372 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
. ++...+..+.+|+.+||+.||.+|| ++.+++++-
T Consensus 213 -~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 213 -R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred -C----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 1 1112346788999999999999998 888888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=371.18 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=204.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 209 (486)
.|.+.+.||+|+||.||+|..... .+..||+|.+..........+.+|+.+|+.++|||||++++++..++.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 488889999999999999987542 256789998765554444567889999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 210 RLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+||||||+++|+|.++|.. ...++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 9999999999999998853 2456889999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
+..............+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ....
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~---~~~~---- 286 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQ---VLYG---- 286 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHhC----
Confidence 8765433322344567999999999999999999999999999999999999999653221 11110 0000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+ .++...+..+.+||.+||..||.+||++.+++.+
T Consensus 287 --~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 287 --KYD-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCC-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 000 0111234578999999999999999999998753
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=344.54 Aligned_cols=261 Identities=28% Similarity=0.471 Sum_probs=209.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|++.+.||+|+||.||+|.+...+. ..+...||+|.+...... ....+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNE----RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCC----CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 478889999999999999998765321 124468999999754332 235688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
...+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence 99999999999999999996532 35788899999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 351 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~ 351 (486)
+.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--- 234 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--- 234 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999986544333223334567889999999988899999999999999999998 999997643321
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
+..... .. .....+..++..+.+|+.+||+.||.+||++.+|+++|+.
T Consensus 235 ~~~~i~----~~----------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIR----SR----------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHH----cC----------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111110 00 0111122345789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=355.27 Aligned_cols=244 Identities=28% Similarity=0.363 Sum_probs=198.5
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 211 (486)
+.||+|+||.||++.+.. +|..||||++..... .....+.+|+++|+.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 469999999999998865 677999999975422 22356788999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011412 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (486)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~ 291 (486)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 72 lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 72 FVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 999999999999888554 46899999999999999999999988 99999999999999999999999999876432
Q ss_pred CCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 011412 292 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 371 (486)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (486)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ..... +
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~---~~~~~--------~ 211 (328)
T cd05593 148 DAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE---LILME--------D 211 (328)
T ss_pred ccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHH---HhccC--------C
Confidence 211 1234679999999999999999999999999999999999999996543211 111 01110 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 372 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 372 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
..+ +...+..+.+|+.+||+.||.+|| ++.+++++.
T Consensus 212 ~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 212 IKF----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred ccC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 111 112345788999999999999997 889988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=354.26 Aligned_cols=255 Identities=26% Similarity=0.313 Sum_probs=214.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCC-CCCceEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLV-HLNLVKLIG 202 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~nIv~~~~ 202 (486)
....|++.+.||+|.||.||++..+. ||..+|+|.+....... ...+.+|+.+|++|. |||||.+++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~---------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~ 103 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKS---------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD 103 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecC---------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34578888999999999999998876 68899999998765533 357899999999998 999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC----CCcE
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----DYNA 278 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~----~~~v 278 (486)
.|.+.+.+++|||+|.||.|.+.|... .+++..+..++.|++.++.|||+.+ |+||||||+|+|+.. ++.+
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcE
Confidence 999999999999999999999999776 3999999999999999999999988 999999999999943 3579
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
|++|||++.....+ ......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.........+...
T Consensus 179 k~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~-- 253 (382)
T KOG0032|consen 179 KLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG-- 253 (382)
T ss_pred EEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--
Confidence 99999999987652 2345689999999999999999999999999999999999999999876543322211100
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
+..+........+..+.+++.+||..||.+|+++.++|++.+
T Consensus 254 ------------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 ------------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ------------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 001122222234578999999999999999999999999855
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=339.63 Aligned_cols=266 Identities=25% Similarity=0.348 Sum_probs=204.5
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCC-ceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLN-LVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~ 206 (486)
.|..++.||+|+||+||+|+.+. +|+.||+|+++..... ......+|+-+|+.|+|+| ||++++++..
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~---------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKR---------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEec---------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence 45566789999999999999876 6789999999865432 2245789999999999999 9999999998
Q ss_pred CC------eeEEEEeecCCCChhHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 207 DD------QRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 207 ~~------~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
.. .+++||||++. +|..++.... ..++...+..+++||+.||+|||+++ |+||||||.||||+.+|.
T Consensus 83 ~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 83 SNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGV 158 (323)
T ss_pred cccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCc
Confidence 77 78999999954 9999997665 46888899999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+|+...-... ..+..++|.+|+|||++.+. .|+..+||||+|||++||+++++.|.+.........+-..
T Consensus 159 lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~ 236 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL 236 (323)
T ss_pred EeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 99999999997543222 25567899999999999876 8999999999999999999999999876552221111000
Q ss_pred h--------hhcc---ccc-ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 357 R--------PHLG---ERR-RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 357 ~--------~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. +... +.. .+...-.+......-........+++.+||+.+|.+|.|+..++++
T Consensus 237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 0000 000 1111110000000000111468899999999999999999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=348.90 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=216.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH--HHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..-|.+.+.||+|.|++|-+|++-- ||..||||++.+...... ..+..|++.|+.++|||||++|.+..
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVF---------TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVF---------TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhc---------ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 3468888999999999999998754 899999999987765443 46889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE-cCCCcEEEeecC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNAKLSDFG 284 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll-~~~~~vkl~DFG 284 (486)
....+|||+|+-++|+|.++|.++...+.+..+.+++.||+.|+.|+|+.+ +|||||||+|+++ ..-|-|||.|||
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecc
Confidence 999999999999999999999999889999999999999999999999999 9999999999887 556899999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
++..+..+.. .+..||+..|-|||++.+..|+ +++||||||||||.|++|++||+..+..+...++
T Consensus 165 FSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------- 231 (864)
T KOG4717|consen 165 FSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------- 231 (864)
T ss_pred ccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh----------
Confidence 9988776654 4568999999999999999997 5899999999999999999999866544322221
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
+|- .-..+...+.++++||..||.+||++|.+..||...-+
T Consensus 232 ------mDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 232 ------MDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred ------hcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 111 11234455788999999999999999999999986543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.59 Aligned_cols=241 Identities=32% Similarity=0.342 Sum_probs=195.3
Q ss_pred eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 137 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
||+|+||.||+|++.. +++.||+|++.... ......+.+|+.+|..++||||+++++++...+..++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 7999999999999865 57789999987532 22235678899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~ 293 (486)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 72 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 72 LAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred EcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 9999999999998654 46899999999999999999999988 9999999999999999999999999998643222
Q ss_pred cceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCc
Q 011412 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373 (486)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (486)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 148 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~~--------- 210 (312)
T cd05585 148 D--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEPL--------- 210 (312)
T ss_pred C--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCC---------
Confidence 1 233467999999999999999999999999999999999999999754221 11111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 011412 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEA 410 (486)
Q Consensus 374 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 410 (486)
.++...+..+.+|+.+||+.||.+||+ +.+++.+
T Consensus 211 ---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 211 ---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 112223467889999999999999986 4555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=352.50 Aligned_cols=267 Identities=24% Similarity=0.345 Sum_probs=204.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++.+.||+|+||.||+|.+.. +|..+|+|++..... .....+.+|+++|+.++|+||++++++|..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 4689999999999999999998865 677899999876432 223568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
++.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCc
Confidence 99999999999999999998654 4688999999999999999999974 5 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh----hhcc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR----PHLG 361 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~----~~~~ 361 (486)
+....... .....||..|+|||++.+..++.++|||||||++|||++|+.||................ ....
T Consensus 151 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (333)
T cd06650 151 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226 (333)
T ss_pred chhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence 97653321 233578999999999998899999999999999999999999997543211110000000 0000
Q ss_pred ---ccc--------------------ccccccCCccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 362 ---ERR--------------------RFYRLIDPRLEGHFS-IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 362 ---~~~--------------------~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
... .+...+.......++ ...+..+.+|+.+||+.||.+||++.|++++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 000 000000000000000 01245688999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=356.67 Aligned_cols=249 Identities=25% Similarity=0.294 Sum_probs=202.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|.+.+.||+|+||.||+|.+... .+..||+|++.... ......+.+|+.+|..++||||+++++++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 35788999999999999999987542 23589999986432 12235678899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+.+.+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCC
Confidence 9999999999999999999998654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+++..... .....||+.|||||++.+..++.++|||||||++|||++|..||....+.. .... ......
T Consensus 177 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~---i~~~~~ 245 (340)
T PTZ00426 177 FAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQK---ILEGII 245 (340)
T ss_pred CCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHHH---HhcCCC
Confidence 99865332 223579999999999999899999999999999999999999997543211 0000 000000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
.++...+..+.+++.+||+.||.+|+ ++.+++++.
T Consensus 246 ------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 246 ------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 01112235688999999999999995 788887653
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=360.43 Aligned_cols=254 Identities=25% Similarity=0.333 Sum_probs=199.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.|++++.||+|+||+||+|.+.. ++..||||++..... .....+.+|+.+|+.++|+||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 58889999999999999998865 677999999975432 223457899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+.+|+|||||++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 99999999999999999998654 46889999999999999999999988 999999999999999999999999997
Q ss_pred CCCCCCCc---------------------------------------------ceeeeeccccccccCccccccCCCCch
Q 011412 287 KDGPEGDK---------------------------------------------THVSTRVMGTYGYAAPEYVMTGHLTSR 321 (486)
Q Consensus 287 ~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 321 (486)
+....... .......+||+.|||||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 64311000 000123579999999999998999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHh--cccCC
Q 011412 322 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC--LSRDP 398 (486)
Q Consensus 322 ~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c--l~~dP 398 (486)
+|||||||++|||++|..||.......... +..+ .. . + .+.. ....+..+.+||.+| +..+|
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-----~~--~----~--~~~~--~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW-----EN--T----L--HIPP--QVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc-----cc--c----c--CCCC--CCCCCHHHHHHHHHHccCcccc
Confidence 999999999999999999997654321110 0000 00 0 0 0000 011245688899884 45566
Q ss_pred CCCCCHHHHHHHh
Q 011412 399 KARPLMSEVVEAL 411 (486)
Q Consensus 399 ~~RPs~~eil~~L 411 (486)
..||++.+++.+-
T Consensus 294 ~~R~~~~~~l~hp 306 (381)
T cd05626 294 LGRNGADDIKAHP 306 (381)
T ss_pred cCCCCHHHHhcCc
Confidence 6799999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=353.31 Aligned_cols=267 Identities=25% Similarity=0.356 Sum_probs=197.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++.+.||+|+||.||+|.+.. +|..||||++.... ......+.+|+++|+.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 47888999999999999998865 67799999987432 22334688999999999999999999988643
Q ss_pred -----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 208 -----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 208 -----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
..+|+||||| +++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEcc
Confidence 2479999999 46899888544 46899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcc-eeeeeccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--
Q 011412 283 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 357 (486)
Q Consensus 283 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~-- 357 (486)
||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999864332211 11234579999999998865 678999999999999999999999997543211110000000
Q ss_pred ------hhcc--cccccccccCCccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 ------PHLG--ERRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ------~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+. ....+...+.......+. ...+..+.+|+.+||+.||++||++.|++++
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 000000000000000000 0123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=359.19 Aligned_cols=265 Identities=23% Similarity=0.374 Sum_probs=207.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCC-CCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 204 (486)
..++|.+.++||+|+||.||+|.+.... ...++..||||++...... ....+.+|+++|..+. |||||+++++|
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLS----RSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccC----CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 3568999999999999999999875321 1123557999999754332 2356889999999996 99999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC------------------------------------------------------
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------ 230 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------ 230 (486)
.+.+..|||||||++|+|.++|....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999999886421
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011412 231 -----------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (486)
Q Consensus 231 -----------------------------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 269 (486)
..+++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence 23677888999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 011412 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 348 (486)
Q Consensus 270 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~ 348 (486)
||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999999986543322222223457788999999998999999999999999999997 999986532211
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.+.. ..... ... ..+...+..+.+|+.+||+.||++||++.+|.+.|+.+
T Consensus 348 --~~~~----~~~~~------~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 348 --TFYN----KIKSG------YRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred --HHHH----HHhcC------CCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 0100 00000 000 11122346789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=349.54 Aligned_cols=262 Identities=24% Similarity=0.397 Sum_probs=207.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|++.+.||+|+||.||+|.+...+.. ....||||.++.... ....++.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCc-----cceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 35799999999999999999987653321 234599999975432 334578899999999999999999999876
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
. ..++|+||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccc
Confidence 4 578999999999999999876667899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+...............++..|+|||++.+..++.++|||||||++|||++ |..||....... +... +.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~ 229 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGER 229 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HhCCCC
Confidence 87654333222222345678999999999999999999999999999998 999996542211 1111 111000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.. .. ..++..+.+++.+||..||.+||++.+++..|..+.
T Consensus 230 ---~~---~~----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 230 ---LP---QP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ---CC---CC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 01 112356889999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=350.32 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=194.8
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHH---hcCCCCCceEEEEEE
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFL---GDLVHLNLVKLIGYC 204 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~~~~~~ 204 (486)
|++++.||+|+||.||+|.+.. +|+.||||+++... ....+.+.+|++++ ..++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 6778899999999999998865 67799999997542 12234566666654 567899999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
...+..|+||||+++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCccc
Confidence 999999999999999999988743 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+++....... .....+||+.|||||++.+..++.++|||||||++|||++|+.||....... ... ......
T Consensus 147 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~~---~i~~~~- 217 (324)
T cd05589 147 LCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VFD---SIVNDE- 217 (324)
T ss_pred CCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCC-
Confidence 9875432221 1234679999999999999999999999999999999999999997543211 111 000000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~ 410 (486)
.. ++...+..+.+||.+||+.||.+||+ +.+++++
T Consensus 218 -------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 -------VR----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -------CC----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 01 11122466889999999999999994 5565543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=354.89 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=195.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|+.++.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+++|+.++|+||+++++++...
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP---------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC---------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 356677899999999999998865 5679999999654322 235688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+.+++|||||++|+|.+.. ...+..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 145 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999999999986532 3557778899999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
....... ......||..|+|||++.. ..++.++|||||||+||||++|+.||..........+..... ..
T Consensus 217 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~- 291 (353)
T PLN00034 217 ILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MS- 291 (353)
T ss_pred ecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--cc-
Confidence 6543221 1233579999999998743 234568999999999999999999997433221111111000 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. ........+..+.+||.+||+.||++||++.|++++-
T Consensus 292 -------~----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 292 -------Q----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred -------C----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0 0111122346789999999999999999999999854
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=341.87 Aligned_cols=261 Identities=25% Similarity=0.343 Sum_probs=202.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC--
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 207 (486)
.|...+++|.|+||.||+|.... +++.||||++-.+.. .--+|+++|+.++|||||++..+|...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 46677899999999999999987 567999999876542 224799999999999999999888652
Q ss_pred C---eeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEE
Q 011412 208 D---QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKL 280 (486)
Q Consensus 208 ~---~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~vkl 280 (486)
. ++.|||||++. +|.+.+.. .+..++...+.-+..||++||.|||+.+ |+||||||.|||+|.+ |.+||
T Consensus 92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEe
Confidence 2 44599999966 99888863 3567888899999999999999999988 9999999999999976 99999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 357 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~-- 357 (486)
||||.|+....+..+ .....|..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.........+....
T Consensus 168 cDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred ccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 999999988766543 34567999999998875 589999999999999999999999998865543322221111
Q ss_pred hhccc---------ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PHLGE---------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+...+ ..++.++.......-+....+.++.+|+.++|..+|.+|.++.|++.+
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 10000 011122222211112334456789999999999999999999999863
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=355.87 Aligned_cols=255 Identities=25% Similarity=0.324 Sum_probs=198.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++++.||+|+||+||+|.+.. +++.||||++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 478899999999999999998865 677999999975322 22345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+...+|||||||++|+|.+++.+. ..+++..+..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccC
Confidence 999999999999999999999654 47899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc---------------------------------eeeeeccccccccCccccccCCCCchhhHHHHHHHHH
Q 011412 286 AKDGPEGDKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 332 (486)
Q Consensus 286 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ 332 (486)
++........ ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 8754321100 0012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 011412 333 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS--RDPKARPLMSEVVEA 410 (486)
Q Consensus 333 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~dP~~RPs~~eil~~ 410 (486)
||++|+.||......... ..... ...... +.+ .. ..+..+.+||.+|+. .++..||++.||+++
T Consensus 228 ell~G~~Pf~~~~~~~~~---~~i~~-~~~~~~----~p~----~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 228 EMLIGYPPFCSETPQETY---KKVMN-WKETLI----FPP----EV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHhCCCCCCCCCHHHHH---HHHHc-CcCccc----CCC----cC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 999999999764332111 00000 000000 111 00 123567788888654 233456899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=337.51 Aligned_cols=261 Identities=26% Similarity=0.452 Sum_probs=209.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++.+.||+|+||.||+|.+...+. +...||||.++..... ...++.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGK------KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCC------CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 3578899999999999999999865321 3457999998754332 23568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchh
Confidence 99999999999999999999776668999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+..... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~ 226 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVE----DGYR 226 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHH----cCCC
Confidence 87652222212222345678999999998899999999999999999998 99998643211 1111110 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.+ .+...+..+.+|+.+||+.+|++||++.+|+++|+.+
T Consensus 227 -----~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 -----LP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 1112346789999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=364.48 Aligned_cols=269 Identities=22% Similarity=0.321 Sum_probs=197.3
Q ss_pred HHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC------CCc
Q 011412 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH------LNL 197 (486)
Q Consensus 124 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nI 197 (486)
+.....+|++++.||+|+||+||+|++.. +++.||||+++... ....++..|+.++..++| .+|
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i 193 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRK---------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPL 193 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcC---------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcce
Confidence 34456789999999999999999998865 56789999996432 122345667777776654 458
Q ss_pred eEEEEEEEeC-CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCC
Q 011412 198 VKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 198 v~~~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~ 275 (486)
++++++|..+ ..+|||||++ +++|.+++.+. ..+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.+
T Consensus 194 ~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~ 268 (467)
T PTZ00284 194 MKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETS 268 (467)
T ss_pred eeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecC
Confidence 8999988764 5789999998 77899988655 478999999999999999999997 47 9999999999999876
Q ss_pred C----------------cEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 011412 276 Y----------------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339 (486)
Q Consensus 276 ~----------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~ 339 (486)
+ .+||+|||++...... ....+||+.|||||++.+..|+.++|||||||+||||++|+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred CcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 5 4999999988653221 234689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHHhhhhhcc----------cccccccc---cCCccCC-----------CCCHHHHHHHHHHHHHhcc
Q 011412 340 SMDKNRPNGEHNLVEWARPHLG----------ERRRFYRL---IDPRLEG-----------HFSIKGAQKAAQLAAHCLS 395 (486)
Q Consensus 340 pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~---~~~~~~~-----------~~~~~~~~~~~~li~~cl~ 395 (486)
||...........+......+. +...+... +.+.... .........+.+||.+||+
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 9976543222111111100000 00000000 0000000 0000113457899999999
Q ss_pred cCCCCCCCHHHHHHHhc
Q 011412 396 RDPKARPLMSEVVEALK 412 (486)
Q Consensus 396 ~dP~~RPs~~eil~~L~ 412 (486)
.||.+||++.|++++-.
T Consensus 424 ~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 424 YDRQKRLNARQMTTHPY 440 (467)
T ss_pred cChhhCCCHHHHhcCcc
Confidence 99999999999998654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=359.34 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=201.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++++.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+|..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 478999999999999999999876 677999999975321 22345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+.+.+|||||||++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeeccc
Confidence 999999999999999999998654 46899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcce------------------------------------eeeeccccccccCccccccCCCCchhhHHHHHH
Q 011412 286 AKDGPEGDKTH------------------------------------VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 329 (486)
Q Consensus 286 a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv 329 (486)
++......... .....+||+.|+|||++....++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 87543211000 011246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 011412 330 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSE 406 (486)
Q Consensus 330 il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~e 406 (486)
++|||++|..||........ .... ...... ... ... ...+..+.+||.+||. +|.+|++ +.+
T Consensus 228 il~el~~G~~Pf~~~~~~~~---~~~i---~~~~~~-~~~-----~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQET---YRKI---INWKET-LQF-----PDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHH---HHHH---HcCCCc-cCC-----CCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 99999999999975532111 0000 000000 000 000 0124578899999996 9999998 888
Q ss_pred HHHHh
Q 011412 407 VVEAL 411 (486)
Q Consensus 407 il~~L 411 (486)
++++-
T Consensus 293 ll~h~ 297 (364)
T cd05599 293 IKSHP 297 (364)
T ss_pred HhcCC
Confidence 87643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=356.53 Aligned_cols=263 Identities=20% Similarity=0.218 Sum_probs=200.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
..+|.+++.||+|+||.||+|.+.. +++.||||.... ..+.+|+++|++|+|||||++++++...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~---------~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK---------TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC---------CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 3579999999999999999998865 677999997642 3467999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
...++|||++ +++|..++... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 156 ~~~~lv~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 156 KFTCLILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred CeeEEEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 9999999999 46898888554 46889999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc----hhHHhhhhhccc-
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH----NLVEWARPHLGE- 362 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~----~~~~~~~~~~~~- 362 (486)
........ ......||+.|+|||++.+..|+.++|||||||+||||++|..||......... ..+.........
T Consensus 231 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~ 309 (391)
T PHA03212 231 FPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH 309 (391)
T ss_pred cccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence 54322111 123467999999999999999999999999999999999999887543221100 000000000000
Q ss_pred -----------ccccc----c--ccCCccCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 363 -----------RRRFY----R--LIDPRLEGHF--SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 363 -----------~~~~~----~--~~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
....+ . ...+...... ....+..+.+||.+||+.||.+|||+.|++++-
T Consensus 310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 00000 0 0000000000 012345788999999999999999999999743
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.10 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=198.7
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+++|+.++|+||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 369999999999998865 567899998865432 2335688999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~ 293 (486)
|||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccc
Confidence 9999999999999766667899999999999999999999988 9999999999999999999999999998654322
Q ss_pred cceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 011412 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 372 (486)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (486)
.........++..|+|||.+.++.++.++|||||||++|||++ |..||........ ... ... ..
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---~~~----~~~------~~-- 213 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---REA----IEQ------GV-- 213 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---HHH----HHc------CC--
Confidence 1111111123567999999998899999999999999999998 8888864322110 000 000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 373 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 373 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
....+...+..+.+|+.+||+.+|++||++.++++.|+
T Consensus 214 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 214 --RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred --CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 01112223467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=340.60 Aligned_cols=262 Identities=26% Similarity=0.430 Sum_probs=205.7
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..++|++.+.||+|+||.||+|.+... ....++..||||.+..... ....++.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456899999999999999999987532 1223567899999865332 23356889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 276 (486)
.....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCC
Confidence 9999999999999999999986432 23567888999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~ 355 (486)
.++|+|||+++...............+++.|||||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~ 233 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRF 233 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986544332222222356788999999998899999999999999999999 78888654321 11111
Q ss_pred hhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.. +. .+ + .++...+..+.+|+.+||+.||++||++.|+++.|+
T Consensus 234 ~~----~~-~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VM----EG-GL-----L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HH----cC-Cc-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 00 00 0 011122456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.54 Aligned_cols=244 Identities=30% Similarity=0.369 Sum_probs=197.0
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 211 (486)
+.||+|+||.||++.+.. +|..||+|++..... .....+..|++++..++||||+++++++...+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 469999999999998765 677999999975422 22345678999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|||||+++|+|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 72 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 999999999999888544 468999999999999999999997 67 9999999999999999999999999987533
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... ......||+.|||||++.+..++.++|||||||+||||++|..||....... .... .....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~~---i~~~~------- 212 (325)
T cd05594 148 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---ILMEE------- 212 (325)
T ss_pred CCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHHH---HhcCC-------
Confidence 2211 1234579999999999999999999999999999999999999996543211 1110 00000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
..+.. ..+..+.+|+.+||+.||++|+ ++.+++++.
T Consensus 213 -~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 213 -IRFPR----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred -CCCCC----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 01111 2245788999999999999996 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=349.58 Aligned_cols=242 Identities=27% Similarity=0.366 Sum_probs=195.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCC-CceEEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHL-NLVKLIGYCI 205 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-nIv~~~~~~~ 205 (486)
+|++++.||+|+||.||+|.+.. +++.||||++.... ......+..|++++..+.|+ +|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 58889999999999999998765 57789999997542 12335677899999999765 5888999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
..+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCc
Confidence 999999999999999999988554 46889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.... ...
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i---~~~--- 216 (324)
T cd05587 148 CKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSI---MEH--- 216 (324)
T ss_pred ceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---HcC---
Confidence 875322221 123467999999999999999999999999999999999999999754321 111110 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 404 (486)
.. .++...+..+.+|+.+||..||.+|++.
T Consensus 217 -----~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 -----NV----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -----CC----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01 1111234578899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=340.13 Aligned_cols=260 Identities=30% Similarity=0.449 Sum_probs=207.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|.+.+.||+|+||.||+|.+.... ...++..||||.++..... ....+.+|+++|..+.|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLE----PENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeecccc----CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 46888899999999999999875421 1124678999999765443 346789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRS-------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 274 (486)
...++||||+++++|.+++...+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcC
Confidence 99999999999999999996542 34788899999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 011412 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 275 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~ 353 (486)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI 234 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH
Confidence 99999999999986533322222233456789999999999999999999999999999998 999986543221 11
Q ss_pred HhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.... . .. ....+...+..+.+|+.+||+.||.+||++.||++.|+
T Consensus 235 ~~~~----~-~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECIT----Q-GR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHH----c-CC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111 0 00 00011123467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=348.76 Aligned_cols=248 Identities=29% Similarity=0.380 Sum_probs=197.7
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCe
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 209 (486)
++.||+|+||.||+++..... .+++.||||+++.... .....+..|+.+|+.++||||+++++++..++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGA------DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred CceeeecCCeEEEEEEEcccC------CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 368999999999999875322 2678999999975321 223456789999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
.|+||||+++++|.+++.+. ..+.+..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 75 LYLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 99999999999999998654 46788889999999999999999988 999999999999999999999999998754
Q ss_pred CCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 011412 290 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369 (486)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (486)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... .. .......
T Consensus 151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~---~~~~~~~------ 216 (323)
T cd05584 151 IHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TI---DKILKGK------ 216 (323)
T ss_pred ccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HH---HHHHcCC------
Confidence 32221 1234579999999999998899999999999999999999999997543211 00 0011100
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
. .++...+..+.+||.+||+.||.+|| ++.+++++-
T Consensus 217 --~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 217 --L----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred --C----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 0 11112245788999999999999999 788887643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=351.72 Aligned_cols=254 Identities=24% Similarity=0.280 Sum_probs=203.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|.+.+.||+|+||.||+|.+.. +|+.||||+++.... .....+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 368899999999999999998865 577999999975432 22345788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+.+..+|||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCC
Confidence 999999999999999999999776668999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
+......... ......||+.|+|||++. ...++.++|||||||++|||++|..||........ ....
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i 221 (330)
T cd05601 149 AARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNI 221 (330)
T ss_pred CeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHH
Confidence 9875433221 223357999999999986 45688999999999999999999999975432111 0000
Q ss_pred cccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+ ........ + . ....+..+.+|+.+||. +|.+||++.+++.+
T Consensus 222 ~-~~~~~~~~--~---~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 222 M-NFQRFLKF--P---E--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred H-cCCCccCC--C---C--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 00000000 0 0 01224678899999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=360.56 Aligned_cols=255 Identities=25% Similarity=0.295 Sum_probs=200.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++++.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+|+.++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 368999999999999999998865 677999999864321 22355788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+++.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 999999999999999999998654 46889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCC-----------------------------------------cceeeeeccccccccCccccccCCCCchhhH
Q 011412 286 AKDGPEGD-----------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 324 (486)
Q Consensus 286 a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 324 (486)
+....... ........+||+.|||||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 85321000 0000123579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC--
Q 011412 325 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-- 402 (486)
Q Consensus 325 wslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-- 402 (486)
|||||+||||++|+.||....+......+ . ........ + ... ..+..+.+||.+|+ .+|.+|+
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~~~i------~-~~~~~~~~--~-~~~----~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQLKV------I-NWETTLHI--P-SQA----KLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHHHHH------h-ccCccccC--C-CCC----CCCHHHHHHHHHHh-cCHhhcCCC
Confidence 99999999999999999765432111100 0 00000000 0 011 12356788898877 5999999
Q ss_pred -CHHHHHHHh
Q 011412 403 -LMSEVVEAL 411 (486)
Q Consensus 403 -s~~eil~~L 411 (486)
++.+++++-
T Consensus 293 ~t~~ell~h~ 302 (376)
T cd05598 293 NGADEIKAHP 302 (376)
T ss_pred CCHHHHhCCC
Confidence 889998763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=359.55 Aligned_cols=253 Identities=26% Similarity=0.310 Sum_probs=197.5
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
+|++++.||+|+||+||+|++.. +++.||||++..... .....+.+|+.+|+.++|+|||++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 58889999999999999998865 677999999975422 223467889999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCC
Confidence 99999999999999999998654 46889999999999999999999988 999999999999999999999999997
Q ss_pred CCCCCCC---------------------------------------------cceeeeeccccccccCccccccCCCCch
Q 011412 287 KDGPEGD---------------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSR 321 (486)
Q Consensus 287 ~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 321 (486)
+...... ........+||+.|+|||++.+..|+.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 5321000 0000123579999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 011412 322 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401 (486)
Q Consensus 322 ~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 401 (486)
+|||||||+||||++|+.||....+..... . ....... ...+ .....+..+.+||.+|+ .+|.+|
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~--~----i~~~~~~---~~~p-----~~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQM--K----VINWQTS---LHIP-----PQAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHHHHH--H----HHccCCC---cCCC-----CcccCCHHHHHHHHHHc-cCHhHc
Confidence 999999999999999999997643321100 0 0000000 0000 00112356788888876 599999
Q ss_pred CC---HHHHHHH
Q 011412 402 PL---MSEVVEA 410 (486)
Q Consensus 402 Ps---~~eil~~ 410 (486)
++ +.+++++
T Consensus 294 ~~~~~~~ei~~h 305 (382)
T cd05625 294 LGKNGADEIKAH 305 (382)
T ss_pred CCCCCHHHHhcC
Confidence 97 7777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=363.30 Aligned_cols=264 Identities=23% Similarity=0.379 Sum_probs=196.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
..+|++.+.||+|+||.||+|.+.. +++.||||++.... ....+|+.+|+.++|+|||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 4679999999999999999998865 67799999986442 2345799999999999999999887532
Q ss_pred --------CeeEEEEeecCCCChhHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011412 208 --------DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (486)
Q Consensus 208 --------~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 276 (486)
..+++||||+++ +|.+++. .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNT 207 (440)
T ss_pred ccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCC
Confidence 246799999965 7777664 24567899999999999999999999988 99999999999998664
Q ss_pred -cEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hH
Q 011412 277 -NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LV 353 (486)
Q Consensus 277 -~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~ 353 (486)
.+||+|||+++....... .....||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+........ ++
T Consensus 208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 699999999987644322 223578999999998875 469999999999999999999999997654321111 00
Q ss_pred Hhh-hhhccc---------ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 354 EWA-RPHLGE---------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 354 ~~~-~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
... .+.... ...+.......+...++...+.++.+||.+||..||.+||++.|++++-
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 000 000000 0000000000111112222346789999999999999999999999753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=378.44 Aligned_cols=264 Identities=31% Similarity=0.443 Sum_probs=216.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
....+.+.||+|.||.||.|...+..... .-..||||.++... .+...+|++|..+|+.++|||||+++|++.+.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~----~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSV----SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCc----cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 45566788999999999999988643210 13469999998653 34456899999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
...+|++|||+||+|..+|++. ...+.....+.++.|||+|+.||++++ +|||||..+|+||+....|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEc
Confidence 9999999999999999999876 567899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
|||+|++....++........-...|||||.+..+.|+.|+|||||||+|||++| |..||...+....... + +
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~--~----~ 918 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD--V----L 918 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH--H----H
Confidence 9999997766666554444445679999999999999999999999999999999 8889876543221110 0 1
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
+.. ++- .+..++..+.+||..||+.+|++||++..|++.+..+.+
T Consensus 919 -~gg---RL~-------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 919 -EGG---RLD-------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred -hCC---ccC-------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 111 111 123456789999999999999999999999997766544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=341.90 Aligned_cols=267 Identities=24% Similarity=0.328 Sum_probs=196.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcC---CCCCceEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGY 203 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~~~~~ 203 (486)
++|++.+.||+|+||.||+|.+... +|..||||.++..... ....+.+|+.+++.+ .||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 3789999999999999999987532 3568999998754321 223456777777665 69999999998
Q ss_pred EEe-----CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 204 CIE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 204 ~~~-----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
+.. ...+++||||+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCC
Confidence 852 456899999995 6999988654 345899999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~ 356 (486)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||.......... +....
T Consensus 149 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 149 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred EEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 9999999998654321 2234578999999999988899999999999999999999999997654321111 11000
Q ss_pred hhhc-ccccc---c-ccccCCcc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 357 RPHL-GERRR---F-YRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 357 ~~~~-~~~~~---~-~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.... .+... + ...+.+.. ...+....+..+.+|+.+||+.||++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 00000 0 00000000 000111234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=348.69 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=196.0
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||.||+|.+.. +++.||||+++.... .....+..|+.++..+ +||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 469999999999999875 577999999975422 2234577899999988 799999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 9999999999999888544 57999999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC--cchhHHhhhhhccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG--EHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 368 (486)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+....+...
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----- 220 (329)
T cd05588 148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----- 220 (329)
T ss_pred cCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-----
Confidence 2111 1234679999999999999999999999999999999999999996432111 111111111111000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL------MSEVVEA 410 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs------~~eil~~ 410 (486)
...+.. ..+..+.+|+.+||+.||.+||+ +.+++++
T Consensus 221 --~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 221 --QIRIPR----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 001111 22456889999999999999997 5666653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=325.18 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=207.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc----cH----HHHHHHHHHHhcC-CCCCc
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----GH----KEWLAEVNFLGDL-VHLNL 197 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----~~----~~~~~E~~~l~~l-~h~nI 197 (486)
+-..|...+.||+|..++|.++.++. +|..+|+|++...... .. +.-.+|+.||+++ .||+|
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~---------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I 85 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKE---------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI 85 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcc---------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence 34578888999999999999998765 7889999998643221 12 2346799999998 59999
Q ss_pred eEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
+++.++|..+..+++|+|.|+.|.|.++|... -.+++.....|++|+..|+.|||..+ ||||||||+|||++++.+
T Consensus 86 I~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMN 161 (411)
T ss_pred EEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccc
Confidence 99999999999999999999999999999544 47899999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~ 351 (486)
+||+|||+++....+.. ....|||++|+|||.+.. ..|+..+|+|++|||||.||.|.+||.......
T Consensus 162 i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml--- 235 (411)
T KOG0599|consen 162 IKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML--- 235 (411)
T ss_pred eEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH---
Confidence 99999999999887765 345899999999998863 478899999999999999999999996432211
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+..+.....| -.|. -.+.+...++||.+||+.||.+|.|++|+|.+-
T Consensus 236 ---MLR~ImeGkyqF---~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 236 ---MLRMIMEGKYQF---RSPE-----WADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred ---HHHHHHhccccc---CCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 111111111111 1111 123456789999999999999999999999754
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=339.03 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=206.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|++.+.||+|+||.||+|.+...+. .++..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGM-----DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCC-----CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 468888999999999999998644222 2567899999975432 2235688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRS----------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 271 (486)
+..|+||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEE
Confidence 99999999999999999985321 24788889999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011412 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 350 (486)
Q Consensus 272 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~ 350 (486)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--- 233 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--- 233 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999987544332222333456788999999988889999999999999999998 98998654321
Q ss_pred hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
.+.+.... . . .. . .+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 234 ~~~~~~~~----~-~---~~--~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEMVRK----R-Q---LL--P----CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHc----C-C---cC--C----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111110 0 0 00 0 111224578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=356.85 Aligned_cols=255 Identities=29% Similarity=0.354 Sum_probs=205.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|.+.+.||+|+||.||+|.+.. +|+.||||+++.... .....+..|+.+|..++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 368899999999999999999865 677999999975422 23356788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+++..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCC
Confidence 999999999999999999999765 57899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCC---------------------------cceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCC
Q 011412 286 AKDGPEGD---------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338 (486)
Q Consensus 286 a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~ 338 (486)
++...... .........||+.|+|||++.+..++.++|||||||+||||++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 98654432 001123357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHh
Q 011412 339 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEAL 411 (486)
Q Consensus 339 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~eil~~L 411 (486)
.||.......... ........ ...+. . ...+..+.+||.+||. ||.+||+ +.+++++.
T Consensus 228 ~Pf~~~~~~~~~~------~i~~~~~~---~~~p~-~----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 228 PPFYSDTLQETYN------KIINWKES---LRFPP-D----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CCCCCCCHHHHHH------HHhccCCc---ccCCC-C----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 9997654211100 00000000 00000 0 0134678899999997 9999999 99999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.84 Aligned_cols=253 Identities=30% Similarity=0.409 Sum_probs=203.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.|++.+.||+|+||.||++.+.. ++..||||++...... ....+.+|+.+++.++|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 47788999999999999998765 5779999999754322 22346789999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
++.+++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999888654 346899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++....... .....|++.|+|||++.+..++.++|||||||++|||++|..||...........+. ..+..
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~--- 219 (285)
T cd05605 149 AVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKE--- 219 (285)
T ss_pred ceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhh---
Confidence 987543221 223578999999999998899999999999999999999999997543221111000 00000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
....++...+..+.+|+.+||+.||.+|| ++.+++++-
T Consensus 220 --------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 220 --------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred --------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 01112223456789999999999999999 788887653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=333.63 Aligned_cols=251 Identities=27% Similarity=0.469 Sum_probs=202.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+.+|++++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 468888999999999999998753 3479999887543 23467889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccc
Confidence 999999999999999998765557899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ........ . .
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~----~---~ 218 (256)
T cd05114 150 VLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISR----G---F 218 (256)
T ss_pred cCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHC----C---C
Confidence 5432221 1122345678999999988899999999999999999999 89999654321 11111110 0 0
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
....+. ..+..+.+|+.+||+.+|++||++.++++.|
T Consensus 219 ~~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 RLYRPK-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 011111 1235689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=358.07 Aligned_cols=255 Identities=23% Similarity=0.288 Sum_probs=199.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|.+++.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+++|..++|||||++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 378899999999999999998865 677999999865321 22345788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+.+..|||||||++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999999998654 46889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc---------------------------------------------eeeeeccccccccCccccccCCCCc
Q 011412 286 AKDGPEGDKT---------------------------------------------HVSTRVMGTYGYAAPEYVMTGHLTS 320 (486)
Q Consensus 286 a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 320 (486)
++........ ......+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 9632210000 0001246999999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 011412 321 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 400 (486)
Q Consensus 321 ~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~ 400 (486)
++|||||||+||||++|..||........ ... .......+ . +... ...+..+.+||.+||. +|.+
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~~---i~~~~~~~-~-----~p~~--~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHET---YRK---IINWRETL-Y-----FPDD--IHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHH---HHH---HHccCCcc-C-----CCCC--CCCCHHHHHHHHHHhc-CHhh
Confidence 99999999999999999999975433111 000 00000000 0 0000 0123568899999997 7776
Q ss_pred C---CCHHHHHHHh
Q 011412 401 R---PLMSEVVEAL 411 (486)
Q Consensus 401 R---Ps~~eil~~L 411 (486)
| +++.+++++.
T Consensus 293 r~~r~~~~~~l~hp 306 (377)
T cd05629 293 RLGRGGAHEIKSHP 306 (377)
T ss_pred cCCCCCHHHHhcCC
Confidence 5 5999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=351.56 Aligned_cols=265 Identities=28% Similarity=0.418 Sum_probs=205.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.....+ ...+++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIE----KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccc----cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3457999999999999999999764321 123567899999975432 2234678899999999 899999999987
Q ss_pred Ee-CCeeEEEEeecCCCChhHHHhhcC-----------------------------------------------------
Q 011412 205 IE-DDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 230 (486)
Q Consensus 205 ~~-~~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 230 (486)
.. +..++++|||+++++|.++|....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 65 456889999999999999985321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccc
Q 011412 231 -------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303 (486)
Q Consensus 231 -------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 303 (486)
..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............+
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 25789999999999999999999988 99999999999999999999999999987543322222223456
Q ss_pred cccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHH
Q 011412 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 382 (486)
Q Consensus 304 t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (486)
+..|+|||++.+..++.++|||||||+||||++ |..||....... .+.. .+..... . ..+...
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~~------~----~~~~~~ 301 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RLKEGTR------M----RAPEYA 301 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HHhccCC------C----CCCccC
Confidence 788999999999999999999999999999998 999996533211 1110 1111000 0 011122
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 383 AQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 383 ~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...+.+|+.+||+.+|++||++.||+++|+.+
T Consensus 302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 45789999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=345.21 Aligned_cols=239 Identities=31% Similarity=0.399 Sum_probs=190.5
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhcCCCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||+||+|.+.. +|+.||||++..... .....+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 469999999999999865 677999999975422 12234555554 56789999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
++||||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred EEEEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 9999999999999988654 47899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... +.........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~------- 212 (323)
T cd05575 148 EHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNKP------- 212 (323)
T ss_pred cCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCC-------
Confidence 2221 233467999999999999999999999999999999999999999754221 1111111100
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e 406 (486)
..+.. ..+..+.+|+.+||+.||.+||++.+
T Consensus 213 -~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 213 -LRLKP----NISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred -CCCCC----CCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 01111 12467889999999999999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=366.34 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=204.7
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|.+.+.||+|+||+||+|++.. +|+.||||++...... ....+.+|+.+|..++|+||++++..+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~ 100 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVS---------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF 100 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence 44689999999999999999998865 5779999999765432 234578899999999999999998877
Q ss_pred EeCC--------eeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 205 IEDD--------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 205 ~~~~--------~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
...+ .+++||||+++|+|.++|..+ ...+++..+..++.|++.||.|||+.+ |+||||||+||||+
T Consensus 101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~ 177 (496)
T PTZ00283 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLC 177 (496)
T ss_pred ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEe
Confidence 5432 368999999999999998643 346899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011412 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 274 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~ 353 (486)
.++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||+||||++|+.||......
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------ 251 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------ 251 (496)
T ss_pred CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------
Confidence 99999999999998754332222334568999999999999999999999999999999999999999754221
Q ss_pred HhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
......+.. ..+ .++...+..+.+|+.+||+.||.+||++.+++++
T Consensus 252 ~~~~~~~~~------~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 EVMHKTLAG------RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHhcC------CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111110 000 1122234678999999999999999999999875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=350.27 Aligned_cols=242 Identities=29% Similarity=0.372 Sum_probs=195.2
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 212 (486)
+.||+|+||.||+++.... ..+|..||+|++...... ....+..|+++|++++||||+++++++..++..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITG------PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEecc------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 5799999999999986432 236889999999754322 23456789999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011412 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~ 292 (486)
||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 99999999999998554 46899999999999999999999988 999999999999999999999999999865432
Q ss_pred CcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 011412 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 372 (486)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (486)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ......
T Consensus 152 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~---i~~~~~-------- 215 (318)
T cd05582 152 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMTM---ILKAKL-------- 215 (318)
T ss_pred CC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHHH---HHcCCC--------
Confidence 21 1234679999999999998899999999999999999999999997543211 1110 000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011412 373 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406 (486)
Q Consensus 373 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e 406 (486)
.++...+..+.+|+.+||+.||.+||++.+
T Consensus 216 ----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ----GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011123467889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=347.28 Aligned_cols=237 Identities=29% Similarity=0.403 Sum_probs=191.8
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||.||+|++.. +++.||||++.... ......+..|+.++..+ +||||+++++++...+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 469999999999998865 57799999987532 12334567888888876 699999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|||||||++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred EEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 9999999999999988654 46899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +... ......
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~---i~~~~~------ 213 (320)
T cd05590 148 FNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEA---ILNDEV------ 213 (320)
T ss_pred cCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHH---HhcCCC------
Confidence 2221 1334679999999999999999999999999999999999999997543211 1111 111100
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 404 (486)
. ++...+..+.+|+.+||+.||.+||++
T Consensus 214 --~----~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 --V----YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --C----CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0 111224578899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.20 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=206.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|.+.+.||+|+||.||+|.+.. ++..||+|++.... ....++.+|+++++.++|+||+++++++..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 467888999999999999999865 56689999987543 33467889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccc
Confidence 999999999999999998654 346899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
........ ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ......
T Consensus 153 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~--------- 219 (263)
T cd05052 153 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE--------- 219 (263)
T ss_pred ccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH---------
Confidence 76443221 1112234678999999998999999999999999999998 899986542211 111000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
... ....+...+..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 220 -~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 220 -KGY----RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCC----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 000 1111222346789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=353.80 Aligned_cols=268 Identities=23% Similarity=0.249 Sum_probs=205.1
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
...+|.+++.||+|+||.||+|..... .++..||||.+... ..+.+|+++|+.++|||||++++++..
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~-------~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGD-------EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCC-------ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee
Confidence 345799999999999999999976532 24678999998653 345689999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
....|+|||++. ++|.+++ .....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred CCEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccc
Confidence 999999999995 6898888 44457999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc---
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--- 363 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--- 363 (486)
+...............||+.|+|||++.+..|+.++|||||||+||||++|+.||..................+...
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 87654333322334679999999999999999999999999999999999999997654432211111100000000
Q ss_pred -------------cccccccCCcc--CCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 364 -------------RRFYRLIDPRL--EGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 364 -------------~~~~~~~~~~~--~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+.....+.. ...+ ....+..+.+||.+||..||++||++.|++.+-
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00000000000 0000 011235678999999999999999999999864
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.05 Aligned_cols=242 Identities=28% Similarity=0.423 Sum_probs=192.7
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||.||+|.+.. +++.||||+++.... .....+..|..++..+ +||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999998865 677899999975421 2233456677777654 899999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
++||||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 9999999999999988654 46899999999999999999999988 9999999999999999999999999998643
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~-------- 211 (316)
T cd05592 148 NGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFD---SILND-------- 211 (316)
T ss_pred CCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHcC--------
Confidence 3221 233467999999999999999999999999999999999999999754321 1111 00000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 409 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~ 409 (486)
.+. ++...+..+.+|+.+||+.||.+||++. ++++
T Consensus 212 ~~~----~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 RPH----FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCC----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 011 1122345688999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=348.25 Aligned_cols=242 Identities=25% Similarity=0.340 Sum_probs=195.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
+|.+.+.||+|+||.||+|.+.. ++..||||++..... .....+..|..++..+ +|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 57889999999999999998865 677999999975432 2223466788888777 5889999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
..+.++|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCC
Confidence 999999999999999999988654 46899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.... ....
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i---~~~~-- 217 (323)
T cd05616 148 CKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSI---MEHN-- 217 (323)
T ss_pred ceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHH---HhCC--
Confidence 975432221 123467999999999999999999999999999999999999999754321 111110 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 404 (486)
..++...+..+.+|+.+||+.||.+|+++
T Consensus 218 ----------~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 ----------VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01112234678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=340.97 Aligned_cols=264 Identities=30% Similarity=0.445 Sum_probs=209.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
..+|.+.+.||+|+||.||++...... ...++..||+|.+..........+.+|+.+|++++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCC----CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 357889999999999999999764311 1224567999999765544456789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRS------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 275 (486)
+.+++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999999986432 24899999999999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 011412 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 354 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~ 354 (486)
+.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... ...
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~ 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE 233 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 9999999999986543332222233446788999999998999999999999999999998 899986543211 111
Q ss_pred hhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 355 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.... . .. ...... .+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 234 ~i~~---~--~~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 CITQ---G--RV-----LQRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHc---C--Cc-----CCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1100 0 00 001111 2356899999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=347.18 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=194.6
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||.||+|.+.. +++.||+|+++.... .....+..|+.++.++ +||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 479999999999998875 677999999975422 2234577899888877 799999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
+|||||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 9999999999999888544 47899999999999999999999988 9999999999999999999999999997532
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC--cchhHHhhhhhccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG--EHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 368 (486)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----- 220 (329)
T cd05618 148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----- 220 (329)
T ss_pred CCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-----
Confidence 2111 1234679999999999999999999999999999999999999996322111 111111111110000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVE 409 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~------~eil~ 409 (486)
.. .++...+..+.+||.+||+.||.+||++ .++++
T Consensus 221 --~~----~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 221 --QI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred --CC----CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 00 1122234578899999999999999984 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=340.52 Aligned_cols=264 Identities=29% Similarity=0.440 Sum_probs=211.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|.+.+.||+|+||.||+|.+..... ..++..+++|.+........+.+.+|+.++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSP----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCC----CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 468888999999999999998643211 1245679999998766555567899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 209 QRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence 9999999999999999996432 34789999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011412 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 352 (486)
Q Consensus 274 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~ 352 (486)
.++.++|+|||+++...............|+..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V 234 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999986544332222333457889999999999999999999999999999999 999986543211 1
Q ss_pred HHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
..... .. . ........+..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 235 ~~~~~----~~-~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECIT----QG-R---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHh----CC-C---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11110 00 0 000111234678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=345.23 Aligned_cols=243 Identities=28% Similarity=0.390 Sum_probs=194.1
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||.||+|.+.. +|..||||+++.... .....+..|..++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 469999999999998865 677999999975421 2234567788888754 899999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
||||||+.+|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred EEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 9999999999999988654 46889999999999999999999988 9999999999999999999999999987533
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .+..... . .
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~---~--------~ 211 (316)
T cd05620 148 FGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIR---V--------D 211 (316)
T ss_pred cCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH---h--------C
Confidence 2221 234467999999999999999999999999999999999999999754321 1111110 0 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 410 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~ 410 (486)
.+.+.. ..+..+.+|+.+||+.||.+||++. +++++
T Consensus 212 ~~~~~~----~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 212 TPHYPR----WITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCCC----CCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 111111 1245788999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=337.91 Aligned_cols=246 Identities=27% Similarity=0.400 Sum_probs=195.9
Q ss_pred eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 137 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
||+|+||+||++.+.. +|+.||+|.+...... ..+.+..|+++|+.++|+||+++++++..+...++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRA---------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEcc---------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 6999999999998865 6779999998754322 224567899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 214 YEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 148 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELK 148 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence 999999999988753 3356899999999999999999999988 9999999999999999999999999997654
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..... ..
T Consensus 149 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~----------~~ 214 (280)
T cd05608 149 DGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQR----------IL 214 (280)
T ss_pred CCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHh----------hc
Confidence 43221 233579999999999999999999999999999999999999997543221110 00000 00
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 410 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~ 410 (486)
.. ...++...+..+.+|+.+||+.||.+|| ++.+++++
T Consensus 215 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 ND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00 0011223356788999999999999999 66666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=352.85 Aligned_cols=245 Identities=26% Similarity=0.409 Sum_probs=206.2
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEEe
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~E 215 (486)
+||+|.||+||-|++.+ |...+|||.+.........-+..||.+.+.|+|.|||+++|++-.++.+-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~---------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeecccc---------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 69999999999999877 566899999987766666678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeecCCCCCCCCC
Q 011412 216 FMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 216 ~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~vkl~DFGla~~~~~~ 292 (486)
-++||+|..+|...-+++ .+...-.+.+||++||.|||++. |||||||-+|+||+. .|.+||+|||.++.+..-
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC
Confidence 999999999998776677 78888999999999999999988 999999999999964 688999999999876543
Q ss_pred CcceeeeeccccccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 293 DKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
. .+..++.||..|||||++..+ .|+.++|||||||++.||.||++||......... .+. . .++
T Consensus 730 n--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----MFk--V----Gmy--- 794 (1226)
T KOG4279|consen 730 N--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----MFK--V----GMY--- 794 (1226)
T ss_pred C--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh----hhh--h----cce---
Confidence 2 245668999999999999754 7999999999999999999999999643221100 000 0 011
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
.....++...+.+++.+|.+|+..||.+||++.++|+
T Consensus 795 --KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 795 --KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1234456677789999999999999999999999986
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=335.40 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=213.1
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCee
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
|.++++||+|+||.||+|.++. +|..+|||.+..+. ...++..|+.+|.+...++||++||.|.....+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~E---------sG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRE---------SGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhc---------cCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence 5566789999999999999887 78899999998653 457899999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|||||||..|++.+.+..++.++.+..+..+++..+.||+|||... -||||||..||||+.+|+.||+|||.|-.+.
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh
Confidence 9999999999999999988899999999999999999999999988 7999999999999999999999999998765
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
+. .....++.||+.|||||++..-.|+.++||||||++..||..|++||.+..+.-...++- .
T Consensus 181 DT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---------------T 243 (502)
T KOG0574|consen 181 DT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---------------T 243 (502)
T ss_pred hh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---------------C
Confidence 42 223456889999999999999999999999999999999999999997654432111110 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
+|...-.-+...+.++.+++++||-.+|++|-++.+++++-
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 11111112345567889999999999999999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=337.53 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=205.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|++.+.||+|+||+||+|.+..++.. ....|++|.+..... ....++..|+.+++.+.||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDS-----IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCc-----eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 5788899999999999999998653321 123588888864432 22356778888999999999999999875 4
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
...++||||+++|+|.+++......+++..++.|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 5678999999999999999877778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
...............++..|+|||++.+..++.++|||||||++|||++ |..||..........++ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~~- 229 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGER- 229 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCCc-
Confidence 7544332222334557789999999998899999999999999999998 99999765332111111 11000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
...+. .++..+.+++.+||..||.+||++.|+++.|..+.
T Consensus 230 --~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 --LAQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred --CCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 00111 12346788999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=346.16 Aligned_cols=243 Identities=27% Similarity=0.381 Sum_probs=195.1
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||.||+|.+.. +++.||||++..... .....+..|++++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 369999999999998865 677999999975421 2234567888888866 799999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
||||||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999999888654 46899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ......
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~---i~~~~~------ 213 (321)
T cd05591 148 LNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFES---ILHDDV------ 213 (321)
T ss_pred cCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHH---HHcCCC------
Confidence 2221 1234679999999999999999999999999999999999999997543211 1111 111000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-------LMSEVVEA 410 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-------s~~eil~~ 410 (486)
. ++...+..+.+|+.+||+.||.+|| ++.+++++
T Consensus 214 --~----~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 --L----YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --C----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0 1111245788999999999999999 67777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=343.34 Aligned_cols=242 Identities=28% Similarity=0.420 Sum_probs=193.5
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhc-CCCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGD-LVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||.||+|.+.. ++..||||+++.... .....+..|..++.. ++||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 469999999999998865 577899999975421 223446678888876 4899999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
+|||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 9999999999999998654 46889999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... .+..... ..
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~-----------~~ 211 (316)
T cd05619 148 LGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIR-----------MD 211 (316)
T ss_pred CCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH-----------hC
Confidence 2221 123467999999999999999999999999999999999999999754321 1111110 00
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 409 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~ 409 (486)
.+.+. ...+..+.+|+.+||+.||.+||++. ++++
T Consensus 212 ~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 NPCYP----RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCC----ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11111 12245688999999999999999997 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=325.45 Aligned_cols=257 Identities=25% Similarity=0.333 Sum_probs=209.0
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
+.+.|++.+.||+|.|+.||++.+.. ||+.+|+|+++.... ...+++.+|++|-+.|+|||||++.+.+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~---------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti 79 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 79 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhcc---------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence 44578888899999999999997765 888999999875432 3567899999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCcEEEe
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLS 281 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~vkl~ 281 (486)
......|||+|++.|++|..-|..+ ..+++..+..+++||+++|.|+|.++ |||||+||+|+||.. .--+||+
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeec
Confidence 9999999999999999998777554 45778888999999999999999988 999999999999943 3458999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||+|.....+. .-..+.|||.|||||++....|+..+|||+.|||||-||.|++||.+.... .+.+... .
T Consensus 156 ~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~---~ 226 (355)
T KOG0033|consen 156 DFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIK---A 226 (355)
T ss_pred ccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHh---c
Confidence 999999876332 234578999999999999999999999999999999999999999763321 1111111 1
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
... .+++..+.+. .+.+++|+++||..||.+|.|+.|.|++-+.
T Consensus 227 g~y----d~~~~~w~~i----s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 227 GAY----DYPSPEWDTV----TPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred ccc----CCCCcccCcC----CHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 111 1223233333 3678999999999999999999999987653
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=337.59 Aligned_cols=254 Identities=34% Similarity=0.564 Sum_probs=196.8
Q ss_pred CCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeE
Q 011412 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (486)
Q Consensus 133 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 211 (486)
+.+.||.|.||.||+|.+... ....+..|+||.++.... ...+.+.+|++.+++++||||++++|++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~-----~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQK-----DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEEST-----TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcc-----cCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 346899999999999999831 123567899999965432 23577999999999999999999999999888899
Q ss_pred EEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 212 LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 212 lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
+|||||++|+|.++|... ...+++..++.|+.||+.||.|||+.+ ++|+||+++|||++.++.+||+|||++....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 999999999999999876 668999999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (486)
............+...|+|||.+....++.++||||||+++|||++ |+.||..... ..+.... .+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~----~~~~~~--- 224 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKL----KQGQRL--- 224 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHH----HTTEET---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc----cccccc---
Confidence 3333322333457889999999998889999999999999999999 6788865421 1111111 111110
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+..++..+.+|+.+||+.||.+||++.+|++.|
T Consensus 225 -------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 -------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01112246788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=337.06 Aligned_cols=272 Identities=26% Similarity=0.397 Sum_probs=210.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCcc-------ccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 199 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~-------~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~ 199 (486)
..+|++.+.||+|+||.||+|.+...+... .....+..||+|.+...... ....+.+|+++|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457999999999999999999887533221 22234567999998865432 3456889999999999999999
Q ss_pred EEEEEEeCCeeEEEEeecCCCChhHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011412 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (486)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 269 (486)
+++++..++..++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986543 26899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 011412 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPN 347 (486)
Q Consensus 270 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--G~~pf~~~~~~ 347 (486)
||++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986544333333334567889999999988899999999999999999998 6677754321
Q ss_pred CcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 348 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.............. ........+...+..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 240 --~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111110000 000000111123467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=345.05 Aligned_cols=244 Identities=27% Similarity=0.372 Sum_probs=193.6
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||.||+|.+.. ++..||||++..... .....+.+|+.++.++ +|+||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 479999999999998876 567899999985432 2234577899999888 699999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|+||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 9999999999999888544 46999999999999999999999988 9999999999999999999999999997532
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.............+........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------- 218 (327)
T cd05617 148 GPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------- 218 (327)
T ss_pred CCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-------
Confidence 2111 1234679999999999999999999999999999999999999997543322222111111111100
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 404 (486)
... ++...+..+.+++.+||+.||.+|+++
T Consensus 219 ~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 219 PIR----IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCC----CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 001 111223568899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=343.57 Aligned_cols=238 Identities=28% Similarity=0.359 Sum_probs=188.9
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhcCCCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
++||+|+||.||+|++.. +|..||+|++..... .....+..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 469999999999999865 567999999875322 12234555554 57889999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|+|||||++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 9999999999999888543 46888999999999999999999988 9999999999999999999999999987642
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... . .........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~---~~~~i~~~~------- 212 (321)
T cd05603 148 EPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---Q---MYDNILHKP------- 212 (321)
T ss_pred CCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---H---HHHHHhcCC-------
Confidence 2221 233467999999999999889999999999999999999999999754211 1 111111100
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ 405 (486)
. .++...+..+.+++.+||+.||.+||++.
T Consensus 213 -~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 -L----QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -C----CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 01112245688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=333.48 Aligned_cols=258 Identities=29% Similarity=0.465 Sum_probs=203.2
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
|.+.+.||+|+||.||+|.+..+.. ++..||||+++..... ....+.+|+.+|+.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDG------SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCC------CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5678899999999999998865322 4578999999754332 2356889999999999999999999887655
Q ss_pred e------eEEEEeecCCCChhHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 209 Q------RLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 209 ~------~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
. .++||||+++|+|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~ 151 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMT 151 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCe
Confidence 4 78999999999999988532 236889999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .+.++.
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~ 228 (273)
T cd05035 152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL 228 (273)
T ss_pred EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 99999999987544332222222345778999999988899999999999999999999 88888654321 111111
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
. ... .. ..+...+..+.+++.+||+.||.+||++.|+++.|+.+
T Consensus 229 ~----~~~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 R----HGN------RL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred H----cCC------CC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 000 00 11122346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=338.15 Aligned_cols=272 Identities=28% Similarity=0.437 Sum_probs=205.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCC-----ccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGT-----APVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLI 201 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~-----~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~ 201 (486)
.++|++.+.||+|+||.||+|++...+. .....+....||||.++.... .....+.+|+++|++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3579999999999999999998754211 001112334699999976432 2234688999999999999999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NI 270 (486)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999985432 23678899999999999999999988 99999999999
Q ss_pred EEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCCC
Q 011412 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPNG 348 (486)
Q Consensus 271 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--G~~pf~~~~~~~ 348 (486)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 999999999999999986544332222233456789999999998899999999999999999998 56677643321
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
..+............. .. ...+...+..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 240 --~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 --QVIENTGEFFRNQGRQ--IY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHHhhhhcccc--cc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111000000000 00 0001112457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=331.55 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=204.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
..+|++.+.||+|+||.||+|.+.. +|..||+|++..........+.+|+.++..++||||+++++++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 3579999999999999999998865 5678999999765444455678999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccce
Confidence 9999999999999999988544 47899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
....... ......|+..|+|||++. ...++.++|||||||++|||++|..||....+...... + ...
T Consensus 155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--~------~~~ 224 (267)
T cd06646 155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--M------SKS 224 (267)
T ss_pred eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--e------ecC
Confidence 6532211 122356899999999874 45578899999999999999999999864432211000 0 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. ...+... .....+..+.+|+.+||..+|++||++.+|+++|
T Consensus 225 ~---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 N---FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C---CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 0001110 0112346788999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=335.43 Aligned_cols=274 Identities=27% Similarity=0.375 Sum_probs=206.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe--
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-- 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-- 206 (486)
.+|++++.||+|+||.||+|.... ....++..||||.+........+.+.+|+++|+.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 478899999999999999998643 1223678999999986655555678999999999999999999998754
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
...+++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccc
Confidence 34689999999999999999766667899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcce-eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc---c
Q 011412 287 KDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---E 362 (486)
Q Consensus 287 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~ 362 (486)
+......... ......++..|+|||++.+..++.++|||||||++|||++|..++...... .......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 231 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMI 231 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccc
Confidence 8764433211 111223455699999998889999999999999999999988776432111 0000000000 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...+...+............+..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000000000011112346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=354.26 Aligned_cols=257 Identities=22% Similarity=0.277 Sum_probs=203.0
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~ 202 (486)
....+|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~ 110 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKS---------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 345689999999999999999998865 677999999964321 22344778999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
++.+++.+|||||||++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 111 AFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEe
Confidence 999999999999999999999988543 5788889999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
||+++........ .....+||+.|||||++.+. .++.++|||||||+||||++|+.||........ . ..
T Consensus 186 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~---~~ 258 (370)
T cd05596 186 FGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---Y---SK 258 (370)
T ss_pred ccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---H---HH
Confidence 9999865432211 12345799999999988653 478999999999999999999999976432110 0 00
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 411 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~eil~~L 411 (486)
....... .. +.. ....+..+.+||.+||+.+|.+ |+++.+++++.
T Consensus 259 i~~~~~~-~~-----~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 259 IMDHKNS-LT-----FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHcCCCc-CC-----CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0000000 00 000 0112467899999999999988 99999998864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=354.27 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=206.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-C-----CCceEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H-----LNLVKLIG 202 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~~~~ 202 (486)
.+|.++++||+|+||+|.+|++.. |++.||||+++... ....+...|+++|..|+ | -|||++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~---------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHK---------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EEEEEEEEecccccceeEEEEecC---------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 478899999999999999999876 78899999998653 33456678999999997 4 38999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC--CcEE
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD--YNAK 279 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~--~~vk 279 (486)
+|...+++|||+|.+ .-+|.++|..+ -..++...+..++.||+.||.+||+.+ |||+||||+||||..- ..||
T Consensus 256 ~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred ccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCcee
Confidence 999999999999999 55999999755 356999999999999999999999988 9999999999999543 4799
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh---
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--- 356 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~--- 356 (486)
|+|||.+........ ..+-+..|+|||++.+..|+.+.||||||||++||++|.+.|.+.++.+....+.-.
T Consensus 332 VIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 332 VIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred EEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 999999998654332 456788999999999999999999999999999999999999877654433221100
Q ss_pred -----hhhcccccccc---------------------------------cccCC----ccCCCCCHHHHHHHHHHHHHhc
Q 011412 357 -----RPHLGERRRFY---------------------------------RLIDP----RLEGHFSIKGAQKAAQLAAHCL 394 (486)
Q Consensus 357 -----~~~~~~~~~~~---------------------------------~~~~~----~~~~~~~~~~~~~~~~li~~cl 394 (486)
........+++ ...-| .+...+.......+.+++++||
T Consensus 407 Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L 486 (586)
T KOG0667|consen 407 PPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL 486 (586)
T ss_pred CCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence 00000000000 00001 0011122233456789999999
Q ss_pred ccCCCCCCCHHHHHHHhc
Q 011412 395 SRDPKARPLMSEVVEALK 412 (486)
Q Consensus 395 ~~dP~~RPs~~eil~~L~ 412 (486)
..||.+|+|..+++++-.
T Consensus 487 ~~dP~~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 487 EWDPAERITPAQALNHPF 504 (586)
T ss_pred ccCchhcCCHHHHhcCcc
Confidence 999999999999998653
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=345.68 Aligned_cols=249 Identities=27% Similarity=0.327 Sum_probs=194.1
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhcCCCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||+||+|++.. ++..||+|++..... .....+..|.. +++.++|+||+++++++...+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 469999999999998865 567899999975321 12234444544 56788999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|+||||+++|+|.+++... ..+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 72 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 9999999999999988654 46788889999999999999999988 9999999999999999999999999997643
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... .... .....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~---i~~~~------- 212 (325)
T cd05602 148 EHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDN---ILNKP------- 212 (325)
T ss_pred cCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHH---HHhCC-------
Confidence 2221 1334679999999999999999999999999999999999999997543211 1111 00000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
. .+....+..+.+|+.+||+.||.+||++.+.+..+...+.
T Consensus 213 -~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 213 -L----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred -c----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence 0 0111224578899999999999999998765544444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=344.09 Aligned_cols=243 Identities=28% Similarity=0.402 Sum_probs=195.9
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||.||+|.+.. ++..||||+++... ......+..|+.++..+ +||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999998865 56789999997542 12234567899999888 699999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|+||||+++|+|..++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 9999999999999888554 47999999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .+... ....
T Consensus 148 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~---i~~~-------- 211 (318)
T cd05570 148 LGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQS---ILED-------- 211 (318)
T ss_pred cCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHH---HHcC--------
Confidence 2221 123457999999999999999999999999999999999999999754321 11110 0000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 410 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~eil~~ 410 (486)
... ++...+..+.+||.+||+.||.+||++ .+++++
T Consensus 212 ~~~----~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 212 EVR----YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCC----CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 000 111234678999999999999999999 777764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.44 Aligned_cols=255 Identities=30% Similarity=0.461 Sum_probs=209.1
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
...+|.+.+.||.|+||.||+|.+.. +..+|+|.+.........++..|+.+++.++|+||+++++++.+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 73 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec
Confidence 34578889999999999999998864 45799999987765556778999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.+..++||||+++++|.+++... +..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccc
Confidence 99999999999999999999753 456899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+......... .....++..|+|||++....++.++||||||+++|+|++ |+.||...... ........ .
T Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~----~- 220 (261)
T cd05148 151 ARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQITA----G- 220 (261)
T ss_pred hhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHHh----C-
Confidence 9875432211 123346778999999988899999999999999999998 89999654321 11111110 0
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
.....+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 221 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 ---------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0011112334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=341.78 Aligned_cols=258 Identities=21% Similarity=0.243 Sum_probs=199.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++.+.||+|+||.||++++.. +++.||||++.... ......+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 478999999999999999998876 56799999997422 122345788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+++.+|+||||+++|+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCc
Confidence 999999999999999999999766667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
+......... ......||+.|||||++.. ..++.++|||||||++|||++|+.||....... ......
T Consensus 149 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~ 221 (331)
T cd05597 149 CLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIM 221 (331)
T ss_pred eeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHH
Confidence 8765432221 1223469999999999863 457889999999999999999999997543211 100011
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHHhc
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK--ARPLMSEVVEALK 412 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~--~RPs~~eil~~L~ 412 (486)
..... .. +.+ .. ...+..+.+|+.+||..++. .|+++.+++++-.
T Consensus 222 ~~~~~-~~-~~~-~~----~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 222 NHKEH-FQ-FPP-DV----TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred cCCCc-cc-CCC-cc----CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 00000 00 000 00 11345788999998865443 3789999988643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=335.78 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=206.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|.+.+.||+|+||.||++..... ....++..+|+|.+..........+.+|+++++.++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 5788889999999999999976431 122356789999987655444567899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 274 (486)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcC
Confidence 9999999999999999986542 24789999999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 011412 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 275 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~ 353 (486)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |.+||....... ..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~ 234 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI 234 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH
Confidence 99999999999976543322222223345788999999998999999999999999999998 899986533211 11
Q ss_pred HhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
... .... .. ..+...+..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 235 ~~~----~~~~------~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECI----TQGR------EL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHH----HcCc------cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 100 0000 00 011122456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.50 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=207.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.+|++.+.||+|+||.||+|++.. ++..||||.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 478999999999999999999865 567999998864322 22345788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
+.+..++||||+++++|.+++.. ....++...++.++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d 149 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999999988853 2345889999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||++........ ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ..+.....
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~----- 221 (267)
T cd08228 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIE----- 221 (267)
T ss_pred cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHh-----
Confidence 999887543221 1223568899999999988889999999999999999999999996543211 11111100
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.... ........+..+.+|+.+||..+|++||++.++++.|+.+
T Consensus 222 -----~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 222 -----QCDY---PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -----cCCC---CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0000 1111223446789999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=340.42 Aligned_cols=268 Identities=24% Similarity=0.342 Sum_probs=203.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|.+.+.||+|+||.||+|++.. ++..||+|.++..... ....+.+|+.++++++|+||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 578999999999999999998765 5678999998754322 234577899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||+++ +|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 77 KSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence 999999999965 898888766667899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------h
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P 358 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~--------~ 358 (486)
....... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+.... +
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 153 AKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred ecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 6433221 1223468999999998864 568999999999999999999999997654322211111100 0
Q ss_pred hcccccccccccCCccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 359 HLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.+.....+...-.+.... ......+..+.+|+.+||+.||.+||++.|++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 000000000000000000 00012345688999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=331.17 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=205.1
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..++|++.+.||+|+||.||+|.+.. +..||||.++.... ..+++.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 34678999999999999999998643 45799999976543 34678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcce
Confidence 999999999999999999996543 56899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||....... +.. .+....
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~ 221 (261)
T cd05068 150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----QVDQGY 221 (261)
T ss_pred EEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCC
Confidence 9876432111 1111223457999999998899999999999999999999 999996543211 111 000000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
. . ..+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 222 ~---~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 R---M-------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred C---C-------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 0 01112346789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=339.13 Aligned_cols=264 Identities=26% Similarity=0.372 Sum_probs=207.9
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|.+.+.||+|+||.||+|.+... ....++..||||+++.... .....+.+|+.+++++ +|+||+++++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 345789999999999999999986421 1123566899999875432 2235688999999999 799999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
...+..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999996543 34899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ +.... ..
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~----~~ 259 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLI----KE 259 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHH----Hc
Confidence 99986544332222223456788999999999999999999999999999998 9999865432111 11110 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
. ... ..+...+..+.+|+.+||..+|++||++.++++.|+.
T Consensus 260 ~------~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 260 G------YRM----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred C------CcC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0 000 0111224578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=330.38 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=202.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|.+.+.||+|+||.||+|.+.. +..||||.+..... ....+.+|+.++..++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 468888999999999999997753 23599999875433 3467899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+.+|+|.+++......+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCcccee
Confidence 999999999999999999765557899999999999999999999988 99999999999999999999999999886
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ...... ....
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~-- 219 (256)
T cd05113 150 VLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVS----QGLR-- 219 (256)
T ss_pred cCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHh----cCCC--
Confidence 5432211 1112345678999999988889999999999999999999 999986543211 111110 0000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
+.... ..+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 220 ----~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 ----LYRPH----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00011 12467899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=351.86 Aligned_cols=257 Identities=22% Similarity=0.281 Sum_probs=201.2
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~ 202 (486)
...++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKS---------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 445789999999999999999999875 677999999864221 22345778999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
++.+++.+|+|||||++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 111 AFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999999988543 5888999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
||+++........ .....+||+.|||||++.+. .++.++|||||||+||||++|+.||........ ...
T Consensus 186 FG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~ 258 (370)
T cd05621 186 FGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSK 258 (370)
T ss_pred cccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHH
Confidence 9999875432211 12346799999999998754 378899999999999999999999975432111 000
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 411 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~eil~~L 411 (486)
....... + .+.. ....+..+.+++.+||..++.+ |+++.|++++-
T Consensus 259 i~~~~~~----~--~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 259 IMDHKNS----L--NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred HHhCCcc----c--CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 0000000 0 0000 1123467889999999855543 88999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=334.09 Aligned_cols=272 Identities=32% Similarity=0.444 Sum_probs=204.5
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC--
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 207 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 207 (486)
|.+.+.||+|+||+||++..... ...++..||+|.+..... .....+.+|+++|+.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPA-----NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEccc-----cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 48889999999999999865431 123677899999976532 2345688999999999999999999987653
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 4688999999999999998653 5899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcce-eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
......... ......++..|+|||++.+..++.++|||||||++|||++|..||........ .......... ....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVVRL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-chhhh
Confidence 764432211 11223456789999999888999999999999999999999999865432110 1110000000 00001
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...++.......+...+..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111111111111223346799999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=333.65 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=199.1
Q ss_pred eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 137 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
||+|+||.||++.... +|+.||+|.+...... ....+..|+++|+.++||||+++++++..+...++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEcc---------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 6999999999998865 6779999999753321 123456799999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~ 292 (486)
|||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9999999999888643 345889999999999999999999988 999999999999999999999999998875432
Q ss_pred CcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 011412 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 372 (486)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (486)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ............ +..
T Consensus 149 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~------~~~ 217 (277)
T cd05607 149 KT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDE------VKF 217 (277)
T ss_pred ce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccc------ccc
Confidence 21 2335689999999999988899999999999999999999999975432111 111111111100 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011412 373 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 417 (486)
Q Consensus 373 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 417 (486)
.. ...+..+.+|+.+||+.||.+||++.|+++.+...+.+
T Consensus 218 -~~----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 218 -EH----QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred -cc----ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 00 12345689999999999999999998877665544443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=332.09 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=205.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4678999999999999999998643 45799999875432 346788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccc
Confidence 9999999999999999998653 456889999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+........ ......++..|+|||++....++.++|||||||++|+|++ |..||....... ...... ..
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~-- 220 (261)
T cd05072 151 RVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ----RG-- 220 (261)
T ss_pred eecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cC--
Confidence 875432211 1222346778999999988889999999999999999998 999996543211 111110 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
....... ..+..+.+|+.+||..+|++||++.++++.|+.+
T Consensus 221 ----~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 221 ----YRMPRME----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCCC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0000111 2245688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=345.70 Aligned_cols=194 Identities=25% Similarity=0.316 Sum_probs=168.7
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
...+|++++.||+|+||.||+|.+.. ++..||+|+.... ....|+.+|++++|+||+++++++..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 34579999999999999999998865 5668999986433 23579999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
....++||||+ .++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 129 GAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred CCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccc
Confidence 99999999999 56899988777778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~ 342 (486)
+...... ......||+.|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 205 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 205 QFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 7543221 1234579999999999999999999999999999999999665553
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=339.93 Aligned_cols=266 Identities=29% Similarity=0.408 Sum_probs=209.3
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~ 202 (486)
....++|++.+.||+|+||.||++.+..... ......||+|.+..... ....++.+|+.++..+ +|+||+++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN----PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCC----CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3455678999999999999999998764321 12446899999875432 2234688999999999 7999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp 267 (486)
++..++..++||||+++|+|..++... ...+++..++.++.|++.||.|||+.+ |+||||||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp 160 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAA 160 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccce
Confidence 999999999999999999999998642 346889999999999999999999988 99999999
Q ss_pred CcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 011412 268 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRP 346 (486)
Q Consensus 268 ~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~ 346 (486)
+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999999999987654332222222345678999999988999999999999999999998 9899865432
Q ss_pred CCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
..... . +... .....+...+..+.+|+.+||..||.+||++.++++.|+.+
T Consensus 241 ~~~~~---~----~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 EELFK---L----LKEG----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHH---H----HHcC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11100 0 0000 00011122346788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=341.26 Aligned_cols=251 Identities=28% Similarity=0.359 Sum_probs=196.3
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhcCCCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
+.||+|+||+||+|.+.. +|..||||++..... .....+..|.. +++.++||||+++++++..++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 469999999999998865 677999999975421 22234555655 46779999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|+||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 72 YFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 999999999999988854 457899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... .....+||+.|||||++.+..++.++|||||||++|||++|..||....... +. ....... ..+
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~~~~~~----~~~ 215 (325)
T cd05604 148 AQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY---DNILHKP----LVL 215 (325)
T ss_pred CCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH---HHHHcCC----ccC
Confidence 2221 1234679999999999999999999999999999999999999997543211 11 1111100 001
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCc
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 418 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 418 (486)
.. ..+..+.+++.+||+.||.+||++.+.++.+...+.+.
T Consensus 216 ----~~----~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~ 255 (325)
T cd05604 216 ----RP----GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255 (325)
T ss_pred ----CC----CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcC
Confidence 11 12356789999999999999999875555554454443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.46 Aligned_cols=265 Identities=24% Similarity=0.275 Sum_probs=200.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
...|.+.+.||+|+||.||+|.+.. ++..||||.... ..+.+|+++|++|+|+|||++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 4579999999999999999998865 567899996432 3357899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..+||||++ .++|..++......+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCce
Confidence 9999999999 56999888766667999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC-----cch---hHHhhhhh
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG-----EHN---LVEWARPH 359 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~-----~~~---~~~~~~~~ 359 (486)
...............||+.|||||++.+..++.++|||||||+||||++|..++....... ... ++......
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 6543322222334679999999999999999999999999999999999887654322110 011 11111000
Q ss_pred cccccc---------c----ccccCCccCC-CCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 360 LGERRR---------F----YRLIDPRLEG-HFS--IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 360 ~~~~~~---------~----~~~~~~~~~~-~~~--~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+... + .....+.... .+. ...+..+.+||.+||+.||.+||++.|+|++-
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 000000 0 0000000000 000 01234688999999999999999999999853
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=340.11 Aligned_cols=266 Identities=27% Similarity=0.390 Sum_probs=206.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
.++|.+.+.||+|+||.||+|.+...... ...++..||+|.+..... ....++.+|+.++..+ +|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKE--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCc--ccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 46799999999999999999987542211 112345799999986432 2345688899999999 7999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NI 270 (486)
..+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 9999999999999999999996532 24788999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 011412 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 349 (486)
Q Consensus 271 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~ 349 (486)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~- 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-
Confidence 999999999999999986543222111222234578999999998899999999999999999998 888886432211
Q ss_pred chhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 350 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
+... +.... ....+...+..+.+|+.+||..+|.+||++.++++.|+.+.
T Consensus 251 --~~~~----~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 251 --LFKL----LKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred --HHHH----HHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1110 00000 00111223467889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=351.93 Aligned_cols=265 Identities=24% Similarity=0.376 Sum_probs=205.7
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCC-CCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLV-HLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~nIv~~~~~~ 204 (486)
..++|.+.+.||+|+||.||+|++.... ...++..||||+++...... ...+.+|+++|..+. |||||+++++|
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLS----HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCC----CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 3456788899999999999999976421 11245689999998653322 346889999999997 99999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC------------------------------------------------------
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------ 230 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------ 230 (486)
...+..+||||||++|+|.++|.+..
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999986432
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 011412 231 -------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (486)
Q Consensus 231 -------------------------------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp 267 (486)
..+++..++.|+.||+.||.|||+.+ |+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 13566778899999999999999987 99999999
Q ss_pred CcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 011412 268 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRP 346 (486)
Q Consensus 268 ~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~ 346 (486)
+|||++.++.+||+|||+++...............++..|||||++.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986533222111223457889999999998899999999999999999998 8889864322
Q ss_pred CCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
... .... +... ..+. .+...+..+.+|+.+||..+|.+||++.+|++.|+.+
T Consensus 348 ~~~--~~~~----~~~~------~~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 NEQ--FYNA----IKRG------YRMA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred hHH--HHHH----HHcC------CCCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 110 0000 0000 0000 1112346789999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=328.18 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=204.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|++++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 468899999999999999998765 5779999998644221 22457889999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+.+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.++|+||
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 99999999999999999999988654 46889999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCccee-eeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 284 GLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 284 Gla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
|+++.......... .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ... ..
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----~~-- 220 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--IFK----IA-- 220 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--HHH----Hh--
Confidence 99876533211110 1235688899999999998899999999999999999999999965322110 000 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.......++...+..+.+|+.+||..+|.+||++.+++++.
T Consensus 221 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 221 --------TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred --------ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 00001112223346789999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=331.19 Aligned_cols=261 Identities=25% Similarity=0.434 Sum_probs=207.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|+..+.||+|+||.||+|.+..++. ....+|+|.+..... .....+..|+++++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGR------KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 3467888999999999999999865322 234799999875532 234568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..++||||+++++|.+++......+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999776677999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceee-eeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 287 KDGPEGDKTHVS-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 287 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
............ .....+..|+|||++.+..++.++|||||||++|||++ |..||....... +.... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i----~~~~ 227 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAI----NDGF 227 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH----hcCC
Confidence 865433221111 11223567999999988899999999999999999998 999996543211 11111 0000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
..+ .....+..+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 228 -----~~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -----RLP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 1112346788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=333.30 Aligned_cols=261 Identities=28% Similarity=0.423 Sum_probs=204.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|.+.+.||+|+||.||+|.+..... ..++..||+|.+...... ....+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDG----DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4578899999999999999998864111 114568999998754322 23468899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---c
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---N 277 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---~ 277 (486)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+|||++.++ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcc
Confidence 999999999999999999986543 25889999999999999999999988 99999999999998654 5
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... +....
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~ 234 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFV 234 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence 99999999987633222111222334578999999998999999999999999999997 999997543221 11110
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
. . .. ...++...+..+.+|+.+||+.+|++||++.+|+++|+
T Consensus 235 ~---~-~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 T---G-GG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H---c-CC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 0 00 01111223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=333.63 Aligned_cols=262 Identities=23% Similarity=0.375 Sum_probs=205.4
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|++.+.||+|+||+||+|.+..++.. ....||+|+++..... ...++.+|+.++..+.|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN-----VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCc-----cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 46789999999999999999987654321 1235899998754332 24568899999999999999999999875
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
...+++|||+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCce
Confidence 4578999999999999999776667999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+...............++..|+|||++.+..++.++|||||||++|||++ |..||....... +..+.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~- 228 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KGE- 228 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCC-
Confidence 87643322211122345678999999988899999999999999999998 899986533211 111111 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.+ ......+..+.+++.+||..||.+||++.++++.|+.+.
T Consensus 229 -----~~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 -----RL----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred -----cC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00 011123457889999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=335.59 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=205.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
+|++.+.||+|+||.||+|....... ......+|+|.+..... .....+.+|+.+++.++||||+++++++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKG----RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCC----CCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 47788999999999999998754211 11345789998875432 22356889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRR-----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL 265 (486)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di 153 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL 153 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 999999999999999988532 134788999999999999999999988 999999
Q ss_pred CCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 011412 266 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 344 (486)
Q Consensus 266 Kp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~ 344 (486)
||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999986543322111223456778999999988899999999999999999998 99999654
Q ss_pred CCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.+.. +....... ... ..+...+..+.+|+.+||+.+|.+||++.++++.|+.+.
T Consensus 234 ~~~~---~~~~~~~~----------~~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 234 APER---LFNLLKTG----------YRM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CHHH---HHHHHhCC----------CCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 3221 11111100 000 111123457889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=315.87 Aligned_cols=265 Identities=26% Similarity=0.346 Sum_probs=210.4
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
+..++|++.+.||+|||+-||++.... ++..||+|++.....+..+..++|++..++++||||++++++..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s---------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLS---------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccC---------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 345789999999999999999998654 67799999999887777888999999999999999999998765
Q ss_pred eC-----CeeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 206 ED-----DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 206 ~~-----~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
.+ ...||++.|...|+|.+.+.+. +..+++..++.|+.+|++||++||+.. .+++||||||.|||+.+.+.
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCc
Confidence 43 3589999999999999998643 457999999999999999999999987 57999999999999999999
Q ss_pred EEEeecCCCCCCCCCCccee-------eeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011412 278 AKLSDFGLAKDGPEGDKTHV-------STRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 347 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~ 347 (486)
++|.|||.++...-...... -.....|..|+|||.+. +...+.++|||||||+||+|+.|..||+.....
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 99999999986532211110 11245789999999886 456789999999999999999999999754332
Q ss_pred CcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 348 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
+.--. ....++.+.-.-....+..+.+|+++||+.||.+||++.+++..++.+
T Consensus 248 GgSla--------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 GGSLA--------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred CCeEE--------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11000 001111110000111457899999999999999999999999988765
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=335.71 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=204.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
+|++.+.||+|+||.||+|.+..... ...+..||||+++...... ...+.+|+.++..++||||+++++++...+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAP----GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCC----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 46777899999999999998754211 1245689999998654322 345789999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 209 QRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
..++++||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence 999999999999999998522 234788889999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011412 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 352 (486)
Q Consensus 274 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~ 352 (486)
.++.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||...... .+
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV 235 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence 999999999999987644333222233456789999999988899999999999999999998 88888654321 11
Q ss_pred HHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
..... ... ...++..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 236 ~~~i~----~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIR----NRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHH----cCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11110 000 001122335678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=351.14 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=198.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++++.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.++..++|+||+++++++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 368889999999999999998875 67799999997432 222356788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+.+.+|||||||++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccC
Confidence 999999999999999999998654 46899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc---------------------------------eeeeeccccccccCccccccCCCCchhhHHHHHHHHH
Q 011412 286 AKDGPEGDKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 332 (486)
Q Consensus 286 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ 332 (486)
++........ ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8754321100 0012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 011412 333 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVE 409 (486)
Q Consensus 333 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~eil~ 409 (486)
||++|+.||....+......+ ......+ .+.+ .. ..+..+.+||.+|+. ||.+|++ +.++++
T Consensus 228 el~tG~~Pf~~~~~~~~~~~i------~~~~~~~--~~p~----~~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 228 EMLIGYPPFCSETPQETYRKV------MNWKETL--VFPP----EV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred ecccCCCCCCCCCHHHHHHHH------HcCCCce--ecCC----CC--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 999999999765432111100 0000000 0111 00 123578899999874 9999996 556554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=338.88 Aligned_cols=269 Identities=26% Similarity=0.396 Sum_probs=209.2
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCceEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 203 (486)
....+|.+.+.||+|+||.||+|.+..... .....+..||+|.+.... ......+.+|+.++..+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 345678899999999999999998643111 011245689999987543 23345688999999999 89999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 268 (486)
+......++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 999999999999999999999996532 24778889999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 011412 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 347 (486)
Q Consensus 269 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~ 347 (486)
|||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999987644332222223446788999999988899999999999999999998 78888643221
Q ss_pred CcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 348 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
. +... +..... ...+..++..+.+|+.+||..+|.+||++.++++.|+.+..
T Consensus 247 ~---~~~~----~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 E---LFKL----LKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred H---HHHH----HHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1 1111 111000 01112234678899999999999999999999999976644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.76 Aligned_cols=245 Identities=29% Similarity=0.426 Sum_probs=207.2
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
|.-++-||.|+||.||-|++.. +.+.||||++.....+.. .+++.||+.|.+|+|||+|.|.|||..+
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~---------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre 98 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE 98 (948)
T ss_pred HHHHHHhcCCccceeEEeeccC---------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence 5556689999999999998866 567999999998766554 4578999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
...||||||| -|+-.|+|.....++.+..+..|..+.+.||+|||+.+ .||||||..||||.+.|.|||+|||.|.
T Consensus 99 ~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 99 HTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSAS 174 (948)
T ss_pred chHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchh
Confidence 9999999999 66999999888889999999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
.... ...++|||+|||||++. .+.|+-++||||||++..||.-.++|+...+...... ++
T Consensus 175 i~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY-------HI---- 237 (948)
T KOG0577|consen 175 IMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HI---- 237 (948)
T ss_pred hcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH-------HH----
Confidence 7544 34589999999999985 5789999999999999999999999986443211111 11
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+--.|.+. ..+++..++.|+..||+.-|.+|||..+++.+
T Consensus 238 --AQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 238 --AQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred --HhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111122222 34667789999999999999999999999875
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=328.76 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=202.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++|+||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 468888999999999999998753 34699999875432 3356889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCccccee
Confidence 999999999999999999766667899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..... ..
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~----- 216 (256)
T cd05059 150 VLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESV----SA----- 216 (256)
T ss_pred ccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHH----Hc-----
Confidence 5432211 1111234568999999998999999999999999999999 899996543211 11110 00
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..... .+...+..+.+|+.+||..+|++||++.++++.|
T Consensus 217 -~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 217 -GYRLY----RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCcCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00111 1112356789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=345.18 Aligned_cols=256 Identities=24% Similarity=0.321 Sum_probs=207.8
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCC-CCCceEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV-HLNLVKLIG 202 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~~~ 202 (486)
+....|++++.||+||.+.||++...++ ..||+|++..... +...-+.+|+..|.+|+ |.+||+||+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~----------~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D 427 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDK----------QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYD 427 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCC----------cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence 3446799999999999999999987653 3577777754332 33455899999999994 899999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
|-..++.+||||||- ..+|..+|.+....++...++.+..|++.++.++|+++ |||.||||.|+|+- .|.+||+|
T Consensus 428 YEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLID 502 (677)
T KOG0596|consen 428 YEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLID 502 (677)
T ss_pred eeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeee
Confidence 999999999999986 55999999877766665688899999999999999999 99999999999995 67899999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-----------LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~ 351 (486)
||+|...............+||+.||+||.+.... .+.++||||||||||+|+.|+.||.... +
T Consensus 503 FGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n 577 (677)
T KOG0596|consen 503 FGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N 577 (677)
T ss_pred echhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H
Confidence 99999988877777788899999999999886432 4578999999999999999999996321 1
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGA-QKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
...++..+.+|.-.-+|+.-.. ..+.++++.||++||++||++.|+|++-
T Consensus 578 ----------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 578 ----------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred ----------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 1123445556543333332111 2389999999999999999999999853
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=334.13 Aligned_cols=271 Identities=26% Similarity=0.435 Sum_probs=205.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCc-------cccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTA-------PVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKL 200 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~-------~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~ 200 (486)
++|++.+.||+|+||.||++.+...... ....+++..||+|.+..... .....+.+|+.+|+.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 5799999999999999999875432110 01223456799999975432 234578899999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NI 270 (486)
++++...+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999986532 23677889999999999999999988 99999999999
Q ss_pred EEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCCC
Q 011412 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPNG 348 (486)
Q Consensus 271 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--G~~pf~~~~~~~ 348 (486)
|++.++.++|+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986544332222223445778999999888899999999999999999998 678886443211
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.+............ ....+ .+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 242 ---~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 ---VIENTGEFFRDQGR--QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHhhccc--cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11110000000000 00000 01123467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=342.02 Aligned_cols=243 Identities=25% Similarity=0.345 Sum_probs=194.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCC-CCCceEEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 205 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 205 (486)
+|++.+.||+|+||.||+|.+.. +|..||||++..... ...+.+..|+.++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 47778899999999999998865 677999999975421 22345778899998885 577888999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
..+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccc
Confidence 999999999999999999988554 46899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... .+.... ....
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i---~~~~-- 217 (323)
T cd05615 148 CKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSI---MEHN-- 217 (323)
T ss_pred ccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhCC--
Confidence 876432221 123457999999999999999999999999999999999999999764321 111110 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ 405 (486)
..++...+..+.+|+.+||+.+|.+|++..
T Consensus 218 ----------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 ----------VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ----------CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 011122345788999999999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.05 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=205.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|.+.+.||+|+||.||+|.+.. +|..|++|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 47788899999999999998875 567899999875432 2345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccc
Confidence 9999999999999999999764 467899999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
+....... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...... ..
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~---~~----- 215 (256)
T cd08529 149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKI---IR----- 215 (256)
T ss_pred eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---Hc-----
Confidence 86544322 123456899999999999999999999999999999999999999754311 111110 00
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. ...+....+..+.+++.+||+.+|++||++.+++++
T Consensus 216 --~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 --GV----FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CC----CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 011111334678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=331.00 Aligned_cols=260 Identities=25% Similarity=0.433 Sum_probs=206.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|++.+.||+|+||.||+|.+...+. .+..||||.+.... .....++..|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC------CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 357888999999999999999876432 23479999987542 22345789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
...++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccc
Confidence 9999999999999999999776667899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCcceeeee-c--cccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 288 DGPEGDKTHVSTR-V--MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 288 ~~~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
............. . .++..|+|||++.+..++.++|||||||++|||++ |..||...... ....+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~~ 227 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----QD 227 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----cC
Confidence 6543322111111 1 12457999999998999999999999999999886 99999654321 1111111 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.... .+...+..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus 228 ------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ------YRLP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CcCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 1112345688999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.80 Aligned_cols=265 Identities=26% Similarity=0.398 Sum_probs=205.6
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
...++|++.+.||+|+||.||+|.+++.. ....+..||+|.+..... .....+.+|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDII----KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccC----CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34568999999999999999999875311 112355899999875432 2234578899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 275 (486)
.+.+..++||||+++|+|.+++.... ..+.+..+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCC
Confidence 99999999999999999999996432 23466788899999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 011412 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 354 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~ 354 (486)
+.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~ 232 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK 232 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 9999999999986543322222223345778999999998899999999999999999998 788886532211 111
Q ss_pred hhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 355 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
... . .. ...++...+..+.+|+.+||+.||++||++.++++.|+..
T Consensus 233 ~~~---~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVM---D-GG----------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHH---c-CC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 100 0 00 0001112246799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.85 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=198.3
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC-
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~- 207 (486)
|.+.+.||+|+||.||+|.+...+. ...||+|.++... ......+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~-------~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDS-------ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCCC-------eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 3567899999999999998865321 2368999987542 22345688999999999999999999987532
Q ss_pred -----CeeEEEEeecCCCChhHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 208 -----DQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 208 -----~~~~lv~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
...++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 150 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMN 150 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCC
Confidence 246899999999999998742 2245889999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... .+....
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~ 227 (272)
T cd05075 151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYL 227 (272)
T ss_pred EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 99999999987644332211222346778999999998999999999999999999999 78898653221 111111
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...... . .....+..+.+|+.+||+.||++||++.+|++.|+.+
T Consensus 228 ----~~~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 ----RQGNRL------K----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ----HcCCCC------C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 010000 0 1112345688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=349.17 Aligned_cols=261 Identities=23% Similarity=0.264 Sum_probs=202.2
Q ss_pred HHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceE
Q 011412 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVK 199 (486)
Q Consensus 123 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~ 199 (486)
++....++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+|+.+++.++||||++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~ 107 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECC---------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 344556899999999999999999998876 677999999864321 12244778999999999999999
Q ss_pred EEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
+++++.+++.+|+|||||++|+|.+++... .++...+..++.||+.||.|||+++ |+||||||+||||+.++.+|
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999988543 4788899999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~ 355 (486)
|+|||+++........ .....+||+.|||||++... .++.++|||||||+||||++|..||....... .
T Consensus 183 L~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~ 255 (371)
T cd05622 183 LADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------T 255 (371)
T ss_pred EEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------H
Confidence 9999999865432211 12346799999999998754 37899999999999999999999997543211 1
Q ss_pred hhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhc
Q 011412 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEALK 412 (486)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~eil~~L~ 412 (486)
.......... ... . .....+..+.+||.+||..++.+ |+++.+++++..
T Consensus 256 ~~~i~~~~~~-~~~-----~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 256 YSKIMNHKNS-LTF-----P--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HHHHHcCCCc-ccC-----C--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 1101100000 000 0 01123467889999999844433 779999988653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=348.82 Aligned_cols=267 Identities=25% Similarity=0.352 Sum_probs=200.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++++.||+|+||.||+|.+.. +|+.||||++.... ....+.+.+|+.+|+.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 57889999999999999998765 57799999986532 22345688999999999999999999999877
Q ss_pred C-----eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 208 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 208 ~-----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
+ ..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecc
Confidence 6 7899999995 588887744 357899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh--h
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--H 359 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~--~ 359 (486)
||+++........ ......+|..|+|||++.+. .++.++|||||||++|||++|+.||....+......+..... .
T Consensus 147 fg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~ 225 (372)
T cd07853 147 FGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225 (372)
T ss_pred ccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999865432221 22334689999999998764 589999999999999999999999976543322111110000 0
Q ss_pred ccc-------cc-cccc-ccC-CccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 360 LGE-------RR-RFYR-LID-PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 360 ~~~-------~~-~~~~-~~~-~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+ .. .+.. ... +.... .+....+..+.+||.+||+.||.+||++.|++++-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 000 00 0000 000 00000 01112246788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=332.94 Aligned_cols=262 Identities=27% Similarity=0.430 Sum_probs=207.9
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..++|.+.+.||+|+||.||+|.+..... ..++..||+|.+..... .....+.+|+.+|..++|+||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVK----GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCC----CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 34678899999999999999998865321 12457899999875532 22346889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 276 (486)
.....++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCC
Confidence 9999999999999999999986432 24678899999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~ 355 (486)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... ...+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~ 233 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKF 233 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHH
Confidence 999999999986544332222233457889999999988889999999999999999998 999986543221 1111
Q ss_pred hhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.. ... ... ++...+..+.+|+.+||+.+|.+||++.++++.|+
T Consensus 234 ~~----~~~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 VI----DGG------HLD----LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred Hh----cCC------CCC----CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11 000 000 11122467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.25 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=207.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|++.+.||+|+||.||+|.+...+. .+..+|+|.++..... ....+.+|+.++..++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGK------REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCC------CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 578889999999999999998764322 3447999998754322 235688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccc
Confidence 9999999999999999999776667899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccee-eeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 288 DGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 288 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ...... +...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~~~ 227 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIE----EGYR 227 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHh----CCCc
Confidence 7644322111 112234568999999998899999999999999999886 999997543221 111110 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.. .....+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 228 ------~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ------LP----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CC----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 1112345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=335.59 Aligned_cols=267 Identities=25% Similarity=0.361 Sum_probs=204.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++.+.||+|+||.||++.+.. +|..||+|.+...... ...++.+|++++.+++||||+++++++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 368899999999999999998765 5778999998754322 234588999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999999999999654 568999999999999999999997 46 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc--
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR-- 364 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 364 (486)
....... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......................
T Consensus 148 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 148 GQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred ccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 7653321 2345789999999999888899999999999999999999999965432111111100000000000
Q ss_pred --------------ccccccC---CccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 365 --------------RFYRLID---PRLEGHFS-IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 365 --------------~~~~~~~---~~~~~~~~-~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
...+..+ .......+ ...+..+.+|+.+||..||++||++.+++++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000000 00000000 013456899999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.35 Aligned_cols=263 Identities=29% Similarity=0.455 Sum_probs=218.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.+...+.++||+|-||.|.+|.... +..||||+++...... .++|.+|+++|.+|+|||||+++|+|..
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~ 606 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ 606 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence 4556778999999999999998753 5789999998765543 4789999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
++.+++||||+++|+|.++|.++..+ +.......|+.||+.||+||.+.+ +|||||.+.|||++.++++||+|||+
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccc
Confidence 99999999999999999999876433 355667789999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
++.+..++..+...+.+-.++|||||.+..++++.++|||+||++|||+++ ...||...... .+++.....+...
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~ 760 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQ 760 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCC
Confidence 999888888888888888999999999999999999999999999999766 66788654322 2222222222221
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
..-. ....+..++..+.+||.+||..|-.+||+++++...|..
T Consensus 761 ~~~~-------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 761 GRQV-------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred Ccce-------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 1111 111233456889999999999999999999999988754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=343.72 Aligned_cols=267 Identities=23% Similarity=0.313 Sum_probs=199.0
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+.. +|..||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV---------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC---------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 34689999999999999999998765 67799999997542 22345678999999999999999999998
Q ss_pred EeCC------eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 205 IEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 205 ~~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
...+ .+|+||||+++ +|.+.+. ..++...+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ccCCCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence 6543 47999999965 6766653 24788899999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hH----
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LV---- 353 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~---- 353 (486)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... +.
T Consensus 163 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 239 (359)
T cd07876 163 KILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239 (359)
T ss_pred EEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999997643221 1234578999999999999999999999999999999999999997543211000 00
Q ss_pred -------Hh----hhhhccccccc-----ccccCCcc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 354 -------EW----ARPHLGERRRF-----YRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 354 -------~~----~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.. ........... ........ ........+..+.+||.+||+.||++||++.|++++-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00 00000000000 00000000 00011112356889999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.54 Aligned_cols=253 Identities=31% Similarity=0.412 Sum_probs=201.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.|++.+.||+|+||.||+|.+.. +++.||||.+....... ...+.+|+.+++.++|+||+.+++.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 36777899999999999998876 67799999987543221 2346789999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999988643 346899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+........ .....|+..|+|||++.+..++.++|||||||++|+|++|+.||............... ..
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~---~~---- 218 (285)
T cd05630 149 AVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VK---- 218 (285)
T ss_pred eeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh---hh----
Confidence 876543221 12346999999999999999999999999999999999999999754321111111000 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 411 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~L 411 (486)
.... .+....+..+.+|+.+||+.||.+||+ +.|++++-
T Consensus 219 ---~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 219 ---EVQE----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred ---hhhh----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 0000 111123456889999999999999999 78888643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.00 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=202.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 206 (486)
++|++.+.||+|+||.||+|+...++. ...+++|.++... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-------~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGL-------KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCC-------cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 478899999999999999998865321 2357888887432 22345688999999999 79999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 271 (486)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil 151 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVL 151 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEE
Confidence 999999999999999999986432 24788999999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011412 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 350 (486)
Q Consensus 272 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~ 350 (486)
++.++.+||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-- 226 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-- 226 (297)
T ss_pred ECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999875322111 111223567999999988899999999999999999997 999996543211
Q ss_pred hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
+.... . ....+. .+...+..+.+|+.+||+.+|.+||++.++++.|+.+.+
T Consensus 227 -~~~~~---~-------~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 227 -LYEKL---P-------QGYRME----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred -HHHHH---h-------cCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11100 0 000111 111234678899999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=329.70 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=200.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++.++||+|+||.||+|.+.. ++..||+|.+.... .....++.+|++++.+++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 368888999999999999998765 67799999987542 22335688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred CEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 9999999999999996542 4678889999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~ 366 (486)
...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ...........
T Consensus 144 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 215 (279)
T cd06619 144 QLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE---- 215 (279)
T ss_pred eccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc----
Confidence 653321 233579999999999999999999999999999999999999996533221110 00000000000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
..+.+. ....+..+.+|+.+||+.+|.+||++.+++++..
T Consensus 216 ---~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 216 ---DPPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred ---CCCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 001100 1112356889999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=343.72 Aligned_cols=267 Identities=26% Similarity=0.413 Sum_probs=221.2
Q ss_pred HHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCceEEE
Q 011412 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHLNLVKLI 201 (486)
Q Consensus 123 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~ 201 (486)
.+.+......+.++||.|-||.||+|.+.+.. ++....||||..+.+ .....+.|+.|.-+|++++|||||+++
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhhee
Confidence 34445556677789999999999999987642 334567999999874 445567799999999999999999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
|+|.+ ...|||||+++-|.|..+|..+...++......++.||+.+|+|||+.. +|||||...|||+.....|||+
T Consensus 458 Gv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 458 GVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred eeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeec
Confidence 99875 4689999999999999999988888999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
|||+++...+....... +..-.+.|||||.+.-..++.++|||.|||++||+|. |..||.+-...+..-.+
T Consensus 534 DFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i------- 605 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI------- 605 (974)
T ss_pred ccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------
Confidence 99999998776655433 4456789999999999999999999999999999876 99999865433221111
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
... -....+..++..++.|+.+||+.+|.+||.+.||...|..+..
T Consensus 606 EnG----------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 ENG----------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cCC----------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 111 1112344567889999999999999999999999998876543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=332.38 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=195.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcC---CCCCceEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGYC 204 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~~~~~~ 204 (486)
+|++.+.||+|+||+||+|.+.. +|+.||+|.++..... ....+.+|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 48888999999999999998876 6779999998754221 123456677776655 799999999988
Q ss_pred Ee-----CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 205 IE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 205 ~~-----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
.. ....++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQV 147 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 64 345799999996 4898888654 345899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhh
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWAR 357 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~~ 357 (486)
||+|||+++....... .....||..|+|||++.+..++.++|||||||++|||++|.+||.......... +.....
T Consensus 148 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~ 224 (288)
T cd07863 148 KLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224 (288)
T ss_pred EECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence 9999999987543221 233568999999999998899999999999999999999999996543221110 110000
Q ss_pred h-hcccccccc----cccCCc---cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 P-HLGERRRFY----RLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~-~~~~~~~~~----~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. ......... ....+. .........+..+.+|+.+||+.||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000000 000000 0001111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=327.85 Aligned_cols=258 Identities=26% Similarity=0.369 Sum_probs=207.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.+|++.+.||+|+||.||+|.+.. +|..||||.+..... ....++.+|+.+++.+.|+||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 468888999999999999998765 567899998865322 22346889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
.++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~d 149 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999999998863 2356899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||....... .......
T Consensus 150 fg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~------ 220 (267)
T cd08229 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKI------ 220 (267)
T ss_pred chhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhhh------
Confidence 999886543322 1223568999999999988899999999999999999999999996432210 0110000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.....+.. .....+..+.+|+.+||..||.+||++.+|++.++.+
T Consensus 221 ----~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 221 ----EQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ----hcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00001111 1112456789999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=330.06 Aligned_cols=249 Identities=23% Similarity=0.420 Sum_probs=193.8
Q ss_pred eeeecCCeEEEEEEEccCCCcc---------------ccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEE
Q 011412 136 LLGEGGFGCVFKGWIEENGTAP---------------VKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 200 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~---------------~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 200 (486)
.||+|+||.||+|.+...+... ........||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999875432211 1222334689999876544444568889999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---- 276 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---- 276 (486)
++++......+|||||+++|+|..++......+++..++.++.||+.||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998766667899999999999999999999988 99999999999997643
Q ss_pred ---cEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCCcch
Q 011412 277 ---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML-TGRRSMDKNRPNGEHN 351 (486)
Q Consensus 277 ---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell-tG~~pf~~~~~~~~~~ 351 (486)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||....+.....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999998654221 12357888999998865 56899999999999999985 6999987543322111
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
+. .... .+... ....+.+||.+||+.+|.+||++.+|++.|.
T Consensus 233 ---~~----~~~~--------~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 ---FY----EKKH--------RLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HH----Hhcc--------CCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 10 0000 01111 1246889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=326.08 Aligned_cols=249 Identities=29% Similarity=0.364 Sum_probs=206.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHH---HHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
-++|..+++||+|.||.|.+++-+. +|+.||+|+++++......+ -+.|-++|...+||.+..+...|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKa---------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKA---------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecc---------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 4678889999999999999998754 88899999999876544443 46799999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
+..+.+|+||||+.||.|.-+|.+. ..+++.....+-..|+.||.|||+.+ ||+||||.+|+|||.+|++||+|||
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecc
Confidence 9999999999999999999888554 47888999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
|++...... .....+|||+.|+|||++....|+.++|+|.+||++|||++|+.||..........+ .+.+..
T Consensus 314 LCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL------Il~ed~ 385 (516)
T KOG0690|consen 314 LCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL------ILMEDL 385 (516)
T ss_pred cchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH------HHhhhc
Confidence 998643222 234569999999999999999999999999999999999999999975432211111 111222
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVE 409 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~ 409 (486)
+ |+...+++++.|+..+|.+||.+|. .+.||.+
T Consensus 386 k------------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 386 K------------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred c------------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 2 3333456789999999999999995 4556654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=323.99 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=208.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++.+.||+|+||.||+|.+.. +|..||+|.++.... .....+.+|++++++++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 578999999999999999998865 577899998864322 22456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
..+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d 149 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEec
Confidence 99999999999999999998853 2345889999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||++........ ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ....... ...
T Consensus 150 ~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~ 222 (267)
T cd08224 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEK 222 (267)
T ss_pred cceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhh-hhc
Confidence 999876543221 122356899999999999889999999999999999999999999654311 1111000 000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
....+ . .....+..+.++|.+||..+|++||++.+|++.|+.+.
T Consensus 223 -----~~~~~-~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 -----CDYPP-L---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----CCCCC-C---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00000 0 01133467889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=331.36 Aligned_cols=250 Identities=31% Similarity=0.424 Sum_probs=199.2
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
|+..+.||+|+||+||+|.+.. +++.||+|.+...... ....+.+|+++|+.++|+||+.+++++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 6677899999999999998875 5779999998754322 223477899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcc
Confidence 9999999999999999888654 346999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
........ .....|+..|+|||++.+..++.++|||||||++|||++|..||...........+. . .....
T Consensus 150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~-~~~~~--- 220 (285)
T cd05632 150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--R-RVLET--- 220 (285)
T ss_pred eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--H-hhhcc---
Confidence 76533221 223578999999999998999999999999999999999999997543211111110 0 00000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 409 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~ 409 (486)
...+....+..+.+|+.+||+.||.+||+ +.+++.
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 --------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00111223456789999999999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.87 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=199.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 45689999999999999999998765 577899999975432 2235678899999999999999999988
Q ss_pred EeC------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 205 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 205 ~~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
... ...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred eccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 654 357999999965 67766642 4788999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHh--
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEW-- 355 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~-- 355 (486)
||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.......... .+..
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred EEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999998653322 1234578999999999999999999999999999999999999997543211100 0000
Q ss_pred -------------hhhhcccccccc-----cccCCcc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 356 -------------ARPHLGERRRFY-----RLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 356 -------------~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
............ ......+ ........+..+.+||.+||+.||.+|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 000000000000 0000000 0001112245688999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=323.94 Aligned_cols=252 Identities=34% Similarity=0.513 Sum_probs=205.6
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
+.||+|+||.||+|.+.... .++..||+|.+....... ...+.+|++++..++|+||+++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 46999999999999987531 236789999998664433 56788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 214 YEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence 9999999999999765 467999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+................++..|+|||.+....++.++|||||||++|||++ |..||...... .+..... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~----~~- 223 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLR----KG- 223 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH----cC-
Confidence 987655432222334567899999999988899999999999999999999 69999765221 1111110 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
. ....+...+..+.+++.+||..+|.+||++.+++++|+
T Consensus 224 -----~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 -----Y----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----C----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 00111222567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=325.10 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=203.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
+|++.+.||.|+||.||++.+.. ++..||+|.++... ....+.+.+|+.+++.++|+||+++++++.+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 57888999999999999998765 57789999986433 223456788999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
.+++||||+++++|.+++.. ....++...++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcce
Confidence 99999999999999998864 3456889999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||....... .... .....
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~---~~~~~---- 216 (255)
T cd08219 149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---LILK---VCQGS---- 216 (255)
T ss_pred eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---HHHH---HhcCC----
Confidence 6543221 1234578999999999988889999999999999999999999997542211 1000 00000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. ..++...+..+.+|+.+||+.||++||++.+++..
T Consensus 217 --~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 --Y-----KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --C-----CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 00112234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=324.20 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=208.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|++.+.||.|+||.||+|.+.. ++..+|+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 578899999999999999998865 56689999998765555678899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
.++++|||+++++|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchh
Confidence 999999999999999998766567999999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCcceeeeeccccccccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
...... ......++..|+|||++.+. .++.++|||||||++|||++|..||......... ..... .
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~~~~~------~- 219 (262)
T cd06613 151 LTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--FLISK------S- 219 (262)
T ss_pred hhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh------c-
Confidence 543221 12335689999999998776 8899999999999999999999999754321110 00000 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
....+. .......+..+.+|+.+||..+|.+||++.+|+.+
T Consensus 220 --~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 220 --NFPPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --cCCCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 11123345678999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=342.15 Aligned_cols=265 Identities=30% Similarity=0.417 Sum_probs=202.6
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+...+ ...+++.||||+++..... ....+.+|+.+|.++ +|+||+++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCC----ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 3468999999999999999999864311 1235778999999754322 235688999999999 689999999987
Q ss_pred EeC-CeeEEEEeecCCCChhHHHhhcC-----------------------------------------------------
Q 011412 205 IED-DQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 230 (486)
Q Consensus 205 ~~~-~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 230 (486)
... ...++|||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 56789999999999999986421
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCccee
Q 011412 231 -------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297 (486)
Q Consensus 231 -------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 297 (486)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 23677888999999999999999988 99999999999999999999999999986533222111
Q ss_pred eeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCC
Q 011412 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 376 (486)
Q Consensus 298 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (486)
.....++..|+|||++.+..++.++|||||||++|||++ |..||....... .... .+..... .....
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~----~~~~~~~------~~~~~ 305 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTR------MRAPD 305 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHH----HHhccCC------CCCCC
Confidence 222345678999999988999999999999999999997 899986532211 1111 0101000 00011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 377 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 377 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
..+..+.+++.+||+.||.+||++.+|+++|+.+
T Consensus 306 ----~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 306 ----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred ----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1234688999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=324.89 Aligned_cols=250 Identities=23% Similarity=0.383 Sum_probs=194.3
Q ss_pred CeeeecCCeEEEEEEEccCCCc---cccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTA---PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~---~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 211 (486)
+.||+|+||.||+|+....... .........||+|.+..........+..|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986532210 0111234568999887654444456888999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc-------EEEeecC
Q 011412 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-------AKLSDFG 284 (486)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-------vkl~DFG 284 (486)
+||||+++|+|..++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988766667999999999999999999999988 999999999999987664 8999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|..||..........+ ...
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~~~ 224 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------YEG 224 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------Hhc
Confidence 98765321 2245788999999886 567899999999999999998 58888764322111000 000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
...... .....+.+||.+||+.||.+||++.+|++.|+
T Consensus 225 ---~~~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 ---QCMLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ---CccCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000111 12356889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=330.93 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=205.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+..........+.+|+.+++.+.|+||+++++++....
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECC---------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 589999999999999999998765 56789999998766555567889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchh
Confidence 99999999999999998854 35788999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
...... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+... ..... ...
T Consensus 166 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~----~~~----- 232 (296)
T cd06654 166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA----TNG----- 232 (296)
T ss_pred cccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh----cCC-----
Confidence 433221 12234689999999999888899999999999999999999999975433111 00000 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+ ....+...+..+.+|+.+||..||++||++.+++++
T Consensus 233 --~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 233 --TP--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CC--CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 001112234678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=324.23 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=196.9
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
.||+|+||.||+|.+... .++..||+|+++.... ...+++.+|+.+++.+.|+||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-------KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEecC-------CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 589999999999976532 2567899999875432 23456889999999999999999999875 4567899
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~ 293 (486)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||.|||++.++.+||+|||+++......
T Consensus 74 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 74 MELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 9999999999998644 46899999999999999999999988 9999999999999999999999999998754432
Q ss_pred cce-eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 011412 294 KTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 371 (486)
Q Consensus 294 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (486)
... ......++..|+|||++....++.++|||||||++|||++ |..||....... +..... ... .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~----~~~------~ 216 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIE----SGE------R 216 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----CCC------C
Confidence 211 1112334679999999988889999999999999999998 999997543221 111111 000 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 372 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 372 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
+ ..+...+..+.+||.+||+.||++||++.+|.+.|+.
T Consensus 217 ~----~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 M----ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred C----CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1 1111234678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=340.84 Aligned_cols=256 Identities=21% Similarity=0.256 Sum_probs=199.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++.+.||+|+||.||++.+.. +++.||+|++..... .....+..|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 378899999999999999998865 567899999864221 12234778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+.+.+||||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecch
Confidence 999999999999999999999776667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
+........ ......+||+.|||||++. ...++.++|||||||+||||++|+.||....... ......
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~ 221 (332)
T cd05623 149 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIM 221 (332)
T ss_pred heecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHh
Confidence 876433221 1223357999999999886 3468899999999999999999999997543211 111011
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEA 410 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~eil~~ 410 (486)
.....+ . + +. .....+..+.+|+.+||..++.+ |+++.+++++
T Consensus 222 ~~~~~~-~-~-p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 222 NHKERF-Q-F-PA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCccc-c-C-CC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 100000 0 0 00 01123467889999998655444 6889998875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=324.31 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=197.9
Q ss_pred eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEEe
Q 011412 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215 (486)
Q Consensus 137 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~E 215 (486)
||+|+||.||+|.+.... ++..||+|++...... ..+.+.+|+.++++++|+||+++++++. .+..++|||
T Consensus 3 ig~G~~g~v~~~~~~~~~-------~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e 74 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRK-------KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVME 74 (257)
T ss_pred cCCCCcccEEEEEEecCC-------CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEE
Confidence 899999999999875321 3557999999765332 2356889999999999999999999875 457899999
Q ss_pred ecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcc
Q 011412 216 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295 (486)
Q Consensus 216 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~ 295 (486)
|+++++|.+++......+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++........
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 99999999999766668999999999999999999999988 999999999999999999999999999865433221
Q ss_pred ee-eeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCc
Q 011412 296 HV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373 (486)
Q Consensus 296 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (486)
.. .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ..... ....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~--------- 215 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFI----EQGK--------- 215 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCC---------
Confidence 11 111234578999999988889999999999999999996 999997543211 11111 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 374 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
....+...+..+.+|+.+||..||++||++.+|++.|+.+
T Consensus 216 -~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 -RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0011122346788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=332.60 Aligned_cols=269 Identities=22% Similarity=0.312 Sum_probs=203.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|.+.+.||.|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++|+||+++++++..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC---------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 578999999999999999998765 577999999875432 2234577899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||++ ++|.+++......+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 99999999996 5999988776667899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------h
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P 358 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~--------~ 358 (486)
....... ......+++.|+|||++.+ ..++.++|||||||++|||++|++||...........+.... +
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 153 AKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred ccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence 6433221 1223457899999998765 458889999999999999999999997653321111000000 0
Q ss_pred hcccccccccccCCccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 359 HLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.......+.....+.... ......+..+.+||.+||..||.+||++.|++++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 000000000000000000 011123456889999999999999999999998543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=329.52 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=203.3
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCee
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
|++.+.||.|+||.||+|.+.. ++..+++|.+..........+.+|+++++.++|+||+++++++..+...
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 5677889999999999998865 5678999999765544456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
++||||+++++|..++.+....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999999999999988766667999999999999999999999988 9999999999999999999999999987653
Q ss_pred CCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
.... ......|+..|+|||++. +..++.++|||||||++|||++|.+||....... ....... .
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~----~--- 223 (282)
T cd06643 155 RTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIAK----S--- 223 (282)
T ss_pred cccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHhh----c---
Confidence 3211 123356899999999874 4567889999999999999999999996543211 1111100 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
..+.+ ..+...+..+.+||.+||+.||.+||++.+++++-.
T Consensus 224 ----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 224 ----EPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred ----CCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 00000 011123467899999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=323.98 Aligned_cols=249 Identities=29% Similarity=0.488 Sum_probs=204.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++.+.||.|+||.||+|... |..||||.+..... ..+++.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 457889999999999999999763 56899999986643 456789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccc
Confidence 99999999999999999986543 36899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+....... ...++..|+|||++....++.++||||||+++|||++ |..||....... +.... ...
T Consensus 150 ~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~-- 215 (256)
T cd05039 150 KEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EKG-- 215 (256)
T ss_pred cccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hcC--
Confidence 87633211 2345678999999988899999999999999999997 999986542211 11110 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
... ..+...+..+.+|+.+||..+|++||++.++++.|+.
T Consensus 216 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 ----YRM----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ----CCC----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 000 1111234678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=327.27 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=202.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|.+.+.||+|+||.||+|.+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVN---------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcC---------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 467778899999999999998865 56789999997665444456788999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 999999999999999988554 47899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
...... ......|+..|+|||++. ...++.++|||||||++|+|++|..||....+....... .. . .
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~----~--~ 225 (267)
T cd06645 156 ITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TK----S--N 225 (267)
T ss_pred ccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hc----c--C
Confidence 532211 123457999999999874 456889999999999999999999998654322111000 00 0 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...+.... ....+..+.+++.+||+.+|++||++.+|+++
T Consensus 226 ---~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 226 ---FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ---CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00010100 00123468899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=330.00 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=204.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
+.|++++.||.|+||.||+|.+.. ++..||+|.+..........+.+|+.+++.++|+||+++++++..+.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 568999999999999999998865 56789999998765555567889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++++|..++.+....+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999888766667999999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
...... ......++..|+|||++. ...++.++|||||||++|||++|..||....... .......
T Consensus 160 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~------ 229 (292)
T cd06644 160 NVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAK------ 229 (292)
T ss_pred cccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHhc------
Confidence 432211 123456889999999884 3457889999999999999999999996543211 1111100
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...+.. ..+...+..+.+|+.+||..||++||++.+++++
T Consensus 230 -----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 230 -----SEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----CCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 0111234568899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=336.11 Aligned_cols=267 Identities=25% Similarity=0.400 Sum_probs=206.0
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
...+|.+.+.||+|+||.||+|.+..... ........||+|.++.... .....+..|+++++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 34578899999999999999998643111 1112455799999875432 2245688999999999 699999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 269 (486)
...+.+++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 99999999999999999999996532 34788999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 011412 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 348 (486)
Q Consensus 270 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~ 348 (486)
||++.++.+||+|||+++...............++..|||||++.+..++.++|||||||++|||++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987543222111122234568999999998899999999999999999999 888886543211
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
+..... ... ....+...+..+.+|+.+||..||.+||++.++++.|+.+.
T Consensus 245 ---~~~~~~----~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 ---LFKLLR----EGH----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHHHHH----cCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111110 000 00111123457889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=329.19 Aligned_cols=274 Identities=29% Similarity=0.381 Sum_probs=209.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe-
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 206 (486)
.+|++.+.||+|+||.||+|.+...+ ..++..||||.+...... ....+.+|+++++.+.|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-----DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-----CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 46788899999999999999876432 236789999999866543 35678999999999999999999999877
Q ss_pred -CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 -~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
....++||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccc
Confidence 56789999999999999999776667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcce-eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc--cc
Q 011412 286 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL--GE 362 (486)
Q Consensus 286 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~ 362 (486)
+.......... ......++..|+|||.+.+..++.++|||||||++|||++|..|+......... +..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~ 231 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQMI 231 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----cccccccccc
Confidence 98765332211 111234566799999998889999999999999999999999998643221100 000000 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...+...+........+..++..+.+|+.+||+.+|.+||++.||++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000001111111111122346788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=339.02 Aligned_cols=269 Identities=27% Similarity=0.393 Sum_probs=208.3
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 203 (486)
....+|.+.+.||+|+||.||+|.+...++ .....+..||+|.++.... ....++.+|+++++++ +|+||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDK--DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCC--ccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 344578999999999999999998754221 1112345799998875432 2345788999999999 79999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 268 (486)
+...+..++||||+++|+|.+++.+.. ..+++..++.++.|++.||.|||+++ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 999999999999999999999986532 24778889999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 011412 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 347 (486)
Q Consensus 269 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~ 347 (486)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999986544322221222345678999999999999999999999999999998 88888654221
Q ss_pred CcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 348 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
. .... +.... ....+...+..+.+|+.+||+.+|.+||++.++++.|+.+..
T Consensus 244 ~------~~~~-~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 E------LFKL-LKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred H------HHHH-HHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1 1100 00000 001111234578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=340.92 Aligned_cols=257 Identities=21% Similarity=0.258 Sum_probs=199.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|.+.+.||+|+||.||++++.. +++.||+|++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 478899999999999999998865 567899999875321 12234778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+++..||||||+++|+|.+++.+....+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccc
Confidence 999999999999999999999776667899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
++........ .....+||+.|+|||++.+ +.++.++|||||||+||||++|+.||....... ......
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~ 221 (331)
T cd05624 149 CLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIM 221 (331)
T ss_pred eeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHH
Confidence 9765432221 1233579999999998875 568899999999999999999999997543211 000000
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 411 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~eil~~L 411 (486)
....++ .+.... ...+..+.+|+.+||..++++ |+++.+++++.
T Consensus 222 ~~~~~~------~~p~~~-~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 222 NHEERF------QFPSHI-TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred cCCCcc------cCCCcc-ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 000000 000000 112467889999999865544 45787777653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=327.34 Aligned_cols=253 Identities=29% Similarity=0.412 Sum_probs=200.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
....|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+..|+.++.++ +|+||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC---------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 34578888999999999999998865 56799999987543 3345788999999998 6999999999987
Q ss_pred eC------CeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 206 ED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 206 ~~------~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
.. ..+|+||||+.+++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCE
Confidence 53 4689999999999999998753 356899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~ 353 (486)
+|+|||+++....... ......|+..|+|||++. ...++.++|||||||++|||++|..||....+......
T Consensus 151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~- 227 (272)
T cd06637 151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL- 227 (272)
T ss_pred EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-
Confidence 9999999986533221 123467899999999886 34688899999999999999999999964332111000
Q ss_pred HhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. ....+.. .....+..+.+|+.+||..||.+||++.+++++
T Consensus 228 ------~~------~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 ------IP------RNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ------Hh------cCCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 0000000 011234578999999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=329.66 Aligned_cols=267 Identities=28% Similarity=0.409 Sum_probs=205.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+.|++++.||+|+||.||+|.+...+ ..++..||+|.++.... .....+.+|+.+|+.+.|+||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCC-----CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 35788899999999999999865321 23678999999875432 2335688999999999999999999998775
Q ss_pred --CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 208 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
...++||||+++++|.+++.+....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcc
Confidence 5689999999999999999766557899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC---------CcchhHHh
Q 011412 286 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN---------GEHNLVEW 355 (486)
Q Consensus 286 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~---------~~~~~~~~ 355 (486)
++........ .......|+..|+|||++.+..++.++|||||||++|||++++.|+...... ...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 234 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-R 234 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-H
Confidence 9875433221 1122355778899999998889999999999999999999987765321110 000000 0
Q ss_pred hhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
....+.... ........+..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 235 ~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000000 0001112346799999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=324.37 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=201.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ....+.+|+.++++++|+||+++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 4578999999999999999997653 45699999876543 3457899999999999999999999875 4
Q ss_pred CeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceee
Confidence 5689999999999999998653 345899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
......... ......++..|+|||++.+..++.++||||||+++|||++ |..||...... ....... ..
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~-- 219 (260)
T cd05070 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVE----RG-- 219 (260)
T ss_pred eeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH----cC--
Confidence 865432211 1122345678999999988899999999999999999999 88999653221 1111110 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
... ..+...+..+.+|+.+||..+|++||++.++++.|+.
T Consensus 220 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 ----YRM----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCC----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 1112234578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=341.95 Aligned_cols=265 Identities=23% Similarity=0.285 Sum_probs=198.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|.+.+.||+|+||.||+|.+.. +++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~ 93 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECC---------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence 4689999999999999999998765 56789999997542 223456789999999999999999999876
Q ss_pred eC------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 206 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 206 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
.. ...|+||||+++ +|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 94 PQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred ccccccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence 43 357999999965 77777642 4788899999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH-Hh---
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW--- 355 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~-~~--- 355 (486)
|+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+ ..
T Consensus 167 L~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred EEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999998653322 123457899999999999999999999999999999999999999764322111000 00
Q ss_pred --------h----hhhcccccccc-----cccCC---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 356 --------A----RPHLGERRRFY-----RLIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 356 --------~----~~~~~~~~~~~-----~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. .....+...+. ..... .............+.+||.+||+.||.+|||+.+++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0 00000000000 00000 000001111235688999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.06 Aligned_cols=241 Identities=27% Similarity=0.329 Sum_probs=187.3
Q ss_pred eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcC---CCCCceEEEEEEEeCCee
Q 011412 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL---VHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 137 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~ 210 (486)
||+|+||+||+|++.. +|..||||++...... ....+..|..++..+ .||||+++++++...+..
T Consensus 1 lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 7999999999998865 6779999998653221 123345677777655 699999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|+||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred EEEEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 9999999999999988654 56899999999999999999999988 9999999999999999999999999997643
Q ss_pred CCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (486)
.... .....+||..|||||++.+. .++.++|||||||++|||++|..||....... +. .........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~~---~~i~~~~~~---- 215 (330)
T cd05586 148 TDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---MY---RNIAFGKVR---- 215 (330)
T ss_pred CCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---HH---HHHHcCCCC----
Confidence 3222 12346799999999998754 58999999999999999999999997543211 10 000000000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 011412 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL----MSEVVE 409 (486)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs----~~eil~ 409 (486)
+.. ...+..+.+|+.+||+.||.+||+ +.++++
T Consensus 216 ----~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 ----FPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ----CCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 000 012456889999999999999995 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=335.31 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=200.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 206 (486)
++|++.+.||+|+||.||+|.+..++. ...+|+|.+..... .....+.+|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~-------~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCc-------eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 578889999999999999999865321 23568887764322 2335688899999999 89999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 271 (486)
++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nil 156 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL 156 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEE
Confidence 999999999999999999986432 25789999999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011412 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 350 (486)
Q Consensus 272 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~ 350 (486)
++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||.......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 231 (303)
T cd05088 157 VGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-- 231 (303)
T ss_pred ecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--
Confidence 9999999999999987432111 1111234678999999988889999999999999999998 999996543211
Q ss_pred hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
...... . .. ....+...+..+.+|+.+||+.+|++||++.++++.|+.+.
T Consensus 232 -~~~~~~----~------~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 232 -LYEKLP----Q------GY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred -HHHHHh----c------CC----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111100 0 00 00011122456889999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=348.93 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=211.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
+.|.|+.-||.|+||.||+|..++ ++...|.|++........++++-||.||+.++||+||+|++.|..++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke---------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE---------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc---------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 357788889999999999998875 66678899998776666778999999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
.++|+.|||.||-.+..+..-+..+.+.++..+++|++.||.|||+++ |||||||..|||+.-+|.|+|+|||.+-.
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc
Confidence 999999999999999998888889999999999999999999999998 99999999999999999999999998765
Q ss_pred CCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
... .......+.||++|||||++. ..+|+.++||||||++|.||..+.+|....++.-. ++..+. .
T Consensus 180 n~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llKiaK---S-- 250 (1187)
T KOG0579|consen 180 NKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK---S-- 250 (1187)
T ss_pred chh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHHHhh---c--
Confidence 322 222345689999999999875 46899999999999999999999999765443211 111110 0
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
....++. +..+...+.+++.+||..||..||++.+++++-
T Consensus 251 -ePPTLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 251 -EPPTLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred -CCCcccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 0111121 234456788999999999999999999999864
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=325.25 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=202.4
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
..+|++.+.||+|+||.||+|.+.. ...||+|+++.... ....+.+|+.+++.++|+||+++++++. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 3579999999999999999998753 23599999985433 3467899999999999999999999874 4
Q ss_pred CeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCce
Confidence 5689999999999999999753 346889999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+........ ......++..|+|||++.+..++.++|||||||++|||++ |..||....... .... ....
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~----~~~~-- 219 (262)
T cd05071 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQ----VERG-- 219 (262)
T ss_pred eeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHH----HhcC--
Confidence 865433221 1122346778999999988899999999999999999999 888886543211 1100 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
. ........+..+.+|+.+||+.||.+||++.++++.|+..
T Consensus 220 ----~----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 ----Y----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----C----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 0011223456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=326.90 Aligned_cols=254 Identities=31% Similarity=0.511 Sum_probs=201.7
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHH--HHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
|++.+.||+|+||+||++.... +++.||+|++......... ...+|+.++++++|+||+++++++....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEECC---------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 5677899999999999999876 5678999999877543322 2456999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 72 ~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 9999999999999999997 3457899999999999999999999988 99999999999999999999999999975
Q ss_pred CCCCCcceeeeeccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
... .........++..|+|||++. +..++.++||||||+++|+|++|..||............. .........
T Consensus 148 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~- 221 (260)
T PF00069_consen 148 LSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKRPLPS- 221 (260)
T ss_dssp STS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHTHHHH-
T ss_pred ccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccccccc-
Confidence 311 111234467899999999988 8899999999999999999999999997651111111111 111000000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... . .......+.+|+.+||+.||++||++.+++++
T Consensus 222 -~~~---~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 222 -SSQ---Q---SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -HTT---S---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -ccc---c---cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 00012678999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=328.99 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++.+.||+|+||.||+|.+... ....++..||+|++..... ....++.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 45799999999999999999987431 1122567899999875432 223568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRS---------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL 265 (486)
++..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 999999999999999999986431 24778889999999999999999988 999999
Q ss_pred CCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 011412 266 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 344 (486)
Q Consensus 266 Kp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~ 344 (486)
||+|||++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876433222111222345678999999988899999999999999999998 88888643
Q ss_pred CCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
... ...... ... .. . ..+...+..+.+|+.+||+.||.+||++.|+++.|+.
T Consensus 237 ~~~---~~~~~~----~~~-~~---~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHE---EVIYYV----RDG-NV---L------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHH---HHHHHH----hcC-CC---C------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 221 111110 000 00 0 0111234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=322.59 Aligned_cols=252 Identities=30% Similarity=0.464 Sum_probs=202.0
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
+.||+|+||.||+|.+...+ ++...||||.+..... ...+.+.+|+.++++++|+||+++++++.+ ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG------GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCC------CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 46899999999999886521 1344799999987765 445678999999999999999999999988 889999
Q ss_pred EeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~ 292 (486)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence 99999999999997654 57899999999999999999999988 999999999999999999999999999876443
Q ss_pred Ccc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 293 DKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 293 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
... .......++..|+|||++.+..++.++|||||||++|||++ |..||....... +..... .... ..
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~---~~~~---~~- 220 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKID---KEGE---RL- 220 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---hcCC---cC-
Confidence 221 11223457889999999998999999999999999999999 999996442211 111100 0000 00
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
..+...+..+.+|+.+||+.+|.+||++.++++.|.
T Consensus 221 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=322.07 Aligned_cols=255 Identities=28% Similarity=0.379 Sum_probs=194.0
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
+.||+|+||.||+|.+... .++..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-------YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcCC-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 3689999999999987542 2456799999876542 2234688899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
|||+++|+|.+++.... ...++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNK 150 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999999986432 24567788899999999999999988 999999999999999999999999999765
Q ss_pred CCCCcceeeeeccccccccCccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 290 PEGDKTHVSTRVMGTYGYAAPEYVMTG-------HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
.............|+..|+|||++.+. .++.++|||||||++|||++ |..||....... ...... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~--~~ 225 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTV--RE 225 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHh--hc
Confidence 433222222335678899999988532 35789999999999999996 999996543221 111100 00
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
......++.+.. ..+..+.+|+.+|| .+|++||++.+|+..|.
T Consensus 226 ---~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 ---QQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---ccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 001111222211 12346788999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=322.83 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=199.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE-eC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-ED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~ 207 (486)
.+|.+.+.||+|+||.||++.. .|..||+|.++... ..+.+.+|+.+++.++|+||+++++++. .+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-----------~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-----------cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 5788999999999999999976 35679999987543 2456889999999999999999999764 45
Q ss_pred CeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccc
Confidence 67899999999999999987544 34889999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+..... ..
T Consensus 150 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~----~~-- 215 (256)
T cd05082 150 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE----KG-- 215 (256)
T ss_pred eeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cC--
Confidence 8643322 12345678999999998899999999999999999998 99998643211 1111110 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
..+ ......+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 216 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 ----YKM----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 001 11112346788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=321.22 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=207.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|++.+.||.|+||.||+|.+.. ++..||+|.+..... ..++.+|+++++.++|+||+++++++....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 578899999999999999998875 466899999975532 567899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..|++|||+++++|.+++......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchh
Confidence 999999999999999999776778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+......+ . .
T Consensus 149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------~-------~ 213 (256)
T cd06612 149 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------P-------N 213 (256)
T ss_pred cccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh------c-------c
Confidence 654321 123356889999999999889999999999999999999999999754332110000 0 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...+ ....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 214 ~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 214 KPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0000 001122234678999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=322.32 Aligned_cols=253 Identities=31% Similarity=0.493 Sum_probs=199.8
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
+.||+|+||.||+|.+.... +++..||+|.+...... ..+++.+|+.+++.+.|+|||++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccC------CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 46999999999999875532 14468999999866542 3456889999999999999999999876 4567999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~ 293 (486)
|||+++++|.+++.... .+++..++.++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++......
T Consensus 74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 74 MELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred EEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 99999999999996554 7899999999999999999999988 9999999999999999999999999998764433
Q ss_pred ccee-eeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 011412 294 KTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 371 (486)
Q Consensus 294 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (486)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+..+... ... .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~----~~~---~-- 217 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLES----GER---L-- 217 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc----CCc---C--
Confidence 2111 111224568999999998899999999999999999998 99999654321 11111110 000 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 372 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 372 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
..+...+..+.+|+.+||..+|.+||++.++++.|+.++
T Consensus 218 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011122457889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.84 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=194.2
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 214 (486)
+.||.|+||.||+|.+...+.. .......||+|.+........+.+..|+.+++.+.||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccc--cccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 3699999999999988653221 01123468899887654444467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--------EEEeecCCC
Q 011412 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--------AKLSDFGLA 286 (486)
Q Consensus 215 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--------vkl~DFGla 286 (486)
||+++|+|..++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++++|||++
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999999776667899999999999999999999988 999999999999987664 699999998
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCcchhHHhhhhhccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||........ .. ......
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~----~~~~~~ 222 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQ----FYEDRH 222 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HH----HHHccc
Confidence 764321 22468889999999876 45899999999999999999995 55543322110 00 000100
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.++......+.+|+.+||+.||++||++.++++.|+
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 ------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011112356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=328.13 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=208.6
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..++|.+.+.||+|+||.||+|.+.... ..++..|++|++..... .....+.+|+.+|+.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3467889999999999999999987532 12467899999875432 22456889999999999999999999876
Q ss_pred e-CCeeEEEEeecCCCChhHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 206 E-DDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 206 ~-~~~~~lv~E~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
. ....++++||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQ 155 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCc
Confidence 6 577899999999999999986532 45889999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||....+.. +..+.
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~ 232 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL 232 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH
Confidence 99999999986544332222233456778999999988899999999999999999999 999997543311 11111
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
. .... . .....++..+.+++.+||..||++||++.++++.|+.+.
T Consensus 233 ~----~~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 233 K----DGYR------L----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred H----cCCC------C----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1 0000 0 011123457889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=330.82 Aligned_cols=199 Identities=24% Similarity=0.381 Sum_probs=162.4
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe--CCeeE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--DDQRL 211 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~ 211 (486)
.+.||+|+||+||+|.+... .++..||+|.+..... ...+.+|+++|+.++||||+++++++.. +...|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-------KDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEccC-------CCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 35899999999999987542 2467899999975432 2457899999999999999999998854 45688
Q ss_pred EEEeecCCCChhHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCcEE
Q 011412 212 LVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAK 279 (486)
Q Consensus 212 lv~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll----~~~~~vk 279 (486)
+||||+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07868 77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEE
Confidence 9999995 5888877422 235889999999999999999999988 9999999999999 4567899
Q ss_pred EeecCCCCCCCCCCcc-eeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 011412 280 LSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345 (486)
Q Consensus 280 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~ 345 (486)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 9999999865432211 11234678999999999876 468999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=326.97 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=207.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|++.+.||+|+||.||+|.+..++.. ....||+|.+..... ....++.+|+.+|..+.|+||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~-----~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEK-----VKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCC-----cceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 5788899999999999999998654321 234699998876543 233568899999999999999999999887
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
...++||||+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 7889999999999999999877667999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
...............++..|+|||.+....++.++|||||||++|||++ |..||....... +..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~- 229 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLE----KGER- 229 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHh----CCCC-
Confidence 7654332211112234678999999988899999999999999999999 999997643211 111111 0000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
. ..+..++..+.+++.+||..||.+||++.++++.|+.+.
T Consensus 230 --~-------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 230 --L-------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred --C-------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 001112356889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=323.87 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=203.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..++|+++++||+|+||.||+|... ++..||+|.+..... ....+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 71 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT- 71 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence 4567999999999999999999864 356899999976543 3467899999999999999999999864
Q ss_pred CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.+..++||||+.+++|.+++... +..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~ 148 (260)
T cd05067 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGL 148 (260)
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcc
Confidence 56789999999999999998643 456899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+......... ......++..|+|||++....++.++|||||||++|||++ |+.||....... ..... ...
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~- 219 (260)
T cd05067 149 ARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNL----ERG- 219 (260)
T ss_pred eeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----HcC-
Confidence 9775432211 1222346788999999988899999999999999999999 999997543211 11110 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
....... ..+..+.+++.+||..+|++||++++++..|+.
T Consensus 220 -----~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 -----YRMPRPD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001111 123578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.61 Aligned_cols=248 Identities=29% Similarity=0.442 Sum_probs=199.5
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
++||.|+||.||+|.+.. ++.||+|.+...... ....+.+|+++++.+.|+||+++++++......++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 469999999999998753 558999998765443 345788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~ 293 (486)
|||+++++|.+++......+++..++.++.+++.+|.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 9999999999999766667899999999999999999999988 9999999999999999999999999998654322
Q ss_pred cceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 011412 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 372 (486)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (486)
.........++..|+|||++.++.++.++|||||||++|||++ |..||........... .. ..
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~~----~~--------- 211 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---IE----SG--------- 211 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---Hh----cC---------
Confidence 1111112234667999999988899999999999999999999 8888865432111110 00 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 373 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 373 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.....+...+..+.+|+.+||..+|++||++.|+++.|+
T Consensus 212 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 212 -YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 000111223467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=328.71 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=205.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|++.+.||.|+||.||+|.+.. ++..||+|.+..........+.+|+.++++++|+||+++++++..+.
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 468888999999999999998865 56789999997665555567889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++++|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence 999999999999999998776667999999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
...... ......|++.|+|||++. ...++.++|||||||++|||++|+.||....... .+..+. .
T Consensus 153 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~~~----~-- 222 (280)
T cd06611 153 NKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKIL----K-- 222 (280)
T ss_pred hccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHHHh----c--
Confidence 533221 123456899999999875 3457789999999999999999999997543211 111100 0
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
...+.+ ..+...+..+.+|+.+||+.+|.+||++.+++++-
T Consensus 223 -----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 223 -----SEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred -----CCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 000000 01112345788999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=322.91 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=201.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++.+.....||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE 76 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence 34455555689999999999998765 566899999886655555678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeec
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDF 283 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~vkl~DF 283 (486)
++..++||||+++++|.+++......+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecc
Confidence 999999999999999999997654455 78889999999999999999988 999999999999976 678999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|++........ ......|+..|+|||++... .++.++|||||||++|+|++|..||........ ..+......
T Consensus 154 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~ 228 (268)
T cd06624 154 GTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK 228 (268)
T ss_pred hhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc
Confidence 99876533221 12234689999999998654 378999999999999999999999964322110 001000000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. ...++......+.+|+.+||+.+|.+||++.+++++
T Consensus 229 --------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 --------I----HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------c----CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 111222334678999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=328.20 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=205.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|++.+.||+|+||.||+|.... +|..||+|.+..........+.+|+.+++.++|+||+++++++..++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECC---------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 689999999999999999998765 57799999998665555567889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceE
Confidence 99999999999999998854 35788999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
...... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+....... ...
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~~~------ 230 (297)
T cd06656 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATN------ 230 (297)
T ss_pred ccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------ccC------
Confidence 543221 123356899999999999889999999999999999999999999654332110000 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
-.+ ....+...+..+.+|+.+||..||.+||++.+++++
T Consensus 231 -~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 231 -GTP--ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -CCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 001112234568899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=327.49 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=199.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++.+.||+|+||.||+|.+.. +|..||||.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 57888999999999999998865 567999999875432 2235688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+.+++||||++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccc
Confidence 99999999996 6898888543 256899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhh-h-----
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWA-R----- 357 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~-~----- 357 (486)
+....... .......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||.......... ..... .
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 87643221 11233467899999998765 457899999999999999999999997543211100 00000 0
Q ss_pred -hhcccccccccccCCccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 -PHLGERRRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 -~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.......+....+.... .......+.++.+||.+||..||.+||++.+|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000000000 00011134677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.02 Aligned_cols=247 Identities=31% Similarity=0.449 Sum_probs=197.4
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
++||+|+||.||+|... ++..||+|.+....... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 36999999999999764 35589999987654322 24588999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~ 293 (486)
|||+++++|.+++......+++..++.++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 9999999999998766667899999999999999999999988 9999999999999999999999999987643322
Q ss_pred cceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 011412 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 372 (486)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (486)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..... ... .
T Consensus 148 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~~----~~~------~-- 211 (250)
T cd05085 148 YS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQV----EKG------Y-- 211 (250)
T ss_pred cc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcC------C--
Confidence 11 1112234678999999998899999999999999999998 999996543211 11100 000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 373 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 373 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
....+...+..+.+|+.+||+.+|++||++.++++.|.
T Consensus 212 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 --RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00111123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.62 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=201.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---------HHHHHHHHHHHhcCCCCCceEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGDLVHLNLVKL 200 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~nIv~~ 200 (486)
+|.+.+.||.|+||.||+|.+.. ++..||+|.+....... .+.+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 47788899999999999998765 46689999887543321 1457789999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEe
Confidence 99999999999999999999999999654 56889999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCc----ceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 281 SDFGLAKDGPEGDK----THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 281 ~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
+|||+++....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~ 222 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-----AIF 222 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-----HHH
Confidence 99999987642111 111123568899999999998899999999999999999999999997532210 000
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. ......+. ++...+..+.+++.+||+.||.+||++.+++++
T Consensus 223 ~--------~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 223 K--------IGENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred H--------HhccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 00011111 222334678899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=322.55 Aligned_cols=254 Identities=26% Similarity=0.451 Sum_probs=195.1
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEE-eCCeeEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-EDDQRLL 212 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~~~l 212 (486)
+.||+|+||.||+|.+.... ..+..||||.+.... ......+.+|+.+++.++||||+++++++. .+...++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCC------CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 46899999999999875422 134579999986432 233456889999999999999999999775 4556899
Q ss_pred EEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011412 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~ 292 (486)
||||+.+|+|.+++.+....+.+..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999999766666778888999999999999999988 999999999999999999999999999865332
Q ss_pred Ccce--eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 011412 293 DKTH--VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369 (486)
Q Consensus 293 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (486)
.... ......++..|+|||++.+..++.++|||||||++|||++| .+||...... .+..... ..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~----~~------ 218 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLL----QG------ 218 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh----cC------
Confidence 1111 11223567789999999888999999999999999999995 5566433211 1111110 00
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
..+.... ..+..+.+++.+||..+|++||++.+|++.|+.+
T Consensus 219 ~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 219 RRLLQPE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000111 1235688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=328.81 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=205.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|++.+.||.|+||.||+|.+.. +|+.||||.+..........+.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA---------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC---------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 468999999999999999998765 67799999997665555677889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
.+++||||+++++|..++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchh
Confidence 999999999999999988543 5899999999999999999999988 99999999999999999999999999886
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
....... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||....+......+ . ...
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--~----~~~----- 231 (296)
T cd06655 165 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--A----TNG----- 231 (296)
T ss_pred ccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H----hcC-----
Confidence 5433221 22356899999999999888999999999999999999999999764432111000 0 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+.+ ..+...+..+.+||.+||..||.+||++.+++.+
T Consensus 232 --~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 232 --TPEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --Cccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000 0111234578899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=365.55 Aligned_cols=257 Identities=29% Similarity=0.432 Sum_probs=195.1
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
+...+|+.+++||+||||.|||++++- +|..||||++..... .....+.+|+++|++|+|||||+||..|
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKl---------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKL---------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecc---------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 455788999999999999999999987 577999999987642 2235688999999999999999999887
Q ss_pred EeCC----------------------------------------------------------------------------
Q 011412 205 IEDD---------------------------------------------------------------------------- 208 (486)
Q Consensus 205 ~~~~---------------------------------------------------------------------------- 208 (486)
.+..
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 5422
Q ss_pred -------------------------------------------eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHH
Q 011412 209 -------------------------------------------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245 (486)
Q Consensus 209 -------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi 245 (486)
.+||.||||+...|.+++.++...-.....++++++|
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREI 706 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHH
Confidence 2389999999977777665443222567889999999
Q ss_pred HHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC----------------CCCcceeeeeccccccccC
Q 011412 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP----------------EGDKTHVSTRVMGTYGYAA 309 (486)
Q Consensus 246 ~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~a 309 (486)
++||+|+|+++ ||||||||.||||+.++.|||+|||+|+... .+......+..+||..|+|
T Consensus 707 lEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 707 LEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 99999999999 9999999999999999999999999998721 0111113456889999999
Q ss_pred ccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHH
Q 011412 310 PEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKA 386 (486)
Q Consensus 310 PE~~~~~---~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (486)
||++.+. .|+.|+|+|||||||+||+. ||...- +....+. .+. ...+ |. ...|........
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~----~LR-~g~i-----P~-~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILT----NLR-KGSI-----PE-PADFFDPEHPEE 847 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHH----hcc-cCCC-----CC-CcccccccchHH
Confidence 9998754 59999999999999999994 454221 1111111 111 0000 00 122333334567
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 011412 387 AQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 387 ~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+|++||+.||.+|||+.|+|..
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhc
Confidence 799999999999999999999963
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.52 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=206.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++.+.||+|+||+||++.+.. +|..||+|++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 568888999999999999998865 567899998875432 2346788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
..+++||||+++++|.+++... ..+++..+..++.+++.+|.|||+ .+ ++||||||+||+++.++.++|+|||++
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcc
Confidence 9999999999999999988553 468999999999999999999997 45 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-----chhHHhhhhhcc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-----HNLVEWARPHLG 361 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~-----~~~~~~~~~~~~ 361 (486)
....... .....|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..+..+......
T Consensus 152 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd06620 152 GELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227 (284)
T ss_pred cchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh
Confidence 7543221 2235789999999999888999999999999999999999999975443211 111111111110
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
+ ..+.+. ....+..+.+|+.+||+.||.+||++.|+++++.-+.
T Consensus 228 ~-------~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 228 E-------PPPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred c-------cCCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0 001111 1123467899999999999999999999998764433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=365.78 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=201.2
Q ss_pred HHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEE
Q 011412 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKL 200 (486)
Q Consensus 123 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~ 200 (486)
+......+|.+++.||.|+||+||+|++.. ++..||+|++...... ....+..|+.+|..|+|||||++
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl 77 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKR---------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECC---------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeE
Confidence 334556789999999999999999999875 5678999998754332 23568899999999999999999
Q ss_pred EEEEEe--CCeeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCcEE
Q 011412 201 IGYCIE--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAE----RPVIYRDFKTSNIL 271 (486)
Q Consensus 201 ~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~----~~iiHrDLKp~NIl 271 (486)
+++|.. ...+|||||||++|+|.++|... ...+++..++.|+.||+.||.|||+.+. .+||||||||+|||
T Consensus 78 ~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred EEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 998865 35689999999999999998642 3579999999999999999999998431 34999999999999
Q ss_pred EcC-----------------CCcEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc--CCCCchhhHHHHHHHHH
Q 011412 272 LDA-----------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLL 332 (486)
Q Consensus 272 l~~-----------------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~ 332 (486)
|+. .+.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||||||
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 954 3458999999998754322 1234579999999999864 45899999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 333 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 333 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
||++|..||....... .+.. .+... +.+.. ...+..+.+||..||+.+|.+||++.++|.
T Consensus 235 ELLTGk~PF~~~~~~~--qli~----~lk~~--------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 235 ELCSGKTPFHKANNFS--QLIS----ELKRG--------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHCCCCCCcCCcHH--HHHH----HHhcC--------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999999996432211 1111 01100 00000 012457889999999999999999999985
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=342.26 Aligned_cols=264 Identities=26% Similarity=0.400 Sum_probs=219.4
Q ss_pred hhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEE
Q 011412 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 200 (486)
Q Consensus 121 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 200 (486)
++.|.....+.....+||-|.||.||.|.|+.. ...||||.++.+. ....+|+.|..+|+.++|||+|+|
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqL 328 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 328 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHH
Confidence 466677777788888999999999999999873 4589999998765 346789999999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
+|+|..+...|||+|||..|+|.++|.+.+ ..++....+.++.||..||.||..++ +|||||...|+|+.++..||
T Consensus 329 LGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVK 405 (1157)
T KOG4278|consen 329 LGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVK 405 (1157)
T ss_pred hhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEE
Confidence 999999999999999999999999998653 45778888999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~ 358 (486)
|+||||++....+.++. .....-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.+..-..
T Consensus 406 vADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq---------- 474 (1157)
T KOG4278|consen 406 VADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------- 474 (1157)
T ss_pred eeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----------
Confidence 99999999876544332 222334678999999999999999999999999999998 888886542211
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.+.++.....-.-+..|+..+++||+.||+.+|.+||++.|+-+.++.+.
T Consensus 475 -------VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 475 -------VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred -------HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 11122222222233456788999999999999999999999999887653
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=321.23 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=205.5
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..++|.+.+.||+|+||.||+|.+.. +..||||.+..... ...++.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 45689999999999999999998753 35799999986543 35678999999999999999999999998
Q ss_pred CCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECcccc
Confidence 899999999999999999997543 56899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ........
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~------ 219 (261)
T cd05034 150 ARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVER------ 219 (261)
T ss_pred ceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc------
Confidence 9875432111 1112235678999999998899999999999999999999 99999654321 11111100
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
...... +...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 220 ----~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 ----GYRMPR----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000001 11124578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=330.80 Aligned_cols=262 Identities=24% Similarity=0.409 Sum_probs=204.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|+..+.||+|+||.||+|.+...+.. ....||+|.+...... ...++.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGET-----VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCc-----ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 35788889999999999999988653321 1236899988755332 23467899999999999999999999875
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
. ..++|+||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccc
Confidence 4 467999999999999999776667899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+...............++..|+|||++.+..++.++|||||||++|||++ |..||....... ...+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~ 229 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLE----KGER 229 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----CCCC
Confidence 87543322211222345778999999998999999999999999999997 889986542211 111111 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
+ . .. ...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 230 ~---~---~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 L---P---QP----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred C---C---CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 0 01 112356889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.43 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=194.9
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCCeeEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLL 212 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l 212 (486)
+.||+|+||.||+|.+..++. ...+|+|.++... ......+.+|+.++.++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCC-------eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 368999999999999865321 2357889887533 22345688999999999 89999999999999999999
Q ss_pred EEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 213 VYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 213 v~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~ 150 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 150 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCe
Confidence 999999999999986432 24788999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |..||...... ......
T Consensus 151 ~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~ 224 (270)
T cd05047 151 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL 224 (270)
T ss_pred EEECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHH
Confidence 99999999864321111 111234667999999988899999999999999999997 99999653221 111110
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
. .. .........+..+.+|+.+||..||.+||++.+++..|+.+
T Consensus 225 ~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 P----QG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred h----CC----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0 00 00001112345688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=337.93 Aligned_cols=265 Identities=22% Similarity=0.321 Sum_probs=197.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|.+++.||+|+||.||+|.+.. ++..||||++..... .....+.+|+++|+.++|+||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR---------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC---------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence 34689999999999999999998765 577999999975432 2234577899999999999999999987
Q ss_pred EeC------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 205 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 205 ~~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
... ...|++||++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 84 TPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCE
Confidence 543 3568999998 7899887743 46899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhh
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWA 356 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~ 356 (486)
||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +....
T Consensus 158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07878 158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232 (343)
T ss_pred EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999875432 233578999999999876 578999999999999999999999997543211000 00000
Q ss_pred hh-------hccc--ccccccccCCccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 357 RP-------HLGE--RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 357 ~~-------~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.. .+.. ...+...+....... ........+.+|+.+||..||.+||++.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00 0000 000000000000000 0001124578999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=326.64 Aligned_cols=264 Identities=23% Similarity=0.303 Sum_probs=199.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++.+.||+|+||.||+|.+.. +|..||+|.+..... .....+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 47888999999999999998875 577999999875322 1224577899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
...++||||++ ++|.+++......+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhh
Confidence 99999999996 5888888766667999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh---------
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------- 357 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~--------- 357 (486)
....... ......++..|+|||++.+. .++.++|||||||++|||++|..||........ ......
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 223 (284)
T cd07839 148 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEE 223 (284)
T ss_pred ccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChH
Confidence 6543221 12234678999999988764 478999999999999999999988653322110 000000
Q ss_pred --hhccccccc--ccccCCcc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 --PHLGERRRF--YRLIDPRL-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 --~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+........ ........ ........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000 00000000 000111234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=323.22 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=205.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++.+.||.|+||.||+|.+.. ++..||+|.+.... ......+.+|+++++.++|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 368888999999999999998865 57799999997654 23345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..+++|+||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccce
Confidence 9999999999999999998654 7899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||....+... .....
T Consensus 147 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~---------- 211 (274)
T cd06609 147 QLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFLIP---------- 211 (274)
T ss_pred eeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHHhh----------
Confidence 7654321 12345788999999999988899999999999999999999999975432111 00000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
....+.+... ..+..+.+++.+||..+|++||++.+++++-
T Consensus 212 ~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 212 KNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred hcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 0011111111 0345688999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.94 Aligned_cols=255 Identities=30% Similarity=0.471 Sum_probs=199.7
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
+.||+|+||.||+|++..... ....+..||||.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILG---PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeeccccc---CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 368999999999998865321 012346799998865432 3346788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-----cEEEee
Q 011412 214 YEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-----NAKLSD 282 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-----~vkl~D 282 (486)
|||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++ .++|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999999998642 234788999999999999999999988 99999999999998877 899999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ...... .
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~----~ 227 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV----T 227 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH----h
Confidence 999986544332222223456789999999999999999999999999999998 99998643221 111111 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
... ........+..+.+|+.+||..+|.+||++.+|++.|+
T Consensus 228 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 AGG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000 00111223567889999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=323.64 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=204.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|.+.+.||+|+||.||+|.+.... ++...||||...... ....+.+.+|+.+++.+.|+||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 46888899999999999999876421 123469999987654 2334578899999999999999999998875
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceee
Confidence 5678999999999999999766667899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
........ ..+...++..|+|||.+....++.++|||||||++|||++ |..||........ .... ....
T Consensus 156 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~----~~~~-- 225 (270)
T cd05056 156 YLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRI----ENGE-- 225 (270)
T ss_pred ecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH----HcCC--
Confidence 65443211 1222334568999999988899999999999999999986 9999975432211 1110 0000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
... .+...+..+.+|+.+||..+|.+||++.++++.|+.+.
T Consensus 226 ----~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 226 ----RLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ----cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000 11123467899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=319.42 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=201.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe-
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 206 (486)
+|++.+.||+|+||.||++.+.. +++.||+|.+..... ...+.+.+|+.++++++|+||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 48889999999999999998865 566899999875432 233568889999999999999999998764
Q ss_pred CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+..+|+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccc
Confidence 44678999999999999998753 456899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+........ ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~~--- 217 (257)
T cd08223 149 ARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIEG--- 217 (257)
T ss_pred eEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhc---
Confidence 876533221 223457899999999999999999999999999999999999999643211 111111100
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+ ..+...+..+.+|+.+||+.||.+||++.+++++
T Consensus 218 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 ----KLP----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CCC----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 001 1122344678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=318.83 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=205.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++++.||.|+||.||.+.... ++..+++|.+.... .....++.+|+.+|++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 58889999999999999998765 56789999987543 23345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+.+++|||||++++|.+++.+. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcce
Confidence 9999999999999999999765 456899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
........ ......|+..|+|||++.+..++.++||||||+++|||++|..||....... ........ .
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~--~- 217 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIVQG--N- 217 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcC--C-
Confidence 86544321 2234568999999999988889999999999999999999999996543211 10000000 0
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+ .....+..+.+++.+||..+|.+||++.++++++
T Consensus 218 ---~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 218 ---YTP-----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---CCC-----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 000 0112346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.54 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=201.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++++.||+|+||.||+|.+.. +|..||+|.+..... .....+.+|+.++.+++|+||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 368889999999999999998865 567999999875422 2235688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
+..++||||+++++|..++... ...+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecC
Confidence 9999999999999999888653 2368999999999999999999996 46 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
++....... .....|+..|+|||++.+. .++.++|||||||++|+|++|..||............. .
T Consensus 149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~ 221 (286)
T cd06622 149 VSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---A 221 (286)
T ss_pred CcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH---H
Confidence 997653321 2234688899999988543 35889999999999999999999996543211111000 0
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+. ....++...+..+.+||.+||+.+|++||++.+++++-
T Consensus 222 ----------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 222 ----------IVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred ----------Hhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 0000 01112223456789999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=319.56 Aligned_cols=252 Identities=29% Similarity=0.508 Sum_probs=202.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+++++.+.||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 467888999999999999998752 45799999875433 3457889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++++|.+++......+++..++.++.|++.+|+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceee
Confidence 999999999999999999766667899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... ......++..|+|||++.++.++.++|||||||++|||++ |..||...... .+... +... .
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~---~ 218 (256)
T cd05112 150 VLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVET----INAG---F 218 (256)
T ss_pred cccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH----HhCC---C
Confidence 5332211 1112335678999999988899999999999999999998 99998643211 11111 0000 0
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
....+.. .+..+.+|+.+||+.+|++||++.++++.|.
T Consensus 219 ~~~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 219 RLYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1111111 2367899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=318.70 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=200.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+++++.+.|+||+++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 468888999999999999998753 23689998875432 3456889999999999999999999875 55
Q ss_pred eeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||+++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccce
Confidence 689999999999999999654 345889999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
........ ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ...... ..
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~--- 219 (260)
T cd05069 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVE----RG--- 219 (260)
T ss_pred EccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cC---
Confidence 65432221 1122346778999999988899999999999999999999 899997543211 111110 00
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
..+ ..+...+..+.+|+.+||..||.+||++.++++.|+.
T Consensus 220 ---~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 ---YRM----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 1112234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=359.51 Aligned_cols=258 Identities=23% Similarity=0.342 Sum_probs=201.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+++.+|+++++.++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 478999999999999999998865 6779999999754222 2356889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 275 (486)
+.+..++||||++||+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~d 149 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLF 149 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCC
Confidence 999999999999999999988532 123556778899999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCc----------------ceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 011412 276 YNAKLSDFGLAKDGPEGDK----------------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~ 339 (486)
+.+||+|||+++....... .......+||+.|||||++.+..++.++|||||||++|||+||..
T Consensus 150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~ 229 (932)
T PRK13184 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229 (932)
T ss_pred CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 9999999999986521100 001123579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcC
Q 011412 340 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKP 413 (486)
Q Consensus 340 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~eil~~L~~ 413 (486)
||......... . .... .++.... .....+..+.+++.+||+.||++|| ++.++++.|+.
T Consensus 230 PF~~~~~~ki~----~-~~~i---------~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 230 PYRRKKGRKIS----Y-RDVI---------LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred CCCCcchhhhh----h-hhhc---------cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99753221100 0 0000 0000000 0012345688999999999999997 56667666654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=332.67 Aligned_cols=264 Identities=30% Similarity=0.421 Sum_probs=214.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.+.|+.-++||+||||.||-+..+. ||+.||.|.+.+.... .....++|-.+|.+++.+.||.+-..|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvra---------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRA---------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred ccceeeeEEEecccccceeEEEEec---------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 3568889999999999999998776 8899999998754432 223468899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
...+.+||||..|.||+|.-+|.+.+ ..+++..+..++.+|+.||++||... ||+|||||+|||||+.|+++|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeecc
Confidence 99999999999999999999887664 46999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
|||.....+... ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||..........-++ +..+.
T Consensus 332 GLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~-- 404 (591)
T KOG0986|consen 332 GLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLE-- 404 (591)
T ss_pred ceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhc--
Confidence 999988776542 23489999999999999999999999999999999999999997543332221111 00111
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCCccC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLKDM 420 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~L~~~~~~~~~ 420 (486)
....++..+++++++|...+|.+||.+|.-.. +=.+.++..+.++++
T Consensus 405 ----------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 405 ----------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred ----------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 13345566678899999999999999997655 333334444444443
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=324.31 Aligned_cols=261 Identities=28% Similarity=0.374 Sum_probs=203.1
Q ss_pred hhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceE
Q 011412 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVK 199 (486)
Q Consensus 121 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~ 199 (486)
++.+....++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+|+.++..+ +|+||++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~ 79 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKK---------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVK 79 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECC---------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeee
Confidence 34445567899999999999999999998865 56789999886532 2235678899999999 6999999
Q ss_pred EEEEEE-----eCCeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011412 200 LIGYCI-----EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (486)
Q Consensus 200 ~~~~~~-----~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 271 (486)
+++++. .++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil 156 (286)
T cd06638 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNIL 156 (286)
T ss_pred eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEE
Confidence 999874 34578999999999999998753 3456888999999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 011412 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346 (486)
Q Consensus 272 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~ 346 (486)
++.++.+||+|||+++....... ......|++.|+|||++. +..++.++|||||||++|||++|+.||.....
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 157 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred ECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 99999999999999886543221 122346899999999875 34578999999999999999999999975432
Q ss_pred CCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
... +.. .... ......++ ...+..+.+|+.+||+.||++||++.|+++++
T Consensus 235 ~~~--~~~-----~~~~-~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 235 MRA--LFK-----IPRN-PPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hHH--Hhh-----cccc-CCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 110 000 0000 00001111 11235688999999999999999999999865
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=330.94 Aligned_cols=265 Identities=19% Similarity=0.237 Sum_probs=196.2
Q ss_pred CCCeeeec--CCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 133 PESLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 133 ~~~~lg~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++++||+| +|++||++.... +|+.||||++..... .....+.+|+.+++.++||||++++++|..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEeecc---------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 45789999 789999998876 678999999976532 22345778999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..++||||+++|+|.+++..+ ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++++||+.+.
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999999999999998654 345899999999999999999999988 9999999999999999999999998754
Q ss_pred CCCCCCcc-e----eeeeccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 288 DGPEGDKT-H----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 288 ~~~~~~~~-~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
........ . ......++..|+|||++.+ ..|+.++|||||||++|||++|+.||........ .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCc
Confidence 43211110 0 0112356788999999875 4689999999999999999999999975322110 000000000
Q ss_pred c---c------------------cccccc--c-------cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 361 G---E------------------RRRFYR--L-------IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 361 ~---~------------------~~~~~~--~-------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. + ...+.. . ........+....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 0 000000 0 00000001122334678899999999999999999999975
Q ss_pred h
Q 011412 411 L 411 (486)
Q Consensus 411 L 411 (486)
.
T Consensus 308 p 308 (327)
T cd08227 308 S 308 (327)
T ss_pred h
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=321.03 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=205.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.|+..+.||.|+||.||+|.+.. ++..||||.+..... .....+.+|+.+++.+.|+||+++++++.++.
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT 75 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 57778899999999999998865 567899999875432 23456889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred EEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence 99999999999999998854 36888999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
...... ......++..|+|||++.+..++.++|||||||++|||++|..||....+......+
T Consensus 151 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--------------- 213 (277)
T cd06640 151 LTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI--------------- 213 (277)
T ss_pred ccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh---------------
Confidence 543221 123356889999999998889999999999999999999999999754332111000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.......+....+..+.+|+.+||+.+|++||++.+++.+-.
T Consensus 214 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 214 --PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred --hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 000112233345678899999999999999999999988643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=321.21 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=205.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++++.||.|+||.||+|+.+.... ..+...|++|.+...... ....+.+|+++|++++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEE----EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCc----CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 578899999999999999999865322 234568999998754433 345789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRS--------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence 99999999999999999986443 15899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~ 358 (486)
|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... +.....
T Consensus 158 l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~- 232 (275)
T cd05046 158 VSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQ- 232 (275)
T ss_pred EcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHH-
Confidence 9999998754322211 1223456788999999988889999999999999999999 788886432211 111100
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.. .. .. ......+..+.+++.+||+.+|.+||++.+++..|.
T Consensus 233 ---~~-~~-~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 ---AG-KL-EL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---cC-Cc-CC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 00 00 011123457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=319.17 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=197.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
.+|...+.||+|+||.||+|.+.. +|..||+|++..... .....+.+|+.+++.++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 368899999999999999998765 677999999864322 122457889999999999999999998
Q ss_pred EEe--CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 204 CIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 204 ~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
+.. ....+++|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEc
Confidence 875 35778999999999999998654 35889999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 282 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 282 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
|||+++........ .......++..|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~~~~--- 220 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----AIFK--- 220 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----HHHH---
Confidence 99998764321111 11123568999999999998899999999999999999999999997532211 0000
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.........++......+.+++ +||..+|++||++.||+++
T Consensus 221 --------~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 221 --------IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --------HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0000001122233345677888 6888999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=307.47 Aligned_cols=255 Identities=29% Similarity=0.422 Sum_probs=203.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
.++.+.+..||.|+.|+|++++++. +|...|||.+..... ...++++..+.++..- +.|+||+.+|||.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs---------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRS---------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcc---------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 3455667789999999999999986 678999999987643 3345677777776555 4899999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.+...+|.||.| ..-++.+|.+-..++++..+-++...++.||.||..++ +|||||+||+|||||+.|.+||||||+
T Consensus 162 ~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 162 TNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred eCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccc
Confidence 999999999999 55677778777788999999999999999999998754 499999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
+-.+.+.. ..++-.|-+.|||||-+. ...|+.++||||||++|+||.||+.||......- .+.....
T Consensus 239 sGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~ltkvl----- 308 (391)
T KOG0983|consen 239 SGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLTKVL----- 308 (391)
T ss_pred cceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHHHHH-----
Confidence 98765432 345567999999999886 4578999999999999999999999998754321 1111111
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
....|.+.++.. ++..+++|+..||.+|+.+||.+.+++++-
T Consensus 309 -----n~ePP~L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 309 -----NEEPPLLPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred -----hcCCCCCCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 111233333221 457789999999999999999999999753
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=316.68 Aligned_cols=248 Identities=26% Similarity=0.459 Sum_probs=194.1
Q ss_pred CeeeecCCeEEEEEEEccCCCcc-ccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAP-VKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~-~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
+.||+|+||.||+|.+...+... ........|++|.+...... ...+.+|+.+|+.++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999987643110 00112246888887655433 5678899999999999999999999888 778999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-------cEEEeecCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-------NAKLSDFGLA 286 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-------~vkl~DFGla 286 (486)
|||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999766657899999999999999999999988 99999999999999887 7999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
+.... .....++..|+|||++... .++.++|||||||++|||++ |..||........ ..+.. ..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~~~----~~ 222 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERFYQ----DQ 222 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHHHh----cC
Confidence 87543 1123567889999998876 78999999999999999999 5777765432111 11100 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
. ....+ ....+.+|+.+||..+|.+||++.++++.|+
T Consensus 223 ~---~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H---RLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C---CCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00000 0156889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=317.21 Aligned_cols=254 Identities=29% Similarity=0.399 Sum_probs=190.2
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEE
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 214 (486)
.||+|+||.||+|..... .....+|+|.+...... ....+.+|+.+++.++|+||+++++++......++||
T Consensus 2 ~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence 589999999999975431 13457899987654322 2346789999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 215 EFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 215 E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
||+++|+|.+++.... ...++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccc
Confidence 9999999999996543 23467788899999999999999988 9999999999999999999999999987643
Q ss_pred CCCcceeeeeccccccccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
............++..|+|||++.. ..++.++|||||||++|||++ |..||....... .... ....
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~---~~~~ 225 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQ---VVRE 225 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHH---Hhhc
Confidence 3222111223346778999998743 356889999999999999999 778886543211 1100 0000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
. ......+.+. ...+..+.+++..|| .||++||++.+|++.|.
T Consensus 226 ~--~~~~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 226 Q--DIKLPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred c--CccCCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0 0011122222 223456778999998 59999999999999773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=322.84 Aligned_cols=267 Identities=28% Similarity=0.342 Sum_probs=202.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++.+.||+|+||.||+|.+.. +|+.||+|++..... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 368889999999999999998865 567899999864422 223557899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
....++||||++++.|..++. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred CCEEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccc
Confidence 999999999999988877664 4446899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh-hhhhcc---
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-ARPHLG--- 361 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~-~~~~~~--- 361 (486)
........ ......++..|+|||++.+ ..++.++|||||||++|||++|..||...........+.. ......
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225 (286)
T ss_pred eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 87644321 1223467889999998875 5688999999999999999999999976543221111110 000000
Q ss_pred ---cccccc-cccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 ---ERRRFY-RLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ---~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
....+. ....+....... ...+..+.+|+.+||+.+|++||++.|++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000 000010000000 1124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=323.33 Aligned_cols=267 Identities=24% Similarity=0.353 Sum_probs=199.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++.+.||+|+||.||+|.... ++..||||.+...... ....+.+|+.+++.++|+||+++++++.++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC---------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 578899999999999999998765 5678999998754322 224567899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||+.+ +|.+++.+....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 76 KTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred CeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccc
Confidence 999999999974 999998776667899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhh--------h
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA--------R 357 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~-~~~~~~--------~ 357 (486)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ..+... .
T Consensus 152 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07844 152 AKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229 (291)
T ss_pred ccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhh
Confidence 6432211 1122357889999998865 56899999999999999999999999654311100 000000 0
Q ss_pred hhcccccccc----cccC-CccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PHLGERRRFY----RLID-PRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~~~~~~~~~----~~~~-~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+......... .... ..+...+ .......+.+++.+||+.+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 0000 0000000 00012567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=320.26 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc----------cHHHHHHHHHHHhcCCCCCceE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------GHKEWLAEVNFLGDLVHLNLVK 199 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv~ 199 (486)
+|.+.+.||.|+||.||+|.... +|..||||.++..... ..+.+.+|+.+++.++|+||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEeecC---------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 47788999999999999998765 5778999988632110 1235778999999999999999
Q ss_pred EEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
+++++...+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICK 148 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEE
Confidence 999999999999999999999999998655 57899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
|+|||+++...............|+..|+|||++.... ++.++||||||+++|+|++|..||...... .....
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~ 223 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFK 223 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHH
Confidence 99999998654322221223356899999999987654 889999999999999999999999643211 00000
Q ss_pred hhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.... ...+.+........+..+.+++.+||..+|.+||++.+++++
T Consensus 224 --~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 224 --LGNK-----RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --hhcc-----ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000 000111111222235678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=324.81 Aligned_cols=197 Identities=24% Similarity=0.386 Sum_probs=161.2
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe--CCeeEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLL 212 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~l 212 (486)
..||+|+||.||+|..... .++..||+|.+..... ...+.+|+.+|+.++||||+++++++.. +...++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~-------~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDG-------KDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eEeccCCCeeEEEEEecCC-------CccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 5799999999999987542 2457899999875432 2457899999999999999999998854 567899
Q ss_pred EEeecCCCChhHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCcEEE
Q 011412 213 VYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKL 280 (486)
Q Consensus 213 v~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll----~~~~~vkl 280 (486)
||||+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEE
Confidence 999995 4787776421 235888999999999999999999988 9999999999999 56678999
Q ss_pred eecCCCCCCCCCCcc-eeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 011412 281 SDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344 (486)
Q Consensus 281 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~ 344 (486)
+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||.+||...
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 999999875433221 11234578999999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=316.00 Aligned_cols=255 Identities=33% Similarity=0.507 Sum_probs=203.7
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCe
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 209 (486)
|++.+.||.|+||.||+|.+...+. .++..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 4567899999999999999876321 13478999999765443 45678899999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 210 RLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
.++||||+++++|.+++...... +++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCcee
Confidence 99999999999999999765434 899999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
......... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .+..... ...
T Consensus 153 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~----~~~--- 221 (258)
T smart00219 153 LYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLK----KGY--- 221 (258)
T ss_pred ccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cCC---
Confidence 654422211 12337789999999988889999999999999999998 78888653211 1111110 000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. .. .....+..+.+++.+||..||++||++.++++.|
T Consensus 222 ~---~~----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 R---LP----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C---CC----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 00 1111346788999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=317.61 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=198.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
.+|++.+.||+|+||.||+|.+.. +|..||||.+..... .....+.+|+.+++.++|+||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 478889999999999999998765 677999999864321 123467889999999999999999999
Q ss_pred EEeC--CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 204 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 204 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
+.+. ..+++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEEC
Confidence 8763 4678999999999999998654 45788899999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 282 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 282 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
|||+++........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .... ..
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~-~~ 222 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AIFK-IA 222 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HHHH-Hh
Confidence 99999864321111 11223568999999999988889999999999999999999999996432110 0000 00
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
........+......+.+++.+|| .+|.+||++.+|+++
T Consensus 223 ----------~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 ----------TQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred ----------cCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 000111223344567889999999 499999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=324.12 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=201.5
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.|+..+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++|+||+++++++..++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 35556789999999999998765 567899999875432 22356889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccc
Confidence 99999999999999998853 46889999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
...... ......|+..|+|||++.+..++.++|||||||++|||++|..||....+.... .. .. .
T Consensus 151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~----~~------~ 215 (277)
T cd06642 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FL----IP------K 215 (277)
T ss_pred ccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hh----hh------c
Confidence 543221 122356889999999999889999999999999999999999998654321110 00 00 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
...+ .+....+..+.+|+.+||+.+|.+||++.+++++-
T Consensus 216 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 216 NSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 0111 11223346788999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=322.89 Aligned_cols=257 Identities=28% Similarity=0.390 Sum_probs=201.5
Q ss_pred HHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEE
Q 011412 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLI 201 (486)
Q Consensus 123 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~ 201 (486)
++......|++.+.||.|+||.||+|.+.. ++..||+|++.... ....++..|+.++.++ +|+||++++
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~ 79 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYY 79 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEe
Confidence 333455789999999999999999999865 56789999986543 2235678899999998 699999999
Q ss_pred EEEEe------CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011412 202 GYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (486)
Q Consensus 202 ~~~~~------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 274 (486)
+++.. .+..|+||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.
T Consensus 80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~ 156 (282)
T cd06636 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTE 156 (282)
T ss_pred eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 99853 46789999999999999988653 346888889999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 011412 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 349 (486)
Q Consensus 275 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~ 349 (486)
++.++|+|||++........ ......|+..|+|||++. ...++.++|||||||++|||++|..||....+...
T Consensus 157 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 157 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred CCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 99999999999876432211 123356899999999875 35688899999999999999999999965432211
Q ss_pred chhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 350 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..... ....+. ......+..+.+||.+||+.||.+||++.||+++
T Consensus 235 ~~~~~-------------~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 235 LFLIP-------------RNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhhHh-------------hCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 10000 000000 0111234678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=341.54 Aligned_cols=252 Identities=28% Similarity=0.425 Sum_probs=208.1
Q ss_pred CCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCee
Q 011412 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 132 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
.+.++||+|.||+|++|.|..... +-..||||+++.+... ...+|++|+.+|.+|+|+|+++|||+..+ ...
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psg------k~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSG------KHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCC------cEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 344689999999999999976322 3447999999987665 55789999999999999999999999887 678
Q ss_pred EEEEeecCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
.||||+++.|+|.+.|.+ ....|.......++.||+.||.||..++ +|||||...||||-....||||||||++.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence 899999999999999986 4567888899999999999999999988 999999999999998889999999999988
Q ss_pred CCCCcceeee-eccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 290 PEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 290 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
...+...... ...-.+.|+|||.+....++.++|||+|||+||||+| |..||-+...... .
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI-----------------L 325 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI-----------------L 325 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH-----------------H
Confidence 7655443322 2345678999999999999999999999999999999 7789876543221 1
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.+|..-.-.-+..++++++++++.||..+|.+||++..|.+.
T Consensus 326 ~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 326 KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1222111222234578899999999999999999999999743
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=323.62 Aligned_cols=268 Identities=27% Similarity=0.362 Sum_probs=203.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++.+.||+|+||.||+|.+.. +++.||||.++.... .....+.+|+++++.++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 368889999999999999998865 567999999875322 234578899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..++||||++++.|..++ .....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecc
Confidence 99999999999886666544 44456899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc-----
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL----- 360 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~----- 360 (486)
......... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||..................+
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 876543321 22345788999999999887 88999999999999999999999997543211110000000000
Q ss_pred ---ccccccc--cccCCc----cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 361 ---GERRRFY--RLIDPR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 361 ---~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.....+. +..+.. +...++...+..+.+||++||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000 000000 0001112235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=317.62 Aligned_cols=255 Identities=22% Similarity=0.376 Sum_probs=203.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
+|+..+.||+|+||.||+|.... ++..||+|.+..... ...+.+.+|+++|+.++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 47888999999999999998755 677999999875431 123568899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEee
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSD 282 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~vkl~D 282 (486)
+.+.+..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcc
Confidence 99999999999999999999998654 47889999999999999999999988 99999999999998776 599999
Q ss_pred cCCCCCCCCCCcc--eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 283 FGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 283 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
||++......... .......|+..|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------ 221 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF------ 221 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH------
Confidence 9998765432111 11223568999999999988899999999999999999999999996443211111110
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.........++...+..+.+++.+||..+|.+||++.+++++
T Consensus 222 -------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 222 -------KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -------HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0000001122333445778999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=317.64 Aligned_cols=252 Identities=29% Similarity=0.486 Sum_probs=200.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
+|.+.+.||.|+||.||+|... +|..+|||.+..... .....+.+|+.+|+.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 4788899999999999999753 467899999874321 112457889999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+.+.+..++||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+||
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccc
Confidence 99999999999999999999999654 46889999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCC----cceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 284 GLAKDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 284 Gla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
|++....... .........|+..|+|||++.+..++.++|||||||++|+|++|..||........ ...
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~----- 219 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFY----- 219 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHH-----
Confidence 9987642211 11112235689999999999988999999999999999999999999965422110 000
Q ss_pred cccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.... ....+.+.. ..+..+.+++.+||+.+|.+||++.+++++
T Consensus 220 ~~~~----~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 220 IGAH----RGLMPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred hhhc----cCCCCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 000111122 234678999999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=321.96 Aligned_cols=264 Identities=26% Similarity=0.341 Sum_probs=203.5
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++.+.||.|+||.||+|.+.. +|..||||++..... .....+.+|+.++++++|+||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 57888999999999999998865 567899999976542 2235688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
...++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 9999999999 99999999766677999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc-----
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----- 361 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~----- 361 (486)
....... .......|+..|+|||++.+. .++.++|||||||++|||++|.++|....... ........+.
T Consensus 148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~ 223 (286)
T cd07832 148 LFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEE 223 (286)
T ss_pred cccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChH
Confidence 7644322 112235689999999988654 56899999999999999999988886543211 1111100000
Q ss_pred ------cccccccccCCcc----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 ------ERRRFYRLIDPRL----EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ------~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.........+.. ........+..+.+|+.+||..||.+||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 000001224678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=316.64 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=202.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEe-
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 206 (486)
+|++.+.||.|+||.||+|.+.. +|..||+|++...... ..+.+..|+.+++.++|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 57888999999999999998865 5678999998754332 23468889999999999999999998764
Q ss_pred -CCeeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCcEEEcCCCc
Q 011412 207 -DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLH-----EEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 207 -~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH-----~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
....+++|||+++++|.+++... ...+++..++.++.||+.||.||| +.+ ++|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNN 148 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCC
Confidence 45679999999999999998653 457899999999999999999999 656 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
+||+|||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...... .+.....
T Consensus 149 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~ 223 (265)
T cd08217 149 VKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIK 223 (265)
T ss_pred EEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHh
Confidence 99999999987654332 123356899999999999888999999999999999999999999754311 1111110
Q ss_pred hhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. .....++...+..+.+|+.+||+.+|.+||++.+|+++
T Consensus 224 ----~----------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 ----E----------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----c----------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00111222345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.50 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=190.6
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEE
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 214 (486)
.||+|+||.||+|...... ....+++|.+..... ...+.+.+|+.+++.++||||+++++++......|+||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCC-------CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 5999999999999764422 233577887765432 33467899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011412 215 EFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (486)
Q Consensus 215 E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~ 291 (486)
||+++|+|.+++.+.. ..++...++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCc
Confidence 9999999999997532 34667778899999999999999988 99999999999999999999999999865322
Q ss_pred CCcceeeeeccccccccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 292 GDKTHVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
...........|+..|+|||++.. ..++.++|||||||++|||++ |..||...... ..... .+.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~---~~~-- 223 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNH---VIK-- 223 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HHh--
Confidence 221112234568899999998743 245789999999999999997 56677543221 11111 011
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.......++.+... ....+.+|+..|| .+|++||++.+|++.|.
T Consensus 224 ~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 224 DQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred hcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11112223333222 2356788999999 68999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=326.63 Aligned_cols=253 Identities=28% Similarity=0.371 Sum_probs=202.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++.+.||+|+||.||+|.... +++.||||.+...... ..+.+..|+++|..++|+||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 368889999999999999998865 5779999999865433 3356889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.....|+||||+.+++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||||+.++.++|+|||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecc
Confidence 999999999999999999998653 356899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcc---------------------------eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhC
Q 011412 285 LAKDGPEGDKT---------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337 (486)
Q Consensus 285 la~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG 337 (486)
++......... .......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98754322110 011134689999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 011412 338 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL----MSEVVE 409 (486)
Q Consensus 338 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs----~~eil~ 409 (486)
..||....... .+.. ...... .... ....+..+.+|+.+||..||++||+ +.+++.
T Consensus 229 ~~pf~~~~~~~--~~~~----~~~~~~--------~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 229 TTPFKGSNRDE--TFSN----ILKKEV--------TFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCCchHH--HHHH----HhcCCc--------cCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 99997543211 0100 000000 0000 1113567999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=317.59 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=202.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
...+|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 45689999999999999999997643 3469999887543 234568899999999999999999999887
Q ss_pred CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcc
Confidence 7789999999999999999653 456788999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+......... ......++..|+|||++....++.++|||||||++|+|++ |..||...... .+..... ..
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----~~- 219 (260)
T cd05073 149 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE----RG- 219 (260)
T ss_pred eeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh----CC-
Confidence 9765432221 1222346678999999988889999999999999999999 99999654321 1111110 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
...... ...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 -----~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 -----YRMPRP----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----CCCCCc----ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000011 1224578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=322.84 Aligned_cols=266 Identities=25% Similarity=0.339 Sum_probs=200.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
+|.+.+.||+|+||.||+|.+.. +|..||||.+...... ....+..|+.+++.++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 47788899999999999998865 5679999999765432 234567899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+.+..++||||+ +++|.+++......+++..++.++.||++||.|||+++ |+|+||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccce
Confidence 9999999999999 89999999665547999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhh-----
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR----- 357 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~-~~~~----- 357 (486)
+++....... ......++..|+|||++.+ ..++.++|||||||++|||++|.++|............ ....
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (298)
T cd07841 148 LARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225 (298)
T ss_pred eeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchh
Confidence 9987644321 1223457889999998864 46789999999999999999998888654321110000 0000
Q ss_pred --hhccccccccc--ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 --PHLGERRRFYR--LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 --~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.......... ...+.-........+..+.+|+.+||+.||++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 000000000111234678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=318.58 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=200.4
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
|.+.+.||+|+||.||+|.+..+. +++..||||++..... ...+++.+|+++|+.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC------CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 567789999999999999876532 3678999999875432 23456889999999999999999999886532
Q ss_pred ------eeEEEEeecCCCChhHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 209 ------QRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 209 ------~~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
..++++||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~ 151 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMT 151 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCC
Confidence 247899999999999887432 224788999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+++...............++..|++||.+....++.++|||||||++|||++ |.+||...... .+..+.
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~ 228 (273)
T cd05074 152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL 228 (273)
T ss_pred EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH
Confidence 99999999987644332222223446678999999998899999999999999999999 88888654321 111111
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
. ..... . .....+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 229 ~----~~~~~------~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 I----KGNRL------K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred H----cCCcC------C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 00000 0 0112345789999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=315.86 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=205.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++.+.||.|+||+||+|.+.. ++..+|+|++..... .....+.+|+.+|+.++|+||+++++.+..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 478899999999999999998765 566899999875432 2346788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccch
Confidence 9999999999999999998654 246899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcce--eeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 286 AKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 286 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
+.......... ......|+..|+|||++... .++.++|||||||++|+|++|+.||........ +..... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~----~ 222 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQ----N 222 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhc----C
Confidence 87654432221 22335689999999998776 789999999999999999999999975433211 111110 0
Q ss_pred ccccccccCCccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 363 RRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+.+.... ....+..+.+|+.+||..||++||++.+|+++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 -------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000011100 11334678899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=315.16 Aligned_cols=249 Identities=29% Similarity=0.427 Sum_probs=201.5
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
+|+..+.||+|+||.||+|.... ++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 47778899999999999998865 466899999865431 2345688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
..+..+++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999999998654 46889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
++....... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||....... ..... .....
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~--~~~~~- 219 (258)
T cd06632 148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKI--GRSKE- 219 (258)
T ss_pred cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHH--Hhccc-
Confidence 988754332 123456899999999987766 8999999999999999999999996543111 00000 00000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...++...+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 220 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 -----------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -----------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 011112234678899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=321.46 Aligned_cols=268 Identities=23% Similarity=0.318 Sum_probs=199.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
+.+|.+.+.||+|+||.||+|.... +|..||+|++....... ...+.+|+.+|+.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 4689999999999999999998865 56789999987543222 2457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..++||||+. ++|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 150 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLA 150 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccc
Confidence 999999999995 6888777665566888889999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh-------
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP------- 358 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~------- 358 (486)
+........ .....++..|+|||++.+ ..++.++|||||||++|||++|..||.............+...
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 151 RAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred cccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 764332211 223457899999998875 4588999999999999999999999975443211100000000
Q ss_pred --hcccccccc-cccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 359 --HLGERRRFY-RLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 359 --~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+....... ..........+. ...+..+.+|+.+||..||.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000 000000000000 0113568899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=320.42 Aligned_cols=246 Identities=28% Similarity=0.401 Sum_probs=201.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++.+.||+|+||.||++.+.. +++.||+|.+..... .....+.+|+++|++++||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 368889999999999999999875 567899999875422 22356889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
..+.+++||||+++++|.+++... ..++...+..++.|++.||.|||+.+ |+|+||+|+||||+.++.+||+|||+
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999999999998655 57899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ..... .....
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~---~~~~~-- 214 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEK---ILEGK-- 214 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HhcCC--
Confidence 9876443 22356899999999998888999999999999999999999999654311 11100 00000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~ 410 (486)
.. ++...+..+.+++.+||..||.+|+ ++.+++++
T Consensus 215 ------~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 ------VR----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ------cc----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 01 1112246788999999999999999 66666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=317.15 Aligned_cols=254 Identities=30% Similarity=0.403 Sum_probs=204.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
+|++.+.||.|+||.||+|.+.. +++.||+|.+..... ....++.+|+++++++.||||+++++++....
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRP---------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcC---------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC
Confidence 67788899999999999998865 567899999876532 33456889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..++||||+++++|.+++......+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccch
Confidence 9999999999999999997665688999999999999999999999 77 9999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... ....|+..|+|||++.+..++.++|||||||++|+|++|..||......... ..........
T Consensus 150 ~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~------ 218 (265)
T cd06605 150 QLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIVN------ 218 (265)
T ss_pred hhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHhc------
Confidence 6532211 1267899999999999899999999999999999999999999654321111 1111111110
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...+.+.. ...+..+.+||.+||..||.+||++.+++.+
T Consensus 219 -~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 219 -EPPPRLPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -CCCCCCCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00011111 1145678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=316.11 Aligned_cols=246 Identities=31% Similarity=0.481 Sum_probs=197.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|.+.+.||+|+||.||++.. ++..||+|.+.... ....+.+|+.++..++||||+++++++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 5688999999999999999864 45689999987543 235688999999999999999999998754
Q ss_pred eeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccce
Confidence 5799999999999999997543 45889999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
...... .....+..|+|||++.+..++.++|||||||++|||++ |+.||........ ... .....
T Consensus 149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~~-- 214 (254)
T cd05083 149 VGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KEC----VEKGY-- 214 (254)
T ss_pred eccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HHH----HhCCC--
Confidence 643321 12234678999999988899999999999999999998 9999975432211 111 00000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
. + ......+..+.+|+.+||+.+|.+||++.++++.|+.
T Consensus 215 -~---~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -R---M----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -C---C----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 0 0111234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=315.83 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=203.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++.+.||+|+||.||++.... +|+.||+|.+..... ....++.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 57888999999999999998865 567899999875432 2335788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccce
Confidence 9999999999999999988654 346889999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ........
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~---- 216 (256)
T cd08218 149 RVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKIIRG---- 216 (256)
T ss_pred eecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHhcC----
Confidence 86543221 1223468899999999988899999999999999999999999996432111 11100100
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. .+ ..+...+..+.++|.+||+.+|.+||++.+|+++
T Consensus 217 --~-~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 217 --S-YP----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --C-CC----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 00 1112234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=313.85 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=201.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++.+.||+|+||.||+|.... ++..||||.+..... .....+.+|+.+|+.++|+||+++++.+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 47888999999999999998865 567899999875432 2345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEEeecCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGL 285 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~vkl~DFGl 285 (486)
+..++||||+++++|.+++... ...+++..++.++.|++.+|.|||+++ |+|+||||+||+++.+ +.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 9999999999999999999764 345899999999999999999999988 9999999999999755 4589999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+........ .....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ..... ... .
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~---~~~--~ 217 (256)
T cd08220 149 SKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKI---MSG--T 217 (256)
T ss_pred ceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHH---Hhc--C
Confidence 987644322 223568999999999988889999999999999999999999996543211 11110 000 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. .+....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 218 -----~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 -----FA----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----CC----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 0111234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=323.67 Aligned_cols=256 Identities=23% Similarity=0.317 Sum_probs=201.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++.+.||+|+||.||++.+.. +++.||+|.+..... .....+.+|+++++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 368889999999999999998865 577899999875532 22346778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCC
Confidence 999999999999999999999654 46899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCc-------------ceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011412 286 AKDGPEGDK-------------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352 (486)
Q Consensus 286 a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~ 352 (486)
++....... ........|+..|+|||++....++.++|||||||++|||++|..||.+..... +
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~ 224 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L 224 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 874211100 001112467889999999988899999999999999999999999997543211 1
Q ss_pred HHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.. ..... ....+.... ..+..+.+|+.+||+.||++||++.++++.|+
T Consensus 225 ~~---~~~~~-----~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 225 FG---QVISD-----DIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HH---HHHhc-----ccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11 00000 000111111 23456899999999999999999766666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=312.59 Aligned_cols=253 Identities=27% Similarity=0.390 Sum_probs=208.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++.+.||.|+||.||+|.+.. ++..||||++..... .....+.+|+.++..++|+||+++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 368889999999999999998875 577999999876644 3346789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
..+++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999999999999655 578999999999999999999999 88 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||................
T Consensus 148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------- 216 (264)
T cd06623 148 KVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--------- 216 (264)
T ss_pred eecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---------
Confidence 876443221 123568899999999998899999999999999999999999997654311111111111
Q ss_pred ccccCCccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 367 YRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
....+. .+.. .+..+.+++.+||..+|++||++.+++++
T Consensus 217 -~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 -DGPPPS----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -cCCCCC----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000111 1112 34678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=333.84 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=210.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
...|.+++.||+|.|+.|.+|++.. ||..||||.+.+..... ...+.+|+++|..|+|||||+++.+..
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~---------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHIL---------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecC---------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence 4578999999999999999999977 78899999998765543 345889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
....+|+||||+.+|.|+++|.+++. +.+..+..++.|+..+++|||+++ |||||||++||||+.+.++||+|||+
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgf 201 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGF 201 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccc
Confidence 99999999999999999999977764 445888999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+..+..+. ...++||++.|.|||++.+..| ++++|+||+|++||-|+.|..||++..-..-.. ..+..+.
T Consensus 202 S~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------rvl~gk~ 272 (596)
T KOG0586|consen 202 STFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------RVLRGKY 272 (596)
T ss_pred ceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------hheeeee
Confidence 99876433 4566899999999999998877 578999999999999999999998654322110 1111111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
++ +.-...++.+||+++|..+|.+|++++++.+.-+
T Consensus 273 rI------------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 273 RI------------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred cc------------cceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 11 1112356889999999999999999999987644
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=323.21 Aligned_cols=267 Identities=28% Similarity=0.352 Sum_probs=200.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++.+.||+|+||.||+|.+.. +++.||+|++...... ..+.+.+|+++++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 368889999999999999998865 5678999998654322 23567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..++||||++++.|..+... ...+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeee
Confidence 9999999999999888876643 345899999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc--
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-- 363 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-- 363 (486)
........ ......++..|+|||++.+ ..++.++|||||||++|||++|.+||..........-+......+...
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 148 RTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred eeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence 86543221 2233568899999998875 457889999999999999999999996543211000000000000000
Q ss_pred -----cc-cccccCCccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 -----RR-FYRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 -----~~-~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. +.....+.... ......+..+.+|+.+||+.+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 00000000000 0011234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.64 Aligned_cols=259 Identities=29% Similarity=0.366 Sum_probs=202.2
Q ss_pred hHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEE
Q 011412 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKL 200 (486)
Q Consensus 122 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~ 200 (486)
.++....++|.+.+.||+|+||.||+|.... +++.||+|++.... .....+.+|+.++.++ +||||+++
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~ 84 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKF 84 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 3444457889999999999999999998865 57799999986542 2235677899999999 79999999
Q ss_pred EEEEEeC-----CeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 201 IGYCIED-----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 201 ~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
++++... +..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili 161 (291)
T cd06639 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILL 161 (291)
T ss_pred EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEE
Confidence 9998754 358999999999999998853 3457899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 347 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltG~~pf~~~~~~ 347 (486)
+.++.+||+|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||......
T Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 162 TTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred cCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 99999999999998865432211 2234689999999987643 3688999999999999999999999754321
Q ss_pred CcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 348 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. .+..+... ......+ .......+.+||.+||+.+|++||++.+++++
T Consensus 240 ~--~~~~~~~~------~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 K--TLFKIPRN------PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H--HHHHHhcC------CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 11111000 0000111 11223568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=324.41 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=200.0
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCee
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
|.....||+|+||.||++.+.. ++..||||.+........+.+.+|+.+++.++|+||+++++++...+..
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKH---------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL 94 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECC---------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence 3334579999999999998765 5679999998765544456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred EEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 999999999999998743 35889999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..... ..+
T Consensus 170 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~----------~~~ 234 (292)
T cd06658 170 KEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRRIR----------DNL 234 (292)
T ss_pred cccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----------hcC
Confidence 2221 12335689999999999888999999999999999999999999975432111 00000 011
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+.+.. ....+..+.+++.+||..||.+||++.+++++
T Consensus 235 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 235 PPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111 11224568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.24 Aligned_cols=254 Identities=30% Similarity=0.405 Sum_probs=201.1
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
.+++|++.+.||.|+||.||+|.+.. ++..|++|++..... ....+.+|+.+++++ .|+||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 35789999999999999999998865 566899999876543 345688999999999 7999999999997
Q ss_pred eCC------eeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011412 206 EDD------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (486)
Q Consensus 206 ~~~------~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 276 (486)
... .+++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNA 150 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCC
Confidence 644 489999999999999988643 367899999999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~ 351 (486)
.+||+|||++........ ......|+..|+|||++.. ..++.++|||||||+||+|++|..||....... .
T Consensus 151 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~ 226 (275)
T cd06608 151 EVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--A 226 (275)
T ss_pred eEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--H
Confidence 999999999876533221 1233568999999998753 357789999999999999999999996432211 1
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.... ....+.+ ......+..+.+|+.+||..||.+||++.+++++
T Consensus 227 ~~~~~-----------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 227 LFKIP-----------RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HHHhh-----------ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11100 0000101 1112245678999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.28 Aligned_cols=267 Identities=25% Similarity=0.348 Sum_probs=201.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++.+.||.|+||.||+|.+.. ++..||+|.++..... ....+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 478888999999999999998865 5678999999754322 12346789999999999999999999988
Q ss_pred C--CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 207 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 207 ~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
. ...||||||+. ++|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecC
Confidence 7 89999999996 5999988766667999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhh-----
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR----- 357 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~-~~~~----- 357 (486)
++........ ......++..|+|||++.+. .++.++|||||||++|||++|..||...........+ ....
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 152 LAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred ceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 9987654321 12234578899999988754 4689999999999999999999999754321111000 0000
Q ss_pred --hh---cc--cccccccccCCccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 --PH---LG--ERRRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 --~~---~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+. +. ............+...++.. .+..+.+||.+||+.||++||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 00 00000000000111112211 35678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=347.87 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=218.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
....+.++||.|-||.|++|+++..++ ....||||.++..... ...+|+.|+.||.+++||||++|.|+....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgk------re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGK------REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hheEEEEEEecccccceecccccCCCC------cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 345677899999999999999998765 3458999999976543 346799999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
....||.|||++|+|+.+|..+.+.|...++.-+++.|+.||+||-+++ +|||||...||||+.+..+|++||||+|
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEecccccee
Confidence 9999999999999999999988888999999999999999999999999 9999999999999999999999999999
Q ss_pred CCCCCCcceeeeecc--ccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 288 DGPEGDKTHVSTRVM--GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
...++... ..+..- -..+|.|||.+...+++.++|||||||+|||.++ |..||.+....+..+-+ .+..
T Consensus 780 vledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-------e~gy 851 (996)
T KOG0196|consen 780 VLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-------EQGY 851 (996)
T ss_pred ecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-------Hhcc
Confidence 87554422 222222 2579999999999999999999999999999777 99998765432221111 1111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
+ -.-+.+++..+.+|+..||++|..+||.+.+|+.+|.++..
T Consensus 852 ---R-------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 852 ---R-------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ---C-------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1 11234678899999999999999999999999999987643
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.45 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=194.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHH-HhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNF-LGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~ 206 (486)
++|++.+.||+|+||.||+|.+.. +|..||||+++.... .....+..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 368889999999999999998865 677999999976432 223456666665 566789999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 207 DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
++..++||||++ |+|.+++.. ....+++..++.++.||+.||.|||++ + ++||||||+|||++.++.+||+|
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~d 147 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCD 147 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEee
Confidence 999999999996 688887753 335689999999999999999999986 6 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
||+++...... ..+...|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ..+...
T Consensus 148 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~--- 220 (283)
T cd06617 148 FGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQV--- 220 (283)
T ss_pred ccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHH---
Confidence 99998653321 1233568899999998864 457889999999999999999999996422110 000000
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. ...+.+. ....+..+.+|+.+||..+|.+||++.+++++
T Consensus 221 -~~-------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 221 -VE-------EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -Hh-------cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0001110 11234678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=315.89 Aligned_cols=259 Identities=28% Similarity=0.362 Sum_probs=203.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC-
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~- 207 (486)
+|+..+.||.|+||.||+|.+.. ++..||+|.+..... .....+.+|+++++.++||||++++++|...
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 67888999999999999999865 567899999875432 2345688999999999999999999998653
Q ss_pred -CeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 208 -DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 208 -~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+.+++||||+++++|.+++.. ....++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeec
Confidence 468999999999999988653 3456889999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--CcchhHHhhhhhcc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN--GEHNLVEWARPHLG 361 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~--~~~~~~~~~~~~~~ 361 (486)
|++....... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .......+....
T Consensus 150 g~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 223 (287)
T cd06621 150 GVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-- 223 (287)
T ss_pred cccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC--
Confidence 9987653322 12346788999999999999999999999999999999999999765321 111222221110
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
... .+..... .....+..+.+|+.+||..+|.+||++.|++++-.
T Consensus 224 ~~~----~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 224 PNP----ELKDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred Cch----hhccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 000 0000000 00123567899999999999999999999998554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=338.44 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=195.6
Q ss_pred CCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC----cccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 133 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
...+||+|+|-+||+|.+.. +|..||--.++... ......|..|+.+|+.|+|+|||++|.+|.+..
T Consensus 44 ~~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred hhhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 34689999999999999866 67778765544222 223467899999999999999999999999876
Q ss_pred e--eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEEeecCC
Q 011412 209 Q--RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGL 285 (486)
Q Consensus 209 ~--~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~vkl~DFGl 285 (486)
. ..+|+|++..|+|..|+.+.+ .+....+..|++||++||.|||++. .+|||||||.+||||+.+ |.|||+|+||
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhH
Confidence 6 678999999999999996654 6888999999999999999999987 789999999999999764 8999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
|+...... .....|||.|||||+.. ..|+..+||||||++|+||+|+..||..... ..+........
T Consensus 193 Atl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~SG--- 259 (632)
T KOG0584|consen 193 ATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVTSG--- 259 (632)
T ss_pred HHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHHcC---
Confidence 99864432 23478999999999765 8999999999999999999999999964321 11111111111
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+ .+..|......++++||.+||.. ..+||++.|+|+.
T Consensus 260 ----i---KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 260 ----I---KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----C---CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 0 11112222245789999999999 9999999999963
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=317.13 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=204.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
+|++.+.||.|+||.||+|.+.. ++..||+|.+..... ...+.+.+|++++++++||||+++++++.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 47888999999999999998865 577999999975432 234678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..++||||+.+++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccc
Confidence 99999999999999999998655 57899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
........ .....|+..|+|||++.+..++.++||||||+++|+|++|..||..........+... ...
T Consensus 148 ~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~---- 216 (258)
T cd05578 148 TKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK----QET---- 216 (258)
T ss_pred cccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH----hcc----
Confidence 87644321 2335688999999999888899999999999999999999999976543211111111 000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM--SEVVE 409 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~--~eil~ 409 (486)
. ...++...+..+.++|.+||..||.+||++ .|+++
T Consensus 217 ---~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 ---A----DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ---c----cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0 111122234678899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=322.90 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=200.3
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCee
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
|.....||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.++..++||||+++++++..++..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcC---------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 3344579999999999998765 5678999999765545556788999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
++||||+++++|..++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 999999999999987744 35889999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... ......|+..|+|||++.+..++.++|||||||++|||++|..||........ ..... .. .
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~----~~------~ 233 (297)
T cd06659 169 KDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLR----DS------P 233 (297)
T ss_pred cccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHh----cc------C
Confidence 3221 12335689999999999988999999999999999999999999975432111 10000 00 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.+... .....+..+.+++.+||+.+|.+||++.+++++-
T Consensus 234 ~~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 234 PPKLK--NAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 00000 0111235688999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=315.30 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=201.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
-|++.+.||.|+||.||+|.+.. ++..||||.+..... .....+.+|+.++..++|+||+++++++..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 36778899999999999998765 567899999865432 22356889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeeccccee
Confidence 99999999999999998853 36889999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||....... .... ...
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~----~~~------ 215 (277)
T cd06641 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFL----IPK------ 215 (277)
T ss_pred cccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHH----Hhc------
Confidence 543221 1223568899999999988889999999999999999999999996533211 1100 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...+ .+....+..+.+++.+||+.+|.+||++.+++++
T Consensus 216 ~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 216 NNPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCC----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0001 1112234678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=318.52 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=204.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|.+.+.||+|+||.||++.... ++..||+|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcC---------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 589999999999999999998754 56689999987554444567889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 999999999999999998543 5788999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
...... ......|++.|+|||.+....++.++|||||||++|+|++|+.||............. ...
T Consensus 165 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-----~~~------ 231 (293)
T cd06647 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-----TNG------ 231 (293)
T ss_pred cccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-----cCC------
Confidence 543322 1233568999999999988889999999999999999999999997543321110000 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+.+ ......+..+.+|+.+||..+|.+||++.+++.+
T Consensus 232 --~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 --TPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111234568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=313.25 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----------ccHHHHHHHHHHHhc-CCCCCce
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----------QGHKEWLAEVNFLGD-LVHLNLV 198 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~h~nIv 198 (486)
+|++.+.||+|+||.||+|.+..+ ++..+|+|.+..... ....++.+|+.++.+ ++|+||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 477888999999999999998652 356899998864321 123457788888875 7999999
Q ss_pred EEEEEEEeCCeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcC
Q 011412 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDA 274 (486)
Q Consensus 199 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~ 274 (486)
++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~ 149 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGE 149 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECC
Confidence 999999999999999999999999988743 34568999999999999999999996 55 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011412 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354 (486)
Q Consensus 275 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~ 354 (486)
++.+||+|||++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ...
T Consensus 150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~~ 223 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LAT 223 (269)
T ss_pred CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HHH
Confidence 9999999999998754432 2334578999999999998889999999999999999999999996432211 000
Q ss_pred hhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 355 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
. .... ...+... ...+..+.+|+.+||+.||++||++.|+..+|+
T Consensus 224 ~---~~~~------~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 K---IVEA------VYEPLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred H---Hhhc------cCCcCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 0000 0001001 122457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=320.11 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=200.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
+.|.+.+.||+|+||.||+|.+.. +|..||+|.+...... ...++.+|+.+++.++||||+++++++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 468889999999999999998865 5678999998754332 2346889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
..+..++||||+. |+|.+++......+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCc
Confidence 9999999999996 5888877666667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
+...... ....|+..|+|||++. ...++.++||||||+++|||++|..||.......... ....
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-------~~~~ 228 (307)
T cd06607 162 ASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQ 228 (307)
T ss_pred ceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-------HHhc
Confidence 8765332 2346888999999874 4568899999999999999999999996542211000 0000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
. ..+.+ .....+..+.+|+.+||+.||.+||++.+|+.+..
T Consensus 229 ~------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 229 N------DSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred C------CCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0 00000 11224567899999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=315.16 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=200.5
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCC---CCCceEEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV---HLNLVKLIGYCI 205 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~ 205 (486)
.|++.+.||.|+||.||+|.+.. ++..||+|.+..... ....++.+|+.+++.+. ||||+++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 47778899999999999998865 567999999875432 33456888999999996 999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.+...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCc
Confidence 999999999999999999988543 7899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+........ ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||........... ..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------~~--- 215 (277)
T cd06917 148 AALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------IP--- 215 (277)
T ss_pred eeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------cc---
Confidence 987654332 1233568999999998865 4578999999999999999999999975432211100 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
....+.+... ..+..+.+++.+||+.||++||++.+++++
T Consensus 216 ---~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 216 ---KSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---cCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0001111111 134578899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.33 Aligned_cols=265 Identities=25% Similarity=0.362 Sum_probs=198.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++++.||.|+||.||+|.+.. +|..||||.+..... .....+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 47888999999999999998865 577999999875432 2235688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+..++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccch
Confidence 99999999995 6898888643 456899999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhh-----
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPH----- 359 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltG~~pf~~~~~~~~~-~~~~~~~~~----- 359 (486)
........ ......++..|+|||++.+.. ++.++|||||||++|||+||+.||......... .........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 148 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred hhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 76533221 122345788999999887644 688999999999999999999999754321100 000000000
Q ss_pred --ccc----ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 --LGE----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 --~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... ...+.......+. ......+..+.+||.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 0000000000000 0001123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=319.20 Aligned_cols=267 Identities=25% Similarity=0.327 Sum_probs=198.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++.+.||+|+||.||+|.... ++..||||.+...... ....+.+|++++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK---------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC---------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 3579999999999999999998765 6779999998654321 2234678999999999999999999987
Q ss_pred eCC--------eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 206 EDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 206 ~~~--------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
... ..++||||+. ++|.+++......+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGI 157 (310)
T ss_pred cccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCc
Confidence 654 4599999995 5888888766667899999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcc--eeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011412 278 AKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~ 354 (486)
+||+|||++......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||...........+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~ 237 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999865432211 112234678899999987654 47889999999999999999999997654322222111
Q ss_pred hhhhhccc-----c--ccccc----------ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 355 WARPHLGE-----R--RRFYR----------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 355 ~~~~~~~~-----~--~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
........ . ..... .+...+... .....+.+||.+||..||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 11100000 0 00000 000000000 013457799999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=306.49 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=206.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 209 (486)
+|.+.+.||+|+||.||++.+.. ++..|++|++..........+.+|+.+++.++|+||+++++++..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 47788999999999999999865 466899999987655455778999999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
.+++|||+++++|.+++......+++..+..++.|++.+|.|||..+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 99999999999999998766567999999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 011412 290 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369 (486)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (486)
..... .....|+..|+|||++.+..++.++||||||+++|+|++|..||........... ... ......
T Consensus 149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~-----~~~~~~ 217 (253)
T cd05122 149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IAT-----NGPPGL 217 (253)
T ss_pred ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHh-----cCCCCc
Confidence 54332 2335689999999999888899999999999999999999999975432111100 000 000000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. ....+..+.+++.+||+.||++||++.+++++
T Consensus 218 ~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 RN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred Cc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 11124578999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=316.12 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=201.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 209 (486)
.|...+.||+|+||.||++.+.. ++..||+|.+........+.+.+|+.+++.++|+||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 34455799999999999998765 567899999876554445668899999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
.++|+||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++...
T Consensus 91 ~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred EEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 9999999999999999865 46889999999999999999999988 999999999999999999999999988764
Q ss_pred CCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 011412 290 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369 (486)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (486)
..... ......|+..|+|||++.+..++.++|||||||++|||++|..||....+... ..... ..
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~~~~----------~~ 230 (285)
T cd06648 166 SKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MKRIR----------DN 230 (285)
T ss_pred ccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHH----------hc
Confidence 33221 12235689999999999888899999999999999999999999965432111 11000 00
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+.... ....+..+.+|+.+||+.+|++||++.+++++
T Consensus 231 ~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 231 LPPKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCCCCcc--cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0011110 11134578999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=313.97 Aligned_cols=266 Identities=24% Similarity=0.357 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
+|++.+.||.|+||.||+|.+.. +|..||||+++..... ....+.+|+.+++.++|+||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 58888999999999999999865 5779999999765432 2356778999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
..+|||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchh
Confidence 99999999975 8988886543 46899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhh-hh----
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWAR-PH---- 359 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~~-~~---- 359 (486)
+....... ......++..|++||++.+ ..++.++|||||||++|+|++|..||.......... +..... +.
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 76433211 1223457889999998865 457899999999999999999999997653321110 000000 00
Q ss_pred --cccccccccccCC---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 --LGERRRFYRLIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 --~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.....+...... .....+....+..+.+++.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000000000 00000111234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=319.24 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=201.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.|...+.||+|+||.||+|.+.. +|..||+|++...... ....+.+|+++++.++|+|++++++++.+
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 37778899999999999998865 5678999998754322 23468889999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..++||||+. |+|.+++......+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++
T Consensus 97 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 97 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence 999999999996 5888887666677999999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
...... ....|+..|+|||++. .+.++.++|||||||++|||++|..||........ ...+. ...
T Consensus 173 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~----~~~ 240 (317)
T cd06635 173 SIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA----QNE 240 (317)
T ss_pred cccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHH----hcc
Confidence 764332 2346889999999874 45789999999999999999999999865321110 00000 000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
.+ .......+..+.+|+.+||+.+|.+||++.++++++..+..
T Consensus 241 -------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 241 -------SP---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -------CC---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 00 00111234578999999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=310.33 Aligned_cols=254 Identities=30% Similarity=0.429 Sum_probs=202.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|.+.+.||+|+||.||+|.... ++..||+|.+...... ....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 57888999999999999998765 5678999999866543 456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccc
Confidence 9999999999999999998654 45889999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccee--eeeccccccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 288 DGPEGDKTHV--STRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 288 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
.......... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||....... . ..+.... .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~-~~~~~~~-~- 222 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--Q-IMFHVGA-G- 222 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--H-HHHHHhc-C-
Confidence 7644332111 11256889999999988766 8899999999999999999999996542111 0 0000000 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+.+... ...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 223 -------~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 -------HKPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -------CCCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 01111111 1124668899999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=326.11 Aligned_cols=266 Identities=24% Similarity=0.306 Sum_probs=200.0
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+.. +|..||||++.... ......+.+|+.+++.++|+||++++++|
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 45789999999999999999998865 67799999986432 22335677899999999999999999988
Q ss_pred EeC------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 205 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 205 ~~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
... ...|+||||+. ++|.+.+... ++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred ccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence 643 35799999995 5888877533 888999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH-H---
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E--- 354 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~-~--- 354 (486)
||+|||+++....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+ .
T Consensus 158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 234 (353)
T cd07850 158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234 (353)
T ss_pred EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999987543221 23356889999999999999999999999999999999999999754321100000 0
Q ss_pred --------hh----hhhcccc-----cccccccCCcc----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 355 --------WA----RPHLGER-----RRFYRLIDPRL----EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 355 --------~~----~~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.. ....... ..+........ ........+..+.+||.+||+.||.+||++.|+|++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 00 0000000 00001110000 0000112355688999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=313.55 Aligned_cols=260 Identities=24% Similarity=0.307 Sum_probs=196.4
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCCceEEEEEEEeC-
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED- 207 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~- 207 (486)
|++.+.||+|+||.||+|.+.. ++..||+|+++.... .......+|+.++.++. |+||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEcC---------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 6678899999999999998865 567899999875422 12234567999999985 99999999999987
Q ss_pred -CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+.+++||||++ ++|.+++......+++..+..++.|++.||.|||+.+ ++||||||+||+++. +.+||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccc
Confidence 88999999996 5888888765567999999999999999999999988 999999999999999 99999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc--
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-- 363 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-- 363 (486)
+....... .....++..|+|||++. +..++.++|||||||++|||++|..||....... .+.+....+...
T Consensus 147 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~ 220 (282)
T cd07831 147 RGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDA 220 (282)
T ss_pred cccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCH
Confidence 87543222 12346889999999765 4567889999999999999999999997644321 111111000000
Q ss_pred -----cccccccCCccCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 -----RRFYRLIDPRLEG-------HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 -----~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.......+..... ......+..+.+||.+||+.+|.+||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000 0011235789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=319.50 Aligned_cols=269 Identities=26% Similarity=0.332 Sum_probs=200.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..+|++.+.||+|+||.||+|.+.. +|..||+|.+...... ....+.+|+.++++++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 3579999999999999999998865 6779999998754322 1234678999999999999999999987
Q ss_pred eC--CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 206 ED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 206 ~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+. +..++||||+. ++|.+++......+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 65 56899999996 5898888766667999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHH-hhhh---
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARP--- 358 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~-~~~~--- 358 (486)
|++......... .....++..|+|||++.+ ..++.++|||||||++|||++|..||...........+. ....
T Consensus 153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 153 GLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230 (309)
T ss_pred ceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 999876433211 222346788999998865 568999999999999999999999997654322111110 0000
Q ss_pred ----hcccccccccc-cCCccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 359 ----HLGERRRFYRL-IDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 359 ----~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
........... +.......+. ...+..+.+||.+||+.||++||++.+++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00000000000 0000000000 01245678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=313.86 Aligned_cols=244 Identities=26% Similarity=0.352 Sum_probs=189.4
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHH---HhcCCCCCceEEEEEEEeCCe
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNF---LGDLVHLNLVKLIGYCIEDDQ 209 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~---l~~l~h~nIv~~~~~~~~~~~ 209 (486)
+||+|+||.||++.+.. +|..||+|.+....... ...+.+|..+ +....|+||+.+++++..++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEECC---------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 48999999999998865 57799999987543221 1223444433 334479999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 99999999999999988654 46999999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCcceeeeeccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 290 PEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
.... .....|+..|+|||++. +..++.++|||||||++|||++|..||..........+.... .
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~-------- 212 (279)
T cd05633 148 SKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L-------- 212 (279)
T ss_pred cccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---h--------
Confidence 3322 12346899999999886 456899999999999999999999999754332211111100 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
..+. .++...+..+.+++.+||..||.+|| ++.|++++.
T Consensus 213 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 213 TVNV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCCc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 0111 12223356789999999999999999 588887754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.19 Aligned_cols=265 Identities=18% Similarity=0.220 Sum_probs=190.1
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH-----------HHHHHHHHHHhcCCCC
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGDLVHL 195 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~ 195 (486)
..++|.+.+.||+|+||.||+|.+...+. .+..+|+|+......... .....++..+..+.|+
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 34689999999999999999998865321 144677776543322111 1123344556677899
Q ss_pred CceEEEEEEEeCC----eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011412 196 NLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (486)
Q Consensus 196 nIv~~~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 271 (486)
||+++++++.... ..+++||++. .++.+.+.. ....++..+..++.|++.||.|||+.+ |+||||||+|||
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nil 158 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIM 158 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 9999999876543 3478888873 467666643 234678889999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 011412 272 LDADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346 (486)
Q Consensus 272 l~~~~~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~ 346 (486)
++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|..||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999865322111 111235699999999999999999999999999999999999999976532
Q ss_pred CCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
... ++......+. .++...... ....+..+.+++..||..+|++||++.++++.|+
T Consensus 239 ~~~--~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NGN--LIHAAKCDFI-----KRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred chH--HHHHhHHHHH-----HHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 221 1100000000 000000000 0112467899999999999999999999998763
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.88 Aligned_cols=253 Identities=28% Similarity=0.421 Sum_probs=206.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|.+.+.||+|+||.||+|.+.. ++..|++|++..... .....+.+|+.++++++|+||+++++++...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 47778899999999999998865 567899999876543 3346788999999999999999999999988
Q ss_pred --CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 208 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
..+++||||+++++|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccccc
Confidence 89999999999999999987654 8999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+................++..|+|||.+....++.++||||||+++|+|++|..||...... ....+. .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~---~----- 216 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAALYK---I----- 216 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHh---c-----
Confidence 98765543211123356899999999998888999999999999999999999999765410 000000 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
........++...+..+.+++.+||+.||.+||++.+++.+
T Consensus 217 ----~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 217 ----GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ----cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00001111222335789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=316.66 Aligned_cols=254 Identities=28% Similarity=0.356 Sum_probs=195.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~ 207 (486)
+|...+.||+|+||.||++.+.. +|..||+|.+..... .....+.+|+.++.++. |+||+++++++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECC---------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 45566789999999999998865 577999999875432 23456889999999996 99999999999999
Q ss_pred CeeEEEEeecCCCChhHHHh----hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 208 DQRLLVYEFMPRGSLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~----~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
...+++|||+. ++|.++.. .....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEee
Confidence 99999999985 46655432 2245789999999999999999999974 6 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
||+++....... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ........
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~ 223 (288)
T cd06616 152 FGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQV 223 (288)
T ss_pred cchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhh
Confidence 999976533221 2234689999999998765 689999999999999999999999965321 11110000
Q ss_pred cccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.. ...+.+........+..+.+|+.+||+.||.+||++.+|+++-
T Consensus 224 ~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 224 VK-------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred cC-------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00 0011111112223456789999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=360.41 Aligned_cols=253 Identities=28% Similarity=0.384 Sum_probs=204.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
-+|.-...||.|.||.||-|.+.+ +|+..|+|-++.... ...+.+.+|+++|..|+|||+|++||+-..
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~---------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLD---------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCC---------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec
Confidence 467777899999999999998866 788999998875432 234568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..+|.||||++|+|.+++ +++.-.++.....+..|++.|++|||+++ ||||||||+||||+.+|.+|++|||.|
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccce
Confidence 99999999999999999988 45556777777889999999999999999 999999999999999999999999999
Q ss_pred CCCCCCCcce--eeeeccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 287 KDGPEGDKTH--VSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 287 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
........+. ......||+.|||||++.+ .....+.|||||||++.||+||+.||...+.. |+....-
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V 1454 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHV 1454 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHH
Confidence 8765542111 1224689999999999975 35677999999999999999999999654321 2211110
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. .- ...++...+..-.++|.+||..||+.|.++.|++++
T Consensus 1455 ~~-----gh----~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AA-----GH----KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hc-----cC----CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 00 00 112333356788999999999999999999999874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=317.82 Aligned_cols=270 Identities=23% Similarity=0.318 Sum_probs=198.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
+|++.+.||+|+||.||+|.+... +++..||||.+.... ......+.+|+.++..++||||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 477889999999999999998652 246799999998633 2233567889999999999999999999998
Q ss_pred C--CeeEEEEeecCCCChhHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC----CC
Q 011412 207 D--DQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----DY 276 (486)
Q Consensus 207 ~--~~~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~----~~ 276 (486)
. +.+++||||+++ +|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++
T Consensus 74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~ 149 (316)
T cd07842 74 HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG 149 (316)
T ss_pred CCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccc
Confidence 8 889999999965 777766422 236889999999999999999999988 999999999999999 89
Q ss_pred cEEEeecCCCCCCCCCCc-ceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc----
Q 011412 277 NAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH---- 350 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~---- 350 (486)
.+||+|||+++....... ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 229 (316)
T cd07842 150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229 (316)
T ss_pred eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence 999999999987543222 111223568899999998876 46899999999999999999999999765433200
Q ss_pred --hhHHhhhhhcc-----------cccccccccCCccCCCCC---------H--HHHHHHHHHHHHhcccCCCCCCCHHH
Q 011412 351 --NLVEWARPHLG-----------ERRRFYRLIDPRLEGHFS---------I--KGAQKAAQLAAHCLSRDPKARPLMSE 406 (486)
Q Consensus 351 --~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~---------~--~~~~~~~~li~~cl~~dP~~RPs~~e 406 (486)
.........+. +........+......++ . ..+..+.+++.+||+.||++||++.|
T Consensus 230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e 309 (316)
T cd07842 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE 309 (316)
T ss_pred HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 00000000000 000000000000000000 0 22356889999999999999999999
Q ss_pred HHHH
Q 011412 407 VVEA 410 (486)
Q Consensus 407 il~~ 410 (486)
++++
T Consensus 310 il~~ 313 (316)
T cd07842 310 ALEH 313 (316)
T ss_pred HhcC
Confidence 9864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=313.29 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=206.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
....|++.+.||+|+||.||+|.+.. ++..||+|++..... ....+.+|+.+++.++|+||+++++++..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 44578888999999999999998865 466899999986543 45678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..++||||+++++|.+++......+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchh
Confidence 99999999999999999999766557999999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
........ ......++..|+|||++.+..++.++|||||||++|+|++|..||....+... ...... . .
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~~~~~----~--~- 232 (286)
T cd06614 164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LFLITT----K--G- 232 (286)
T ss_pred hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh----c--C-
Confidence 75433221 12234588899999999888899999999999999999999999965432111 000000 0 0
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. +... .....+..+.+|+.+||+.+|.+||++.+++++.
T Consensus 233 ---~-~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 233 ---I-PPLK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred ---C-CCCc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 0 0000 0111346789999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=313.87 Aligned_cols=264 Identities=22% Similarity=0.318 Sum_probs=198.1
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
|++.+.||.|++|.||+|.+.. +|..||||++..... .....+.+|+.+++.++|+||+++++++.+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 6778899999999999998865 567999999875432 22356788999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..++||||++ ++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++.
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 9999999995 68999886543 46899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhh------
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPH------ 359 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~-~~~~~~~~~------ 359 (486)
....... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||......... .........
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07835 148 AFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225 (283)
T ss_pred ccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 6432211 12223578899999987654 5789999999999999999999999754321110 000000000
Q ss_pred -cccccc----cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 -LGERRR----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 -~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...... +....... ........+..+.+++.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhchhhhhhcccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00000000 000111223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=333.71 Aligned_cols=267 Identities=28% Similarity=0.387 Sum_probs=203.4
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC--
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 207 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 207 (486)
|...+.||+||||.||+|+++. ||+.||||.++.... ...+.+.+|+++|++|+|+|||+++++-.+.
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnke---------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKE---------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred eeehhhhcCCccceeeeecccc---------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 4455789999999999999876 899999999986543 3346688999999999999999999975443
Q ss_pred ----CeeEEEEeecCCCChhHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE--cCCC--c
Q 011412 208 ----DQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADY--N 277 (486)
Q Consensus 208 ----~~~~lv~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll--~~~~--~ 277 (486)
....+|||||.||+|...|.+ +...+++...+.++.++..||.|||+++ ||||||||.||++ ..+| .
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceE
Confidence 356799999999999999974 3567999999999999999999999988 9999999999998 3334 4
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
-||+|||.|+...++. ..+.++||..|.+||++. ...|+..+|.|||||++|++.||..||...........+.|.
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 6999999999986654 467789999999999988 488999999999999999999999999764433211111121
Q ss_pred hhhc-----------ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHhc
Q 011412 357 RPHL-----------GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP--LMSEVVEALK 412 (486)
Q Consensus 357 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP--s~~eil~~L~ 412 (486)
.... .+...+.....-....+++......+-.++..+|..+|.+|. .+.+....+.
T Consensus 240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~ 308 (732)
T KOG4250|consen 240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD 308 (732)
T ss_pred hhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence 1100 000111000000113344555556677899999999999998 5555544443
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=306.75 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=205.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|.+.+.||.|+||.||++.+.. ++..||+|++..... .....+.+|+++++.++|+|++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 57888999999999999999865 567899999986543 3446688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCcc
Confidence 9999999999999999999764 367999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++....... .......|++.|+|||.+....++.++||||||+++|+|++|..||....... +... ....
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~---~~~~-- 218 (258)
T cd08215 149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALK---ILKG-- 218 (258)
T ss_pred ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHH---HhcC--
Confidence 998764432 12334578999999999988889999999999999999999999996543211 1110 0000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. +. ++...+..+.+++.+||..+|++||++.+++++
T Consensus 219 ----~~-~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 219 ----QY-PP----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CC-CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 11 111234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=306.99 Aligned_cols=274 Identities=23% Similarity=0.295 Sum_probs=200.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-cc-HHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..|+.+..||+|.||.||+|...+.... ..+.+|||.++.... .. -....+|+.+++.|+|+||+.+..+|..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~k-----r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDK-----RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcc-----cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 4688899999999999999965542110 134799999986521 11 1347899999999999999999999887
Q ss_pred -CCeeEEEEeecCCCChhHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC----Cc
Q 011412 207 -DDQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YN 277 (486)
Q Consensus 207 -~~~~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~----~~ 277 (486)
+..++|++||.+. +|...|.-+ ...++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence 7889999999977 898888532 346899999999999999999999988 9999999999999877 99
Q ss_pred EEEeecCCCCCCCCCCcce-eeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-----
Q 011412 278 AKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH----- 350 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~----- 350 (486)
|||+|||+++.+...-... ....++-|++|+|||.+.+ ..|+.+.||||+|||+.||||-.+.|.+.......
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 9999999999875543322 2344678999999999886 57999999999999999999999999764332111
Q ss_pred --hhHHhh----hhhccccccccc---------ccCCccCCCCCH--------HHHHHHHHHHHHhcccCCCCCCCHHHH
Q 011412 351 --NLVEWA----RPHLGERRRFYR---------LIDPRLEGHFSI--------KGAQKAAQLAAHCLSRDPKARPLMSEV 407 (486)
Q Consensus 351 --~~~~~~----~~~~~~~~~~~~---------~~~~~~~~~~~~--------~~~~~~~~li~~cl~~dP~~RPs~~ei 407 (486)
.+.... .+...++..+.. .+........+. .-++...+|+.++|..||.+|.++.+.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 111110 000000000000 000000000000 011237899999999999999999999
Q ss_pred HHHh
Q 011412 408 VEAL 411 (486)
Q Consensus 408 l~~L 411 (486)
+++.
T Consensus 335 leh~ 338 (438)
T KOG0666|consen 335 LEHP 338 (438)
T ss_pred hccc
Confidence 9864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=314.85 Aligned_cols=267 Identities=22% Similarity=0.305 Sum_probs=196.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCC-CCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 205 (486)
++|++.+.||+|+||.||+|.+.. +|..||||.+..... .....+.+|+.+++.+. |+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 368889999999999999998865 577999999865432 22356788999999995 699999999998
Q ss_pred eCCe-----eEEEEeecCCCChhHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-C
Q 011412 206 EDDQ-----RLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-D 275 (486)
Q Consensus 206 ~~~~-----~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~ 275 (486)
..+. .|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~ 147 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQK 147 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCC
Confidence 7665 8999999975 898887643 245899999999999999999999988 999999999999998 8
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hH
Q 011412 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LV 353 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~ 353 (486)
+.+||+|||+++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......... +.
T Consensus 148 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 225 (295)
T cd07837 148 GLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225 (295)
T ss_pred CeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 89999999998764322111 122357889999998864 467999999999999999999999997543211100 00
Q ss_pred Hhh-hhh------cccccccccc--cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 354 EWA-RPH------LGERRRFYRL--IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 354 ~~~-~~~------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... .+. .......... ..+..........+..+.+||.+||..||.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 000 0000000000 00000000011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=309.42 Aligned_cols=250 Identities=21% Similarity=0.357 Sum_probs=201.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|.+.+.||+|+||.||+|.+.. +|..||+|.+..... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 47788999999999999999876 566899999875422 2335678999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEeecCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGL 285 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~vkl~DFGl 285 (486)
+..++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccccc
Confidence 99999999999999999986543 35899999999999999999999988 99999999999998885 469999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+........ ......|++.|+|||++.+..++.++|||||||++|||++|..||...... .........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~--- 217 (257)
T cd08225 149 ARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQG--- 217 (257)
T ss_pred chhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhcc---
Confidence 987543221 122346899999999998888999999999999999999999999654221 111111100
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+. ......+..+.+++.+||..+|++||++.+++++
T Consensus 218 ---~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 218 ---YFA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---cCC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000 0111223578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.61 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=199.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
.+|++.+.||+|+||.||+|.+.. +|..||+|.+.... ......+.+|+++++.++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 478899999999999999998765 67799999875321 1223468889999999999999999999
Q ss_pred EEeC--CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 204 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 204 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
+.+. ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 8764 4688999999999999998654 35889999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 282 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 282 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
|||+++........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||....... .....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~----- 221 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKI----- 221 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHH-----
Confidence 99999865321110 11223568999999999988889999999999999999999999996532211 01100
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
........++......+.+++.+||. +|..||++.+++.+
T Consensus 222 ---------~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 222 ---------ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---------HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 00001112233345679999999999 57999999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=339.16 Aligned_cols=279 Identities=19% Similarity=0.218 Sum_probs=190.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCcccc------CCCCcE----EEEEEecCCCcccHHHHHHHHHHHhcCCCCC
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK------PGTGLT----VAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~------~~~g~~----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 196 (486)
...+|++++.||+|+||+||+|.++........ ...+.. ++.|.+... ......+.+|+.+|+.++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG-SRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcc-hHHHHHHHHHHHHHHhCCCCC
Confidence 457899999999999999999976542111000 000011 111222111 112345789999999999999
Q ss_pred ceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 197 Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
||++++++...+..|+|||++ +++|.+++.... .......+..|+.||+.||.|||+++ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999999999999999999 457777765332 22345667789999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCCCCcch
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHN 351 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf-~~~~~~~~~~ 351 (486)
+.++.+||+|||+++........ ......||..|+|||++.+..|+.++|||||||+||||++|..++ ..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999876433221 123467999999999999999999999999999999999987544 3322221111
Q ss_pred hHHhhhhhc--cc-----ccccccccCCcc----CCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 352 LVEWARPHL--GE-----RRRFYRLIDPRL----EGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 352 ~~~~~~~~~--~~-----~~~~~~~~~~~~----~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
+........ .+ ...++..++... ...+. ...+..+.++|.+||+.||.+||++.|++.+-
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 111110000 00 000000100000 00000 01124567889999999999999999999753
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.87 Aligned_cols=244 Identities=31% Similarity=0.434 Sum_probs=193.3
Q ss_pred eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 137 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
||+|+||+||+|.+.. +|+.||+|.+..... .....+..|+++|+.++||||+++++++...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 6899999999998765 577999999865322 1233467899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~ 292 (486)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999999999986543 36899999999999999999999988 999999999999999999999999998765432
Q ss_pred CcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 011412 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 372 (486)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (486)
.. .....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+. ..... .
T Consensus 149 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~--------~-- 213 (277)
T cd05577 149 KK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLE--------M-- 213 (277)
T ss_pred Cc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hcccc--------c--
Confidence 11 223467889999999988889999999999999999999999997544321111110 00000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 011412 373 RLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVE 409 (486)
Q Consensus 373 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~ 409 (486)
...++...+..+.+++.+||+.||.+|| ++.+++.
T Consensus 214 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 214 --AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0111122356789999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=305.86 Aligned_cols=246 Identities=21% Similarity=0.226 Sum_probs=192.1
Q ss_pred HhcCCCCCCee--eecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEE
Q 011412 127 ATRNFRPESLL--GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (486)
Q Consensus 127 ~~~~y~~~~~l--g~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 203 (486)
..++|.+.+.+ |+|+||.||++.... ++..+|+|.+........ |+.....+ +|+||++++++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~ 77 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKP---------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYS 77 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcC---------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEE
Confidence 34567777766 999999999998765 577899999875432211 22222222 69999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEee
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSD 282 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~vkl~D 282 (486)
+...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 78 VTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred EecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence 999999999999999999999986554 7999999999999999999999988 99999999999999988 999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||+++..... ....|+..|+|||++.+..++.++|||||||++|||++|..||....... .....+.... ..
T Consensus 154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~ 225 (267)
T PHA03390 154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK 225 (267)
T ss_pred CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc
Confidence 9998765322 12468999999999998899999999999999999999999997443221 1111111100 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEA 410 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~eil~~ 410 (486)
........+..+.+||.+||+.+|.+||+ +.+++++
T Consensus 226 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 ------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00111134567899999999999999995 6998864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=303.87 Aligned_cols=256 Identities=23% Similarity=0.249 Sum_probs=201.5
Q ss_pred HhcCCCCC-CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
.+++|.+. ++||-|-.|.|..+.++. ||+.+|+|++... ....+|+++.-.. .|||||.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~---------T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR---------TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc---------chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 34566554 579999999999998875 8889999998654 4567888876655 599999999987
Q ss_pred Ee----CCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CC
Q 011412 205 IE----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DY 276 (486)
Q Consensus 205 ~~----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~ 276 (486)
.. ...+++|||.++||.|+..|..++ ..+++..+..|+.||+.|+.|||+.+ |.||||||+|+|... |.
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCc
Confidence 54 467889999999999999998664 56999999999999999999999999 999999999999954 45
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
.+||+|||+|+...... ...+.|-|++|.|||++....|+..+|+||+||++|-||+|.+||....... .
T Consensus 202 ~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-------i 271 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------I 271 (400)
T ss_pred ceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------C
Confidence 69999999999765322 2345788999999999999999999999999999999999999997543211 0
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.+.+..+.+..+. .+....-...++.++++|+.+|..+|.+|.++.+++++-+
T Consensus 272 spgMk~rI~~gqy---~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 272 SPGMKRRIRTGQY---EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred ChhHHhHhhccCc---cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 1111111110000 0111112244678999999999999999999999998765
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.84 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=196.6
Q ss_pred eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 137 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
||.|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++|+||+++++++.++...++|
T Consensus 1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 6999999999999865 577999999975432 2235688999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~ 293 (486)
|||+++++|.+++.+. ..++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 72 MEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred EecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 9999999999999654 45899999999999999999999988 9999999999999999999999999998765432
Q ss_pred cceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCc
Q 011412 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373 (486)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (486)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||........ ... .... ...
T Consensus 148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~---~~~~----------~~~ 210 (262)
T cd05572 148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIY---NDIL----------KGN 210 (262)
T ss_pred ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHH---HHHh----------ccC
Confidence 12235689999999999888899999999999999999999999976542111 110 0000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 011412 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 409 (486)
Q Consensus 374 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~ 409 (486)
....++...+..+.+++.+||+.||.+||+ +.|+++
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 011122222567899999999999999999 677766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=312.51 Aligned_cols=266 Identities=24% Similarity=0.326 Sum_probs=201.1
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC-
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~- 207 (486)
|++.+.||.|+||.||+|.+.. +|..||+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 6678899999999999998875 56789999998653 22335688999999999999999999999988
Q ss_pred -CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+..++||||+++ +|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~ 147 (287)
T cd07840 72 KGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLA 147 (287)
T ss_pred CCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccce
Confidence 899999999964 899888766567999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--hhcccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PHLGER 363 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~--~~~~~~ 363 (486)
......... ..+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... +.....
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 148 RPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226 (287)
T ss_pred eeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhc
Confidence 876543211 1223457889999997764 468899999999999999999999997654321111110000 000000
Q ss_pred ccc-----ccccC------CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 RRF-----YRLID------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 ~~~-----~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+ ..... ..+...+....+..+.+++.+||..+|.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 00000 000001111125678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=322.18 Aligned_cols=265 Identities=24% Similarity=0.327 Sum_probs=196.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++.+.||+|+||.||+|.+.. +|..||||.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP---------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC---------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 4689999999999999999998865 67799999987432 2233567889999999999999999998765
Q ss_pred CC-----eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 207 DD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 207 ~~-----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
.+ ..++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence 43 5799999996 488877743 46899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 282 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 282 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
|||+++........ .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .......
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~ 225 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGV 225 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH
Confidence 99999765432211 11223578999999998654 5689999999999999999999999965422110 0000000
Q ss_pred ccc-------------ccccccccCCccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 LGE-------------RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 ~~~-------------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.. ............... .....+..+.+|+.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000000000000000 001124568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=309.08 Aligned_cols=243 Identities=27% Similarity=0.361 Sum_probs=189.4
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHH---HHHHhcCCCCCceEEEEEEEeCCe
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAE---VNFLGDLVHLNLVKLIGYCIEDDQ 209 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E---~~~l~~l~h~nIv~~~~~~~~~~~ 209 (486)
+||+|+||.||+|.+.. +|+.||+|.+....... ...+..| ++.++...||||+++++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEec---------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 48999999999998765 57799999987543221 1123334 344555689999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
.++||||+.|++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 99999999999999888543 57999999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 290 PEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
.... .....|+..|+|||++.++ .++.++|||||||++|||++|+.||.............. . .
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~---~--------~ 212 (278)
T cd05606 148 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---T--------L 212 (278)
T ss_pred CccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH---h--------h
Confidence 3322 1234699999999998754 689999999999999999999999976533221111100 0 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 410 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~ 410 (486)
...+.+. ...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 213 ~~~~~~~----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 213 TMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ccCCCCC----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0111111 12246789999999999999999 89999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=359.27 Aligned_cols=263 Identities=30% Similarity=0.509 Sum_probs=207.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
...|...+.||+|+||.||+|.+.. +|..||||++...... ...|++++++++|||||+++++|.+.
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 3467788899999999999998865 5678999998754322 23568899999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..|+||||+++|+|.+++. .++|..+..|+.||+.||+|||.....+|+||||||+|||++.++..++. ||...
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 99999999999999999994 37899999999999999999996544559999999999999999888875 66654
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
..... ....||+.|||||++.+..|+.++|||||||++|||+||+.||+.... ....+..|....... ....
T Consensus 831 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~ 902 (968)
T PLN00113 831 LLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLD 902 (968)
T ss_pred ccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchh
Confidence 43211 123688999999999999999999999999999999999999954322 223444554433221 1223
Q ss_pred cccCCccCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 368 RLIDPRLEGH--FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 368 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
..+++.+... ........+.+++.+||+.||++||+|.|+++.|+.+..
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3445544332 334555678899999999999999999999999986643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=350.36 Aligned_cols=258 Identities=25% Similarity=0.286 Sum_probs=208.8
Q ss_pred hHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCce
Q 011412 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLV 198 (486)
Q Consensus 122 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv 198 (486)
.++.....+|.++++||+|+||.|.+++++. |++.||+|++++.... ...-|..|-.+|..-+.+-||
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~---------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv 138 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKS---------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIV 138 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeec---------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHH
Confidence 4445567899999999999999999999876 7889999999874322 223477888999888899999
Q ss_pred EEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 199 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
.++..|.++.++|+||||++||+|..++.+.. .+++..+..|+..|+.||..||+.| +|||||||+|||||..|+|
T Consensus 139 ~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 139 QLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred HHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcE
Confidence 99999999999999999999999999997766 8999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccc----c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----T-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~ 353 (486)
||+|||.+-..... ........+|||.|.+||++. + +.|+..+|+||+||++||||.|..||+... ++
T Consensus 215 kLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lv 287 (1317)
T KOG0612|consen 215 KLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LV 287 (1317)
T ss_pred eeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HH
Confidence 99999998776542 333455678999999999986 3 679999999999999999999999997542 22
Q ss_pred HhhhhhcccccccccccCCccCCCCC--HHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 011412 354 EWARPHLGERRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLSRDPKARPL---MSEVVEA 410 (486)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 410 (486)
+.....+ +-.-.-.|+ .+.+..+++||.+++ -+|..|.. +.++..+
T Consensus 288 eTY~KIm----------~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 288 ETYGKIM----------NHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHHHHh----------chhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 2111111 110011122 235678999999988 58888887 7776654
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.98 Aligned_cols=268 Identities=28% Similarity=0.339 Sum_probs=198.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcC-CCCCceEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 203 (486)
..++|.+.+.||+|+||.||+|.+.. +|..||||++.... ......+.+|+.+++++ +|+||++++++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 45678899999999999999998765 56789999885432 22335577899999999 99999999999
Q ss_pred EEeC--CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 204 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 204 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
+... ...++||||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 8654 36899999996 5999888543 6888999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc---eeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 282 DFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 282 DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
|||+++........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999865443321 12234578999999998764 567899999999999999999999996543221100000000
Q ss_pred hhc----------ccccccccccC----CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PHL----------GERRRFYRLID----PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~~----------~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... .....+...+. ..+. ......+..+.+||.+||+.||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 00000000000 0000 0111134678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.04 Aligned_cols=267 Identities=22% Similarity=0.328 Sum_probs=196.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++.+.||+|+||.||+|.+.. +|+.||+|.+..... .....+.+|+++++.++|+||+++++++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 468889999999999999998765 577899999865432 223567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeecC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFG 284 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~vkl~DFG 284 (486)
....++||||++ ++|.+++... ...+++..+..++.||+.||+|||+++ ++||||+|+||+++. ++.+||+|||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccc
Confidence 999999999995 5888877543 334678888999999999999999988 999999999999985 5679999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhh-hh--
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWAR-PH-- 359 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~~-~~-- 359 (486)
++........ ......|++.|+|||++.+ ..++.++|||||||++|+|+||+.||.......... ...... +.
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 149 LARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226 (294)
T ss_pred cccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9976433211 1223467899999998865 457899999999999999999999997543321110 000000 00
Q ss_pred -------cccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 -------LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.+.........+..........+..+.+++.+||+.+|.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000000000011224568899999999999999999999873
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.74 Aligned_cols=261 Identities=26% Similarity=0.344 Sum_probs=202.8
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
|++.+.||.|++|.||+|.+.. +|+.+++|.+...... ....+.+|+.+|+.++|+||+++++++...+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 5677899999999999998765 5678999998755432 3456888999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||+++ +|.+++......+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+..
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 99999999965 898888776678999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc-----
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE----- 362 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~----- 362 (486)
...... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........... ....+..
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 222 (283)
T cd05118 148 FGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEV 222 (283)
T ss_pred cCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHh
Confidence 654331 12234688899999998776 789999999999999999999999965442111000 0000000
Q ss_pred cccccc-----------ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 363 RRRFYR-----------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 363 ~~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...+.. ..... ........+..+.++|.+||+.||.+||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 223 WPKFTSLARNYKFSFPKKAGMP-LPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cccchhhhhhhhhhhccccccC-HHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 00000 011122345789999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=312.65 Aligned_cols=270 Identities=27% Similarity=0.333 Sum_probs=201.2
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
...++|++.+.||+|+||.||+|.+.. +|+.||||+++.... .....+.+|+++++.++||||++++++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~ 74 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence 455789999999999999999999865 567899999975432 223457789999999999999999999
Q ss_pred EEeCC----------eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 204 CIEDD----------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 204 ~~~~~----------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
+.+.. .+++||||+++ +|.+.+......+++..+..++.||+.||+|||+.+ |+||||||+||+++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~ 150 (302)
T cd07864 75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLN 150 (302)
T ss_pred ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 87655 78999999976 787777666567999999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011412 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352 (486)
Q Consensus 274 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~ 352 (486)
.++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|||++|++||...........
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~ 229 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229 (302)
T ss_pred CCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999999876443321 1122356788999998764 4578999999999999999999999975432211111
Q ss_pred HHhhh--------hhcccccccc-----cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 353 VEWAR--------PHLGERRRFY-----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 353 ~~~~~--------~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.... +.+.+...+. ..........+. ..+..+.+|+.+||+.||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11000 0000000000 000000000000 124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.14 Aligned_cols=266 Identities=25% Similarity=0.348 Sum_probs=199.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|.+.+.||+|+||+||+|.+.. +|..||||.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC---------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 3579999999999999999998765 67799999987532 223456778999999999999999999876
Q ss_pred eC-----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 206 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 206 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
.. ...||||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 75 PPHREAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cccccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence 54 34799999995 6898888544 57999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHH-hhhh
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARP 358 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~-~~~~ 358 (486)
+|||+++...... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||...........+. ....
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999998754332 11233568899999998764 568999999999999999999999996543211000000 0000
Q ss_pred -------hc--cccccccc----ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 359 -------HL--GERRRFYR----LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 359 -------~~--~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. .......+ ..++... ......+..+.+|+.+||+.+|.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00 00000000 0000000 0111234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=305.17 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=203.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++.+.||+|+||.||++.+.. ++..||+|.+..... ....++.+|+++++.++|+||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 47888999999999999998765 567899999875432 2234678899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
...++||||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeecc
Confidence 9999999999999999998652 356889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++....... .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||...... .+.... .
T Consensus 149 ~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---~---- 214 (256)
T cd08530 149 ISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKV---Q---- 214 (256)
T ss_pred chhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---h----
Confidence 998765431 22346889999999999989999999999999999999999999654321 111000 0
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.......+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 215 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 215 -------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -------cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001111222445779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=301.99 Aligned_cols=248 Identities=31% Similarity=0.492 Sum_probs=204.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|++++.+++|+||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 47888999999999999998765 567899999987654 3345788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccce
Confidence 9999999999999999998655 57899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
........ .....++..|+|||.+.+..++.++|||+||+++|+|++|..||...... .........
T Consensus 148 ~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~------ 214 (254)
T cd06627 148 KLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFRIVQD------ 214 (254)
T ss_pred ecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhcc------
Confidence 76543321 23356899999999988888899999999999999999999999653311 000000000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
..+ .++...+..+.+++.+||..+|++||++.+++.
T Consensus 215 --~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 --DHP----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCC----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 001 111222467889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=313.54 Aligned_cols=244 Identities=27% Similarity=0.380 Sum_probs=201.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHH---HHHHHHHHHhcC-CCCCceEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL-VHLNLVKLIG 202 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~---~~~~E~~~l~~l-~h~nIv~~~~ 202 (486)
...+|..+.+||+|+||.|.+|..+ +|.+.||||+++++...... --+.|-++|+.. +-|.+++++.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerk---------gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERK---------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred eecccceEEEeccCccceeeeeccc---------CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH
Confidence 3468899999999999999999764 47789999999977543322 235678888766 4678999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
+|+.-+.+|+||||+.||+|.-.|++-+ .+.+..+..++..|+-||-+||+++ ||+||||.+|||||.+|++||+|
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeee
Confidence 9999999999999999999999886654 6888899999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||+++....+..+ ..++|||+.|+|||++..++|+..+|+|||||+|||||.|++||++..... + ....
T Consensus 494 FGmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---l---F~aI--- 562 (683)
T KOG0696|consen 494 FGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L---FQAI--- 562 (683)
T ss_pred cccccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHH---
Confidence 9999875443332 456999999999999999999999999999999999999999998764322 1 1111
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 403 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 403 (486)
.+. .-.++...+.++..+.+..|...|.+|..
T Consensus 563 -------~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 -------MEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -------HHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 111 12344555678899999999999999964
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=321.21 Aligned_cols=270 Identities=22% Similarity=0.320 Sum_probs=200.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.+|++.+.||.|+||.||+|.... +|..||+|++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 75 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTR---------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRP 75 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence 689999999999999999998865 677999999875432 334567889999999999999999998763
Q ss_pred ----CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 207 ----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 207 ----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
...+++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 76 PGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred cCCCCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecc
Confidence 356899999995 6899888544 45999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcc--eeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 283 FGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 283 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
||++......... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~ 230 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence 9999765332211 11234578999999998765 56899999999999999999999999764332111100000000
Q ss_pred --------c-cc-ccccccccCC---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 360 --------L-GE-RRRFYRLIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 360 --------~-~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
. .+ .......... .....+....+..+.+++.+||+.+|.+||++.+++.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 0 00 0000000000 0000011123567899999999999999999999998543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=312.06 Aligned_cols=245 Identities=27% Similarity=0.391 Sum_probs=197.4
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 214 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 214 (486)
..||+|+||.||++.+.. +|..||||.+..........+.+|+.+++.++|+||+++++++...+..++||
T Consensus 26 ~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 26 IKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 479999999999998865 57799999987554444566889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCc
Q 011412 215 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294 (486)
Q Consensus 215 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~ 294 (486)
||+++++|.+++.. ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 97 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred ecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 99999999987743 35789999999999999999999988 99999999999999999999999999876543221
Q ss_pred ceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCcc
Q 011412 295 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374 (486)
Q Consensus 295 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (486)
......|+..|+|||++.+..++.++|||||||++|+|++|..||........ ....... +.+.+
T Consensus 172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~~----------~~~~~ 236 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDN----------LPPKL 236 (292)
T ss_pred --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhh----------CCccc
Confidence 12335689999999999888899999999999999999999999965322111 1111100 00100
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 375 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. ....+..+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 237 KN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 00 01123568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=305.39 Aligned_cols=244 Identities=25% Similarity=0.314 Sum_probs=189.4
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHH-HhcCCCCCceEEEEEEEeCCee
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNF-LGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
+.||.|+||.||+|.+.. +|+.||||++....... ...+..|..+ +..+.|+||+++++++...+..
T Consensus 2 ~~l~~g~~~~v~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecC---------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 569999999999998865 56789999987543221 2234445444 4455899999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||+++...
T Consensus 73 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 9999999999999998654 46899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... .... ....... .
T Consensus 149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~---~~~~~~~----~ 212 (260)
T cd05611 149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDN---ILSRRIN----W 212 (260)
T ss_pred c------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHhcccC----C
Confidence 3 223468899999999988889999999999999999999999996543211 1100 0000000 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
........+..+.+++.+||+.+|++||++..+.+.|
T Consensus 213 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 213 ----PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ----CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0011112346789999999999999999776555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=311.67 Aligned_cols=245 Identities=29% Similarity=0.424 Sum_probs=196.7
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
|...+.||+|+||.||+|.+.. +|..||+|++...... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 93 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSH---------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE 93 (313)
T ss_pred hhcceeeccCCCeEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 6666789999999999998765 5779999998754332 234578899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..|+||||+. |+|.+++......+++..+..++.||+.+|.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 99999999995 5888888766677999999999999999999999988 9999999999999999999999999986
Q ss_pred CCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
.... .....|+..|+|||++. ...++.++|||||||++|||++|..||............. ..
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~-----~~--- 235 (313)
T cd06633 170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QN--- 235 (313)
T ss_pred ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-----hc---
Confidence 5422 12356899999999874 4568899999999999999999999986543211110000 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. .+. ......+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 236 ~-----~~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 D-----SPT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C-----CCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 0111223568899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=314.89 Aligned_cols=262 Identities=21% Similarity=0.263 Sum_probs=192.8
Q ss_pred eeeec--CCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeE
Q 011412 136 LLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211 (486)
Q Consensus 136 ~lg~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 211 (486)
.||+| +||+||+|++.. +|+.||||++...... ..+.+.+|+.+++.++||||++++++|..++..+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~ 75 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTP---------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW 75 (328)
T ss_pred HhCCcccCceeEEEEEEcC---------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceE
Confidence 46666 999999998865 6779999998754322 2356788999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 212 LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 212 lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
+||||+.+++|.+++.+. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+||+.+....
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence 999999999999998754 345889999999999999999999988 9999999999999999999999998654322
Q ss_pred CCCcc-e----eeeeccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh-hccc
Q 011412 291 EGDKT-H----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-HLGE 362 (486)
Q Consensus 291 ~~~~~-~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~ 362 (486)
..... . ......++..|||||++.+ ..++.++|||||||++|||++|..||........ ....... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~ 230 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSP 230 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCC
Confidence 11110 0 0011235667999999876 3578999999999999999999999975432110 0000000 0000
Q ss_pred ----------------cccc--------------ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 363 ----------------RRRF--------------YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 363 ----------------~~~~--------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
...+ .......+.......++..+.+|+.+||+.||.+||++.|++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0000 000001111112234567789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=307.81 Aligned_cols=255 Identities=27% Similarity=0.360 Sum_probs=197.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
+|++.+.||.|+||.||+|...... .+|..||+|++..... ...+.+.+|+++|..+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~------~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH------DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC------CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 4778899999999999999875321 2678999999875322 2235678899999999 599999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
..+...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999999999998654 46889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
+++........ ......|+..|+|||++.. ..++.++||||||+++|+|++|..||........ ...........
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~ 227 (290)
T cd05613 151 LSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS 227 (290)
T ss_pred cceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc
Confidence 99875432211 1223568999999998875 3578899999999999999999999964322111 11111111000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVE 409 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~ 409 (486)
.+ .++...+..+.+|+.+||+.||.+|| ++.+++.
T Consensus 228 --------~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 --------EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --------CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01 11222346788999999999999997 5666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=312.47 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=200.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..|...+.||+|+||.||+|++.. ++..||+|.+..... ....++.+|+++++.++|+|++++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 346677889999999999999865 567899999874322 22346788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.....++||||+. |+|.+++......+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCccc
Confidence 9999999999996 6888887666667899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
+...... ....|+..|+|||++. ...++.++|||||||++|+|++|..||........ ...+..
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~----- 228 (308)
T cd06634 162 ASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ----- 228 (308)
T ss_pred ceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHHHhh-----
Confidence 8765332 2346889999999874 35678899999999999999999999865322110 000000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
...+.. .....+..+.+||.+||+.+|.+||++.+++++.....
T Consensus 229 ------~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 229 ------NESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ------cCCCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 000000 01123466889999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=314.31 Aligned_cols=269 Identities=28% Similarity=0.333 Sum_probs=197.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++.+.||+|+||.||+|.+.. ++..||||++...... ....+.+|+++++.++|+||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 4689999999999999999998865 5678999998644322 1245678999999999999999999875
Q ss_pred eCC--------eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 206 EDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 206 ~~~--------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
+.. .+++||||+.+ +|...+......+++..+..++.|+++||.|||+.+ |+|+||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGI 153 (311)
T ss_pred cccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 533 46999999964 788777666668999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcc---------eeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011412 278 AKLSDFGLAKDGPEGDKT---------HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 347 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~ 347 (486)
++|+|||+++........ ...+...|++.|+|||++.+ ..++.++|||||||++|||++|++||......
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999765332211 11123467889999998765 45889999999999999999999999754432
Q ss_pred CcchhHHhhhhh-----ccccccccc--------ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 348 GEHNLVEWARPH-----LGERRRFYR--------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 348 ~~~~~~~~~~~~-----~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.....+...... ......... ...+.+...+ ......+.+++.+||+.||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 111111000000 000000000 0000000000 0112568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=304.53 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=196.2
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcC---CCCCceEEEEEEE
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGYCI 205 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~~~~~~~ 205 (486)
|++.+.||+|+||.||+|.+.. ++..||+|+++..... ....+.+|+.++.++ .|+||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 5678899999999999999865 5678999999754322 123466777776655 6999999999998
Q ss_pred eCCe-----eEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 206 EDDQ-----RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 206 ~~~~-----~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
..+. .+++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.+|
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEE
Confidence 8776 899999996 48998886543 36899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP 358 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~~~ 358 (486)
|+|||++........ .....++..|+|||++.+..++.++|||||||++|||++|.+||.......... +......
T Consensus 148 l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07838 148 IADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL 224 (287)
T ss_pred EeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCC
Confidence 999999987643322 123457889999999998899999999999999999999999997644321100 0000000
Q ss_pred hcc-----c----ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 359 HLG-----E----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 359 ~~~-----~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... . ...+....... ........+..+.+|+.+||+.||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRS-FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CChHhcCCCcccchhhcccccccc-hhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000 0 00000000000 011112334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=307.80 Aligned_cols=259 Identities=27% Similarity=0.340 Sum_probs=201.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
+|++.+.||+|+||.||+++...+. .++..||||+++.... .....+.+|+.++.++ +|+||+++++++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH------DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc------cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 4778899999999999999865432 2567899999875322 2234578899999999 599999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
..+...++||||+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++||||||.|||++.++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECc
Confidence 9999999999999999999998654 46889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
+++........ ......|+..|+|||.+.+.. ++.++||||||+++|||++|..||........ ...........
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~ 227 (288)
T cd05583 151 LSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS 227 (288)
T ss_pred ccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc
Confidence 98875433221 122356899999999987654 78899999999999999999999964322111 11111111110
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
.+.. +...+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 228 --------~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 --------KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0111 11233568899999999999999998888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.30 Aligned_cols=256 Identities=26% Similarity=0.358 Sum_probs=202.1
Q ss_pred ccChhHHHHHh---cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhc
Q 011412 118 KFTFNDLKLAT---RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGD 191 (486)
Q Consensus 118 ~~~~~~~~~~~---~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~ 191 (486)
+..|..++++. .-|..++.||-|+||.|.++.-.+ |...||+|.+++.+.... ..+..|-.||+.
T Consensus 615 ESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvD---------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAE 685 (1034)
T KOG0608|consen 615 ESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVD---------TRALYAMKTLRKADVLMRNQVAHVKAERDILAE 685 (1034)
T ss_pred hhhHHHHHHhhccccceEEEeeecccccceeEEEeecc---------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhh
Confidence 34555665554 348888999999999999997654 666899999987654332 346789999999
Q ss_pred CCCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011412 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (486)
Q Consensus 192 l~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 271 (486)
.+.+-||+||..|.+++.+|+||||++||++..+|.+.+ -|++..+..++..+..|+++.|.+| +|||||||+|||
T Consensus 686 ADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNIL 761 (1034)
T KOG0608|consen 686 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNIL 761 (1034)
T ss_pred cCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceE
Confidence 999999999999999999999999999999999998876 5889999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCC---------CCCcc-------------------------------eeeeeccccccccCcc
Q 011412 272 LDADYNAKLSDFGLAKDGP---------EGDKT-------------------------------HVSTRVMGTYGYAAPE 311 (486)
Q Consensus 272 l~~~~~vkl~DFGla~~~~---------~~~~~-------------------------------~~~~~~~gt~~y~aPE 311 (486)
||.+|+|||+||||++-+. .++.. ...-..+||+.|+|||
T Consensus 762 IDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiape 841 (1034)
T KOG0608|consen 762 IDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPE 841 (1034)
T ss_pred EccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChH
Confidence 9999999999999986321 00000 0011268999999999
Q ss_pred ccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHH
Q 011412 312 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 390 (486)
Q Consensus 312 ~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 390 (486)
++....|+..+|+||.|||||||+.|++||....+.+.+. ++.|. . .++-...+.+ +.++.+||
T Consensus 842 vl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~--------~---~l~~~~~~~l----s~e~~~li 906 (1034)
T KOG0608|consen 842 VLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR--------N---FLHIPYQGNL----SKEALDLI 906 (1034)
T ss_pred HhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh--------h---cccccccccc----CHHHHHHH
Confidence 9999999999999999999999999999998887765432 22221 1 1222223333 45666777
Q ss_pred HHhcccCCCCCC
Q 011412 391 AHCLSRDPKARP 402 (486)
Q Consensus 391 ~~cl~~dP~~RP 402 (486)
.+++ .+++.|.
T Consensus 907 ~kLc-~sad~RL 917 (1034)
T KOG0608|consen 907 QKLC-CSADSRL 917 (1034)
T ss_pred HHHh-cChhhhh
Confidence 7655 4667776
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=304.73 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=196.4
Q ss_pred eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 137 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
||.|+||.||++.+.. +|+.||+|.+..... .....+.+|++++.+++|+||+++++++......|+|
T Consensus 1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 6899999999998865 577999999976543 2345688999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~ 293 (486)
|||+++++|.+++.+.+ .+++..+..++.|++.||+|||+.+ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 72 MEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 99999999999986554 7899999999999999999999988 9999999999999999999999999987654321
Q ss_pred c------ceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 294 K------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 294 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
. ........++..|+|||.+....++.++||||||+++|+|++|..||....... .... ........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~---~~~~~~~~- 220 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQN---ILNGKIEW- 220 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HhcCCcCC-
Confidence 1 112233568899999999988889999999999999999999999996543211 1100 00000000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.... ..+..+.+++.+||+.+|.+||++..+.+.|+
T Consensus 221 -------~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 -------PEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -------Cccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000 02467899999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=314.30 Aligned_cols=269 Identities=25% Similarity=0.307 Sum_probs=197.7
Q ss_pred cCCC-CCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--------------HHHHHHHHHHHhcCC
Q 011412 129 RNFR-PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------HKEWLAEVNFLGDLV 193 (486)
Q Consensus 129 ~~y~-~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~ 193 (486)
++|. +.+.||.|+||+||+|.+.. +++.||||.+....... ...+.+|+.+++.++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTL---------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECC---------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence 4555 45779999999999998765 57799999987543221 124778999999999
Q ss_pred CCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 194 h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
|+||+++++++...+..++||||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+|||++
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~ 153 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFIN 153 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEEC
Confidence 9999999999999999999999996 699998854 346899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCC------------cceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCC
Q 011412 274 ADYNAKLSDFGLAKDGPEGD------------KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 340 (486)
Q Consensus 274 ~~~~vkl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~p 340 (486)
.++.++|+|||+++...... .........++..|+|||++.+. .++.++|||||||++|||++|..|
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999997654110 00111224578899999988754 478999999999999999999999
Q ss_pred CCCCCCCCcchhH-Hhhhhh----ccccc------ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 341 MDKNRPNGEHNLV-EWARPH----LGERR------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 341 f~~~~~~~~~~~~-~~~~~~----~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
|...........+ ...... ..... .+.....+.... .....+..+.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 9765432111000 000000 00000 000000000000 00112456889999999999999999999997
Q ss_pred Hhc
Q 011412 410 ALK 412 (486)
Q Consensus 410 ~L~ 412 (486)
+..
T Consensus 313 ~~~ 315 (335)
T PTZ00024 313 HEY 315 (335)
T ss_pred Ccc
Confidence 554
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=298.37 Aligned_cols=259 Identities=26% Similarity=0.371 Sum_probs=199.7
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 213 (486)
+.||+|+|+.|--+.... +|..||||++.+...-.+..+.+|++++... .|+||++++++|.+++..|||
T Consensus 84 e~LGeGAyasVqtcv~i~---------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQ---------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhcCccceeeeeeeeec---------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 479999999999998766 7889999999887655667899999999998 599999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc---EEEeecCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGP 290 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~---vkl~DFGla~~~~ 290 (486)
||-|.||.|..+|.++ ..+++..+..+..+|+.||.|||.++ |.||||||+|||...... ||||||.|..-..
T Consensus 155 fEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 9999999999999665 47999999999999999999999988 999999999999965443 7999999875432
Q ss_pred CCCc-----ceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 291 EGDK-----THVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 291 ~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
.... +....+.+|+..|||||++. ...|+.++|.||||||||-||+|.+||.+.=..+.. |-+...
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG----WdrGe~ 306 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG----WDRGEV 306 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC----ccCCCc
Confidence 2211 11223478999999999874 347899999999999999999999999754221100 111000
Q ss_pred cc--ccccccccCCccCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 361 GE--RRRFYRLIDPRLEGHFS----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 361 ~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.. ...+++.+... .-+|+ ...+.++.+|+..+|..|+..|.++.+++++-
T Consensus 307 Cr~CQ~~LFesIQEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred cHHHHHHHHHHHhcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 00 00111111100 00111 23456789999999999999999999998743
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=308.25 Aligned_cols=256 Identities=30% Similarity=0.435 Sum_probs=197.9
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+.. ++..||||.++.... ....++..|+.++..+. |+||+++++++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 34678899999999999999998865 567899999975432 22345677887776664 99999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
.+....|+||||+. ++|.+++......+++..+..++.|++.||+|||+ .+ |+||||+|+|||++.++.+||+||
T Consensus 84 ~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 84 ITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred ecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECcc
Confidence 99999999999984 57888776655689999999999999999999997 46 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
|++........ .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...... ...... .
T Consensus 160 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~---~ 231 (296)
T cd06618 160 GISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTK---I 231 (296)
T ss_pred ccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHH---H
Confidence 99876543221 12345788999999987553 888999999999999999999999643211 011110 0
Q ss_pred cccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
+... .+.+.. ....+..+.+|+.+||..||.+||++.+++++..
T Consensus 232 ~~~~-------~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 232 LQEE-------PPSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred hcCC-------CCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 1100 000000 0013457899999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=307.92 Aligned_cols=251 Identities=27% Similarity=0.348 Sum_probs=203.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCC-CCCceEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV-HLNLVKLIGYC 204 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 204 (486)
++|.+.+.||.|+||.||+|.... +|..||+|++..... .....+.+|+.++.++. |+||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 368899999999999999998865 577999999875332 22356788999999998 99999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
..++..++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCc
Confidence 9999999999999999999999655 47999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcc------------------eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 011412 285 LAKDGPEGDKT------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346 (486)
Q Consensus 285 la~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~ 346 (486)
++......... .......|+..|+|||++....++.++||||||+++++|++|..||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 98865432211 122235688999999999888899999999999999999999999975532
Q ss_pred CCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 011412 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM----SEVVEA 410 (486)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~----~eil~~ 410 (486)
.. ..... .. ....++...+..+.+|+.+||+.+|.+||++ .+++++
T Consensus 228 ~~---~~~~~---~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YL---TFQKI---LK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HH---HHHHH---Hh------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11 00000 00 0111112224678899999999999999999 787764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=315.53 Aligned_cols=267 Identities=25% Similarity=0.341 Sum_probs=202.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|++.+.||.|+||.||+|.+.. +|..||||.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 58888999999999999998765 57799999987643 23346788999999999999999999998877
Q ss_pred C-----eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 208 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 208 ~-----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
+ ..|+||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||.|||++.++.++|+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 5 7899999996 5898888544 48999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcc-eeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh-hhh-
Q 011412 283 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-ARP- 358 (486)
Q Consensus 283 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~-~~~- 358 (486)
||++......... .......++..|+|||++.+. .++.++|||||||++|+|++|..||...........+.. ...
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9999876543210 112335689999999999877 889999999999999999999999976543211100000 000
Q ss_pred --------hcccccccccccCCcc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 359 --------HLGERRRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 359 --------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.......+........ ........+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000000000 000011134678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.18 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=183.6
Q ss_pred CCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHH
Q 011412 162 TGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIR 238 (486)
Q Consensus 162 ~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~ 238 (486)
+|..||||+++... ......+.+|+.+++.++|+||+++++++...+..+++|||+++|+|.+++... ...+++..+
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~ 103 (314)
T cd08216 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI 103 (314)
T ss_pred CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHH
Confidence 57799999997652 233457889999999999999999999999999999999999999999998754 456889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcc-----eeeeeccccccccCcccc
Q 011412 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYV 313 (486)
Q Consensus 239 ~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~ 313 (486)
..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......... .......++..|+|||++
T Consensus 104 ~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (314)
T cd08216 104 AFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180 (314)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHh
Confidence 999999999999999988 999999999999999999999999988754322110 111234578899999998
Q ss_pred cc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc---cc-------ccccc----ccCC----c
Q 011412 314 MT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---ER-------RRFYR----LIDP----R 373 (486)
Q Consensus 314 ~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~~-------~~~~~----~~~~----~ 373 (486)
.. ..++.++|||||||++|||++|..||....... ...+....... .. ..... ..++ .
T Consensus 181 ~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
T cd08216 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDS 258 (314)
T ss_pred cCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhh
Confidence 65 468899999999999999999999997543211 11110000000 00 00000 0000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 374 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
............+.+|+.+||..||++||++.+++++-
T Consensus 259 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 259 VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred hhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 01112233456788999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.60 Aligned_cols=269 Identities=25% Similarity=0.290 Sum_probs=193.5
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcC-CCCCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 206 (486)
+|++.+.||+|+||.||++.+.... .+..||||++..... ...+.+.+|+.++.++ .|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS-------EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC-------cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 4778889999999999999986520 166899999874321 2245678899999999 59999999987543
Q ss_pred C----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 207 D----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 207 ~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
. ...+++|||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D 148 (332)
T cd07857 74 FPGNFNELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICD 148 (332)
T ss_pred ccccCCcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCc
Confidence 2 45789999985 689988854 457899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcc--eeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH-H----
Q 011412 283 FGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E---- 354 (486)
Q Consensus 283 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~-~---- 354 (486)
||+++........ .......||..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+ .
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence 9999865432211 11223578999999998765 56899999999999999999999999754321100000 0
Q ss_pred ----hhhhhcccc-cccccccCCccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 355 ----WARPHLGER-RRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 355 ----~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
......... ..+.......... ......+..+.+|+.+||+.||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0000000000000 0000123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.02 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=194.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..+|.+.+.||+|+||.||+|.+.. +|..||||++..... .....+.+|+.+++.++|+||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR---------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC---------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 3689999999999999999998764 677999999875322 22345789999999999999999999987
Q ss_pred eCC------eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 206 ~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
... .+++||||+. .+|..++ +..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 543 4689999995 4776654 236889999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR- 357 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~- 357 (486)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 232 (342)
T ss_pred EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999865332 123467889999998876 468999999999999999999999997643211110000000
Q ss_pred -------hhcccc--cccccccCCccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 -------PHLGER--RRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 -------~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
....+. ..............+. ...+..+.+||.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0000000000000000 1123568899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.89 Aligned_cols=263 Identities=27% Similarity=0.367 Sum_probs=197.6
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCC-CCCceEEEEEEEeCC
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDD 208 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~ 208 (486)
|.+.+.||.|+||+||+|.... +++.||||++...... ......+|+..++++. |+||+++++++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 6678899999999999999865 5678999998754321 2234567999999999 999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..++||||+ +|+|.+++.... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||+++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccce
Confidence 999999999 889998886553 57899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh-HHhhhhh----cc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWARPH----LG 361 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~-~~~~~~~----~~ 361 (486)
....... .....|+..|+|||++. ...++.++||||||+++|||++|+.||........... ....... ..
T Consensus 148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 148 EIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224 (283)
T ss_pred eccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence 6543221 22346889999999875 45678999999999999999999999965533211100 0000000 00
Q ss_pred ccc----ccccccC----CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 ERR----RFYRLID----PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ~~~----~~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.. .+...+. ..+...+. ..+..+.+|+.+||+.||.+||++.|++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hHhhhhccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000 0000000 00000011 113578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=304.43 Aligned_cols=264 Identities=27% Similarity=0.385 Sum_probs=201.1
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
|++.+.||+|+||.||+|.... +++.||+|.+.... ......+..|+.+++.++|+||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeeecC---------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 5667889999999999998865 57799999998653 223456788999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++||||++ ++|.+++.+....+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||+++.
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccc
Confidence 9999999997 5999999776567999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhh-------hh
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWAR-------PH 359 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~~-------~~ 359 (486)
...... ......++..|+|||.+.+. .++.++|||||||++|||++|..||.......... +..... ..
T Consensus 148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 148 FGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred cCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 544322 12234567889999998766 88999999999999999999999996543211100 000000 00
Q ss_pred cccc----cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 LGER----RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.... ..+...........+ ...+..+.+++.+||..||.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 000000000000001 1124678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=315.07 Aligned_cols=268 Identities=24% Similarity=0.293 Sum_probs=196.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
..+|.+.+.||.|+||.||+|.... +|..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~---------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD---------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC---------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 3689999999999999999998865 6779999999776655567788999999999999999999876543
Q ss_pred --------------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 208 --------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 208 --------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
...|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~ 148 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFIN 148 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEc
Confidence 35789999996 589887743 36889999999999999999999988 99999999999997
Q ss_pred C-CCcEEEeecCCCCCCCCCCcce-eeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011412 274 A-DYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350 (486)
Q Consensus 274 ~-~~~vkl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~ 350 (486)
. ++.+||+|||+++......... ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+....
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4 5678999999997643221111 1122457889999998654 56889999999999999999999999755432111
Q ss_pred hhHHhhhhhcc--ccccccccc----C-CccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 351 NLVEWARPHLG--ERRRFYRLI----D-PRLEGH-----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 351 ~~~~~~~~~~~--~~~~~~~~~----~-~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.......+... +...+.... . ...... +....+..+.+|+.+||+.||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 11100000000 000000000 0 000000 001123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=273.57 Aligned_cols=266 Identities=24% Similarity=0.295 Sum_probs=205.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+|...++||+|.||+||+|++.+ +++.||+|.++.+.. ......++||.+|+.|.|.|||+++++...+
T Consensus 3 ~ydkmekigegtygtvfkarn~~---------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC---------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 45566789999999999999876 788999999986532 2234678999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..+-+|+|||. -+|..+...-++.++.+.+..++.|+++||.|+|+++ ++||||||.|+||+.+|.+||+|||+++
T Consensus 74 kkltlvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 74 KKLTLVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred ceeEEeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhh
Confidence 99999999994 4999998888889999999999999999999999988 9999999999999999999999999999
Q ss_pred CCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc--c
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE--R 363 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~--~ 363 (486)
...-. -.+....+-|.+|++|.++.+. -|+...|+||.|||+.||.. |++.|.+....+...-+-|......+ +
T Consensus 150 afgip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 150 AFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred hcCCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence 86533 2344556789999999998764 68899999999999999987 66666655433322222222211111 1
Q ss_pred cccccccCCccCCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 RRFYRLIDPRLEGHFS---------IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+..+-|-..-..++ +.....-++|++++|.-+|..|.++.+.+++
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111111111111 1222345799999999999999999998874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.48 Aligned_cols=146 Identities=25% Similarity=0.320 Sum_probs=131.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|.+++.||+|+||.||+|++.. +++.||||+++...... ...+..|+.++..++|+||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 578999999999999999999875 57799999997543222 356788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
..+.+||||||+.+++|.+++... ..+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 999999999999999999998654 46889999999999999999999988 99999999999999999999999999
Q ss_pred CC
Q 011412 286 AK 287 (486)
Q Consensus 286 a~ 287 (486)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 86
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=312.45 Aligned_cols=269 Identities=24% Similarity=0.345 Sum_probs=199.0
Q ss_pred HHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEE
Q 011412 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKL 200 (486)
Q Consensus 123 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~ 200 (486)
++....++|.+.+.||+|+||.||+|.+.. +|..||+|++..... ...+.+.+|+.++.+++|+||+++
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~ 81 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcC---------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccce
Confidence 344566889999999999999999998765 577999999975422 223567789999999999999999
Q ss_pred EEEEEeC------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011412 201 IGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (486)
Q Consensus 201 ~~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 274 (486)
++++... ...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~ 155 (345)
T cd07877 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 155 (345)
T ss_pred eeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence 9988643 3468888887 7899887743 35899999999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011412 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 275 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~ 353 (486)
++.+||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+
T Consensus 156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999865332 223568899999998765 57889999999999999999999999654321111000
Q ss_pred -Hhh-------hhhcccc--cccccccCCccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 354 -EWA-------RPHLGER--RRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 354 -~~~-------~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
... ...+... ..+...+.......+ ....+..+.+||.+||+.||.+||++.+++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 000 0000000 000000000000000 001245688999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=309.31 Aligned_cols=264 Identities=25% Similarity=0.319 Sum_probs=198.6
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
..+++|++.+.||.|+||.||+|.+.. +|..||||++.... ....+.+.+|+.++..++||||++++++
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 77 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQL---------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECC---------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeee
Confidence 456789999999999999999998765 67799999886432 1233567899999999999999999999
Q ss_pred EEe-CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 204 CIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 204 ~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
|.. ....++||||+ +++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||+|.|||++.++.++|+|
T Consensus 78 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 78 FISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred EecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCc
Confidence 876 56789999999 6689887743 35788889999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh-HHh-----
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEW----- 355 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~-~~~----- 355 (486)
||+++..... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||........... .+.
T Consensus 152 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 152 FGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred cccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999864322 123467889999998765 5789999999999999999999999965432111000 000
Q ss_pred ---hhhhcc-cccccccccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 356 ---ARPHLG-ERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 356 ---~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
...... ...++...+. .....+ ...+..+.++|.+||+.+|++||++.+++.+-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 227 DDVINTICSENTLRFVQSLP--KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred HHHHHhccchhhHHHHhhcc--ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 000000 0000000000 000011 11246789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=310.80 Aligned_cols=264 Identities=24% Similarity=0.326 Sum_probs=196.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.... +|..||||++..... .....+.+|+.+|+.++|+||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 35679999999999999999998765 577999999864322 1234578999999999999999999998
Q ss_pred EeCC------eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 205 IEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 205 ~~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
..+. ..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 7654 358999999 7799888753 46899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhh
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA 356 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~-~~~~~~ 356 (486)
+|+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||......... ......
T Consensus 158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999865332 123467899999998875 46889999999999999999999999754321100 000000
Q ss_pred hh-------hcc-c-ccccccccCCccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 357 RP-------HLG-E-RRRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 357 ~~-------~~~-~-~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. .+. . ...+...+..... ..+....+..+.++|.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000 0 0000000000000 00011223468899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=298.61 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=194.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC---Cc--ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---GL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~---~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
+|.+.+.||+|+||.||++.+... +..+++|.++.. .. .....+..|+.+++.++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA---------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC---------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 578889999999999999987652 334555555431 11 2233567899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
.+....++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.++|+
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~ 147 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIG 147 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeec
Confidence 999999999999999999998863 3457899999999999999999999988 999999999999975 579999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ........
T Consensus 148 d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~- 218 (260)
T cd08222 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV- 218 (260)
T ss_pred ccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-
Confidence 9999876543222 12335688999999999888899999999999999999999999964321 11100000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
....+ .++...+..+.++|.+||..||++||++.+++++
T Consensus 219 ------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 219 ------EGPTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------cCCCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00111 1223445678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=316.78 Aligned_cols=245 Identities=26% Similarity=0.291 Sum_probs=199.9
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
++..|.+...+|.|+|+.|-.+.+.. +++.++||++.... .+..+|+.++... .||||+++.+.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~---------t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP---------TDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc---------cccchhheeccccc----cccccccchhhhhcCCCcceeecceec
Confidence 35678888899999999999998876 67789999998763 2234677665555 7999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE-cCCCcEEEeecC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNAKLSDFG 284 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll-~~~~~vkl~DFG 284 (486)
+..+.|+|||++.|+.|.+.+.... .+ ...+..|+.+|+.++.|||.++ ||||||||+|||+ +..++++|+|||
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~-~~-~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP-EF-CSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc-hh-HHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEec
Confidence 9999999999999999988875443 22 2677789999999999999988 9999999999999 689999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
.++..... ....+-|..|.|||++...+|+.++||||||++||+||+|+.||...... .++..
T Consensus 462 ~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~---------- 524 (612)
T KOG0603|consen 462 FWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT---------- 524 (612)
T ss_pred hhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----------
Confidence 99886543 22346789999999999999999999999999999999999999754332 11110
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
++ ..+.++...+..+++|+.+||+.||.+||++.++..+-+.
T Consensus 525 ---~i----~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 525 ---RI----QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---hh----cCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 01 1222334456789999999999999999999999876554
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=309.70 Aligned_cols=247 Identities=25% Similarity=0.318 Sum_probs=202.0
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 212 (486)
++||+|.||+||-|+++. +|+.||||++.+... .....+.+|+.||.+++||.||.+...|+..+..|.
T Consensus 570 evLGSGQFG~VYgg~hRk---------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRK---------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred hhccCCcceeeecceecc---------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 689999999999999986 788999999975432 233568899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CcEEEeecCCCCCC
Q 011412 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAKDG 289 (486)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~---~~vkl~DFGla~~~ 289 (486)
|||-+.|.-|+-.|....+.+++.....++.||+.||.|||.++ |+|+||||+||||... -.+||||||+|+..
T Consensus 641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeec
Confidence 99999554455455555678999999999999999999999988 9999999999999543 46999999999998
Q ss_pred CCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 011412 290 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369 (486)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (486)
.+.. .....+||+.|+|||++++..|+..-|+||+|||+|--|+|..||..+..- .+.++.+.. +
T Consensus 718 gEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaF----------M 782 (888)
T KOG4236|consen 718 GEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAF----------M 782 (888)
T ss_pred chhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhcccc----------c
Confidence 6643 244578999999999999999999999999999999999999999754321 122221111 1
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
..+..+. +.+..+.+||..+|+..-.+|-+....+.+.+
T Consensus 783 yPp~PW~----eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 783 YPPNPWS----EISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred cCCCchh----hcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 1222222 33467889999999999999999998887654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=293.83 Aligned_cols=254 Identities=27% Similarity=0.339 Sum_probs=196.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhc-CCCCCceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGD-LVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~ 207 (486)
+.+-+..||.|+||+|+|-.++. +|+..|||+++.... ..+++++.|.....+ -+.||||++||.+..+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~---------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKP---------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCc---------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 34445679999999999998876 788999999987765 445678888876544 4789999999999999
Q ss_pred CeeEEEEeecCCCChhHHHh----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 208 DQRLLVYEFMPRGSLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~----~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+..||.||+| ..+|..+.. .....+++..+-.|...++.||.||-...+ |||||+||+||||+..|.||||||
T Consensus 136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecc
Confidence 9999999999 558876653 234578999999999999999999987543 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|++-.+.+. ...+...|-..|||||-+. ...|+.++||||||++|||+.||+.|+..... +.+.......
T Consensus 213 GIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~ 284 (361)
T KOG1006|consen 213 GICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI 284 (361)
T ss_pred cchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc
Confidence 999775432 2345567999999999886 34699999999999999999999999976432 1111111111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
. ....+..+ .-.......+..+|.-||.+|-.+||.+.++++
T Consensus 285 g--dpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 285 G--DPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred C--CCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1 11111111 111234567899999999999999999999876
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.86 Aligned_cols=264 Identities=24% Similarity=0.342 Sum_probs=198.5
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|.+.+.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.+++.+.|+||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 35689999999999999999999865 56789999987532 12235577899999999999999999988
Q ss_pred EeCCe------eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 205 IEDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 205 ~~~~~------~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
...+. .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence 76654 89999999 6799998854 46899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA 356 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~-~~~ 356 (486)
+|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+ ...
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~ 232 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence 99999999875432 223468889999998765 46789999999999999999999999754332111100 000
Q ss_pred h---hhccc------ccccccccCCccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 357 R---PHLGE------RRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 357 ~---~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. ..+.. ...+...+.......+. ...+..+.+|+.+||+.||.+||++.+|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 00000 00000000000000000 1124678999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=313.87 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=209.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..+++.+..||-||||.|=++..... ...+|+|++++..... .+.+..|-+||...+.|.||++|-.|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 35667778899999999999877642 2258999998765433 34578899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+..++|++||-|-||.|+..|..+ +.|+......++..+++|++|||.++ ||+|||||+|++|+.+|-+||.|||
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehh
Confidence 9999999999999999999988555 57999999999999999999999999 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+|+....+.. .-++|||+.|.|||++.+...+.++|.||||+++||||+|.+||.+.++...-+++-...
T Consensus 566 FAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi------- 635 (732)
T KOG0614|consen 566 FAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI------- 635 (732)
T ss_pred hHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-------
Confidence 9999877654 345899999999999999999999999999999999999999998876654333322111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhc
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEALK 412 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~L~ 412 (486)
| .-+++......+.+||++++..+|.+|.- +.+|.++-+
T Consensus 636 ------d---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 636 ------D---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred ------h---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 1 11233344567889999999999999975 455555443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=301.96 Aligned_cols=272 Identities=23% Similarity=0.298 Sum_probs=206.7
Q ss_pred ChhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC--CC-
Q 011412 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LN- 196 (486)
Q Consensus 120 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~n- 196 (486)
.|......+.+|.+...||+|.||.|-.+++.. ++..||||+++.-. ...+..+-|+++|.++.+ |+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g 149 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNG 149 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCC
Confidence 344444567899999999999999999999876 46789999997432 223456779999999942 32
Q ss_pred ---ceEEEEEEEeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 197 ---LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 197 ---Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
+|++.+||...++.|||+|.+ |-++.++|..+ -.+++...+..++.|++++|+|||+.+ ++|.||||+|||+
T Consensus 150 ~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILf 225 (415)
T KOG0671|consen 150 KFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILF 225 (415)
T ss_pred ceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEE
Confidence 788889999999999999999 66999999764 467999999999999999999999988 9999999999998
Q ss_pred cC--------------------CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHH
Q 011412 273 DA--------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 332 (486)
Q Consensus 273 ~~--------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ 332 (486)
.. +..|+|+|||.|+...... ...+.|..|+|||++.+-+++..+||||+||||+
T Consensus 226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ 300 (415)
T KOG0671|consen 226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV 300 (415)
T ss_pred eccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence 31 2358999999999865543 3456789999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhHHhhhhhccc----c--------------------cccccccCCccCC----CCCHHHHH
Q 011412 333 EMLTGRRSMDKNRPNGEHNLVEWARPHLGE----R--------------------RRFYRLIDPRLEG----HFSIKGAQ 384 (486)
Q Consensus 333 elltG~~pf~~~~~~~~~~~~~~~~~~~~~----~--------------------~~~~~~~~~~~~~----~~~~~~~~ 384 (486)
||.||...|+.....+...+.+.....+.. + .+.....++.... .-......
T Consensus 301 ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~ 380 (415)
T KOG0671|consen 301 ELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHV 380 (415)
T ss_pred EeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHh
Confidence 999999999876543332233222111100 0 0000000000000 00112345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 385 KAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 385 ~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+.+|+++||..||.+|+|+.|+|.+
T Consensus 381 ~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 381 QLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHHHccCccccccHHHHhcC
Confidence 68999999999999999999999874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=289.78 Aligned_cols=240 Identities=32% Similarity=0.405 Sum_probs=194.7
Q ss_pred eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 137 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
||.|+||.||++.+.. ++..||+|++...... ....+..|+.+++.++|+||+++++.+..+...++|
T Consensus 1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 6999999999998865 5678999998765432 234688999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~ 293 (486)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 72 LEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 9999999999998655 36899999999999999999999988 9999999999999999999999999998754432
Q ss_pred cceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCc
Q 011412 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373 (486)
Q Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (486)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....... ....
T Consensus 148 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~~~~---------- 209 (250)
T cd05123 148 S--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI---LKDP---------- 209 (250)
T ss_pred C--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---hcCC----------
Confidence 1 12345689999999999888899999999999999999999999965432 1111111 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCH---HHHHH
Q 011412 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLM---SEVVE 409 (486)
Q Consensus 374 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~---~eil~ 409 (486)
..++...+..+.+++.+||..||++||++ .++++
T Consensus 210 --~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 210 --LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 01111224678899999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=302.58 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=199.9
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------ccHHHHHHHHHHHhcCCCCCceE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLVHLNLVK 199 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~ 199 (486)
..++|-++.+||+|||+.||+|.+.. ..+.||||+-..... ...+...+|.+|.+.|+||.||+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 34678888999999999999998875 356899998653321 11344678999999999999999
Q ss_pred EEEEEE-eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CC
Q 011412 200 LIGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---AD 275 (486)
Q Consensus 200 ~~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~---~~ 275 (486)
+|++|. +.+..|-|+|||+|.+|+-+|..+ ..+++..+..|+.||+.||.||.... .+|||-||||.||||. .-
T Consensus 532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred eeeeeeeccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCccc
Confidence 999985 567789999999999999888555 46889999999999999999999877 7899999999999994 34
Q ss_pred CcEEEeecCCCCCCCCCCcc-----eeeeeccccccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 011412 276 YNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltG~~pf~~~~~ 346 (486)
|.+||.||||++........ .......||.+|++||.+.-+ ..+.++||||+|||+|..+.|+.||..+..
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 78999999999987654433 234457899999999987633 578899999999999999999999976533
Q ss_pred CCcchhHHhhhhhcccccccccccCCccCCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
. .++.+... ++... .-.|+ +....++.++|++||+.--++|.+.-++..
T Consensus 690 Q--QdILqeNT-----------IlkAt-EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 690 Q--QDILQENT-----------ILKAT-EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred H--HHHHhhhc-----------hhcce-eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 2 12221110 00000 00111 123467899999999999999998877654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=290.08 Aligned_cols=220 Identities=24% Similarity=0.242 Sum_probs=178.1
Q ss_pred cCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEEeecCC
Q 011412 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219 (486)
Q Consensus 140 G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~ 219 (486)
|.||.||++++.. +|+.||+|.+.... .+.+|...+....||||+++++++...+..++||||+++
T Consensus 4 g~~~~v~~~~~~~---------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDTR---------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEcc---------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 8999999999876 67799999997642 234555556666799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeee
Q 011412 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299 (486)
Q Consensus 220 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~ 299 (486)
|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 70 ~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~ 140 (237)
T cd05576 70 GKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CD 140 (237)
T ss_pred CCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cc
Confidence 9999998654 35899999999999999999999988 999999999999999999999999988665332 12
Q ss_pred eccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCC
Q 011412 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 379 (486)
Q Consensus 300 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (486)
...++..|+|||++....++.++|||||||++|||++|..|+....... .. ... ..++
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~------~~~----~~~~ 198 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT------HTT----LNIP 198 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc------ccc----cCCc
Confidence 2456778999999988889999999999999999999998875321100 00 000 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH
Q 011412 380 IKGAQKAAQLAAHCLSRDPKARPLM 404 (486)
Q Consensus 380 ~~~~~~~~~li~~cl~~dP~~RPs~ 404 (486)
...+..+.+|+.+||+.||++||++
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCC
Confidence 1224568899999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=291.00 Aligned_cols=271 Identities=26% Similarity=0.351 Sum_probs=206.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..|+-..+||+|.||.||+|+.+. +|+.||+|++-.+.. ..-...++|+++|..|.|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n---------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKN---------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcC---------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 345556789999999999998876 677899987654321 122457899999999999999999887753
Q ss_pred --------CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 207 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 207 --------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
...+|+||.+|+. +|..+|......++...+.+++.+++.||.|+|... |+|||+|++|+||+.+|.+
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGIL 163 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceE
Confidence 2357999999976 899998777778999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcc--eeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011412 279 KLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~ 355 (486)
||+|||+++.+...... ...+..+-|.+|++||.+.+ ..|+.+.|||+.|||+.||+|+.+.|+++.......++..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 99999999865433221 12344567999999998875 5899999999999999999999999988776554444443
Q ss_pred hhhhccc-------cccccccc--CCccCCCCCH--------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 356 ARPHLGE-------RRRFYRLI--DPRLEGHFSI--------KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 356 ~~~~~~~-------~~~~~~~~--~~~~~~~~~~--------~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.+..+.. ...+++.+ .|-..+.+.. .-++.+.+|+.++|..||.+|+++++++.+..
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 3222111 01111212 1111111111 11346889999999999999999999998654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=327.53 Aligned_cols=270 Identities=29% Similarity=0.438 Sum_probs=211.4
Q ss_pred HHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcC-CCCCceEEE
Q 011412 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLI 201 (486)
Q Consensus 124 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~ 201 (486)
+++..++..+.+.||+|.||.|++|......... ......||||.++..... ..+.+..|+++|..+ .|+||+.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 3344455566679999999999999876532211 112457999999865443 346789999999999 699999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 266 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK 266 (486)
|+|...+.+++|+|||..|+|.++|..++ ..+.....+.++.||+.||+||++.. +|||||.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence 99999999999999999999999997665 34889999999999999999999988 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCCCCCCcceeee-eccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 011412 267 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 344 (486)
Q Consensus 267 p~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~ 344 (486)
.+||||..+..+||+|||+|+............ ...-...|||||.+....|+.++|||||||+||||+| |..||.+.
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999999765544433221 1113456999999999999999999999999999999 77888652
Q ss_pred CCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
... .++.++. .+. .....+..+..++.+|++.||+.+|++||++.++.+.|+.+
T Consensus 526 ~~~--~~l~~~l----~~G----------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 PPT--EELLEFL----KEG----------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CcH--HHHHHHH----hcC----------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 211 1122211 111 11122333457889999999999999999999999998763
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=288.36 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=202.3
Q ss_pred HHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcC-CCCCceE
Q 011412 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVK 199 (486)
Q Consensus 124 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~ 199 (486)
+....++|.++++||+|+|+.|.+++++. |.+.||+|++++.-.. ....+..|-.+..+. +||.+|-
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~---------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvg 315 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKK---------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVG 315 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcc---------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEe
Confidence 34566899999999999999999998876 7789999999865332 223345666666665 7999999
Q ss_pred EEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
++.||..+..+++|.||++||+|.-++++. ..++++.+..+...|+.||.|||+.+ ||+||||.+|+|||..|++|
T Consensus 316 lhscfqtesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghik 391 (593)
T KOG0695|consen 316 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIK 391 (593)
T ss_pred hhhhhcccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCcee
Confidence 999999999999999999999998777544 47999999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCCCcchhHHhhhh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN-RPNGEHNLVEWARP 358 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~-~~~~~~~~~~~~~~ 358 (486)
|.|+|+++....... ...++|||+.|.|||++.+..|+..+|+|+|||+++||+.|+.||+-- ..+.+.+...+...
T Consensus 392 ltdygmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq 469 (593)
T KOG0695|consen 392 LTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ 469 (593)
T ss_pred ecccchhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence 999999986433222 245699999999999999999999999999999999999999999732 22223333333332
Q ss_pred hccc-ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011412 359 HLGE-RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404 (486)
Q Consensus 359 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 404 (486)
.+-+ ..++ +...+-++..+++.-|.+||.+|...
T Consensus 470 vilekqiri------------prslsvkas~vlkgflnkdp~erlgc 504 (593)
T KOG0695|consen 470 VILEKQIRI------------PRSLSVKASHVLKGFLNKDPKERLGC 504 (593)
T ss_pred HHhhhcccc------------cceeehhhHHHHHHhhcCCcHHhcCC
Confidence 2222 1111 11223456789999999999999643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=317.40 Aligned_cols=257 Identities=27% Similarity=0.397 Sum_probs=213.2
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCe
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 209 (486)
.+..++||+|+||+||+|.+.-.++. -...||||++.... .+...+++.|+-+|.+|+|||+++|++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~-----vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGEN-----VKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCce-----ecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 44557899999999999998765443 34589999987543 345678999999999999999999999998766
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
+.||++|++.|.|.++++.++..+.....+.|..||++||.|||.+. ++||||-.+||||..-.++||.|||+++..
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 78999999999999999988889999999999999999999999888 999999999999999999999999999987
Q ss_pred CCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 290 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
.............-.+.|||-|.+....|+.++|||||||++||||| |..|+++....+..++.+.. . +
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g-------e---R 918 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG-------E---R 918 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-------c---c
Confidence 66554433333445678999999999999999999999999999999 88999876554433333211 1 1
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
+- -+..+..++..++.+||..|+..||+++++...+..
T Consensus 919 Ls-------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 919 LS-------QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred CC-------CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 11 123456789999999999999999999999876643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=296.28 Aligned_cols=273 Identities=30% Similarity=0.453 Sum_probs=197.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~ 206 (486)
....+.++||+|.||.||||.+. ++.||||++.... ...|..|-+|.+. +.|+||+++++.-..
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-----------CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence 34556678999999999999884 4689999998553 3457777777664 589999999998665
Q ss_pred CC----eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCcEEEcCCC
Q 011412 207 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------ERPVIYRDFKTSNILLDADY 276 (486)
Q Consensus 207 ~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------~~~iiHrDLKp~NIll~~~~ 276 (486)
.+ .++||+||.+.|+|.+||..+ .++|....+|+..+++||+|||+.. +.+|+|||||..||||..|+
T Consensus 276 ~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 276 GTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred CCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 55 789999999999999999664 6899999999999999999999764 34699999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCccccccC-CCC-----chhhHHHHHHHHHHHHhCCCCCCC-CCCCCc
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLT-----SRSDVYSFGVVLLEMLTGRRSMDK-NRPNGE 349 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DvwslGvil~elltG~~pf~~-~~~~~~ 349 (486)
+..|+|||||..+..+......-..+||.+|||||++.+. .+. .+.||||+|.+||||++...-++. ..+...
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 9999999999887654433333347899999999998753 222 368999999999999997765542 111111
Q ss_pred chhHH--hhhhhcccccc--cccccCCccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011412 350 HNLVE--WARPHLGERRR--FYRLIDPRLEGHFS-IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 417 (486)
Q Consensus 350 ~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 417 (486)
..+.. -..+.+.+... ..+...|.+..... -.....+.+.+..||..||+.|.|+.=+.+.+..+...
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 11110 00011111000 00011111111100 02245688999999999999999998888877665443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.65 Aligned_cols=254 Identities=28% Similarity=0.385 Sum_probs=208.6
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
.-+.-|++++.||.|.+|.||+++... +|+.+|||++.... ...+++..|.++|+.+ +|||++.+||+|
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~---------~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVK---------TGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeee---------cCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 345678999999999999999999877 56688999887654 3346788899999888 699999999998
Q ss_pred Ee-----CCeeEEEEeecCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 205 IE-----DDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 205 ~~-----~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
.. ++.+|||||||.+|+.-|++.. .+..+.|..+..|++.++.||.+||... +||||||-.||||+.++.|
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence 64 5789999999999999998863 3667999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~ 353 (486)
||+|||++........ ...+..||+.|||||++.. ..|+..+|+||||++..||.-|.+|+.+..+.-.
T Consensus 163 KLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---- 236 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---- 236 (953)
T ss_pred EEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh----
Confidence 9999999987654332 2445789999999999864 3578899999999999999999999976543211
Q ss_pred Hhhhhhcccccccccc-cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 354 EWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 354 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
++.+ -+|...-.-+....+++.++|..||..|-.+||++.++|++
T Consensus 237 ------------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 ------------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ------------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111 12222222345678899999999999999999999999874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=284.53 Aligned_cols=267 Identities=28% Similarity=0.409 Sum_probs=200.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~ 204 (486)
..++..+.+.||+|.||.||+|.++ |+.||||++...+ ...+.+|.+|... |+|+||+.+++.-
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-----------CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 4467888899999999999999995 6799999998654 2457788777765 5999999999875
Q ss_pred EeC----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCcEEEcCC
Q 011412 205 IED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-----EAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 205 ~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-----~~~~~iiHrDLKp~NIll~~~ 275 (486)
..+ .++|||.+|-+.|+|.|+|.+ ..++....++++..++.||++||. +++..|.|||||..|||+..+
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 443 368999999999999999966 478999999999999999999995 355669999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcc--eeeeeccccccccCccccccC----CC--CchhhHHHHHHHHHHHHhC----------
Q 011412 276 YNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG----HL--TSRSDVYSFGVVLLEMLTG---------- 337 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~----~~--~~~~DvwslGvil~elltG---------- 337 (486)
+..-|+|+|||......... ...+..+||.+|||||++... .+ -..+||||||+++||+...
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 99999999999765443211 123346899999999998643 12 2369999999999999863
Q ss_pred CCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 338 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 338 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
+.||.+..+.+-.. .+..... ..+-+.|.+... .+......+.+||+.||..+|..|.++-.|.+.|..+.+
T Consensus 433 ~~Pyyd~Vp~DPs~-eeMrkVV------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSF-EEMRKVV------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCcccCCCCCCCH-HHHhcce------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 36666543332111 0000000 011122222221 223455678899999999999999999999998877654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=311.18 Aligned_cols=268 Identities=21% Similarity=0.269 Sum_probs=172.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEE---
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY--- 203 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~--- 203 (486)
..++|.+.+.||+|+||.||+|++..+.. ..+..||||++...... +.+..| .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 45789999999999999999999876311 12678999998643321 111111 1122222222222211
Q ss_pred ---EEeCCeeEEEEeecCCCChhHHHhhcCCCC-------------------CHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011412 204 ---CIEDDQRLLVYEFMPRGSLENHLFRRSLPL-------------------PWSIRMKIALGAAKGLAFLHEEAERPVI 261 (486)
Q Consensus 204 ---~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l-------------------~~~~~~~i~~qi~~~l~yLH~~~~~~ii 261 (486)
...+..++|||||+.+++|.+++....... ....+..++.||+.||.|||+.+ |+
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---Ii 277 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IV 277 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 245678899999999999999886443211 12345679999999999999988 99
Q ss_pred ecCCCCCcEEEcC-CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccC----------------------CC
Q 011412 262 YRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----------------------HL 318 (486)
Q Consensus 262 HrDLKp~NIll~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 318 (486)
||||||+||||+. ++.+||+|||+++....... .......||+.|||||++... .+
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 9999999999985 57999999999986543322 123456899999999965422 24
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCC----CC--HHHHHHHHHHHHH
Q 011412 319 TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH----FS--IKGAQKAAQLAAH 392 (486)
Q Consensus 319 ~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~~~li~~ 392 (486)
+.++|||||||+||||+++..++.... ..+.......-.+...+...+.+..... +. ........+||.+
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 456799999999999999766543210 0000000000000000000111110000 00 0012245689999
Q ss_pred hcccCCCCCCCHHHHHHHh
Q 011412 393 CLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 393 cl~~dP~~RPs~~eil~~L 411 (486)
||+.||.+||++.+++++-
T Consensus 433 mL~~dP~kR~ta~e~L~Hp 451 (566)
T PLN03225 433 MMRFKGRQRISAKAALAHP 451 (566)
T ss_pred HccCCcccCCCHHHHhCCc
Confidence 9999999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.96 Aligned_cols=273 Identities=21% Similarity=0.285 Sum_probs=186.9
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCc-------cccCCCCcEEEEEEecCCCcccHHH--------------HHHH
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTA-------PVKPGTGLTVAVKTLNHDGLQGHKE--------------WLAE 185 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~-------~~~~~~g~~vavK~~~~~~~~~~~~--------------~~~E 185 (486)
..++|++.++||+|+||+||+|.....+.. ......++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457899999999999999999976432211 1122356789999987543322222 3347
Q ss_pred HHHHhcCCCCCc-----eEEEEEEEe--------CCeeEEEEeecCCCChhHHHhhcC----------------------
Q 011412 186 VNFLGDLVHLNL-----VKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFRRS---------------------- 230 (486)
Q Consensus 186 ~~~l~~l~h~nI-----v~~~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~---------------------- 230 (486)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766654 677777653 356899999999999999886421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccC
Q 011412 231 -LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309 (486)
Q Consensus 231 -~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 309 (486)
..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++......... .....+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence 12456778899999999999999988 9999999999999999999999999997654322111 112345889999
Q ss_pred ccccccCC--------------------CC--chhhHHHHHHHHHHHHhCCC-CCCCCCCCC------cchhHHhhhhhc
Q 011412 310 PEYVMTGH--------------------LT--SRSDVYSFGVVLLEMLTGRR-SMDKNRPNG------EHNLVEWARPHL 360 (486)
Q Consensus 310 PE~~~~~~--------------------~~--~~~DvwslGvil~elltG~~-pf~~~~~~~------~~~~~~~~~~~~ 360 (486)
||++.... |+ .+.||||+|||||+|++|.. ||....... ...+..|.. ..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~ 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YK 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hc
Confidence 99875322 12 24799999999999999875 664321110 001111110 00
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHhcCC
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP---KARPLMSEVVEALKPL 414 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP---~~RPs~~eil~~L~~~ 414 (486)
... .+ -......+....+|+.+||..+| .+|+|+.|+|+|-.-.
T Consensus 458 ~~~------~~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 458 GQK------YD----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred ccC------CC----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 000 00 00111234678899999999876 6899999999876543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=272.22 Aligned_cols=239 Identities=31% Similarity=0.424 Sum_probs=193.5
Q ss_pred CCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEEeecCC
Q 011412 141 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 219 (486)
Q Consensus 141 ~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~ 219 (486)
+||.||+|.+.. +|..||+|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++
T Consensus 1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 689999998865 56789999998765544 57889999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeee
Q 011412 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299 (486)
Q Consensus 220 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~ 299 (486)
++|..++.... .+++..++.++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++....... ...
T Consensus 72 ~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~ 144 (244)
T smart00220 72 GDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLT 144 (244)
T ss_pred CCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccc
Confidence 99999986544 3889999999999999999999988 9999999999999999999999999998765432 123
Q ss_pred eccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCC
Q 011412 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 379 (486)
Q Consensus 300 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (486)
...++..|++||.+....++.++|||+||+++|+|++|..||..... ............. . .. . ..
T Consensus 145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~---~----~~---~--~~ 210 (244)
T smart00220 145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKP---P----FP---P--PE 210 (244)
T ss_pred cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCC---C----Cc---c--cc
Confidence 45688999999999888899999999999999999999999965311 1111111110000 0 00 0 00
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 380 IKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 380 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
...+..+.+++.+||..+|++||++.++++
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 003457889999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=276.68 Aligned_cols=268 Identities=27% Similarity=0.361 Sum_probs=218.8
Q ss_pred hHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEE
Q 011412 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKL 200 (486)
Q Consensus 122 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~ 200 (486)
.++.....+++...++-+|.||.||.|.+++.+. ..+.+.|-+|.++....+ ....++.|...|..+.|||+..+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt----~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDT----YNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCC----cchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 4455566778889999999999999998886433 234556788888755433 34568899999999999999999
Q ss_pred EEEEEeC-CeeEEEEeecCCCChhHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 201 IGYCIED-DQRLLVYEFMPRGSLENHLFRR-------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 201 ~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~-------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
.+++.++ +..+.++.++.-|+|..+|... ...+...+...++.|++.||+|||.++ |||.||..+|++|
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVI 429 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhccee
Confidence 9998764 6678899999999999999722 234667778899999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 351 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~ 351 (486)
|+.-.+||+|=.++|.....++............||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+...
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ 509 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH 509 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence 9999999999999999988888777666777889999999999999999999999999999999 889987665532211
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
.+.+..+ +. -+..+++++..++.-||..+|++||++.+++..|.+
T Consensus 510 -------ylkdGyR---la-------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 -------YLKDGYR---LA-------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------HHhccce---ec-------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1112222 22 233567899999999999999999999999998853
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=255.84 Aligned_cols=200 Identities=28% Similarity=0.366 Sum_probs=168.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 206 (486)
++...+..||+|+||.|=+-++.. +|...|+|.+...- .+.++++++|+.+..+. .+|.+|.+||.+..
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~---------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQ---------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred hhhhhhhhhcCCccchhhheeecc---------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 344455679999999999888876 67799999997543 23456788899886655 69999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 207 DDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
....+|.||.| ..+|+.+.. .++..+++..+-+|+..+..||.|||++-. +||||+||+||||+.+|++|||||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEccc
Confidence 99999999999 458887754 567889999999999999999999999654 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccc----cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TGHLTSRSDVYSFGVVLLEMLTGRRSMDK 343 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslGvil~elltG~~pf~~ 343 (486)
|++-.+.+.. ..+-..|-..|||||.+. ...|+-++||||||+++.||.+++.||+.
T Consensus 194 GIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 194 GISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 9998764432 233356888999999875 34799999999999999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=272.00 Aligned_cols=269 Identities=23% Similarity=0.344 Sum_probs=202.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.+.+..+.||-|+||+||.+.+. .+|+.||+|++..- .....+.+.+|+++|..++|.|++..++...-
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDP---------RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQP 123 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDP---------RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQP 123 (449)
T ss_pred ccCCCCCcccccceeEEEeccCC---------CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCC
Confidence 46778899999999999998764 47889999998643 23344678999999999999999998887654
Q ss_pred C-----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 207 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 207 ~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
. ..+|.|+|++ ..+|.+.|. ....++...+.-+..||++||+|||+.+ |+||||||.|+|++.+..+|||
T Consensus 124 ph~dfFqEiYV~TELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKIC 198 (449)
T KOG0664|consen 124 ANPSFFQELYVLTELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKIC 198 (449)
T ss_pred CCchHHHHHHHHHHHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEec
Confidence 3 2467889998 448888774 4457888999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh--
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-- 358 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~-- 358 (486)
|||+++.-...+.. ..+..+-|.+|+|||++.+ ..|+.++||||+|||+.|||..+..|+...+....+++.-...
T Consensus 199 DFGLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 199 DFGLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP 277 (449)
T ss_pred ccccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence 99999976544333 3455678999999999886 4799999999999999999999999988776554444322110
Q ss_pred hcc------cccc--ccc--ccCCccCCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 359 HLG------ERRR--FYR--LIDPRLEGHF----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 359 ~~~------~~~~--~~~--~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.+. +..+ +.+ ...|.+.--+ ......+...++.++|..||++|.+..+.+.++.
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 010 1100 000 0001110000 0112345778999999999999999999887653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=297.27 Aligned_cols=246 Identities=29% Similarity=0.408 Sum_probs=187.9
Q ss_pred CCCCCeeeecCCeE-EEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCC
Q 011412 131 FRPESLLGEGGFGC-VFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDD 208 (486)
Q Consensus 131 y~~~~~lg~G~fg~-Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 208 (486)
|...+++|.|+-|+ ||+|... |+.||||++-... ..-..+||..|+.- .|||||++|+.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 44456789998876 8999884 6799999986543 23467899999888 5999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCC---HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---C--CcEEE
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---D--YNAKL 280 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~---~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~--~~vkl 280 (486)
.+||+.|.| ..+|.+++........ ......+..|++.||++||+.+ ||||||||.||||+. + ..++|
T Consensus 577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEe
Confidence 999999999 5699999976421111 1334678899999999999988 999999999999965 3 46899
Q ss_pred eecCCCCCCCCCCcce-eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcchhHHhhhh
Q 011412 281 SDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG-~~pf~~~~~~~~~~~~~~~~~ 358 (486)
+|||+++....+.... ......||-+|+|||++....-+.++|||||||++|+.++| .+||...-... .++
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NI------ 725 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANI------ 725 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhh------
Confidence 9999999876544321 23456799999999999988888899999999999999996 89997542211 011
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
+.....+..+. + ....++.+||.+|+..+|..||++.+||.+-
T Consensus 726 -l~~~~~L~~L~-~--------~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 726 -LTGNYTLVHLE-P--------LPDCEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred -hcCccceeeec-c--------CchHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 11111111110 0 0011788999999999999999999999753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=266.44 Aligned_cols=131 Identities=24% Similarity=0.347 Sum_probs=112.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-----CC---CceEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----HL---NLVKL 200 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~---nIv~~ 200 (486)
.+|.+.++||.|.|++||+|++.. +.+.||+|+++.... ..+..+.||++|++++ |+ .||+|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 789999999999999999999987 456899999986532 2355788999999883 33 59999
Q ss_pred EEEEEe----CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 201 IGYCIE----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 201 ~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
++.|.. +.++|||+|++ |.+|..+|... -..++...+.+|++||+.||.|||.+. +|||.||||+||||
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 999975 46899999999 77999998754 456999999999999999999999865 39999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=250.97 Aligned_cols=256 Identities=20% Similarity=0.295 Sum_probs=197.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~ 206 (486)
.++|++.+.+|+|.|+.||.|.+.. +.+.++||+++.- ..+.+.+|++||..|. ||||++++++..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~---------~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINIT---------NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccC---------CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 4689999999999999999998765 4568999999753 2467899999999997 9999999999887
Q ss_pred CC--eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEEeec
Q 011412 207 DD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDF 283 (486)
Q Consensus 207 ~~--~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~vkl~DF 283 (486)
.. ...||+||+.+.+...+. ..++...+..++.+++.||.|||++| |+|||+||.|++||.. -.++|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeec
Confidence 53 467999999998877655 35777888999999999999999999 9999999999999865 56999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh----
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP---- 358 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~---- 358 (486)
|||.+...+.... ..+.+..|--||.+. -..|+..-|+|||||+|..|+..+.||.....+..+ ++..+.-
T Consensus 178 GLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~ 253 (338)
T KOG0668|consen 178 GLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTD 253 (338)
T ss_pred chHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChH
Confidence 9999887665432 235678899999875 467899999999999999999999999765544332 1111110
Q ss_pred ---------------hcc------cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 359 ---------------HLG------ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 359 ---------------~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+. .+......+.+.-..- ...++.+|+.++|..|-++|+|+.|++.+
T Consensus 254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl----~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHL----VSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccccc----CChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000 0011111121111111 13678899999999999999999999763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=288.04 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=206.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
..+|+++..+|.|.||.||||+++. +++..|||+++...-....-+..|+-+++..+|||||.|++.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~---------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKR---------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhhcccc---------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 4589999999999999999999876 7889999999987766667778999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+.++|+||||.+|+|.+..+ -.+++.+.++..+.+..++||+|||+++ =+|||||-.|||+++.|.+|++|||.+-
T Consensus 85 dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchh
Confidence 99999999999999998664 3457999999999999999999999998 7999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
....... ....+.||++|||||+.. .+.|...+|||++|++..||---++|.....+.....+. ... ..
T Consensus 161 qitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-----TkS-~~ 232 (829)
T KOG0576|consen 161 QITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-----TKS-GF 232 (829)
T ss_pred hhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-----hcc-CC
Confidence 6543222 234588999999999763 678999999999999999999888887544332111111 000 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
+-..+-|+ ......+.+|++.||..+|++||++..+|.
T Consensus 233 qpp~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 QPPTLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCcccCC-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111122 123467889999999999999999987764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=277.75 Aligned_cols=269 Identities=24% Similarity=0.298 Sum_probs=204.9
Q ss_pred HHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC------CCCc
Q 011412 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV------HLNL 197 (486)
Q Consensus 124 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nI 197 (486)
....-.+|.+....|+|-|++|..|.+.. -|..||||+|...... .+.=+.|++||++|+ .-++
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~---------r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQA---------RGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccC---------CCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHH
Confidence 34556789999999999999999998765 4669999999876433 244568999999995 2379
Q ss_pred eEEEEEEEeCCeeEEEEeecCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011412 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 275 (486)
++|+-.|....++|||+|-+ ..+|.++|..-+ ..|....+..++.|+.-||..|-..+ |+|.||||.|||+++.
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence 99999999999999999998 669999997543 45777889999999999999999988 9999999999999875
Q ss_pred -CcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011412 276 -YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354 (486)
Q Consensus 276 -~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~ 354 (486)
..+||||||.|........ +.+.-+..|.|||++.+..|+...|+||+||+||||.||+..|.+...+....+..
T Consensus 573 k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred cceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 5689999999988765442 33456778999999999999999999999999999999999998765432211110
Q ss_pred ---------------hhhhhc--------------cccc--ccccccCC------ccCC--CCC---HHHHHHHHHHHHH
Q 011412 355 ---------------WARPHL--------------GERR--RFYRLIDP------RLEG--HFS---IKGAQKAAQLAAH 392 (486)
Q Consensus 355 ---------------~~~~~~--------------~~~~--~~~~~~~~------~~~~--~~~---~~~~~~~~~li~~ 392 (486)
+...++ .+.. .+...+.| .+.+ .++ ....+.+.+|+.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 000011 0000 01111111 0100 122 2334568899999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 011412 393 CLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 393 cl~~dP~~RPs~~eil~~ 410 (486)
||..||.+|.+..++|.+
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-33 Score=260.29 Aligned_cols=263 Identities=23% Similarity=0.301 Sum_probs=196.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.+|.-++.+|.|.- .|.-|.+.- ++..||+|.+.... ....+...+|..++..+.|+||++++.+|.-
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v---------~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQV---------LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhh---------ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 46777778898887 666665544 67789999986542 2334667899999999999999999999865
Q ss_pred C------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 207 D------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 207 ~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
. ...|+||||| ..+|...+. ..++-..+..|+.|++.|++|||+.+ |+||||||+||++..++.+||
T Consensus 87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred cccHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheee
Confidence 4 3568999999 559988886 45778889999999999999999999 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch---------
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN--------- 351 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~--------- 351 (486)
.|||+|+..... ...+..+.|..|.|||++.+..|...+||||+||++.||++|...|.+...-+.-.
T Consensus 160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred ccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence 999999875433 24566789999999999998889999999999999999999999997542211100
Q ss_pred -------hHHhhhhhcccc-----cccccccCCc-cCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 352 -------LVEWARPHLGER-----RRFYRLIDPR-LEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 352 -------~~~~~~~~~~~~-----~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
+...++...... ..+.+.+... +.. +.+......+++|+.+||..||++|-++.++|++-
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 000000000000 1111111111 111 01112235688999999999999999999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=244.16 Aligned_cols=212 Identities=36% Similarity=0.570 Sum_probs=184.1
Q ss_pred eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEEe
Q 011412 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215 (486)
Q Consensus 137 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~E 215 (486)
||+|++|.||++.... +|..+++|++...... ....+.+|++.++.+.|++|+++++++......+++||
T Consensus 1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 6899999999998864 4678999999866432 23568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeecCCCCCCCCCCc
Q 011412 216 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDK 294 (486)
Q Consensus 216 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~vkl~DFGla~~~~~~~~ 294 (486)
|+.+++|.+++......+++..+..++.+++.+|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 99999999998765456899999999999999999999988 999999999999998 89999999999987544321
Q ss_pred ceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCc
Q 011412 295 THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373 (486)
Q Consensus 295 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (486)
......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 149 --~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------- 187 (215)
T cd00180 149 --LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------- 187 (215)
T ss_pred --hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------
Confidence 12234578899999998877 889999999999999998
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 374 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+.+++.+|++.||.+||++.++++.|
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2467899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-33 Score=276.73 Aligned_cols=197 Identities=24% Similarity=0.346 Sum_probs=170.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH--------HHHHHHHHHHhcCC---CCCc
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--------KEWLAEVNFLGDLV---HLNL 197 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~---h~nI 197 (486)
.+|..++.||+|+||.|++|.++.+ ...|+||.+.+...-.. -.+-.||+||..|+ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n---------~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKEN---------NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEEeeeccc---------ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 4799999999999999999999875 34799999986543211 12456999999997 9999
Q ss_pred eEEEEEEEeCCeeEEEEeec-CCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011412 198 VKLIGYCIEDDQRLLVYEFM-PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (486)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~-~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 276 (486)
++++++|++++++||+||-- +|-+|+++|..+ ..+++..+..|++|++.|+++||+.+ |||||||-+|+.++.+|
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNG 707 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCC
Confidence 99999999999999999964 456899999655 46999999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 342 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~ 342 (486)
.+||+|||.+.....+. ...++||..|.|||++.+..| +..-|||+||++||.++....||.
T Consensus 708 ~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999998765543 345789999999999998887 567899999999999998888875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=241.83 Aligned_cols=200 Identities=33% Similarity=0.418 Sum_probs=173.6
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCe
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 209 (486)
|.+.+.||.|+||.||++.+.. ++..+|+|.+...... ..+.+.+|+..++.++|+|++++++++...+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 5667899999999999998865 4668999999876544 45678899999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
.++++||+++++|.+++......+++..+..++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++...
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 99999999999999998665433889999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCcceeeeeccccccccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011412 290 PEGDKTHVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 343 (486)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltG~~pf~~ 343 (486)
...... ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 149 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 149 HRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 543210 12335688899999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=243.66 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=188.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEE-EE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY-CI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~-~~ 205 (486)
.+.|.+.+.||+|-||.+-++.++. +...+++|.+.... ...++|.+|...--.| .|.||+.-|++ |+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~---------s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQ---------SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccC---------CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 3578889999999999999999987 56689999997653 3457899998876666 48899988764 66
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE-c-CCCcEEEeec
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-D-ADYNAKLSDF 283 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll-~-~~~~vkl~DF 283 (486)
..+.++++|||++.|+|..-+... .+.+....+++.|++.||.|+|+++ +||||||.+|||| + +..+||||||
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred cCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeec
Confidence 778899999999999998877543 4778888999999999999999999 9999999999999 2 3458999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCcccccc---C--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---G--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
|+.+....... ...-+..|.+||++.. + ...+.+|||.||+++|.+|||+.||+..... .....+|..
T Consensus 168 G~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~- 240 (378)
T KOG1345|consen 168 GLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQ- 240 (378)
T ss_pred ccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHH-
Confidence 99987543221 2234678999997653 2 2467899999999999999999999854322 222222211
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
.. .-..+.+...|. .++..+.++.++-|..+|.+|-...++.+
T Consensus 241 -w~------~rk~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 241 -WL------KRKNPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred -Hh------cccCccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 00 111122222222 23467889999999999999954444443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=252.70 Aligned_cols=271 Identities=25% Similarity=0.317 Sum_probs=199.4
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 203 (486)
....+.|.++++||+|.|++||++.+... ......||+|.+...... ..+.+|+++|..+ -+.||+++.++
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhh
Confidence 34556799999999999999999988762 235678999999765433 5688999999999 48999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEee
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSD 282 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~vkl~D 282 (486)
+..++..++||||++.....+++. .++...+..+++.++.||+++|.+| ||||||||.|+|.+. .+.-.|+|
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence 999999999999999999888873 4668889999999999999999999 999999999999975 46789999
Q ss_pred cCCCCCC-----------------CC--C-----------------------CcceeeeeccccccccCccccc-cCCCC
Q 011412 283 FGLAKDG-----------------PE--G-----------------------DKTHVSTRVMGTYGYAAPEYVM-TGHLT 319 (486)
Q Consensus 283 FGla~~~-----------------~~--~-----------------------~~~~~~~~~~gt~~y~aPE~~~-~~~~~ 319 (486)
||+|... .. + ..........||++|+|||++. ....+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 9998611 00 0 0000111257999999999986 45678
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh----------hhh------ccc---------ccccccccC---
Q 011412 320 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA----------RPH------LGE---------RRRFYRLID--- 371 (486)
Q Consensus 320 ~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~----------~~~------~~~---------~~~~~~~~~--- 371 (486)
.++||||.|||++-+++++.||.....+.. .+.+.+ ... +.+ ...-++.++
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CccceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 899999999999999999999965432211 111100 000 001 000011110
Q ss_pred --C-----ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 372 --P-----RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 372 --~-----~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
+ ..........+..+.+|+.+||..||.+|.++++.|++-
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0 000111112234788999999999999999999998743
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=284.37 Aligned_cols=198 Identities=19% Similarity=0.243 Sum_probs=141.7
Q ss_pred cCCC-CCceEEEEEE-------EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 011412 191 DLVH-LNLVKLIGYC-------IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (486)
Q Consensus 191 ~l~h-~nIv~~~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiH 262 (486)
.++| .||++++++| ...+.++++|||+ +++|.++|......+++..++.|+.||+.||.|||+++ |||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4445 5788888877 2334677889988 66999999766667999999999999999999999988 999
Q ss_pred cCCCCCcEEEcCCC-------------------cEEEeecCCCCCCCCCCc--------------ceeeeeccccccccC
Q 011412 263 RDFKTSNILLDADY-------------------NAKLSDFGLAKDGPEGDK--------------THVSTRVMGTYGYAA 309 (486)
Q Consensus 263 rDLKp~NIll~~~~-------------------~vkl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~a 309 (486)
|||||+||||+..+ .+||+|||+++....... .......+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996544 455666666553211000 000112468999999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHH
Q 011412 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 389 (486)
Q Consensus 310 PE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 389 (486)
||++.+..|+.++|||||||+||||++|..|+..... .+..... ..+.+... .....+..+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~----------~~~~~~~~-----~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH----------RVLPPQIL-----LNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH----------hhcChhhh-----hcCHHHHHH
Confidence 9999999999999999999999999999888643210 0000000 01111110 112345688
Q ss_pred HHHhcccCCCCCCCHHHHHHHh
Q 011412 390 AAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 390 i~~cl~~dP~~RPs~~eil~~L 411 (486)
+.+||+.+|.+||++.|++++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHhCCCChhhCcChHHHhhch
Confidence 9999999999999999998754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=227.38 Aligned_cols=260 Identities=20% Similarity=0.222 Sum_probs=202.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~ 207 (486)
-.|++.++||+|.||++|.|.+.. +++.||||.-..... ..++..|.+..+.|. .++|...|.+..++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~---------nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY---------NNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred ccceeccccccCcceeeecccccc---------cCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 379999999999999999998876 567999998765432 246778888888874 68999999888888
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-----CcEEEee
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-----YNAKLSD 282 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-----~~vkl~D 282 (486)
-+-.||||++ |.+|+|+..-.+..|+...+..+|.|++.-|+|+|++. +|+|||||+|+||... ..|.|+|
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEe
Confidence 8888999999 88999999888889999999999999999999999998 9999999999999643 3589999
Q ss_pred cCCCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 283 FGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 283 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
||+|+...+.... .......||.+||+.....+.+.+...|+-|||-+++++|-|..||++........-.+
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe--- 249 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE--- 249 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH---
Confidence 9999987654332 22345789999999999999999999999999999999999999999865433221111
Q ss_pred hhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
.+++.++. .-...++..++.++..-+...-..+-.+-|+.+-+...+..
T Consensus 250 -KIGe~Kr~------T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 250 -KIGETKRS------TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred -Hhcccccc------CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11221111 00111222334566677777777888888988766655543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=221.09 Aligned_cols=280 Identities=19% Similarity=0.199 Sum_probs=215.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC-CCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~ 205 (486)
....|.++++||+|+||.+|+|.... +|+.||||+-+.... ..++..|.++.+.|+| ..|..+..++.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~---------~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISIT---------SGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeeeeecc---------CCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 34689999999999999999998876 677999999875532 3568899999999975 67888888999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CcEEEee
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSD 282 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~---~~vkl~D 282 (486)
+.++-.+||+++ |.+|++++.-....++..+++-++-|++.-++|+|.++ +|||||||+|+|+.-+ ..+.|+|
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEe
Confidence 999999999999 88999999877778999999999999999999999988 9999999999999543 4689999
Q ss_pred cCCCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 283 FGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 283 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
||+++...+.... .......||.+|.+-....+.+.+...|+-|+|.+|.++.-|..||++..........+...
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~ 237 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS 237 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence 9999876443221 12335789999999988888889999999999999999999999999876544332222111
Q ss_pred hhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCcc-CCCCchhhhhhh
Q 011412 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD-MASSSYYFQTMQ 431 (486)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~-~~~~~~~~~~~~ 431 (486)
+..-......++..++.++.-.+..|-..--++-|+..-+-+.+..+..-.+ ...--|+|....
T Consensus 238 ----------EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 238 ----------EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred ----------HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence 1111111112222334567788899999999999998877766654432222 233456676654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=216.36 Aligned_cols=166 Identities=25% Similarity=0.243 Sum_probs=126.4
Q ss_pred CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeee
Q 011412 220 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299 (486)
Q Consensus 220 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~ 299 (486)
|+|.+++..++..+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999876778999999999999999999999855 999999999999999 99988654321
Q ss_pred eccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCC
Q 011412 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 379 (486)
Q Consensus 300 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (486)
..||+.|||||++.+..|+.++|||||||++|||++|+.||....... ............ ..+... ...
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~-------~~~~~~-~~~ 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPA-------DDPRDR-SNL 132 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhcc-------CCcccc-ccH
Confidence 258999999999999999999999999999999999999996543211 111111000000 000000 011
Q ss_pred HHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 380 IKGAQ--KAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 380 ~~~~~--~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
..... .+.+++.+||..||.+||++.++++++..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 12222 58999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=231.38 Aligned_cols=260 Identities=23% Similarity=0.237 Sum_probs=196.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC----CCceEEEEEE-
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH----LNLVKLIGYC- 204 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~~~~~~- 204 (486)
+|.+.+.||+|+||.||+|.....+ ...+|+|............+..|+.+|..+.. .++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 7999999999999999999886521 34789998876533322367788998888863 5899999998
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-----CcE
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-----YNA 278 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-----~~v 278 (486)
..+...||||+.+ |.+|.++..... ..++...++.|+.|++.+|.+||+.+ +|||||||+|+++... ..+
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceE
Confidence 4778899999999 889999886554 78999999999999999999999998 9999999999999754 469
Q ss_pred EEeecCCCC--CCCCCCc---ce--e-eeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011412 279 KLSDFGLAK--DGPEGDK---TH--V-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350 (486)
Q Consensus 279 kl~DFGla~--~~~~~~~---~~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~ 350 (486)
.|.|||+++ ....... .. . ...+.||..|+++.+..+...+.+.|+||++.++.||+.|..||.........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 999999999 3222111 00 1 12356999999999999999999999999999999999999999655432221
Q ss_pred hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.... ..... ..... +....+..+..+...+-..+..++|....+...|+..
T Consensus 247 ~~~~--~~~~~------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 247 SKFE--KDPRK------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHH--HHhhh------hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1110 00000 00000 1111234566777777779999999999998887544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=229.82 Aligned_cols=176 Identities=19% Similarity=0.170 Sum_probs=133.1
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhcCCCCCceE-E
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVK-L 200 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~-~ 200 (486)
...+|.+.+.||+|+||+||+|++... ++..||||++.... ......+.+|+++|..|+|+||+. +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 456899999999999999999987641 45678999875331 112345889999999999999985 4
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCcEEEcCCCcEE
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF-KTSNILLDADYNAK 279 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL-Kp~NIll~~~~~vk 279 (486)
+++ +..|||||||+|++|.. + .. .. ...++.|++++|.|||+.+ |+|||| ||+|||++.++.+|
T Consensus 88 ~~~----~~~~LVmE~~~G~~L~~-~-~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 88 LAT----GKDGLVRGWTEGVPLHL-A-RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred EEc----CCcEEEEEccCCCCHHH-h-Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 432 45799999999999963 2 11 11 1467889999999999988 999999 99999999999999
Q ss_pred EeecCCCCCCCCCCccee------eeeccccccccCccccccC------CCCchhhHH
Q 011412 280 LSDFGLAKDGPEGDKTHV------STRVMGTYGYAAPEYVMTG------HLTSRSDVY 325 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~Dvw 325 (486)
|+|||+++.......... .+...+++.|+|||.+.-. ..+...|-|
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999999987644321111 1346789999999988532 223446666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-24 Score=214.19 Aligned_cols=259 Identities=32% Similarity=0.420 Sum_probs=197.3
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCC-CceEEEEEEEe
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHL-NLVKLIGYCIE 206 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~-nIv~~~~~~~~ 206 (486)
|.+.+.||.|+||.||++.+. ..+++|.+....... ...+.+|+.+++.+.|+ +|+++++++..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 667789999999999999885 378999998654432 56789999999999988 79999999977
Q ss_pred CCeeEEEEeecCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEeec
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDF 283 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~vkl~DF 283 (486)
....+++++|+.+++|.+++.... ..+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEecc
Confidence 777899999999999997665443 26889999999999999999999988 99999999999999988 7999999
Q ss_pred CCCCCCCCCCcce----eeeeccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-CcchhHHh
Q 011412 284 GLAKDGPEGDKTH----VSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEW 355 (486)
Q Consensus 284 Gla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~-~~~~~~~~ 355 (486)
|+++......... ......||..|+|||.+.+ ..+....|+|++|++++++++|..||...... ........
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence 9998654433221 2355789999999999987 57889999999999999999999997654321 00111111
Q ss_pred hhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...... . .................+.+++..|+..+|..|.+..+....
T Consensus 227 ~~~~~~---~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 ILELPT---P---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHhcCC---c---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 110000 0 000000000001223467899999999999999998877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=241.98 Aligned_cols=255 Identities=20% Similarity=0.252 Sum_probs=187.4
Q ss_pred CCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEec----CC-Cccc-HHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN----HD-GLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 132 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~----~~-~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
....++|.|++|.|+.+......+ .++.|... .. .... ...+..|+.+-..|.|+|++..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~---------~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLK---------SFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEecCCCc---------cchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 456789999999888776654322 33333322 11 1111 112566888888899999988777776
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+....+-+||||++ +|..++... ..+....+..++.|++.||.|||+.+ |.|||||++|+++..+|.+||+|||.
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCc
Confidence 66666666999999 999988654 46788888999999999999999999 99999999999999999999999999
Q ss_pred CCCCCCCCcc--eeeeeccccccccCccccccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 286 AKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 286 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
+......... .....++|+..|+|||++.+..|++ .+||||.|++++.|++|+.||............. ....
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----~~~~ 542 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----NYSD 542 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----cccc
Confidence 9876554443 4556789999999999999999986 6899999999999999999997544332211000 0000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
... .. .-...+....+...+.+|.+||+.||.+|.++.+|++
T Consensus 543 ~~~---~~--~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 543 QRN---IF--EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccc---cc--cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 00 0001112233567889999999999999999999986
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-26 Score=228.73 Aligned_cols=170 Identities=26% Similarity=0.432 Sum_probs=128.6
Q ss_pred EEEEeecCCCChhHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
||.|++|...+|.+||.++ ....++...+.++.|++.|+.| ++ .+||||||.||++..+..+||+|||+.+.
T Consensus 332 yI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 332 YIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred hhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheee
Confidence 7999999999999999643 4567888999999999999999 56 99999999999999999999999999987
Q ss_pred CCCCC----cceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 289 GPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 289 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
..... .....+...||..||+||++.+..|+.++||||||+||+||++ -...|... ..+.+.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-------------~t~~d~ 472 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-------------ATLTDI 472 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-------------Hhhhhh
Confidence 65543 1223456789999999999999999999999999999999997 22222110 000000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e 406 (486)
+ ...++|.....+ ..-..|+.++|...|.+||++.+
T Consensus 473 r--~g~ip~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 R--DGIIPPEFLQDY-----PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred h--cCCCChHHhhcC-----cHHHHHHHHhcCCCcccCchHHH
Confidence 0 011221111111 24568999999999999995444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=201.04 Aligned_cols=172 Identities=9% Similarity=0.074 Sum_probs=134.7
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHH---------HHHHHHHHhcCCCCC
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGDLVHLN 196 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~n 196 (486)
....+|+++++||.|+||.||++.. ++..+|||.+.......... +.+|++.+.++.|++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G 96 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG 96 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence 4568999999999999999998643 23469999997554332222 578999999999999
Q ss_pred ceEEEEEEEeC--------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011412 197 LVKLIGYCIED--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (486)
Q Consensus 197 Iv~~~~~~~~~--------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 268 (486)
|..+..++... ...+|||||++|.+|.++. .++. ....+++.+|..||..+ ++||||||+
T Consensus 97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~ 164 (232)
T PRK10359 97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHG---MVSGDPHKG 164 (232)
T ss_pred CCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcC---CccCCCChH
Confidence 99999886643 3578999999999998874 1222 34568999999999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHH
Q 011412 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 335 (486)
Q Consensus 269 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell 335 (486)
||+++.+| ++|+|||..+........ ..++....|+.++|||+||+++..+.
T Consensus 165 Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 165 NFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999888 999999988765321110 00345566778999999999988765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=197.90 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=187.7
Q ss_pred CCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCceEEEEEEEeCCe
Q 011412 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209 (486)
Q Consensus 132 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 209 (486)
.++.+|.+...|..|+|++..+ .+++|+++...... .++|..|.-.|+-+.||||+.+++.|.....
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-----------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-----------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred hhhhhhccCCCcccccccccCc-----------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 3445688899999999999653 57788887554332 2568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 210 RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
+.++..||+.|+|...|.... -..+..++.+++.++++|++|||+..+ -|.---|....++||++.+.+|. .+-+++
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-mad~kf 339 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MADTKF 339 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-ccccee
Confidence 999999999999999997653 346778899999999999999999763 23344689999999999888764 111111
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
... .....-.+.||+||.++...-+ .++|+|||.++||||.|...||.+..+.+..-.+
T Consensus 340 sfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------------ 401 (448)
T KOG0195|consen 340 SFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------------ 401 (448)
T ss_pred eee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------------
Confidence 100 0112246899999998765443 5799999999999999999999876554321111
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.-..+..++++..+..+.+|+.-|+..||.+||.+..|+-.|+.+
T Consensus 402 ----aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 402 ----ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ----hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 111223333444456788999999999999999999999888765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=188.57 Aligned_cols=139 Identities=17% Similarity=0.166 Sum_probs=107.8
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--c------------------------HHHHHHHHH
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--G------------------------HKEWLAEVN 187 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~E~~ 187 (486)
...||+|+||.||+|.+. +|+.||||+++..... . ......|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 468999999999999874 4779999999754211 0 012245999
Q ss_pred HHhcCCCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCC
Q 011412 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIYRDFK 266 (486)
Q Consensus 188 ~l~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yL-H~~~~~~iiHrDLK 266 (486)
+|.++.++++.....+.. ...+|||||+++++|...+.. ...++...+..++.|++.+|.|| |+.+ |+|||||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlk 145 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLS 145 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999998877644333222 223899999998877655333 34788999999999999999999 6878 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCC
Q 011412 267 TSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 267 p~NIll~~~~~vkl~DFGla~~~ 289 (486)
|+|||++ ++.++|+|||++...
T Consensus 146 P~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 146 EYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHEEEE-CCcEEEEEccccccC
Confidence 9999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-24 Score=217.11 Aligned_cols=229 Identities=28% Similarity=0.354 Sum_probs=181.2
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH--HHHHHHHHHHhcCC-CCCceEEEEEEEeCCeeEE
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLL 212 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~l 212 (486)
.+|.|.||.||++.-.. ....|..+|+|++++...... .....|..++...+ ||.+|++...++.+..+++
T Consensus 1 vlg~g~~gkvfLvrk~~------g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAG------GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHhc------cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 37999999999874332 122566799998876543221 13456788888886 9999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011412 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~ 292 (486)
+++|..||.|...+... ..+.......+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++.....
T Consensus 75 ~ld~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhhcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 99999999998887544 35667777777888999999999988 999999999999999999999999999876543
Q ss_pred CcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 011412 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 372 (486)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (486)
.. .|||..|||||++. ....++|+||||++++||+||..||.. +.. .. ++.
T Consensus 151 ~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~---~~----------Il~- 201 (612)
T KOG0603|consen 151 KI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTM---KR----------ILK- 201 (612)
T ss_pred hh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHH---HH----------Hhh-
Confidence 22 28999999999987 678899999999999999999999975 110 00 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011412 373 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404 (486)
Q Consensus 373 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 404 (486)
....++......+++++..++..+|..|.-.
T Consensus 202 -~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 -AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1122345556788999999999999999755
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-22 Score=181.92 Aligned_cols=141 Identities=17% Similarity=0.154 Sum_probs=110.5
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---------------------c-----HHHHHHHHH
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---------------------G-----HKEWLAEVN 187 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---------------------~-----~~~~~~E~~ 187 (486)
.+.||+|+||.||+|.+. +|+.||||+++..... . ...+..|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 2 NGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred CceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 568999999999999864 4779999998864211 0 112357899
Q ss_pred HHhcCCCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCC
Q 011412 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFK 266 (486)
Q Consensus 188 ~l~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLK 266 (486)
.+.++.|++|.....+... ..+|||||++|+++...+.. ...++...+..++.|++.+|.+||. .+ |+|||||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlk 145 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLS 145 (190)
T ss_pred HHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 9999999987554444333 24899999988865443222 2457788899999999999999999 88 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCCCC
Q 011412 267 TSNILLDADYNAKLSDFGLAKDGPE 291 (486)
Q Consensus 267 p~NIll~~~~~vkl~DFGla~~~~~ 291 (486)
|+|||++ ++.++|+|||+++....
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecCC
Confidence 9999998 88999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=179.10 Aligned_cols=188 Identities=18% Similarity=0.079 Sum_probs=139.2
Q ss_pred CCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc----HHHHHHHHHHHhcCC-CCCceEEEEEEEe
Q 011412 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (486)
Q Consensus 132 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~nIv~~~~~~~~ 206 (486)
-+...|++|+||+||.+.. .+..++.+.+.....-. ...+.+|+++|++|. |++|++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 3456899999999997644 34577777776543311 124678999999995 5789999886
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF-KTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL-Kp~NIll~~~~~vkl~DFGl 285 (486)
+..+++|||+.|.+|...+.. ....++.|++.+|.+||..+ |+|||| ||+|||++.++.++|+|||+
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCC
Confidence 346999999999998754311 12357889999999999998 999999 79999999999999999999
Q ss_pred CCCCCCCCcc----ee-------eeeccccccccCccccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 011412 286 AKDGPEGDKT----HV-------STRVMGTYGYAAPEYVMTG-HLT-SRSDVYSFGVVLLEMLTGRRSMDKNR 345 (486)
Q Consensus 286 a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslGvil~elltG~~pf~~~~ 345 (486)
+......... .. ......++.|++|+...-. ..+ ...++++.|+.+|.++|+..++..+.
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 9865432210 00 0012367788888754322 233 57899999999999999998875443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=186.47 Aligned_cols=231 Identities=21% Similarity=0.283 Sum_probs=148.6
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCC----------CCc
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVH----------LNL 197 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~nI 197 (486)
+...+.||.|+|+.||.+.+.. ||+.+|||+...... ...+++.+|.-....+.+ -.+
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~---------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~ 84 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVE---------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF 84 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred EEEccccccCCceEEEEEEEcc---------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence 3455789999999999999876 889999999864432 234556666655544332 122
Q ss_pred eEEEEEEE---------eC---C-----eeEEEEeecCCCChhHHHh---hcCC---CCCHHHHHHHHHHHHHHHHHHHh
Q 011412 198 VKLIGYCI---------ED---D-----QRLLVYEFMPRGSLENHLF---RRSL---PLPWSIRMKIALGAAKGLAFLHE 254 (486)
Q Consensus 198 v~~~~~~~---------~~---~-----~~~lv~E~~~~gsL~~~l~---~~~~---~l~~~~~~~i~~qi~~~l~yLH~ 254 (486)
+..++... .. . ..+++|+-+ .++|.+++. .... .+....++.+..|+++.+++||.
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 22222221 11 1 336788888 558888753 2222 24455667888999999999999
Q ss_pred CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc--------CCCCchhhHHH
Q 011412 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------GHLTSRSDVYS 326 (486)
Q Consensus 255 ~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvws 326 (486)
.+ |+|+||+|+|+|++.+|.++|+||+........ ... ...+..|.+||.... -.++.+.|.|+
T Consensus 164 ~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 164 YG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp TT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred cc---eEecccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 99 999999999999999999999999987664321 111 345678999997643 25788999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 011412 327 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401 (486)
Q Consensus 327 lGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 401 (486)
||+++|.|.+|..||....+...... .+.. +.+.++.++.||..+|+.||.+|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~----------------~f~~------C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW----------------DFSR------CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG----------------GGTT------SS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCccccccc----------------cchh------cCCcCHHHHHHHHHHccCCcccC
Confidence 99999999999999975433221110 0110 11446789999999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=214.78 Aligned_cols=209 Identities=26% Similarity=0.382 Sum_probs=147.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|..+++|..|+||.||+.+++. +.+.+|+ .++++.. +++- +|.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~---------trqrfa~-kiNkq~l-----ilRn--ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKE---------TRQRFAM-KINKQNL-----ILRN--ILTFAGNPFVV---------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccc---------cccchhh-cccccch-----hhhc--cccccCCccee----------
Confidence 578889999999999999999876 6678998 4544321 1111 23223334333
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
|+-..++. ..++++... +.+++|||+.+ |+|||+||+|.||..-|++|+.|||+++.
T Consensus 136 -----------gDc~tllk-~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 -----------GDCATLLK-NIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred -----------chhhhhcc-cCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence 45555453 223444333 67899999988 99999999999999999999999999875
Q ss_pred CCCCCcce-------------eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011412 289 GPEGDKTH-------------VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 289 ~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~ 355 (486)
........ ....++||+.|.|||++..+.|+..+|||++|+|+||++-|+.||.++.+.....
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg---- 268 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG---- 268 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh----
Confidence 32211100 1123699999999999999999999999999999999999999999876543211
Q ss_pred hhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 011412 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402 (486)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 402 (486)
..+.+...+.+- | ...+.+++++|.++|+.+|..|-
T Consensus 269 --~visd~i~wpE~-d--------ea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 269 --QVISDDIEWPEE-D--------EALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred --hhhhhhcccccc-C--------cCCCHHHHHHHHHHHHhChHhhc
Confidence 111111111111 1 12246789999999999999996
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=177.89 Aligned_cols=136 Identities=19% Similarity=0.210 Sum_probs=106.6
Q ss_pred CCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-----CCCCceEEEEEEEeC
Q 011412 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-----VHLNLVKLIGYCIED 207 (486)
Q Consensus 133 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~~~~~~~ 207 (486)
-.++||+|+||.||. +.. ++.. +||++........+.+.+|+++++.+ .||||+++++++.++
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~ 73 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD 73 (210)
T ss_pred CcceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence 346899999999995 433 3334 69988765444557799999999999 579999999999887
Q ss_pred C---eeE-EEEee--cCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCcEEEcC----CC
Q 011412 208 D---QRL-LVYEF--MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL-AFLHEEAERPVIYRDFKTSNILLDA----DY 276 (486)
Q Consensus 208 ~---~~~-lv~E~--~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l-~yLH~~~~~~iiHrDLKp~NIll~~----~~ 276 (486)
. .++ +|||| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++ ||||||||+|||++. ++
T Consensus 74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 74 CGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEV 146 (210)
T ss_pred CCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCC
Confidence 3 434 78999 5579999999553 35555 35677888777 9999988 999999999999974 34
Q ss_pred cEEEeecCCCC
Q 011412 277 NAKLSDFGLAK 287 (486)
Q Consensus 277 ~vkl~DFGla~ 287 (486)
.++|+||+.+.
T Consensus 147 ~~~LiDg~G~~ 157 (210)
T PRK10345 147 IPVVCDNIGES 157 (210)
T ss_pred cEEEEECCCCc
Confidence 79999955443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=196.52 Aligned_cols=218 Identities=26% Similarity=0.406 Sum_probs=166.6
Q ss_pred HhcCCCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011412 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (486)
Q Consensus 189 l~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 268 (486)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+......+++.....++++|+.||.|||...- ..|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeeeeccc
Confidence 467899999999999999999999999999999999998878889999999999999999999998651 299999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCC-------CCchhhHHHHHHHHHHHHhCCCCC
Q 011412 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-------LTSRSDVYSFGVVLLEMLTGRRSM 341 (486)
Q Consensus 269 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslGvil~elltG~~pf 341 (486)
|+++|....+||+|||+.................-...|.|||.+.... .+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999988764311111112223456899999887531 466799999999999999999999
Q ss_pred CCCCCCCcc-hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 342 DKNRPNGEH-NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 342 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
......... .++.+... .. ...+.|.+.... +....+..++..||..+|.+||++..+-..++.+..
T Consensus 159 ~~~~~~~~~~eii~~~~~--~~----~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK--GG----SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHHh--cC----CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 764433322 22222111 00 011222222111 233468899999999999999999999998887654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=210.93 Aligned_cols=198 Identities=20% Similarity=0.209 Sum_probs=158.4
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCCceEEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLI 201 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~ 201 (486)
......|.|.+.||+|+||.||+|...+ |+.||+|+-+....-. |.-=.+++.+|+ -+-|..+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~----------~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~ 760 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN----------GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHIS 760 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC----------CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHH
Confidence 3445678888999999999999998753 6799999987654321 211222333333 24466666
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-------
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA------- 274 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~------- 274 (486)
.++...+.-+||+||.+.|+|.+++. ....+++..++.++.|++..|+.||..+ |||+||||+|+||..
T Consensus 761 ~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 761 SAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCc
Confidence 66677788899999999999999996 5567999999999999999999999999 999999999999932
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 011412 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339 (486)
Q Consensus 275 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~ 339 (486)
...++|+|||.+.+...-.........++|-.+-.+|+..+..+++.+|.|.|..+++-||.|+.
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 34589999999987544333333556788999999999999999999999999999999999864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-22 Score=211.20 Aligned_cols=251 Identities=24% Similarity=0.283 Sum_probs=177.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-c---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-L---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
+|...+.||++.|=.|.+|++.+ |. |+||++-... . ....+.+.|++ ...++|||++.+.-+-.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 56677899999999999998764 44 8899875443 2 22344555666 55668999999888777
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.+..-|||-+|+.+ +|.|.|-.+. -+...+.+-|+.|++.||.-+|..+ |+|+|||.+||||..-.=+.|+||..
T Consensus 92 t~kAAylvRqyvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred hhHHHHHHHHHHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccc
Confidence 77778899999944 9999885443 4566677889999999999999999 99999999999998777789999987
Q ss_pred CCCC--CCCCc---ceeeeeccccccccCccccccC-----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 011412 286 AKDG--PEGDK---THVSTRVMGTYGYAAPEYVMTG-----------HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 348 (486)
Q Consensus 286 a~~~--~~~~~---~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~ 348 (486)
-+.. ++++. .....+-..-..|.|||-+... ..+++-||||+||+++||++ |+++|.-.
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---- 242 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---- 242 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----
Confidence 6542 22111 1111111223479999977531 15678999999999999998 68888421
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.+..+......+.....+.+ .+..++.|+..|++.||.+|.++++.|+.-..+
T Consensus 243 --QL~aYr~~~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 243 --QLLAYRSGNADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --HHHhHhccCccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11112111111111111111 123578999999999999999999999865543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=168.04 Aligned_cols=134 Identities=18% Similarity=0.260 Sum_probs=112.3
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--------HHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
+.||+|++|.||+|.+ .|..|+||+........ ...+.+|+.++..+.|++|.....++.+
T Consensus 2 ~~l~~G~~~~vy~~~~-----------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEee-----------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 5799999999999986 34578999865432211 1347789999999999998877777777
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..++||||++|++|.+++.... . .+..++.+++.+|.+||+.+ ++|+||+|.|||++ ++.++|+|||++
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcc
Confidence 788899999999999999885432 2 78899999999999999988 99999999999999 789999999998
Q ss_pred CC
Q 011412 287 KD 288 (486)
Q Consensus 287 ~~ 288 (486)
+.
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 75
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=171.50 Aligned_cols=143 Identities=18% Similarity=0.163 Sum_probs=110.7
Q ss_pred CCCCCCeeeecCCeEEEEEE-EccCCCccccCCCCcEEEEEEecCCCcc------------------------cHHHHHH
Q 011412 130 NFRPESLLGEGGFGCVFKGW-IEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------------GHKEWLA 184 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~-~~~~~~~~~~~~~g~~vavK~~~~~~~~------------------------~~~~~~~ 184 (486)
.|.+.+.||+|+||.||+|. +.. +|..||||+++..... ....+.+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG---------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC---------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 48899999999999999998 333 5789999998754210 0122568
Q ss_pred HHHHHhcCCCCC--ceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 011412 185 EVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (486)
Q Consensus 185 E~~~l~~l~h~n--Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiH 262 (486)
|+.++.++.+.+ +.+++++ ...+|||||++|++|..++... ..+....+..++.||+.+|.+||..+. |+|
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH 172 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGE--LVH 172 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCC--EEe
Confidence 999999997633 4445543 2358999999998887655332 345666678999999999999998652 999
Q ss_pred cCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 263 RDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 263 rDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
|||||+|||++ ++.++|+|||++...
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999 889999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=165.47 Aligned_cols=131 Identities=21% Similarity=0.317 Sum_probs=106.0
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.||+|+||.||+|.+ +|..|++|........ ....+.+|++++..+.|+++.....++...
T Consensus 1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 489999999999985 3567999986533211 124567899999999988765555555667
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||++|++|.+++..... .++.+++.+|.+||+.+ ++|+||+|.|||++ ++.++|+|||++.
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 778999999999999988754321 78999999999999988 99999999999999 8899999999987
Q ss_pred CC
Q 011412 288 DG 289 (486)
Q Consensus 288 ~~ 289 (486)
..
T Consensus 138 ~~ 139 (199)
T TIGR03724 138 YS 139 (199)
T ss_pred CC
Confidence 64
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=172.62 Aligned_cols=197 Identities=22% Similarity=0.249 Sum_probs=138.0
Q ss_pred CCCCceEEEEEEEeC---------------------------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHH
Q 011412 193 VHLNLVKLIGYCIED---------------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245 (486)
Q Consensus 193 ~h~nIv~~~~~~~~~---------------------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi 245 (486)
.|||||+++++|.+. ..+|+||...+ .+|..++..+ ..+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC--CCchHHHHHHHHHH
Confidence 599999999987642 15589998874 4999998654 34556667788899
Q ss_pred HHHHHHHHhCCCCCeEecCCCCCcEEE--cCCC--cEEEeecCCCCCCCCCC----cceeeeeccccccccCccccccC-
Q 011412 246 AKGLAFLHEEAERPVIYRDFKTSNILL--DADY--NAKLSDFGLAKDGPEGD----KTHVSTRVMGTYGYAAPEYVMTG- 316 (486)
Q Consensus 246 ~~~l~yLH~~~~~~iiHrDLKp~NIll--~~~~--~vkl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~- 316 (486)
++|+.|||.++ |.|||||.+|||| |+|+ .+.|+|||++-...... .....-..-|...-||||+....
T Consensus 351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999998 9999999999998 4443 47899999875432211 01111124578899999987532
Q ss_pred -C----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHH
Q 011412 317 -H----LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 391 (486)
Q Consensus 317 -~----~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 391 (486)
. --.++|.|+.|.+.||+++...||...-. ...+.-. ..+.--|. ++..++..+++|+.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~-----------Yqe~qLPa----lp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT-----------YQESQLPA----LPSRVPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh-----------hhhhhCCC----CcccCChHHHHHHH
Confidence 1 12489999999999999999999976211 0001000 11111122 23334567899999
Q ss_pred HhcccCCCCCCCHHHHHHHh
Q 011412 392 HCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 392 ~cl~~dP~~RPs~~eil~~L 411 (486)
.+|+.||.+|++..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876555544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=185.58 Aligned_cols=137 Identities=22% Similarity=0.270 Sum_probs=111.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC--Cc------ccHHHHHHHHHHHhcCCCCCceEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GL------QGHKEWLAEVNFLGDLVHLNLVKL 200 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~nIv~~ 200 (486)
..|...+.||+|+||.||+|.+.. ..+++|+.... .. .....+.+|++++..++|++|+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG-----------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC-----------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 455678899999999999998743 23444432111 11 112457899999999999999988
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
+.++......++||||+++++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence 888777778899999999999999884 35678999999999999988 9999999999999 6789999
Q ss_pred eecCCCCCC
Q 011412 281 SDFGLAKDG 289 (486)
Q Consensus 281 ~DFGla~~~ 289 (486)
+|||+++..
T Consensus 469 iDFGla~~~ 477 (535)
T PRK09605 469 IDFGLGKYS 477 (535)
T ss_pred EeCcccccC
Confidence 999999763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=161.21 Aligned_cols=138 Identities=17% Similarity=0.073 Sum_probs=108.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc----------------------cHHHHHHHHH
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVN 187 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~ 187 (486)
.|.+.+.||+|+||.||+|... +|+.||||++...... ....+..|+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 85 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA 85 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence 4788899999999999999763 4779999987643210 0112567899
Q ss_pred HHhcCCCCC--ceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 011412 188 FLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (486)
Q Consensus 188 ~l~~l~h~n--Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL 265 (486)
++..+.|++ +...++ ....++||||++|++|..+... .....++.+++.++.++|..+ |+||||
T Consensus 86 ~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 86 ALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 999998774 455544 2456899999999999765421 235678899999999999988 999999
Q ss_pred CCCcEEEcCCCcEEEeecCCCCCCCC
Q 011412 266 KTSNILLDADYNAKLSDFGLAKDGPE 291 (486)
Q Consensus 266 Kp~NIll~~~~~vkl~DFGla~~~~~ 291 (486)
||+||+++.++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-19 Score=192.34 Aligned_cols=256 Identities=25% Similarity=0.290 Sum_probs=192.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCC-CCCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~ 206 (486)
.|.+.+.||+|+|+.|-+.....+ ....+|+|.+.... .........|..+-..+. |.|++++++....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 466677899999999988766443 33467888776554 122233445777777776 9999999999999
Q ss_pred CCeeEEEEeecCCCChhHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCcEEEcCCC-cEEEeec
Q 011412 207 DDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDADY-NAKLSDF 283 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l-~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~~~~~iiHrDLKp~NIll~~~~-~vkl~DF 283 (486)
.+..+++++|..|+++...+ .......+......++.|+..++.|+| ..+ +.||||||+|.+++..+ .++++||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence 99999999999999999888 433335667778889999999999999 777 99999999999999999 9999999
Q ss_pred CCCCCCCC-CCcceeeeeccc-cccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 284 GLAKDGPE-GDKTHVSTRVMG-TYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 284 Gla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
|+|+.... ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..||......... ...|.
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~---- 244 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWK---- 244 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeec----
Confidence 99998776 444444455788 9999999988874 4567899999999999999999999754432211 00011
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
.....+. ............+++.+++..+|..|.+.+++..
T Consensus 245 ~~~~~~~--------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 245 SNKGRFT--------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccccccc--------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 0000000 0011122345778999999999999999887754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=145.02 Aligned_cols=136 Identities=22% Similarity=0.147 Sum_probs=114.2
Q ss_pred CCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC--CCceEEEEEEEeCCee
Q 011412 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDDQR 210 (486)
Q Consensus 133 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~ 210 (486)
+.+.||.|.++.||++... +..++||....... ...+..|+.++..+.| .++++++.+....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 4568999999999999874 24799999876543 4568899999999976 5899999988888889
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
+++|||++++.+..+ +......++.+++.+|++||.....+++|+||+|+|||++..+.++++|||+++..
T Consensus 69 ~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 69 YLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred EEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 999999998877653 45667788999999999999864345999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.2e-17 Score=148.37 Aligned_cols=136 Identities=21% Similarity=0.152 Sum_probs=97.9
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHH----------------------HHHHHHHH
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKE----------------------WLAEVNFL 189 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l 189 (486)
.+.||+|+||.||+|.+. +|..||||++....... ... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 468999999999999764 36689999987542211 011 13566666
Q ss_pred hcCCCC--CceEEEEEEEeCCeeEEEEeecCCCChhHH-HhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCC
Q 011412 190 GDLVHL--NLVKLIGYCIEDDQRLLVYEFMPRGSLENH-LFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDF 265 (486)
Q Consensus 190 ~~l~h~--nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDL 265 (486)
..+.+. .+.+.+++ ...++||||++++.+... +.... . ......++.+++.++.++|. .+ |+||||
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl 141 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAG---LVHGDL 141 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccC---cCcCCC
Confidence 666443 34555543 246899999998544321 21111 1 15678899999999999999 77 999999
Q ss_pred CCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 266 KTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 266 Kp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
||+||+++ ++.++|+|||.+....
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred ChhhEEEE-CCcEEEEECccccccc
Confidence 99999999 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-16 Score=151.12 Aligned_cols=135 Identities=22% Similarity=0.238 Sum_probs=104.0
Q ss_pred Ceee-ecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------------ccHHHHHHHHHHHhcCCCCCc--e
Q 011412 135 SLLG-EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGDLVHLNL--V 198 (486)
Q Consensus 135 ~~lg-~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nI--v 198 (486)
..|| .||.|+||++... +..++||.+..... .....+.+|+.++..|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4688 8999999998763 45789988854221 112457889999999998875 6
Q ss_pred EEEEEEEeCCe----eEEEEeecCC-CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 199 KLIGYCIEDDQ----RLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 199 ~~~~~~~~~~~----~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
+.+++...... .+|||||++| .+|.+++... .++.. .+.+|+.+|.+||+.+ |+||||||+|||++
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~ 176 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLD 176 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEc
Confidence 77776544322 2599999997 6898887542 34443 3568999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCC
Q 011412 274 ADYNAKLSDFGLAKDG 289 (486)
Q Consensus 274 ~~~~vkl~DFGla~~~ 289 (486)
.++.++|+|||.++..
T Consensus 177 ~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 177 PDGKFWLIDFDRGELR 192 (239)
T ss_pred CCCCEEEEECCCcccC
Confidence 9899999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.2e-16 Score=160.06 Aligned_cols=253 Identities=25% Similarity=0.289 Sum_probs=187.5
Q ss_pred hcCCCCCCeeee--cCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcC-CCCCceEEEE
Q 011412 128 TRNFRPESLLGE--GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (486)
Q Consensus 128 ~~~y~~~~~lg~--G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~~~~ 202 (486)
...|.+...+|. |.+|.||.+.... ..++..+|+|.-+.... .....=.+|+.....+ .|+|.++.+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 356777889999 9999999998722 12567899998443222 2223335677777777 4999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCcEEEcCC-Cc
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK----GLAFLHEEAERPVIYRDFKTSNILLDAD-YN 277 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~----~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~ 277 (486)
.|.+.+.+|+-+|+| +.+|..+.......++...++.++.+... ||.++|..+ ++|-|+||+||++..+ ..
T Consensus 186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 186 AWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred ccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccce
Confidence 999999999999999 57888888766666888999999999999 999999988 9999999999999998 88
Q ss_pred EEEeecCCCCCCCCCCcce---eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011412 278 AKLSDFGLAKDGPEGDKTH---VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~ 354 (486)
.+++|||+......+.... ...+..|...|++||+. .+-++...|||+||.++.+..++...+.......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------ 334 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS------ 334 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC------
Confidence 9999999998876654221 22234688899999954 5688999999999999999999877654321110
Q ss_pred hhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 355 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
|.. +.... +..++.......+...+..|++.+|..|+++..+..
T Consensus 335 W~~--------~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 WSQ--------LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc--------ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 110 00100 111121112334556899999999999999877664
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=150.15 Aligned_cols=141 Identities=20% Similarity=0.139 Sum_probs=98.0
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH----------------------------------
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---------------------------------- 179 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---------------------------------- 179 (486)
.+.||.|++|+||+|+.. +|+.||||+.+.......
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 368999999999999875 477999999864321100
Q ss_pred ------HHHHHHHHHHhcCC----CCCceEEEEEE-EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHH-
Q 011412 180 ------KEWLAEVNFLGDLV----HLNLVKLIGYC-IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK- 247 (486)
Q Consensus 180 ------~~~~~E~~~l~~l~----h~nIv~~~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~- 247 (486)
-++.+|.+.+.++. |.+-+.+-.++ ......+|||||++|++|.++......... ...++.+++.
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~ 268 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARS 268 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHH
Confidence 01344555555542 33333333332 224457999999999999887643222222 3445555555
Q ss_pred HHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 248 ~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
.+..+|..+ ++|+|+||.||+++.++.++|+|||++....
T Consensus 269 ~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 269 FLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 467889877 9999999999999999999999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.6e-15 Score=141.20 Aligned_cols=204 Identities=23% Similarity=0.279 Sum_probs=142.6
Q ss_pred HHHHhcCCCCCceEEEEEEEeCC-----eeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 011412 186 VNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAE 257 (486)
Q Consensus 186 ~~~l~~l~h~nIv~~~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~ 257 (486)
+.-|-.+.|.|||+++.||.+.. ...++.||+..|+|..+|.+. ...+......+|+.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 44455678999999999987643 467999999999999999743 456778888999999999999999987
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC---cceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHH
Q 011412 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334 (486)
Q Consensus 258 ~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el 334 (486)
.+|+|++|..+-|++..+|-+||+- +.-....... .........+-++|.|||.-.....+.++|||+||...+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 7799999999999999999888752 1111100000 00011224577899999987777788899999999999999
Q ss_pred HhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 335 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 335 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..|..--.......... ....... ..+-+ ..-+.++.+||+..|..||+|.+++.+.
T Consensus 276 ailEiq~tnseS~~~~e-e~ia~~i-------~~len------------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVE-ENIANVI-------IGLEN------------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCcceeehh-hhhhhhe-------eeccC------------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 88764321111110000 0000000 00001 1123688999999999999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-13 Score=123.77 Aligned_cols=131 Identities=19% Similarity=0.049 Sum_probs=96.9
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCce-EEEEEEEeCCeeEE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLL 212 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~l 212 (486)
++.|+.|.++.||++... |..|++|....... ....+..|+.++..+.+.+++ +++.+. .+..++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence 357899999999998763 55799998765432 123467899999988665544 455443 334589
Q ss_pred EEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
||||++|.++.... .....++.+++++|+.||... ...++|+|++|.||+++ ++.++|+|||.+..
T Consensus 69 v~e~i~G~~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 69 ITEFIEGSELLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EEEecCCCcccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99999998886530 111345678999999999876 22359999999999998 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.1e-14 Score=144.00 Aligned_cols=248 Identities=21% Similarity=0.154 Sum_probs=178.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHH--HHHHHHHHhcC-CCCCceEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGDL-VHLNLVKLIGY 203 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~nIv~~~~~ 203 (486)
...+|..+..||.|.|+.||+...... ++..|++|.+...-.....+ -+.|+-+...+ .|.++++++..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~--------~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPE--------GDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCC--------CCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 345788889999999999999874422 45689999887654333332 24566666666 58899999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEEee
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSD 282 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~vkl~D 282 (486)
|...+..||-.|||+++++...+ .-...+.+..++.+..|++.++.++|++. ++|+|+||+||++..+ +..+++|
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred ccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence 98888899999999999988766 22345677788999999999999999988 9999999999999876 7789999
Q ss_pred cCCCCCCCCCCcceeeeecccccccc--CccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYA--APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
||+.+...... ....+.-+++ +++......+..++|+++||+.+.|.+++...-.... .|..
T Consensus 411 ~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~--- 474 (524)
T KOG0601|consen 411 FGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT--- 474 (524)
T ss_pred cccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee---
Confidence 99987532111 1122333444 4555556788899999999999999999875332110 0110
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
+..-. ....+... ..+..+.+.++..++..||.+.++..+.+
T Consensus 475 -----i~~~~----~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 475 -----IRSGD----TPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -----eeccc----ccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00000 11111122 56778999999999999999988776544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.5e-12 Score=136.32 Aligned_cols=143 Identities=17% Similarity=0.128 Sum_probs=95.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc------------------------------
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG------------------------------ 178 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~------------------------------ 178 (486)
.+|+. +.||+|++|+||+|++++ +|+.||||+++..-...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 45666 799999999999999875 57899999997542100
Q ss_pred ----HH------HHHHHHHHHhcCC----CCCceEEEEEEEe-CCeeEEEEeecCCCChhHHH--hhcCC---CCCHHHH
Q 011412 179 ----HK------EWLAEVNFLGDLV----HLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHL--FRRSL---PLPWSIR 238 (486)
Q Consensus 179 ----~~------~~~~E~~~l~~l~----h~nIv~~~~~~~~-~~~~~lv~E~~~~gsL~~~l--~~~~~---~l~~~~~ 238 (486)
.+ ++.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.|.++- ...+. .+....+
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 01 1344555544442 4444444444433 45678999999999998743 22221 1223333
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----cEEEeecCCCCCCCC
Q 011412 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NAKLSDFGLAKDGPE 291 (486)
Q Consensus 239 ~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~----~vkl~DFGla~~~~~ 291 (486)
..++.|++ ..+ ++|+|+||.||+++.++ .++++|||++.....
T Consensus 270 ~~~~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQVF-------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHH-------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34444443 455 99999999999999888 999999999987644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.2e-12 Score=132.19 Aligned_cols=164 Identities=16% Similarity=0.181 Sum_probs=124.7
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHH
Q 011412 162 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241 (486)
Q Consensus 162 ~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i 241 (486)
++..|.|+..+...........+-++.|+.|+||||+++++.+..++.+|||+|-+ .-|..++.+.+ ...+..-
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~~G 109 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVCLG 109 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHHHH
Confidence 57788888887665433345678899999999999999999999999999999998 35776775443 5666777
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCch
Q 011412 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 321 (486)
Q Consensus 242 ~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 321 (486)
+.||+.||.|||+.+. ++|++|.-..|+|+..|..||++|-++......... .....--..|..|+.+.... -.
T Consensus 110 l~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 110 LFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--cc
Confidence 8899999999986443 999999999999999999999999988654332210 00011122456666443222 35
Q ss_pred hhHHHHHHHHHHHHhC
Q 011412 322 SDVYSFGVVLLEMLTG 337 (486)
Q Consensus 322 ~DvwslGvil~elltG 337 (486)
.|.|.|||+++|++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 7999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.6e-13 Score=145.67 Aligned_cols=249 Identities=23% Similarity=0.214 Sum_probs=169.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..|.+.+.+-+|.|+.++.+.-.. +|-..++|........ ..+....+-.++-..+||-+++..--+.
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~---------sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAG---------SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred ccceecccccCCCCcccccCCccc---------cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC
Confidence 456667788889999998875433 4545555554432111 1112223333333334566666555555
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.....+|||+|+.+++|...|...+ ..+.+....+...+.++++|||... ++|||++|.|+|+..+++.++.|||+
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence 6778899999999999999886554 4455555566667888999999876 89999999999999999999999984
Q ss_pred CCCCCCC-----------------------------CcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh
Q 011412 286 AKDGPEG-----------------------------DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336 (486)
Q Consensus 286 a~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt 336 (486)
....... +.........||+.|.+||...+......+|+|++|++++|.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 3221000 00011223679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 011412 337 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405 (486)
Q Consensus 337 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ 405 (486)
|.+||....+..... ..+. ..+ + +..-+...+..+++++...|..+|.+|-.+.
T Consensus 1031 g~pp~na~tpq~~f~------ni~~------~~~-~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFE------NILN------RDI-P--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchhhhhh------cccc------CCC-C--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999998765532211 0000 000 0 1111223346788999999999999998776
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=2e-11 Score=111.72 Aligned_cols=145 Identities=14% Similarity=0.088 Sum_probs=100.6
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---------------------cc-HHH----HHHHHH
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------------------QG-HKE----WLAEVN 187 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---------------------~~-~~~----~~~E~~ 187 (486)
..+||.|--+.||.|...+... ....+..+|||+.+.... .. .+. ..+|++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 3579999999999997543100 011346899998752110 00 112 237999
Q ss_pred HHhcCCC--CCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecC
Q 011412 188 FLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIYRD 264 (486)
Q Consensus 188 ~l~~l~h--~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yL-H~~~~~~iiHrD 264 (486)
.|.++.. -++.+++++ ..-+|||||+.++.+.....+. ..++......+..+++.+|..| |..+ |||+|
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9999853 466777765 4568999999765443221111 2345556677889999999999 8877 99999
Q ss_pred CCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 265 FKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 265 LKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|++.|||++ ++.+.|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2e-11 Score=108.07 Aligned_cols=131 Identities=23% Similarity=0.297 Sum_probs=98.8
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC-----Ccc---cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-----GLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-----~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++++|+-+.+|.+.+. |..+++|.--.. ... ......+|+++|.++.--.|.-.+=+..+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 36789999999999663 345666643211 111 11345789999999876666555555667
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+...|+|||++|..|.+.|... ...++..+-.-+.-||..+ |||+||.++||++..++ +.++||||+
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcc
Confidence 78889999999999998888654 2466777778888999988 99999999999997664 999999999
Q ss_pred CC
Q 011412 287 KD 288 (486)
Q Consensus 287 ~~ 288 (486)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 75
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.6e-11 Score=106.01 Aligned_cols=142 Identities=23% Similarity=0.235 Sum_probs=106.6
Q ss_pred CCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEec-----CCCcc---cHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-----HDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 133 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~-----~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.+.+|-+|+-+.|+++.+ .|+.++||.-. +.... .....++|+++|.++.--.|.-..=++
T Consensus 11 ~l~likQGAEArv~~~~~-----------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeecc-----------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 567899999999999987 46677777532 22211 124578899999998766665555566
Q ss_pred EeCCeeEEEEeecCC-CChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---cEE
Q 011412 205 IEDDQRLLVYEFMPR-GSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---NAK 279 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---~vk 279 (486)
.+...-+|+|||++| .++.+++.... ..........+++.|-+.|.-||..+ |||+||..+||+|..++ .+.
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceE
Confidence 777777899999977 47888876443 23333344788999999999999988 99999999999996554 358
Q ss_pred EeecCCCCC
Q 011412 280 LSDFGLAKD 288 (486)
Q Consensus 280 l~DFGla~~ 288 (486)
|+|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999865
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.7e-11 Score=113.65 Aligned_cols=143 Identities=20% Similarity=0.242 Sum_probs=109.2
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCC--CCceEEEEEEEeC---C
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVH--LNLVKLIGYCIED---D 208 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~---~ 208 (486)
+.|+.|.++.||++...+ |..+++|+...... .....+..|++++..+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 578999999999997632 45799999865432 133568899999999975 3467777776653 2
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------------- 256 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-------------------------------- 256 (486)
..++||||++|.+|.+.+.. ..++......++.++++.|.+||+..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred CceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 66899999999988775532 34677777888888888888888531
Q ss_pred ---------------------CCCeEecCCCCCcEEEcC--CCcEEEeecCCCCCC
Q 011412 257 ---------------------ERPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDG 289 (486)
Q Consensus 257 ---------------------~~~iiHrDLKp~NIll~~--~~~vkl~DFGla~~~ 289 (486)
...++|+|++|.|||++. ++.+.|+||+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 134799999999999988 667899999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-09 Score=109.39 Aligned_cols=166 Identities=20% Similarity=0.281 Sum_probs=129.0
Q ss_pred eEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE----eCCeeEEEEeecC
Q 011412 143 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI----EDDQRLLVYEFMP 218 (486)
Q Consensus 143 g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~----~~~~~~lv~E~~~ 218 (486)
.+.|+++... +|..|++|++..+..........-+++++++.|.|||++.++|. .+..++||++|.+
T Consensus 290 ~Ttyk~~s~~---------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 290 ITTYKATSNV---------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred ceeEeeeecc---------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 5689998876 56689999996554444334556788899999999999999886 3567899999988
Q ss_pred C-CChhHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 219 R-GSLENHLFRR--------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 219 ~-gsL~~~l~~~--------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+ ++|.++.... +...++..+|.++.|++.||.++|+.| +.-+-|.|.+||++.+.+++|...
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecc
Confidence 6 4777765322 234778999999999999999999999 888999999999999999999988
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~ 339 (486)
|.......... |-+.. -.+-|.=.||.+++-|.||..
T Consensus 438 ~i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 438 GIMDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cceeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 87765433220 11111 235689999999999999965
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.6e-09 Score=100.74 Aligned_cols=139 Identities=14% Similarity=0.057 Sum_probs=97.8
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----------cHHHHHHHHHHHhcCCCCC--ceEEEE
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVNFLGDLVHLN--LVKLIG 202 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--Iv~~~~ 202 (486)
.+-.-....|++... .|+.|.||........ ....+.+|.+.+..|..-+ +..+++
T Consensus 29 ~v~~~~~rrvvr~~~-----------~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa 97 (268)
T PRK15123 29 VFRELEGRRTLRFEL-----------AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVA 97 (268)
T ss_pred EEecCCCceEEEEEE-----------CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeE
Confidence 344333344666654 3568999977543311 0113678999888884333 344555
Q ss_pred EEEe-----CCeeEEEEeecCCC-ChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-
Q 011412 203 YCIE-----DDQRLLVYEFMPRG-SLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA- 274 (486)
Q Consensus 203 ~~~~-----~~~~~lv~E~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~- 274 (486)
+... ...-+||||++++. +|.+++... ....+......++.+++..+.-||..+ |+|+||++.||||+.
T Consensus 98 ~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~ 174 (268)
T PRK15123 98 FGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLP 174 (268)
T ss_pred EEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEecc
Confidence 5433 23468999999886 798887532 234556777899999999999999999 999999999999975
Q ss_pred ------CCcEEEeecCCCCC
Q 011412 275 ------DYNAKLSDFGLAKD 288 (486)
Q Consensus 275 ------~~~vkl~DFGla~~ 288 (486)
++.+.|+||+.++.
T Consensus 175 ~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 175 FPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccCCCCCceEEEEECCcccc
Confidence 46899999998864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.3e-08 Score=98.67 Aligned_cols=260 Identities=16% Similarity=0.155 Sum_probs=157.5
Q ss_pred CCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEE------
Q 011412 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYC------ 204 (486)
Q Consensus 132 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~------ 204 (486)
...+.||+|+-+.+|-.-.- ...+.|+..........+. +..|... .||-+-.-+.+-
T Consensus 14 ~~gr~LgqGgea~ly~l~e~------------~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G 78 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV------------RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHG 78 (637)
T ss_pred CCCccccCCccceeeecchh------------hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhC
Confidence 45578999999999964211 1245677765543322222 2233333 466433211111
Q ss_pred -EeCCeeEEEEeecCCCC-hhHHHh-----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 205 -IEDDQRLLVYEFMPRGS-LENHLF-----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 205 -~~~~~~~lv~E~~~~gs-L~~~l~-----~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
......-++|..+.+.. +..++. +.-....|...++.++.++.+.+.||..| .+-+|+.++|+|+++++.
T Consensus 79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~ 155 (637)
T COG4248 79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSK 155 (637)
T ss_pred CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCce
Confidence 11222568888887652 222221 11235789999999999999999999998 888999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCc--
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGE-- 349 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG-~~pf~~~~~~~~-- 349 (486)
|.|.|=..-....++. .....+|...|.+||.-. +-.-+...|.|.|||++++||.| ++||.+......
T Consensus 156 V~LVdsDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap 232 (637)
T COG4248 156 VVLVDSDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP 232 (637)
T ss_pred EEEEcccceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence 9999854433322221 233357999999999654 33456789999999999999987 999976432111
Q ss_pred ---chhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHhcCC
Q 011412 350 ---HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR--DPKARPLMSEVVEALKPL 414 (486)
Q Consensus 350 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~--dP~~RPs~~eil~~L~~~ 414 (486)
..-+............ .....+.....+ ...+..+..|..+|+.. ++.-||+++.++..|..+
T Consensus 233 ~p~E~~Ia~g~f~ya~~~~-~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 233 NPLETDIAHGRFAYASDQR-RGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred Ccchhhhhcceeeechhcc-CCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 0011111111111111 011111111111 12345678888889854 367899999988877654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.8e-09 Score=95.58 Aligned_cols=126 Identities=21% Similarity=0.220 Sum_probs=79.6
Q ss_pred EEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------------c--------c-----HHHHHHHHHHHhcCCCC--
Q 011412 144 CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------Q--------G-----HKEWLAEVNFLGDLVHL-- 195 (486)
Q Consensus 144 ~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------------~--------~-----~~~~~~E~~~l~~l~h~-- 195 (486)
.||.|... .|..+|||+.+.... . . .....+|++.|.++..-
T Consensus 1 ~Vy~~~~~----------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv 70 (188)
T PF01163_consen 1 DVYHAIDP----------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGV 70 (188)
T ss_dssp EEEEEEEC----------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-
T ss_pred CEEEEECC----------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCc
Confidence 38888764 367899999763210 0 0 12356899999999765
Q ss_pred CceEEEEEEEeCCeeEEEEeecC--CCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCcEEE
Q 011412 196 NLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 196 nIv~~~~~~~~~~~~~lv~E~~~--~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~y-LH~~~~~~iiHrDLKp~NIll 272 (486)
++.+++++. .-+|||||++ |..|..+. ... +.......++.+++..+.. +|..+ |||+||.+.|||+
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv 140 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILV 140 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEE
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEe
Confidence 466776552 3479999998 55554433 221 1123445667777775555 57877 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCC
Q 011412 273 DADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~ 290 (486)
+++ .+.|+|||.+....
T Consensus 141 ~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 141 DDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ETT-CEEE--GTTEEETT
T ss_pred ecc-eEEEEecCcceecC
Confidence 877 89999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=6.4e-08 Score=90.15 Aligned_cols=106 Identities=24% Similarity=0.203 Sum_probs=83.4
Q ss_pred HHHHHHHHHHhcCCCC--CceEEEEEEEeC----CeeEEEEeecCCC-ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 011412 180 KEWLAEVNFLGDLVHL--NLVKLIGYCIED----DQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252 (486)
Q Consensus 180 ~~~~~E~~~l~~l~h~--nIv~~~~~~~~~----~~~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yL 252 (486)
....+|...+..|..- .+.+.+++.... ...+||+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 4577888888877533 345666665542 2348999999884 79998865332 56677889999999999999
Q ss_pred HhCCCCCeEecCCCCCcEEEcCCC---cEEEeecCCCCCC
Q 011412 253 HEEAERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDG 289 (486)
Q Consensus 253 H~~~~~~iiHrDLKp~NIll~~~~---~vkl~DFGla~~~ 289 (486)
|..+ |+|+||++.|||++.++ .+.|+||+.++..
T Consensus 135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 99999999999998887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.9e-09 Score=112.36 Aligned_cols=150 Identities=22% Similarity=0.309 Sum_probs=103.0
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCccee-------eeeccccccccCccccccC
Q 011412 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-------STRVMGTYGYAAPEYVMTG 316 (486)
Q Consensus 244 qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 316 (486)
+++.||.|+|... .+||++|.|++|.++..+..||+.|+.+........... ..-..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4558999999854 499999999999999999999999998765433111100 0012235689999999998
Q ss_pred CCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcc
Q 011412 317 HLTSRSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 395 (486)
Q Consensus 317 ~~~~~~DvwslGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 395 (486)
..+.++|+|||||++|.+. .|+.-+........ +.. ....+..-.-.++...+.++.+=+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~---------~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSF---------SRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcch-----hhh---------hhcccccccccccccCcHHHHHHHHHHhc
Confidence 8899999999999999999 45554443211110 000 00011111112234456788999999999
Q ss_pred cCCCCCCCHHHHHH
Q 011412 396 RDPKARPLMSEVVE 409 (486)
Q Consensus 396 ~dP~~RPs~~eil~ 409 (486)
.++.-||++.+++.
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999997776653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.9e-08 Score=103.69 Aligned_cols=143 Identities=15% Similarity=0.121 Sum_probs=94.0
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc------------------------------HH----
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG------------------------------HK---- 180 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~------------------------------~~---- 180 (486)
+.|+.++-|+||+|+.+ +|+.||||+.+..-... ..
T Consensus 131 ~PiAsASIaQVH~A~L~----------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLK----------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEec----------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 68999999999999986 48899999986432100 00
Q ss_pred ------HHHHHHHHHhcCC-----CCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHH
Q 011412 181 ------EWLAEVNFLGDLV-----HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249 (486)
Q Consensus 181 ------~~~~E~~~l~~l~-----h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l 249 (486)
++.+|...+.+++ .++|.--.=||.......|+|||++|-.+.+...-....++...+.....++.--.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q 280 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQ 280 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 1344555555542 33332222233345667999999999999888533333455444433333322222
Q ss_pred HHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011412 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 250 ~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~ 292 (486)
-+- .+ ++|.|.+|.||+++.+|.+.+.|||+.......
T Consensus 281 ~~~--dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 281 LLR--DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHh--cC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 222 34 999999999999999999999999999876543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=9.8e-08 Score=89.84 Aligned_cols=136 Identities=18% Similarity=0.080 Sum_probs=94.3
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----------------------ccHHHHHHHHHH
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----------------------QGHKEWLAEVNF 188 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~ 188 (486)
+.+...||.|--+.||.|... .|..+|||.-+.... .......+|+++
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 456678999999999999875 377899997542210 011235689999
Q ss_pred HhcCCCC--CceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 011412 189 LGDLVHL--NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 266 (486)
Q Consensus 189 l~~l~h~--nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK 266 (486)
|..|.-. .|.+.+++ +...+||||++|-.|...-. ..+..-.++..|++-+.-+-..| |||+||.
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G---iVHGDlS 229 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG---IVHGDLS 229 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC---ccccCCc
Confidence 9999644 66666654 45689999999876654321 12222333334444444333555 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCC
Q 011412 267 TSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 267 p~NIll~~~~~vkl~DFGla~~~ 289 (486)
+-|||++++|.+.++||--+...
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred hheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999877654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.3e-07 Score=86.57 Aligned_cols=138 Identities=17% Similarity=0.144 Sum_probs=85.3
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC--ceEEEEEEEeCCeeEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGYCIEDDQRLL 212 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~~l 212 (486)
..||.|..+.||+.. |..+++|...... ....+.+|.+++..+..-+ +.+.+++....+...+
T Consensus 7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEec-------------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 478999999999841 2357788876432 2355789999999886443 4677888777778889
Q ss_pred EEeecCCCC-hhHHH--------------hh-----cC---CCCCHHHHH-HHHH----------HHHH-HHHHHHhC-C
Q 011412 213 VYEFMPRGS-LENHL--------------FR-----RS---LPLPWSIRM-KIAL----------GAAK-GLAFLHEE-A 256 (486)
Q Consensus 213 v~E~~~~gs-L~~~l--------------~~-----~~---~~l~~~~~~-~i~~----------qi~~-~l~yLH~~-~ 256 (486)
|||+++|.. +...+ .+ +. ......... .+.. .+.. ...+|... .
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999998863 21111 00 00 011111000 0000 0001 11222211 1
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 257 ~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
...++|+|+.|.||++++++ +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 23479999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=5.2e-07 Score=82.98 Aligned_cols=138 Identities=17% Similarity=0.113 Sum_probs=101.4
Q ss_pred eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEec-CC--C---cccHHHHHHHHHHHhcCCCC--CceEEEEEEEe--
Q 011412 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HD--G---LQGHKEWLAEVNFLGDLVHL--NLVKLIGYCIE-- 206 (486)
Q Consensus 137 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~-~~--~---~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~-- 206 (486)
-|+||.+.|+..... |..|-+|.-. +- . ......|.+|+..|..|..- .+.+...+...
T Consensus 26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~ 94 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKI 94 (216)
T ss_pred cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeecc
Confidence 477999999997663 3467788764 11 1 22456799999999998532 34454422222
Q ss_pred --CCeeEEEEeecCC-CChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--EEE
Q 011412 207 --DDQRLLVYEFMPR-GSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--AKL 280 (486)
Q Consensus 207 --~~~~~lv~E~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--vkl 280 (486)
.-.-+||+|-++| -+|.+++.... .+.+......+..+|+..|.-||+.+ +.|+|+-+.|||++.++. +++
T Consensus 95 ~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~l 171 (216)
T PRK09902 95 EGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGF 171 (216)
T ss_pred CCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEE
Confidence 1235799997754 48988885532 34567777899999999999999998 999999999999986677 999
Q ss_pred eecCCCCC
Q 011412 281 SDFGLAKD 288 (486)
Q Consensus 281 ~DFGla~~ 288 (486)
+||.-++.
T Consensus 172 IDlEk~r~ 179 (216)
T PRK09902 172 LDLEKSRR 179 (216)
T ss_pred EEhhccch
Confidence 99987765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.8e-09 Score=109.91 Aligned_cols=182 Identities=18% Similarity=0.124 Sum_probs=133.9
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC-ceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv 213 (486)
.-+++|+++.++|.+... +. ....+.+... ....-++++|.+++||| .+++++-+..++..+++
T Consensus 248 h~fvK~altknpKkRpta---------ek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTA---------EK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred HHHHHHHhcCCCccCCCh---------hh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 447899999999886532 11 2224444432 34456889999999999 88888888889999999
Q ss_pred EeecCCC-ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011412 214 YEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 214 ~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~ 292 (486)
|+++.++ +-..........+...+...+.+.-+++++|||+.. =+||| ||+..+ +..+..||+....+...
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999887 222222111222334455567777788999999864 48999 887755 67999999998877654
Q ss_pred CcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011412 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342 (486)
Q Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~ 342 (486)
. ......+|+.|+|||+...+.+....|+|++|+--.+|--|-+|-.
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3 2345789999999999999999999999999987777777766643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.5e-07 Score=83.72 Aligned_cols=139 Identities=12% Similarity=0.079 Sum_probs=92.5
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHH---------HHHHHHHHhcCCC--
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGDLVH-- 194 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h-- 194 (486)
....+|.+++++-.....-|.+-.. .|..+++|..+.......+. ..+++..+.++..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g 96 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG 96 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence 4557888888888887777776654 46689999987654332222 2234444444422
Q ss_pred -CCceEEEEEEE-----eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011412 195 -LNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (486)
Q Consensus 195 -~nIv~~~~~~~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 268 (486)
..++.++.+.. .....+|||||++|..|.+... ++. .++..+.++|.-||..| +.|+|+.|.
T Consensus 97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpg 164 (229)
T PF06176_consen 97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPG 164 (229)
T ss_pred ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcC
Confidence 22223222222 2345579999999988876541 222 24456778899999998 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCC
Q 011412 269 NILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 269 NIll~~~~~vkl~DFGla~~ 288 (486)
|++++.+ .++++||+..+.
T Consensus 165 NFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 165 NFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred cEEEECC-cEEEEECccccc
Confidence 9999855 499999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.9e-06 Score=82.41 Aligned_cols=139 Identities=21% Similarity=0.146 Sum_probs=84.4
Q ss_pred eeeecCC-eEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCceEEEEEEEeCCeeEEE
Q 011412 136 LLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 136 ~lg~G~f-g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv 213 (486)
.|-.|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+.+++++....+..++|
T Consensus 5 ~~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 70 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLL 70 (244)
T ss_pred ecCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEE
Confidence 4555655 789998542 2368888886543 235678999888874 44466888887776778999
Q ss_pred EeecCCCChhHHHh----------------h-cCC-----CCCHH--HHHHHHH--------------------HHHHHH
Q 011412 214 YEFMPRGSLENHLF----------------R-RSL-----PLPWS--IRMKIAL--------------------GAAKGL 249 (486)
Q Consensus 214 ~E~~~~gsL~~~l~----------------~-~~~-----~l~~~--~~~~i~~--------------------qi~~~l 249 (486)
||+++|.+|..... + +.. ++... ....... .+...+
T Consensus 71 ~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (244)
T cd05150 71 TSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELY 150 (244)
T ss_pred EEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHH
Confidence 99999987764320 0 000 11100 0000000 011111
Q ss_pred HHHHhC----CCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 250 AFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 250 ~yLH~~----~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..|-.. ....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 151 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 151 AELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 122110 113389999999999999887788999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.2e-06 Score=82.60 Aligned_cols=140 Identities=18% Similarity=0.156 Sum_probs=82.5
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--CceEEEEEEEe---CCe
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGYCIE---DDQ 209 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~---~~~ 209 (486)
+.|+.|..+.||+....+ ..+++|..... .....+..|+.+++.|... .+.+++.+... ...
T Consensus 3 ~~l~~G~~n~~~~v~~~~-----------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-----------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEESSSSEEEEEEETT-----------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred ccCCCCCeeeEEEEEECC-----------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 579999999999997643 37999997654 3345678899988888533 35677764433 335
Q ss_pred eEEEEeecCCCChhH----------------HHh---hc---CCCCCHHH---------HHHH------------HHHHH
Q 011412 210 RLLVYEFMPRGSLEN----------------HLF---RR---SLPLPWSI---------RMKI------------ALGAA 246 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~----------------~l~---~~---~~~l~~~~---------~~~i------------~~qi~ 246 (486)
.+++|++++|..+.. .+. .. ...+.... .... ...+.
T Consensus 70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE 149 (239)
T ss_dssp EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence 689999999988777 111 11 01111100 0000 11122
Q ss_pred H-HHHHHHhC----CCCCeEecCCCCCcEEEc-CCCcEEEeecCCCC
Q 011412 247 K-GLAFLHEE----AERPVIYRDFKTSNILLD-ADYNAKLSDFGLAK 287 (486)
Q Consensus 247 ~-~l~yLH~~----~~~~iiHrDLKp~NIll~-~~~~vkl~DFGla~ 287 (486)
. .+..++.. ....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 33333321 234599999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.5e-06 Score=78.71 Aligned_cols=152 Identities=20% Similarity=0.154 Sum_probs=99.9
Q ss_pred cChhHHHHHhcCCCCCCeee---ecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------------------
Q 011412 119 FTFNDLKLATRNFRPESLLG---EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------ 177 (486)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lg---~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------------------ 177 (486)
.+...+.....+..+....| .|--+.||+|... .+..||||+.+.....
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~----------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~ 104 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETG----------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSR 104 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC----------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCC
Confidence 44455555556666655544 5666789998653 4678999998643211
Q ss_pred -cHH-----HHHHHHHHHhcCC--CCCceEEEEEEEeCCeeEEEEeecCCCChh-HHHhhcCCCCCHHHHHHHHHHHHHH
Q 011412 178 -GHK-----EWLAEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPLPWSIRMKIALGAAKG 248 (486)
Q Consensus 178 -~~~-----~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~-~~l~~~~~~l~~~~~~~i~~qi~~~ 248 (486)
..+ ....|+..|.++. +-.+.+.+.+.. -.|||||+....+- -.|.. -.+.......+..++++.
T Consensus 105 ~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~ 178 (268)
T COG1718 105 SNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEY 178 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHH
Confidence 111 1356888888884 455666666643 37999999553110 01111 122333566677778888
Q ss_pred HHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 249 LAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 249 l~yLH~-~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
|.-|-. .+ +||+||..-|||+. ++.+.|+|||-|....
T Consensus 179 ~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 179 MRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 877766 45 99999999999999 8899999999887654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.7e-06 Score=90.30 Aligned_cols=141 Identities=16% Similarity=0.099 Sum_probs=91.2
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---------------------------H----H---
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------------------------H----K--- 180 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---------------------------~----~--- 180 (486)
+.||.-+.|+||+|+.++ |+.||||+-+..-... . +
T Consensus 167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 589999999999999874 7899999865321100 0 0
Q ss_pred ---HHHHHHHHHhc----CCCCC------ceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHH
Q 011412 181 ---EWLAEVNFLGD----LVHLN------LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247 (486)
Q Consensus 181 ---~~~~E~~~l~~----l~h~n------Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~ 247 (486)
+|.+|.+...+ +.|-+ |.++|. .-.....|+||||+|..+.+.-.-....++...+..-+.++..
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL 314 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH
Confidence 13344443333 23444 333332 2245679999999999887764433334555555444444333
Q ss_pred HHHHHHhCCCCCeEecCCCCCcEEEcC----CCcEEEeecCCCCCCCCC
Q 011412 248 GLAFLHEEAERPVIYRDFKTSNILLDA----DYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 248 ~l~yLH~~~~~~iiHrDLKp~NIll~~----~~~vkl~DFGla~~~~~~ 292 (486)
-+-+.| | ++|.|=.|.||++.. ++.+.+-|||+.......
T Consensus 315 ~qIf~~--G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 315 EQIFKT--G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHhc--C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 233333 3 999999999999983 678999999999876543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.4e-06 Score=75.57 Aligned_cols=130 Identities=18% Similarity=0.135 Sum_probs=91.1
Q ss_pred CCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCce-EEEEEEEeCCee
Q 011412 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQR 210 (486)
Q Consensus 132 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~ 210 (486)
+..+.|++|++|.||+|.+. |..+|+|+-+.+.. ...+..|+++|..+.-.++- ++|.|.. -
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~ 87 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----D 87 (201)
T ss_pred hhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----h
Confidence 44568999999999999884 55899999887654 36688999999988876654 4555432 3
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-CCcEEEcCCCcEEEeecCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK-TSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK-p~NIll~~~~~vkl~DFGla~~~ 289 (486)
++.|||+.|-.|.++-... +..++. .+++.---|-..+ |-|..|. |..++|..++.+.|+||.-|+..
T Consensus 88 ~i~me~i~G~~L~~~~~~~----~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG----DRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhhcCcchhhhhhcc----cHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 5669999998988765321 223333 3444444455556 8888886 44455545558999999999853
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.31 E-value=5.1e-06 Score=78.96 Aligned_cols=74 Identities=15% Similarity=0.112 Sum_probs=47.7
Q ss_pred CCeeeecCCeE-EEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC---CceEEEEEEEeC--
Q 011412 134 ESLLGEGGFGC-VFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL---NLVKLIGYCIED-- 207 (486)
Q Consensus 134 ~~~lg~G~fg~-Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~~~-- 207 (486)
++.|+.||... ||+.. ..+++|...... ....+.+|+++|..|... -+.++++.....
T Consensus 2 ~~~~~~gG~~n~vy~~~--------------~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~ 65 (235)
T cd05155 2 IEPVDSGGTDNATFRLG--------------DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEG 65 (235)
T ss_pred ceeccCCCcccceEEcC--------------CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccC
Confidence 45788887774 98751 247788765422 235688999999887532 344555543332
Q ss_pred -CeeEEEEeecCCCChh
Q 011412 208 -DQRLLVYEFMPRGSLE 223 (486)
Q Consensus 208 -~~~~lv~E~~~~gsL~ 223 (486)
...++||++++|.+|.
T Consensus 66 ~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 66 YPWPWSVYRWLEGETAT 82 (235)
T ss_pred CCcceEEEEeecCCCCC
Confidence 2358899999997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.6e-05 Score=71.31 Aligned_cols=101 Identities=29% Similarity=0.258 Sum_probs=80.6
Q ss_pred HHHHHHhcCCC-CCceEEEEEEEeCCeeEEEEeecCCCChhHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 011412 184 AEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 260 (486)
Q Consensus 184 ~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~i 260 (486)
.|.-+|..+.+ +++.+++|+|- .++|.||...+++..... ..-...+|..+.+|+.++++.+.+|+......+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57888888865 58999999983 378999998776542100 111246899999999999999999998654558
Q ss_pred EecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 261 IYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 261 iHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
.-.|++++|+-+++++++|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 8899999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.9e-05 Score=88.61 Aligned_cols=149 Identities=16% Similarity=0.189 Sum_probs=91.5
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCCc--eEEEEEEEeC--
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNL--VKLIGYCIED-- 207 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nI--v~~~~~~~~~-- 207 (486)
++.|+.|.++.+|+......+ ....+++|+...... .....+.+|+++|+.|. |.+| .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 457899999999998654311 113577887654322 23356889999999995 6664 7888877654
Q ss_pred -CeeEEEEeecCCCChhH--------------------HH---hhcC----------CCCC--HHHHHHHHH--------
Q 011412 208 -DQRLLVYEFMPRGSLEN--------------------HL---FRRS----------LPLP--WSIRMKIAL-------- 243 (486)
Q Consensus 208 -~~~~lv~E~~~~gsL~~--------------------~l---~~~~----------~~l~--~~~~~~i~~-------- 243 (486)
+..|+||||++|..+.+ .| +.-. .+.. ...+..|..
T Consensus 116 ~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~ 195 (822)
T PLN02876 116 IGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGE 195 (822)
T ss_pred CCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcc
Confidence 46789999998865321 01 0000 0000 011111111
Q ss_pred -------HHHHHHHHHHhCCC--------CCeEecCCCCCcEEEcCC-Cc-EEEeecCCCCCC
Q 011412 244 -------GAAKGLAFLHEEAE--------RPVIYRDFKTSNILLDAD-YN-AKLSDFGLAKDG 289 (486)
Q Consensus 244 -------qi~~~l~yLH~~~~--------~~iiHrDLKp~NIll~~~-~~-vkl~DFGla~~~ 289 (486)
.+...+.+|..+-+ ..+||+|+++.|||++.+ +. +-|.||.++...
T Consensus 196 ~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 196 GKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred cCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12234556644322 239999999999999753 33 579999998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.3e-05 Score=71.03 Aligned_cols=128 Identities=17% Similarity=0.236 Sum_probs=89.3
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC----------------cccHHHHHHHHHHHhcCC----
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----------------LQGHKEWLAEVNFLGDLV---- 193 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~---- 193 (486)
..+||+|+.-.||.- ..+ -...||++.... ....++..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H--P~d----------p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDD----------PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEEC--CCC----------CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 357999999999974 222 246789887665 122355667777666665
Q ss_pred --CCCceEEEEEEEeCCeeEEEEeecCC------CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 011412 194 --HLNLVKLIGYCIEDDQRLLVYEFMPR------GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265 (486)
Q Consensus 194 --h~nIv~~~~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL 265 (486)
+.+|.+++|+..++.-+-+|+|.+.+ -+|.+++.+. .++. ..... +-+-..||-+.+ |+.+||
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl 144 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQA---LDEFKRYLLDHH---IVIRDL 144 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHH---HHHHHHHHHHcC---CeecCC
Confidence 77899999999999999999998643 2577777433 3444 33333 334456777666 999999
Q ss_pred CCCcEEEcCC--C--cEEEee
Q 011412 266 KTSNILLDAD--Y--NAKLSD 282 (486)
Q Consensus 266 Kp~NIll~~~--~--~vkl~D 282 (486)
+|.||++... + .+.|+|
T Consensus 145 ~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CcccEEEEecCCCceEEEEEe
Confidence 9999999432 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.5e-05 Score=72.77 Aligned_cols=125 Identities=29% Similarity=0.403 Sum_probs=90.0
Q ss_pred cCCCCCCeeeecCC-eEEEEEEEccCCCccccCCCCcEEEEEEecC---CCc-------c-----------cHHHHHHHH
Q 011412 129 RNFRPESLLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNH---DGL-------Q-----------GHKEWLAEV 186 (486)
Q Consensus 129 ~~y~~~~~lg~G~f-g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~---~~~-------~-----------~~~~~~~E~ 186 (486)
.+++.++.||.|.- |.||++.. .|..||+|+... ... . ...-|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-----------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-----------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-----------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 78999999999999 99999988 467999999331 111 0 012367788
Q ss_pred HHHhcCC---CCCc--eEEEEEEEeC------------------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHH
Q 011412 187 NFLGDLV---HLNL--VKLIGYCIED------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243 (486)
Q Consensus 187 ~~l~~l~---h~nI--v~~~~~~~~~------------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~ 243 (486)
+...+|+ +.++ |+.+||..-. ....||.||++... .+ ...-+.
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~----~~~~~~ 171 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PL----QIRDIP 171 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------cc----chhHHH
Confidence 8877774 4456 9999987432 12357888876543 11 223455
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 244 qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 172 ~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 172 QMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 7778889999988 999999999987 3489999964
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.09 E-value=6.8e-05 Score=73.89 Aligned_cols=77 Identities=12% Similarity=0.060 Sum_probs=55.5
Q ss_pred CCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC---CCceEEEEEEEe---
Q 011412 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH---LNLVKLIGYCIE--- 206 (486)
Q Consensus 133 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~--- 206 (486)
-.+.||.|..+.||+....+ + .+.+|..+... ....+..|...|+.|.. ..+.++++++..
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~----------~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ----------G-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred eeeecCCccceeEEEEEcCC----------C-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 34579999999999985432 2 46677754311 22468899999998853 357888887754
Q ss_pred CCeeEEEEeecCCCCh
Q 011412 207 DDQRLLVYEFMPRGSL 222 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL 222 (486)
.+..+||||+++|+++
T Consensus 85 ~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 PGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCeEEEEeccCCEec
Confidence 3668999999998765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.3e-05 Score=88.65 Aligned_cols=196 Identities=20% Similarity=0.231 Sum_probs=138.2
Q ss_pred HHHHHHHHhcCCCCCceEEEEEEEeCCeeE----EEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 011412 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 257 (486)
Q Consensus 182 ~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~----lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~ 257 (486)
...|+..+..+.|+|++.++.|.......- +.-|+|..-++...+.. -..++....+.+..++..||.|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 455777888889999999999876654333 34578888888887744 357888999999999999999999875
Q ss_pred CCeEecCCCCC---cEEEcCCCcEEEe--ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCch--hhHHHHHHH
Q 011412 258 RPVIYRDFKTS---NILLDADYNAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR--SDVYSFGVV 330 (486)
Q Consensus 258 ~~iiHrDLKp~---NIll~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwslGvi 330 (486)
..|.-|... +-..+.++.+.++ ||+........... ....-+..|.++|......+..+ .|+|.+|..
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 666555554 4445666777777 99998876554332 12334566888887776665554 799999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 331 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 331 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+..+..|..+-..... ...+++ .. ......++..+|+..++++|+++.+++.+
T Consensus 382 ~~~~~~~~~i~~~~~~-------------------~~~~l~-----~~---~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV-------------------PVSLLD-----VL---STSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HhhhhhcCcccccccc-------------------hhhhhc-----cc---cchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999987654321100 000111 00 11146688899999999999999999875
Q ss_pred h
Q 011412 411 L 411 (486)
Q Consensus 411 L 411 (486)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.06 E-value=5.4e-05 Score=71.76 Aligned_cols=75 Identities=20% Similarity=0.130 Sum_probs=47.3
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC-ceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv 213 (486)
+.|..|-...||+...... .+..|++|+....... .....+|+.++..+...+ ..++++.+. -.+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEE
Confidence 4677788889999864310 1347889977643221 123357888888885433 345554432 2489
Q ss_pred EeecCCCCh
Q 011412 214 YEFMPRGSL 222 (486)
Q Consensus 214 ~E~~~~gsL 222 (486)
|||++|.+|
T Consensus 71 ~e~i~G~~l 79 (235)
T cd05157 71 YEFIPGRTL 79 (235)
T ss_pred EEeeCCCcC
Confidence 999999776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.7e-05 Score=74.94 Aligned_cols=141 Identities=18% Similarity=0.119 Sum_probs=84.2
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC--ceEEEEE------EE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGY------CI 205 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~------~~ 205 (486)
++.|..|....+|+.... +..+++|+.... ....+..|++++..|.+.+ +.+++.. ..
T Consensus 19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEeC-----------CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 456777877899987542 236889987642 2345677888888775332 4455432 23
Q ss_pred eCCeeEEEEeecCCCChhH----HH----------hhc--C--C------CCCHHHHH----------HHHHHHHHHHHH
Q 011412 206 EDDQRLLVYEFMPRGSLEN----HL----------FRR--S--L------PLPWSIRM----------KIALGAAKGLAF 251 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~----~l----------~~~--~--~------~l~~~~~~----------~i~~qi~~~l~y 251 (486)
..+..++||+|++|..+.. .+ +.. . . ...|.... .....+...+.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456789999999877532 00 100 0 0 01111100 011112334444
Q ss_pred HHh----CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 252 LHE----EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 252 LH~----~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
+.. ..+..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 443 1224599999999999999887778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.8e-05 Score=73.26 Aligned_cols=138 Identities=17% Similarity=0.131 Sum_probs=78.0
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-eEEEEEEEeCCeeEEEE
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVY 214 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~ 214 (486)
.+..|-.+.+|+... .+..+++|..........-...+|..+++.+...++ .+++... . -++||
T Consensus 3 ~~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~ 67 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLV 67 (256)
T ss_pred cCCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEE
Confidence 355677788998753 345788887654322211134678888888864433 3444433 2 37899
Q ss_pred eecCCCChhHH----------H-------hhc---CCCCCHH-HHHHHHHHH---------HHHHHHHHhC-----CCCC
Q 011412 215 EFMPRGSLENH----------L-------FRR---SLPLPWS-IRMKIALGA---------AKGLAFLHEE-----AERP 259 (486)
Q Consensus 215 E~~~~gsL~~~----------l-------~~~---~~~l~~~-~~~~i~~qi---------~~~l~yLH~~-----~~~~ 259 (486)
||++|..+... + +.. ..+++.. .+..+..++ ...+..+-.. ....
T Consensus 68 e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (256)
T TIGR02721 68 EWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA 147 (256)
T ss_pred EeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe
Confidence 99998765421 1 110 1112211 111111111 1112222111 1124
Q ss_pred eEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 260 VIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 260 iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
++|+|+.|.||++++++ +.|+||..+...
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence 89999999999999877 789999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00065 Score=67.60 Aligned_cols=140 Identities=17% Similarity=0.139 Sum_probs=76.3
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--CceEEEE------EEEe
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIG------YCIE 206 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~------~~~~ 206 (486)
+.|+.|....+|+..... | .+++|+.... ....+..|+.++..|... .+.+++. +...
T Consensus 28 ~~l~~G~~n~~y~v~t~~----------g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~ 93 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQ----------G-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGEL 93 (319)
T ss_pred chhccccccceEEEEeCC----------C-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeee
Confidence 457778778899886432 2 5889987621 123444566666655322 2333332 1223
Q ss_pred CCeeEEEEeecCCCChhH-----------HH---hhcCC----------CCCH-HHHHH------------HHHH-HHHH
Q 011412 207 DDQRLLVYEFMPRGSLEN-----------HL---FRRSL----------PLPW-SIRMK------------IALG-AAKG 248 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~-----------~l---~~~~~----------~l~~-~~~~~------------i~~q-i~~~ 248 (486)
.+..+++|||++|..+.. .| +.... .+.+ ..... ...+ +...
T Consensus 94 ~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 173 (319)
T PRK05231 94 AGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQ 173 (319)
T ss_pred CCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHH
Confidence 566789999999875421 11 11000 0111 11110 1111 1112
Q ss_pred HHHHHhC----CCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 249 LAFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 249 l~yLH~~----~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
+..+... -+.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 174 ~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 174 LAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 2222211 234599999999999998665568999998865
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0002 Score=70.78 Aligned_cols=146 Identities=23% Similarity=0.261 Sum_probs=83.9
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-eEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv 213 (486)
+.|..|--..||+....... .....+..|++|+..... .......+|++++..+...++ .++++++.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 35666767789988653211 012245689999976543 222345788888888754333 455555432 468
Q ss_pred EeecCCCChhHH--------------H---hhcCCC--------CC--HHHHHH--------------------------
Q 011412 214 YEFMPRGSLENH--------------L---FRRSLP--------LP--WSIRMK-------------------------- 240 (486)
Q Consensus 214 ~E~~~~gsL~~~--------------l---~~~~~~--------l~--~~~~~~-------------------------- 240 (486)
|||++|..|... | ++.... .+ +..+..
T Consensus 76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (302)
T cd05156 76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL 155 (302)
T ss_pred hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence 999998776431 0 110000 01 001101
Q ss_pred HHHHHHHHHHHHHh------CCCCCeEecCCCCCcEEEcCC----CcEEEeecCCCCC
Q 011412 241 IALGAAKGLAFLHE------EAERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 288 (486)
Q Consensus 241 i~~qi~~~l~yLH~------~~~~~iiHrDLKp~NIll~~~----~~vkl~DFGla~~ 288 (486)
+...+..-+.+|-. ..+..++|+||.+.|||++.+ +.+.|+||..+..
T Consensus 156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 11122222334432 123459999999999999874 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.001 Score=67.86 Aligned_cols=76 Identities=20% Similarity=0.133 Sum_probs=52.6
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC------C-cccHHHHHHHHHHHhcCC---CCCceEEEEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------G-LQGHKEWLAEVNFLGDLV---HLNLVKLIGYC 204 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~ 204 (486)
+.||.|.+..||++...+ .++.|+||.-... . .........|.+.|..+. ..++.+++.+
T Consensus 32 ~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~- 101 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY- 101 (401)
T ss_pred eEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence 578999999999998753 1247999985411 1 123456677888888763 2457777776
Q ss_pred EeCCeeEEEEeecCCCC
Q 011412 205 IEDDQRLLVYEFMPRGS 221 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gs 221 (486)
+.+..++||||+++..
T Consensus 102 -D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 -DEELAVTVMEDLSDHK 117 (401)
T ss_pred -CCCCCEEEEecCCCcc
Confidence 4466789999998744
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=4.3e-06 Score=94.07 Aligned_cols=158 Identities=15% Similarity=0.012 Sum_probs=117.1
Q ss_pred HHHHHHHHhcCCCCCceEEEEEEEe--CCeeEEEEeecCCCChhHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 011412 182 WLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEA 256 (486)
Q Consensus 182 ~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~yLH~~~ 256 (486)
++.|..-++...|++++..+.-... ....+++++||.+|.+.+.|.+.. ..+....+.....+.+....-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4456666667789988876654433 345689999999999999986442 33444444444444455566666543
Q ss_pred --CCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHH
Q 011412 257 --ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 334 (486)
Q Consensus 257 --~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el 334 (486)
..-.+|++||+-|.+|..+..+|++++|+.+..... ........+++.|++|++...-.++.++|+|..|+-+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 234799999999999999999999999999943221 1123446788999999998888999999999999999999
Q ss_pred HhCCCCC
Q 011412 335 LTGRRSM 341 (486)
Q Consensus 335 ltG~~pf 341 (486)
..|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 9888776
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.0014 Score=64.84 Aligned_cols=142 Identities=18% Similarity=0.169 Sum_probs=82.1
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--CceEEEEE------EE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGY------CI 205 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~------~~ 205 (486)
++.++.|--..||+.... +| .+++|+..... ...++..|++++..|... .+.+++.. ..
T Consensus 27 i~~~~~G~~n~~y~v~t~----------~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~ 93 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD----------VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST 93 (307)
T ss_pred ccccCCccccceEEEEeC----------CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence 556777777899987542 22 57789875421 234556677777777432 23444432 12
Q ss_pred eCCeeEEEEeecCCCChhH-----------HH---hhcCCCC-----------CHHHHH------------HHHHHHHHH
Q 011412 206 EDDQRLLVYEFMPRGSLEN-----------HL---FRRSLPL-----------PWSIRM------------KIALGAAKG 248 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~-----------~l---~~~~~~l-----------~~~~~~------------~i~~qi~~~ 248 (486)
..+..++||||++|..+.. .+ +.....+ .|.... .....+...
T Consensus 94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~ 173 (307)
T TIGR00938 94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE 173 (307)
T ss_pred cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence 2456789999998865421 11 1100000 011000 011123334
Q ss_pred HHHHHh----CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 249 LAFLHE----EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 249 l~yLH~----~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
++++.. ..+..+||+|+.+.||+++.++.+.|+||+.+..
T Consensus 174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 555542 1234599999999999999887778999998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0015 Score=65.86 Aligned_cols=144 Identities=17% Similarity=0.110 Sum_probs=82.5
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-eEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv 213 (486)
+.|-.|-...+|++....... ..+..|++|+........ -...+|+.++..+..-++ .++++++... .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~-----~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEG-----NLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCCCC-----CCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 355557788999986543111 134679999886543222 223678888888854444 3556655322 58
Q ss_pred EeecCCCChhHH-------H----------hhcC---C--CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 011412 214 YEFMPRGSLENH-------L----------FRRS---L--PLPWSIRMKIALGA-----------------AKGLAFL-- 252 (486)
Q Consensus 214 ~E~~~~gsL~~~-------l----------~~~~---~--~l~~~~~~~i~~qi-----------------~~~l~yL-- 252 (486)
+||+++.+|... + +... . ...+..+..+..++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999988776421 0 1101 0 11122222332221 1111122
Q ss_pred --Hh-CCCCCeEecCCCCCcEEEcC-CCcEEEeecCCCCC
Q 011412 253 --HE-EAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 288 (486)
Q Consensus 253 --H~-~~~~~iiHrDLKp~NIll~~-~~~vkl~DFGla~~ 288 (486)
.. .....++|+||++.|||+++ ++.+.|+||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 11234899999999999976 46899999998864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0025 Score=62.79 Aligned_cols=122 Identities=19% Similarity=0.268 Sum_probs=74.6
Q ss_pred CcEEEEEEecC--CCcccHHHHHHHHHHHhcCCC--CCceEEEEEEEeCC--eeEEEEeecCCCChhHHHhhcCCCCCHH
Q 011412 163 GLTVAVKTLNH--DGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWS 236 (486)
Q Consensus 163 g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~l~~~ 236 (486)
++.+++. ... ..........+|+.+|+.+.- .-+.+.+++|.++. ..|.||+|++|..+.+.+.... ..
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~----~~ 122 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPES----LG 122 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCccc----ch
Confidence 5578887 331 222334556788888888743 23456677776665 6799999998853322211000 00
Q ss_pred HHHHHH-HHHHHHHH--------------------------------------------------HHHhCC-----CCCe
Q 011412 237 IRMKIA-LGAAKGLA--------------------------------------------------FLHEEA-----ERPV 260 (486)
Q Consensus 237 ~~~~i~-~qi~~~l~--------------------------------------------------yLH~~~-----~~~i 260 (486)
..++ ..++..|+ +|+.+. ...+
T Consensus 123 --~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~l 200 (321)
T COG3173 123 --RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVL 200 (321)
T ss_pred --HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCcee
Confidence 0111 13333333 343322 2359
Q ss_pred EecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011412 261 IYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (486)
Q Consensus 261 iHrDLKp~NIll~~~~~vkl~DFGla~~~~~ 291 (486)
+|+|+.+.||+|+.++-+-|.||+++.....
T Consensus 201 vHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 201 VHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred eeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 9999999999999888899999999987543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0018 Score=63.96 Aligned_cols=141 Identities=17% Similarity=0.138 Sum_probs=89.9
Q ss_pred CCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----------------------ccHH----HHHHHH
Q 011412 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----------------------QGHK----EWLAEV 186 (486)
Q Consensus 133 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----------------------~~~~----~~~~E~ 186 (486)
+-.+|..|--+.||.|.-. .|..+|||+++-.-. ..++ ....|+
T Consensus 148 inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~ 217 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM 217 (520)
T ss_pred cccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence 4457888999999998765 477899998752110 0011 135688
Q ss_pred HHHhcCCCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 011412 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 266 (486)
Q Consensus 187 ~~l~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK 266 (486)
+-|.+|+...|.-.--+.. ....|||+|+.+..--.-. -+...++...+..+-.|++.-|.-|-+... +||.||.
T Consensus 218 RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLS 292 (520)
T KOG2270|consen 218 RNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLS 292 (520)
T ss_pred HHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchh
Confidence 8888887655431111111 1237999999532211111 122346666677777777777776655432 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCC
Q 011412 267 TSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 267 p~NIll~~~~~vkl~DFGla~~~ 289 (486)
--|+|+. +|.+.|+|-+-+...
T Consensus 293 EfN~Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 293 EFNLLYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred hhhheEE-CCEEEEEEccccccC
Confidence 9999995 678999998876543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.00086 Score=65.16 Aligned_cols=134 Identities=16% Similarity=0.081 Sum_probs=90.3
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----------------c-----cHHHHHHHHHH
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----------------Q-----GHKEWLAEVNF 188 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----------------~-----~~~~~~~E~~~ 188 (486)
+.+.+.||-|--+.||.+-+. .|...++|.-+.... . +.-...+|+..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred hhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 677889999999999999775 367888886432110 0 01124568888
Q ss_pred HhcCCC-C-CceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 011412 189 LGDLVH-L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 266 (486)
Q Consensus 189 l~~l~h-~-nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK 266 (486)
|+.|.. - -|.+.+++ +..++|||++.|-.|...-. ..+... +...+..-+.-|-.+| +||+|..
T Consensus 164 mkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~----v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFN 229 (465)
T KOG2268|consen 164 MKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH----VEDPPT---LYDDLMGLIVRLANHG---LIHGDFN 229 (465)
T ss_pred HHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee----cCChHH---HHHHHHHHHHHHHHcC---ceecccc
Confidence 888843 2 34455544 45689999998877765321 112222 2333334445565666 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCC
Q 011412 267 TSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 267 p~NIll~~~~~vkl~DFGla~~ 288 (486)
-=||+|++++.++++||--+..
T Consensus 230 EFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 230 EFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred hheeEEecCCCEEEeechHhhc
Confidence 9999999999999999976543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.019 Score=56.74 Aligned_cols=30 Identities=27% Similarity=0.344 Sum_probs=25.9
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 258 ~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++|+|+.+.|||++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 45999999999999987 6789999997754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.009 Score=58.18 Aligned_cols=31 Identities=32% Similarity=0.459 Sum_probs=26.1
Q ss_pred CeEecCCCCCcEEEcCCCc-EEEeecCCCCCC
Q 011412 259 PVIYRDFKTSNILLDADYN-AKLSDFGLAKDG 289 (486)
Q Consensus 259 ~iiHrDLKp~NIll~~~~~-vkl~DFGla~~~ 289 (486)
.++|+|+.|.|||++.++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 3899999999999987555 469999988764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0093 Score=59.71 Aligned_cols=142 Identities=16% Similarity=0.199 Sum_probs=79.2
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-eEEEEEEEeCCeeEEEE
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVY 214 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~ 214 (486)
.|..|--..+|+....... .++..|++|+....... .-.-.+|+.+++.+..-++ .++++++. .+ +|.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~------~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~ 89 (330)
T PLN02421 21 RISGGITNLLLKVSVKEEN------GNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ 89 (330)
T ss_pred EeCCcccceEEEEEecCCC------CCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence 4555777789988654311 12347889987654321 1223578888888865555 45666552 22 589
Q ss_pred eecCCCChhH-------HH----------hhcCCC----C-CHHHHHHHHHHH----------------------HHHHH
Q 011412 215 EFMPRGSLEN-------HL----------FRRSLP----L-PWSIRMKIALGA----------------------AKGLA 250 (486)
Q Consensus 215 E~~~~gsL~~-------~l----------~~~~~~----l-~~~~~~~i~~qi----------------------~~~l~ 250 (486)
+|+++..|.. .+ +....+ . .+..+..+..++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 9998776532 01 110100 1 122222222221 11111
Q ss_pred HH---H-hCC-CCCeEecCCCCCcEEEcC-CCcEEEeecCCCCC
Q 011412 251 FL---H-EEA-ERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 288 (486)
Q Consensus 251 yL---H-~~~-~~~iiHrDLKp~NIll~~-~~~vkl~DFGla~~ 288 (486)
.+ . ..+ +.-++|.||.+.|||+++ ++.++++||..|..
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 1 111 123799999999999974 57899999998864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.012 Score=57.58 Aligned_cols=73 Identities=22% Similarity=0.283 Sum_probs=46.2
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCCceEEEEEEEeCCee
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~ 210 (486)
.+.|+.|....+|+... ++..+.||+-.... ...|..|..-|+.|. --.+.+.+++....+..
T Consensus 22 ~~~v~GG~i~~a~~~~~-----------~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDT-----------DGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEET-----------TS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEEC-----------CCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 35688888999998762 46689999887322 245778888888883 34577899988877778
Q ss_pred EEEEeecCCC
Q 011412 211 LLVYEFMPRG 220 (486)
Q Consensus 211 ~lv~E~~~~g 220 (486)
||||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0026 Score=59.25 Aligned_cols=30 Identities=33% Similarity=0.403 Sum_probs=21.3
Q ss_pred CeEecCCCCCcEEE-cCCCcEEEeecCCCCC
Q 011412 259 PVIYRDFKTSNILL-DADYNAKLSDFGLAKD 288 (486)
Q Consensus 259 ~iiHrDLKp~NIll-~~~~~vkl~DFGla~~ 288 (486)
-++|+||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 38999999999999 8889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0014 Score=67.24 Aligned_cols=50 Identities=24% Similarity=0.341 Sum_probs=40.6
Q ss_pred HHHHHHHHHHhcCCCCCceEEEEEEEeC-CeeEEEEeecCCCChhHHHhhcC
Q 011412 180 KEWLAEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRS 230 (486)
Q Consensus 180 ~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~ 230 (486)
.+++-..++++.+.|+|...++++-... ....+|||++ +.+|++.+..+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 5677888999999999999999987664 3467899999 779999886543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.025 Score=55.99 Aligned_cols=32 Identities=16% Similarity=0.170 Sum_probs=28.6
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 258 ~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
..+||+|+.+.|||++.++.+.|+||..+...
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 45999999999999999999999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.027 Score=57.43 Aligned_cols=73 Identities=10% Similarity=0.021 Sum_probs=48.2
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------ccHHHHHHHHHHHhcCC---CCCceEEEEE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLV---HLNLVKLIGY 203 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~nIv~~~~~ 203 (486)
.+.||-|-...||+.... +..|+||.-..... -.......|+..|..+. ..++.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 457899999999998652 23588988651111 12233445667666553 3478888887
Q ss_pred EEeCCeeEEEEeecCC
Q 011412 204 CIEDDQRLLVYEFMPR 219 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~ 219 (486)
+. +..+++|||+++
T Consensus 106 de--d~~vlvME~L~~ 119 (418)
T PLN02756 106 DR--TMALIGMRYLEP 119 (418)
T ss_pred CC--CCCEEEEeecCC
Confidence 75 456889999977
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.0078 Score=59.56 Aligned_cols=75 Identities=19% Similarity=0.160 Sum_probs=57.5
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
..+.|++|++- |+.|.- + ....++++..++.+.+..+.-+..+ .++=||||.-.||||+ +|.|.|+||-++
T Consensus 298 ~~y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence 34567888875 556542 1 2345788899999988777766653 4589999999999999 999999999999
Q ss_pred CCCC
Q 011412 287 KDGP 290 (486)
Q Consensus 287 ~~~~ 290 (486)
|...
T Consensus 369 Rl~~ 372 (488)
T COG5072 369 RLSY 372 (488)
T ss_pred eccc
Confidence 9643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.035 Score=55.71 Aligned_cols=74 Identities=15% Similarity=0.117 Sum_probs=46.6
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecC------CC-cccHHHHHHHHHHHhcCC--CC-CceEEEEEEE
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH------DG-LQGHKEWLAEVNFLGDLV--HL-NLVKLIGYCI 205 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~ 205 (486)
.||-|-..-||++.... .+..|+||.-.. .. .....+...|...|.... -| .+.++|.+
T Consensus 2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-- 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-- 70 (370)
T ss_pred cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--
Confidence 47889999999998632 224789997431 11 222345566777776653 24 45555543
Q ss_pred eCCeeEEEEeecCCC
Q 011412 206 EDDQRLLVYEFMPRG 220 (486)
Q Consensus 206 ~~~~~~lv~E~~~~g 220 (486)
+.+...+|||+++..
T Consensus 71 D~e~~~~vMEdL~~~ 85 (370)
T TIGR01767 71 DTEMAVTVMEDLSHH 85 (370)
T ss_pred ccccceehHhhCccc
Confidence 455667999999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.0063 Score=61.03 Aligned_cols=61 Identities=18% Similarity=0.135 Sum_probs=39.8
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011412 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 274 (486)
..|+-+|..|-++..++.... .++....+++.--+.++--+---. +++|.||.|.||++.-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence 357777888889988885543 344555555554444444332211 2999999999999943
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.017 Score=53.36 Aligned_cols=103 Identities=14% Similarity=0.096 Sum_probs=68.6
Q ss_pred EEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHH
Q 011412 165 TVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243 (486)
Q Consensus 165 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~ 243 (486)
...+|++..-... ...-+..+.+++++++ .|+++..- ..-.+-+++|+|..... . . ..++.
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~---~-~N~i~ 148 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------N---F-SNFIT 148 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------c---h-hHHHH
Confidence 3456666543333 2345678899998875 48888732 34456699999954221 0 0 12222
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 244 qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.=+..|.-.|+.. ...+|+|..|+||+-|..|.+||.|=+..
T Consensus 149 agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 149 AGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 2246788889654 45999999999999999999999997643
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.075 Score=52.98 Aligned_cols=139 Identities=23% Similarity=0.283 Sum_probs=80.4
Q ss_pred eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC------ceEEEE----EEE
Q 011412 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN------LVKLIG----YCI 205 (486)
Q Consensus 136 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~~~----~~~ 205 (486)
.|.+ .-..||+....+ | .+++|+.... ....++..|+..|..|.-.+ |..+-| ...
T Consensus 33 ~l~s-~eN~~f~~~~~~----------g-~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~ 98 (331)
T COG2334 33 GLNS-EENSNFRVQTED----------G-RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALS 98 (331)
T ss_pred cccc-ccCceEEEEecC----------C-CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhcc
Confidence 4444 556789886643 3 3489988765 33456777788777773222 111111 121
Q ss_pred eCCeeEEEEeecCCCChhH-H----H----------hh--cCC---------CCCHHH-------------HHHHHHHHH
Q 011412 206 EDDQRLLVYEFMPRGSLEN-H----L----------FR--RSL---------PLPWSI-------------RMKIALGAA 246 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~-~----l----------~~--~~~---------~l~~~~-------------~~~i~~qi~ 246 (486)
.....+-|++|++|..+.. . + .. ++. ...|.. -.....++.
T Consensus 99 ~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~ 178 (331)
T COG2334 99 GGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALL 178 (331)
T ss_pred CCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHH
Confidence 2237788999999988772 1 1 10 000 112220 011333344
Q ss_pred HHHHHHHhC----CCCC---eEecCCCCCcEEEcCCCc-EEEeecCCCCC
Q 011412 247 KGLAFLHEE----AERP---VIYRDFKTSNILLDADYN-AKLSDFGLAKD 288 (486)
Q Consensus 247 ~~l~yLH~~----~~~~---iiHrDLKp~NIll~~~~~-vkl~DFGla~~ 288 (486)
..+..+... -+.. +||+|+.|.|||++.+.. +.++|||-+..
T Consensus 179 ~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 179 AALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 444444432 1222 899999999999998874 88999997754
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.05 Score=55.24 Aligned_cols=75 Identities=20% Similarity=0.228 Sum_probs=48.8
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecC-----CC-cccHHHHHHHHHHHhcCC--CC-CceEEEEEE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-----DG-LQGHKEWLAEVNFLGDLV--HL-NLVKLIGYC 204 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~-----~~-~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~ 204 (486)
.+.||-|--.-||++.+.. .+..|+||.-.. .. .-...+...|..+|+.+. -| .+.++|.+
T Consensus 34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~- 103 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF- 103 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-
Confidence 4578999999999998732 134688887431 11 223455667778887663 34 45566653
Q ss_pred EeCCeeEEEEeecCC
Q 011412 205 IEDDQRLLVYEFMPR 219 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~ 219 (486)
+.+...+|||+++.
T Consensus 104 -D~e~~~~vMEdL~~ 117 (409)
T PRK12396 104 -DSVMNCCVMEDLSD 117 (409)
T ss_pred -CcHHhhHHHHhCcc
Confidence 45566799999865
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.069 Score=54.48 Aligned_cols=81 Identities=14% Similarity=0.071 Sum_probs=46.0
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-eEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv 213 (486)
+.|..|--..+|++........ .-..+.|.++...... ...-+-.+|+++++.|...++ .++++.+. -++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~---~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKD---RYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCCCC---ccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence 4565688889999875432100 0001124444432211 111223578999999876555 45666653 2699
Q ss_pred EeecCCCChh
Q 011412 214 YEFMPRGSLE 223 (486)
Q Consensus 214 ~E~~~~gsL~ 223 (486)
.||++|..|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999988764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.13 Score=48.09 Aligned_cols=57 Identities=26% Similarity=0.347 Sum_probs=41.5
Q ss_pred cEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCCceEEEEEEEeCCeeEEEEeecCCCChh
Q 011412 164 LTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 223 (486)
Q Consensus 164 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~ 223 (486)
..|-||+-... ....|..|+.-|..|. .-++.+++.+....++.|+||||++-+.+.
T Consensus 40 ~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 40 DPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 36778865432 2345777877777664 355778888888899999999999987665
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.48 Score=47.28 Aligned_cols=72 Identities=17% Similarity=0.092 Sum_probs=43.1
Q ss_pred cCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--CceEEE---E--EEEeCCeeEE
Q 011412 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLI---G--YCIEDDQRLL 212 (486)
Q Consensus 140 G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~---~--~~~~~~~~~l 212 (486)
+.-..||+.... +|..+++|+.+... ....++..|+..+..|... .++... | +...++..+.
T Consensus 36 s~eN~vy~v~~~----------~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~ 104 (325)
T PRK11768 36 SYENRVYQFGDE----------DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFA 104 (325)
T ss_pred cccceEEEEecC----------CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEE
Confidence 445679988653 35578999875332 2345677788887766321 122211 1 1233567788
Q ss_pred EEeecCCCCh
Q 011412 213 VYEFMPRGSL 222 (486)
Q Consensus 213 v~E~~~~gsL 222 (486)
|+++++|..+
T Consensus 105 l~~~~~G~~~ 114 (325)
T PRK11768 105 LFPRRGGRAP 114 (325)
T ss_pred EEeeeCCCCC
Confidence 9999987643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.31 Score=56.22 Aligned_cols=31 Identities=45% Similarity=0.493 Sum_probs=26.3
Q ss_pred CCeEecCCCCCcEEEcCCC--cEE-EeecCCCCC
Q 011412 258 RPVIYRDFKTSNILLDADY--NAK-LSDFGLAKD 288 (486)
Q Consensus 258 ~~iiHrDLKp~NIll~~~~--~vk-l~DFGla~~ 288 (486)
..+||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4599999999999998775 555 999998865
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 486 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-40 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 8e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 538 bits (1388), Expect = 0.0
Identities = 110/321 (34%), Positives = 172/321 (53%), Gaps = 31/321 (9%)
Query: 107 EEELKVAS-RLRKFTFNDLKLATRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVK 159
+ L+V+ R F+F +LK T NF + +GEGGFG V+KG++
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT------ 55
Query: 160 PGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 215
TVAVK L + + +++ E+ + H NLV+L+G+ + D LVY
Sbjct: 56 -----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110
Query: 216 FMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273
+MP GSL + L + PL W +R KIA GAA G+ FLHE I+RD K++NILLD
Sbjct: 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167
Query: 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 333
+ AK+SDFGLA+ + +T +++R++GT Y APE + G +T +SD+YSFGVVLLE
Sbjct: 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLE 226
Query: 334 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 393
++TG ++D++R L++ E + ID ++ + +A+ C
Sbjct: 227 IITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQC 283
Query: 394 LSRDPKARPLMSEVVEALKPL 414
L RP + +V + L+ +
Sbjct: 284 LHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 519 bits (1338), Expect = 0.0
Identities = 116/332 (34%), Positives = 181/332 (54%), Gaps = 17/332 (5%)
Query: 93 TTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEE 152
+ + +NS L V + DL+ AT NF + L+G G FG V+KG + +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 153 NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212
G VA+K + QG +E+ E+ L H +LV LIG+C E ++ +L
Sbjct: 63 ----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112
Query: 213 VYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269
+Y++M G+L+ HL+ ++ + W R++I +GAA+GL +LH +I+RD K+ N
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSIN 169
Query: 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 329
ILLD ++ K++DFG++K G E D+TH+ST V GT GY PEY + G LT +SDVYSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 330 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 389
VL E+L R ++ ++ P NL EWA + +++DP L + +K
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDT 288
Query: 390 AAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 421
A CL+ + RP M +V+ L+ L++
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-161
Identities = 119/304 (39%), Positives = 187/304 (61%), Gaps = 18/304 (5%)
Query: 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 174
+L++F+ +L++A+ NF +++LG GGFG V+KG + +GT VAVK L +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGT---------LVAVKRLKEE 65
Query: 175 GLQGHK-EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---S 230
QG + ++ EV + VH NL++L G+C+ +RLLVY +M GS+ + L R
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
PL W R +IALG+A+GLA+LH+ + +I+RD K +NILLD ++ A + DFGLAK
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
D THV+T V GT G+ APEY+ TG + ++DV+ +GV+LLE++TG+R+ D R +
Sbjct: 186 YKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 351 --NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
L++W + L + ++ L+D L+G++ + ++ Q+A C P RP MSEVV
Sbjct: 245 DVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 409 EALK 412
L+
Sbjct: 304 RMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 1e-86
Identities = 77/348 (22%), Positives = 129/348 (37%), Gaps = 50/348 (14%)
Query: 96 NAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 155
+ +S ++ +L + + + G FGCV+K +
Sbjct: 2 GHHHHHHSSGVD-----------LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---- 46
Query: 156 APVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLGDLVHLNLVKLIGYCIEDD----Q 209
VAVK +Q + W E V L + H N+++ IG
Sbjct: 47 -------NEYVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96
Query: 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER-------PVIY 262
L+ F +GSL + L + W+ IA A+GLA+LHE+ + +
Sbjct: 97 LWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH 154
Query: 263 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-- 320
RD K+ N+LL + A ++DFGLA G + +GT Y APE +
Sbjct: 155 RDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD 214
Query: 321 ---RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE--WARPHLGERRRF--YRLIDPR 373
R D+Y+ G+VL E+ + + D E P L + + ++ P
Sbjct: 215 AFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPV 274
Query: 374 LEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 420
L ++ G + C D +AR V E + + L ++
Sbjct: 275 LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-65
Identities = 69/332 (20%), Positives = 121/332 (36%), Gaps = 54/332 (16%)
Query: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQ 177
++ L N + L+G G +G V+KG E VAVK +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER------------PVAVKVFS---FA 47
Query: 178 GHKEWLAEVN--FLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS 230
+ ++ E N + + H N+ + I + LLV E+ P GSL +L +
Sbjct: 48 NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT 107
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAER------PVIYRDFKTSNILLDADYNAKLSDFG 284
W ++A +GLA+LH E R + +RD + N+L+ D +SDFG
Sbjct: 108 SD--WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165
Query: 285 LAK------DGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVYSFGVVL 331
L+ G++ + + +GT Y APE + + D+Y+ G++
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
Query: 332 LEMLTGRRSMDKNRPNGEHNL----VEWARPHLGERRRF-----YRLIDPRLEGHFSIKG 382
E+ + E+ + P + + R P S+
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-A 284
Query: 383 AQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+ + C +D +AR E + L
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-62
Identities = 77/301 (25%), Positives = 124/301 (41%), Gaps = 53/301 (17%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ ++++ +G G FG V K W VA+K + + +
Sbjct: 7 YKEIEVEEV-------VGRGAFGVVCKAKW------------RAKDVAIKQIESESER-- 45
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSI 237
K ++ E+ L + H N+VKL G C+ LV E+ GSL N H +
Sbjct: 46 KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 103
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTH 296
M L ++G+A+LH + +I+RD K N+LL A K+ DFG A D
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQT 158
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
T G+ + APE + + + DV+S+G++L E++T R +P E +
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFR 212
Query: 357 RP---HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413
H G R + + + L C S+DP RP M E+V+ +
Sbjct: 213 IMWAVHNGTRPPLIKNLPKPI------------ESLMTRCWSKDPSQRPSMEEIVKIMTH 260
Query: 414 L 414
L
Sbjct: 261 L 261
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 5e-62
Identities = 82/313 (26%), Positives = 138/313 (44%), Gaps = 62/313 (19%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH- 179
N+++ E +G+GGFG V KG + ++ + VA+K+L +G
Sbjct: 18 DNEIEY-------EKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGET 61
Query: 180 ------KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+E+ EV + +L H N+VKL G +V EF+P G L + L ++ P+
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPI 119
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-----ADYNAKLSDFGLAKD 288
WS+++++ L A G+ ++ + P+++RD ++ NI L A AK++DFGL++
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ- 177
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
H + ++G + + APE + T ++D YSF ++L +LTG
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGE------G 226
Query: 346 P----NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
P + G R PRL + C S DPK R
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKR 274
Query: 402 PLMSEVVEALKPL 414
P S +V+ L L
Sbjct: 275 PHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-61
Identities = 82/301 (27%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ DL + + +G G FG V + W +G+ VAVK L
Sbjct: 36 WCDLNIKEK-------IGAGSFGTVHRAEW---HGS---------DVAVKILMEQDFHAE 76
Query: 180 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPW 235
E+L EV + L H N+V +G + +V E++ RGSL L + L
Sbjct: 77 RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE 136
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
R+ +A AKG+ +LH P+++R+ K+ N+L+D Y K+ DFGL++ +
Sbjct: 137 RRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE- 354
S GT + APE + +SDVYSFGV+L E+ T + +P G N +
Sbjct: 196 --SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQV 247
Query: 355 -WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413
A +R R ++P++ A + C + +P RP + +++ L+P
Sbjct: 248 VAAVGFKCKRLEIPRNLNPQV------------AAIIEGCWTNEPWKRPSFATIMDLLRP 295
Query: 414 L 414
L
Sbjct: 296 L 296
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-60
Identities = 73/309 (23%), Positives = 119/309 (38%), Gaps = 56/309 (18%)
Query: 129 RNFRPESL-----LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
R FRP L LG+G FG K TG + +K L + + +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHR----------ETGEVMVMKELIRFDEETQRTF 54
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L EV + L H N++K IG +D + + E++ G+L + PWS R+ A
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------------DGP 290
A G+A+LH +I+RD + N L+ + N ++DFGLA+
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
+ V+G + APE + + DV+SFG+VL E++ + P+
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLP 227
Query: 351 NLVEWARPHLGERRRFYRL-----IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405
+++ R F P + C DP+ RP
Sbjct: 228 RTMDFGLNV----RGFLDRYCPPNCPPSF------------FPITVRCCDLDPEKRPSFV 271
Query: 406 EVVEALKPL 414
++ L+ L
Sbjct: 272 KLEHWLETL 280
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-59
Identities = 85/309 (27%), Positives = 131/309 (42%), Gaps = 58/309 (18%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
F +L L +G GGFG V++ W G VAVK HD +
Sbjct: 6 FAELTLEEI-------IGIGGFGKVYRAFW---IGD---------EVAVKAARHDPDEDI 46
Query: 180 ----KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 235
+ E L H N++ L G C+++ LV EF G L L + +P
Sbjct: 47 SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPP 104
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--------ADYNAKLSDFGLAK 287
I + A+ A+G+ +LH+EA P+I+RD K+SNIL+ ++ K++DFGLA+
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP- 346
E +T + G Y + APE + + SDV+S+GV+L E+LTG P
Sbjct: 165 ---EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPF 214
Query: 347 NGEHNL-VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405
G L V + A+L C + DP +RP +
Sbjct: 215 RGIDGLAVAYGVAMNKLALPIPSTCPEPF------------AKLMEDCWNPDPHSRPSFT 262
Query: 406 EVVEALKPL 414
+++ L +
Sbjct: 263 NILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-57
Identities = 67/312 (21%), Positives = 115/312 (36%), Gaps = 70/312 (22%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
F L T+ L E G ++KG W G + VK L
Sbjct: 9 FKQLNFLTK-------LNENHSGELWKGRW---QGN---------DIVVKVLKVRDWSTR 49
Query: 180 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFR-RSLPLP 234
+++ E L H N++ ++G C + +MP GSL N L + +
Sbjct: 50 KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
S +K AL A+G+AFLH E + + ++++D D A++S +
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------F 161
Query: 295 THVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
+ S M + APE + +D++SF V+L E++T P +
Sbjct: 162 SFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADL 214
Query: 351 NLVEWA--------RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
+ +E RP + I P + ++L C++ DP RP
Sbjct: 215 SNMEIGMKVALEGLRPTIPPG------ISPHV------------SKLMKICMNEDPAKRP 256
Query: 403 LMSEVVEALKPL 414
+V L+ +
Sbjct: 257 KFDMIVPILEKM 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-57
Identities = 62/351 (17%), Positives = 123/351 (35%), Gaps = 69/351 (19%)
Query: 98 ESNSSTSKLEEELKVASRLRKFT------FNDLKLATRNFRPESLLGEGGFGCVFKG-WI 150
E N S + AS+ F F L++ +G+G FG V+ G W
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVYHGRW- 54
Query: 151 EENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208
+G VA++ ++ + K + EV H N+V +G C+
Sbjct: 55 --HGE----------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102
Query: 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268
++ +L + + + L + +IA KG+ +LH + ++++D K+
Sbjct: 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSK 159
Query: 269 NILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTG--------- 316
N+ D + ++DFGL G + G + APE +
Sbjct: 160 NVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218
Query: 317 HLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 373
+ SDV++ G + E+ ++ + W + +
Sbjct: 219 PFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQ------MGTGMKPNLSQ 265
Query: 374 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSS 424
+ I + C + + + RP +++++ L+ LP K S
Sbjct: 266 IGMGKEIS------DILLFCWAFEQEERPTFTKLMDMLEKLP--KRNRRLS 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 5e-57
Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 42/301 (13%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ + R +G G FG V+KG W +G VAVK LN
Sbjct: 23 DGQITVGQR-------IGSGSFGTVYKGKW---HGD----------VAVKMLNVTAPTPQ 62
Query: 180 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
+ + EV L H+N++ +GY Q +V ++ SL +HL
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ IA A+G+ +LH + +I+RD K++NI L D K+ DFGLA + +H
Sbjct: 122 LIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 298 STRVMGTYGYAAPE---YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354
++ G+ + APE + + +SDVY+FG+VL E++TG+ P N +
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRD 232
Query: 355 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+G ++ + ++ +L A CL + RP ++ ++ L
Sbjct: 233 QIIEMVGRGSL--SPDLSKVRSNCP----KRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
Query: 415 P 415
Sbjct: 287 A 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 6e-56
Identities = 71/311 (22%), Positives = 114/311 (36%), Gaps = 53/311 (17%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 190
+G+G +G V++G W G VAVK + + K W E +
Sbjct: 13 LECVGKGRYGEVWRGSW---QGE---------NVAVKIFSS---RDEKSWFRETELYNTV 57
Query: 191 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L H N++ I + Q L+ + GSL ++L + L ++I L A
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIA 115
Query: 247 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 299
GLA LH E + +RD K+ NIL+ + ++D GLA +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 300 RVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNRP------ 346
+GT Y APE V+ + R D+++FG+VL E+ S
Sbjct: 176 PRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 347 --NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 403
E R + ++ R I R A+L C ++P AR
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQ--RPNIPNRWFSD---PTLTSLAKLMKECWYQNPSARLT 289
Query: 404 MSEVVEALKPL 414
+ + L +
Sbjct: 290 ALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 7e-56
Identities = 68/313 (21%), Positives = 119/313 (38%), Gaps = 45/313 (14%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLG 190
+G+G +G V+ G W E VAVK W E+
Sbjct: 42 VKQIGKGRYGEVWMGKWRGE------------KVAVKVFFT---TEEASWFRETEIYQTV 86
Query: 191 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+ H N++ I I+ Q L+ ++ GSL ++L +S L +K+A +
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSV 144
Query: 247 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 299
GL LH E + +RD K+ NIL+ + ++D GLA +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 300 RVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--H 350
+GT Y PE V+ L +D+YSFG++L E+ R + +
Sbjct: 205 TRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPY 262
Query: 351 NLVEWARPHLGERRRF--YRLIDPRLEGHFSIKGAQKA-AQLAAHCLSRDPKARPLMSEV 407
+ + + P + R + + P +S + +L C + +P +R V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 408 VEALKPLPNLKDM 420
+ L + +D+
Sbjct: 323 KKTLAKMSESQDI 335
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 7e-55
Identities = 73/317 (23%), Positives = 123/317 (38%), Gaps = 53/317 (16%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 190
+ +G+G FG V++G W E VAVK + + + W E +
Sbjct: 47 QESIGKGRFGEVWRGKWRGE------------EVAVKIFS---SREERSWFREAEIYQTV 91
Query: 191 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L H N++ I +D+ Q LV ++ GSL ++L + +K+AL A
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTA 149
Query: 247 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 299
GLA LH E + +RD K+ NIL+ + ++D GLA D
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 300 RVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNRP------ 346
+GT Y APE V+ + R+D+Y+ G+V E+ +
Sbjct: 210 HRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268
Query: 347 --NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 403
VE R + E++ R I R + +++ A++ C + AR
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKL--RPNIPNRWQSCEALR---VMAKIMRECWYANGAARLT 323
Query: 404 MSEVVEALKPLPNLKDM 420
+ + L L + +
Sbjct: 324 ALRIKKTLSQLSQQEGI 340
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 71/280 (25%), Positives = 112/280 (40%), Gaps = 31/280 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G G FG VF G + + T VAVK+ ++L E L H
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
N+V+LIG C + +V E + G L L +++ AA G+ +L
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE-- 230
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 315
+ I+RD N L+ K+SDFG++++ +G + APE +
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPRL 374
G +S SDV+SFG++L E + S N N + VE + RL P
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----------KGGRL--PCP 337
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
E +L C + +P RP S + + L+ +
Sbjct: 338 ELC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 88/302 (29%), Positives = 122/302 (40%), Gaps = 44/302 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 187
R + LGEG FG V + P GTG VAVK L D G Q W E++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H +++K G C + LV E++P GSL ++L R S+ L + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF--AQQI 143
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 299
+G+A+LH + I+RD N+LLD D K+ DFGLAK PEG + +
Sbjct: 144 CEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 300 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 357
APE + SDV+SFGV L E+LT S E + +
Sbjct: 201 VFWY------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ 254
Query: 358 PHLGERRRF----YRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410
+ RL P E + L +C + RP ++
Sbjct: 255 MTVLRLTELLERGERLPRPDKCPAEVY----------HLMKNCWETEASFRPTFENLIPI 304
Query: 411 LK 412
LK
Sbjct: 305 LK 306
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-41
Identities = 82/306 (26%), Positives = 122/306 (39%), Gaps = 47/306 (15%)
Query: 129 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
R+ + S LG+G FG V + P+ TG VAVK L H G +++ E+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYD------PLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L +VK G ++ LV E++P G L + L R L S + +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 299
KG+ +L R ++RD NIL++++ + K++DFGLAK P +V
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 300 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 357
APE + + +SDV+SFGVVL E+ T +S + E
Sbjct: 194 IFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
Query: 358 PHLGERRRF----YRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408
P L RL P H +L C + P+ RP S +
Sbjct: 248 PALSRLLELLEEGQRL--PAPPACPAEVH----------ELMKLCWAPSPQDRPSFSALG 295
Query: 409 EALKPL 414
L L
Sbjct: 296 PQLDML 301
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-41
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
R+ + LG+G FG V + P++ TG VAVK L H + +++ E+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 299
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ +
Sbjct: 124 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 300 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-----V 353
APE + + SDV+SFGVVL E+ T +
Sbjct: 181 IFWY------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 354 EWARPHLGER-RRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ HL E + RL P E + + C + + RP ++
Sbjct: 235 QMIVFHLIELLKNNGRLPRPDGCPDEIY----------MIMTECWNNNVNQRPSFRDLAL 284
Query: 410 ALKPL 414
+ +
Sbjct: 285 RVDQI 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 25/218 (11%)
Query: 129 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
R+ + LG+G FG V + P++ TG VAVK L H + +++ E+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 299
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ + +
Sbjct: 155 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 300 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
APE + + SDV+SFGVVL E+ T
Sbjct: 212 IFWY------APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 79/304 (25%), Positives = 119/304 (39%), Gaps = 42/304 (13%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 187
R + LGEG FG V + P TG VAVK+L + G + E+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L +L H N+VK G C ED L+ EF+P GSL+ +L + + ++K A+
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 299
KG+ +L R ++RD N+L+++++ K+ DFGL K + +
Sbjct: 136 CKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 300 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV---E 354
APE +M SDV+SFGV L E+LT + +
Sbjct: 193 VFWY------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246
Query: 355 WARPHLGER-RRFYRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410
L + RL P E + QL C P R ++E
Sbjct: 247 MTVTRLVNTLKEGKRLPCPPNCPDEVY----------QLMRKCWEFQPSNRTSFQNLIEG 296
Query: 411 LKPL 414
+ L
Sbjct: 297 FEAL 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 20/229 (8%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLN 172
+ LR + K LG G FG V+KG WI E + VA+K L
Sbjct: 7 ALLRILKETEFKKIKV-------LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELR 53
Query: 173 HD-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 231
+ +KE L E + + + ++ +L+G C+ L+ + MP G L +++
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD 112
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
+ + + AKG+ +L +R +++RD N+L+ + K++DFGLAK
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 292 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
+K + + + A E ++ T +SDV+S+GV + E++T G +
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVH 194
LGEG FG V +G + GT L VAVKT+ D + +E+L+E + D H
Sbjct: 42 LGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 195 LNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IALG 244
N+++L+G CIE + +++ FM G L +L + R P I ++ +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHVSTRV- 301
A G+ +L + R ++RD N +L D ++DFGL+K GD + ++
Sbjct: 156 IALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 302 ---MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E + TS+SDV++FGV + E+ T
Sbjct: 213 VKWI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-38
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 33 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAA 246
++V+L+G + L++ E M RG L+++L P S +++A A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV----- 301
G+A+L ++RD N ++ D+ K+ DFG+ +D E D +
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 302 -MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
M +PE + G T+ SDV+SFGVVL E+ T
Sbjct: 206 WM------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-38
Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 18/220 (8%)
Query: 128 TRNFRPESL-----LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 180
R F+ L LG G FG V KG WI E + + V +K + G Q +
Sbjct: 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIP------VCIKVIEDKSGRQSFQ 60
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ +G L H ++V+L+G C LV +++P GSL +H+ + L + +
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+ AKG+ +L E +++R+ N+LL + +++DFG+A P DK + +
Sbjct: 120 WGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
+ A E + G T +SDV+S+GV + E++T G
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-38
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G G FGCV+ G T G + AVK+LN + ++L E + D H
Sbjct: 33 IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 196 NLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N++ L+G C+ + L+V +M G L N + + + L AKG+ +L
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-- 144
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG------TYGYA 308
A + ++RD N +LD + K++DFGLA+D + + V +
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM---- 199
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLT 336
A E + T T++SDV+SFGV+L E++T
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 194
LG G FG V+KG WI E + VA+K L + +KE L E + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
++ +L+G C+ L+ + MP G L +++ + + + AKG+ +L
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
+R +++RD N+L+ + K++DFGLAK +K + + + A E ++
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 315 TGHLTSRSDVYSFGVVLLEMLT-GRR 339
T +SDV+S+GV + E++T G +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 63/220 (28%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E + P + VAVK L +++ E L L H +
Sbjct: 49 LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------MKIA 242
+V+ G C E L+V+E+M G L L + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV- 301
A G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 302 -----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
M PE ++ T+ SDV+SFGVVL E+ T
Sbjct: 222 LPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 27/216 (12%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+G F +FKG V +K L+ + + + + L H
Sbjct: 16 LGQGTFTKIFKGVR---REVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
+LV G C+ D+ +LV EF+ GSL+ +L + + + W + + A A + FL
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMHFL- 129
Query: 254 EEAERPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
E +I+ + NILL + + KLSD G++ D +
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV--- 184
Query: 306 GYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT-GRR 339
PE + +L +D +SFG L E+ + G +
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVH 194
LG+G FG V + + G+ + VAVK L D + +E+L E + + H
Sbjct: 31 LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 195 LNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IAL 243
++ KL+G + + +++ FM G L L R P+++ ++ +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHVSTRV 301
A G+ +L + R I+RD N +L D ++DFGL++ GD + ++++
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 302 ----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ A E + T SDV++FGV + E++T
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 69/275 (25%), Positives = 114/275 (41%), Gaps = 30/275 (10%)
Query: 79 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPE---- 134
S I +TS + S + + +L A ++
Sbjct: 30 GSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSL 89
Query: 135 -----SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNF 188
++G G FGCV+ G T G + AVK+LN + ++L E
Sbjct: 90 IVHFNEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 143
Query: 189 LGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ D H N++ L+G C+ + L+V +M G L N + + + L AK
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG---- 303
G+ FL A + ++RD N +LD + K++DFGLA+D + + V +
Sbjct: 204 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 304 --TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
A E + T T++SDV+SFGV+L E++T
Sbjct: 261 KWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+G+G FG V+ G + + A+K+L+ +Q + +L E + L H
Sbjct: 29 IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 196 NLVKLIGYCIEDD-QRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFL 252
N++ LIG + + ++ +M G L + +R+ + I L A+G+ +L
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEYL 140
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG------TYG 306
AE+ ++RD N +LD + K++DFGLA+D + + V T
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
A E + T T++SDV+SFGV+L E+LT
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 67/221 (30%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LGEG FG VF E +P K VAVK L L K++ E L +L H +
Sbjct: 23 LGEGAFGKVFLA--ECYNLSPTKDKM--LVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------MKI 241
+VK G C + D ++V+E+M G L L + + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A A G+ +L A + ++RD T N L+ A+ K+ DFG+++D D V
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 302 ------MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
M PE +M T+ SDV+SFGV+L E+ T
Sbjct: 196 MLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-37
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGD 191
+ LG G FG V +G + V A+K L +E + E +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L + +V+LIG C + + +LV E G L L + +P S ++ + G+ +
Sbjct: 67 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG----- 306
L E+ ++RD N+LL + AK+SDFGL+K D + +
Sbjct: 126 L---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPL 177
Query: 307 -YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
+ APE + +SRSDV+S+GV + E L+ G++
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 67/285 (23%), Positives = 95/285 (33%), Gaps = 43/285 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVN 187
+F+ S LG G +G VFK G AVK G + LAEV
Sbjct: 58 SFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108
Query: 188 FLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+ H V+L E L E SL+ H LP +
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
LA LH + +++ D K +NI L KL DFGL + V G
Sbjct: 168 LALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPR 221
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR- 365
Y APE + + + +DV+S G+ +LE+ PH GE +
Sbjct: 222 YMAPELLQGSY-GTAADVFSLGLTILEVACNME-----------------LPHGGEGWQQ 263
Query: 366 -FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ P S + + L DPK R ++
Sbjct: 264 LRQGYLPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 192
E ++G G G V G + G V VA+K L + + ++L+E + +G
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G ++V E+M GSL+ L + + G G+ +L
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPE 311
++ ++RD N+L+D++ K+SDFGL++ + D + +T + APE
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
+ +S SDV+SFGVV+ E+L G R
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 41/305 (13%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G +G V++G W LTVAVKTL D ++ +E+L E + ++ H
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 254
NLV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 334
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
++ I+R+ N L+ ++ K++DFGL++ GD + APE +
Sbjct: 335 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPR 373
+ +SDV++FGV+L E+ T S + + L+E + YR+ P
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERPE 442
Query: 374 LEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQA 432
G + +L C +P RP +E+ +A + + SS +
Sbjct: 443 --------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ----ESSISDEVEKEL 490
Query: 433 ERIGS 437
+ G+
Sbjct: 491 GKRGT 495
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL 192
LG+G FG V +G W +G ++VAVK L D L + +++ EVN + L
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKT-------VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLA 250
H NL++L G + +V E P GSL + L + L R A+ A+G+
Sbjct: 79 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGY 307
+L + I+RD N+LL K+ DFGL + P+ D +V + +
Sbjct: 136 YL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAW 190
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
APE + T + SD + FGV L EM T G+
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-36
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V G W G V AVK + +G E+ E + L H
Sbjct: 16 LGSGQFGVVKLGKW---KGQYDV--------AVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
LVK G C ++ +V E++ G L N+L + L + M +G+AFL
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFL- 120
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAP 310
I+RD N L+D D K+SDFG+ + + +GT ++AP
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAP 174
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
E +S+SDV++FG+++ E+ + G+
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-36
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVH 194
+G G FG V+KG +G V VA+KTL + ++L E +G H
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVP------VAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 254
N+++L G + +++ E+M G+L+ L + + + G A G+ +L
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRV----MGTYGY 307
A ++RD NIL++++ K+SDFGL+ +D PE T ++
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----- 217
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
APE + TS SDV+SFG+V+ E++T G R
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-36
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G G FG V G W V A+KT+ +G ++++ E + L H
Sbjct: 16 IGSGQFGLVHLGYW---LNKDKV--------AIKTI-REGAMSEEDFIEEAEVMMKLSHP 63
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
LV+L G C+E LV EFM G L ++L R + M L +G+A+L
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYL- 120
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRV----MGTYGYA 308
E VI+RD N L+ + K+SDFG+ + + + T+
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------ 172
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
+PE +S+SDV+SFGV++ E+ + G+
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-36
Identities = 72/333 (21%), Positives = 123/333 (36%), Gaps = 74/333 (22%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
+L++ + + ++ LGE FG V+KG G AP + VA+KTL
Sbjct: 1 GKLKEISLSAVRF-------MEELGEDRFGKVYKG--HLFGPAPGEQTQ--AVAIKTLKD 49
Query: 174 D-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 232
+E+ E L H N+V L+G +D +++ + G L L RS
Sbjct: 50 KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 109
Query: 233 LPWSIR---------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277
+ + A G+ +L + V+++D T N+L+ N
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLN 166
Query: 278 AKLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 331
K+SD GL ++ D K ++ + M APE +M G + SD++S+GVVL
Sbjct: 167 VKISDLGLFREVYAADYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVL 220
Query: 332 LEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPR---LEGHFSIKGA 383
E+ + G + N + ++ L P +
Sbjct: 221 WEVFSYGLQPYCGY----SNQDVVEMIR----------NRQVLPCPDDCPAWVY------ 260
Query: 384 QKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416
L C + P RP ++ L+ N
Sbjct: 261 ----ALMIECWNEFPSRRPRFKDIHSRLRAWGN 289
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-36
Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 122 NDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGL--QG 178
L L + LG G FG V KG + + V AVK L ++
Sbjct: 16 KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTV--------AVKILKNEANDPAL 61
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSI 237
E LAE N + L + +V++IG C E + +LV E G L +L R + I
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ + G+ +L E ++RD N+LL + AK+SDFGL+K + +
Sbjct: 121 EL--VHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 298 STRVMGTYG------YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
+ + APE + +S+SDV+SFGV++ E + G++
Sbjct: 176 AQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------M 239
N++ L+G C +D ++ E+ +G+L +L R P +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHV 297
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D K
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 298 STRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ R+ M APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
LGEG FG V++G G + VAVKT D +K ++++E + +L H
Sbjct: 20 LGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
++VKLIG E+ ++ E P G L ++L + SL + + +L K +A+L
Sbjct: 74 HIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYL- 129
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-----RVMGTYGYA 308
++RD NIL+ + KL DFGL++ + D S + M
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------ 181
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
+PE + T+ SDV+ F V + E+L+ G++
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 75/305 (24%), Positives = 124/305 (40%), Gaps = 49/305 (16%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
H+ + T +AES+SS + +++ +RL +
Sbjct: 7 HHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS 66
Query: 130 N----------FRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 174
F + L LGEG FG V E G KP +TVAVK L D
Sbjct: 67 EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDD 124
Query: 175 -GLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 232
+ + ++E+ + + H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 125 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 184
Query: 233 LPWSIR---------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277
+ A+G+ +L A + I+RD N+L+ +
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 241
Query: 278 AKLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 331
K++DFGLA+D D K + R+ M APE + T +SDV+SFGV++
Sbjct: 242 MKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLM 295
Query: 332 LEMLT 336
E+ T
Sbjct: 296 WEIFT 300
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 64/281 (22%), Positives = 106/281 (37%), Gaps = 38/281 (13%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
R + + +G G F V+KG E T + VA L L + + E
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 187 NFLGDLVHLNLVKLIGYCI---EDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L L H N+V+ + + +++ E M G+L+ +L +R + +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWC 135
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRV 301
KGL FLH P+I+RD K NI + + K+ D GLA + + V
Sbjct: 136 RQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAV 190
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
+GT + APE + DVY+FG+ +LEM T E+ E
Sbjct: 191 IGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMAT-----------SEYPYSECQNAAQI 238
Query: 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
RR + + + ++ C+ ++ R
Sbjct: 239 YRRVTSGVKPASFDKVAI----PEVKEIIEGCIRQNKDERY 275
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-35
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V G W G V A+K + +G E++ E + +L H
Sbjct: 32 LGTGQFGVVKYGKW---RGQYDV--------AIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
LV+L G C + ++ E+M G L N+L R + M + + +L
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYL- 136
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAP 310
+ ++RD N L++ K+SDFGL++ + + T +G+ ++ P
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPP 190
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
E +M +S+SD+++FGV++ E+ + G+
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL 192
+ ++G G FG V G ++ + VA+KTL + +++L E + +G
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEIS------VAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
H N+++L G + ++V E+M GSL++ L + + + G A G+ +L
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRV----MGTY 305
++ ++RD NIL++++ K+SDFGL +D PE T ++
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT--- 217
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
+PE + TS SDV+S+G+VL E+++ G R
Sbjct: 218 ---SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 40/225 (17%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 192
+ ++GEG FG V K I+ K G + A+K + H+++ E+ L L
Sbjct: 30 QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 193 V-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------------- 238
H N++ L+G C L E+ P G+L + L R+S L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 141
Query: 239 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL++ K
Sbjct: 142 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 296 HVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
R+ M A E + T+ SDV+S+GV+L E+++
Sbjct: 199 T-MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-35
Identities = 71/316 (22%), Positives = 112/316 (35%), Gaps = 50/316 (15%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKE 181
+ + +++ LGEGGF V V+ G A+K + Q +E
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDL----------VEGLHDGHFYALKRILCHEQQDREE 72
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSL---PLP 234
E + H N+++L+ YC+ + L+ F RG+L N + R L
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
+ + LG +GL +H + +RD K +NILL + L D G +
Sbjct: 133 EDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 295 THVSTRVM-------GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344
+ T Y APE + R+DV+S G VL M+ G D
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249
Query: 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-- 402
G+ L + + P S QL ++ DP RP
Sbjct: 250 FQKGDSVA-------LAVQNQLSIPQSP----RHS----SALWQLLNSMMTVDPHQRPHI 294
Query: 403 --LMSEVVEALKPLPN 416
L+S++ P P
Sbjct: 295 PLLLSQLEALQPPAPG 310
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 64/313 (20%), Positives = 112/313 (35%), Gaps = 69/313 (22%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+F ++LG+G FG V K A+K + H + L+EV
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEVM 54
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRL-------------LVYEFMPRGSLENHLFRRSLPLP 234
L L H +V+ +E + + E+ G+L + + +L
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 235 ----WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--- 287
W + +I L+++H + +I+RD K NI +D N K+ DFGLAK
Sbjct: 115 RDEYWRLFRQILEA----LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 288 ----------DGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEML 335
G ++++ + GT Y A E V+ TGH + D+YS G++ EM+
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 336 TGRRSMDKNRPNGEHNLVE-WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 394
+ V + P + + + ++ +
Sbjct: 226 YP--------FSTGMERVNILKKLRSVSIE-----FPPDFDDNKM----KVEKKIIRLLI 268
Query: 395 SRDPKARPLMSEV 407
DP RP +
Sbjct: 269 DHDPNKRPGARTL 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-35
Identities = 73/309 (23%), Positives = 113/309 (36%), Gaps = 58/309 (18%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+F+ L+G GGFG VFK G T +K + ++ + +E V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNNEKAERE----VKA 57
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL----------------LVYEFMPRGSLENHL-FRRSL 231
L L H+N+V G D + EF +G+LE + RR
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
L + +++ KG+ ++H + +I RD K SNI L K+ DFGL
Sbjct: 118 KLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---S 171
Query: 292 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
TR GT Y +PE + + D+Y+ G++L E+L
Sbjct: 172 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSK 226
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
F L D + F +K L LS+ P+ RP SE++ L
Sbjct: 227 F-------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTL 269
Query: 412 KPLPNLKDM 420
+
Sbjct: 270 TVWKKSPEK 278
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 43/230 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
+GEG FG VF+ G P +P T VAVK L + ++ E + + +
Sbjct: 55 IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 238
N+VKL+G C L++E+M G L L S S+
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 239 ------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
+ IA A G+A+L +ER ++RD T N L+ + K++DFGL+++
Sbjct: 171 LSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 293 D--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
D K + + M PE + T+ SDV+++GVVL E+ +
Sbjct: 228 DYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 77 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----------FRRSLPLPWSIRMK--- 240
N++ L+G C +D ++ E+ +G+L +L + S + K
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 241 -IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHV 297
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D K
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 298 STRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ R+ M APE + T +SDV+SFGV+L E+ T
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 39/285 (13%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 192
E LG+G FG V+ G W NGT V A+KTL G + +L E + L
Sbjct: 189 EVKLGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKL 236
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 251
H LV+L E+ +V E+M +GSL + L L + +A A G+A+
Sbjct: 237 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+ ++RD + +NIL+ + K++DFGLA+ E ++ + APE
Sbjct: 296 V---ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLI 370
+ G T +SDV+SFG++L E+ T R N E + VE R YR+
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMP 401
Query: 371 DPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPL 414
P ++ L C ++P+ RP + L+
Sbjct: 402 CPP--------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 195
+GEG FG V +G L VA+KT + + ++L E + H
Sbjct: 23 IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 253
++VKLIG E+ ++ E G L + L + SL L I A + LA+L
Sbjct: 77 HIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY--AYQLSTALAYL- 132
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-----RVMGTYGYA 308
+ ++RD N+L+ ++ KL DFGL++ + S + M
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------ 184
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
APE + TS SDV+ FGV + E+L G +
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-34
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGD 191
+ LG G FG V +G + V A+K L +E + E +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L + +V+LIG C + + +LV E G L L + +P S ++ + G+ +
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 451
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYA 308
L E+ ++R+ N+LL + AK+SDFGL+K D + + +
Sbjct: 452 L---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWY 506
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
APE + +SRSDV+S+GV + E L+ G++
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG G FG V++G + +G VAVKTL Q ++L E + H
Sbjct: 38 LGHGAFGEVYEG--QVSGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------LPWSIRMKIALGAAKG 248
N+V+ IG ++ R ++ E M G L++ L R + P L + +A A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+L E I+RD N LL AK+ DFG+A+D M
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ PE M G TS++D +SFGV+L E+ +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G+G FG V G + G VAVK + +D + +LAE + + L H
Sbjct: 29 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 253
NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L + + +L
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 133
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV----MGTYGYAA 309
++RD N+L+ D AK+SDFGL K+ T + ++ A
Sbjct: 134 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWT------A 182
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
PE + +++SDV+SFG++L E+ + GR
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G +G V++G V LTVAVKTL + +E+L E + ++ H N
Sbjct: 21 LGGGQYGEVYEG---------VWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHEE 255
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 256 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRV----MGTYGYAAP 310
++ I+RD N L+ ++ K++DFGL++ H + AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------AP 181
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
E + + +SDV++FGV+L E+ T G
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-34
Identities = 61/286 (21%), Positives = 115/286 (40%), Gaps = 25/286 (8%)
Query: 64 VSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFND 123
V+G + + + + R P+ +++ S++ + ++ + T+
Sbjct: 321 VNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDY-AEIIDEEDTYTM 379
Query: 124 LKLATRNFRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQ 177
+ E + +GEG FG V +G + VA+KT +
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDS 433
Query: 178 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 237
+++L E + H ++VKLIG ++ ++ E G L + L R L +
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLAS 492
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ A + LA+L + ++RD N+L+ ++ KL DFGL++ +
Sbjct: 493 LILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549
Query: 298 STR---VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
S + APE + TS SDV+ FGV + E+L G +
Sbjct: 550 SKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 26/207 (12%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+G+G FG V G + G VAVK + +D + +LAE + + L H
Sbjct: 201 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 246
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 253
NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L + + +L
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 305
Query: 254 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 313
++RD N+L+ D AK+SDFGL K+ T + ++ + APE +
Sbjct: 306 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKL--PVKWTAPEAL 358
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT-GRR 339
+++SDV+SFG++L E+ + GR
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LG G FG V++G + +G VAVKTL Q ++L E + H
Sbjct: 79 LGHGAFGEVYEG--QVSGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIR--MKIALGAAKG 248
N+V+ IG ++ R ++ E M G L++ L R + P ++ + +A A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+L E I+RD N LL AK+ DFG+A+D M
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ PE M G TS++D +SFGV+L E+ +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG G FG V+ G + NG V AVK+L G +LAE N + L H
Sbjct: 21 LGAGQFGEVWMGYY---NGHTKV--------AVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 254
LV+L ++ ++ E+M GSL + L + L + + +A A+G+AF+
Sbjct: 69 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRVMGTYGYAAPEYV 313
ER I+RD + +NIL+ + K++DFGLA+ + + + + APE +
Sbjct: 126 -EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAI 182
Query: 314 MTGHLTSRSDVYSFGVVLLEMLT-GRR 339
G T +SDV+SFG++L E++T GR
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 75/367 (20%), Positives = 123/367 (33%), Gaps = 53/367 (14%)
Query: 73 SKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFR 132
S S + A+ + ++ S + E + + K + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 192
+ +G G FG V + TG AVK + L+ + E+ L
Sbjct: 62 HQPRVGRGSFGEVHRM---------KDKQTGFQCAVKKVR---LEVFRV--EELVACAGL 107
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 252
+V L G E + E + GSL L ++ LP + A +GL +L
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 253 HEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYA 308
H +++ D K N+LL +D A L DFG A G + GT +
Sbjct: 167 HTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 309 APEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE VM ++ D++S ++L ML G P W
Sbjct: 224 APEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH------P--------WT--QYFRGPLCL 266
Query: 368 RL-----IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEALKPLPNLK 418
++ + + AQ L ++P R L +V +AL+ + LK
Sbjct: 267 KIASEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLK 322
Query: 419 DMASSSY 425
Y
Sbjct: 323 SPWKGEY 329
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 68/231 (29%), Positives = 100/231 (43%), Gaps = 45/231 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 195
LGEG FG V K T TVAVK L + ++ L+E N L + H
Sbjct: 31 LGEGEFGKVVKA--TAFHLKGRAGYT--TVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 238
+++KL G C +D LL+ E+ GSL L R S +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 239 -------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
+ A ++G+ +L AE +++RD NIL+ K+SDFGL++D E
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 292 GD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
D R+ M A E + T++SDV+SFGV+L E++T
Sbjct: 203 EDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 66/348 (18%), Positives = 123/348 (35%), Gaps = 39/348 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 186
+ +GEG FG G +K +N + KE EV
Sbjct: 25 KYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMS-SKEREESRREV 74
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGA 245
L ++ H N+V+ E+ +V ++ G L + ++ + + +
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +H+ R +++RD K+ NI L D +L DFG+A+ + GT
Sbjct: 135 CLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTP 189
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
Y +PE ++SD+++ G VL E+ T + + + +
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF------- 242
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE---ALKPLPNLKDMAS 422
P + H+S L + R+P+ RP ++ ++E K +
Sbjct: 243 ------PPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
Query: 423 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASP 470
+ F + GS P + S+S + ++ P Y P
Sbjct: 293 IAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIP 340
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 65/309 (21%), Positives = 110/309 (35%), Gaps = 64/309 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
+F P LG GGFG VF+ A+K + + +E + EV
Sbjct: 6 DFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 189 LGDLVHLNLVKLIGYCIEDD---------QRLLVY---EFMPRGSLENHLFRR--SLPLP 234
L L H +V+ +E + ++ +Y + + +L++ + R
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------- 287
S+ + I L A+ + FLH + +++RD K SNI D K+ DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 288 ---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344
T +GT Y +PE + + + D++S G++L E+L
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------- 225
Query: 345 RPNGEHNLVEWARPHLGERRRFYRLID----PRLEGHFSIKGAQKAAQLAAHCLSRDPKA 400
+ + ER R + P L + LS P
Sbjct: 226 PFSTQM-----------ERVRTLTDVRNLKFPPLFTQKY----PCEYVMVQDMLSPSPME 270
Query: 401 RPLMSEVVE 409
RP ++E
Sbjct: 271 RPEAINIIE 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 72/292 (24%), Positives = 116/292 (39%), Gaps = 50/292 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 186
NFR E +G G F V++ G+ VA+K + L K + E+
Sbjct: 33 NFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIAL 243
+ L L H N++K IED++ +V E G L + ++ +P K +
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
L +H R V++RD K +N+ + A KL D GL + T + V G
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-G 198
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363
T Y +PE + +SD++S G +L EM + P G++
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDK 240
Query: 364 RRFYRLI--------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
Y L P H+S ++ QL C++ DP+ RP ++ V
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDVTYV 288
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 78/282 (27%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 137 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
LG+G FG V+ G W NGT V A+KTL G + +L E + L H
Sbjct: 275 LGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKLRHE 322
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 254
LV+L E+ +V E+M +GSL + L L + +A A G+A++
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 379
Query: 255 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 314
++RD + +NIL+ + K++DFGLA+ E ++ + APE +
Sbjct: 380 -ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAAL 437
Query: 315 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPR 373
G T +SDV+SFG++L E+ T R N E + VE R YR+ P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMPCPP 487
Query: 374 LEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPL 414
++ L C ++P+ RP + L+
Sbjct: 488 --------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 134 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 192
E LG G FG V+ + N V AVKT+ G + +LAE N + L
Sbjct: 193 EKKLGAGQFGEVWMATY---NKHTKV--------AVKTM-KPGSMSVEAFLAEANVMKTL 240
Query: 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAF 251
H LVKL ++ ++ EFM +GSL + L P + + A+G+AF
Sbjct: 241 QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
+ +R I+RD + +NIL+ A K++DFGLA+ E ++ + APE
Sbjct: 300 I---EQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLT-GRR 339
+ G T +SDV+SFG++L+E++T GR
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-33
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 34/221 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V + G VAVK L + ++E+ + L H
Sbjct: 54 LGAGAFGKVVEA--TAFGLGKEDAVL--KVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKI 241
N+V L+G C L++ E+ G L N L R+S L +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-- 299
+ A+G+AFL A + I+RD N+LL + AK+ DFGLA+D V
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 300 ----RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ M APE + T +SDV+S+G++L E+ +
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 39/225 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V + + G TVAVK L H+ ++E+ L + H
Sbjct: 35 LGRGAFGQVIEA--DAFGIDKTATCR--TVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 195 LNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 238
LN+V L+G C + +++ EF G+L +L R +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KT 295
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 150 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 296 HVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
R+ M APE + T +SDV+SFGV+L E+ +
Sbjct: 207 KGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 65/225 (28%), Positives = 91/225 (40%), Gaps = 38/225 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V + G TVAVK L L + ++E+ L L H
Sbjct: 31 LGAGAFGKVVEA--TAYGLIKSDAAM--TVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 238
+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+ + AKG+AFL A + I+RD NILL K+ DFGLA+D V
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 298 ST------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ M APE + T SDV+S+G+ L E+ +
Sbjct: 204 KGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 72/293 (24%), Positives = 112/293 (38%), Gaps = 45/293 (15%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EV 186
++ LG GG V+ VA+K + + +E L EV
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNI---------KVAIKAI-FIPPREKEETLKRFEREV 62
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+ L H N+V +I EDD LV E++ +L ++ PL +
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQIL 121
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
G+ H+ +++RD K NIL+D++ K+ DFG+AK E T + V+GT
Sbjct: 122 DGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQ 177
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGE--- 362
Y +PE +D+YS G+VL EML G P NGE V A H+ +
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGE------PPFNGE-TAVSIAIKHIQDSVP 230
Query: 363 --RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 412
+ I L + +D R + E+ + L
Sbjct: 231 NVTTDVRKDIPQSLS------------NVILRATEKDKANRYKTIQEMKDDLS 271
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 68/322 (21%), Positives = 118/322 (36%), Gaps = 60/322 (18%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
S +T + S + + E +LG+G +G V+ G
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYD------------------ENGDRVVLGKGTYGIVYAG- 41
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 209
+ +A+K + + + E+ L H N+V+ +G E+
Sbjct: 42 --------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93
Query: 210 RLLVYEFMPRGSLENHLFRRSLPLPWS---IRMKIALGAAKGLAFLHEEAERPVIYRDFK 266
+ E +P GSL L + PL + I +GL +LH+ +++RD K
Sbjct: 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDNQ---IVHRDIK 149
Query: 267 TSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV---MTGHLTSRS 322
N+L++ K+SDFG +K + + GT Y APE + G+ +
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGY-GKAA 206
Query: 323 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--HLGERRRFYRLIDPRLEGHFSI 380
D++S G ++EM TG+ P + L E +G + + P + S
Sbjct: 207 DIWSLGCTIIEMATGK------PPF--YELGEPQAAMFKVGMFK-----VHPEIPESMS- 252
Query: 381 KGAQKAAQLAAHCLSRDPKARP 402
+A C DP R
Sbjct: 253 ---AEAKAFILKCFEPDPDKRA 271
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 57/230 (24%), Positives = 89/230 (38%), Gaps = 43/230 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 194
LG G FG V G + VAVK L + ++E+ + L H
Sbjct: 53 LGSGAFGKVMNA--TAYGISKTGVSI--QVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 238
N+V L+G C L++E+ G L N+L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 239 ------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
+ A AKG+ FL + ++RD N+L+ K+ DFGLA+D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 293 D--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
+ R+ M APE + G T +SDV+S+G++L E+ +
Sbjct: 226 SNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 68/295 (23%), Positives = 105/295 (35%), Gaps = 41/295 (13%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EV 186
+R L+G GG G V++ VA+K + + L + E
Sbjct: 36 YRLRRLVGRGGMGDVYEA---------EDTVRERIVALKLM-SETLSSDPVFRTRMQREA 85
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
G L ++V + + D Q + + L L RR PL + I
Sbjct: 86 RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIG 144
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
L H +RD K NIL+ AD A L DFG+A + T + +GT
Sbjct: 145 SALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLY 200
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRR 365
Y APE H T R+D+Y+ VL E LTG P G+ + H+ +
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGS------PPYQGDQ--LSVMGAHINQAIP 252
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALKPLP 415
+ P + + A ++++P+ R L + AL
Sbjct: 253 RPSTVRPGI--------PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 37/290 (12%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
++ +G G +G K + G + K L++ + + ++EV
Sbjct: 6 EDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEV 56
Query: 187 NFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 241
N L +L H N+V+ + L +V E+ G L + + + L +++
Sbjct: 57 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116
Query: 242 ALGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
L H + V++RD K +N+ LD N KL DFGLA+ D + T
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT 175
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
V GT Y +PE + +SD++S G +L E+ + +
Sbjct: 176 FV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF- 233
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R+ +S + ++ L+ RP + E++E
Sbjct: 234 ------------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 267
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 66/338 (19%), Positives = 107/338 (31%), Gaps = 51/338 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+LG+G VF+G TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 195 LNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGL 249
N+VKL E+ EF P GSL L + LP S + + G+
Sbjct: 67 KNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 250 AFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L E +++R+ K NI+ D KL+DFG A++ + ++ + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTE 179
Query: 306 GYAAPEYVMTGHLTSRS--------DVYSFGVVLLEMLTGRR-------------SMDKN 344
Y P+ L D++S GV TG M K
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 404
+ + + D + S + A+ L D +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 405 SEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 442
+ + + + + Q M A +I
Sbjct: 298 DQFFAETSDILHRMVIH--VFSLQQMTAHKIYIHSYNT 333
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 44/381 (11%), Positives = 84/381 (22%), Gaps = 64/381 (16%)
Query: 83 QPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGF 142
+ +I + ++ + + L R + L G
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 143 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVK 199
VF A+K E L+ + +
Sbjct: 76 SVVFLV---------RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 200 LIGYC-----------------------IEDDQRLLVYEFMPR--------GSLENHLFR 228
+D MP S + ++
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ + A L + +++ F N+ + D L D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW- 242
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRP 346
G + S+ YA E++ T + + G+ + + P
Sbjct: 243 -KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
+ W RP L + L L+ D + R L E
Sbjct: 299 GIKG---SWKRPSLRVPGTDS--LAFGSCTPLP----DFVKTLIGRFLNFDRRRRLLPLE 349
Query: 407 VVE--ALKPLPNLKDMASSSY 425
+E L N + S+
Sbjct: 350 AMETPEFLQLQNEISSSLSTG 370
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 49/290 (16%), Positives = 88/290 (30%), Gaps = 28/290 (9%)
Query: 68 STHYESKSTNDTSRDQPA----AAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFND 123
S S T D +I + ++ SS E ++ T +
Sbjct: 2 SPQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKT--E 59
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 183
+L ++ LLGEG F V++ + K +K
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEA--TQGDLNDAK--NKQKFVLKVQKPANPWEFYIGT 115
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----PLPWSIRM 239
+ L + +K + + +LV E G+L N + +P + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-----------DADYNAKLSDFGLAKD 288
A+ + +H+ +I+ D K N +L D L D G + D
Sbjct: 176 SFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
K + T T G+ E + + D + + ML G
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-30
Identities = 67/355 (18%), Positives = 122/355 (34%), Gaps = 55/355 (15%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
H+ S+ R ++ + +++ +S + R
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG-----R 56
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+ +G GG VF+ V A+K +N + Q + E+
Sbjct: 57 IYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 188 FLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
+L L + ++L Y DQ + +V E L + L ++ + R
Sbjct: 107 YLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKN 163
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+ + +H+ +++ D K +N L+ D KL DFG+A + V +G
Sbjct: 164 MLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 305 YGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNL 352
Y PE + ++ +SDV+S G +L M G+ P N
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQ 273
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
+ + + +IDP E F + + CL RDPK R + E+
Sbjct: 274 IS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 49/328 (14%), Positives = 92/328 (28%), Gaps = 85/328 (25%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------------- 174
R ++LG+ + +E TG + V
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKE 127
Query: 175 ---------GLQGHKEWLAEVNFL--GDLVHLNLVKLIGYCIEDDQRLLV---YEFMPRG 220
G++ K+ + F+ DLV K + D++ + V + PR
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 221 SLENHLFRRSL--------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272
F L L R+++ L + LA LH +++ + +I+L
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVL 244
Query: 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TGHLTSRS 322
D L+ F +G S G+A PE +T
Sbjct: 245 DQRGGVFLTGFEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 323 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 382
D ++ G+ + + PN + + + + P+
Sbjct: 299 DTWTLGLAIYWIWCAD------LPNTDDAALGGSEWIFRSCKNI-----PQP-------- 339
Query: 383 AQKAAQLAAHCLSRDPKARPLMSEVVEA 410
L L + R L + +E
Sbjct: 340 ---VRALLEGFLRYPKEDRLLPLQAMET 364
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 66/242 (27%), Positives = 114/242 (47%), Gaps = 20/242 (8%)
Query: 101 SSTSKLEEELKVASRLRKFTFNDLK---LATRNFRPESLLGEGGFGCVFKGWIEENGTAP 157
+LE + + RL F K L +F S LG G G VFK +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP----- 56
Query: 158 VKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 216
+GL +A K ++ + + + E+ L + +V G D + + E
Sbjct: 57 ----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
M GSL+ + +++ +P I K+++ KGL +L E+ +++RD K SNIL+++
Sbjct: 113 MDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRG 169
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
KL DFG++ + + ++ V GT Y +PE + H + +SD++S G+ L+EM
Sbjct: 170 EIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 337 GR 338
GR
Sbjct: 226 GR 227
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 49/395 (12%), Positives = 102/395 (25%), Gaps = 95/395 (24%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFN------- 122
H+ S + P VI ++N T+ + S + +N
Sbjct: 5 HHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRV 64
Query: 123 --DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---- 176
+L R ++LG+ + TG + V
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSN 115
Query: 177 ------------------------QGHKEWLAEVNFLGDLVHLNLVKLIGYC--IEDDQR 210
+ H ++ + + D ++++ + R
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 211 LLVYEFMP-----RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 265
+Y M G + L R+++ L + LA LH +++
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL 232
Query: 266 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---------- 315
+ +I+LD L+ F + + G+ PE
Sbjct: 233 RPVDIVLDQRGGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDR 286
Query: 316 -GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 374
+T D ++ G+V+ + P + + + R
Sbjct: 287 RTLMTFSFDAWALGLVIYWIWCAD------LPITKDAALGGSEWIF------------RS 328
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ Q L L + R L + +E
Sbjct: 329 CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 62/297 (20%), Positives = 98/297 (32%), Gaps = 49/297 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 194
+LG+G VF+G TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 195 LNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGL 249
N+VKL E+ EF P GSL L + LP S + + G+
Sbjct: 67 KNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 250 AFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L E +++R+ K NI+ D KL+DFG A++ + ++ + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTE 179
Query: 306 GYAAPEYVMTGHL--------TSRSDVYSFGVVLLEMLTGRR-------------SMDKN 344
Y P+ L + D++S GV TG M K
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
+ + + D + S + A+ L D +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 64/308 (20%), Positives = 111/308 (36%), Gaps = 50/308 (16%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
F + + R + +G GG VF+ V A+K +N +
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEA 65
Query: 177 QGH--KEWLAEVNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSL 231
+ E+ +L L + ++L Y DQ + +V E L + L ++
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKK- 122
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
+ R + + +H+ +++ D K +N L+ D KL DFG+A
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178
Query: 292 GDKTHVSTRVMGTYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRS 340
+ V +GT Y PE + ++ +SDV+S G +L M G+
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT- 237
Query: 341 MDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 399
P N + + + +IDP E F + + CL RDPK
Sbjct: 238 -----PFQQIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 282
Query: 400 ARPLMSEV 407
R + E+
Sbjct: 283 QRISIPEL 290
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 69/301 (22%), Positives = 105/301 (34%), Gaps = 43/301 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
+ + LG GGFG V + + TG VA+K + ++E W E+
Sbjct: 15 PWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 189 LGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFR--RSLPLPWSIR 238
+ L H N+V + D + LL E+ G L +L + L
Sbjct: 66 MKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA---KLSDFGLAKDGPEGDKT 295
+ + L +LHE +I+RD K NI+L K+ D G AK+ +G+
Sbjct: 124 RTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR---------SMDKNRP 346
V GT Y APE + T D +SFG + E +TG R
Sbjct: 181 T--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
+ + G + L P H S A K + L + R +
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPN---HLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294
Query: 407 V 407
Sbjct: 295 N 295
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 59/289 (20%), Positives = 101/289 (34%), Gaps = 43/289 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+F P+ +LG G G + + VAVK + + EV L
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFSFADR---EVQLL 71
Query: 190 GDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
+ H N+++ + + + E +L+ ++ ++ + + G
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 249 LAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAK--DGPEGDKTHVSTRV 301
LA LH +++RD K NIL+ A +SDFGL K + S
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 302 MGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
GT G+ APE + + T D++S G V +++ P G+ +
Sbjct: 188 -GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQ---- 237
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
L E H A +L ++ DP+ RP V
Sbjct: 238 -ANILLGACSLDCLHPEKHED----VIARELIEKMIAMDPQKRPSAKHV 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 69/307 (22%), Positives = 116/307 (37%), Gaps = 49/307 (15%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWL 183
L+ R + +LG GG V VAVK L L +
Sbjct: 10 LSDR-YELGEILGFGGMSEVHLAR-----------DLRDHRDVAVKVL-RADLARDPSFY 56
Query: 184 A----EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPW 235
E L H +V + + +V E++ +L + + P+
Sbjct: 57 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTP 115
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+++ A + L F H+ +I+RD K +NI++ A K+ DFG+A+ + +
Sbjct: 116 KRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 296 HVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLV 353
T V+GT Y +PE + +RSDVYS G VL E+LTG P G+ + V
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGD-SPV 225
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVV 408
A H+ E L + + L+++P+ R + +++V
Sbjct: 226 SVAYQHVREDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLV 277
Query: 409 EALKPLP 415
P
Sbjct: 278 RVHNGEP 284
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-29
Identities = 59/289 (20%), Positives = 104/289 (35%), Gaps = 53/289 (18%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 189
+ + + GG G ++ G V +K L H G + +AE FL
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVN--------GRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 190 GDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
++VH ++V++ + D+ +V E++ SL+ + LP+ +I L
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQKLPVAEAIA--YLLE 190
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
L++LH ++Y D K NI+L + KL D G + GT
Sbjct: 191 ILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFGY-LYGT 240
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
G+ APE ++ T +D+Y+ G L + + + +G P L
Sbjct: 241 PGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----PVLKTYD 295
Query: 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 412
+ RL+ + DP+ R E+ L
Sbjct: 296 SYGRLL--------------------RRAIDPDPRQRFTTAEEMSAQLT 324
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 80/335 (23%), Positives = 121/335 (36%), Gaps = 54/335 (16%)
Query: 84 PAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFG 143
PA A + + + ++ L + R + LG+GGF
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD------PRSRRRYVRGRFLGKGGFA 55
Query: 144 CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLVHLNLVKL 200
F+ T A K + L + E++ L H ++V
Sbjct: 56 KCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 201 IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 259
G+ ED+ + +V E R SL RR R G +LH
Sbjct: 107 HGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---NR 161
Query: 260 VIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL 318
VI+RD K N+ L+ D K+ DFGLA K +G++ V GT Y APE V++
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE-VLSKKG 217
Query: 319 TS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI---DPRL 374
S DV+S G ++ +L G+ P L E Y I + +
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE-----------TYLRIKKNEYSI 260
Query: 375 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
H + AA L L DP ARP ++E++
Sbjct: 261 PKHIN----PVAASLIQKMLQTDPTARPTINELLN 291
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 66/347 (19%), Positives = 124/347 (35%), Gaps = 54/347 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 193
+G GG VF+ A+K +N + + E+ +L L
Sbjct: 16 QIGSGGSSKVFQV----------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 194 HLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
+ ++L Y DQ + +V E L + L ++ + R + +
Sbjct: 66 QHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH 122
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+H+ +++ D K +N L+ D KL DFG+A + V +GT Y P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 311 EYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARP 358
E + ++ +SDV+S G +L M G+ P N +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------PFQQIINQIS---- 228
Query: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE----ALKPL 414
+ + +IDP E F + + CL RDPK R + E++ ++
Sbjct: 229 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282
Query: 415 PNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLS 461
P + ++ + + + +G + A+ +G S +
Sbjct: 283 PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHN 329
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 86/322 (26%), Positives = 117/322 (36%), Gaps = 41/322 (12%)
Query: 31 DEVEVEEEEETGCWVKLRFFGSCISSRSKVDSSVSGTSTHYESKSTNDTSR--DQPAAAV 88
E EV +++ + G ++ + TN T R P +
Sbjct: 88 AEYEVTPDDKR------KACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDL 141
Query: 89 ISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDL---KLATRNFRPESLLGEGGFGCV 145
T E S + + L R + L + FR +LG+GGFG V
Sbjct: 142 FQELTRLTHE-YLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEV 200
Query: 146 FKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIG 202
A TG A K L ++ K L E L + +V L
Sbjct: 201 C---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 203 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK-----IALGAAKGLAFLHEEA 256
Y E L LV M G L+ H++ R I G L LH E
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHRER 306
Query: 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 316
++YRD K NILLD + ++SD GLA PEG RV GT GY APE V
Sbjct: 307 ---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNE 360
Query: 317 HLTSRSDVYSFGVVLLEMLTGR 338
T D ++ G +L EM+ G+
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 75/296 (25%), Positives = 111/296 (37%), Gaps = 60/296 (20%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAE 185
R + LG+GGF F+ T A K + L + E
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM----- 239
++ L H ++V G+ ED+ + +V E R SL RR +
Sbjct: 66 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK-------ALTEPEA 117
Query: 240 -KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHV 297
G +LH VI+RD K N+ L+ D K+ DFGLA K +G++ V
Sbjct: 118 RYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
Query: 298 STRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
GT Y APE V++ S DV+S G ++ +L G+ P L E
Sbjct: 175 LC---GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE-- 222
Query: 357 RPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
Y I + + H + AA L L DP ARP ++E++
Sbjct: 223 ---------TYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 265
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 67/281 (23%), Positives = 112/281 (39%), Gaps = 46/281 (16%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL 192
LG+G FG V+ + + +A+K L L+ + EV L
Sbjct: 16 PLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N+++L GY D R+ L+ E+ P G++ L ++ A L++
Sbjct: 67 RHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 124
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
H + VI+RD K N+LL + K++DFG + P + GT Y PE
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---GTLDYLPPE 177
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI- 370
+ + D++S GV+ E L G+ P + E Y+ I
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQE-----------TYKRIS 220
Query: 371 --DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ + +GA+ L + L +P RP++ EV+E
Sbjct: 221 RVEFTFPDFVT-EGARD---LISRLLKHNPSQRPMLREVLE 257
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 44/231 (19%), Positives = 86/231 (37%), Gaps = 49/231 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------------ 184
L +G F + E++ A+K L+ +++
Sbjct: 39 LNQGKFNKIILC--EKDNK---------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 185 -----EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-------FRRSL 231
E+ + D+ + + G I + + ++YE+M S+ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
+P + I +++H E+ + +RD K SNIL+D + KLSDFG ++ +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 292 GD-KTHVSTRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 338
K GTY + PE + + ++ D++S G+ L M
Sbjct: 205 KKIKG-----SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 61/302 (20%), Positives = 97/302 (32%), Gaps = 66/302 (21%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAE 185
T F +G G FG VFK VK G A+K G + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 186 VNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 241
V L H ++V+ EDD L+ E+ GSL + + +R + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-------------------YNAKLSD 282
L +GL ++H +++ D K SNI + K+ D
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRS 340
G V G + A E + HL +D+++ + ++
Sbjct: 178 LGHVT---RISSPQVEE---GDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPL 230
Query: 341 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 400
P +W G PR+ S Q+ +L + DP+
Sbjct: 231 -----PRNGD---QWHEIRQGRL--------PRIPQVLS----QEFTELLKVMIHPDPER 270
Query: 401 RP 402
RP
Sbjct: 271 RP 272
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 69/229 (30%), Positives = 91/229 (39%), Gaps = 38/229 (16%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
+ F +LG GGFG VF A TG A K LN L+ K +
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQG 231
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPW 235
+ E L + +V L Y E L LV M G + H++ P
Sbjct: 232 AMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP- 289
Query: 236 SIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
R I G L LH+ +IYRD K N+LLD D N ++SD GLA +
Sbjct: 290 --RAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
G GT G+ APE ++ G S D ++ GV L EM+ R
Sbjct: 341 AGQTK-TKGYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEV 186
+F+ +LLG+G F V++ TGL VA+K ++ + EV
Sbjct: 12 DFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L H ++++L Y ED + LV E G + +L R P +
Sbjct: 63 KIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGT 304
G+ +LH +++RD SN+LL + N K++DFGLA + +K + GT
Sbjct: 122 ITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GT 175
Query: 305 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y +PE + H SDV+S G + +L GR
Sbjct: 176 PNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 69/348 (19%), Positives = 129/348 (37%), Gaps = 64/348 (18%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW 182
++L R +L EGGF V++ + G+G A+K L + + ++
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYE----------AQDVGSGREYALKRLLSNEEEKNRAI 72
Query: 183 LAEVNFLGDLV-HLNLVKLIGYCIEDDQR-------LLVYEFMPRGSLENHLFRRSL--P 232
+ EV F+ L H N+V+ + L+ + +G L L + P
Sbjct: 73 IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDG 289
L +KI + + +H + P+I+RD K N+LL KL DFG A
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191
Query: 290 PEGDKTHVSTRVM-------GTYGYAAPEYV-MTGHL--TSRSDVYSFGVVLLEMLTGRR 339
P+ + ++ T Y PE + + + + D+++ G +L + +
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ- 250
Query: 340 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI----KGAQKAAQLAAHCLS 395
P + + I + G +SI L L
Sbjct: 251 -----HPFEDGAKLR---------------I---VNGKYSIPPHDTQYTVFHSLIRAMLQ 287
Query: 396 RDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM-QAERIGSSPNTR 442
+P+ R ++EVV L+ + +++ S + + Q GS+ +R
Sbjct: 288 VNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-27
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 22/207 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLA-EVNFLGDL 192
LG+G FG V+ + +A+K L L+ L E+ L
Sbjct: 21 PLGKGKFGNVYLA---------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 193 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
H N++++ Y D +R+ L+ EF PRG L L ++ A L +
Sbjct: 72 RHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHY 129
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 311
HE R VI+RD K N+L+ K++DFG + P + GT Y PE
Sbjct: 130 CHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPE 182
Query: 312 YVMTGHLTSRSDVYSFGVVLLEMLTGR 338
+ + D++ GV+ E L G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 69/253 (27%), Positives = 100/253 (39%), Gaps = 45/253 (17%)
Query: 100 NSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK 159
S + K T ND F ++G GGFG V+ K
Sbjct: 167 ESDKFTRFCQWKNVELNIHLTMND-------FSVHRIIGRGGFGEVY---------GCRK 210
Query: 160 PGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLN---LVKLIGYCIEDDQRL-L 212
TG A+K L+ ++ + L E L + + +V + Y +L
Sbjct: 211 ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSF 269
Query: 213 VYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFK 266
+ + M G L HL + M+ I LG L +H V+YRD K
Sbjct: 270 ILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHMHNRF---VVYRDLK 319
Query: 267 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVY 325
+NILLD + ++SD GLA D + K H V GT+GY APE + G S D +
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSK-KKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWF 375
Query: 326 SFGVVLLEMLTGR 338
S G +L ++L G
Sbjct: 376 SLGCMLFKLLRGH 388
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 55/296 (18%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEW 182
+++ + P LG G +G V K +G +AVK + Q K
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRL 52
Query: 183 LAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIR 238
L +++ + + V G + + E M SL+ + + +P I
Sbjct: 53 LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDIL 111
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
KIA+ K L LH + VI+RD K SN+L++A K+ DFG++
Sbjct: 112 GKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAK 166
Query: 299 TRVMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354
G Y APE + + +SD++S G+ ++E+ R
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR-----------FPYDS 215
Query: 355 WARPHLGERRRFYRLID-------PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARP 402
W P ++ + P+L FS + + CL ++ K RP
Sbjct: 216 WGTP--------FQQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERP 259
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 70/249 (28%), Positives = 107/249 (42%), Gaps = 39/249 (15%)
Query: 101 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160
S ++ V K + F +LG+G FG VF +++
Sbjct: 3 GSIKEIAITHHVKEGHEKADPSQ-------FELLKVLGQGSFGKVFL--VKKISG----S 49
Query: 161 GTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFM 217
A+K L L+ E + L ++ H +VKL Y + + +L L+ +F+
Sbjct: 50 DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFL 108
Query: 218 PRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271
G L L + +K +AL L LH +IYRD K NIL
Sbjct: 109 RGGDLFTRLSKEVMFTEE---DVKFYLAELALA----LDHLHS---LGIIYRDLKPENIL 158
Query: 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGV 329
LD + + KL+DFGL+K+ + +K GT Y APE V+ ++S D +SFGV
Sbjct: 159 LDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGV 214
Query: 330 VLLEMLTGR 338
++ EMLTG
Sbjct: 215 LMFEMLTGT 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 74/315 (23%), Positives = 123/315 (39%), Gaps = 76/315 (24%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFL 189
F +G+G FG VFKG + T VA+K ++ + + E + E+ L
Sbjct: 24 FTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAA 246
+ K G ++D + ++ E++ GS + L L IA
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREIL 129
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMG 303
KGL +LH E I+RD K +N+LL KL+DFG+A G T + +G
Sbjct: 130 KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVG 181
Query: 304 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGEHN 351
T + APE + S++D++S G+ +E+ G + + KN P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP----- 236
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE----- 406
P LEG++S + + CL+++P RP E
Sbjct: 237 --------------------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHK 272
Query: 407 -VVEALKPLPNLKDM 420
++ K L ++
Sbjct: 273 FILRNAKKTSYLTEL 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 61/243 (25%), Positives = 93/243 (38%), Gaps = 47/243 (19%)
Query: 112 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKT 170
V F+ F +G+G FG V V K T A+K
Sbjct: 5 VFDENEDVNFDH-------FEILRAIGKGSFGKVCI----------VQKNDTKKMYAMKY 47
Query: 171 LNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL 226
+N E E+ + L H LV L Y +D++ + +V + + G L HL
Sbjct: 48 MNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL 106
Query: 227 FR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280
+ +K + + L +L + +I+RD K NILLD + +
Sbjct: 107 QQNVHFKEE---TVKLFICELVMA----LDYLQN---QRIIHRDMKPDNILLDEHGHVHI 156
Query: 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TGHLTSRSDVYSFGVVLLEMLT 336
+DF +A P + T + GT Y APE G+ + D +S GV E+L
Sbjct: 157 TDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLR 212
Query: 337 GRR 339
GRR
Sbjct: 213 GRR 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 76/313 (24%), Positives = 120/313 (38%), Gaps = 47/313 (15%)
Query: 99 SNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV 158
S+ S+ K L + + + NDL+ +G G G V+K +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLEN-------LGEMGSGTCGQVWKMRFRK------ 48
Query: 159 KPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEF 216
TG +AVK + G + +K L +++ + +V+ G I + + E
Sbjct: 49 ---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
M E R P+P I K+ + K L +L E+ VI+RD K SNILLD
Sbjct: 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERG 162
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-----TSRSDVYSFGVVL 331
KL DFG++ R G Y APE + R+DV+S G+ L
Sbjct: 163 QIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219
Query: 332 LEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 389
+E+ TG+ + + E +++ P L FS
Sbjct: 220 VELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG------------HMGFS----GDFQSF 263
Query: 390 AAHCLSRDPKARP 402
CL++D + RP
Sbjct: 264 VKDCLTKDHRKRP 276
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 78/353 (22%), Positives = 121/353 (34%), Gaps = 67/353 (18%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
+ + AA S+ E + + K +
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN------ 55
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----LAE 185
F +LG G +G VF + + TG A+K L + + E
Sbjct: 56 -FELLKVLGTGAYGKVFL--VRKISG----HDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 186 VNFLGDLVHLN-LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-- 240
L + LV L Y + + +L L+ +++ G L HL + ++
Sbjct: 109 RQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIY 164
Query: 241 ---IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
I L L LH+ +IYRD K NILLD++ + L+DFGL+K+ +
Sbjct: 165 VGEIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217
Query: 298 STRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHN 351
GT Y AP+ V +GH + D +S GV++ E+LTG + E
Sbjct: 218 YDFC-GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAE-- 273
Query: 352 LVEWARPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
R I +P S A L L +DPK R
Sbjct: 274 --------------ISRRILKSEPPYPQEMS----ALAKDLIQRLLMKDPKKR 308
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 77/275 (28%), Positives = 114/275 (41%), Gaps = 34/275 (12%)
Query: 72 ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNF 131
E + T D + + + ++ E E+ +A + T N+ F
Sbjct: 98 EWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-------F 150
Query: 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNF 188
LLG+G FG V + TG A+K L + + E L E
Sbjct: 151 EYLKLLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 201
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGA 245
L + H L L Y + RL V E+ G L HL R R R +
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEI 257
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GT 304
L +LH +E+ V+YRD K N++LD D + K++DFGL K+G + T + GT
Sbjct: 258 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGT 312
Query: 305 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
Y APE V+ + R+ D + GVV+ EM+ GR
Sbjct: 313 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 55/255 (21%), Positives = 97/255 (38%), Gaps = 39/255 (15%)
Query: 95 SNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENG 154
A + + + + RK D F+ +LGEG F V
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLA------ 49
Query: 155 TAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211
+ T A+K L + + E + + L H VKL + +DD++L
Sbjct: 50 ---RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKL 105
Query: 212 -LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRD 264
+ G L ++ + S + I L +LH + +I+RD
Sbjct: 106 YFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSA----LEYLHG---KGIIHRD 155
Query: 265 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSD 323
K NILL+ D + +++DFG AK K + +GT Y +PE + SD
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSD 214
Query: 324 VYSFGVVLLEMLTGR 338
+++ G ++ +++ G
Sbjct: 215 LWALGCIIYQLVAGL 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 84/293 (28%), Positives = 116/293 (39%), Gaps = 62/293 (21%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + TG A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 239
+ E L + H L L Y + RL V E+ G L HL R R R
Sbjct: 52 TVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RA 107
Query: 240 K-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 294
+ I L +LH R V+YRD K N++LD D + K++DFGL K+G
Sbjct: 108 RFYGAEIVSA----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
Query: 295 THVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
T + GT Y APE V+ + R+ D + GVV+ EM+ G R
Sbjct: 161 T---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCG-------RL------ 203
Query: 353 VEWARPHLGE-RRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
P + R + LI + R S +A L A L +DPK R
Sbjct: 204 -----PFYNQDHERLFELILMEEIRFPRTLS----PEAKSLLAGLLKKDPKQR 247
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 58/257 (22%), Positives = 97/257 (37%), Gaps = 38/257 (14%)
Query: 102 STSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 156
S+L ++ VA L+ +++L +F ++G G F V
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAV--------- 79
Query: 157 PV-KPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL- 211
V TG A+K +N + E + E + L + + +L + +D+ L
Sbjct: 80 -VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLY 137
Query: 212 LVYEFMPRGSLENHLFR--RSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKTS 268
LV E+ G L L + +P + R +A + A + +H ++RD K
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHR---LGYVHRDIKPD 191
Query: 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY--- 325
NILLD + +L+DFG V GT Y +PE + + Y
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 326 ----SFGVVLLEMLTGR 338
+ GV EM G+
Sbjct: 251 CDWWALGVFAYEMFYGQ 267
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 70/301 (23%), Positives = 105/301 (34%), Gaps = 59/301 (19%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKE 181
+ + +G G +G V K + +G +AVK + + K+
Sbjct: 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQ 66
Query: 182 WLAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL----FRRSLPLPWS 236
L +++ + +V+ G + + E M S + +P
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEE 125
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
I KI L K L L E +I+RD K SNILLD N KL DFG++ + +
Sbjct: 126 ILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSI 180
Query: 297 VSTRVMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
TR G Y APE + RSDV+S G+ L E+ TGR K
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS------ 234
Query: 353 VEWARPHLGERRRFYRLID-------PRL----EGHFSIKGAQKAAQLAAHCLSRDPKAR 401
+ + P+L E FS CL++D R
Sbjct: 235 -------------VFDQLTQVVKGDPPQLSNSEEREFS----PSFINFVNLCLTKDESKR 277
Query: 402 P 402
P
Sbjct: 278 P 278
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 66/245 (26%), Positives = 101/245 (41%), Gaps = 41/245 (16%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
E V K F +LG+GG+G VF+ + + TG
Sbjct: 2 SSETSVNRGPEKIRPEC-------FELLRVLGKGGYGKVFQ--VRKVTG----ANTGKIF 48
Query: 167 AVKTLNHDGLQGHK---EW-LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS 221
A+K L + + AE N L ++ H +V LI Y + +L L+ E++ G
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGE 107
Query: 222 LENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275
L L R I++ L LH++ +IYRD K NI+L+
Sbjct: 108 LFMQLEREGIFMED---TACFYLAEISMA----LGHLHQKG---IIYRDLKPENIMLNHQ 157
Query: 276 YNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLE 333
+ KL+DFGL K+ T GT Y APE ++ +R+ D +S G ++ +
Sbjct: 158 GHVKLTDFGLCKESIHDGTV---THTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYD 213
Query: 334 MLTGR 338
MLTG
Sbjct: 214 MLTGA 218
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 47/283 (16%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+ + +G+G G V+ + TG VA++ +N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ + + N+V + + D+ +V E++ GSL + + + I + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-I-AAVCRECLQ 127
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYG 306
L FLH VI+RD K+ NILL D + KL+DFG A+ PE K T V GT
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPY 181
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--R 364
+ APE V + D++S G++ +EM+ G P P+L E R
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EP-----------PYLNENPLR 223
Query: 365 RFYRLID---PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 402
Y + P L+ S CL D + R
Sbjct: 224 ALYLIATNGTPELQNPEKLS----AIFRDFLNRCLEMDVEKRG 262
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 52/306 (16%), Positives = 103/306 (33%), Gaps = 46/306 (15%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
+ R + + L G F W+E + + + ++ +
Sbjct: 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMD 106
Query: 183 LA--EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------ 234
++ + N V + + + + +L++ + RR
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------ 288
I ++IA + FLH + +++RD K SNI D K+ DFGL
Sbjct: 167 LHIFIQIAEA----VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219
Query: 289 ----GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344
T +GT Y +PE + + + + D++S G++L E+L +
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-- 277
Query: 345 RPNGEHNLVEWARPHLGERRRFYRLI-DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 403
ER R + + + F+ K + + LS P RP
Sbjct: 278 -----------------ERVRIITDVRNLKFPLLFTQK-YPQEHMMVQDMLSPSPTERPE 319
Query: 404 MSEVVE 409
++++E
Sbjct: 320 ATDIIE 325
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 71/316 (22%), Positives = 107/316 (33%), Gaps = 78/316 (24%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
E +LG G G V G VAVK + + L E+ L
Sbjct: 17 VVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRML---IDFCDIALMEIKLLT 63
Query: 191 DLV-HLNLVKLIGYCIEDDQRL--LVYEFMPRGSL-----ENHLFRRSLPLPWSIRMKIA 242
+ H N+++ YC E R + E +L ++ +L L
Sbjct: 64 ESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 243 L-GAAKGLAFLHEEAERPVIYRDFKTSNILLD-------------ADYNAKLSDFGLAK- 287
L A G+A LH +I+RD K NIL+ + +SDFGL K
Sbjct: 121 LRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 288 --DGPEGDKTHVSTRVMGTYGYAAPE-------YVMTGHLTSRSDVYSFGVVLLEMLTG- 337
G +T+++ GT G+ APE LT D++S G V +L+
Sbjct: 178 LDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 338 ------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 391
+ S + N G +L E H + +A L +
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLH---------------DRSLI----AEATDLIS 277
Query: 392 HCLSRDPKARPLMSEV 407
+ DP RP +V
Sbjct: 278 QMIDHDPLKRPTAMKV 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 74/322 (22%), Positives = 126/322 (39%), Gaps = 54/322 (16%)
Query: 96 NAESNSSTSKLEEELKVASRLRKFTFND-LKLATRNFRPESL------LGEGGFGCVFKG 148
+ S+ E + + F L++ P L +GEG G V
Sbjct: 5 HHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 149 WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208
+ +G VAVK ++ Q + EV + D H N+V++ + +
Sbjct: 65 ---------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115
Query: 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268
+ ++ EF+ G+L + + + L + + LA+LH + VI+RD K+
Sbjct: 116 ELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD 170
Query: 269 NILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 327
+ILL D KLSDFG A+ + K + V GT + APE + + D++S
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEVISRSLYATEVDIWSL 227
Query: 328 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--RRFYRLID---PRLEG--HFSI 380
G++++EM+ G P P+ + + RL D P+L+ S
Sbjct: 228 GIMVIEMVDG-------EP-----------PYFSDSPVQAMKRLRDSPPPKLKNSHKVS- 268
Query: 381 KGAQKAAQLAAHCLSRDPKARP 402
L RDP+ R
Sbjct: 269 ---PVLRDFLERMLVRDPQERA 287
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 63/289 (21%), Positives = 110/289 (38%), Gaps = 58/289 (20%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 190
+ LG+G FG V+K TG A K + + ++++ E+ L
Sbjct: 21 WEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILA 71
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
H +VKL+G D + ++ EF P G+++ + L + + L
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGY 307
FLH + +I+RD K N+L+ + + +L+DFG++ + +GT +
Sbjct: 132 FLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYW 183
Query: 308 AAPEYVMTGHLT-----SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
APE VM + ++D++S G+ L+EM P PH
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-------EP-----------PHHEL 225
Query: 363 ---RRRFYRLID----PRLE--GHFSIKGAQKAAQLAAHCLSRDPKARP 402
R I P L +S + L ++P+ RP
Sbjct: 226 NPMRVLL--KIAKSDPPTLLTPSKWS----VEFRDFLKIALDKNPETRP 268
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 68/284 (23%), Positives = 113/284 (39%), Gaps = 49/284 (17%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
F LGEG +G V+K +E TG VA+K + + +E + E++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ ++VK G ++ +V E+ GS+ + + R+ L I K
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYG 306
GL +LH I+RD K NILL+ + +AKL+DFG+ + K + V+GT
Sbjct: 137 GLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPF 190
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--R 364
+ APE + +D++S G+ +EM G +P P+ R
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEG-------KP-----------PYADIHPMR 232
Query: 365 RFYRLID----PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 402
+ +I P +S CL + P+ R
Sbjct: 233 AIF-MIPTNPPPTFRKPELWS----DNFTDFVKQCLVKSPEQRA 271
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 83/343 (24%), Positives = 132/343 (38%), Gaps = 60/343 (17%)
Query: 79 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLG 138
+ TT N + EE K A R+ L ++F ++G
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61
Query: 139 EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-H 194
G + V T A++ + + + ++ E + H
Sbjct: 62 RGSYAKVLLV---------RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAK 247
LV L C + + RL V E++ G L H+ R R LP + I+L
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA--- 165
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYG 306
L +LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T T GT
Sbjct: 166 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPN 218
Query: 307 YAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR----RSMDKNRPNGEHNLVEWARPHLG 361
Y APE ++ G S D ++ GV++ EM+ GR + P+
Sbjct: 219 YIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------------ 265
Query: 362 ERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
+++I R+ S KAA + L++DPK R
Sbjct: 266 TEDYLFQVILEKQIRIPRSLS----VKAASVLKSFLNKDPKER 304
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 65/252 (25%), Positives = 105/252 (41%), Gaps = 33/252 (13%)
Query: 102 STSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 156
L + + + L ++ DL++ ++ ++G G FG V
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL--------- 87
Query: 157 PVKP-GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL- 211
V+ T A+K L+ + + + E + + +V+L Y +DD+ L
Sbjct: 88 -VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLY 145
Query: 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKTSNI 270
+V E+MP G L N + +P W+ R A + A L +H I+RD K N+
Sbjct: 146 MVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAEVVLA--LDAIHS---MGFIHRDVKPDNM 199
Query: 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYS 326
LLD + KL+DFG + T V GT Y +PE + + G+ D +S
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 258
Query: 327 FGVVLLEMLTGR 338
GV L EML G
Sbjct: 259 VGVFLYEMLVGD 270
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-22
Identities = 63/256 (24%), Positives = 96/256 (37%), Gaps = 36/256 (14%)
Query: 101 SSTSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 155
+ S L E + L ++L +F ++G G FG V
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAV-------- 92
Query: 156 APV-KPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 211
V A+K LN + E + E + L + + L Y +DD L
Sbjct: 93 --VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNL 149
Query: 212 -LVYEFMPRGSLENHL--FRRSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKT 267
LV ++ G L L F LP + R +A + A + +H+ ++RD K
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA--IDSVHQ---LHYVHRDIKP 203
Query: 268 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS----- 322
NIL+D + + +L+DFG E S V GT Y +PE +
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPEC 262
Query: 323 DVYSFGVVLLEMLTGR 338
D +S GV + EML G
Sbjct: 263 DWWSLGVCMYEMLYGE 278
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 66/249 (26%), Positives = 101/249 (40%), Gaps = 44/249 (17%)
Query: 103 TSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 162
T+ + + D F +LG+G FG V + GT
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTD-------FNFLMVLGKGSFGKVMLS---------ERKGT 44
Query: 163 GLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFM 217
AVK L D + + + E L L +L C + RL V E++
Sbjct: 45 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYV 103
Query: 218 PRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271
G L H+ + P IA+G L FL + +IYRD K N++
Sbjct: 104 NGGDLMYHIQQVGRFKEP---HAVFYAAEIAIG----LFFLQS---KGIIYRDLKLDNVM 153
Query: 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGV 329
LD++ + K++DFG+ K+ T T+ GT Y APE ++ +S D ++FGV
Sbjct: 154 LDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGV 209
Query: 330 VLLEMLTGR 338
+L EML G+
Sbjct: 210 LLYEMLAGQ 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 73/262 (27%), Positives = 102/262 (38%), Gaps = 44/262 (16%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
NA + ++ S +D F ++G+G FG V
Sbjct: 6 QEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD-------FHFLKVIGKGSFGKVLLA- 57
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCI 205
+ AVK L + KE ++E N L V H LV L +
Sbjct: 58 --------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSF 108
Query: 206 EDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAER 258
+ +L V +++ G L HL R R P R + IA L +LH
Sbjct: 109 QTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA----LGYLHS---L 158
Query: 259 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGH 317
++YRD K NILLD+ + L+DFGL K+ E + T T GT Y APE V+
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE-VLHKQ 214
Query: 318 LTSRS-DVYSFGVVLLEMLTGR 338
R+ D + G VL EML G
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGL 236
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 68/294 (23%), Positives = 114/294 (38%), Gaps = 50/294 (17%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 188
++ + ++G G V VA+K +N + Q + L E+
Sbjct: 16 DYELQEVIGSGATAVVQAA---------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 66
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIR-MKIAL- 243
+ H N+V + D+ LV + + GS+ + H+ + + IA
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 244 --GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTR 300
+GL +LH+ I+RD K NILL D + +++DFG+ A GD T R
Sbjct: 127 LREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 301 --VMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357
+GT + APE + ++D++SFG+ +E+ TG K P
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM---------- 233
Query: 358 PHLGERRRFYRLI----DPRLEGHFSIKGAQKA-----AQLAAHCLSRDPKARP 402
+ L P LE K K ++ + CL +DP+ RP
Sbjct: 234 -------KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 82/349 (23%), Positives = 127/349 (36%), Gaps = 68/349 (19%)
Query: 97 AESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESL------LGEGGFGCVFKGWI 150
N + + R D+ PE L +G G FG V+
Sbjct: 16 TTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA-- 73
Query: 151 EENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIED 207
VA+K +++ G Q +++W + EV FL L H N ++ G + +
Sbjct: 74 -------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126
Query: 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267
LV E+ GS + L PL + GA +GLA+LH +I+RD K
Sbjct: 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKA 182
Query: 268 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPEYVMT---GHLTSRS 322
NILL KL DFG A + ++ +GT + APE ++ G +
Sbjct: 183 GNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKV 234
Query: 323 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-RRFYRLID----PRLE-G 376
DV+S G+ +E+ +P P I P L+ G
Sbjct: 235 DVWSLGITCIELAER-------KP-----------PLFNMNAMSALYHIAQNESPALQSG 276
Query: 377 HFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALKPLPNLKDM 420
H+S + CL + P+ RP L V +P + D+
Sbjct: 277 HWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 321
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+GEG +G VFK + TG VA+K L E+ L
Sbjct: 11 IGEGSYGVVFKCRNRD---------TGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQ 58
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H NLV L+ + LV+E+ ++ + L R +P + I + + F
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRVMGTYGYA 308
H+ I+RD K NIL+ KL DFG A+ GP V+TR Y
Sbjct: 118 CHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYR 169
Query: 309 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+PE ++ DV++ G V E+L+G
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 66/289 (22%), Positives = 108/289 (37%), Gaps = 62/289 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG G +G V T + A+K + + + + L EV L L H
Sbjct: 45 LGSGAYGEVLLC---------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 248
N++KL + ED + LV E G L + + R ++ +K L
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSG--- 148
Query: 249 LAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ +LH+ +++RD K N+LL + D K+ DFGL+ K +GT
Sbjct: 149 VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTA 202
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERR 364
Y APE V+ + DV+S GV+L +L G P G+ + +
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------PPFGGQTD------------Q 243
Query: 365 RFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 407
R + +G ++ + A L L D + R +
Sbjct: 244 EILRKV---EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 66/300 (22%), Positives = 110/300 (36%), Gaps = 73/300 (24%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN------------HDGLQGHKEWLA 184
LG G +G V + A+K + + ++ E +
Sbjct: 44 LGSGAYGEVLLC---------KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 185 -EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR---- 238
E++ L L H N++KL ED + LV EF G L + R +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAAN 150
Query: 239 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDK 294
MK L + +LH + +++RD K NILL ++ N K+ DFGL+ + K
Sbjct: 151 IMKQILSG---ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 295 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLV 353
+GT Y APE V+ + DV+S GV++ +L G P G+++
Sbjct: 205 LR---DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY------PPFGGQND-- 252
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 407
+ + + +G + +A +L L+ D R E
Sbjct: 253 ----------QDIIKKV---EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 68/290 (23%), Positives = 109/290 (37%), Gaps = 63/290 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 193
LG+G FG V TG AVK ++ ++ + L EV L L
Sbjct: 34 LGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 194 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAK 247
H N++KL + ED LV E G L + + R +S ++ L
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSG-- 138
Query: 248 GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+ ++H+ +++RD K N+LL D N ++ DFGL+ K +GT
Sbjct: 139 -ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGT 191
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-R 363
Y APE V+ G + DV+S GV+L +L+G P G
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC------------------PPFNGANE 232
Query: 364 RRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 407
+ + +G ++ + + A L L+ P R +
Sbjct: 233 YDILKKV---EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 77/295 (26%), Positives = 123/295 (41%), Gaps = 56/295 (18%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
L ++F ++G G + V T A+K + + + ++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDRIYAMKVVKKELVNDDEDIDW 55
Query: 183 -LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 238
E + H LV L C + + RL V E++ G L H+ R R LP + R
Sbjct: 56 VQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-R 113
Query: 239 M---KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+I+L L +LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T
Sbjct: 114 FYSAEISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166
Query: 296 HVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR----RSMDKNRPNGE 349
T GT Y APE ++ G S D ++ GV++ EM+ GR + P+
Sbjct: 167 ---TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
Query: 350 HNLVEWARPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 401
+++I R+ S KAA + L++DPK R
Sbjct: 223 ------------TEDYLFQVILEKQIRIPRSLS----VKAASVLKSFLNKDPKER 261
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 72/245 (29%), Positives = 99/245 (40%), Gaps = 44/245 (17%)
Query: 107 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 166
E + S K D F +LG+G FG VF T
Sbjct: 2 ELNKERPSLQIKLKIED-------FILHKMLGKGSFGKVFLA---------EFKKTNQFF 45
Query: 167 AVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGS 221
A+K L D + + + E L H L + + + L V E++ G
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGD 104
Query: 222 LENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275
L H+ L R I LG L FLH + ++YRD K NILLD D
Sbjct: 105 LMYHIQSCHKFDLS---RATFYAAEIILG----LQFLHS---KGIVYRDLKLDNILLDKD 154
Query: 276 YNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLE 333
+ K++DFG+ K+ GD T GT Y APE ++ G + S D +SFGV+L E
Sbjct: 155 GHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYE 210
Query: 334 MLTGR 338
ML G+
Sbjct: 211 MLIGQ 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 5e-22
Identities = 71/281 (25%), Positives = 111/281 (39%), Gaps = 30/281 (10%)
Query: 68 STHYESKSTNDTSRDQPAAAVI-SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKL 126
+ E + N + + A+ T EE+ N ++
Sbjct: 279 LSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRM 338
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---L 183
+F +LG+G FG V + GT AVK L D + + +
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTM 389
Query: 184 AEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 240
E L L +L C + RL V E++ G L H+ + P
Sbjct: 390 VEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAV 445
Query: 241 I-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
A A GL FL + +IYRD K N++LD++ + K++DFG+ K+ T T
Sbjct: 446 FYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---T 499
Query: 300 RVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
+ GT Y APE ++ +S D ++FGV+L EML G+
Sbjct: 500 KTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 64/260 (24%), Positives = 105/260 (40%), Gaps = 37/260 (14%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
++ S + + K + T + F LG G FG V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML-- 59
Query: 150 IEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCI 205
VK +G A+K L+ + K+ L E L + LVKL +
Sbjct: 60 --------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSF 110
Query: 206 EDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM---KIALGAAKGLAFLHEEAERPV 260
+D+ L +V E++ G + +HL R P + R +I L +LH +
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAAQIVLT----FEYLHS---LDL 162
Query: 261 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLT 319
IYRD K N+L+D +++DFG AK T + GT APE +++ G+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY-- 215
Query: 320 SRS-DVYSFGVVLLEMLTGR 338
+++ D ++ GV++ EM G
Sbjct: 216 NKAVDWWALGVLIYEMAAGY 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 56/310 (18%), Positives = 91/310 (29%), Gaps = 64/310 (20%)
Query: 138 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHL 195
G V TG V V+ +N + E++ H
Sbjct: 36 GFEDLMTVNLA---------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAAKGLAFL 252
N+V I D++ +V FM GS + L + + IA G K L ++
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMN-ELAIAYILQGVLKALDYI 144
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGDKTHV----STRVMGTYGY 307
H ++R K S+IL+ D LS G + V + +
Sbjct: 145 HHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 308 AAPEYVMTGHL---TSRSDVYSFGVVLLEMLTGR-------------------------- 338
+PE V+ +L ++SD+YS G+ E+ G
Sbjct: 202 LSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260
Query: 339 ------RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 392
+ ++ + + R FS
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQ 316
Query: 393 CLSRDPKARP 402
CL R+P ARP
Sbjct: 317 CLQRNPDARP 326
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 70/250 (28%), Positives = 100/250 (40%), Gaps = 44/250 (17%)
Query: 102 STSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG 161
S E + + ++ F +LG+G FG V
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDN-------FEFIRVLGKGSFGKVMLA---------RVKE 46
Query: 162 TGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEF 216
TG AVK L D + + + E L H L +L C + RL V EF
Sbjct: 47 TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEF 105
Query: 217 MPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNI 270
+ G L H+ + R R + I L FLH+ + +IYRD K N+
Sbjct: 106 VNGGDLMFHIQKSRRFDEA---RARFYAAEIISA----LMFLHD---KGIIYRDLKLDNV 155
Query: 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFG 328
LLD + + KL+DFG+ K+G T T GT Y APE ++ L + D ++ G
Sbjct: 156 LLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPE-ILQEMLYGPAVDWWAMG 211
Query: 329 VVLLEMLTGR 338
V+L EML G
Sbjct: 212 VLLYEMLCGH 221
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 69/289 (23%), Positives = 107/289 (37%), Gaps = 62/289 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G FG V K T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 248
N++KL ED +V E G L + + +R +S +K
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSG--- 133
Query: 249 LAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ ++H+ +++RD K NILL + D + K+ DFGL+ + K +GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTA 187
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-RR 364
Y APE V+ G + DV+S GV+L +L+G P G+
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------PPFYGKNEY 228
Query: 365 RFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 407
+ + G ++ A L L+ P R ++
Sbjct: 229 DILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 41/227 (18%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW- 182
K + ++F+ LG G FG V ++ G A+K L + + K+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHL----------IRSRHNGRYYAMKVLKKEIVVRLKQVE 51
Query: 183 --LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 238
E L + H ++++ +D Q++ ++ +++ G L + L + + P P
Sbjct: 52 HTNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---V 107
Query: 239 MK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
K + L L +LH + +IYRD K NILLD + + K++DFG AK P+
Sbjct: 108 AKFYAAEVCLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160
Query: 294 KTHVSTRVMGTYGYAAPEYVMT-GHLTSRS-DVYSFGVVLLEMLTGR 338
T + GT Y APE V T + ++S D +SFG+++ EML G
Sbjct: 161 YT-----LCGTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGY 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 30/218 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LA 184
+ L+GEG +G V K ++ TG VA+K + +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFL---ESDDDKMVKKIAMR 73
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
E+ L L H NLV L+ C + + LV+EF+ ++ + L L + + K
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRV 301
G+ F H +I+RD K NIL+ KL DFG A+ P V+TR
Sbjct: 133 IINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR- 188
Query: 302 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
Y APE ++ DV++ G ++ EM G
Sbjct: 189 ----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 74/296 (25%), Positives = 118/296 (39%), Gaps = 63/296 (21%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----E 185
N+R +G+G F V TG VA+K ++ L L E
Sbjct: 16 NYRLLKTIGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLN--PTSLQKLFRE 64
Query: 186 VNFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
V + L H N+VKL + IE ++ L L+ E+ G + ++L RMK
Sbjct: 65 VRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHG-------RMKEKE 115
Query: 244 GAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 297
+K + + H+ + +++RD K N+LLDAD N K++DFG + + G K
Sbjct: 116 ARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172
Query: 298 STRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355
G YAAPE + G DV+S GV+L +++G D NL E
Sbjct: 173 FC---GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKE- 221
Query: 356 ARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ L G + I + L L +P R + ++++
Sbjct: 222 ----------LRERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 72/303 (23%), Positives = 112/303 (36%), Gaps = 52/303 (17%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 193
E +LGEG V + T AVK + EV L
Sbjct: 18 EDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 194 -HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAA 246
H N+++LI + E++ R LV+E M GS+ +H+ +R ++ ++ A
Sbjct: 69 GHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASA- 123
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKD-GPEGDKTHVSTRVM 302
L FLH + + +RD K NIL + K+ DF L GD + +ST +
Sbjct: 124 --LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 303 ----GTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGRRSMDKNRP-NGEHNL 352
G+ Y APE V + D++S GV+L +L+G P G
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCGS 232
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSE 406
L + EG + A L + L RD K R ++
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292
Query: 407 VVE 409
V++
Sbjct: 293 VLQ 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 62/258 (24%), Positives = 96/258 (37%), Gaps = 62/258 (24%)
Query: 114 SRLRKFTFNDLKLATRNFRPESL---------LGEGGFGCVFKGWIEENGTAPVKPGTGL 164
SR + F F DL + ++ P++L LG G G V + T
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---------FERKTCK 161
Query: 165 TVAVKTLNHDGLQGHKEWLA--------EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 216
VA++ ++ A E+ L L H ++K+ + + + +V E
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLEL 220
Query: 217 MPRGSLENHLFRRSLPLPWSIRMKIALG---AAK-------GLAFLHEEAERPVIYRDFK 266
M G E LF + + L + +LHE +I+RD K
Sbjct: 221 MEGG--E--LFDK-------VVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLK 266
Query: 267 TSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL----T 319
N+LL + D K++DFG +K E T GT Y APE V+
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLC-GTPTYLAPE-VLVSVGTAGYN 322
Query: 320 SRSDVYSFGVVLLEMLTG 337
D +S GV+L L+G
Sbjct: 323 RAVDCWSLGVILFICLSG 340
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 81/323 (25%), Positives = 119/323 (36%), Gaps = 76/323 (23%)
Query: 113 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 172
A L + + L+ F L+G G +G V+KG + TG A+K ++
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMD 58
Query: 173 HDGLQGHKEWLAEVNFLGDLV-HLNLVKLIG------YCIEDDQRLLVYEFMPRGSLE-- 223
G +E E+N L H N+ G DDQ LV EF GS+
Sbjct: 59 VTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 224 -NHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279
+ +L W IA +GL+ LH+ VI+RD K N+LL + K
Sbjct: 118 IKNTKGNTLKEEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169
Query: 280 LSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEYVMTGHLT-----SRSDVYSFGVVL 331
L DFG++ R +GT + APE + +SD++S G+
Sbjct: 170 LVDFGVS-----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224
Query: 332 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGE---RRRFYRLID----PRLEG-HFSIKGA 383
+EM G P P R F LI PRL+ +S
Sbjct: 225 IEMAEG-------AP-----------PLCDMHPMRALF--LIPRNPAPRLKSKKWS---- 260
Query: 384 QKAAQLAAHCLSRDPKARPLMSE 406
+K CL ++ RP +
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQ 283
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 74/403 (18%), Positives = 136/403 (33%), Gaps = 80/403 (19%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V+K ++ A+K + G+ E+ L +L H N
Sbjct: 29 VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 197 LVKLIGYCIED-DQRL-LVYEFMP---RGSLENH----LFRRSLPLPWSIRMKIALGAAK 247
++ L + D+++ L++++ ++ H ++ + LP + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DGPEGDKTHVSTRV 301
G+ +LH V++RD K +NIL+ + K++D G A+ + P + V
Sbjct: 140 GIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 302 MGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR-----RSMDKNRPNGEH---- 350
+ T+ Y APE ++ G H T D+++ G + E+LT R D N H
Sbjct: 197 V-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254
Query: 351 ----------NLVEW-----------ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 389
+W + +E H + KA L
Sbjct: 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS-KAFHL 313
Query: 390 AAHCLSRDPKARPLMSEVVEALK-------PLPNLKDMASSSYYFQTMQAERIGSSPNTR 442
L+ DP R +A++ PLP A + + P+ +
Sbjct: 314 LQKLLTMDPIKRITSE---QAMQDPYFLEDPLPTSDVFAGCQIPYP-KREFLTEEEPDDK 369
Query: 443 NGIRAQGGSLSRNGQRSLSIPNGSYASPYHHQFPHPSPKPNGK 485
+ Q N P + H P K
Sbjct: 370 GDKKNQQQQQGNNHTNGTGHPG-------NQDSSHTQGPPLKK 405
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 6e-20
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G V+K + G T A+K + L+ E + E++ L +
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+VKL + +LV+E + + L+ L L L G+A+
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
H+ R V++RD K N+L++ + K++DFGLA+ P TH ++ T Y A
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRA 168
Query: 310 PEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 338
P+ V+ G ++ D++S G + EM+ G
Sbjct: 169 PD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 184
+ LGEG + V+KG + T VA+K + + H+E +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLE----HEEGAPCTAIR 49
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
EV+ L DL H N+V L + LV+E++ + L+ +L +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVSTRVM 302
+GLA+ H + V++RD K N+L++ KL+DFGLA K P + V+
Sbjct: 109 LLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV 162
Query: 303 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 338
T Y P+ ++ G +++ D++ G + EM TGR
Sbjct: 163 -TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 9e-20
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G VFK E T VA+K + L E L E+ L +
Sbjct: 10 IGEGTYGTVFKAKNRE---------THEIVALKRVR---LDDDDEGVPSSALREICLLKE 57
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+V+L D + LV+EF + L+ + + L I KGL F
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
H R V++RD K N+L++ + KL++FGLA+ P + V+ T Y
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRP 169
Query: 310 PEYVMTG--HLTSRSDVYSFGVVLLEMLTGRR 339
P+ V+ G ++ D++S G + E+ R
Sbjct: 170 PD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 9e-20
Identities = 70/272 (25%), Positives = 114/272 (41%), Gaps = 37/272 (13%)
Query: 81 RDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEG 140
R A +A + S+ ++ KV + + + ++ ++G G
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNG 65
Query: 141 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 200
FG V++ + + +G VA+K + LQ + E+ + L H N+V+L
Sbjct: 66 SFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 201 IGYCI------EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
Y +D+ L LV +++P + H R LP + LA+
Sbjct: 113 R-YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYA 308
+H + +RD K N+LLD D KL DFG AK G+ + +R Y Y
Sbjct: 172 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y-YR 223
Query: 309 APEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 338
APE ++ G TS DV+S G VL E+L G+
Sbjct: 224 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 65/300 (21%), Positives = 112/300 (37%), Gaps = 41/300 (13%)
Query: 55 SSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVAS 114
SS + + + S + S A V S+ + S + + +
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 115 RLRKFTFNDLKLATRNFR------PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 168
F + +LG G FG V K + TGL +A
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---------EETATGLKLAA 119
Query: 169 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL----- 222
K + G++ +E E++ + L H NL++L E + LV E++ G L
Sbjct: 120 KIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRII 178
Query: 223 -ENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYN 277
E++ ++ MK G+ +H + +++ D K NIL
Sbjct: 179 DESYNLTELDTILF-----MKQICE---GIRHMH---QMYILHLDLKPENILCVNRDAKQ 227
Query: 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
K+ DFGLA+ +K V GT + APE V ++ +D++S GV+ +L+G
Sbjct: 228 IKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G V+K K G VA+K + L E + E++ L +
Sbjct: 29 VGEGTYGVVYKA----------KDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKE 75
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+V LI + LV+EFM + L+ L L S +G+A
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 309
H+ +++RD K N+L+++D KL+DFGLA+ P TH V+ T Y A
Sbjct: 135 CHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRA 187
Query: 310 PEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 338
P+ V+ G ++ D++S G + EM+TG+
Sbjct: 188 PD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 72/292 (24%), Positives = 109/292 (37%), Gaps = 66/292 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 195
LG G FG V + +GL +KT+N D Q E + E+ L L H
Sbjct: 30 LGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----------MKIALG 244
N++K+ ED + +V E G E L R + + MK +
Sbjct: 81 NIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A LA+ H + V+++D K NIL K+ DFGLA+ + +
Sbjct: 136 A---LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAA 187
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
GT Y APE V +T + D++S GVV+ +LTG P G
Sbjct: 188 -GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC------------------LPFTG 227
Query: 362 E-RRRFYRLIDPRLEGHFSIKGA-----QKAAQLAAHCLSRDPKARPLMSEV 407
+ + +A L L++DP+ RP ++V
Sbjct: 228 TSLEEVQQKA---TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 33/214 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 194
LGEG +G V V T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 247
N+VK G + L E+ G L + + I M A +
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115
Query: 248 -GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 307 YAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 338
Y APE ++ DV+S G+VL ML G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EVNFLGD 191
LLGEG +G V + E T AVK L L+ A E+ L
Sbjct: 12 LLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 192 LVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLE--NHLFRRSLPLPWSIRMKIALGAAK 247
L H N+++L+ E+ Q++ +V E+ G E + + + P+ + L
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL--ID 120
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMGT 304
GL +LH + ++++D K N+LL K+S G+A D S G+
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GS 174
Query: 305 YGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 338
+ PE + G T + D++S GV L + TG
Sbjct: 175 PAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
F+ E + G+G FG V G + TG++VA+K + D ++E L +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPRFRNRE-LQIMQ 71
Query: 188 FLGDLVHLNLVKLI------GYCIEDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIR 238
L L H N+V+L G D L +V E++P + +RR + P +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131
Query: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKD-GPEGDKTH 296
+ + LH + V +RD K N+L++ AD KL DFG AK P
Sbjct: 132 KVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 297 -VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 338
+ +R Y Y APE ++ G H T+ D++S G + EM+ G
Sbjct: 191 YICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 70/295 (23%), Positives = 104/295 (35%), Gaps = 76/295 (25%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
+G G +G V V+ GT + A K + ++ + E+ + L H N
Sbjct: 17 IGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKIA 242
+++L ED+ + LV E G E LF R + MK
Sbjct: 68 IIRLYET-FEDNTDIYLVMELCTGG--E--LFER-------VVHKRVFRESDAARIMKDV 115
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVST 299
L A +A+ H+ V +RD K N L D KL DFGLA G + T
Sbjct: 116 LSA---VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRT 167
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
+V GT Y +P+ V+ G D +S GV++ +L G P
Sbjct: 168 KV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY------------------PPF 207
Query: 360 LGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 407
I EG F+ +A L L++ PK R +
Sbjct: 208 SAPTDSEVMLKI---REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-19
Identities = 74/292 (25%), Positives = 115/292 (39%), Gaps = 66/292 (22%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGDL 192
LG G FG V G TG VAVK LN ++ E+ L
Sbjct: 18 TLGVGTFGKVKIG---------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 193 VHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK--- 247
H +++KL Y I +V E++ G L +++ + R++
Sbjct: 69 RHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG-------RVEEMEARRLFQQ 119
Query: 248 ---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
+ + H V++RD K N+LLDA NAK++DFGL+ +G+ S G+
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 173
Query: 305 YGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
YAAPE V++G L D++S GV+L +L G D + ++
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHV---------- 216
Query: 363 RRRFYRLIDPRLEGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
++ I G F I + L H L DP R + ++ E
Sbjct: 217 -PTLFKKI---RGGVFYIPEYLNRSVAT---LLMHMLQVDPLKRATIKDIRE 261
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 68/295 (23%), Positives = 107/295 (36%), Gaps = 62/295 (21%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 191
+G+G F V + + TG AVK ++ E +
Sbjct: 32 IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW------SIRMKIALG 244
L H ++V+L+ D L +V+EFM L + +R+ S M+ L
Sbjct: 83 LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A L + H + +I+RD K +LL + KL FG+A E RV
Sbjct: 142 A---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV 194
Query: 302 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
GT + APE V+ + DV+ GV+L +L+G P
Sbjct: 195 -GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGC------------------LPFY 234
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQ------KAAQLAAHCLSRDPKARPLMSEVVE 409
G + R + I ++G + + Q A L L DP R + E +
Sbjct: 235 GTKERLFEGI---IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
LGEG F V+K + T VA+K + K+ L E+ L +
Sbjct: 18 LGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N++ L+ LV++FM LE + SL L S L +GL +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRVMGTYGYA 308
LH+ +++RD K +N+LLD + KL+DFGLAK P TH V TR Y
Sbjct: 128 LHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----WYR 179
Query: 309 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 338
APE + + D+++ G +L E+L
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 67/313 (21%), Positives = 113/313 (36%), Gaps = 58/313 (18%)
Query: 55 SSRSKVDSSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVAS 114
R + + + + + ++ + N + K E L S
Sbjct: 17 KERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQS 76
Query: 115 RLRKFTFNDLKLA---TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 171
+ D A + + P+ ++G G V + V TG AVK +
Sbjct: 77 MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIM 127
Query: 172 NHDGLQGHKEWLA--------EVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGS 221
+ E L E + L + H +++ LI E + LV++ M +G
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG- 185
Query: 222 LENHLFRRSLPLPWSIRMKIALG---AAK-------GLAFLHEEAERPVIYRDFKTSNIL 271
E LF + K+AL ++FLH +++RD K NIL
Sbjct: 186 -E--LFDY-------LTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENIL 232
Query: 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-------DV 324
LD + +LSDFG + G+K GT GY APE ++ + D+
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKL--RELC-GTPGYLAPE-ILKCSMDETHPGYGKEVDL 288
Query: 325 YSFGVVLLEMLTG 337
++ GV+L +L G
Sbjct: 289 WACGVILFTLLAG 301
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 63/263 (23%), Positives = 109/263 (41%), Gaps = 39/263 (14%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
S T ++ + + L++ KV L + + ++G G FG VF+
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA-YTNCKVIGNGSFGVVFQAK 60
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI---- 205
+ E+ VA+K + LQ + E+ + + H N+V L
Sbjct: 61 LVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLK-AFFYSNG 105
Query: 206 --EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 260
+D+ L LV E++P H + +P + + LA++H +
Sbjct: 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGI 162
Query: 261 IYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG- 316
+RD K N+LLD KL DFG AK G+ + +R Y Y APE ++ G
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPE-LIFGA 216
Query: 317 -HLTSRSDVYSFGVVLLEMLTGR 338
+ T+ D++S G V+ E++ G+
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
LG G + V+KG + TG+ VA+K + D +E + E++ + +
Sbjct: 13 LGNGTYATVYKGLNKT---------TGVYVALKEVKLD----SEEGTPSTAIREISLMKE 59
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRS-LPLPWSIRMKIALGAAK 247
L H N+V+L +++ LV+EFM + +++ + L ++ +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVSTRVMGTY 305
GLAF HE +++RD K N+L++ KL DFGLA P + V+ T
Sbjct: 120 GLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TL 172
Query: 306 GYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 338
Y AP+ V+ G ++ D++S G +L EM+TG+
Sbjct: 173 WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 55/255 (21%), Positives = 90/255 (35%), Gaps = 68/255 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 191
+G+G +G V ++ T A+K +N + ++ EV +
Sbjct: 34 IGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 192 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------ 244
L H N+ +L ED+Q + LV E G L + L M +
Sbjct: 85 LHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 245 --------------------------AAK-------GLAFLHEEAERPVIYRDFKTSNIL 271
+ L +LH + + +RD K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 272 LDADYNA--KLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSD 323
+ + KL DFGL+K G+ ++T+ GT + APE V+ S + D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE-VLNTTNESYGPKCD 258
Query: 324 VYSFGVVLLEMLTGR 338
+S GV+L +L G
Sbjct: 259 AWSAGVLLHLLLMGA 273
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 59/287 (20%), Positives = 98/287 (34%), Gaps = 30/287 (10%)
Query: 62 SSVSGTSTHYESKSTNDTSRDQPAAAVISSTTTSN-AESNSSTSKLEEELKVASRLRKFT 120
+ G S E + D+ T + V +++
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 121 FNDLKLATRNFRP----ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
+++ + LG G FG V + + TG A K +
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHE 195
Query: 177 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 236
+ E+ + L H LV L +D++ +++YEFM G E LF +
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHNK 251
Query: 237 IRMKIALGAAK----GLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGP 290
+ A+ + GL +H E ++ D K NI+ KL DFGL
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
V GT +AAPE + +D++S GV+ +L+G
Sbjct: 309 PKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 33/214 (15%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 194
LGEG +G V V T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 247
N+VK G + L E+ G L + + I M A +
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115
Query: 248 -GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 307 YAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 338
Y APE ++ DV+S G+VL ML G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 72/299 (24%), Positives = 107/299 (35%), Gaps = 78/299 (26%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G FG V K T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MK 240
N++KL ED +V E G E LF I +K
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGG--E--LFDE-------IIKRKRFSEHDAARIIK 128
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHV 297
+ ++H+ +++RD K NILL + D + K+ DFGL+ + K
Sbjct: 129 QVFSG---ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-- 180
Query: 298 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357
R+ GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------P 220
Query: 358 PHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 409
P G+ + + G ++ A L L+ P R ++ +E
Sbjct: 221 PFYGKNEYDILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 56/226 (24%), Positives = 84/226 (37%), Gaps = 53/226 (23%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--------EVNF 188
LG G G V + T VA+K ++ A E+
Sbjct: 18 LGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---A 245
L L H ++K+ + + + +V E M G E LF + + L
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK-------VVGNKRLKEATC 116
Query: 246 AK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 295
+ +LHE +I+RD K N+LL + D K++DFG +K E
Sbjct: 117 KLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSR----SDVYSFGVVLLEMLTG 337
T GT Y APE V+ T+ D +S GV+L L+G
Sbjct: 174 --RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 54/219 (24%), Positives = 83/219 (37%), Gaps = 48/219 (21%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 195
+LG G F VF + TG A+K + E+ L + H
Sbjct: 16 VLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------AAK- 247
N+V L E LV + + G E LF R I + G A+
Sbjct: 67 NIVTLEDI-YESTTHYYLVMQLVSGG--E--LFDR-------I---LERGVYTEKDASLV 111
Query: 248 ------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVS 298
+ +LHE +++RD K N+L + + ++DFGL+K G +
Sbjct: 112 IQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IM 164
Query: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ GT GY APE + + D +S GV+ +L G
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 37/297 (12%), Positives = 78/297 (26%), Gaps = 68/297 (22%)
Query: 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 182
R +R G ++ VA+ ++ G+ +E
Sbjct: 29 ANGR-YRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQET 78
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L+ L + + +++ L+V E++ GSL+ + P P ++
Sbjct: 79 LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGA-IRAM 135
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
A H V S + + D + L+
Sbjct: 136 QSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------------------ 174
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
+ D+ G L +L R + + G + + A
Sbjct: 175 ----TMPDA-------NPQDDIRGIGASLYALLVNRWPLPE---AGVRSGLAPAERDTAG 220
Query: 363 R----RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415
+ R I ++ +AA + D R S ++ ++
Sbjct: 221 QPIEPADIDRDIPFQIS------------AVAARSVQGDGGIRSA-STLLNLMQQAT 264
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 68/366 (18%), Positives = 116/366 (31%), Gaps = 77/366 (21%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 184
+ S LG G FG V+ V V VK + + +
Sbjct: 25 KYSTMSPLGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 185 ---EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS-LENHLFRRSLPLPWSIRM 239
E+ L + H N++K++ E+ LV E G L + R R+
Sbjct: 76 VTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHP-------RL 127
Query: 240 KIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
L + + +L + +I+RD K NI++ D+ KL DFG A G
Sbjct: 128 DEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGE 349
+ GT Y APE V+ G+ +++S GV L ++ +
Sbjct: 185 LFYTFC---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAA 240
Query: 350 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
P S ++ L + L P+ R + ++V
Sbjct: 241 -----------------IHP--PY---LVS----KELMSLVSGLLQPVPERRTTLEKLVT 274
Query: 410 A--LKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSY 467
+ NL D Y ++ + S G + ++ + G
Sbjct: 275 DPWVTQPVNLAD-----YTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEG 329
Query: 468 ASPYHH 473
+HH
Sbjct: 330 HHHHHH 335
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 52/258 (20%), Positives = 92/258 (35%), Gaps = 29/258 (11%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRP----ESLLGEGGFGCV 145
+ + + +K+ +++ + LG G FG V
Sbjct: 8 HHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVV 67
Query: 146 FKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205
+ V+ TG K +N E++ + L H L+ L
Sbjct: 68 HRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-F 117
Query: 206 EDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFLHEEAERPVI 261
ED + L+ EF+ G L + + + M+ A GL +H E ++
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMH---EHSIV 171
Query: 262 YRDFKTSNILL--DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 319
+ D K NI+ + K+ DFGLA + V T +AAPE V +
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVG 228
Query: 320 SRSDVYSFGVVLLEMLTG 337
+D+++ GV+ +L+G
Sbjct: 229 FYTDMWAIGVLGYVLLSG 246
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 68/289 (23%), Positives = 110/289 (38%), Gaps = 53/289 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHL 195
LGEG F K V + AVK ++ ++ E+ L H
Sbjct: 19 LGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHP 66
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 249
N+VKL D LV E + G L + ++ +S M+ + A +
Sbjct: 67 NIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSA---V 119
Query: 250 AFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+ +H+ V++RD K N+L + + K+ DFG A+ P ++ + T T
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLH 174
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
YAAPE + D++S GV+L ML+G+ P +
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQ------VPF-------QSHDRSLTCTSA 221
Query: 367 YRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 409
++ +G FS +G Q+A L L+ DP R MS +
Sbjct: 222 VEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 60/238 (25%), Positives = 97/238 (40%), Gaps = 56/238 (23%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--------HDGLQGH 179
N+ P+ +LG G V + + T AVK ++ + +Q
Sbjct: 16 YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 180 KEWLA-EVNFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWS 236
+E EV+ L + H N+++L E + LV++ M +G E LF
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKG--E--LFDY------- 114
Query: 237 IRMKIALG---AAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286
+ K+ L K + LH+ +++RD K NILLD D N KL+DFG +
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-------DVYSFGVVLLEMLTG 337
G+K GT Y APE ++ + D++S GV++ +L G
Sbjct: 172 CQLDPGEKL--REVC-GTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 67/342 (19%), Positives = 113/342 (33%), Gaps = 80/342 (23%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
S+ S+ + K+A K ++ LLG GGFG V+ G
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES------QYQVGPLLGSGGFGSVYSG- 62
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLGDLVHL--NLVKLI 201
++ L VA+K + D + E EV L + +++L+
Sbjct: 63 --------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114
Query: 202 GYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLH 253
+ E L+ E P L + + R ++ L + + H
Sbjct: 115 DW-FERPDSFVLILERPEPVQDLFDFITERG-------ALQEELARSFFWQVLEAVRHCH 166
Query: 254 EEAERPVIYRDFKTSNILLDADY-NAKLSDFGLA---KDGPEGDKTHVSTRVMGTYGYAA 309
V++RD K NIL+D + KL DFG KD GT Y+
Sbjct: 167 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFD-----GTRVYSP 216
Query: 310 PEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
PE++ H + V+S G++L +M+ G + + ++
Sbjct: 217 PEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ----------V 260
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ S + L CL+ P RP E+
Sbjct: 261 FF--RQ---RVS----SECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
LGEG +G V+K T TVA+K + L+ +E + EV+ L +
Sbjct: 42 LGEGTYGEVYKAIDTV---------TNETVAIKRIR---LEHEEEGVPGTAIREVSLLKE 89
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L H N+++L + + L++E+ L+ ++ ++ + + G+ F
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNF 147
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--GPEGDKTHVSTRVMGT 304
H R ++RD K N+LL + K+ DFGLA+ P TH ++ T
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-T 200
Query: 305 YGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 338
Y PE ++ G H ++ D++S + EML
Sbjct: 201 LWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 74/295 (25%), Positives = 117/295 (39%), Gaps = 60/295 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 186
++ LG G FG V G TG VAVK LN ++ E+
Sbjct: 17 HYILGDTLGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 187 NFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
L H +++KL Y I + +V E++ G L +++ + R+
Sbjct: 68 QNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG-------RLDEKES 118
Query: 245 AAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
G+ + H V++RD K N+LLDA NAK++DFGL+ +G+ S
Sbjct: 119 RRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175
Query: 299 TRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
G+ YAAPE V++G L D++S GV+L +L G D + ++
Sbjct: 176 C---GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD------DDHV---- 221
Query: 357 RPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 409
++ I +G F L H L DP R + ++ E
Sbjct: 222 -------PTLFKKI---CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 49/229 (21%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 185
+ N+ + LG+G F V + V TGL A K +N L ++ E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG- 244
L H N+V+L E+ LV++ + G E LF I +A
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--LFED-------I---VAREF 101
Query: 245 -----AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDG 289
A+ +A+ H +++R+ K N+LL KL+DFGLA +
Sbjct: 102 YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158
Query: 290 PEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 337
+ + H GT GY +PE V+ + D+++ GV+L +L G
Sbjct: 159 NDSEAWH--GFA-GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 66/305 (21%), Positives = 104/305 (34%), Gaps = 78/305 (25%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN------HDGLQGHKEWL 183
+R LLG+GGFG VF G + L VA+K + L
Sbjct: 32 EYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 184 AEVNFL----GDLVHLNLVKLIGYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSI 237
EV L H +++L+ + E + LV E +P L +++ +
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKG------- 134
Query: 238 RMKIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLA---K 287
+ + H R V++RD K NIL+D KL DFG
Sbjct: 135 PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
Query: 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRP 346
D P GT Y+ PE++ + V+S G++L +M+ G
Sbjct: 192 DEPY--TDFD-----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD-------- 236
Query: 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLM 404
P ++ I LE + L CL+ P +RP +
Sbjct: 237 ----------IPFERDQE-----I---LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSL 278
Query: 405 SEVVE 409
E++
Sbjct: 279 EEILL 283
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 71/298 (23%), Positives = 116/298 (38%), Gaps = 67/298 (22%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 186
+ LGEG FG V T VA+K ++ L+ + E+
Sbjct: 10 PYIIRETLGEGSFGKVKLA---------THYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 187 NFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
++L L H +++KL Y I + +V E+ G L +++ + RM G
Sbjct: 61 SYLKLLRHPHIIKL--YDVITTPTDIVMVIEYAG-GELFDYIVEKK-------RMTEDEG 110
Query: 245 AAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 298
+ + H +++RD K N+LLD + N K++DFGL+ +G+ S
Sbjct: 111 RRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167
Query: 299 TRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
G+ YAAPE V+ G L DV+S G+VL ML GR D + +
Sbjct: 168 C---GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFI---- 213
Query: 357 RPHLGERRRFYRLIDPRLEGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
++ + + + GAQ L + DP R + E+
Sbjct: 214 -------PNLFKKV---NSCVYVMPDFLSPGAQS---LIRRMIVADPMQRITIQEIRR 258
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 33/238 (13%)
Query: 111 KVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT 170
+ R +F N + N+ + LG+G F V + V TGL A K
Sbjct: 11 QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKI 61
Query: 171 LNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLF 227
+N L ++ E L H N+V+L I+++ LV++ + G L +
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIV 120
Query: 228 RRSLPLPWSIR-----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAK 279
R +S ++ L + +A+ H +++R+ K N+LL K
Sbjct: 121 ARE---FYSEADASHCIQQILES---IAYCHS---NGIVHRNLKPENLLLASKAKGAAVK 171
Query: 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
L+DFGLA + + + H GT GY +PE + + D+++ GV+L +L G
Sbjct: 172 LADFGLAIEVNDSEAWH--GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 40/218 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + + EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 71 QVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 299
G+ +LH + + + D K NI+L + KL DFGLA + +G +
Sbjct: 126 D---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 38/219 (17%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+GEG +G VFK +N G VA+K + +Q +E + EV L
Sbjct: 19 IGEGAYGKVFKARDLKN--------GGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 192 L---VHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 240
L H N+V+L + + +L LV+E + L+ +P
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD 124
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVST 299
+ +GL FLH V++RD K NIL+ + KL+DFGLA+ + T
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--- 178
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
V+ T Y APE ++ + D++S G + EM +
Sbjct: 179 VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 40/218 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 71 QVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 299
G+ +LH + + + D K NI+L + KL DFGLA + +G +
Sbjct: 126 D---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 61/294 (20%), Positives = 101/294 (34%), Gaps = 62/294 (21%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 194
+LG G G V + TG A+K L + EV+
Sbjct: 36 VLGLGVNGKVLEC---------FHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGG 81
Query: 195 LNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALG 244
++V ++ E+ L++ E M G L + + R ++ R M+
Sbjct: 82 PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGT 139
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
A + FLH + +RD K N+L + D KL+DFG AK+ + + T
Sbjct: 140 A---IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC 190
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
T Y APE + D++S GV++ +L G ++
Sbjct: 191 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------------YSNTGQA 236
Query: 362 ERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 409
R I G + + A QL L DP R +++ +
Sbjct: 237 ISPGMKRRI---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 42/222 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF-------- 188
+G G +G V+K +G VA+K++ + +
Sbjct: 17 IGVGAYGTVYKARDPH---------SGHFVALKSVR---VPNGGGGGGGLPISTVREVAL 64
Query: 189 ---LGDLVHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSI 237
L H N+V+L+ + + ++ LV+E + R L+ LP
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAET 121
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTH 296
+ +GL FLH +++RD K NIL+ + KL+DFGLA+ + T
Sbjct: 122 IKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
V+ T Y APE ++ + D++S G + EM +
Sbjct: 179 ---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 40/218 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + GTG A K + L + ++ EVN L
Sbjct: 13 LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++ H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEA----TQFLKQIL 118
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 299
G+ +LH + + + D K NI+L + KL DFG+A G++
Sbjct: 119 D---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-- 170
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 171 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 42/207 (20%), Positives = 81/207 (39%), Gaps = 26/207 (12%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 196
LG G FG V + V+ + T K + G E++ L H N
Sbjct: 13 LGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62
Query: 197 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFL 252
++ L E + L +++EF+ + + + L + + L FL
Sbjct: 63 ILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFL 118
Query: 253 HEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
H + + D + NI+ ++ K+ +FG A+ GD + + Y AP
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTG 337
E +++ +D++S G ++ +L+G
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 46/225 (20%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 191
+G+G FG VFK + TG VA+K + ++ KE L E+ L
Sbjct: 25 IGQGTFGEVFKARHRK---------TGQKVALKKVL---MENEKEGFPITALREIKILQL 72
Query: 192 LVHLNLVKLIGYCIEDDQRL--------LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 240
L H N+V LI C LV++F G L N L + +L + M+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-MQ 131
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA------KDGPEGDK 294
+ L GL ++H +++RD K +N+L+ D KL+DFGLA K+
Sbjct: 132 MLL---NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 295 THVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 338
T+ RV+ T Y PE ++ D++ G ++ EM T
Sbjct: 186 TN---RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 36/114 (31%), Positives = 50/114 (43%), Gaps = 3/114 (2%)
Query: 223 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282
E L + + AKG+ FL A R I+RD NILL K+ D
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
FGLA+D + + APE + T +SDV+SFGV+L E+ +
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 12/107 (11%)
Query: 131 FRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLA 184
F + L LG G FG V + K T TVAVK L H+ ++
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMS 74
Query: 185 EVNFLGDLV-HLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRR 229
E+ L + HLN+V L+G C + L+V EF G+L +L +
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 65/294 (22%), Positives = 103/294 (35%), Gaps = 67/294 (22%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL 195
+G G + + + T + AVK ++ E E+ L H
Sbjct: 30 IGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRDP-TE---EIEILLRYGQHP 76
Query: 196 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 249
N++ L +D + + +V E M G L + + R+ +S R + +
Sbjct: 77 NIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKT---V 129
Query: 250 AFLHEEAERPVIYRDFKTSNILL-DADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+LH + V++RD K SNIL D N ++ DFG AK + + T T
Sbjct: 130 EYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YTA 184
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHLG 361
+ APE + + D++S GV+L MLTG D
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--------------- 229
Query: 362 ERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 409
I G FS+ G A L + L DP R + V+
Sbjct: 230 ---EILARI---GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 33/222 (14%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ ++ +G G G V VA+K L+ K E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ + + H N++ L+ +E+ Q + LV E M + + + L RM
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL---DHERM 166
Query: 240 KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--H 296
L G+ LH +I+RD K SNI++ +D K+ DFGLA+ +
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
V TR Y APE ++ D++S G ++ EM+ +
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 36/215 (16%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG G F V + + TG A K L E L E+ L
Sbjct: 37 LGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 195 L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW--------SIRMKIALGA 245
++ L + +L+ E+ G E +F LP +K L
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQILE- 142
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
G+ +LH + +++ D K NILL + K+ DFG+++ + +M
Sbjct: 143 --GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IM 194
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
GT Y APE + +T+ +D+++ G++ +LT
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 66/363 (18%), Positives = 119/363 (32%), Gaps = 64/363 (17%)
Query: 67 TSTHYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKL 126
+++ +S + P + A+ + + V S L+ +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV 186
+LG G G V + T A+K L + EV
Sbjct: 62 --DYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREV 105
Query: 187 NFLGDLV-HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-- 238
++V+++ E+ L+V E + G L + + R ++ R
Sbjct: 106 ELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREA 163
Query: 239 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDGPEG 292
MK A + +LH + +RD K N+L NA KL+DFG AK+
Sbjct: 164 SEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
+ ++T T Y APE + D++S GV++ +L G P
Sbjct: 218 NS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPF----- 263
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSE 406
++ L I G + ++ L + L +P R ++E
Sbjct: 264 --YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 318
Query: 407 VVE 409
+
Sbjct: 319 FMN 321
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 40/218 (18%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 190
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 191 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 243
++ H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 70 EIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEA----TEFLKQIL 124
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 299
+ +LH + + D K NI+L K+ DFGLA G++
Sbjct: 125 NG---VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 50/238 (21%), Positives = 89/238 (37%), Gaps = 55/238 (23%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----------- 184
+G+G +G V A+K L+ L +
Sbjct: 20 EIGKGSYGVVKLA---------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 185 ---------------EVNFLGDLVHLNLVKLIGYCI----EDDQRLLVYEFMPRGSLENH 225
E+ L L H N+VKL + +D +V+E + +G +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 226 LFRRSLPLPWSIRM--KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283
+ L + + G + +LH + +I+RD K SN+L+ D + K++DF
Sbjct: 129 PTLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 338
G++ + +G +S V GT + APE + DV++ GV L + G+
Sbjct: 182 GVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 79/363 (21%), Positives = 120/363 (33%), Gaps = 84/363 (23%)
Query: 70 HYESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 129
H+ S D + S ++ A + T+ L + + + +D
Sbjct: 4 HHHHSSGVDLGTENLYF---QSMSSVTASAAPGTASLVPDYWIDGS-NRDALSDF----- 54
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
F ES LG G V++ + GT A+K L K E+ L
Sbjct: 55 -FEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVRTEIGVL 102
Query: 190 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---- 244
L H N++KL E + LV E + G L F R I + G
Sbjct: 103 LRLSHPNIIKLKEIF-ETPTEISLVLELVTGGEL----FDR-------I---VEKGYYSE 147
Query: 245 --AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEG 292
AA +A+LHE +++RD K N+L D K++DFGL+K
Sbjct: 148 RDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
V GT GY APE + D++S G++ +L G
Sbjct: 205 VLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF-------------- 247
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSE 406
P ER + L + A L + DPK R +
Sbjct: 248 ----EPFYDERGD-QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ 302
Query: 407 VVE 409
++
Sbjct: 303 ALQ 305
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 35/219 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+++ LG G + VF+ N V VK L K+ E+ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILK---PVKKKKIKREIKIL 84
Query: 190 GDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIR--MKIALG 244
+L N++ L + R F + N F++ + IR M L
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEIL- 140
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDG-PEGDKTH-VSTRV 301
K L + H +++RD K N+++D ++ +L D+GLA+ P + V++R
Sbjct: 141 --KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 302 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRR 339
+ PE ++ + S D++S G +L M+ +
Sbjct: 196 -----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 65/297 (21%), Positives = 98/297 (32%), Gaps = 60/297 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 188
+ +G G FG T VAVK + E + E+
Sbjct: 21 RYDFVKDIGSGNFGVARLM---------RDKLTKELVAVKYIERGAAI--DENVQREIIN 69
Query: 189 LGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
L H N+V+ I L ++ E+ G L + R
Sbjct: 70 HRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAG-------RFSEDEARF 120
Query: 247 K------GLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDKTHVS 298
G+++ H + +RD K N LLD K+ DFG +K +
Sbjct: 121 FFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 175
Query: 299 TRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
+ V GT Y APE V+ +DV+S GV L ML G + P +
Sbjct: 176 STV-GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE--DPEEPRDY---- 227
Query: 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR----DPKARPLMSEVVE 409
R+ + I L +SI + + H +SR DP R + E+
Sbjct: 228 -------RKTIQRI---LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 194
LG+G F V + VK G A +N L H++ E L H
Sbjct: 19 LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 195 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 248
N+V+L I ++ L+++ + G L + R +S ++ L A
Sbjct: 70 PNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEA--- 122
Query: 249 LAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
+ H+ V++R+ K N+LL KL+DFGLA + EG++ GT
Sbjct: 123 VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGFA-GTP 177
Query: 306 GYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 337
GY +PE V+ D+++ GV+L +L G
Sbjct: 178 GYLSPE-VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 55/231 (23%), Positives = 89/231 (38%), Gaps = 40/231 (17%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----- 182
+ + + G +G V G+ VA+K + + G
Sbjct: 21 QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 183 ------LAEVNFLGDLVHLNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSL 231
L E+ L H N++ L + + +L LV E M L + + +
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI 129
Query: 232 PLPWSIRMK-IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDG 289
+ ++ GL LHE A V++RD NILL + + + DF LA +D
Sbjct: 130 VIS-PQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 290 PEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 338
+ +KT +V+ R Y APE VM T D++S G V+ EM +
Sbjct: 186 ADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 53/258 (20%), Positives = 97/258 (37%), Gaps = 71/258 (27%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-TLNHDGLQGHKEWLAEV 186
++ + LG G FG V + + E +G A+K L + E+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDP-----RYKNREL 51
Query: 187 NFLGDLVHLNLVKLIGY-------------------------------------CIEDDQ 209
+ + L H+N++KL+ Y ++
Sbjct: 52 DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111
Query: 210 RL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAFLHEEAERPVIYRDF 265
L ++ E++P + R +P + I + + + F+H + +RD
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG---ICHRDI 167
Query: 266 KTSNILLDA-DYNAKLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG--HLTS 320
K N+L+++ D KL DFG AK + + +R + Y APE +M G T
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE-LMLGATEYTP 221
Query: 321 RSDVYSFGVVLLEMLTGR 338
D++S G V E++ G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 33/222 (14%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ ++ +G G G V VA+K L+ K E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRE 74
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ + + H N++ L+ +E+ Q + +V E M +L + + L RM
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANL-CQVIQMEL---DHERM 129
Query: 240 KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKT-H 296
L G+ LH +I+RD K SNI++ +D K+ DFGLA G T +
Sbjct: 130 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
V TR Y APE ++ D++S G ++ EM+ G
Sbjct: 187 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 54/232 (23%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+ + + +G G +G V + +G VA+K L+ K E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRE 73
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 239
+ L + H N++ L+ + + LV FM + L + + +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQK-------IMGL 121
Query: 240 KIA-----------LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
K + L KGL ++H A V++RD K N+ ++ D K+ DFGLA+
Sbjct: 122 KFSEEKIQYLVYQML---KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR- 174
Query: 289 GPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 338
+ + T V TR + Y APE +++ H D++S G ++ EMLTG+
Sbjct: 175 HADAEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
++ S +G G +G V + + TGL VAVK L+ + K E
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 237
+ L + H N++ L+ +E+ + LV M L + L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-H 296
+ +GL ++H A+ +I+RD K SN+ ++ D K+ DFGLA+ + T +
Sbjct: 134 VQFLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGY 189
Query: 297 VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 338
V+TR Y APE ++ H D++S G ++ E+LTGR
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 56/243 (23%), Positives = 94/243 (38%), Gaps = 42/243 (17%)
Query: 116 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 175
+ F+ + LG GG G VF V VA+K +
Sbjct: 2 MNIHGFD----LGSRYMDLKPLGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTD 48
Query: 176 LQGHKEWLAEVNFLGDLVHLNLVKLI-------------GYCIEDDQRL-LVYEFMPRGS 221
Q K L E+ + L H N+VK+ + + + +V E+M
Sbjct: 49 PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM---- 104
Query: 222 LENHLFR--RSLPLPWSIRMK-IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYN 277
E L PL + +GL ++H A V++RD K +N+ ++ D
Sbjct: 105 -ETDLANVLEQGPLL-EEHARLFMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLV 159
Query: 278 AKLSDFGLAK-DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 335
K+ DFGLA+ P + + T Y +P +++ + T D+++ G + EML
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 336 TGR 338
TG+
Sbjct: 220 TGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
+R +G G +G V V TG VA+K L K E
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRE 74
Query: 186 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 237
+ L + H N++ L+ ++D LV FM L + + L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129
Query: 238 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-H 296
+ KGL ++H A +I+RD K N+ ++ D K+ DFGLA+ + + T +
Sbjct: 130 IQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGY 185
Query: 297 VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 338
V TR Y APE ++ T D++S G ++ EM+TG+
Sbjct: 186 VVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 35/225 (15%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 186
+ S +GEG +G V + VA+K ++ + + L E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA---------YDNLNKVRVAIKKISPFEHQTYCQRTLREI 76
Query: 187 NFLGDLVHLNLVKLIG----YCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 239
L H N++ + IE + + +V + M E L++ ++ L + +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLS-NDHI 130
Query: 240 KI----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDK 294
L +GL ++H A V++RD K SN+LL+ + K+ DFGLA+ P+ D
Sbjct: 131 CYFLYQIL---RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 295 THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 338
T T + T Y APE ++ T D++S G +L EML+ R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 186
+ +F+ +SLLGEG +G V TG VA+K + D L E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA---------THKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 187 NFLGDLVHLNLVKLI----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 239
L H N++ + E+ + ++ E M + L R + L +
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS-DDHI 114
Query: 240 KI----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA----KDGPE 291
+ L + + LH + VI+RD K SN+L++++ + K+ DFGLA + +
Sbjct: 115 QYFIYQTL---RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 292 GDKTHVSTRVMGTY----GYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 338
+ M + Y APE ++T + DV+S G +L E+ R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 53/315 (16%), Positives = 98/315 (31%), Gaps = 78/315 (24%)
Query: 85 AAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLAT-----RNFRPESLLGE 139
A + S + S S+ E + + K T + + + + L+G
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63
Query: 140 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGDLVH 194
G +G V + VA+K + E+ L L H
Sbjct: 64 GSYGHVCEA---------YDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNH 111
Query: 195 LNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA--- 246
++VK+ I +E L +V E ++ + R + L
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKK-------LFRTPVYLTELHIK 159
Query: 247 -------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---------KDGP 290
G+ ++H A +++RD K +N L++ D + K+ DFGLA
Sbjct: 160 TLLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGH------------LTSRS-----DVYSFGVVLLE 333
++ + +TGH L + DV+S G + E
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 334 MLTGRRSMDKNRPNG 348
+L + +
Sbjct: 277 LLNMIKENVAYHADR 291
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 54/258 (20%), Positives = 91/258 (35%), Gaps = 62/258 (24%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
N+ + L+G G +G V+ T VA+K +N + L K L E
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA---------YDKNTEKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ L L +++L I DD +V E ++ L + +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK-------LFKTP 123
Query: 241 IALGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---- 286
I L G F+HE + +I+RD K +N LL+ D + K+ DFGLA
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-----------------SDVYSFGV 329
+ + + +T H+ +R D++S G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240
Query: 330 VLLEMLTGRRSMDKNRPN 347
+ E+L +S + N
Sbjct: 241 IFAELLNMLQSHINDPTN 258
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 44/240 (18%), Positives = 79/240 (32%), Gaps = 46/240 (19%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----------LQG 178
R ++ +S G +++ + ++K DG
Sbjct: 42 RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 179 HKEWLAEVNFLGDLVHLNLVKLIGY-CIEDDQRLLVYEFMPR--GSLENHLFRRSLPLPW 235
+ + L L + +G+ +D R LV +P SL+ S
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQ-SALDVSPKHVL 156
Query: 236 SIRM--KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAK---D 288
S R ++A L FLH E ++ + NI +D + ++ L+ +G A
Sbjct: 157 SERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 289 GPEGDKTHVSTR------VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 338
HV+ G + + M H + RSD+ S G +L+ L G
Sbjct: 214 ----SGKHVAYVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 46/247 (18%), Positives = 85/247 (34%), Gaps = 53/247 (21%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
LG G F V+ N T VA+K + D + E+ L +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDK-VYTEAAEDEIKLLQRVND 74
Query: 195 LNLVKLIG----YCIEDDQRLLVYEFMPRGSLENHLF------RRSL----------PLP 234
+ K + + +LL + F +G H+ +L +P
Sbjct: 75 ADNTKEDSMGANHIL----KLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 235 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD------ADYNAKLSDFGLAKD 288
+I+ GL ++H +I+ D K N+L++ K++D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-----RSMDK 343
E + TR Y +PE ++ +D++S ++ E++TG
Sbjct: 188 YDEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242
Query: 344 NRPNGEH 350
+ +H
Sbjct: 243 YTKDDDH 249
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 52/277 (18%), Positives = 96/277 (34%), Gaps = 49/277 (17%)
Query: 90 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 149
+S+ L E+ V + ++ +G+GGFGC++
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAA-------AWKVGLPIGQGGFGCIYLAD 55
Query: 150 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGDLVHLNLVKLIG-- 202
+ + G+ VK D E A+ + + +K +G
Sbjct: 56 MNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111
Query: 203 ---YCIEDDQRLLVYEF--MPR-G-SLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 252
D+ Y F M R G L+ ++ + ++ ++L L ++
Sbjct: 112 KYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEANAKRFSRK-TVLQ-LSLRILDILEYI 168
Query: 253 HEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAKD-GPEGDKTHVSTR----VMGTY 305
H E ++ D K SN+LL+ + L D+GLA PEG + GT
Sbjct: 169 H---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI 225
Query: 306 GYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 338
+ + + H + R D+ G +++ LTG
Sbjct: 226 EFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 52/225 (23%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLV 193
++G+G FG V K + + VA+K + N H++ E+ L L
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQ---------HVALKMVRNEKRF--HRQAAEEIRILEHLR 151
Query: 194 HL------NLVKLIGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPW 235
N++ ++ C+ E LL +YE + + + LP
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYELIKKNKF------QGFSLP- 200
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA-KLSDFGLAKDGPEGD 293
+R K A + L LH+ +I+ D K NILL + K+ DFG + +
Sbjct: 201 LVR-KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
T++ +R Y APE ++ D++S G +L E+LTG
Sbjct: 257 YTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 56/239 (23%), Positives = 101/239 (42%), Gaps = 46/239 (19%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 185
R + LG+G +G V+K + TG VAVK + + E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS---------IDRRTGEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 186 VNFLGDL-VHLNLVKLIGYCI-EDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRMK 240
+ L +L H N+V L+ ++D+ + LV+++M E L R+ L + +
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILE-PVHKQ 112
Query: 241 -IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTH 296
+ K + +LH +++RD K SNILL+A+ + K++DFGL+ +
Sbjct: 113 YVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 297 VSTRVMGTYGYAAPEYVMTGH------------LTSRS-----DVYSFGVVLLEMLTGR 338
+ T + + ++T + L S D++S G +L E+L G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 56/243 (23%), Positives = 91/243 (37%), Gaps = 54/243 (22%)
Query: 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 176
+ R + +SL+G+G FG V K + VA+K + N
Sbjct: 45 IVKNGEK-WMDR-YEIDSLIGKGSFGQVVKAYDRVEQE---------WVAIKIIKNKKAF 93
Query: 177 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 218
+ EV L + +V L + C+ E +L +Y+
Sbjct: 94 --LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----MLSYNLYDL-- 145
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278
L N FR + ++ K A L FL +I+ D K NILL +
Sbjct: 146 ---LRNTNFR---GVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRS 198
Query: 279 --KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEML 335
K+ DFG + + ++ +R Y +PE V+ G + D++S G +L+EM
Sbjct: 199 AIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPE-VLLGMPYDLAIDMWSLGCILVEMH 252
Query: 336 TGR 338
TG
Sbjct: 253 TGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 51/230 (22%), Positives = 85/230 (36%), Gaps = 46/230 (20%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 187
+++ +GEG FG +F+G VA+K D Q E+
Sbjct: 11 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL 61
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALG 244
G + + + E +LV + + SLE L R + ++ M A
Sbjct: 62 LAG---CTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVK-TVAM-AAKQ 114
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTH 296
+ +H E+ ++YRD K N L+ + + DFG+ K D K H
Sbjct: 115 MLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQH 169
Query: 297 VSTR----VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 338
+ R + GT Y + + HL + R D+ + G V + L G
Sbjct: 170 IPYREKKNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 52/225 (23%), Positives = 82/225 (36%), Gaps = 38/225 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+R +G G FG ++ G G VA+K H + E
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVK--TKHPQLHIESKIY 58
Query: 190 GDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 245
+ + + E D ++V E + SLE LF R L ++ + +A
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLK-TVLL-LADQM 114
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR- 300
+ ++H + I+RD K N L+ + DFGLAK H+ R
Sbjct: 115 ISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171
Query: 301 ---VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 338
+ GT YA+ + HL + R D+ S G VL+ G
Sbjct: 172 NKNLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 54/301 (17%), Positives = 92/301 (30%), Gaps = 98/301 (32%)
Query: 137 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL 195
LG G G V + T A+K L + EV
Sbjct: 26 LGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQCP 71
Query: 196 NLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG-----A 245
++V+++ E+ L+V E + G E LF R I+ + A
Sbjct: 72 HIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSR-------IQDRGDQAFTEREA 119
Query: 246 A-------KGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 295
+ + + +LH + +RD K N+L + KL+DFG A E
Sbjct: 120 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KE---- 169
Query: 296 HVSTRVMGT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354
G Y + D++S GV++ +L G P
Sbjct: 170 -----TTGEKYDKSC-------------DMWSLGVIMYILLCGY------PPF------- 198
Query: 355 WARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVV 408
++ L I G + ++ L + L +P R ++E +
Sbjct: 199 YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 255
Query: 409 E 409
Sbjct: 256 N 256
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 55/229 (24%), Positives = 84/229 (36%), Gaps = 44/229 (19%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
NFR +G G FG + G T VA+K E F
Sbjct: 10 NFRVGKKIGCGNFGELRLG---------KNLYTNEYVAIKLEPMKSRAPQLHL--EYRFY 58
Query: 190 GDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 245
L + ++ + +V E + SLE LF R+ L ++ M IA+
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLK-TVLM-IAIQL 114
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTHV 297
+ ++H + +IYRD K N L+ N + DF LAK D K H+
Sbjct: 115 ISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKHI 169
Query: 298 STR----VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 338
R + GT Y + + HL + R D+ + G + + L G
Sbjct: 170 PYREHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 41/278 (14%), Positives = 76/278 (27%), Gaps = 88/278 (31%)
Query: 212 LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270
+V+E + L + + LP KI +GL +LH + +I+ D K NI
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178
Query: 271 LLDAD-------------------------------------------------YNAKLS 281
LL + K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 341
D G A + + TR Y + E ++ + +D++S + E+ TG
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293
Query: 342 DKNRPNGEHN-------------------LVEWARPHL-----GERRRFYRLIDPRLEG- 376
+ + +V G+ + +L L
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353
Query: 377 -----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+S + A L P+ R +E +
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 41/238 (17%), Positives = 80/238 (33%), Gaps = 45/238 (18%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----L 183
+ +G GGFG ++ + VK + E +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKP------EKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 184 AEVNFLGDLVHLNLVKLIG-----YC-----IEDDQRLLVYEFMPR--GSLENHLFRRSL 231
A+ + + + + +G R +V M R L+ + ++
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQ-KISGQNG 146
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAKD- 288
S +++ + L ++H E ++ D K +N+LL + L+D+GL+
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 289 GPEGDKTHVSTRV----MGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 338
P G+ GT + + + H + RSDV G +L L G+
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 59/225 (26%), Positives = 89/225 (39%), Gaps = 38/225 (16%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
FR +G G FG ++ G + VA+K N H + L E
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNE---------EVAIKLENVK--TKHPQLLYESKIY 56
Query: 190 GDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 245
L + + + +E D +LV + + SLE LF R L L ++ M +A
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLK-TVLM-LADQM 112
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR- 300
+ F+H + ++RD K N L+ A + DFGLAK H+ R
Sbjct: 113 INRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Query: 301 ---VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 338
+ GT YA+ + HL + R D+ S G VL+ L G
Sbjct: 170 NKNLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 60/259 (23%), Positives = 87/259 (33%), Gaps = 72/259 (27%)
Query: 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 176
D L R + LGEG FG V + VA+K + N
Sbjct: 10 VCRIGDW-LQER-YEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVGKY 59
Query: 177 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 218
+ E+N L + V + + CI E LL +EF
Sbjct: 60 --REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEF-- 111
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYN 277
L+ + F+ P P +A L FLHE + + D K NIL ++++
Sbjct: 112 ---LKENNFQ---PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFE 162
Query: 278 A------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL- 318
+++DFG A E T V+TR Y PE V+
Sbjct: 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPE-VILELGW 216
Query: 319 TSRSDVYSFGVVLLEMLTG 337
DV+S G +L E G
Sbjct: 217 AQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 67/259 (25%), Positives = 95/259 (36%), Gaps = 72/259 (27%)
Query: 118 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 176
D+ L+ R + LGEG FG V + + G G VAVK + N D
Sbjct: 5 ICQSGDV-LSAR-YEIVDTLGEGAFGKVVECIDHKAG--------GRHVAVKIVKNVDRY 54
Query: 177 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 218
+ +E+ L L V+++ + CI E LL Y+F
Sbjct: 55 --CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDF-- 106
Query: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYN 277
++ + F P K+A K + FLH + + D K NIL +DY
Sbjct: 107 ---IKENGFL---PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYT 157
Query: 278 A------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL- 318
K+ DFG A E T VSTR Y APE V+
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPE-VILALGW 211
Query: 319 TSRSDVYSFGVVLLEMLTG 337
+ DV+S G +L+E G
Sbjct: 212 SQPCDVWSIGCILIEYYLG 230
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 4e-07
Identities = 39/225 (17%), Positives = 59/225 (26%), Gaps = 63/225 (28%)
Query: 110 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
+ S+ F+ L T + +GEG FG VF+ VA+K
Sbjct: 2 MGECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIK 49
Query: 170 TLNHDGLQGH--------KEWLAEVNFLGDLVHL---------NLVKLIGYCI------- 205
+ +G +E L E+ +L L + L
Sbjct: 50 IIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPP 109
Query: 206 -----------------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+DDQ +V EF G + + + I
Sbjct: 110 LLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSIL 167
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287
LA +RD N+LL KL K
Sbjct: 168 HQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 54/247 (21%), Positives = 83/247 (33%), Gaps = 76/247 (30%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLV 193
+G+G FG V +N AVK + N + E + L +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKK---------YYAVKVVRNIKKY--TRSAKIEADILKKIQ 89
Query: 194 HL-----NLVKLIGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPWS 236
+ N+VK G C+ E L +YE + + +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEI-----ITRNNYN---GFHIE 137
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA----------------- 278
+ K L +L + + + + D K NILL D +
Sbjct: 138 DIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 279 -------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVV 330
KL DFG A + + ++TR Y APE V+ S D++SFG V
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGCV 248
Query: 331 LLEMLTG 337
L E+ TG
Sbjct: 249 LAELYTG 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 1e-06
Identities = 63/385 (16%), Positives = 124/385 (32%), Gaps = 97/385 (25%)
Query: 79 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFT---FNDLKLATRNFRPE- 134
T+R + +S+ TT++ + + L + +V S L K+ DL P
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPD-EVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 135 -SLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 191
S++ E + W N K T + ++ L + + L+ V F
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCD---KLTTIIESSLNVLEPAEYRKMFDRLS-V-FPPS 384
Query: 192 LVHLN---LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
H+ L + I+ D ++V + +E ++ +P SI +++ +
Sbjct: 385 -AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP-SIYLEL-KVKLEN 441
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK---THVSTRVMGTY 305
LH ++D YN + P D+ +H+
Sbjct: 442 EYALH---------------RSIVDH-YNIPKTFDSDDLIPPYLDQYFYSHI-------- 477
Query: 306 GYAAPEYVMTGHLTS--RSDVYS-FGVVLLEMLTGRRSMD-KNRPNGEHNLVEWARPHLG 361
G+ HL + + + F +V L+ R ++ K R + + +
Sbjct: 478 GH---------HLKNIEHPERMTLFRMVFLDF----RFLEQKIRHDSTAWNASGSILNTL 524
Query: 362 ERRRFYR----LIDPRLE------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-A 410
++ +FY+ DP+ E F K L ++ A
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPK--------IEENLICSKYTD-----LLRIA 571
Query: 411 LKPLPNLKDMASSSYYFQTMQAERI 435
L MA F+ +A +
Sbjct: 572 L--------MAEDEAIFE--EAHKQ 586
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 486 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.19 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.83 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.61 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.49 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.43 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.29 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.01 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.64 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.61 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.6 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.55 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.29 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.98 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.52 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.0 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.34 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.85 | |
| 2khx_A | 85 | Ribonuclease 3; drosha, RNA binding domain, hydrol | 83.73 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.27 | |
| 1x49_A | 97 | Interferon-induced, double-stranded RNA- activated | 80.19 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-60 Score=472.92 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=204.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++++.||+|+||+||+|++.. +|+.||||++...... ..+.+.+|+++|++|+|||||+++++|.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE---------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT---------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 589999999999999999999876 6789999999765432 24568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
++.+|||||||+||+|.++|..+ ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccc
Confidence 99999999999999999999754 456799999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
|+...... ...+..+||+.|||||++.+..|+.++||||||||||||+||+.||...... .+.. ......
T Consensus 172 a~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~---~i~~~~-- 241 (350)
T 4b9d_A 172 ARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLVL---KIISGS-- 241 (350)
T ss_dssp ESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---HHHHTC--
T ss_pred ceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH---HHHcCC--
Confidence 98764321 1234578999999999999999999999999999999999999999764321 1111 111110
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. +.+.. ..+..+.+||.+||+.||.+|||+.|++++
T Consensus 242 ----~-~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 242 ----F-PPVSL----HYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ----C-CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----C-CCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 11122 234678999999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-60 Score=465.80 Aligned_cols=262 Identities=30% Similarity=0.448 Sum_probs=213.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|.+.+.||+|+||+||+|.+... ....++..||||+++.......++|.+|+++|++|+|||||+++++|.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 5788889999999999999988642 112367899999998766555678999999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRR------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 276 (486)
.+|||||||++|+|.++|... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCC
Confidence 999999999999999999753 246999999999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~ 355 (486)
.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+...
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~ 242 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIEC 242 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986544433333344679999999999999999999999999999999999 89999764321 11111
Q ss_pred hhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.. ... .+ ..+..++..+.+||.+||+.||++||++.+|++.|+.+
T Consensus 243 i~----~~~------~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 IT----QGR------VL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HH----HTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----cCC------CC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 100 01 11223356789999999999999999999999988754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=467.16 Aligned_cols=263 Identities=27% Similarity=0.436 Sum_probs=207.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|.+.+.||+|+||+||+|.+... ....++..||||+++.......++|.+|+++|++|+|||||+++++|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4677888999999999999988641 122367899999998766555678999999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 274 (486)
.+|||||||++|+|.++|.... .++++..++.|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECC
Confidence 9999999999999999996532 35899999999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 011412 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 275 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~ 353 (486)
++.+||+|||+++...........+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+.
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~ 270 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAI 270 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHH
Confidence 99999999999997655444444556789999999999999999999999999999999999 89999764321 111
Q ss_pred HhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.... ... .+. .+..++..+.+||.+||+.||++|||+.||+++|+.+.
T Consensus 271 ~~i~----~g~------~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 271 DCIT----QGR------ELE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHH----HTC------CCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHH----cCC------CCC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 1111 110 111 12223467899999999999999999999999997653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-59 Score=458.07 Aligned_cols=262 Identities=26% Similarity=0.453 Sum_probs=206.0
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
+..++|.+.+.||+|+||+||+|.+.. .||||+++.... ...+.|.+|+.+|++|+|||||+++++
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 344678889999999999999998643 699999975432 234678999999999999999999998
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+. ++.+|||||||++|+|.++|......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 101 ~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 101 MT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp EC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCC
T ss_pred EE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeec
Confidence 75 46789999999999999999877778999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
|+|+..............+||+.|||||++.+ +.|+.++|||||||+||||+||+.||........ +... +
T Consensus 177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~~----~ 250 (307)
T 3omv_A 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIFM----V 250 (307)
T ss_dssp SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHH----H
T ss_pred cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHHH----H
Confidence 99987654443334456789999999999864 4699999999999999999999999976432211 1111 1
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
... ...|.+ ...+..++..+.+|+.+||+.||.+|||+.||++.|+.+.
T Consensus 251 ~~~-----~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 251 GRG-----YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp HTT-----CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred hcC-----CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 100 011111 1122234567899999999999999999999999887553
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-59 Score=465.79 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=210.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
..|++++.||+|+||+||+|+++. +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEEECC---------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 569999999999999999999876 78899999997665555567889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
.+|||||||+||+|.+++.+ ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCcee
Confidence 99999999999999999865 35999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
...... .....+||+.|||||++.+..|+.++||||||||||||++|+.||.+..... ........
T Consensus 220 ~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~--------- 285 (346)
T 4fih_A 220 VSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDN--------- 285 (346)
T ss_dssp CCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHS---------
T ss_pred cCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcC---------
Confidence 644322 2445789999999999999999999999999999999999999997643211 11111100
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+.+. .....+..+.+||.+||+.||.+|||+.|++++
T Consensus 286 -~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 286 -LPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -SCCCCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCCCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011110 111234678999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=461.57 Aligned_cols=250 Identities=22% Similarity=0.268 Sum_probs=210.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++++.||+|+||+||+|++.. +|+.||||++.... ....+.+.+|+++|+.|+|||||+++++|.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 479999999999999999999876 67899999997432 233567899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 999999999999999999999655 47999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
|+..............+||+.|||||++.+..|+.++|||||||+||||+||+.||...+.. .+.. ......
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~---~i~~~~-- 250 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFA---KIIKLE-- 250 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHTC--
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHcCC--
Confidence 99765444333455689999999999999999999999999999999999999999754321 1111 111111
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
..+... .+..+.+||.+||+.||.+||++.|++.
T Consensus 251 ------~~~p~~----~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 ------YDFPEK----FFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ------CCCCTT----CCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ------CCCCcc----cCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 111222 2457899999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-59 Score=459.38 Aligned_cols=265 Identities=26% Similarity=0.378 Sum_probs=213.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++++++.||+|+||+||+|.+.... ...+++.||||+++.... ...++|.+|+.+|++|+|||||+++|+|.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~----~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPA----PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCc----cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 45677789999999999999875311 123577999999975432 3357799999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
+.++||||||++|+|.++|..+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEE
Confidence 99999999999999999996432 35899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 351 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~ 351 (486)
+.++.+||+|||+++.....+.....+..+||+.|||||++.++.|+.++|||||||+||||+| |..||.+.... .
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---H
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999987644433333455789999999999999999999999999999999998 89999765321 2
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 417 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 417 (486)
+..... .... ...+..++..+.+|+.+||+.||.+||+|.||++.|+.+.++
T Consensus 256 ~~~~i~----~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 256 VVEMIR----NRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp HHHHHH----TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred HHHHHH----cCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 222111 1100 011223456789999999999999999999999999876553
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-58 Score=456.13 Aligned_cols=252 Identities=24% Similarity=0.248 Sum_probs=206.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
+.|++.++||+|+||+||+|+++. +|+.||||+++.... ..+|+.+|+.|+|||||+++++|.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~---------~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQ---------TGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEEEECC---------CCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 467888899999999999999876 788999999986533 247999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEeecCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAK 287 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~vkl~DFGla~ 287 (486)
.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+| .+||+|||+|+
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred EEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 999999999999999999665 47999999999999999999999988 99999999999999987 69999999998
Q ss_pred CCCCCCcc---eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 288 DGPEGDKT---HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 288 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
........ .....++||+.|||||++.+..|+.++|||||||+||||+||+.||...........+. ....
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~~ 273 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEPP 273 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSCC
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCCC
Confidence 76443211 12234689999999999999999999999999999999999999998655433221111 1111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
.+. .++...+..+.+||.+||+.||.+|||+.|++++|..
T Consensus 274 ~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 274 PIR---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GGG---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Cch---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 110 1122234678999999999999999999999988753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-58 Score=468.39 Aligned_cols=252 Identities=26% Similarity=0.363 Sum_probs=211.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+.|++++.||+|+||.||+|++.. +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 3579999999999999999999876 7889999999876655566789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+.+|||||||+||+|.+++... .+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccce
Confidence 9999999999999999998643 5899999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... .....+||+.|||||++.+..|+.++||||||||||||++|+.||.+..... .......
T Consensus 296 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~--------- 361 (423)
T 4fie_A 296 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRD--------- 361 (423)
T ss_dssp ECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHH---------
T ss_pred ECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHc---------
Confidence 7644322 2445789999999999999999999999999999999999999997543211 1111110
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...+.+. .....+..+.+||.+||+.||.+||++.|++++
T Consensus 362 -~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 362 -NLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -SCCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111111 011224678999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=442.05 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=199.0
Q ss_pred CCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe---
Q 011412 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--- 206 (486)
Q Consensus 132 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--- 206 (486)
++.+.||+|+||+||+|.+.. ++..||||++..... ...+.+.+|+++|++|+|||||+++++|.+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred EeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 566789999999999999876 678999999975432 224568999999999999999999999875
Q ss_pred -CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeecC
Q 011412 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFG 284 (486)
Q Consensus 207 -~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~vkl~DFG 284 (486)
++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ .+||||||||+||||+. ++.+||+|||
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFG 177 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCc
Confidence 35689999999999999999654 47999999999999999999999876 45999999999999974 7999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+|+..... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||....... .+..... ...
T Consensus 178 la~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i~----~~~ 246 (290)
T 3fpq_A 178 LATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVT----SGV 246 (290)
T ss_dssp GGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHT----TTC
T ss_pred CCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHHH----cCC
Confidence 99864332 2345789999999998864 69999999999999999999999996532211 1111110 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+.+... .+..+.+||.+||+.||.+|||+.|++++
T Consensus 247 -----~~~~~~~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 247 -----KPASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----CCGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011111 23568899999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-57 Score=434.92 Aligned_cols=248 Identities=27% Similarity=0.355 Sum_probs=193.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++++.||+|+||+||+|++.. +|+.||||++..... .....+.+|+++|+.++|||||++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 589999999999999999998865 678999999975432 23456899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+++.+||||||| +|+|.++|.++ ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCC
Confidence 999999999999 68999999665 47999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
|+...... .....+||+.|||||++.+..| +.++|||||||+||||+||+.||...... .+.. ......
T Consensus 159 a~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~---~i~~~~- 228 (275)
T 3hyh_A 159 SNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFK---NISNGV- 228 (275)
T ss_dssp C------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHTC-
T ss_pred CeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHcCC-
Confidence 98754432 2345789999999999998876 57999999999999999999999754221 1111 111111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+... .+..+.+||.+||+.||.+|||+.|++++-
T Consensus 229 -------~~~p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 229 -------YTLPKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp -------CCCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred -------CCCCCC----CCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 111122 246789999999999999999999999853
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=454.69 Aligned_cols=271 Identities=28% Similarity=0.382 Sum_probs=218.8
Q ss_pred hhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCC-CCce
Q 011412 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVH-LNLV 198 (486)
Q Consensus 121 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~nIv 198 (486)
...|.+..++|++.+.||+|+||+||+|.+...+. ..+++.||||+++..... ..+.+.+|+++|.++.| ||||
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~----~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSS----TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 34455666789999999999999999999875322 235678999999865433 24568999999999965 8999
Q ss_pred EEEEEEEeC-CeeEEEEeecCCCChhHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 011412 199 KLIGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (486)
Q Consensus 199 ~~~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiH 262 (486)
+++++|... +.+|||||||++|+|.++|... ...+++..++.|+.||+.||+|||+++ |||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eec
Confidence 999998764 5689999999999999999643 235899999999999999999999988 999
Q ss_pred cCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 011412 263 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 341 (486)
Q Consensus 263 rDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf 341 (486)
|||||+||||+.++.+||+|||+|+...........+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998765544444556789999999999999999999999999999999998 99999
Q ss_pred CCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 342 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.+..... .+... +.+.. .+... ..++..+.+||.+||+.||.+|||+.||+++|+.+
T Consensus 289 ~~~~~~~--~~~~~----i~~g~------~~~~p----~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 289 PGVKIDE--EFCRR----LKEGT------RMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp TTCCCSH--HHHHH----HHHTC------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHHH--HHHHH----HHcCC------CCCCC----ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 7654321 11111 11110 11111 22346789999999999999999999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-57 Score=443.43 Aligned_cols=251 Identities=28% Similarity=0.343 Sum_probs=199.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++++.||+|+||+||+|++..+. .+++.||||+++.... .....+.+|+++|++|+|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGS------DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSST------TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCC------CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 57999999999999999999875432 2688999999975432 122357889999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999999999665 47999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
+....... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+... +.. .......
T Consensus 174 ~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~---~i~~~~~-- 243 (304)
T 3ubd_A 174 KESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMT---MILKAKL-- 243 (304)
T ss_dssp EC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCCC--
T ss_pred eeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHH---HHHcCCC--
Confidence 86543322 2345789999999999999999999999999999999999999997643211 111 1111111
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVE 409 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~eil~ 409 (486)
.+.. ..+..+.+||.+||+.||.+||++ .|+++
T Consensus 244 ------~~p~----~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 ------GMPQ----FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------CCCT----TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CCCC----cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1112 234678999999999999999985 56655
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=431.42 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=189.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|++++.||+|+||+||+|+++. +|+.||||+++..... ..+.+.+|+++|++|+|||||+++++|.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 74 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 74 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETT---------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred chhCEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 3579999999999999999999876 6789999999755432 23568899999999999999999999976
Q ss_pred CC------------eeEEEEeecCCCChhHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 207 DD------------QRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 207 ~~------------~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
.+ .+|||||||++|+|.+++..+.. ..++..++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 75 ~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl 151 (299)
T 4g31_A 75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFF 151 (299)
T ss_dssp EC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred cCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEE
Confidence 54 36999999999999999975532 3566778999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcc----------eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKT----------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~ 342 (486)
+.++.+||+|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||.
T Consensus 152 ~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 99999999999999876443221 11234689999999999999999999999999999999996 664
Q ss_pred CCCCCCcchhHHhhhhhcccccccccccCCccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 343 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... +...... .. . ...++ ......+.+||.+||+.||.+|||+.|++++
T Consensus 229 ~~~-----~~~~~~~-~~---------~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 229 TQM-----ERVRTLT-DV---------R----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp SHH-----HHHHHHH-HH---------H----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Ccc-----HHHHHHH-HH---------h----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 211 1110000 00 0 01111 1223457789999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=435.57 Aligned_cols=267 Identities=26% Similarity=0.323 Sum_probs=199.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|.+.+.||+|+||+||+|++ +|+.||||+++..... ...+..|+..+..++|||||++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-----------~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-----------TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 4677889999999999999987 4678999999754321 122345677778899999999999998764
Q ss_pred ----eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCcEEEcCCCcEE
Q 011412 209 ----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 209 ----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-----~~~iiHrDLKp~NIll~~~~~vk 279 (486)
.+|||||||++|+|.++|... .+++..+..++.|++.||+|||++. ..+||||||||+||||+.++.+|
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K 148 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence 579999999999999999654 5899999999999999999999861 12499999999999999999999
Q ss_pred EeecCCCCCCCCCCcce--eeeeccccccccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-
Q 011412 280 LSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH- 350 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~- 350 (486)
|+|||+++......... .....+||+.|||||++.+. .|+.++|||||||+||||+||.+||.........
T Consensus 149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 99999998654332221 22346899999999998754 4678999999999999999999887543221100
Q ss_pred --------hhHHhhhhhcccccccccccCCccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 351 --------NLVEWARPHLGERRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 351 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.......... ...++|.+.... .......+.+|+.+||+.||.+||||.||++.|+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~------~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp TTTSCSSCCHHHHHHHHT------TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHh------cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0000000000 011222222211 2345677899999999999999999999999997653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=433.76 Aligned_cols=269 Identities=22% Similarity=0.294 Sum_probs=204.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++++.||+|+||+||+|++.. +|+.||||+++.... ...+.+.+|+++|+.|+|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 124 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRL---------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 124 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence 579999999999999999999876 788999999975433 223568899999999999999999999764
Q ss_pred ------CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 207 ------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 207 ------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
.+.+|||||||+ |+|.++|... ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||
T Consensus 125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 125 TVPYGEFKSVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp SSCTTTCCCEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred ccccccCCEEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEE
Confidence 357899999995 6899998554 57999999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCCCC--cceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 281 SDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 281 ~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
+|||+|+...... ........+||+.|||||++.+. .|+.++||||||||||||++|++||.+.........+....
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998754321 11223457899999999998865 56999999999999999999999998654322211111000
Q ss_pred hhcc--c--------ccccccccCCccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 358 PHLG--E--------RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 358 ~~~~--~--------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.... . .......+.+..... +....+..+.+||.+||..||.+|||+.|+|++-
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 0000 0 000000000000000 0011245788999999999999999999999853
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=421.66 Aligned_cols=204 Identities=25% Similarity=0.330 Sum_probs=173.7
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
..++|++++.||+|+||+||+|+++.+ .++++.||||++.... ....+.+|+++|..+ +|||||+++++|.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~------~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQ------VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBT------TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEccc------CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 457899999999999999999987632 2367899999987543 345688999999998 6999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEEeecC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFG 284 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~vkl~DFG 284 (486)
+.+.+|||||||++|+|.+++ ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ECCEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 999999999999999999988 35899999999999999999999988 9999999999999877 799999999
Q ss_pred CCCCCCCCCc--------------------------ceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhC
Q 011412 285 LAKDGPEGDK--------------------------THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 337 (486)
Q Consensus 285 la~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG 337 (486)
+|+....... ....+..+||+.|||||++.+. .|+.++||||+|||+|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9975433211 0112345899999999998765 589999999999999999999
Q ss_pred CCCCCCCC
Q 011412 338 RRSMDKNR 345 (486)
Q Consensus 338 ~~pf~~~~ 345 (486)
+.||....
T Consensus 244 ~~Pf~~~~ 251 (361)
T 4f9c_A 244 RYPFYKAS 251 (361)
T ss_dssp CSSSSCCS
T ss_pred CCCCCCCC
Confidence 99996543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=447.17 Aligned_cols=256 Identities=22% Similarity=0.280 Sum_probs=214.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++++.||+|+||+||+|.++. +|+.||||++........+.+.+|+++|+.|+|||||+++++|.++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~---------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3689999999999999999999876 7889999999876655556788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC--CcEEEeecCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD--YNAKLSDFGL 285 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~--~~vkl~DFGl 285 (486)
+.+|||||||+||+|.++|......+++..+..|+.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccc
Confidence 9999999999999999999776678999999999999999999999988 9999999999999754 8999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
|+....... ....+||+.|||||++.+..|+.++||||||||||||++|..||.+..... ..... ......
T Consensus 304 a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~~~i---~~~~~~ 374 (573)
T 3uto_A 304 TAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNV---KSCDWN 374 (573)
T ss_dssp CEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH---HTTCCC
T ss_pred eeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHH---HhCCCC
Confidence 998754332 345689999999999999999999999999999999999999997643221 11111 000000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
+....... .+..+.+||.+||+.||.+||++.|+|++-+
T Consensus 375 ----~~~~~~~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 375 ----MDDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp ----CCSGGGTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred ----CCcccccC----CCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 11111112 2467899999999999999999999999643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=442.78 Aligned_cols=251 Identities=27% Similarity=0.361 Sum_probs=203.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHH---HHHHHHhcCCCCCceEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWL---AEVNFLGDLVHLNLVKLI 201 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~nIv~~~ 201 (486)
.++|+++++||+|+||.||+|+++. +|+.||||++..... .....+. .++.+++.++|||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~---------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 4689999999999999999999876 788999999964321 1122233 446777888999999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
++|.+.+.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.+|++||+
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~ 334 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEec
Confidence 9999999999999999999999999765 47999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
|||+|+...... ....+||+.|||||++.. ..|+.++||||||||||||++|++||..........+... ..
T Consensus 335 DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~ 407 (689)
T 3v5w_A 335 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL 407 (689)
T ss_dssp CCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HH
T ss_pred ccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hc
Confidence 999998764432 234689999999999964 5899999999999999999999999976443322111111 11
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 410 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~ 410 (486)
.. ...+... .+..+.+||.+||+.||.+|++ +.||+++
T Consensus 408 ~~--------~~~~p~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 408 TM--------AVELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HC--------CCCCCTT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CC--------CCCCCcc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11 1111222 3467899999999999999998 6777764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=396.83 Aligned_cols=282 Identities=40% Similarity=0.696 Sum_probs=238.3
Q ss_pred ChhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceE
Q 011412 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVK 199 (486)
Q Consensus 120 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 199 (486)
.+.++....++|++.+.||+|+||.||+|.+. +|..||||++........+.+.+|+.+|+.++||||++
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 99 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS 99 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEee
Confidence 33444456789999999999999999999863 46789999998776666678999999999999999999
Q ss_pred EEEEEEeCCeeEEEEeecCCCChhHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011412 200 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (486)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 276 (486)
+++++...+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~ 176 (321)
T 2qkw_B 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENF 176 (321)
T ss_dssp EEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTC
T ss_pred EEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCC
Confidence 9999999999999999999999999986543 35899999999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|.
T Consensus 177 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~ 256 (321)
T 2qkw_B 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256 (321)
T ss_dssp CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT
T ss_pred CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh
Confidence 99999999998654433333334467999999999999999999999999999999999999999877666555555554
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.... ....+...+++.+...+....+..+.+|+.+||+.||.+||++.+++++|+.+.
T Consensus 257 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 257 VESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp HHHH-TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcc-ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 3222 223344566666677778888999999999999999999999999999997553
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=382.46 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=210.4
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++.+.||+|+||+||+|.+.. +|+.||||++........+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEEECC---------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 4689999999999999999998765 6779999999866656667789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++|||||++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999999999999999654 5899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... ......||+.|+|||++.+..|+.++|||||||++|||++|..||...........+ . ...
T Consensus 165 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~----~~~---- 232 (297)
T 3fxz_A 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--A----TNG---- 232 (297)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--H----HHC----
T ss_pred ecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H----hCC----
Confidence 7544332 233467999999999999999999999999999999999999999754321110000 0 000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.+ ....+...+..+.+||.+||+.||.+||++.|++++-
T Consensus 233 ---~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 233 ---TP--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp ---SC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred ---CC--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 00 0001112346788999999999999999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=388.02 Aligned_cols=289 Identities=40% Similarity=0.728 Sum_probs=235.5
Q ss_pred cccccChhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCC
Q 011412 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV 193 (486)
Q Consensus 115 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~ 193 (486)
.+..+.+.++....++|++.+.||+|+||.||+|.+. +|..||||++...... ....+.+|+.+++.++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~ 85 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAV 85 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTCC
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhcc
Confidence 3567888999999999999999999999999999643 4678999999765322 1236889999999999
Q ss_pred CCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 011412 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (486)
Q Consensus 194 h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NI 270 (486)
||||+++++++...+..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+....+|+||||||+||
T Consensus 86 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp CTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred CCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 9999999999999999999999999999999997543 3599999999999999999999998111299999999999
Q ss_pred EEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCC
Q 011412 271 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR--PNG 348 (486)
Q Consensus 271 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~--~~~ 348 (486)
||+.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (326)
T 3uim_A 166 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244 (326)
T ss_dssp EECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred EECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc
Confidence 9999999999999999876443322 2344669999999999998999999999999999999999999996311 112
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
......|..... .........+..+...+....+..+.+|+.+||+.||.+||++.+|+++|+...
T Consensus 245 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 245 DVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred chhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 222333333222 223344556666677788888899999999999999999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=386.08 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=213.4
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|.+.+.||+|+||+||+|.+.. ++..||+|++........+.+.+|+.+|+.++||||+++++++.++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hhHeeccceecCCCCEEEEEEEECC---------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 3578899999999999999999876 5779999999766555567799999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccce
Confidence 9999999999999999999887778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcce------------eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011412 288 DGPEGDKTH------------VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 288 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~ 355 (486)
......... ......||+.|+|||++.+..++.++|||||||++|||++|..||..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~ 236 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence 654332211 11146799999999999999999999999999999999999999875433221110000
Q ss_pred hhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
. ...+..... .++..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 237 -~----------~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 237 -R----------GFLDRYCPP----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -H----------HHHHHTCCT----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -h----------ccccccCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 000000011 12345889999999999999999999999997653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=393.46 Aligned_cols=266 Identities=26% Similarity=0.391 Sum_probs=214.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+..... ....++..||||+++..... ....+.+|+.+|+.+ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34689999999999999999998754221 12235678999999865432 345689999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 269 (486)
...+.+||||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 99999999999999999999997643 34789999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 011412 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 348 (486)
Q Consensus 270 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~ 348 (486)
|||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++ |..||.......
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999986554333222334567899999999999999999999999999999999 999997643221
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
+..... .. ..+ ..+..++..+.+||.+||+.||.+||++.|+++.|+.+
T Consensus 314 ---~~~~~~----~~------~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 ---LFKLLK----EG------HRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp ---HHHHHH----TT------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHh----cC------CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 00 001 11222346789999999999999999999999999765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=382.19 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=208.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..+|++++.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL---------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4689999999999999999999865 678999999975432 23456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
..+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred ECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccC
Confidence 999999999999999999999665 46999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++....... ....+||+.|+|||++.+..+. .++|||||||++|||++|+.||....... +.. .......
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~---~i~~~~~ 231 (328)
T 3fe3_A 161 SNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRE---RVLRGKY 231 (328)
T ss_dssp CGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCCC
T ss_pred ceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCCC
Confidence 986544322 3446899999999999988875 79999999999999999999997643211 111 1111100
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.+. ...+..+.+|+.+||..||.+|||+.|++++-+
T Consensus 232 --------~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 232 --------RIP----FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp --------CCC----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred --------CCC----CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 011 112457889999999999999999999998643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=387.37 Aligned_cols=272 Identities=26% Similarity=0.343 Sum_probs=208.0
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..++|++.+.||+|+||+||+|.+. ++.||||++..... ......+|+.+|++++|||||++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 4468999999999999999999873 56899999975432 23446679999999999999999999987
Q ss_pred CC----eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCcEEE
Q 011412 207 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE----------AERPVIYRDFKTSNILL 272 (486)
Q Consensus 207 ~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~----------~~~~iiHrDLKp~NIll 272 (486)
.. .+++|||||++|+|.+++... .+++..++.++.|++.||.|||+. + |+||||||+||||
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill 164 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLL 164 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEE
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEE
Confidence 54 369999999999999999654 589999999999999999999998 6 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 347 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltG~~pf~~~~~~ 347 (486)
+.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 99999999999999765443332223346799999999998763 4567899999999999999999999865443
Q ss_pred CcchhHHhhhh--hccccc--ccccccCCccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 348 GEHNLVEWARP--HLGERR--RFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 348 ~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
........... ...+.. .......+.+...+ ....+..+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 32222111000 000000 00001111111111 1234567999999999999999999999999997654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=385.08 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=211.4
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|++.+.||+|+||.||+|.+...+. .+..||||+++.... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTS------CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCC------CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 4679999999999999999999875433 455799999986532 234568999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcc
Confidence 99999999999999999999777678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 287 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 287 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... +..... ..
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~----~~- 270 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSVE----EG- 270 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHH----TT-
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cC-
Confidence 876443221 12223457889999999999999999999999999999999 999996543211 111110 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
... ..+..++..+.+||.+||+.||.+||++.+|++.|+.+.
T Consensus 271 -----~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 271 -----YRL----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp -----CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCC----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001 111223467899999999999999999999999997653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=380.07 Aligned_cols=251 Identities=30% Similarity=0.363 Sum_probs=207.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++++.||+|+||.||+|.+.. +|+.||||+++... ......+.+|+.+|..++||||+++++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 74 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence 3579999999999999999998865 67899999997532 23346788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
...+.+|||||||++|+|..++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 75 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 75 QTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999998654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+.. .......
T Consensus 151 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~~~~ 222 (337)
T 1o6l_A 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LILMEEI 222 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCCC
T ss_pred chhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHH---HHHcCCC
Confidence 9986433221 234568999999999999999999999999999999999999999754221 1111 1111111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
. ++...+..+.+||.+||+.||.+|| ++.||+++-
T Consensus 223 --------~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 223 --------R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp --------C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred --------C----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 1 1112246789999999999999999 899998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=382.59 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=209.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCCceEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKL 200 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~ 200 (486)
..++|++.+.||+|+||.||+|.+.. +|..||||++...... ....+.+|+.+|..++||||+++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~---------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l 80 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECC---------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcE
Confidence 34679999999999999999999875 6789999999765332 34678999999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---- 276 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---- 276 (486)
++++.+.+.++||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 81 HDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSC
T ss_pred EEEEEeCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCcc
Confidence 99999999999999999999999999554 57999999999999999999999988 99999999999998776
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
.+||+|||+++....... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||....... .....
T Consensus 157 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~~i 230 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANI 230 (361)
T ss_dssp CEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH
T ss_pred CEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence 799999999987654322 234679999999999999999999999999999999999999997643211 11110
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
...... +++..... .+..+.+||.+||..||.+||++.|++++-+
T Consensus 231 ---~~~~~~----~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 231 ---TAVSYD----FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp ---HTTCCC----CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred ---HhcCCC----CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 000000 01111111 2356889999999999999999999998643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=380.12 Aligned_cols=257 Identities=26% Similarity=0.352 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++++.||+|+||.||+|.+.. +++.||||++...... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEECC---------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4689999999999999999998875 6779999999754332 23558899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..|||||||++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecc
Confidence 9999999999999999998854 346999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+..............+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+....
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~------ 225 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK------ 225 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTC------
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhccc------
Confidence 86543333333345689999999999987775 7789999999999999999999976543211 111111100
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
....+ . ...+..+.+||.+||+.||.+||++.|++++.+
T Consensus 226 --~~~~~--~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 226 --TYLNP--W----KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp --TTSTT--G----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred --ccCCc--c----ccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 00000 0 112356889999999999999999999987644
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=367.37 Aligned_cols=282 Identities=37% Similarity=0.621 Sum_probs=225.6
Q ss_pred ccccChhHHHHHhcCCCCC------CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC----cccHHHHHHH
Q 011412 116 LRKFTFNDLKLATRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAE 185 (486)
Q Consensus 116 ~~~~~~~~~~~~~~~y~~~------~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~E 185 (486)
...|.+.++...+.+|... +.||+|+||.||+|.+ ++..||||++.... ....+.+.+|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~E 80 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQE 80 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHHH
Confidence 4567888888888888766 8999999999999976 35689999987532 2234678899
Q ss_pred HHHHhcCCCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 011412 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 263 (486)
Q Consensus 186 ~~~l~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHr 263 (486)
+.+++.++||||+++++++...+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||
T Consensus 81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~ 157 (307)
T 2nru_A 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHR 157 (307)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecC
Confidence 99999999999999999999999999999999999999998643 456999999999999999999999988 9999
Q ss_pred CCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011412 264 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 343 (486)
Q Consensus 264 DLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~ 343 (486)
||||+|||++.++.+||+|||+++...............||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence 9999999999999999999999987654333333344679999999998764 589999999999999999999999986
Q ss_pred CCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 344 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
........ .+..........+...+++.+ .......+..+.+|+.+||+.||.+||++.+|+++|+.+.
T Consensus 237 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 237 HREPQLLL--DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TBSSSBTT--HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred CcchHHHH--HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 54332111 111111111112223333332 2345667788999999999999999999999999997653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=377.53 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=201.6
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
...+|++.+.||+|+||+||+|.+ +|..||||++...... ..+.+.+|+++|++++||||+++++++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-----------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 456899999999999999999976 3668999999765432 235688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
...+..++|||||++|+|.+++..... .+++..++.++.||+.||+|||+.+ .+|+||||||+||||+.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECC
Confidence 999999999999999999999965432 3899999999999999999999865 4499999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... .
T Consensus 183 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~-~-- 254 (309)
T 3p86_A 183 FGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVGF-K-- 254 (309)
T ss_dssp CC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHHH-S--
T ss_pred CCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh-c--
Confidence 999986433221 1334679999999999999999999999999999999999999997543211 1111000 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
..... ++...+..+.+||.+||+.||.+||++.++++.|+.+.
T Consensus 255 ------~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 255 ------CKRLE----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp ------CCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00011 11223467899999999999999999999999997654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=375.77 Aligned_cols=255 Identities=19% Similarity=0.256 Sum_probs=210.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++.+.||+|+||.||+|.+.. +|..||+|.+.... .....+.+|+.+|+.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECC---------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 4689999999999999999998865 67899999997543 2345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--CCcEEEeecCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--DYNAKLSDFGL 285 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~--~~~vkl~DFGl 285 (486)
+..++|||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 9999999999999999999776668999999999999999999999988 999999999999987 78999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...... ......
T Consensus 151 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i---~~~~~~ 221 (321)
T 1tki_A 151 ARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENI---MNAEYT 221 (321)
T ss_dssp CEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH---HHTCCC
T ss_pred CeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHH---HcCCCC
Confidence 987654332 34467999999999999888999999999999999999999999754321 111110 000000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
+ +..... ..+..+.+|+.+||..||.+||++.|++++-.
T Consensus 222 ~----~~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 222 F----DEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp C----CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred C----Chhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 0 000011 12357889999999999999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=373.33 Aligned_cols=264 Identities=25% Similarity=0.351 Sum_probs=208.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
..++|++++.||+|+||.||+|.+.. ++..||||++....... .+.+.+|+.++..++||||++++++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~ 79 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTI---------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV 79 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETT---------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECC---------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence 34689999999999999999998865 67799999986543322 3568899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+...+..|+||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 80 DEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred eeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999999999655 47999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
|+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus 156 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~ 228 (294)
T 4eqm_A 156 GIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDS 228 (294)
T ss_dssp SSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSC
T ss_pred CCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhcc
Confidence 999876443221 2334679999999999999999999999999999999999999997543211 000011100
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCCCCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPNL 417 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~eil~~L~~~~~~ 417 (486)
. +.....+....+..+.+++.+||+.||.+|| ++.++++.|..+...
T Consensus 229 ~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 229 V-------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp C-------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred C-------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0 0000011112346789999999999999999 899999999876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=388.96 Aligned_cols=273 Identities=28% Similarity=0.397 Sum_probs=217.1
Q ss_pred cChhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcC-CCCC
Q 011412 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLN 196 (486)
Q Consensus 119 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~n 196 (486)
+....+....++|++.+.||+|+||.||+|.+.... ...+++.||||+++..... ..+.+.+|+++|..+ +|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEecccc----ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcc
Confidence 344555566789999999999999999999865421 1236789999999865432 235689999999999 7999
Q ss_pred ceEEEEEEEeCCe-eEEEEeecCCCChhHHHhhcCC--------------------------------------------
Q 011412 197 LVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSL-------------------------------------------- 231 (486)
Q Consensus 197 Iv~~~~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------- 231 (486)
||++++++...+. .++|||||++|+|.+++.....
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9999999987554 8999999999999999975432
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 232 ---------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 232 ---------------------~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
.+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 1889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (486)
............||+.|+|||++.+..++.++|||||||++|||++ |..||........ +..... ..
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~----~~------ 312 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLK----EG------ 312 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHH----HT------
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHH----cC------
Confidence 5444334455678999999999999999999999999999999998 9999976543211 111110 00
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
....... ..+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 313 ~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 313 TRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 0011111 1235789999999999999999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=383.09 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=201.9
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCceEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 202 (486)
..++|++++.||+|+||.||+|++.. +|+.||||+++... ......+.+|+.+|..+ +||||+++++
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 91 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC 91 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcC---------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence 34689999999999999999999875 67799999997532 22345678899999988 7999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
++.+.+.+|||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 92 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 92 CFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcc
Confidence 999999999999999999999999655 46999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .+.. .....
T Consensus 168 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~ 239 (353)
T 3txo_A 168 FGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFE---AILND 239 (353)
T ss_dssp CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHC
T ss_pred ccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHH---HHHcC
Confidence 999986433222 234578999999999999999999999999999999999999999764321 1111 11111
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 410 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~------~eil~~ 410 (486)
... ++...+..+.+||.+||+.||.+||++ .+++++
T Consensus 240 ~~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 240 EVV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 111 111124578899999999999999998 777764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=370.67 Aligned_cols=272 Identities=23% Similarity=0.272 Sum_probs=213.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++.+.||+|+||+||+|.+.. +|+.||||++.... ....+.+.+|+++|+.++||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 3579999999999999999999875 67799999997543 2345678899999999999999999999987
Q ss_pred CC--eeEEEEeecCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCcE
Q 011412 207 DD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNA 278 (486)
Q Consensus 207 ~~--~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll----~~~~~v 278 (486)
.+ ..+||||||++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceE
Confidence 65 7899999999999999997543 34899999999999999999999988 9999999999999 788889
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~ 350 (486)
||+|||+++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.........
T Consensus 156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 232 (319)
T 4euu_A 156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (319)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence 9999999987654332 23457999999999886 578899999999999999999999999754332211
Q ss_pred -hhHHhhhhhcc-cc-ccc-------ccc-cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 351 -NLVEWARPHLG-ER-RRF-------YRL-IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 351 -~~~~~~~~~~~-~~-~~~-------~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
........... .. ..+ ... -.-.....+....+..+.+|+.+||+.||.+||++.|++++....
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11111110000 00 000 000 011122345677888999999999999999999999999988643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=384.57 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcC-CCCCceEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVKLIGY 203 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~~~~~ 203 (486)
.++|+++++||+|+||.||+|++.. +++.||||+++...... ...+.+|..+|.++ +|||||+++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 4579999999999999999999876 67899999997643222 23578899999887 89999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
|.+.+.+|||||||++|+|..++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeec
Confidence 99999999999999999999998654 46999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc--chhHHhh-hhhc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWA-RPHL 360 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~--~~~~~~~-~~~~ 360 (486)
|+++....... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||........ ....... ....
T Consensus 198 Gla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~ 275 (396)
T 4dc2_A 198 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275 (396)
T ss_dssp TTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred ceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence 99986332222 23457899999999999999999999999999999999999999964322111 0001111 1011
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 410 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~------~eil~~ 410 (486)
... .. ++...+..+.+||.+||+.||.+||++ .||+++
T Consensus 276 ~~~--------~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 276 EKQ--------IR----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HCC--------CC----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ccc--------cC----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 111 11 112234678999999999999999985 566654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=392.17 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=211.4
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
.+..++|.+.+.||+|+||.||+|.+.. ++..||||+++..... ....+.+|+++|+.++|||||+++++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445689999999999999999999865 5679999999754322 22457899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+...+..+||||||++|+|.+++...+..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCG
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcC
Confidence 99999999999999999999999876667999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
|+++...............+++.|+|||++.+..++.++|||||||+||||++ |..||....... ...... .
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~~~----~ 330 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFVE----K 330 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHHHH----T
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----c
Confidence 99986543221111122346788999999998999999999999999999998 999997543211 111110 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.. . . ..+..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 331 ~~---~---~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 331 GG---R---L----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp TC---C---C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---C---C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 00 0 0 01112346788999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=373.58 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=207.5
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCee
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 210 (486)
|...+.||+|+||.||+|.+.. +|+.||||++........+.+.+|+.+|+.++||||+++++++...+..
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhccEEeccCCCeEEEEEEECC---------CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 6666799999999999998865 5779999999877666677899999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011412 211 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290 (486)
Q Consensus 211 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~ 290 (486)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 118 ~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192 (321)
T ss_dssp EEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecc
Confidence 999999999999998854 36899999999999999999999988 9999999999999999999999999998754
Q ss_pred CCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ ..
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~~~~----------~~ 257 (321)
T 2c30_A 193 KDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRD----------SP 257 (321)
T ss_dssp SSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH----------SS
T ss_pred cCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc----------CC
Confidence 4322 123467999999999999999999999999999999999999999754321 11111100 00
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.+.+. .....+..+.+|+.+||+.||.+||++.+++++..
T Consensus 258 ~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 258 PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 11110 01122457889999999999999999999998643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=385.32 Aligned_cols=256 Identities=20% Similarity=0.273 Sum_probs=211.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++++.||+|+||.||+|.+.. +|+.||+|++..........+.+|+.+|+.++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEECC---------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 3579999999999999999998865 6779999999876544456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--CCcEEEeecCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--DYNAKLSDFGL 285 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~--~~~vkl~DFGl 285 (486)
...+||||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999999999999999776668999999999999999999999988 999999999999974 57899999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++....... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ....... ....
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~---~~~~- 267 (387)
T 1kob_A 198 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVK---RCDW- 267 (387)
T ss_dssp CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH---HCCC-
T ss_pred ceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHH---hCCC-
Confidence 987654322 23457999999999999999999999999999999999999999754321 1111100 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
..++.... ..+..+.+||.+||+.||.+||++.+++++-.
T Consensus 268 ---~~~~~~~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 268 ---EFDEDAFS----SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp ---CCCSSTTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred ---CCCccccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 01111111 22467899999999999999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=384.08 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=206.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++++.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.+|..++|||||+++++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND---------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3579999999999999999998875 67799999986432 23346788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+.+.+|+|||||.+|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccc
Confidence 999999999999999999999865 457999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
+++....... ....+||+.|+|||++.. ..|+.++|||||||+||||++|+.||..........+.......
T Consensus 161 ~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-- 235 (384)
T 4fr4_A 161 IAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-- 235 (384)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--
T ss_pred eeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--
Confidence 9987644322 345789999999999863 46899999999999999999999999765443322222211110
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVE 409 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~eil~ 409 (486)
.. .++...+..+.+||.+||+.||.+||+ +.++++
T Consensus 236 ---------~~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ---------VV----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---------CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---------cc----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 111123467899999999999999998 777765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=373.46 Aligned_cols=267 Identities=24% Similarity=0.320 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||+||+|.+. +|+.||||++...... ....+.+|+++|+.++||||+++++++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 468999999999999999999874 3678999999754322 2356889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+++..+||||||+ ++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 90 SERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcC
Confidence 9999999999997 4898888777777999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh------
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP------ 358 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~------ 358 (486)
++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus 166 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 166 ARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243 (311)
T ss_dssp CEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred ceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence 987543222 2334578999999999876 5689999999999999999999999976554332211110000
Q ss_pred --hccccc----ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 359 --HLGERR----RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 359 --~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...+.. ..................+..+.+||.+||+.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 0000000000000001123578899999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=373.68 Aligned_cols=275 Identities=24% Similarity=0.357 Sum_probs=208.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++++.||+|+||.||+|++.. ....+|..||||++........+.+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4689999999999999999998643 12237889999999876655556789999999999999999999998653
Q ss_pred --CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 208 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
..+++|||||++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcc
Confidence 5689999999999999999877667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc--
Q 011412 286 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-- 362 (486)
Q Consensus 286 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-- 362 (486)
++........ .......|+..|+|||++.+..++.++|||||||++|||++|..||...... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQM 236 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccch
Confidence 9876443221 1223356788899999999999999999999999999999999998642110 00000000000
Q ss_pred -ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 363 -RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 363 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.......+........+..++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000000000001111223346789999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=367.71 Aligned_cols=266 Identities=24% Similarity=0.292 Sum_probs=204.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++++.||+|+||+||+|.+.. +|+.||||++...... ....+.+|+.+|++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 478999999999999999999876 6779999999755432 23668899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..+||||||++ +|.+++......+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 9999999999965 777777666678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc----
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---- 361 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---- 361 (486)
+....... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||....... ...........
T Consensus 149 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTE 224 (292)
T ss_dssp EECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCT
T ss_pred eecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCCh
Confidence 86543222 233457899999999987765 8999999999999999999988864332211 11111000000
Q ss_pred -ccccccccc---------CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 362 -ERRRFYRLI---------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 362 -~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
......... ............+..+.+||.+||+.||.+|||+.|++++-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 000000000 00000111122346788999999999999999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=376.80 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=207.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCCceEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 201 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~ 201 (486)
.++|.+.+.||+|+||.||+|.+.. +|..||||++...... ....+.+|+.+|+.++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECC---------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3568999999999999999999865 6779999999754322 356789999999999999999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----c
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 277 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~----~ 277 (486)
+++...+..++|||||++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCC
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCC
Confidence 9999999999999999999999999544 57999999999999999999999988 99999999999998877 7
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......
T Consensus 157 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~ 230 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS 230 (326)
T ss_dssp EEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH
T ss_pred EEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHH
Confidence 99999999987643322 234579999999999999999999999999999999999999997543211 111000
Q ss_pred hhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.....+ ...... ..+..+.+||.+||+.||.+||++.+++++-.
T Consensus 231 ---~~~~~~----~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 231 ---AVNYEF----EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp ---HTCCCC----CHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred ---hcCCCc----Cccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000000 000001 12356889999999999999999999998654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=377.83 Aligned_cols=262 Identities=23% Similarity=0.381 Sum_probs=205.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|++++.||+|+||.||+|.+...+.. ....||+|.+.... ....+++.+|+.+|++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCce-----EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 35799999999999999999998764321 12357999886443 2345679999999999999999999999987
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.. .++||||+.+|+|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcce
Confidence 54 78999999999999999887778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+. . ..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~----~~- 236 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K----GE- 236 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---T----TC-
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH---c----CC-
Confidence 86544333333334567899999999999999999999999999999999 999997654322111111 0 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
....+...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 237 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00111123457889999999999999999999999987553
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=385.15 Aligned_cols=262 Identities=25% Similarity=0.426 Sum_probs=200.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|.+.+.||+|+||.||+|++.... .++..||||+++.... ...+.+.+|+.+|++++||||+++++++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPS------KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTT------SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCC------CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 458999999999999999999876322 2567899999976532 234568999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..+||||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccc
Confidence 99999999999999999999877778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcce-eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 287 KDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 287 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+......... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .+..... ...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i~----~~~ 267 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAVD----EGY 267 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHHH----TTE
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCC
Confidence 8764432211 1122346788999999999999999999999999999998 99999654321 1111111 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
. ...+..++..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 268 ~----------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 268 R----------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp E----------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 0 0011123467899999999999999999999999997653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=380.35 Aligned_cols=251 Identities=28% Similarity=0.402 Sum_probs=205.6
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCceEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLI 201 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~ 201 (486)
...++|.+.+.||+|+||.||+|+++. +|+.||||+++... ......+..|..+|..+ +||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 445789999999999999999999875 67899999997542 22345678899999877 899999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
+++.+.+.+|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEe
Confidence 9999999999999999999999999654 46899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+.... ..
T Consensus 161 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i---~~ 232 (345)
T 1xjd_A 161 DFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSI---RM 232 (345)
T ss_dssp CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HH
T ss_pred EChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH---Hh
Confidence 9999986433222 234578999999999999999999999999999999999999999754321 111111 11
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 409 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~ 409 (486)
. .+.+.. ..+..+.+||.+||..||.+||++. +|++
T Consensus 233 ~--------~~~~p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 233 D--------NPFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp C--------CCCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C--------CCCCCc----ccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1 111111 2246789999999999999999997 6654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=371.23 Aligned_cols=248 Identities=26% Similarity=0.360 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++++.||+|+||.||+|++.. +|+.||||+++... ......+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 75 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence 3579999999999999999999865 67799999997532 23346678999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+.+.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 76 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 76 QDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecC
Confidence 9999999999999999999999654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+++..... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .. ....+....
T Consensus 152 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~---~~~i~~~~~ 220 (318)
T 1fot_A 152 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KT---YEKILNAEL 220 (318)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHHHHHCCC
T ss_pred cceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhCCC
Confidence 99875432 23468999999999999999999999999999999999999999754321 11 111111110
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
.+.. ..+..+.+||.+||..||.+|| ++.+++++-
T Consensus 221 --------~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 221 --------RFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp --------CCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred --------CCCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 1111 2246789999999999999999 888888643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=378.78 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=205.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhcCCCCCceEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~ 202 (486)
.++|++.+.||+|+||.||+|.+.. +|+.||||++.... ....+.+.+|+.+|+.++||||+++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE---------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 4579999999999999999998875 67799999986321 123567899999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-- 277 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-- 277 (486)
++.+++.+|||||||++++|.+++... +..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCC
Confidence 999999999999999999999887643 345899999999999999999999988 999999999999976654
Q ss_pred -EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 278 -AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 -vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..... .+....
T Consensus 171 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i 244 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGI 244 (351)
T ss_dssp CEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHH
T ss_pred cEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHH
Confidence 99999999987654322 23346799999999999999999999999999999999999999975321 111110
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
...... ..+..... .+..+.+||.+||+.||.+||++.+++++-
T Consensus 245 ---~~~~~~----~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 245 ---IKGKYK----MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp ---HHTCCC----CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---HcCCCC----CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 000000 01100111 235789999999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=384.46 Aligned_cols=267 Identities=26% Similarity=0.375 Sum_probs=215.5
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|.+.+.||+|+||.||+|.+...+. .....+..||||++...... ....+.+|+++++.+ +|||||++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 44689999999999999999998754221 12234568999999765432 235688999999999 999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 269 (486)
...+..+||||||++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 99999999999999999999997653 35899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 011412 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 348 (486)
Q Consensus 270 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~ 348 (486)
|||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~- 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999987654433333344568899999999999999999999999999999999 99999754321
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.+...... . ....... ..+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 301 --~~~~~~~~----~------~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 301 --ELFKLLKE----G------HRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp --HHHHHHHT----T------CCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHc----C------CCCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111110 0 0111111 22467899999999999999999999999998664
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=394.53 Aligned_cols=265 Identities=20% Similarity=0.241 Sum_probs=212.0
Q ss_pred hhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCc
Q 011412 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNL 197 (486)
Q Consensus 121 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nI 197 (486)
+.++....++|+++++||+|+||+||+|++.. +++.||||++..... .....+.+|+.+|..++||||
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~I 136 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTB
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcC---------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCE
Confidence 44455667899999999999999999999875 677999999974221 111237889999999999999
Q ss_pred eEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
++++++|.+.+.+|||||||++|+|.+++.+....+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.
T Consensus 137 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCC
Confidence 99999999999999999999999999999776678999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~ 352 (486)
+||+|||+++....... ......+||+.|||||++. ...|+.++|||||||+||||++|+.||........
T Consensus 214 vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--- 289 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--- 289 (437)
T ss_dssp EEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---
T ss_pred EEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---
Confidence 99999999986544322 2234468999999999987 56789999999999999999999999976432111
Q ss_pred HHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 011412 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 411 (486)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~eil~~L 411 (486)
... .+.... ...-|..... .+..+.+||.+||..+|++ ||++.|++++-
T Consensus 290 ~~~---i~~~~~---~~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 290 YGK---IMNHKE---RFQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHH---HHTHHH---HCCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred HHh---hhhccc---cccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 110 010000 0001111111 2467899999999888888 99999999854
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=364.49 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=212.5
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..++|++.+.||+|+||.||+|.+. ++..||||++..... ...++.+|+.++..++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3468999999999999999999775 355799999986543 34678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
....++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccc
Confidence 99999999999999999999877667999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+........ ......||+.|+|||++.+..++.++||||||+++|||++ |..||....... ..... ...
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~-- 221 (268)
T 3sxs_A 152 RYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VVLKV----SQG-- 221 (268)
T ss_dssp EECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHH----HTT--
T ss_pred eecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HHHHH----HcC--
Confidence 876543322 2233456788999999998899999999999999999999 999996543211 11000 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
..... .. ..+..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 222 -~~~~~---~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 222 -HRLYR---PH----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -CCCCC---CT----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -CCCCC---CC----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 00111 11 123578899999999999999999999999988765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=389.29 Aligned_cols=256 Identities=21% Similarity=0.273 Sum_probs=207.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+.. +|..||+|++...... ....+.+|+.+|+.++|||||++++++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~---------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVL---------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETT---------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 45689999999999999999998865 6789999999765432 235688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCcEEEe
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLS 281 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~---~~~~vkl~ 281 (486)
.+++..|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence 9999999999999999999998665 46999999999999999999999988 99999999999998 46789999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...... .+..... .
T Consensus 156 DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~i~---~ 227 (444)
T 3soa_A 156 DFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQIK---A 227 (444)
T ss_dssp CCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH---H
T ss_pred cCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHHHH---h
Confidence 9999987654322 223468999999999999999999999999999999999999999654321 1111110 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.... . ...... ..+..+.+||.+||+.||.+||++.|++++-
T Consensus 228 ~~~~---~-~~~~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 228 GAYD---F-PSPEWD----TVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp TCCC---C-CTTTTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred CCCC---C-Cccccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 0000 0 000111 2246789999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=366.96 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=210.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++.+.||+|+||.||+|.+.. +..||||++..... ..+++.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhhceeeheecCCCccEEEEEEecC----------CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4678999999999999999998753 55799999986543 346799999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccc
Confidence 9999999999999999999877778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||....... ...... .
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~~~----~---- 222 (269)
T 4hcu_A 155 FVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIS----T---- 222 (269)
T ss_dssp GBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH----T----
T ss_pred ccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHh----c----
Confidence 6543221 11223457889999999999999999999999999999999 999997543211 111110 0
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
........ ..+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 223 --~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 223 --GFRLYKPR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp --TCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CccCCCCC----cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 00111111 1246789999999999999999999999999754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=380.71 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=207.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+.. +|..||||++...... ....+.+|+.+|+.++|||||++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45679999999999999999998865 6779999999765432 235688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CcEEEe
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLS 281 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~---~~vkl~ 281 (486)
.+.+..|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEe
Confidence 9999999999999999999998654 46899999999999999999999988 9999999999999765 459999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||+++....... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...... .+..... .
T Consensus 174 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~---~ 244 (362)
T 2bdw_A 174 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIK---A 244 (362)
T ss_dssp CCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---H
T ss_pred ecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH---h
Confidence 9999987654322 23467999999999999999999999999999999999999999754321 1111110 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
....+ ...... ..+..+.+||.+||+.||.+||++.+++++-
T Consensus 245 ~~~~~----~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 245 GAYDY----PSPEWD----TVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp TCCCC----CTTGGG----GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred CCCCC----Cccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 00000 000011 1235789999999999999999999998763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=372.80 Aligned_cols=261 Identities=19% Similarity=0.181 Sum_probs=210.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 206 (486)
..+|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+|+.+++.| +||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY---------TNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT---------TTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECC---------CCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 4689999999999999999998765 6789999999755332 3578999999999 99999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc-----EEEe
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-----AKLS 281 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-----vkl~ 281 (486)
.+..+|||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEE
Confidence 99999999999 99999999876678999999999999999999999988 999999999999998887 9999
Q ss_pred ecCCCCCCCCCCcce-----eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 282 DFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 282 DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
|||+++......... ......||+.|+|||++.+..++.++|||||||+||||++|..||...............
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence 999998654332211 123568999999999999999999999999999999999999999876443322222111
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.... ... ....+.. ..+ .+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 233 ~~~~---~~~---~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 233 GDTK---RAT---PIEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHH---HHS---CHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred Hhhh---ccC---CHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 1000 000 0000000 113 789999999999999999999999988754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=367.52 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=199.6
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..++|++.+.||+|+||.||+|.+...+. .+..||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 44689999999999999999999865322 4668999998764332 2456889999999999999999999974
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
++..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccc
Confidence 56789999999999999999877778999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ...... ...
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i~----~~~ 234 (281)
T 1mp8_A 163 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIE----NGE 234 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TTC
T ss_pred ccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHHH----cCC
Confidence 9876443221 1233467889999999999999999999999999999997 999997643321 111110 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
... ++...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 235 ------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 235 ------RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001 1112346788999999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=364.24 Aligned_cols=256 Identities=29% Similarity=0.544 Sum_probs=206.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-------HHHHHHHHHHHhcCCCCCceEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGDLVHLNLVKL 200 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~~ 200 (486)
.++|++.+.||+|+||.||+|.+.. +++.||||++....... .+.+.+|+.+++.++||||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVK---------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETT---------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred hccceehhccccCCceeEEEEEEcC---------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 3679999999999999999999865 57799999997543321 1568899999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc---
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--- 277 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--- 277 (486)
++++.+.. ++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCS
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCc
Confidence 99986554 7999999999999999877778999999999999999999999865 45999999999999988776
Q ss_pred --EEEeecCCCCCCCCCCcceeeeeccccccccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011412 278 --AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 278 --vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~ 353 (486)
+||+|||+++..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||............
T Consensus 166 ~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 240 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240 (287)
T ss_dssp CCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred eeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence 999999999864331 33467999999999983 556789999999999999999999999765432211111
Q ss_pred HhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.... ....+.+ +...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 241 ~~~~----------~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 MIRE----------EGLRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHH----------SCCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHhc----------cCCCCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1000 0111111 222346789999999999999999999999999754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=373.55 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=204.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcC-CCCCceEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~~~~~ 203 (486)
.++|++++.||+|+||.||+|++.. +|+.||||++...... ....+.+|+.+|..+ +|||||+++++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence 3579999999999999999999875 6789999999865332 234578899999988 89999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+.+.+.+|||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 79 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 79 FQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCG
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999998654 46999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc--hhHHhhhhhcc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARPHLG 361 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~ 361 (486)
|+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... .........+.
T Consensus 155 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~ 232 (345)
T 3a8x_A 155 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232 (345)
T ss_dssp GGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred cccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence 99986432221 234568999999999999999999999999999999999999999653221100 00000000000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 410 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~------~eil~~ 410 (486)
.. ... ++...+..+.+||.+||+.||.+||++ .+++++
T Consensus 233 ~~-------~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 233 EK-------QIR----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HC-------CCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred cC-------CCC----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 00 011 112234678999999999999999996 566543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=388.13 Aligned_cols=264 Identities=26% Similarity=0.384 Sum_probs=208.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++++.||+|+||.||+|.+.... ...++..||||++..... .....+.+|+.+|..++|||||++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCC----CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 357889999999999999999975421 123678999999975432 233568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---c
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---N 277 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---~ 277 (486)
....+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence 999999999999999999997543 45899999999999999999999988 99999999999998555 5
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+++...............||+.|+|||++.+..++.++|||||||+||||++ |..||...... .+....
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~i 299 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV 299 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 99999999974322111112334568999999999999999999999999999999998 99999754321 111111
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.. .. ... .+...+..+.+|+.+||+.||.+||++.+|+++|+.+.
T Consensus 300 ~~----~~------~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 300 TS----GG------RMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HT----TC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hc----CC------CCC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 10 00 001 11122456889999999999999999999999997553
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=378.78 Aligned_cols=268 Identities=25% Similarity=0.376 Sum_probs=213.4
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 203 (486)
...++|.+.+.||+|+||.||+|.+.... ..+++..||||++..... .....+.+|+.+|.++ .||||++++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccc----cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34578999999999999999999974321 123577899999975432 2335788999999999 89999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSL----------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 261 (486)
+...+..+|||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 194 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV 194 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 9999999999999999999999976532 3789999999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 011412 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 340 (486)
Q Consensus 262 HrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~p 340 (486)
||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+||||+| |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987654433333444668899999999999999999999999999999998 9999
Q ss_pred CCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 341 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
|....... .+....... ..+ ..+...+..+.+|+.+||+.||.+||++.+|+++|+.+..
T Consensus 275 ~~~~~~~~--~~~~~~~~~----------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 275 YPGIPVDA--NFYKLIQNG----------FKM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp STTCCCSH--HHHHHHHTT----------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cccCCcHH--HHHHHHhcC----------CCC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 97654321 111111100 011 1111224678999999999999999999999999986543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=379.17 Aligned_cols=263 Identities=26% Similarity=0.429 Sum_probs=208.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++++.||+|+||.||+|.+...+.. ....||+|.+.... ......+.+|+.++..++||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGES-----IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCS-----CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCce-----EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 35799999999999999999998764331 22358889886443 222345778999999999999999999886
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..++||||+.+|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcc
Confidence 56789999999999999999776667999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+...............||..|+|||++.+..++.++|||||||++|||++ |..||...........+... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~-- 235 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-----ER-- 235 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-----CB--
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----CC--
Confidence 87655444434455678899999999999999999999999999999999 99999865433221111110 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
...+ ...+..+.+|+.+||+.||.+||++.+++++|+.+..
T Consensus 236 ---~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 ---LAQP-------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---CCCC-------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCCC-------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0000 0112356799999999999999999999999976643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=365.48 Aligned_cols=264 Identities=17% Similarity=0.161 Sum_probs=212.9
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
..++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+|+.++..+ +|+||+++++++.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 34689999999999999999998765 678999999875432 24578899999999 7999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc-----EEE
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-----AKL 280 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-----vkl 280 (486)
.....++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +||
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEE
Confidence 999999999999 99999999877777999999999999999999999988 999999999999987776 999
Q ss_pred eecCCCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011412 281 SDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 281 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~ 355 (486)
+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence 999999865443221 113346799999999999999999999999999999999999999987544332222211
Q ss_pred hhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
....... .... .+.. ..+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 233 ~~~~~~~-~~~~-----~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 233 IGEKKQS-TPLR-----ELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHHHHHH-SCHH-----HHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHhhccC-ccHH-----HHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 1110000 0000 0011 12367899999999999999999999999998654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=389.43 Aligned_cols=264 Identities=20% Similarity=0.246 Sum_probs=209.4
Q ss_pred hhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCc
Q 011412 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNL 197 (486)
Q Consensus 121 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nI 197 (486)
+.+.....++|++++.||+|+||.||+|+++. +|+.||||+++.... .....+.+|+.+|..++||||
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~---------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~I 123 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTB
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCe
Confidence 34445567899999999999999999999875 678999999975321 112347889999999999999
Q ss_pred eEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
+++++++.+.+.+|||||||++|+|.+++.+.+..+++..+..++.||+.||.|||+++ ||||||||+||||+.+++
T Consensus 124 v~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred eeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCC
Confidence 99999999999999999999999999999876668999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~ 350 (486)
+||+|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||.........
T Consensus 201 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 279 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279 (412)
T ss_dssp EEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred EEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999987644322 1223468999999999987 357899999999999999999999999764321110
Q ss_pred hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHh
Q 011412 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR---PLMSEVVEAL 411 (486)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Ps~~eil~~L 411 (486)
..+ ..... ....+..... .+..+.+||.+||. +|.+| |++.|++++-
T Consensus 280 ~~i------~~~~~---~~~~p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 280 GKI------VHYKE---HLSLPLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHH------HTHHH---HCCCC----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred HHH------Hhccc---CcCCCccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 000 00000 0001111112 24678999999999 99998 5899998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=378.73 Aligned_cols=267 Identities=25% Similarity=0.383 Sum_probs=213.6
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
...++|++++.||+|+||.||+|.+..... ..++..||||+++..... ....+.+|+.+|+.++||||+++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLP----YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSST----TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCC----CCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345789999999999999999999864211 125678999999865432 245688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 261 (486)
...+..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 99999999999999999999997642 56899999999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 011412 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 340 (486)
Q Consensus 262 HrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~p 340 (486)
||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999976433222222334568999999999999999999999999999999999 9999
Q ss_pred CCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 341 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
|...... .+..... .. .. +. ++...+..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 277 ~~~~~~~---~~~~~~~----~~-~~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 277 YYGMAHE---EVIYYVR----DG-NI-----LA----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTSCHH---HHHHHHH----TT-CC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCChH---HHHHHHh----CC-Cc-----CC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 9754321 1111110 00 00 01 111234678999999999999999999999999987654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=377.03 Aligned_cols=248 Identities=25% Similarity=0.307 Sum_probs=206.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++++.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+++|..++||||+++++++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3689999999999999999999875 67799999996532 23346788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+.+.+|||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccc
Confidence 9999999999999999999999755 46999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+++..... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+.. ......
T Consensus 187 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~~~- 254 (350)
T 1rdq_E 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYE---KIVSGK- 254 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCC-
T ss_pred cceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHHH---HHHcCC-
Confidence 99875432 23467999999999999999999999999999999999999999754321 1111 111110
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 411 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~L 411 (486)
..+... .+..+.+||.+||+.||.+||+ +.+|+++-
T Consensus 255 -------~~~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 255 -------VRFPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp -------CCCCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred -------CCCCCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 011112 2467899999999999999998 78877643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=374.49 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=205.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCceEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 202 (486)
...+|++++.||+|+||.||+|.+.. +|+.||||+++... ......+..|..+|..+ +||||+++++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETT---------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 34689999999999999999999865 67799999997542 23346688999999988 7999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
++.+.+.+|||||||+||+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEe
Confidence 999999999999999999999999654 36999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .+.. .....
T Consensus 165 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~ 236 (353)
T 2i0e_A 165 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIMEH 236 (353)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHC
T ss_pred CCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHH---HHHhC
Confidence 999986432221 234578999999999999999999999999999999999999999754321 1111 11111
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 410 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~ 410 (486)
.. . ++...+..+.+||.+||..||.+||+ +.+|+++
T Consensus 237 ~~--------~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 NV--------A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CC--------C----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CC--------C----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 10 1 11123467899999999999999995 4677654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=373.24 Aligned_cols=265 Identities=27% Similarity=0.390 Sum_probs=214.1
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
...++|.+.+.||+|+||.||+|.+.... ...++..||||++..... ...+.+.+|+++|+.++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLK----GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGG----GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccC----cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 34578999999999999999999875321 122567899999976532 2345688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 261 (486)
...+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 99999999999999999999997543 23889999999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 011412 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 340 (486)
Q Consensus 262 HrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~p 340 (486)
||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654433333334567899999999999999999999999999999999 9999
Q ss_pred CCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 341 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
|......... ..... . ..+. .+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 253 ~~~~~~~~~~---~~~~~----~------~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 253 YPGIPPERLF---NLLKT----G------HRME----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp STTCCGGGHH---HHHHT----T------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHH---HHhhc----C------CcCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9765432211 11100 0 0011 1112346789999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=371.08 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=191.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|++++.||+|+||.||+|.+.. +|+.||||+++.... .....+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEECSS---------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 3579999999999999999998765 677999999975432 233678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRS-----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
++..+||||||+ |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEEC
Confidence 999999999997 59999886432 45899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh---
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--- 357 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~--- 357 (486)
|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 228 (317)
T 2pmi_A 151 DFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228 (317)
T ss_dssp CCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999987543221 1234578999999999876 468999999999999999999999997653321111110000
Q ss_pred -----hhcccccc------------cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 -----PHLGERRR------------FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 -----~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+....... +.+.+.+..... .+..+.+||.+||+.||.+||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ChhHhhhhhhhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000000 000001111111 23578999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=367.31 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=197.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------------------------cHHH
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------GHKE 181 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------------------------~~~~ 181 (486)
.++|++.+.||+|+||.||+|++.. +|+.||||++...... ..+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---------TTEEEEEEEEECC-------------------------------CH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 3579999999999999999998865 6779999999754321 1245
Q ss_pred HHHHHHHHhcCCCCCceEEEEEEEe--CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 011412 182 WLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 259 (486)
Q Consensus 182 ~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~ 259 (486)
+.+|+++|+.++||||+++++++.+ .+..+|||||+++++|.+++. ...+++..++.++.||+.||.|||+.+
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 157 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK--- 157 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 8899999999999999999999987 568899999999999988653 346999999999999999999999988
Q ss_pred eEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCC---CCchhhHHHHHHHHHHHHh
Q 011412 260 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLT 336 (486)
Q Consensus 260 iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~ellt 336 (486)
|+||||||+||||+.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 99999999999999999999999999987644322 233467999999999987655 4788999999999999999
Q ss_pred CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 337 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 337 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
|+.||...... .+... ..... ........ .+..+.+||.+||+.||.+||++.|++++
T Consensus 236 g~~pf~~~~~~---~~~~~---~~~~~------~~~~~~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 236 GQCPFMDERIM---CLHSK---IKSQA------LEFPDQPD----IAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSCSSCCSSHH---HHHHH---HHHCC------CCCCSSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCCCCccHH---HHHHH---Hhccc------CCCCCccc----cCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99999754211 11110 00000 00000111 23578999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.52 Aligned_cols=265 Identities=26% Similarity=0.397 Sum_probs=215.0
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+... .+..++..||||++..... ...+.+.+|+.+|.++ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 446899999999999999999986431 1223678999999986543 2345688999999999 999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSL-----------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp 267 (486)
...+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCcc
Confidence 999999999999999999999976542 4899999999999999999999988 99999999
Q ss_pred CcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 011412 268 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRP 346 (486)
Q Consensus 268 ~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~ 346 (486)
+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999987765444333444568899999999999999999999999999999999 9999976533
Q ss_pred CCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
... ...... .. ....... ..+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 254 ~~~--~~~~~~----~~------~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 254 DSK--FYKMIK----EG------FRMLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp SHH--HHHHHH----HT------CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhH--HHHHhc----cC------CCCCCcc----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 211 111110 00 0111111 2246789999999999999999999999998743
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=374.93 Aligned_cols=249 Identities=24% Similarity=0.297 Sum_probs=204.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..+|.+.+.||+|+||.||+|.+.. +|..||||++.... ......+.+|+.+|+.++||||+++++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 78 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYK---------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3689999999999999999999865 67799999986432 12235688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
...+..+|||||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 79 TTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp ECSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSS
T ss_pred EeCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEec
Confidence 9999999999999 78999988655 46999999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+ .
T Consensus 154 ~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------~-- 221 (336)
T 3h4j_B 154 LSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------N-- 221 (336)
T ss_dssp CTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-------C--
T ss_pred cceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-------H--
Confidence 9987654332 234679999999999988776 78999999999999999999999754322110000 0
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.... .++...+..+.+||.+||+.||.+|||+.|++++-
T Consensus 222 -----~~~~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 222 -----SCVY----VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp -----SSCC----CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred -----cCCC----CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 0000 11112246788999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=366.38 Aligned_cols=267 Identities=23% Similarity=0.327 Sum_probs=201.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++++.||+|+||.||+|.+. +|+.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 47889999999999999999873 467899999975432 223568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..++||||+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccc
Confidence 9999999999975 999999776678999999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh-h-------
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R------- 357 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~-~------- 357 (486)
+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+... .
T Consensus 148 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (288)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhc
Confidence 76432211 1234578999999999875 46899999999999999999999999764321111000000 0
Q ss_pred hhccccccc---ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 358 PHLGERRRF---YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 358 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
+...+...+ .....+.....+....+..+.+||.+||+.||.+||++.|++++-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 000000000 000000000111112346788999999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=372.11 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=198.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..++|++++.||+|+||.||+|++.. +|+.||||++...... ..+.+.+|+++|++++|||||+++++|.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 74 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 74 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETT---------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEE
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcC---------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34679999999999999999999875 6779999999754433 3467899999999999999999999986
Q ss_pred eCC---------------------------------------------------------eeEEEEeecCCCChhHHHhh
Q 011412 206 EDD---------------------------------------------------------QRLLVYEFMPRGSLENHLFR 228 (486)
Q Consensus 206 ~~~---------------------------------------------------------~~~lv~E~~~~gsL~~~l~~ 228 (486)
+.. ..++|||||++++|.+++..
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 154 (332)
T 3qd2_B 75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154 (332)
T ss_dssp ECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT
T ss_pred EeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc
Confidence 643 37999999999999999975
Q ss_pred cC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcc----------e
Q 011412 229 RS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT----------H 296 (486)
Q Consensus 229 ~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~----------~ 296 (486)
.. ...++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++........ .
T Consensus 155 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~ 231 (332)
T 3qd2_B 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231 (332)
T ss_dssp CCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------
T ss_pred ccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccc
Confidence 43 23566778999999999999999988 999999999999999999999999999876543211 1
Q ss_pred eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCC
Q 011412 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 376 (486)
Q Consensus 297 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (486)
......||+.|+|||++.+..++.++|||||||++|||++|..|+... ...... .. ... ..
T Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~-~~------~~~----~~ 292 (332)
T 3qd2_B 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITD-VR------NLK----FP 292 (332)
T ss_dssp CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHH-HH------TTC----CC
T ss_pred cccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHH-hh------ccC----CC
Confidence 123457999999999999999999999999999999999987665210 000000 00 000 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 377 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 377 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.........+.+|+.+||+.||.+||++.|++++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 0112233567899999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=375.18 Aligned_cols=264 Identities=24% Similarity=0.396 Sum_probs=194.2
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
...++|++.+.||+|+||.||+|.+...+. ....||||+++... ....+.+.+|+.+++.++||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDG------SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCC------cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 445789999999999999999998865321 22379999997653 2334678999999999999999999999
Q ss_pred EEeCCee------EEEEeecCCCChhHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 204 CIEDDQR------LLVYEFMPRGSLENHLFRRS-----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 204 ~~~~~~~------~lv~E~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
+...... ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli 170 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCML 170 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEE
Confidence 9877655 99999999999999986432 25899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 351 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~ 351 (486)
+.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-- 248 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-- 248 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--
Confidence 9999999999999987654443333334567889999999999999999999999999999999 9999976433211
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
..... . .. ... .+...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 249 -~~~~~---~-~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 249 -YNYLI---G-GN------RLK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp -HHHHH---T-TC------CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHh---c-CC------CCC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11100 0 00 001 11122467899999999999999999999999987653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=373.63 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=196.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++++.||+|+||+||+|++.. +|+.||||++...... ...+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---------TKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---------TCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 3579999999999999999999875 6779999999765433 35688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--EEEeecCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--AKLSDFGL 285 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--vkl~DFGl 285 (486)
+..+||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 9999999999999999998654 36999999999999999999999988 999999999999987765 99999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........... ..........
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--~~~~~~~~~~ 239 (361)
T 3uc3_A 165 SKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK--TIQRILSVKY 239 (361)
T ss_dssp C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH--HHHHHHTTCC
T ss_pred cccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH--HHHHHhcCCC
Confidence 98543222 1234579999999999988888765 8999999999999999999976543222111 1110010000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.+ .. .. ..+..+.+||.+||+.||.+||++.|++++-
T Consensus 240 ~~----~~--~~----~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 240 SI----PD--DI----RISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp CC----CT--TS----CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CC----CC--cC----CCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 00 00 00 1235788999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=365.80 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=208.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|.+.+.||+|+||.||+|.+...+... ...+..||+|++........+.+.+|+.+|+.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYG--QLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGG--CEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccc--cccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 467899999999999999999987633210 001247999999876656667899999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--------EE
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--------AK 279 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--------vk 279 (486)
+..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999877666999999999999999999999988 999999999999988887 99
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
|+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+....... .....
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~~--- 230 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQF--- 230 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHH---
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHHH---
Confidence 999999976532 123568999999999987 779999999999999999999655443221110 01100
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 417 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 417 (486)
......+ .. . .+..+.+|+.+||+.||.+||++.+++++|+.+...
T Consensus 231 -~~~~~~~----~~----~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 231 -YEDRHQL----PA----P----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp -HHTTCCC----CC----C----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred -hhccCCC----CC----C----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0011111 11 1 123578999999999999999999999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=360.36 Aligned_cols=254 Identities=31% Similarity=0.503 Sum_probs=195.4
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
..+|++.+.||+|+||.||+|.+ +|..||||++..... ...+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-----------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-----------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 35789999999999999999987 356899999875432 224668899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--------C
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--------D 275 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~--------~ 275 (486)
+...+..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++. +
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 75 CLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp ECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred EecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 9999999999999999999998843 46899999999999999999999987445889999999999986 7
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011412 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~ 355 (486)
+.+||+|||+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .. .
T Consensus 153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~-~ 224 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---VA-Y 224 (271)
T ss_dssp CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---HH-H
T ss_pred cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-H
Confidence 789999999998654322 223579999999999999999999999999999999999999997543211 00 0
Q ss_pred hhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
. ... .......+...+..+.+|+.+||+.||.+||++.|++++|+.+
T Consensus 225 ~--~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 225 G--VAM----------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp H--HHT----------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred h--hhc----------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 000 0001111222346789999999999999999999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=387.60 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=208.9
Q ss_pred hHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCce
Q 011412 122 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLV 198 (486)
Q Consensus 122 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv 198 (486)
.++....++|++++.||+|+||.||+|++.. +++.||||++..... .....+.+|+.+|..++|||||
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv 132 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBC
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECC---------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence 3444566899999999999999999999876 677999999864211 1123477899999999999999
Q ss_pred EEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 199 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
+++++|.+.+.+|||||||+||+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+
T Consensus 133 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~i 207 (410)
T 3v8s_A 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHL 207 (410)
T ss_dssp CEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred eEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCE
Confidence 9999999999999999999999999998653 5899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~ 354 (486)
||+|||+++....... ......+||+.|+|||++.+.. |+.++|||||||+||||++|+.||........ ..
T Consensus 208 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~ 283 (410)
T 3v8s_A 208 KLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YS 283 (410)
T ss_dssp EECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH
T ss_pred EEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---HH
Confidence 9999999987644322 1233578999999999998665 88999999999999999999999975432111 11
Q ss_pred hhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhc
Q 011412 355 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEALK 412 (486)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~eil~~L~ 412 (486)
..+..... ..-| .... .+..+.+||.+||..+|.+ ||++.||+++-.
T Consensus 284 ---~i~~~~~~---~~~p-~~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 284 ---KIMNHKNS---LTFP-DDND----ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp ---HHHTHHHH---CCCC-TTCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred ---HHHhcccc---ccCC-Cccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 01100000 0000 0111 2367899999999999988 999999998643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=396.43 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=215.5
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.+...+|++.+.||+|+||.||+|.+.. ++..||||+++... ...+++.+|+.+|++++|||||++++++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~ 285 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC 285 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3445678899999999999999999875 56789999998654 3457899999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
...+.++||||||++|+|.++|... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeec
Confidence 9999999999999999999999764 356899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
|+++....... .......+++.|+|||++.+..++.++|||||||+||||++ |..||....... +......
T Consensus 363 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---- 434 (495)
T 1opk_A 363 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEK---- 434 (495)
T ss_dssp TCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHT----
T ss_pred ccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----
Confidence 99987644321 12223456789999999999999999999999999999999 999997653221 1111110
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
. . ....+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 435 ~------~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 D------Y----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp T------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred C------C----CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0 0 111122234678999999999999999999999999988754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=370.18 Aligned_cols=263 Identities=23% Similarity=0.383 Sum_probs=205.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|++++.||+|+||.||+|.+...+.. ....||+|.+.... ......+.+|+.+|+.++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCS-----CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCce-----EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 46899999999999999999998764332 12357888886433 3446789999999999999999999999987
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.. .++||||+.+|+|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 54 78999999999999999887778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~~- 236 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE- 236 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC-
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC-
Confidence 87654433333334567889999999999999999999999999999999 999997654322111111 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
.. ..+...+..+.+|+.+||+.||.+||++.|+++.|+.+..
T Consensus 237 -----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 -----RL----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -----CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 00 0111234578899999999999999999999999986543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=376.98 Aligned_cols=248 Identities=24% Similarity=0.329 Sum_probs=200.0
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEEE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 213 (486)
.+.||+|+||.||+|.+.. +|..||||+++.......+.+.+|+.+|.+++||||+++++++...+.++||
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA---------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEEcC---------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5689999999999998865 6779999999876655567799999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE--cCCCcEEEeecCCCCCCCC
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPE 291 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll--~~~~~vkl~DFGla~~~~~ 291 (486)
||||++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 9999999999999776667999999999999999999999988 9999999999999 5678899999999987654
Q ss_pred CCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 011412 292 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 371 (486)
Q Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (486)
... ....+||+.|+|||++.+..++.++|||||||+||||++|..||....... .... ....... +.
T Consensus 242 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~---i~~~~~~----~~ 308 (373)
T 2x4f_A 242 REK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TLNN---ILACRWD----LE 308 (373)
T ss_dssp TCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH---HHHTCCC----SC
T ss_pred ccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhccCC----CC
Confidence 332 233579999999999999999999999999999999999999997643211 1110 0000000 01
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 372 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 372 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...... .+..+.+||.+||+.||.+||++.|++++
T Consensus 309 ~~~~~~----~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 309 DEEFQD----ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp SGGGTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhhcc----CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111111 23678999999999999999999999984
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=362.85 Aligned_cols=261 Identities=27% Similarity=0.469 Sum_probs=196.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
...+|++.+.||+|+||.||+|.+.. .||||+++..... ..+.+.+|+.+|+.++||||+++++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 45689999999999999999997643 6999999765432 235688999999999999999999965
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.....++|||||++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC
T ss_pred -cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccce
Confidence 556789999999999999999777778999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
+++...............||+.|+|||++. +..++.++|||||||++|||++|+.||....... .+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~-- 241 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRG-- 241 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHT--
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhccc--
Confidence 998654433333334567999999999986 6678999999999999999999999997543211 111111100
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
...+. ...+...++..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 242 -------~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 242 -------SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -------SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -------ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 00010 01111223467899999999999999999999999998664
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=365.73 Aligned_cols=262 Identities=26% Similarity=0.367 Sum_probs=200.5
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||+||+|.+ +|..||||++.... ...+..|.+++.. ++||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~ 71 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASD 71 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEee
Confidence 356899999999999999999987 46789999997542 3456666666665 7999999999987
Q ss_pred EeC----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCcEEE
Q 011412 205 IED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 205 ~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~~~~~iiHrDLKp~NIll 272 (486)
... ...++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+||||
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill 146 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILV 146 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEE
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEE
Confidence 653 458999999999999999943 46999999999999999999999 766 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcce--eeeeccccccccCccccccC------CCCchhhHHHHHHHHHHHHhC-------
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEMLTG------- 337 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltG------- 337 (486)
+.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 999999999999997643322211 12234799999999998876 455799999999999999999
Q ss_pred ---CCCCCCCCCCCcchhHHhhhhhcccccccccccCCccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 338 ---RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE-GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 338 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
..||................ .... ...+.+. ..+....+..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKV-VCVD------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHH-HTTS------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccccccccCCCCcchhhhhHH-Hhcc------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 78886543332211110000 0000 0011111 11223456789999999999999999999999999874
Q ss_pred C
Q 011412 414 L 414 (486)
Q Consensus 414 ~ 414 (486)
+
T Consensus 300 i 300 (301)
T 3q4u_A 300 I 300 (301)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=389.31 Aligned_cols=251 Identities=29% Similarity=0.368 Sum_probs=198.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---GLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++++.||+|+||.||+|.+.. +|..||||++... .......+.+|+++|+.++||||+++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcC---------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 4679999999999999999999865 6779999999753 222335678899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
...+.+|||||||++|+|.+++... ..+++..+..++.||+.||+|||+ .+ ||||||||+||||+.++.+||+||
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCC
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccC
Confidence 9999999999999999999998654 479999999999999999999998 77 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
|+++....... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...... .+... .....
T Consensus 294 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~---i~~~~ 365 (446)
T 4ejn_A 294 GLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL---ILMEE 365 (446)
T ss_dssp CCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHCC
T ss_pred CCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHH---HHhCC
Confidence 99986433222 234578999999999999999999999999999999999999999754321 11111 11111
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
.. ++...+..+.+||.+||+.||.+|| ++.|++++-
T Consensus 366 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 366 IR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp CC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 11 1112246789999999999999999 999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=368.81 Aligned_cols=248 Identities=25% Similarity=0.263 Sum_probs=197.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
.++|++++.||+|+||+||+|.+.. +|+.||||++...... ....+..|+..+..+ .|+||++++++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 3579999999999999999999875 5779999998754332 223455666666555 899999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+.+.++|||||| +++|.+++...+..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCT
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccce
Confidence 9999999999999 77999999877778999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|..++.... ...... .
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~-----~-- 266 (311)
T 3p1a_A 203 LLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQLR-----Q-- 266 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHHHT-----T--
T ss_pred eeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHh-----c--
Confidence 998754332 2334579999999998875 79999999999999999999977664321 110000 0
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
....+.+.. ..+..+.+||.+||+.||.+||++.|++++-
T Consensus 267 ---~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 267 ---GYLPPEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp ---TCCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ---cCCCccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 000111111 1236789999999999999999999999743
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=368.26 Aligned_cols=257 Identities=21% Similarity=0.362 Sum_probs=207.5
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
...++|++++.||+|+||.||+|.+. ++..||||++..... ..+++.+|++++..++||||+++++++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 34568999999999999999999875 356799999986543 3467899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccc
Confidence 999999999999999999999775667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... ...... .
T Consensus 167 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~-- 236 (283)
T 3gen_A 167 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIA----Q-- 236 (283)
T ss_dssp GGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHH----T--
T ss_pred ccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHHHHh----c--
Confidence 986543211 11223457889999999999999999999999999999998 999997543211 111100 0
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
........ ..+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 237 ----~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 237 ----GLRLYRPH----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ----TCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----ccCCCCCC----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00111111 1235788999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=368.83 Aligned_cols=254 Identities=28% Similarity=0.359 Sum_probs=197.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
.++|++.+.||+|+||.||+|+.... ..+|+.||||+++.... .....+.+|+.+|+.++||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTG------ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSS------TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEecc------CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 35799999999999999999987532 23688999999986532 223457889999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+...+.+|||||||++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeC
Confidence 99999999999999999999999654 46899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... .....
T Consensus 166 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~---i~~~~ 237 (327)
T 3a62_A 166 GLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDK---ILKCK 237 (327)
T ss_dssp SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH---HHHTC
T ss_pred CcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHH---HHhCC
Confidence 99986432221 233467999999999999999999999999999999999999999754321 11111 11100
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 411 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L 411 (486)
..+.. ..+..+.+||.+||+.||.+|| ++.+++++-
T Consensus 238 --------~~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 238 --------LNLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp --------CCCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred --------CCCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 01111 2246789999999999999999 778888754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=377.74 Aligned_cols=257 Identities=26% Similarity=0.333 Sum_probs=199.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHH-HhcCCCCCceEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNF-LGDLVHLNLVKLIGY 203 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~nIv~~~~~ 203 (486)
.++|++++.||+|+||.||+|+++. ++..||||++...... ....+..|..+ ++.++|||||+++++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKA---------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETT---------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 3579999999999999999999875 6779999999765432 23446677776 567899999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+.+.+.+|||||||+||+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+||
T Consensus 108 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 108 FQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeC
Confidence 99999999999999999999999654 46889999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
|+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+ ....+...
T Consensus 184 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~---~~~i~~~~ 255 (373)
T 2r5t_A 184 GLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EM---YDNILNKP 255 (373)
T ss_dssp CBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HH---HHHHHHSC
T ss_pred ccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HH---HHHHHhcc
Confidence 99986332221 234578999999999999999999999999999999999999999754221 11 11111110
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 417 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 417 (486)
. .+... .+..+.+||.+||+.||.+||++.+.++.+...+.+
T Consensus 256 ~--------~~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f 297 (373)
T 2r5t_A 256 L--------QLKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297 (373)
T ss_dssp C--------CCCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred c--------CCCCC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence 0 11112 235789999999999999999986555555544444
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=377.69 Aligned_cols=254 Identities=21% Similarity=0.254 Sum_probs=195.7
Q ss_pred hcCCCCC-CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHh-cCCCCCceEEEEEEE
Q 011412 128 TRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG-DLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~ 205 (486)
.++|.+. ++||+|+||+||+|.+.. +|+.||||++... ..+.+|+.++. .++||||++++++|.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~---------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECC---------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 3567666 689999999999999875 6779999999643 46778898874 458999999999987
Q ss_pred e----CCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCc
Q 011412 206 E----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYN 277 (486)
Q Consensus 206 ~----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~ 277 (486)
. ...+|||||||++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.
T Consensus 126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCC
T ss_pred ecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCcc
Confidence 6 567899999999999999997653 46999999999999999999999988 999999999999987 789
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~-~~~~~ 356 (486)
+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||.......... .....
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i 279 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred EEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence 9999999998654322 2345689999999999999999999999999999999999999997654332111 11111
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.. ... ....+ ... ..+..+.+||.+||+.||.+||++.+++++..
T Consensus 280 ~~---~~~---~~~~~-~~~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 280 RM---GQY---EFPNP-EWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp HH---TCC---CCCTT-TTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred Hc---Ccc---cCCCc-ccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 00 000 00000 011 22467899999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=375.92 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=203.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
..++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+|+.+|.++ .||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKA---------TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 34679999999999999999999865 6789999999765432 35688888888 7999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC----CcEEEe
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YNAKLS 281 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~----~~vkl~ 281 (486)
+.+..|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+..+ +.+||+
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEE
Confidence 999999999999999999998654 46999999999999999999999988 9999999999998433 359999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..........+..... .
T Consensus 163 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~---~ 237 (342)
T 2qr7_A 163 DFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG---S 237 (342)
T ss_dssp CCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH---H
T ss_pred ECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc---c
Confidence 9999986543322 2334689999999999988889999999999999999999999997543222222221111 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.... +...+....+..+.+||.+||..||.+||++.+++++-
T Consensus 238 ~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 238 GKFS--------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp CCCC--------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred CCcc--------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 0000 11111112346789999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=373.43 Aligned_cols=278 Identities=27% Similarity=0.340 Sum_probs=214.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE--
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-- 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-- 205 (486)
.++|++.+.||+|+||.||+|.+... ...++..||||++........+.+.+|+++|+.++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPL-----GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTT-----SSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccC-----CCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 36899999999999999999986431 22378899999998776555667899999999999999999999987
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+....+|||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccc
Confidence 456689999999999999999876667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-hhcccc
Q 011412 286 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-PHLGER 363 (486)
Q Consensus 286 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~ 363 (486)
++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...+.. ......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCERDVPAL 250 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHCC----CCHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh---hhhcccccccccH
Confidence 9876543322 12233568899999999999999999999999999999999999985421100 000000 000000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
......+........+...+..+.+|+.+||+.||.+||++.+++++|+.+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00001111111111222335678999999999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=373.59 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=197.4
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCC--CCceEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVH--LNLVKLIGY 203 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~nIv~~~~~ 203 (486)
.++|++++.||+|+||.||+|.+. ++..||||++...... ....+.+|+.+|..+.| +||++++++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 457999999999999999999764 4678999999765432 23568899999999976 999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+..++..+||||+ .+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+ ++.+||+||
T Consensus 78 ~~~~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DF 151 (343)
T 3dbq_A 78 EITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDF 151 (343)
T ss_dssp EECSSEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCC
T ss_pred EeeCCEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeec
Confidence 9999999999995 588999999664 47899999999999999999999988 99999999999997 678999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~ 352 (486)
|+++..............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~ 227 (343)
T 3dbq_A 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----I 227 (343)
T ss_dssp SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----H
T ss_pred ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----H
Confidence 99987655443333445689999999999865 67899999999999999999999999643211 0
Q ss_pred HHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
. .. ...+++.....++...+..+.+||.+||+.||.+||++.+++++..
T Consensus 228 ~-~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 228 S-KL----------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp H-HH----------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred H-HH----------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 0 00 0111111111222222357889999999999999999999998653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=386.32 Aligned_cols=269 Identities=22% Similarity=0.313 Sum_probs=187.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||+||+|++.. +|+.||||++..... ...+.+.+|+++|+.++|||||++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL---------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-----------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC---------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 3689999999999999999998875 677999999975432 23456889999999999999999999985
Q ss_pred eC-----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 206 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 206 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
.. ..+||||||+ +++|.+++.. ...+++..+..|+.||+.||+|||+.+ ||||||||+||||+.++.+||
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred cCCcccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEee
Confidence 43 5689999998 5799998854 457999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcc-------------------------eeeeeccccccccCcccc-ccCCCCchhhHHHHHHHHHHH
Q 011412 281 SDFGLAKDGPEGDKT-------------------------HVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEM 334 (486)
Q Consensus 281 ~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~el 334 (486)
+|||+++........ ...+..+||+.|+|||++ ....|+.++||||||||||||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999875432110 123446899999999976 466799999999999999999
Q ss_pred Hh-----------CCCCCCCCCCCCc-----------------chhHHhhhhhccc-------------ccccccccCC-
Q 011412 335 LT-----------GRRSMDKNRPNGE-----------------HNLVEWARPHLGE-------------RRRFYRLIDP- 372 (486)
Q Consensus 335 lt-----------G~~pf~~~~~~~~-----------------~~~~~~~~~~~~~-------------~~~~~~~~~~- 372 (486)
++ |+++|.+...... .+........+.. ...+...+..
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 99 5666654321100 0000000000000 0000000000
Q ss_pred ---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 373 ---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 373 ---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.+...+ ...+..+.+||.+||..||.+|||+.|++++-
T Consensus 358 ~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 358 EGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp CCCCGGGGS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCCHHHHC-CCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 000001 12246789999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=383.73 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=206.2
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
+..++|++.+.||+|+||.||+|.+. |..||||+++... ..+.+.+|+.+|++++|||||++++++.
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 34567899999999999999999873 5689999998654 3467999999999999999999999987
Q ss_pred eCC-eeEEEEeecCCCChhHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 206 EDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 206 ~~~-~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
..+ .++||||||++|+|.+++...+. .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df 333 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDF 333 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCC
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeC
Confidence 765 78999999999999999976543 4799999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
|+++..... .....+++.|+|||++.+..++.++|||||||+||||++ |+.||......... .... .
T Consensus 334 G~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~----~ 401 (450)
T 1k9a_A 334 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVE----K 401 (450)
T ss_dssp TTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---HHHH----T
T ss_pred CCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH----c
Confidence 999864322 122357899999999999999999999999999999998 99999765433211 1110 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
. ... ..+..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 402 ~------~~~----~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 402 G------YKM----DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp T------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C------CCC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 001 11122346789999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=372.92 Aligned_cols=255 Identities=24% Similarity=0.282 Sum_probs=192.6
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... ..+.+.+|+.+|.+++||||+++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKG---------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECC---------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 45679999999999999999999865 57799999998653 23567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCcEEEeec
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDF 283 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~vkl~DF 283 (486)
.+..+|||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+. ++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccC
Confidence 99999999999999999998654 46899999999999999999999988 999999999999975 889999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... .+.... ....
T Consensus 196 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i---~~~~ 267 (349)
T 2w4o_A 196 GLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRI---LNCE 267 (349)
T ss_dssp C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHH---HTTC
T ss_pred ccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHH---HhCC
Confidence 9998754322 2334679999999999999999999999999999999999999997543211 011100 0000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
. ... ..... ..+..+.+||.+||+.||.+||++.+++++-.
T Consensus 268 ~---~~~-~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 268 Y---YFI-SPWWD----EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp C---CCC-TTTTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred C---ccC-Cchhh----hCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 0 000 01111 22467889999999999999999999998643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=392.01 Aligned_cols=255 Identities=31% Similarity=0.424 Sum_probs=209.7
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
..++|++.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.+|..++|||||+++++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 252 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 34679999999999999999999865 67899999996532 2234568899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
+.+.+.+|||||||+||+|.+++...+ ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|
T Consensus 253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~D 329 (576)
T 2acx_A 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329 (576)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEe
Confidence 999999999999999999999987543 35999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||+++....... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...........+.... ..
T Consensus 330 FGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~- 403 (576)
T 2acx_A 330 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KE- 403 (576)
T ss_dssp CTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HH-
T ss_pred cccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hc-
Confidence 999987654332 234689999999999999999999999999999999999999997654322211111100 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 410 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~ 410 (486)
.... ++...+..+.+||.+||+.||.+|| ++.||+++
T Consensus 404 -------~~~~----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 -------VPEE----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -------CCCC----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -------cccc----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0111 1122346789999999999999999 78888875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=372.60 Aligned_cols=267 Identities=25% Similarity=0.392 Sum_probs=212.5
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+..... ....++..||||++..... .....+.+|+.+|+.+ +||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 45689999999999999999999864221 1223677899999986543 2345688999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 269 (486)
...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 99999999999999999999997543 24889999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 011412 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 348 (486)
Q Consensus 270 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~ 348 (486)
|||+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~- 266 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 266 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH-
Confidence 9999999999999999987655433333334567899999999998899999999999999999999 99999754321
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.+..... .. ..... +...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 267 --~~~~~~~----~~------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 267 --ELFKLLK----EG------HRMDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp --HHHHHHH----HT------CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHh----cC------CCCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111110 00 00111 1123467899999999999999999999999997653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=366.11 Aligned_cols=274 Identities=28% Similarity=0.400 Sum_probs=209.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++++.||+|+||.||+|.+.... ..+++.||||++.... ......+.+|+.+|+.++||||+++++++...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTS-----SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhccCCCCceEEEEEEEcccc-----CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 46888999999999999999864321 2378899999997543 23456789999999999999999999999876
Q ss_pred --CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 208 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 208 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
...++||||+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccc
Confidence 6789999999999999999777778999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc--c
Q 011412 286 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--E 362 (486)
Q Consensus 286 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~ 362 (486)
++........ .......||..|+|||++.+..++.++|||||||++|||++|..|+..... .......+... .
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMT 248 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccC
Confidence 9876543322 223346789999999999999999999999999999999999998743210 00000000000 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...+...+........+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0000000000011111223346789999999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=364.39 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=215.5
Q ss_pred HHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEE
Q 011412 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 123 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~ 202 (486)
++.....+|++.+.||+|+||.||+|.+.. ++..||||++.... ...+.+.+|+.+++.++||||+++++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~ 76 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG 76 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344566789999999999999999999876 57799999997653 33567899999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEc
Confidence 999999999999999999999999764 456999999999999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||........ ......
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~~~-- 227 (288)
T 3kfa_A 154 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEK-- 227 (288)
T ss_dssp CCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHT--
T ss_pred cCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhc--
Confidence 9999987654332 22334567889999999999999999999999999999999 9999976533211 111110
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
....... ...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 228 --------~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 228 --------DYRMERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp --------TCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------cCCCCCC----CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0011111 12246789999999999999999999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=371.76 Aligned_cols=276 Identities=23% Similarity=0.282 Sum_probs=211.9
Q ss_pred ccccChhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC--
Q 011412 116 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-- 193 (486)
Q Consensus 116 ~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-- 193 (486)
...+.+.+.....++|++++.||+|+||.||+|.+.. +++.||||++.... .....+..|+.+|+.+.
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~ 91 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---------NKKYYAVKVVRNIK-KYTRSAKIEADILKKIQND 91 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---------CCeEEEEEEeccch-hhhhhhHHHHHHHHHhccc
Confidence 3456666777778899999999999999999999865 57799999997432 22355778999999986
Q ss_pred ---CCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011412 194 ---HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (486)
Q Consensus 194 ---h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 269 (486)
|||||++++++...+..+|||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 167 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPEN 167 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCccc
Confidence 999999999999999999999999 999999997653 45999999999999999999999988 9999999999
Q ss_pred EEEcC-------------------------CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhH
Q 011412 270 ILLDA-------------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 324 (486)
Q Consensus 270 Ill~~-------------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 324 (486)
|||+. ++.+||+|||+++..... .....||+.|+|||++.+..++.++||
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di 242 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDM 242 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccch
Confidence 99975 789999999999864432 234579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc----------cccc-----ccccCCccCCC----------CC
Q 011412 325 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE----------RRRF-----YRLIDPRLEGH----------FS 379 (486)
Q Consensus 325 wslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~-----~~~~~~~~~~~----------~~ 379 (486)
|||||++|||++|+.||...........+......... .... .....+..... .+
T Consensus 243 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 322 (360)
T 3llt_A 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322 (360)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence 99999999999999999764322111111110000000 0000 00000000000 00
Q ss_pred ---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 380 ---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 380 ---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
......+.+||.+||+.||.+|||+.|++++
T Consensus 323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0011567799999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=369.60 Aligned_cols=252 Identities=25% Similarity=0.296 Sum_probs=181.3
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCceEEEEEEEeCCeeEE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLL 212 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~l 212 (486)
.+.||+|+||.||+|.+.. +|+.||||++... ....+.+|+.+|..+. ||||+++++++.+....||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKK---------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEETT---------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEECC---------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 3789999999999999875 6779999999754 3456789999999997 9999999999999999999
Q ss_pred EEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---cEEEeecCCCCCC
Q 011412 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDG 289 (486)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---~vkl~DFGla~~~ 289 (486)
|||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999654 57999999999999999999999988 99999999999997665 8999999999865
Q ss_pred CCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhhccccccccc
Q 011412 290 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPHLGERRRFYR 368 (486)
Q Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 368 (486)
..... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||......... ...+.........
T Consensus 160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~----- 232 (325)
T 3kn6_A 160 PPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD----- 232 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-----
T ss_pred CCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-----
Confidence 43322 233467899999999999999999999999999999999999999764432111 1111111000000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+........+..+.+||.+||+.||.+||++.+++++-
T Consensus 233 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 233 ---FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp ---CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred ---CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 0000000012246789999999999999999999998654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=370.80 Aligned_cols=263 Identities=24% Similarity=0.408 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|.+.+.||+|+||.||+|.+...+. ..+..||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCC-----CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 4578888999999999999998865321 12456999999765332 23468899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcc
Confidence 99999999999999999999877778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcce-eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 287 KDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 287 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+..... ...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~----~~~ 267 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAIN----DGF 267 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----TTC
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----CCC
Confidence 8764432211 1223456889999999999999999999999999999999 99999654321 1111110 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
... .+...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 268 ------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 ------RLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ------CCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------cCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000 11123467899999999999999999999999997653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=375.33 Aligned_cols=269 Identities=19% Similarity=0.240 Sum_probs=205.0
Q ss_pred hcCCCCCCeeeec--CCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 128 TRNFRPESLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 128 ~~~y~~~~~lg~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
..+|++++.||+| +||.||+|.+.. +|+.||||++..... .....+.+|+.+|+.++|||||+++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 4579999999999 999999999875 677999999975532 223567889999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
+.+.+.+|||||||++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 99999999999999999999999754 356999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcc-----eeeeeccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011412 283 FGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 283 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~ 355 (486)
||++......... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.......... ..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~ 249 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EK 249 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HH
Confidence 9988643221110 11122478999999999987 679999999999999999999999997654322111 00
Q ss_pred hhhhcc---ccc-----c-------------ccccc---CC------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 011412 356 ARPHLG---ERR-----R-------------FYRLI---DP------RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405 (486)
Q Consensus 356 ~~~~~~---~~~-----~-------------~~~~~---~~------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ 405 (486)
...... +.. . +...+ .+ .....+....+..+.+||.+||+.||.+||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 000000 000 0 00000 00 000011222346789999999999999999999
Q ss_pred HHHHH
Q 011412 406 EVVEA 410 (486)
Q Consensus 406 eil~~ 410 (486)
|++++
T Consensus 330 ell~h 334 (389)
T 3gni_B 330 TLLNH 334 (389)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=377.56 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=197.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCC--CCCceEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV--HLNLVKLIGYC 204 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~nIv~~~~~~ 204 (486)
.+|++++.||+|+||.||+|.+. ++..||||++..... .....+.+|+.+|..|. |||||++++++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 46999999999999999999864 366899999976543 23456889999999996 59999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
..++.+||||| +.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG 199 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG 199 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCS
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecC
Confidence 99999999999 56889999997654 7899999999999999999999988 99999999999995 5899999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~ 353 (486)
+++..............+||+.|+|||++.+ ..|+.++||||||||||||++|+.||...... .
T Consensus 200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~ 274 (390)
T 2zmd_A 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I 274 (390)
T ss_dssp SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----H
T ss_pred ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----H
Confidence 9987654433333345689999999999865 46899999999999999999999999653211 0
Q ss_pred HhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.... .++++.....++...+..+.+||.+||+.||.+||++.|++++.
T Consensus 275 ~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 275 SKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHH----------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 0100 11111111111111245789999999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=362.83 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=208.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCCceEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 201 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~ 201 (486)
.++|++.+.||+|+||.||+|.+.. +|..||||++...... ....+.+|+.+|..++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC---------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 4579999999999999999999865 6779999999754322 356789999999999999999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----c
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 277 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~----~ 277 (486)
+++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence 999999999999999999999999965 457899999999999999999999988 99999999999999887 7
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......
T Consensus 158 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~ 231 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANIT 231 (321)
T ss_dssp EEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH
T ss_pred EEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH
Confidence 99999999987654322 23457999999999999999999999999999999999999999754321 1111000
Q ss_pred hhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.... ..++..... .+..+.+||.+||+.||.+||++.+++++-.
T Consensus 232 ---~~~~----~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 232 ---SVSY----DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp ---TTCC----CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred ---hccc----ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 0000 001111111 2356889999999999999999999998643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=360.47 Aligned_cols=260 Identities=26% Similarity=0.372 Sum_probs=207.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..++|.+.+.||+|+||.||+|.+.... +++..||||++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTT------CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCC------CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 3468999999999999999999876532 2456799999986532 33466889999999999999999999976
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+ +..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCC
Confidence 5 4578999999999999999877777999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ...... ..
T Consensus 160 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~~~----~~ 231 (281)
T 3cc6_A 160 SRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLEK----GD 231 (281)
T ss_dssp GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHHHH----TC
T ss_pred Cccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHHhc----CC
Confidence 9876443221 1233467889999999999999999999999999999998 9999975432211 111100 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...... ..+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 232 ------~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 ------RLPKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 000111 1235789999999999999999999999999754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=370.35 Aligned_cols=269 Identities=26% Similarity=0.418 Sum_probs=213.4
Q ss_pred HHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEE
Q 011412 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 124 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~ 202 (486)
+....++|++.+.||+|+||.||+|.+... ....++..||||++..... .....+.+|+.+|+.++||||+++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 344567899999999999999999987631 1112467899999975533 22346889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
++.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence 9999999999999999999999986432 45789999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011412 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 352 (486)
Q Consensus 274 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~ 352 (486)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~ 249 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QV 249 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HH
Confidence 999999999999986543322222334567899999999999999999999999999999999 88998654221 11
Q ss_pred HHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
..... .. . . .. .+...+..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 250 ~~~~~----~~-~---~--~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRFVM----EG-G---L--LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHH----TT-C---C--CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHH----cC-C---c--CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11110 00 0 0 00 111234678999999999999999999999999987643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=364.04 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=195.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++.+.||+|+||.||+|.+.. +++.||||++....... ...+.+|+.++..++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR---------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC---------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 4689999999999999999999865 67799999998654332 34688999999999999999999998
Q ss_pred EeCCe----eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 205 IEDDQ----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 205 ~~~~~----~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
..... .||||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEE
Confidence 77543 49999999999999999655 46999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 281 SDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 281 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~ 231 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQH 231 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHH
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHH
Confidence 999999875443221 12234679999999999999999999999999999999999999997543211 10001
Q ss_pred cccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
.......... .... .+..+.+||.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~----~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 232 VREDPIPPSA----RHEG----LSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHCCCCCHHH----HSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred hcCCCCCccc----ccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 1110000000 0111 2357889999999999999997777664
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=376.71 Aligned_cols=274 Identities=23% Similarity=0.265 Sum_probs=213.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|.+.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+++|+.++||||+++++++..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 3579999999999999999999875 67799999997543 2335678899999999999999999999987
Q ss_pred CC--eeEEEEeecCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCcE
Q 011412 207 DD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNA 278 (486)
Q Consensus 207 ~~--~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll----~~~~~v 278 (486)
.+ ..+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeE
Confidence 65 7799999999999999996542 34899999999999999999999988 9999999999999 778889
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCcccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE- 349 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~- 349 (486)
||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 156 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 9999999987644322 234679999999998865 5678899999999999999999999975433221
Q ss_pred chhHHhhhhhccc----------ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 350 HNLVEWARPHLGE----------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 350 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
............. ...+.-.-+......++...+..+.+|+.+||+.||.+||++.++++.++.+..
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111111100000 000000001112234567788899999999999999999999999998876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=360.49 Aligned_cols=264 Identities=25% Similarity=0.263 Sum_probs=201.6
Q ss_pred hcCCCCC-CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 128 TRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
.+.|++. +.||+|+||.||+|.+.. +++.||||++..........+.+|+.+|.++ .||||+++++++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLI---------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSS---------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcC---------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3578875 789999999999998765 6779999999876655667899999999985 7999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc---EEEee
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSD 282 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~---vkl~D 282 (486)
+.+..+||||||++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred eCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEE
Confidence 999999999999999999999655 46899999999999999999999988 999999999999988766 99999
Q ss_pred cCCCCCCCCCCc-----ceeeeeccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011412 283 FGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352 (486)
Q Consensus 283 FGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~ 352 (486)
||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence 999986532211 111223569999999999875 5688999999999999999999999976543321100
Q ss_pred H---------HhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 353 V---------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 353 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
. ............+ ...... ..+..+.+||.+||+.||.+||++.|++++-.
T Consensus 238 ~~~~~~~~~~~~~~~i~~~~~~~----~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 238 RGEACPACQNMLFESIQEGKYEF----PDKDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp ---CCHHHHHHHHHHHHHCCCCC----CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred ccccchhHHHHHHHHHhccCccc----Cchhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 0 0000000000000 000001 12357899999999999999999999998543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=364.66 Aligned_cols=270 Identities=25% Similarity=0.314 Sum_probs=200.7
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhcCC---CCCc
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLV---HLNL 197 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~nI 197 (486)
...++|++++.||+|+||+||+|++.. +|+.||||++..... .....+.+|+.+++.+. ||||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni 76 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTT---------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred ccccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe
Confidence 346799999999999999999998765 677999999874321 11245677877777664 9999
Q ss_pred eEEEEEEEeCC-----eeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011412 198 VKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (486)
Q Consensus 198 v~~~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 271 (486)
+++++++.... ..++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil 152 (308)
T 3g33_A 77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL 152 (308)
T ss_dssp CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEE
T ss_pred EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence 99999998765 5799999996 59999987654 34999999999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011412 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351 (486)
Q Consensus 272 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~ 351 (486)
|+.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 229 (308)
T 3g33_A 153 VTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 229 (308)
T ss_dssp ECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999987643322 344689999999999999999999999999999999999999997643321111
Q ss_pred hHHhhhhhc--ccc---ccccc-ccCCccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 352 LVEWARPHL--GER---RRFYR-LIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 352 ~~~~~~~~~--~~~---~~~~~-~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.+....... ... ..+.. .+.+... .......+..+.+||.+||+.||.+|||+.|++++-
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 110000000 000 00000 0000000 000011235788999999999999999999999754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=388.65 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=211.0
Q ss_pred HHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 124 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
+.+..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|+.++|||||+++++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 34456789999999999999999998753 5679999998654 346789999999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
+. .+..+||||||++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D 327 (454)
T 1qcf_A 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 327 (454)
T ss_dssp EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECS
T ss_pred Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEee
Confidence 86 66789999999999999999743 236889999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
||+++....... .......+|+.|+|||++....++.++|||||||+||||++ |+.||...... .+.....
T Consensus 328 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~---- 399 (454)
T 1qcf_A 328 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE---- 399 (454)
T ss_dssp TTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH----
T ss_pred CCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----
Confidence 999987543211 11223456889999999999999999999999999999999 99999754321 1111111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
... +.. .+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 400 ~~~---~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 400 RGY---RMP-------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HTC---CCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred cCC---CCC-------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 000 011 111234678999999999999999999999999988754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=366.81 Aligned_cols=272 Identities=28% Similarity=0.394 Sum_probs=215.8
Q ss_pred ChhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcC-CCCCc
Q 011412 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNL 197 (486)
Q Consensus 120 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nI 197 (486)
....+....++|++.+.||+|+||.||+|.+.... ...+++.||||++...... ..+.+.+|+.+|..+ +||||
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCC----ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe
Confidence 34444556678999999999999999999875311 1236789999999865432 235688999999999 79999
Q ss_pred eEEEEEEEeCC-eeEEEEeecCCCChhHHHhhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011412 198 VKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRMKIALGAAKGLAFLHEEAERPVI 261 (486)
Q Consensus 198 v~~~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 261 (486)
+++++++...+ ..++|||||++|+|.+++...... +++..++.++.||+.||.|||+.+ |+
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~ 170 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 170 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 99999988754 589999999999999999765432 889999999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 011412 262 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 340 (486)
Q Consensus 262 HrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~p 340 (486)
||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654443333444678999999999999999999999999999999998 9999
Q ss_pred CCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 341 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
|....... .+..... .. ....... ..+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 251 ~~~~~~~~--~~~~~~~----~~------~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 251 YPGVKIDE--EFCRRLK----EG------TRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp STTCCCSH--HHHHHHH----HT------CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccchhH--HHHHHhc----cC------ccCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 97644321 1111110 00 0011111 1235789999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=372.84 Aligned_cols=249 Identities=27% Similarity=0.394 Sum_probs=203.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..|++++.||+|+||.||+|.+.. +|..||||++....... .+.+.+|+++|+.++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEcc---------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 458889999999999999998765 67799999997654322 346889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.++..+||||||. |+|.+++......+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999996 6888888766678999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
++..... ....||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+.. ....
T Consensus 201 a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~----~~~~ 268 (348)
T 1u5q_A 201 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH----IAQN 268 (348)
T ss_dssp CBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH----HHHS
T ss_pred ceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH----HHhc
Confidence 9875432 2357999999999885 5678999999999999999999999996543211 0000 0000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
..+.+. ....+..+.+||.+||+.||.+||++.+++++..
T Consensus 269 -------~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 269 -------ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -------CCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -------CCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 001110 1112456889999999999999999999998654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=373.41 Aligned_cols=274 Identities=19% Similarity=0.243 Sum_probs=207.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH-----------HHHHHHHHHHhcCCCC
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGDLVHL 195 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~ 195 (486)
..++|++.+.||+|+||.||+|.+..... ...++.||||++........ ..+..|+..+..+.||
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSES----VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSC----CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccc----cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 34589999999999999999998875322 12467899999876542111 1234566777888999
Q ss_pred CceEEEEEEEeC----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011412 196 NLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (486)
Q Consensus 196 nIv~~~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 271 (486)
||+++++++... ...||||||| +++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+|||
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil 184 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL 184 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence 999999998775 4589999999 99999999877778999999999999999999999988 999999999999
Q ss_pred Ec--CCCcEEEeecCCCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 011412 272 LD--ADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344 (486)
Q Consensus 272 l~--~~~~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~ 344 (486)
|+ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 98 8899999999999765332111 1113356999999999999999999999999999999999999999753
Q ss_pred CCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.... .......... ...+..++++.+.. ...+..+.+|+..||+.||.+||++.+|++.|+.+.
T Consensus 265 ~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 265 LKDP--KYVRDSKIRY--RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp TTCH--HHHHHHHHHH--HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCH--HHHHHHHHHh--hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 3221 1111111111 01111222221110 012367899999999999999999999999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=363.25 Aligned_cols=266 Identities=23% Similarity=0.364 Sum_probs=201.1
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC--CCCCceEEEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL--VHLNLVKLIG 202 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~~~~ 202 (486)
....++|++.+.||+|+||.||+|.+ +|..||||++.... ...+..|.+++..+ +||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-----------RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-----------CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEE
Confidence 34557899999999999999999987 36789999986442 24455566666554 8999999999
Q ss_pred EEEeC----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEecCCCCCcE
Q 011412 203 YCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE--------AERPVIYRDFKTSNI 270 (486)
Q Consensus 203 ~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------~~~~iiHrDLKp~NI 270 (486)
++... ...++|||||++|+|.+++... .+++..++.++.|++.||.|||+. + |+||||||+||
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Ni 173 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNI 173 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGE
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHE
Confidence 99887 7899999999999999999654 689999999999999999999987 6 99999999999
Q ss_pred EEcCCCcEEEeecCCCCCCCCCCcce--eeeeccccccccCccccccCCCCch------hhHHHHHHHHHHHHhC-----
Q 011412 271 LLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGHLTSR------SDVYSFGVVLLEMLTG----- 337 (486)
Q Consensus 271 ll~~~~~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslGvil~elltG----- 337 (486)
||+.++.+||+|||+++......... ......||+.|+|||++.+..+... +|||||||++|||++|
T Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~ 253 (337)
T 3mdy_A 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253 (337)
T ss_dssp EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence 99999999999999997654332211 1124579999999999987766665 9999999999999999
Q ss_pred -----CCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 338 -----RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 338 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..||............ ... .. ......+.+...+ ...++..+.+|+.+||+.||.+||++.+|+++|
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~-~~~-~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 254 IVEEYQLPYHDLVPSDPSYED-MRE-IV-----CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp BCCCCCCTTTTTSCSSCCHHH-HHH-HH-----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccccccccHhhhcCCCCchhh-hHH-HH-----hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 5555443222211100 000 00 0001111111111 125677899999999999999999999999999
Q ss_pred cCCCC
Q 011412 412 KPLPN 416 (486)
Q Consensus 412 ~~~~~ 416 (486)
+.+..
T Consensus 327 ~~l~~ 331 (337)
T 3mdy_A 327 AKMSE 331 (337)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 86644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=362.21 Aligned_cols=267 Identities=24% Similarity=0.318 Sum_probs=200.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++++.||+|+||.||+|.+.. +|+.||||++....... .+.+.+|+++++.++||||+++++++..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 579999999999999999999865 67799999986554322 3557899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..++|||||++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 9999999999999999887744 456999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh------
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH------ 359 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~------ 359 (486)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 150 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 150 RLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence 87543222 2234579999999999876 67899999999999999999999999765432211111110000
Q ss_pred --ccccccc--ccccCCccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 --LGERRRF--YRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 --~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
......+ ....++.....+ ....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 000010000000 01123568899999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=371.72 Aligned_cols=265 Identities=25% Similarity=0.373 Sum_probs=212.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|.+.+.||+|+||.||+|.+...+. ...+..||||.+..... .....+.+|+.+|..+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGK----EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSS----SCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCc----ccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34689999999999999999999875332 12345899999976543 2345688999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRR-------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 271 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 271 (486)
...+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 9999999999999999999998643 346899999999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011412 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 350 (486)
Q Consensus 272 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~ 350 (486)
|+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 99999999999999986544333333344568899999999999999999999999999999999 9999976433211
Q ss_pred hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
+....... ..... +...+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 276 -~~~~~~~~----------~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 -FYKLVKDG----------YQMAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -HHHHHHHT----------CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHhcC----------CCCCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111100 00001 111246789999999999999999999999998643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=379.73 Aligned_cols=270 Identities=23% Similarity=0.318 Sum_probs=193.5
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCC-CCCceEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLV-HLNLVKLIG 202 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~ 202 (486)
...++|++++.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.+|..+. ||||+++++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 76 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETT---------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence 345789999999999999999998876 67799999986542 223456789999999997 999999999
Q ss_pred EEEeCC--eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 203 YCIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 203 ~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
++...+ .+|||||||+ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||
T Consensus 77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 77 VLRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp EEECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred EEecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEe
Confidence 997654 6899999996 589998865 36899999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCC-------------------cceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCC
Q 011412 281 SDFGLAKDGPEGD-------------------KTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 340 (486)
Q Consensus 281 ~DFGla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~p 340 (486)
+|||+++...... .....+..+||+.|+|||++.+ ..|+.++||||||||||||++|++|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 9999997643211 1112344689999999999876 6899999999999999999999999
Q ss_pred CCCCCCCCcchhHHhhhhhcccccccccc------------------cCCccCCCCC------------HHHHHHHHHHH
Q 011412 341 MDKNRPNGEHNLVEWARPHLGERRRFYRL------------------IDPRLEGHFS------------IKGAQKAAQLA 390 (486)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~------------~~~~~~~~~li 390 (486)
|.+.........+..... ......+..+ ........++ ...+..+.+|+
T Consensus 231 f~~~~~~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 309 (388)
T 3oz6_A 231 FPGSSTMNQLERIIGVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309 (388)
T ss_dssp CCCSSHHHHHHHHHHHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence 976532211111100000 0000000000 0000000000 01235788999
Q ss_pred HHhcccCCCCCCCHHHHHHHh
Q 011412 391 AHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 391 ~~cl~~dP~~RPs~~eil~~L 411 (486)
.+||+.||.+|||+.|++++-
T Consensus 310 ~~~L~~dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 310 DKLLQFNPNKRISANDALKHP 330 (388)
T ss_dssp HHHCCSSGGGSCCHHHHTTST
T ss_pred HHhhccCcccCCCHHHHhCCH
Confidence 999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=355.78 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=186.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIH---------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEcc---------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence 578999999999999999998865 57799999996432 122467889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecc
Confidence 999999999999999999999877678999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~---- 226 (278)
T 3cok_A 159 ATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------VVL---- 226 (278)
T ss_dssp CEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS----
T ss_pred eeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH------Hhh----
Confidence 9875432221 2235799999999999988999999999999999999999999976433211100 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.+..... ..+..+.+||.+||+.||.+||++.+++++-
T Consensus 227 ----~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 227 ----ADYEMPS----FLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp ----SCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred ----cccCCcc----ccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 0001111 2245788999999999999999999998743
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=355.59 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=205.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++.+.||+|+||.||+|.+.. ++..||+|++........+.+.+|+++|+.++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4579999999999999999998865 5678999999876556677899999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEeecC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFG 284 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~vkl~DFG 284 (486)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 9999999999999999988654 46899999999999999999999988 9999999999999 788999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++........ .....||+.|+|||++.+ .++.++|||||||++|||++|+.||....... ..... .....
T Consensus 155 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~---~~~~~ 224 (277)
T 3f3z_A 155 LAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VMLKI---REGTF 224 (277)
T ss_dssp TCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHCCC
T ss_pred cceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HhCCC
Confidence 9987544332 234579999999998765 49999999999999999999999997543211 11100 00000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+ ...... ..+..+.+|+.+||+.||.+||++.+++++
T Consensus 225 ~~----~~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 TF----PEKDWL----NVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CC----CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CC----Cchhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000000 123578899999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=382.28 Aligned_cols=249 Identities=27% Similarity=0.346 Sum_probs=206.4
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..+|.+.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.+|+.++||||+++++++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHEL---------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETT---------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4689999999999999999999875 67899999997532 12345788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
...+..|||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EECCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEecc
Confidence 9999999999999999999998544 57999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
+++....... ....+||+.|+|||++.+..+ +.++|||||||++|||++|..||...... .+.... ....
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i---~~~~ 232 (476)
T 2y94_A 162 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKI---CDGI 232 (476)
T ss_dssp SCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHH---HTTC
T ss_pred chhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHH---hcCC
Confidence 9987654332 334689999999999988766 68999999999999999999999754321 111111 0000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. ..... .+..+.+||.+||+.||.+||++.+++++
T Consensus 233 ~--------~~p~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 F--------YTPQY----LNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp C--------CCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred c--------CCCcc----CCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 01111 23578899999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.20 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=203.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++.+.||+|+||.||+|.+. |..||||++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 357899999999999999999873 56899999986543 22456899999999999999999999998
Q ss_pred eC--CeeEEEEeecCCCChhHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 206 ED--DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 206 ~~--~~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
+. ...++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.++|+|
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEe
Confidence 87 788999999999999999976543 5899999999999999999999865 4599999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
||++..... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||....... ... ..
T Consensus 157 ~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~---~~ 223 (271)
T 3kmu_A 157 ADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---IGM---KV 223 (271)
T ss_dssp GGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---HHH---HH
T ss_pred ccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---HHH---HH
Confidence 988765322 1246899999999998765544 8999999999999999999997543211 000 00
Q ss_pred cccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.. ....+.+.. ..+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 224 ~~------~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 224 AL------EGLRPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HH------SCCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred Hh------cCCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00 011111122 23467899999999999999999999999997654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=382.71 Aligned_cols=266 Identities=23% Similarity=0.258 Sum_probs=197.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||+||+|++.. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 4689999999999999999998875 67899999997542 223456889999999999999999999997
Q ss_pred eC------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 206 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 206 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
.. ..+|||||||++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+|
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence 65 356999999966 56666632 4889999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh-h--
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-A-- 356 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~-~-- 356 (486)
|+|||+++...... ..+..+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.........+.. .
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999998764332 23456899999999999999999999999999999999999999976532111110000 0
Q ss_pred -------------hhhccc-----ccccccccCCccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 357 -------------RPHLGE-----RRRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 357 -------------~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
...+.. ...+...+...+.. ......+..+.+||.+||..||.+|||+.|++++-.
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 000000 00000011000000 011122567899999999999999999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=357.02 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=198.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|.+.+.||+|+||.||+|.+.. +|..||+|++.... ....+.+.+|+++|+.++||||+++++++.+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERS---------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hheeecceeccCCCeEEEEEEEcc---------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 468889999999999999998865 57799999987653 23457789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEe
Q 011412 208 DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLS 281 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~vkl~ 281 (486)
+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEE
Confidence 999999999999999998853 2467999999999999999999999988 9999999999999 456889999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||+++....... .....||+.|+|||++. ..++.++|||||||++|||++|+.||................
T Consensus 170 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---- 241 (285)
T 3is5_A 170 DFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE---- 241 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----
T ss_pred eeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC----
Confidence 9999987543322 33467999999999875 578999999999999999999999997543211111000000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+ . ..... .+..+.+|+.+||+.||.+||++.|++++
T Consensus 242 --~~~----~-~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 --PNY----A-VECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --CCC----C-C--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred --ccc----c-cccCc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 00011 13568899999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=365.85 Aligned_cols=264 Identities=27% Similarity=0.426 Sum_probs=200.3
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~ 202 (486)
....++|.+.+.||+|+||.||+|.+.... .++..||||++...... ..+.+.+|+.+++.++||||+++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQED------GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTT------SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccC------CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 345678999999999999999999886532 25678999999765332 2356889999999999999999999
Q ss_pred EEEeCC-----eeEEEEeecCCCChhHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 203 YCIEDD-----QRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 203 ~~~~~~-----~~~lv~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
++...+ ..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli 180 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCML 180 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEE
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEE
Confidence 998755 35999999999999999853 2356999999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011412 273 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 351 (486)
Q Consensus 273 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~ 351 (486)
+.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 257 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--- 257 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---
Confidence 9999999999999987654433223334567899999999999999999999999999999999 889997543221
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
+....... ..+.... ..+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 258 ~~~~~~~~----------~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 258 MYDYLLHG----------HRLKQPE----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HHHHHHTT----------CCCCCBT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcC----------CCCCCCc----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111000 0011111 2235789999999999999999999999999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=386.73 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=207.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|.+.+.||+|+||.||+|++.. +|+.||||++.... ......+.+|+.+|+.++||||+++++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA---------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3679999999999999999999865 67899999997532 12345688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
.+.+.+|||||||+||+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEe
Confidence 9999999999999999999998654 346999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||+++........ ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.......... ........
T Consensus 332 DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~~i~~ 407 (543)
T 3c4z_A 332 DLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRVLE 407 (543)
T ss_dssp CCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHHHHHH
T ss_pred ecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHHHHhh
Confidence 99999876543321 234689999999999999999999999999999999999999997654322111 11111111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVE 409 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~eil~ 409 (486)
... .++...+..+.+||.+||+.||.+||++ .+|++
T Consensus 408 ~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 QAV------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ccc------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 110 1112234678999999999999999975 55654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=356.95 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=209.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEecC----------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4678999999999999999998753 56899999986543 346789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccc
Confidence 9999999999999999999877678999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
...... ........||+.|+|||++.+..++.++||||||+++|||++ |..||...... ....... ..
T Consensus 153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~i~----~~--- 221 (267)
T 3t9t_A 153 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIS----TG--- 221 (267)
T ss_dssp GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----TT---
T ss_pred cccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHHHh----cC---
Confidence 653321 111223457889999999998999999999999999999999 89999754321 1111110 00
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
....... ..+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 222 ---~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 222 ---FRLYKPR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp ---CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CcCCCCc----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000111 1245788999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=355.67 Aligned_cols=262 Identities=20% Similarity=0.208 Sum_probs=208.4
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEE-EEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY-CIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~-~~~ 206 (486)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+|+.++..+.|++++..+.+ +..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC---------CCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 4689999999999999999999865 6779999998765433 468899999999998876655554 466
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEeec
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 283 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~vkl~DF 283 (486)
.+..++||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 77889999999 99999999766678999999999999999999999988 9999999999999 58899999999
Q ss_pred CCCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 284 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 284 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
|+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 999865443221 112346799999999999999999999999999999999999999987544332222211111
Q ss_pred -hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 359 -HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 359 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
..... .+.+... .+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 233 ~~~~~~-------~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 233 KKMSTP-------IEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHSC-------HHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred cccCCc-------hHHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 00000 0001111 2357899999999999999999999999998654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=360.78 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEE-
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI- 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~- 205 (486)
..+|++.+.||+|+||+||+|.+..+.. ++..||||.+..... ...+.+.+|+.++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCC------ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 3568889999999999999998765322 345799999976433 23456889999999999999999999865
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.++..++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccc
Confidence 456789999999999999999877778999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc--eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 286 AKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 286 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
++........ .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.......... ... ..
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~---~~~---~~ 248 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLL---QG 248 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH---HHH---TT
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HHh---cC
Confidence 9876443221 12234568899999999999999999999999999999999 556665443322111 100 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
. ...... ..+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 249 ~-------~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 249 R-------RLLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp C-------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------CCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 000111 1235789999999999999999999999999765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=354.76 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECC---------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence 4679999999999999999998865 577999999975432 334678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence 9999999999999999998854 346899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
................||+.|+|||++.+..+ +.++|||||||++|||++|..||........ ....+... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-----~~ 226 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK-----KT 226 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT-----CT
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc-----cc
Confidence 86543322222344679999999999987665 7799999999999999999999976443211 11111110 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
...+ . ...+..+.+|+.+||+.||.+||++.+++++.
T Consensus 227 ---~~~~--~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 227 ---YLNP--W----KKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp ---TSTT--G----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ---ccCc--h----hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 0000 0 11235688999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=354.70 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=205.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+.. +|..||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcC---------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 35689999999999999999998876 577999999975432 2235688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc---EEEe
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLS 281 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~---vkl~ 281 (486)
...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+
T Consensus 75 ~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 75 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEEC
T ss_pred EcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEe
Confidence 9999999999999999999988655 46899999999999999999999988 999999999999976655 9999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... .
T Consensus 151 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~---~ 221 (284)
T 3kk8_A 151 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIK---A 221 (284)
T ss_dssp CCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---H
T ss_pred eceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHHHHH---h
Confidence 9999977544322 234679999999999999999999999999999999999999996543211 111100 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... ....+ ... ..+..+.+|+.+||+.||.+||++.|++++
T Consensus 222 ~~~---~~~~~-~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 222 GAY---DYPSP-EWD----TVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TCC---CCCTT-TTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ccc---cCCch-hhc----ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 00000 011 123568899999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=365.57 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=198.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccH-HHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++++.||+|+||.||+|.+.. ++..||||++........ ..+.+|+.+|+.++||||+++++++...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 478999999999999999999875 577999999975432211 1355799999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..+|||||++ |+|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 99999999996 5999999877778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh--------
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-------- 358 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~-------- 358 (486)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus 149 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 149 AKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence 6543222 2334578999999999876 5789999999999999999999999976533211111110000
Q ss_pred hcccccccccccCCccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 359 HLGERRRFYRLIDPRLEGH----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.......+.....+..... .....+..+.+||.+||+.||.+|||+.|++++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 0000000000000000000 0011235688999999999999999999998743
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=357.39 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=208.5
Q ss_pred hcCCCCCC-eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|.+.+ .||+|+||.||+|.+... .++..||||+++.... ...+.+.+|+++|+.++||||+++++++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred HHHhhhhhccccccCceeEEEeEeccC-------CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 34666666 899999999999987532 2567899999986533 2346688999999999999999999998
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
..+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccc
Confidence 556789999999999999999777778999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcce-eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 286 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 286 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
++......... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... +...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~----~ 229 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQ----G 229 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHT----T
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhc----C
Confidence 98764432211 1223457899999999998899999999999999999998 999997643321 1111110 0
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
..+. ++...+..+.+||.+||+.||.+||++.+++++|+.+
T Consensus 230 ------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 230 ------KRME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ------CCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CcCC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011 1122346789999999999999999999999999755
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=359.22 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=205.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.|.+.++||+|+||.||+|.+..... ++..||+|++..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQ------NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSS------CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecCCC------ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 56677899999999999998765332 345799999976433 23456889999999999999999999998766
Q ss_pred ee-EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 209 QR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 209 ~~-~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
.. ++||||+.+|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 55 9999999999999999876778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcc--eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 288 DGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 288 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|..|+...... ..+.......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~------ 244 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLAQG------ 244 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHHTT------
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhhcC------
Confidence 65432211 1223456899999999999999999999999999999999966554332211 1111111100
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
....... ..+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 245 ----~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 245 ----RRLPQPE----YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ----CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCc----cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0001111 2235789999999999999999999999998765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=354.95 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=202.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++.+.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 4679999999999999999998876 56789999986432 12245688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCC
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecc
Confidence 9999999999999999999998654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... ..... ..
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~---~~--- 221 (279)
T 3fdn_A 155 WSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRI---SR--- 221 (279)
T ss_dssp EESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---HH---
T ss_pred ccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---HHHHH---Hh---
Confidence 987643322 234579999999999999999999999999999999999999997543211 10000 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
....+.. ..+..+.+||.+||+.||.+||++.|++++.
T Consensus 222 -----~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 222 -----VEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp -----TCCCCCT----TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred -----CCCCCCC----cCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0111111 1235788999999999999999999999854
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=353.74 Aligned_cols=264 Identities=20% Similarity=0.229 Sum_probs=205.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEE-E
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC-I 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~ 205 (486)
..++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+|+.++..+.|++++..+.++ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcC---------CCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 45689999999999999999998765 6779999987654322 3478899999999988766665554 6
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEee
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSD 282 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~vkl~D 282 (486)
..+..++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECC
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEec
Confidence 678889999999 99999999876778999999999999999999999988 9999999999999 7889999999
Q ss_pred cCCCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 283 FGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 283 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence 9999865443221 11234679999999999999999999999999999999999999998755433322222111
Q ss_pred h-hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 358 P-HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 358 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
. ..... . +.+... .+..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 232 ~~~~~~~---~----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 232 EKKMSTP---I----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHHSC---H----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cccccch---h----hhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 1 00000 0 000111 13578999999999999999999999999986543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=365.31 Aligned_cols=246 Identities=23% Similarity=0.301 Sum_probs=204.6
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhcCCCCCce
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLV 198 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv 198 (486)
..++|++.+.||+|+||.||+|.+.. +|..||||++...... ....+.+|+.+|+.++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKE---------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETT---------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEEEECC---------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 34689999999999999999998865 6779999999865321 123467899999999999999
Q ss_pred EEEEEEEeCCeeEEEEeecCCC-ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 199 KLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 199 ~~~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
++++++.+.+..++||||+.+| +|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence 9999999999999999999777 999988544 46999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+++....... ....+||+.|+|||++.+..+ +.++|||||||++|||++|..||......
T Consensus 169 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------- 236 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------- 236 (335)
T ss_dssp EEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------
T ss_pred EEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------
Confidence 99999999987654332 234679999999999988777 78999999999999999999999642110
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.. ....+ ... .+..+.+||.+||+.||.+||++.+++++-.
T Consensus 237 ---~~------~~~~~--~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 237 ---VE------AAIHP--PYL----VSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp ---TT------TCCCC--SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred ---Hh------hccCC--Ccc----cCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00 00000 111 2357899999999999999999999999654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=374.23 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=197.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe-
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 206 (486)
..|.+.+.||+|+||.||+|.+..... .+..||||.++.... ...+.+.+|+.+|++++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTT------EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCC------cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 357778899999999999998864321 245789999875432 334678999999999999999999998754
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccc
Confidence 56789999999999999999877777899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcce--eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 287 KDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 287 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
+......... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||......... .... ..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~~~~----~~ 312 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLL----QG 312 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---HHHH----TT
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---HHHH----cC
Confidence 8654322111 1233567889999999999999999999999999999999 67777654332211 1111 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
. .... . ..++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 313 ~---~~~~---p----~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 313 R---RLLQ---P----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp C---CCCC---C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---CCCC---C----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0111 1 12245789999999999999999999999999765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=364.92 Aligned_cols=260 Identities=22% Similarity=0.261 Sum_probs=200.3
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC-----CcccHHHHHHHHHHHhcCCCCCceEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-----GLQGHKEWLAEVNFLGDLVHLNLVKL 200 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~ 200 (486)
...++|++.+.||+|+||.||+|.+.. ++..||||++... .....+.+.+|+++|+.++||||+++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 93 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQ---------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhheeecceeeecCCeEEEEEEECC---------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence 455789999999999999999998865 6779999998643 22334678999999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhc---------------------------------------CCCCCHHHHHHH
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------------------------------SLPLPWSIRMKI 241 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i 241 (486)
++++.+.+..+||||||++|+|.+++... ...+++..++.+
T Consensus 94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 173 (345)
T 3hko_A 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173 (345)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence 99999999999999999999999988421 112356778899
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC--cEEEeecCCCCCCCCCCc--ceeeeeccccccccCcccccc--
Q 011412 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMT-- 315 (486)
Q Consensus 242 ~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~--~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-- 315 (486)
+.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||+++....... ........||+.|+|||++.+
T Consensus 174 ~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 174 MRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 999999999999988 99999999999998776 899999999985432111 112334679999999999875
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcc
Q 011412 316 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 395 (486)
Q Consensus 316 ~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 395 (486)
..++.++|||||||++|||++|+.||....... .. ......... ...+. . ...+..+.+||.+||+
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~---~~~~~~~~~---~~~~~-~----~~~~~~~~~li~~~l~ 316 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD---TI---SQVLNKKLC---FENPN-Y----NVLSPLARDLLSNLLN 316 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCCCC---TTSGG-G----GGSCHHHHHHHHHHSC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH---HH---HHHHhcccc---cCCcc-c----ccCCHHHHHHHHHHcC
Confidence 688999999999999999999999997543211 11 001111000 00000 0 1123578899999999
Q ss_pred cCCCCCCCHHHHHHHh
Q 011412 396 RDPKARPLMSEVVEAL 411 (486)
Q Consensus 396 ~dP~~RPs~~eil~~L 411 (486)
.||.+||++.+++++-
T Consensus 317 ~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 317 RNVDERFDAMRALQHP 332 (345)
T ss_dssp SCTTTSCCHHHHHHSH
T ss_pred CChhHCCCHHHHhcCh
Confidence 9999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=359.19 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=204.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|.+.+.||+|+||.||+|.+.. +|+.||||++..........+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRL---------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccceeeeeccCCCCceEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 4578999999999999999998865 5779999999865544456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEeecC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFG 284 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~vkl~DFG 284 (486)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred CEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 9999999999999999998654 46899999999999999999999988 9999999999999 788999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||...... .+..... ....
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~---~~~~ 224 (304)
T 2jam_A 155 LSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIK---EGYY 224 (304)
T ss_dssp TTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH---HCCC
T ss_pred cceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH---cCCC
Confidence 998654321 23357999999999999999999999999999999999999999754321 1111110 0000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. ....... ..+..+.+||.+||..||.+||++.+++++.
T Consensus 225 ~----~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 225 E----FESPFWD----DISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp C----CCTTTTT----TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred C----CCccccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 0 0111111 2246789999999999999999999999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=368.49 Aligned_cols=271 Identities=18% Similarity=0.195 Sum_probs=201.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----------HHHHHHHHHHHhcCCCCC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------HKEWLAEVNFLGDLVHLN 196 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~n 196 (486)
.++|++.+.||+|+||.||+|.+...+. ++..||||++....... ...+.+|+.++..+.|||
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPE------KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCG------GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCC------ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 3679999999999999999999875322 46689999997654221 123667889999999999
Q ss_pred ceEEEEEEEe----CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 197 LVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 197 Iv~~~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
|+++++++.. ....||||||| +++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 184 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEE
Confidence 9999999988 67899999999 999999986554 7999999999999999999999988 9999999999999
Q ss_pred cCCC--cEEEeecCCCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 011412 273 DADY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345 (486)
Q Consensus 273 ~~~~--~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~ 345 (486)
+.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8877 9999999999765322111 11134579999999999999999999999999999999999999996432
Q ss_pred CCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 346 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
.... ............ +...+..... ....+..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 265 ~~~~-~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 KDPV-AVQTAKTNLLDE---LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TCHH-HHHHHHHHHHHT---TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccH-HHHHHHHhhccc---ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 2111 011000000000 0000000000 00123578999999999999999999999999987643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=382.79 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=205.5
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.+..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|++++||||+++++++
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 248 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 248 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3455678999999999999999998853 3579999998654 3356799999999999999999999998
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
.+ +..+||||||++|+|.+++... +..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df 324 (452)
T 1fmk_A 249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF 324 (452)
T ss_dssp CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCC
Confidence 76 6789999999999999999643 356899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
|+++........ ......+++.|+|||++.+..++.++|||||||+||||++ |+.||...... .+..... .
T Consensus 325 G~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~----~ 396 (452)
T 1fmk_A 325 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVE----R 396 (452)
T ss_dssp CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH----T
T ss_pred ccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----c
Confidence 999876432221 1223457889999999999999999999999999999999 99999754321 1111110 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
. ... ..+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 397 ~------~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 397 G------YRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp T------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred C------CCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 0 000 1112234678999999999999999999999999987754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=378.47 Aligned_cols=201 Identities=28% Similarity=0.385 Sum_probs=168.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKN---------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 4689999999999999999999875 678999999975432 23456889999999999999999999997
Q ss_pred eC-----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 206 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 206 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
.. ..+||||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEE
Confidence 76 57899999995 599998854 457999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcc--------------------eeeeeccccccccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCC
Q 011412 281 SDFGLAKDGPEGDKT--------------------HVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGRR 339 (486)
Q Consensus 281 ~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltG~~ 339 (486)
+|||+++........ ...+..+||+.|+|||++ ....|+.++||||||||||||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999875433211 123457899999999986 56679999999999999999998655
Q ss_pred CCC
Q 011412 340 SMD 342 (486)
Q Consensus 340 pf~ 342 (486)
||.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 553
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=364.81 Aligned_cols=272 Identities=31% Similarity=0.426 Sum_probs=207.3
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC--
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 207 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 207 (486)
|++++.||+|+||.||++.+... ...+|+.||||++..... .....+.+|+++|+.++||||+++++++.+.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPT-----NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSC-----C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HhhhheecCCCCeEEEEEEEccC-----CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 48899999999999999976532 234788999999986543 2245688999999999999999999999874
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..+++||||+++|+|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 6789999999999999999654 4899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
........ .......||..|+|||++.+..++.++|||||||++|||++|..||....... .....+..... ....+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~ 260 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQM-TVLRL 260 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHH-HHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccch-hHHHH
Confidence 76544322 22334568899999999999999999999999999999999999986421100 00000000000 00000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...+........+...+..+.+||.+||+.||.+||++.++++.|+.+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 011111111112223346789999999999999999999999999755
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=358.57 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=198.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.+|++.+.||+|+||.||+|.+.. +|..||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETT---------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcC---------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 579999999999999999998865 577999999975432 23456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
..+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEe
Confidence 99999999999999999999864 3567899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .+..... .
T Consensus 180 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----~ 252 (310)
T 2wqm_A 180 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKIE----Q 252 (310)
T ss_dssp C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHHHH----T
T ss_pred ccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHHhh----c
Confidence 999986543221 12345799999999999999999999999999999999999999975432111 1111000 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
.. ..+.... ..+..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 253 -~~----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 253 -CD----YPPLPSD----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -TC----SCCCCTT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cc----CCCCccc----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 00 0000011 224578999999999999999999999999976543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=363.18 Aligned_cols=265 Identities=19% Similarity=0.246 Sum_probs=209.1
Q ss_pred ccChhHHHHHhcCCCCC-CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcC-C
Q 011412 118 KFTFNDLKLATRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDL-V 193 (486)
Q Consensus 118 ~~~~~~~~~~~~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~ 193 (486)
++.|.......++|.+. +.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.++..+ .
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~ 87 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTT
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccC
Confidence 34555566677788887 899999999999998875 67799999997543 23356789999999999 4
Q ss_pred CCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011412 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 272 (486)
Q Consensus 194 h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 272 (486)
||||+++++++...+..++|||||++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 88 ~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~ 164 (327)
T 3lm5_A 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILL 164 (327)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEE
Confidence 699999999999999999999999999999998543 457999999999999999999999988 9999999999999
Q ss_pred cC---CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 011412 273 DA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 349 (486)
Q Consensus 273 ~~---~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~ 349 (486)
+. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 165 ~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 241 (327)
T 3lm5_A 165 SSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241 (327)
T ss_dssp SCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 87 78999999999987643321 2346799999999999999999999999999999999999999975432111
Q ss_pred chhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 350 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..... ... ...........+..+.+||.+||+.||.+||++.+++++-
T Consensus 242 ---~~~i~---~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 242 ---YLNIS---QVN--------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp ---HHHHH---HTC--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred ---HHHHH---hcc--------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 00000 000 0001111112346788999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=366.63 Aligned_cols=267 Identities=22% Similarity=0.302 Sum_probs=194.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||+||+|.+.. +|+.||||++....... ...+.+|+.+|+.++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTV---------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECC---------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3579999999999999999998865 67799999997554322 345779999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-----CCCcEEE
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-----ADYNAKL 280 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-----~~~~vkl 280 (486)
+.+..+||||||+ |+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+ .++.+||
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred cCCEEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEE
Confidence 9999999999997 5999998655 46999999999999999999999988 99999999999994 4556999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 357 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~-- 357 (486)
+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...........+....
T Consensus 179 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 179 GDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp CCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 99999976432211 23345789999999998864 58999999999999999999999997643221111000000
Q ss_pred hh------cccccccccccCCccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 358 PH------LGERRRFYRLIDPRLEGH-----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 358 ~~------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
+. ........... +..... +....+..+.+||.+||+.||.+||++.|++++-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSF-PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTC-CCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred Cchhhhhhhhhhhhhhhhh-hhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 00 00000000000 000000 0001235788999999999999999999999743
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=366.71 Aligned_cols=271 Identities=24% Similarity=0.304 Sum_probs=201.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----HHHHHHHHHHHhcCCCCCceEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGDLVHLNLVKLI 201 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~ 201 (486)
..++|++++.||+|+||.||+|.+.. +|+.||||++....... ...+.+|+.+|+.++||||++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 34689999999999999999998765 67799999997543211 13578999999999999999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
+++...+..++||||+++ +|.+++......+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEE
Confidence 999999999999999975 899988777677999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh-hh
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-RP 358 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~-~~~-~~ 358 (486)
|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||...........+ ... .+
T Consensus 155 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 155 DFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp CCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999987643222 2334679999999999865 45899999999999999999999999765321111000 000 00
Q ss_pred hccccccccc---ccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 359 HLGERRRFYR---LIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 359 ~~~~~~~~~~---~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.......... .+........+ ...+..+.+||.+||+.||.+||++.|++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 0000000000 00000000000 122367899999999999999999999998653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=377.64 Aligned_cols=263 Identities=22% Similarity=0.244 Sum_probs=210.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC-CCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~ 206 (486)
.++|++++.||+|+||.||+|.+.. +++.||||++...... .++.+|++++..|.| ++|..+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ---------TNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT---------TCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC---------CCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 4689999999999999999999865 5779999998755432 357899999999987 566677777788
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEeec
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 283 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~vkl~DF 283 (486)
.+..+|||||+ +++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||| +.++.+||+||
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeC
Confidence 88999999999 99999999876778999999999999999999999988 9999999999999 68899999999
Q ss_pred CCCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 284 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 284 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
|+++........ .......||+.|+|||++.+..++.++||||||||||||++|+.||.................
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence 999875443221 112256899999999999999999999999999999999999999987654333222221111
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
... ...+. .+... ++..+.+||.+||+.||.+||++.+|++.|+.+.
T Consensus 231 ~~~-----~~~~~-~l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 231 KKV-----ATSIE-ALCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHH-----HSCHH-HHHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccc-----cccHH-HHhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 000 00000 00111 1357899999999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=354.25 Aligned_cols=250 Identities=28% Similarity=0.434 Sum_probs=206.2
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
....+|++.+.||+|+||.||+|.+.. +|+.||||++.... ..+.+|+++++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 74 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETT---------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhccccceeeeeccCCceEEEEEEEcC---------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence 345679999999999999999999865 57799999997654 35678999999999999999999986
Q ss_pred e----------------CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011412 206 E----------------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268 (486)
Q Consensus 206 ~----------------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 268 (486)
. ...+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~ 151 (284)
T 2a19_B 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPS 151 (284)
T ss_dssp EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHH
Confidence 5 44579999999999999999754 457999999999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011412 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348 (486)
Q Consensus 269 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~ 348 (486)
|||++.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 152 Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 225 (284)
T 2a19_B 152 NIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--- 225 (284)
T ss_dssp GEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---
T ss_pred HEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---
Confidence 99999999999999999987644322 233569999999999999999999999999999999999998874210
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
.... . +....+...+ +..+.+||.+||+.||.+||++.|++++|+.+..
T Consensus 226 --~~~~----~---------~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 226 --KFFT----D---------LRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp --HHHH----H---------HHTTCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred --HHHH----H---------hhcccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 0000 0 0011111222 3568899999999999999999999999976644
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=362.64 Aligned_cols=263 Identities=25% Similarity=0.330 Sum_probs=205.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..++|++.+.||+|+||.||+|.+.. +|+.||||++........+.+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLH---------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecC---------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 34689999999999999999998865 577999999976655556678999999999999999999999873
Q ss_pred ----CCeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 207 ----DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 207 ----~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
....++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~k 174 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPV 174 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEE
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEE
Confidence 3478999999999999999875 3567999999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcce-------eeeeccccccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 011412 280 LSDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 349 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltG~~pf~~~~~~~~ 349 (486)
|+|||+++......... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........
T Consensus 175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 254 (317)
T 2buj_A 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254 (317)
T ss_dssp ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS
T ss_pred EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc
Confidence 99999987643211000 011245799999999987554 68999999999999999999999953111100
Q ss_pred chhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 350 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
. +... .... ...... ...+..+.+||.+||+.||.+||++.+++++|+.+..
T Consensus 255 ~-~~~~----~~~~------~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 255 S-VALA----VQNQ------LSIPQS----PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp C-HHHH----HHCC--------CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred h-hhHH----hhcc------CCCCcc----ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 0000 0000 000001 1224678999999999999999999999999987654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=362.80 Aligned_cols=275 Identities=24% Similarity=0.361 Sum_probs=211.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++++.||+|+||.||+|.+.. ....+|..||||++........+.+.+|+.+|+.++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3578899999999999999998643 12237889999999876655567799999999999999999999998765
Q ss_pred C--eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 208 D--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 208 ~--~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+ ..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcc
Confidence 4 789999999999999999877777999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc-c-
Q 011412 286 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-E- 362 (486)
Q Consensus 286 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~-~- 362 (486)
++........ .......++..|+|||++.+..++.++|||||||++|||++|..||..... ........... .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQM 267 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhh
Confidence 9876543322 112234678889999999988999999999999999999999998853210 00000000000 0
Q ss_pred -ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 363 -RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 363 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...+...+........+..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0000000000000111122346789999999999999999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=357.49 Aligned_cols=259 Identities=27% Similarity=0.373 Sum_probs=204.8
Q ss_pred HhcCCCCCC-eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 127 ATRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 127 ~~~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
...+|.+.+ .||+|+||.||+|.+... .++..||||++...... ..+.+.+|+++++.++||||++++++
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCC-------CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 346788888 999999999999976432 25678999999765332 24678999999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+ ..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence 8 567789999999999999999654 46999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcce-eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 284 GLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 284 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|+++......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||....... +.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~---- 234 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLE---- 234 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----
Confidence 9998764433221 1223457789999999998899999999999999999999 999997643211 111111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.. ..+. ++...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 235 ~~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 235 KG------ERMG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp TT------CCCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cC------CCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 0011 1122346789999999999999999999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=372.02 Aligned_cols=257 Identities=24% Similarity=0.316 Sum_probs=195.4
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhcCCCCCc
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLVHLNL 197 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nI 197 (486)
...++|.+.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+|++++||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 202 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECC---------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence 456789999999999999999999876 677999999875321 111247899999999999999
Q ss_pred eEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC--
Q 011412 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-- 275 (486)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-- 275 (486)
|++++++. .+..+||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.+
T Consensus 203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS
T ss_pred eeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC
Confidence 99999975 45689999999999999988544 57999999999999999999999988 9999999999999654
Q ss_pred -CcEEEeecCCCCCCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011412 276 -YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351 (486)
Q Consensus 276 -~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~ 351 (486)
+.+||+|||+++...... .....+||+.|+|||++. ...|+.++|||||||++|+|++|..||........
T Consensus 278 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-- 352 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-- 352 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--
T ss_pred cceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--
Confidence 459999999998764322 234568999999999985 36788999999999999999999999975433211
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
+....... ... ..+..... .+..+.+||.+||+.||.+||++.|++++-.
T Consensus 353 ~~~~i~~~---~~~----~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 353 LKDQITSG---KYN----FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp HHHHHHTT---CCC----CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHhcC---CCC----CCchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 11111000 000 00000111 2357899999999999999999999998643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=389.67 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=203.3
Q ss_pred CCCCCC-eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 130 NFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++.+.+ .||+|+||.||+|.+... .++..||||+++.... ...+++.+|+++|+.++|||||++++++..
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECS-------SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeEcCcEEecCCCcEEEEEEEecC-------CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 334444 799999999999988642 2456899999986533 345789999999999999999999999876
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+.++||||||++|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 5689999999999999999877778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 288 DGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 288 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
........ .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||....... +..... ...
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~----~~~- 556 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIE----QGK- 556 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHH----TTC-
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCC-
Confidence 76443221 11222346789999999999999999999999999999998 999997654321 111111 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...++..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 557 ---------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 ---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0111222346789999999999999999999999998743
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=358.49 Aligned_cols=252 Identities=31% Similarity=0.476 Sum_probs=196.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+++|++++||||+++++++. +
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--N 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence 57889999999999999999873 5689999997543 3467899999999999999999999876 4
Q ss_pred eeEEEEeecCCCChhHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc-EEEeecCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGL 285 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-vkl~DFGl 285 (486)
..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+.++|+||||||+||||+.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 58999999999999999975432 4788999999999999999999943233999999999999998886 79999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...
T Consensus 153 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~------- 218 (307)
T 2eva_A 153 ACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH------- 218 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH-------
T ss_pred ccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh-------
Confidence 9765332 2234699999999999999999999999999999999999999975432211 0111100
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
....+..... .+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 219 --~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 219 --NGTRPPLIKN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp --TTCCCCCBTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred --cCCCCCcccc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0001111122 2356889999999999999999999999997653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=362.65 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=203.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcE--EEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT--VAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
++|++.+.||+|+||.||+|.+.. +|.. ||||.+.... ....+.+.+|+.+|.++ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 578999999999999999999876 4444 4999987532 22345688999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 269 (486)
.+.+..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 172 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 172 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccce
Confidence 99999999999999999999996543 46999999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 011412 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 348 (486)
Q Consensus 270 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~ 348 (486)
|||+.++.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~- 248 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA- 248 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred EEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-
Confidence 999999999999999997532211 1223457889999999998899999999999999999998 99999754321
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.+.... .. .... ..+...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 249 --~~~~~~----~~------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 249 --ELYEKL----PQ------GYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp --HHHHHG----GG------TCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHh----hc------CCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111 00 0011 111123467899999999999999999999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=365.15 Aligned_cols=257 Identities=18% Similarity=0.172 Sum_probs=204.8
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCCceEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIG 202 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~ 202 (486)
...++|.+.+.||+|+||+||+|.+.... ...+++.||||++.... ..++..|++++..++ |+||+++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLN----DAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCc----ccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 34567999999999999999999653311 12367899999997653 456778888888886 999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC----
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---- 274 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---- 274 (486)
++...+..|||||||++|+|.+++.. ....+++..++.|+.||+.||+|||+.+ ||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 99999999999999999999999964 3457999999999999999999999988 999999999999988
Q ss_pred -------CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011412 275 -------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 347 (486)
Q Consensus 275 -------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~ 347 (486)
++.+||+|||+++..............+||+.|||||++.+..|+.++|||||||+||||+||+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997543323333445678999999999999999999999999999999999999998543211
Q ss_pred CcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCC
Q 011412 348 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPL 414 (486)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~eil~~L~~~ 414 (486)
. + .....+. . +. ....+.+++..||+.+|.+|+ ++.++.+.|+.+
T Consensus 292 ~------~---------~~~~~~~----~-~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 292 E------C---------KPEGLFR----R-LP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp E------E---------EECSCCT----T-CS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred c------e---------eechhcc----c-cC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0 0 0000111 0 01 145678999999999999995 778887777643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=349.50 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=202.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCCceEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 201 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~ 201 (486)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+|+.++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 3578999999999999999999865 5779999998754321 357789999999999999999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----c
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 277 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~----~ 277 (486)
+++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCC
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCc
Confidence 9999999999999999999999999654 46899999999999999999999988 99999999999998877 8
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... ......
T Consensus 151 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~ 224 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLTNIS 224 (283)
T ss_dssp EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH
T ss_pred eEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHHHhH
Confidence 99999999987543322 234579999999999999999999999999999999999999997543211 110000
Q ss_pred hhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..... .++.... ..+..+.+|+.+||..||.+||++.+++++
T Consensus 225 ---~~~~~----~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 225 ---AVNYD----FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ---TTCCC----CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ---hcccC----Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 00000 0000011 123568899999999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=355.14 Aligned_cols=260 Identities=23% Similarity=0.261 Sum_probs=200.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++.+.||+|+||.||+|.+.. +++.||||++....... .+.+.+|+.++..++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV---------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC---------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 3689999999999999999998865 57799999997553322 35688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
..++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCC
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCc
Confidence 9999999999999999999999654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+....
T Consensus 180 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----~~~~~~ 251 (309)
T 2h34_A 180 IASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGA----HINQAI 251 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHH----HHHSCC
T ss_pred cCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHH----HhccCC
Confidence 99875443221 223457999999999999999999999999999999999999999754221 0100 111100
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCCCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPN 416 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~eil~~L~~~~~ 416 (486)
..... +....+..+.+||.+||+.||.+|| ++.++++.|+....
T Consensus 252 ~~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 252 PRPST--------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp CCGGG--------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CCccc--------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 00001 1112235688999999999999999 99999999976543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=365.63 Aligned_cols=268 Identities=26% Similarity=0.395 Sum_probs=200.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||.||+|.+.. +|+.||||++....... .+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETT---------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECC---------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 3579999999999999999999875 67799999986554322 345789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+.+..++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCEEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCC
Confidence 9999999999999988888764 3457999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh-hh-----
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RP----- 358 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~-~~----- 358 (486)
++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+... ..
T Consensus 171 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 171 ARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 986543222 22345799999999998765 7899999999999999999999999765332111100000 00
Q ss_pred --hcccccccccccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 359 --HLGERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 359 --~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.......+.....+.+..... ...+..+.+||.+||+.||.+||++.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000011111111111 1224678999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=354.82 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=207.7
Q ss_pred HHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 124 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
+....++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+++|+.++||||++++++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~ 76 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEE
Confidence 3445578999999999999999999874 35679999997654 345778999999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
+. .+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 77 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 77 VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred Ec-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECC
Confidence 86 456899999999999999986432 36899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.....
T Consensus 153 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---- 224 (279)
T 1qpc_A 153 FGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLE---- 224 (279)
T ss_dssp CTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH----
T ss_pred CcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHHh----
Confidence 9999876543221 1223457889999999998899999999999999999999 99999754321 1111110
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.. ....... ..+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 225 ~~------~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 225 RG------YRMVRPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp TT------CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc------cCCCCcc----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 00 0111111 2246789999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=366.00 Aligned_cols=264 Identities=26% Similarity=0.385 Sum_probs=203.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++.+.||+|+||.||+|.+.... ...++..||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCC----CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 468999999999999999999864311 123677999999975432 334568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCc
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYN 277 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~ 277 (486)
.+..||||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence 999999999999999999997653 35889999999999999999999988 999999999999984 456
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+....
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHH
Confidence 99999999875433222222334568999999999999999999999999999999998 99999754321 111111
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.. . ..+... ...+..+.+||.+||+.||.+||++.+++++|+.+.
T Consensus 259 ~~----~------~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 259 TS----G------GRMDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HT----T------CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hc----C------CCCCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 10 0 000111 122457889999999999999999999999997553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=368.42 Aligned_cols=259 Identities=27% Similarity=0.335 Sum_probs=204.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcC-CCCCceEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 203 (486)
.+|++++.||+|+||.||+|++... ..+|+.||||+++.... .....+.+|+++|..+ .||||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISG------HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSS------TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEccc------CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 5799999999999999999988532 12688999999875321 2234567899999999 69999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+...+..+||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeC
Confidence 99999999999999999999999655 36899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|+++....... ......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||........... .......
T Consensus 204 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~ 280 (355)
T 1vzo_A 204 GLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILK 280 (355)
T ss_dssp SEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHH
T ss_pred CCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH--HHHHHhc
Confidence 99986543222 12334679999999999885 3578999999999999999999999975433222111 1111111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhc
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALK 412 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~L~ 412 (486)
. .+.+.. ..+..+.+||.+||..||.+|| ++.+++++..
T Consensus 281 ~--------~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 281 S--------EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp C--------CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred c--------CCCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0 111112 2345788999999999999999 9999988654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=374.77 Aligned_cols=242 Identities=18% Similarity=0.207 Sum_probs=190.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC---CcccHHHHHHHH---HHHhcCCCCCceEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---GLQGHKEWLAEV---NFLGDLVHLNLVKLI 201 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~~~ 201 (486)
.++|++.+.||+|+||+||+|.+.. +|+.||||++... .....+.+.+|+ ++|+.++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECC---------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 4678999999999999999998765 6779999999743 223346788999 555566899999998
Q ss_pred -------EEEEeCC-----------------eeEEEEeecCCCChhHHHhhcCC------CCCHHHHHHHHHHHHHHHHH
Q 011412 202 -------GYCIEDD-----------------QRLLVYEFMPRGSLENHLFRRSL------PLPWSIRMKIALGAAKGLAF 251 (486)
Q Consensus 202 -------~~~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~------~l~~~~~~~i~~qi~~~l~y 251 (486)
+++...+ ..||||||| +|+|.+++..... .+++..++.|+.||+.||+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 6666553 278999999 6899999975421 23358888999999999999
Q ss_pred HHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccC-----------CCCc
Q 011412 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----------HLTS 320 (486)
Q Consensus 252 LH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ 320 (486)
||+++ |+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .|+.
T Consensus 222 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 292 (377)
T 3byv_A 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF 292 (377)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred HHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence 99988 99999999999999999999999999986332 2344678 999999999887 8999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 011412 321 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 400 (486)
Q Consensus 321 ~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~ 400 (486)
++|||||||+||||++|+.||...........+ ... ...+ +..+.+||.+||+.||.+
T Consensus 293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------~~~--~~~~----~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 293 SFDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------FRS--CKNI----PQPVRALLEGFLRYPKED 350 (377)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------CCSGGG----------------GSS--CCCC----CHHHHHHHHHHTCSSGGG
T ss_pred hhhHHHHHHHHHHHHHCCCCCcccccccchhhh----------------hhh--ccCC----CHHHHHHHHHHcCCCchh
Confidence 999999999999999999999754332211100 000 0112 357889999999999999
Q ss_pred CCCHHHHHHH
Q 011412 401 RPLMSEVVEA 410 (486)
Q Consensus 401 RPs~~eil~~ 410 (486)
||++.+++++
T Consensus 351 Rpt~~e~l~h 360 (377)
T 3byv_A 351 RLLPLQAMET 360 (377)
T ss_dssp CCCHHHHHTS
T ss_pred CCCHHHHhhC
Confidence 9999999873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=352.98 Aligned_cols=247 Identities=21% Similarity=0.265 Sum_probs=200.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcC-CCCCceEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKLIGY 203 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 203 (486)
..++|++++.||+|+||.||+|.+.. +++.||||++..... ....++.+|+.++..+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~ 79 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRL---------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA 79 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcC---------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 34679999999999999999999865 577999999986433 2345688999999999 99999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-----
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----- 275 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~----- 275 (486)
+.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------
T ss_pred eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcc
Confidence 99999999999999999999999654 256899999999999999999999988 9999999999999844
Q ss_pred --------------CcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCC
Q 011412 276 --------------YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 340 (486)
Q Consensus 276 --------------~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~p 340 (486)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.++
T Consensus 157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp -------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 479999999998764422 23599999999998765 667899999999999999999887
Q ss_pred CCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 341 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
+.... ....... ...+.+...+ +..+.+|+.+||+.||.+||++.+++++-
T Consensus 231 ~~~~~-----~~~~~~~-----------~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 231 PRNGD-----QWHEIRQ-----------GRLPRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp CSSSH-----HHHHHHT-----------TCCCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred Ccchh-----HHHHHHc-----------CCCCCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 64321 1111100 0011122222 36789999999999999999999999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=369.25 Aligned_cols=267 Identities=24% Similarity=0.348 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++.+.||+|+||.||+|.+.. +|..||+|++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECC---------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 4689999999999999999999875 677999999986532 224568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
++..+|||||+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 178 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCC
Confidence 99999999999999999999655 3689999999999999999999985 7 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh------
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH------ 359 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~------ 359 (486)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus 179 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 179 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp CHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred Ccccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 8653221 123457999999999999999999999999999999999999999754321110000000000
Q ss_pred ---------c-------ccccccc----cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 360 ---------L-------GERRRFY----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 360 ---------~-------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. ....... ...............+..+.+||.+||+.||.+|||+.|++++-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 0 0000000 00000000000111245789999999999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=365.10 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=189.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 205 (486)
...+|++.+.||+|+||.||+|.+.. +|+.||||++..........+.+|+.++.++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVG---------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCceEEEEEEEccCCceEEEEEEECC---------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 34579999999999999999999865 67799999997665555567899999999996 999999999984
Q ss_pred --------eCCeeEEEEeecCCCChhHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011412 206 --------EDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 206 --------~~~~~~lv~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 275 (486)
....+++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTT
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCC
Confidence 3345799999995 799998864 3457999999999999999999999865 349999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcce----------eeeeccccccccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011412 276 YNAKLSDFGLAKDGPEGDKTH----------VSTRVMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~elltG~~pf~ 342 (486)
+.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 999999999998764432211 11135699999999998 56778999999999999999999999996
Q ss_pred CCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 343 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
....... . ... ........ .+..+.+|+.+||+.||.+||++.|++++|+.+.
T Consensus 255 ~~~~~~~---~-------~~~------~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 255 DGAKLRI---V-------NGK------YSIPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ---------------------------CCCCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHh---h-------cCc------ccCCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 5322110 0 000 00000011 1234789999999999999999999999997654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=351.36 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=200.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|....+||+|+||.||+|.+.. ++..||||++........+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETT---------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEeecCcEEEEEEEECC---------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 345566699999999999998865 57799999998766555677999999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeecCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGL 285 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~vkl~DFGl 285 (486)
..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccc
Confidence 9999999999999999997653 34678899999999999999999988 999999999999987 89999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ...+....
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~---- 240 (295)
T 2clq_A 170 SKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGM---- 240 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHHH----
T ss_pred ccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhcc----
Confidence 986543221 12345799999999998764 38999999999999999999999996432111 00000000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
....+.+.. ..+..+.+|+.+||+.||.+||++.+++++
T Consensus 241 ----~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 241 ----FKVHPEIPE----SMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ----HCCCCCCCT----TSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ----ccccccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011111222 234678899999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=361.26 Aligned_cols=270 Identities=24% Similarity=0.313 Sum_probs=203.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.+|++++.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETT---------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEECC---------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 579999999999999999999865 6779999998654322 23568899999999999999999999987
Q ss_pred --------CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 207 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 207 --------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
.+..+||||||++ +|.+.+......+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp C--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred cccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence 3468999999965 888888776678999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCc--ceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011412 279 KLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 279 kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~ 355 (486)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+..
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999986542221 112234678999999998875 5689999999999999999999999986543221111111
Q ss_pred hhhhccc-------ccccccccCCccCCCCCH--H-----HHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 356 ARPHLGE-------RRRFYRLIDPRLEGHFSI--K-----GAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 356 ~~~~~~~-------~~~~~~~~~~~~~~~~~~--~-----~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
....... .......+.......... . .+..+.+||.+||+.||.+||++.|++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 0000000 000000000000000000 0 134588999999999999999999999854
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=357.58 Aligned_cols=257 Identities=21% Similarity=0.282 Sum_probs=201.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~ 206 (486)
.++|++++.||+|+||.||+|.+.. +++.||||++.... .+.+.+|+.+|+.+. ||||+++++++.+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECC---------CCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 3679999999999999999998865 57799999997543 467899999999997 9999999999988
Q ss_pred --CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEeec
Q 011412 207 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDF 283 (486)
Q Consensus 207 --~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~vkl~DF 283 (486)
....++||||+++++|.+++. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 667899999999999999874 3789999999999999999999988 99999999999999776 8999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh----h
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR----P 358 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~----~ 358 (486)
|+++....... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......... +..... .
T Consensus 176 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~ 251 (330)
T 3nsz_A 176 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTE 251 (330)
T ss_dssp TTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHH
T ss_pred CCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCc
Confidence 99986544332 233579999999999876 67999999999999999999999999644321110 000000 0
Q ss_pred hc----c-----------------cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 359 HL----G-----------------ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 359 ~~----~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.. . ........... ......+..+.+||.+||+.||.+|||+.|++++-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS----ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCT----TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhccc----cccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 00 0 00000001111 11111346789999999999999999999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=352.72 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=205.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++.+.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ---------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcC---------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 3579999999999999999998865 57789999986432 12346788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 84 HDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred EcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccc
Confidence 9999999999999999999999655 36899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... .. .....
T Consensus 160 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~--- 226 (284)
T 2vgo_A 160 WSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---TH---RRIVN--- 226 (284)
T ss_dssp TCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHT---
T ss_pred ccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HH---HHHhc---
Confidence 987654322 234579999999999999999999999999999999999999997542211 10 00000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+..+.. ..+..+.+||.+||+.||.+||++.+++++
T Consensus 227 -----~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 227 -----VDLKFPP----FLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -----TCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -----cccCCCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0111111 224578899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=362.04 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=205.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|.+.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4679999999999999999999876 577999999875432 2345688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred ecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeecc
Confidence 9999999999999999999988654 47899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. .......
T Consensus 187 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~~~- 257 (335)
T 2owb_A 187 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TY---LRIKKNE- 257 (335)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHHTC-
T ss_pred CceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HHHhcCC-
Confidence 9987543222 1234679999999999999999999999999999999999999996532111 10 0000000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+.. ..+..+.+||.+||+.||.+||++.+++++
T Consensus 258 -------~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 -------YSIPK----HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -------CCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111 123568899999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=380.03 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=203.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||+||+|.+.. +|+.||||++.... ......+.+|+.+|+.++|||||++++++.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETT---------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 4579999999999999999999865 67799999986432 233567899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCcEEEee
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSD 282 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~---~~~~vkl~D 282 (486)
+....|+|||||.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEE
Confidence 999999999999999999988655 46999999999999999999999988 99999999999994 456799999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||+++....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....... +..... ..
T Consensus 168 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~---~~ 237 (486)
T 3mwu_A 168 FGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVE---TG 237 (486)
T ss_dssp CSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---HT
T ss_pred CCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH---hC
Confidence 999987544322 334579999999998875 59999999999999999999999997643211 111110 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
... .+..... ..+..+.+||.+||+.||.+||++.+++++-
T Consensus 238 ~~~----~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 238 KYA----FDLPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp CCC----SCSGGGG----GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred CCC----CCCcccC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 000 0000011 1245789999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=355.22 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=202.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..++|++.+.||+|+||.||+|.+.. +|..||||++.... ....+.+|+.++..++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETT---------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECC---------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 45689999999999999999998865 67799999997653 23678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 172 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVA 172 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccc
Confidence 99999999999999999999766678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... ..
T Consensus 173 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~---~~---- 240 (314)
T 3com_A 173 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AIFMIP---TN---- 240 (314)
T ss_dssp EECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH---HS----
T ss_pred hhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHh---cC----
Confidence 76543221 1234579999999999999999999999999999999999999997543211 000000 00
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+.+ ..+...+..+.+||.+||+.||.+||++.+++++
T Consensus 241 ---~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 241 ---PPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ---CCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---CCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 0011124578899999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=388.69 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=211.2
Q ss_pred HHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEE
Q 011412 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 123 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~ 202 (486)
.+.+..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+++.+|+++|+.|+|+|||++++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 329 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344556788899999999999999998853 3579999998654 34577999999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
++.+ +..+||||||++|+|.++|... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+
T Consensus 330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 405 (535)
T 2h8h_A 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 405 (535)
T ss_dssp EECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEc
Confidence 9876 6789999999999999999643 356899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+.....
T Consensus 406 DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i~--- 478 (535)
T 2h8h_A 406 DFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVE--- 478 (535)
T ss_dssp CTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHHH---
T ss_pred ccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---
Confidence 9999987643211 11223457889999999999999999999999999999999 99999754321 1111110
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
... + .. .+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 479 -~~~---~---~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 479 -RGY---R---MP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -TTC---C---CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -cCC---C---CC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 000 0 00 111234678999999999999999999999999988754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=371.28 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=198.1
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
...++|++.+.||+|+||+||+|.+.. +|+.||||++..... ...+|+++|+.++|||||+++++|.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccceEEEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheee
Confidence 456789999999999999999999865 678999999975532 2347999999999999999999985
Q ss_pred e--------------------------------------CCeeEEEEeecCCCChhHHHh---hcCCCCCHHHHHHHHHH
Q 011412 206 E--------------------------------------DDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALG 244 (486)
Q Consensus 206 ~--------------------------------------~~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~q 244 (486)
. ...+++|||||+ |+|.+.+. .....+++..+..++.|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQ 149 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 4 334889999997 58877765 34567999999999999
Q ss_pred HHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccC-CCCchh
Q 011412 245 AAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRS 322 (486)
Q Consensus 245 i~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 322 (486)
|+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++
T Consensus 150 i~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 150 LFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcch
Confidence 999999999988 99999999999997 688999999999986544332 2345789999999988764 599999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhh-hhcc---------cccccccccCCccCCCCCHHHHHHHHHHHH
Q 011412 323 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR-PHLG---------ERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 391 (486)
Q Consensus 323 DvwslGvil~elltG~~pf~~~~~~~~~~~~-~~~~-~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 391 (486)
|||||||++|||++|+.||...........+ .... +... ....+.......+...++...+..+.+||.
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence 9999999999999999999764322111100 0000 0000 000000000000111122223467899999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 011412 392 HCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 392 ~cl~~dP~~RPs~~eil~~ 410 (486)
+||+.||.+|||+.|++++
T Consensus 304 ~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHCCSSGGGSCCHHHHHTS
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=391.83 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=206.2
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCceEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLI 201 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~ 201 (486)
....+|++++.||+|+||.||+|.+.. +++.||||+++... ......+..|..+|..+ +||||++++
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~ 408 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESS---------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 345789999999999999999999875 67799999997431 12335678899999988 799999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
+++.+.+.+||||||+++|+|.++|... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+
T Consensus 409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp EECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEEC
T ss_pred EEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEe
Confidence 9999999999999999999999999765 46999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||+++....... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+.. ..+.
T Consensus 485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~~---~i~~ 556 (674)
T 3pfq_A 485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIME 556 (674)
T ss_dssp CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHS
T ss_pred ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHHH---HHHh
Confidence 9999986433222 234578999999999999999999999999999999999999999764321 1111 1111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 410 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~eil~~ 410 (486)
... .++...+..+.+||.+||+.||.+||++ .||+++
T Consensus 557 ~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 557 HNV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp SCC------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCC------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 111 1122234678999999999999999997 666653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=354.57 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=207.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+.|++++.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.+.||||+++++++...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHhhhhcccCCeEEEEEEECC---------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 568899999999999999998765 677999999976543 3457789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
...++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence 999999999999999999854 46899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......
T Consensus 168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~---------- 232 (303)
T 3a7i_A 168 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLIP---------- 232 (303)
T ss_dssp ECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----------
T ss_pred ecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHhh----------
Confidence 6543221 1234579999999999999999999999999999999999999997543211 111100
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
....+.+...+ +..+.+|+.+||+.||.+||++.+++++..
T Consensus 233 ~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 233 KNNPPTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp HSCCCCCCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred cCCCCCCcccc----CHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 00111122222 356889999999999999999999987653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=354.12 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=197.6
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..++|++.+.||+|+||.||+|.+ +|..||||+++... ..+.+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-----------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 346899999999999999999976 36689999997653 34678999999999999999999999765
Q ss_pred C-CeeEEEEeecCCCChhHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 207 D-DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 207 ~-~~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
. +..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecc
Confidence 4 478999999999999999975432 3789999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
+++...... ....+++.|+|||++.+..++.++|||||||++|||++ |..||....... +..... .
T Consensus 163 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~----~- 229 (278)
T 1byg_A 163 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----K- 229 (278)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHT----T-
T ss_pred ccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----c-
Confidence 998654321 22457899999999999999999999999999999998 999997543211 111110 0
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
..... .+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 230 -----~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 230 -----GYKMD----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp -----TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCC----CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 00111 1122346789999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=382.13 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=206.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
..++|++.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.+|++++|||||+++++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 94 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKI---------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECC---------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34579999999999999999999875 67799999996543 2345678999999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEE
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKL 280 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~vkl 280 (486)
+.+.+..++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||| +.++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 95 FEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEE
Confidence 99999999999999999999998654 46999999999999999999999988 9999999999999 56789999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
+|||+++....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....... +.....
T Consensus 171 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~--- 240 (484)
T 3nyv_A 171 IDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKVE--- 240 (484)
T ss_dssp CCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---
T ss_pred EeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---
Confidence 99999986544322 234679999999998865 79999999999999999999999997643211 111110
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..... ....... ..+..+.+||.+||+.||.+|||+.+++++-
T Consensus 241 ~~~~~----~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 241 KGKYT----FELPQWK----KVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HCCCC----CCSGGGG----GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred cCCCC----CCCcccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 00000 0000011 1246789999999999999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=367.51 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=197.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+++|+.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 3679999999999999999998865 6789999999654322 2356889999999999999999999997
Q ss_pred eCC------eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 206 ~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
... .+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEE
Confidence 753 459999999 8899999865 46899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
|+|||+++..... .+...||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.....
T Consensus 169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999875432 234579999999999887 7899999999999999999999999976432211110000000
Q ss_pred --------hccc--cccc----ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 359 --------HLGE--RRRF----YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 359 --------~~~~--~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.+.. ...+ .......+. .+....+..+.+|+.+||..||.+|||+.+++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 0000 0000 000000000 11112346789999999999999999999999853
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=353.25 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=205.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|.+.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.+++.+.||||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC---------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 4679999999999999999998865 577999999875432 2245688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEecc
Confidence 9999999999999999999988654 47899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... . ........
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---~~~~~~~~- 231 (294)
T 2rku_A 161 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---T---YLRIKKNE- 231 (294)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHTTC-
T ss_pred CceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHhhcc-
Confidence 9987543222 1234579999999999998899999999999999999999999997542211 0 00000000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+.. ..+..+.+|+.+||+.||.+||++.+++++
T Consensus 232 -------~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 -------YSIPK----HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -------CCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CCCcc----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01111 223568899999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=376.90 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=199.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||+||+|.+.. ++..||||++.... ......+.+|+.+|+.++|||||+++++|.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKV---------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETT---------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3578999999999999999999865 67799999997543 223467899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCcEEEee
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSD 282 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~vkl~D 282 (486)
+....|||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence 999999999999999999988655 46899999999999999999999988 999999999999975 45599999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
||+++...... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||....... +..... ..
T Consensus 183 fG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~---~~ 252 (494)
T 3lij_A 183 FGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRKVE---KG 252 (494)
T ss_dssp CTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---HT
T ss_pred CCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH---hC
Confidence 99998764432 233467999999999875 579999999999999999999999997643221 111110 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... .+...... .+..+.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~----~~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 253 KYT----FDSPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCC----CCSGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCC----CCchhccc----CCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000 01111111 23578899999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=359.68 Aligned_cols=265 Identities=23% Similarity=0.371 Sum_probs=188.4
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
...++|++.+.||+|+||.||+|.+.. ++..||||++..... ....++.+|+.++..++||||+++++++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAP---------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECC---------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 445789999999999999999998765 567999999875432 2345688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
...+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 159 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGS 159 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCC
Confidence 999999999999999999999864 2456899999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCc---ceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011412 278 AKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~ 353 (486)
+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.........
T Consensus 160 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--- 236 (303)
T 2vwi_A 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--- 236 (303)
T ss_dssp EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---
T ss_pred EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---
Confidence 99999999876543211 111234579999999999875 57899999999999999999999999764332111
Q ss_pred Hhhhhhcccccccc-cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 354 EWARPHLGERRRFY-RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 354 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.... ........ ...++.....+ +..+.+|+.+||+.||.+||++.+++++-
T Consensus 237 ~~~~--~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 237 MLTL--QNDPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp HHHH--TSSCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred HHHh--ccCCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0000 00000000 00111111222 35688999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=355.49 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=203.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3578999999999999999998865 577999999976543 22456889999999999999999999885
Q ss_pred e--CCeeEEEEeecCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCcEEEcCCCcE
Q 011412 206 E--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 206 ~--~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~--~~~iiHrDLKp~NIll~~~~~v 278 (486)
+ ....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence 4 57889999999999999999643 345999999999999999999999865 2349999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .+.....
T Consensus 156 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~- 229 (279)
T 2w5a_A 156 KLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIR- 229 (279)
T ss_dssp EECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-
T ss_pred EEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHHh-
Confidence 9999999986543221 122357999999999999999999999999999999999999999754321 1111110
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
.. ..+.+.. ..+..+.+|+.+||+.||.+||++.+|+++++.
T Consensus 230 ---~~------~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 230 ---EG------KFRRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---HT------CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---hc------ccccCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 00 0011111 234678999999999999999999999987753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=358.66 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=202.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..++|++++.||+|+||.||+|.+.. +|..||+|++..........+.+|+.+|+.++||||+++++++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETT---------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccceeecceeccCCCeEEEEEEEcC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 34689999999999999999999865 577999999987766667889999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..++||||+++++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCC
Confidence 99999999999999999998776678999999999999999999999988 999999999999999999999999987
Q ss_pred CCCCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
...... ........||+.|+|||++. ...++.++|||||||++|+|++|..||....... ..... ..
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~----~~ 236 (302)
T 2j7t_A 165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKI----AK 236 (302)
T ss_dssp HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH----HH
T ss_pred cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHHH----hc
Confidence 532110 01122357999999999883 6778999999999999999999999997543211 00000 00
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.. ..... .+...+..+.+|+.+||+.||.+||++.+++++-
T Consensus 237 ~~--~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 237 SD--PPTLL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp SC--CCCCS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred cC--CcccC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 00 00000 1112245788999999999999999999998753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=356.63 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=199.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++.+.||+|+||+||+|.+.... +.+..||||+++.... ...+.+.+|++++..++||||+++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCC------CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 357999999999999999999875421 1334699999875432 2346788999999999999999999998
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.... .++||||+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred ccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccc
Confidence 8765 89999999999999999876667999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcce-eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 285 LAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 285 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
+++......... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||...... .+.... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~---~~~ 240 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI---DKE 240 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HTS
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHHH---Hcc
Confidence 998765433221 2233568889999999998899999999999999999999 99999754321 111110 000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.. ..... ...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 241 ~~------~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 241 GE------RLPRP----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC------CCCCC----cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 00 00111 123467899999999999999999999999997654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=367.74 Aligned_cols=265 Identities=20% Similarity=0.248 Sum_probs=205.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC--------CCCceE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV--------HLNLVK 199 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~ 199 (486)
.++|++.+.||+|+||+||+|++.. +++.||||++.... .....+.+|+.+|+.+. |+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ---------GKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC---------CCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 4689999999999999999998865 67799999997542 23456889999999985 788999
Q ss_pred EEEEEE----eCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEc
Q 011412 200 LIGYCI----EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLD 273 (486)
Q Consensus 200 ~~~~~~----~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~ 273 (486)
+++++. .....||||||+ +++|.+++... ...+++..++.|+.||+.||.|||++ + |+||||||+||||+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~ 181 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLS 181 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEEC
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEe
Confidence 999987 456889999999 66777766544 35799999999999999999999997 7 99999999999998
Q ss_pred CCC-------------------------------------------------cEEEeecCCCCCCCCCCcceeeeecccc
Q 011412 274 ADY-------------------------------------------------NAKLSDFGLAKDGPEGDKTHVSTRVMGT 304 (486)
Q Consensus 274 ~~~-------------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt 304 (486)
.++ .+||+|||+++..... .....||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt 256 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT 256 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence 775 7999999999875432 2335799
Q ss_pred ccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHH---hhhhhccc------------------c
Q 011412 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE---WARPHLGE------------------R 363 (486)
Q Consensus 305 ~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~---~~~~~~~~------------------~ 363 (486)
+.|+|||++.+..|+.++|||||||+||||++|+.||............. .....+.. .
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 99999999999999999999999999999999999998655433211110 00000000 0
Q ss_pred cccccccCCc---------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 364 RRFYRLIDPR---------LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 364 ~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.....+.+.. ....++...+..+.+||.+||+.||.+||++.|++++-
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 0000000000 01123556678899999999999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=350.19 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=199.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecC---------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 357888899999999999998865 677999999875432 234568899999999999999999999876
Q ss_pred ----CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCcEEEe
Q 011412 207 ----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLS 281 (486)
Q Consensus 207 ----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~~~vkl~ 281 (486)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ .+|+||||||+||||+ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEe
Confidence 35689999999999999999654 46899999999999999999999865 3499999999999997 78999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||++....... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||....... .......
T Consensus 175 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~---- 243 (290)
T 1t4h_A 175 DLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVT---- 243 (290)
T ss_dssp CTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHT----
T ss_pred eCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHHHh----
Confidence 999997654332 23457999999999876 569999999999999999999999996532211 1111000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
... ....+... .+..+.+||.+||+.||.+||++.+++++-
T Consensus 244 ~~~-----~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 244 SGV-----KPASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp TTC-----CCGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccC-----CccccCCC----CCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 000 00001111 125689999999999999999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=376.02 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=202.9
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------------ccHHHHHHHHHHHhcCC
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGDLV 193 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~ 193 (486)
..++|.+++.||+|+||+||+|.+.. ++..||||++..... ...+.+.+|+.+|+.++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKN---------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEEEECC---------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 35689999999999999999999875 677999999975432 22467889999999999
Q ss_pred CCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 194 h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
|||||++++++.+...+|||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLE 180 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEe
Confidence 999999999999999999999999999999998655 46999999999999999999999988 99999999999998
Q ss_pred CCC---cEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011412 274 ADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350 (486)
Q Consensus 274 ~~~---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~ 350 (486)
.++ .+||+|||+++....... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.......
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-- 254 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-- 254 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred cCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 776 699999999987644322 23467999999999876 579999999999999999999999997643221
Q ss_pred hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
+..... ..... .+...... .+..+.+||.+||+.||.+|||+.|++++-
T Consensus 255 -~~~~i~---~~~~~----~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 255 -IIKKVE---KGKYY----FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp -HHHHHH---HCCCC----CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -HHHHHH---cCCCC----CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 111110 00000 00000011 235789999999999999999999999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=368.28 Aligned_cols=254 Identities=15% Similarity=0.053 Sum_probs=183.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHH---HHHhcCCCCCceEEE-
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEV---NFLGDLVHLNLVKLI- 201 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~h~nIv~~~- 201 (486)
.+|.+.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+ ++|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE---------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred eeeeeeeeccCCCCEEEEEEEECC---------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 458889999999999999999865 6779999999876532 234566775 45555 699988865
Q ss_pred ------EEEEeC-----------------CeeEEEEeecCCCChhHHHhhcCCCCCHHHH------HHHHHHHHHHHHHH
Q 011412 202 ------GYCIED-----------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------MKIALGAAKGLAFL 252 (486)
Q Consensus 202 ------~~~~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~------~~i~~qi~~~l~yL 252 (486)
+++... ..+|||||||+ |+|.+++...+..+++..+ +.++.||+.||+||
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 444433 33799999998 8999999765445566666 78889999999999
Q ss_pred HhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc--CCCCchhhHHHHHHH
Q 011412 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVV 330 (486)
Q Consensus 253 H~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvi 330 (486)
|+++ |+||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.+ ..|+.++|||||||+
T Consensus 211 H~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 211 QSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp HHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred HHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 9988 999999999999999999999999999865321 223567799999999987 789999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 331 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 331 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
||||++|+.||....+....... ..... ...............+..+.+||.+||+.||.+||++.+++++
T Consensus 283 l~elltg~~Pf~~~~~~~~~~~~---~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGSWK---RPSLR------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTCCC---BCCTT------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HHHHHhCCCCCCCcCcccccchh---hhhhh------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999999866433211100 00000 0000000000011234678999999999999999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=360.19 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=206.2
Q ss_pred HHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhcC-CC
Q 011412 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDL-VH 194 (486)
Q Consensus 124 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h 194 (486)
......+|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.++.++ .|
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h 159 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRA---------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECC---------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34456789999999999999999999865 5779999998754321 124577899999999 79
Q ss_pred CCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011412 195 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 274 (486)
Q Consensus 195 ~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 274 (486)
|||+++++++......+|||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.
T Consensus 160 p~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDD 235 (365)
T ss_dssp TTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred CCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999999999654 46899999999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011412 275 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 348 (486)
Q Consensus 275 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~elltG~~pf~~~~~~~ 348 (486)
++.+||+|||++........ ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 236 ~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~- 311 (365)
T 2y7j_A 236 NMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI- 311 (365)
T ss_dssp TCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred CCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-
Confidence 99999999999987654332 234679999999998863 36889999999999999999999999653221
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
....... .....+ ..+ .... .+..+.+||.+||+.||.+||++.+++++-
T Consensus 312 --~~~~~i~---~~~~~~---~~~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 312 --LMLRMIM---EGQYQF---SSP-EWDD----RSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp --HHHHHHH---HTCCCC---CHH-HHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred --HHHHHHH---hCCCCC---CCc-cccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 1111100 000000 000 0011 135688999999999999999999999853
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=374.00 Aligned_cols=261 Identities=26% Similarity=0.361 Sum_probs=196.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC-
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~- 207 (486)
.+|++.+.||+|+||.||+|++.. +|+.||||++..... .+.+|+++|+.|+|||||+++++|...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECC---------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 468889999999999999999875 677999999975432 234799999999999999999988542
Q ss_pred -----CeeEEEEeecCCCChhHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcE
Q 011412 208 -----DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNA 278 (486)
Q Consensus 208 -----~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~v 278 (486)
..++|||||+++ +|.+++. .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.+ +.+
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeE
Confidence 236799999975 6666554 34567999999999999999999999988 9999999999999965 568
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
||+|||+++....... .....||+.|+|||++.+. .|+.++||||||||||||++|+.||....... .+.....
T Consensus 197 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~ 271 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIK 271 (420)
T ss_dssp EECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred EeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence 9999999987544332 2345799999999998764 79999999999999999999999997653211 1111110
Q ss_pred h-------hcccc-cccccccCCccC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 358 P-------HLGER-RRFYRLIDPRLE-----GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 358 ~-------~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. .+... ..+....-+.+. ..+....+..+.+||.+||+.||.+||++.|++++-
T Consensus 272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 0 00000 000000001000 001122346789999999999999999999999754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=358.50 Aligned_cols=269 Identities=24% Similarity=0.369 Sum_probs=195.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHH--HhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF--LGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~~~~~~~ 205 (486)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+..|..+ +..++|+||+++++++.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 46899999999999999999976 46789999997543 2344444444 55689999999998654
Q ss_pred e-----CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCcEE
Q 011412 206 E-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE---------AERPVIYRDFKTSNIL 271 (486)
Q Consensus 206 ~-----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------~~~~iiHrDLKp~NIl 271 (486)
. ...++||||||++|+|.+++... ..++..++.++.||+.||.|||+. + |+||||||+|||
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nil 152 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVL 152 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEE
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEE
Confidence 3 23578999999999999999654 358899999999999999999998 6 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCc------ceeeeeccccccccCcccccc-------CCCCchhhHHHHHHHHHHHHhCC
Q 011412 272 LDADYNAKLSDFGLAKDGPEGDK------THVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLTGR 338 (486)
Q Consensus 272 l~~~~~vkl~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~elltG~ 338 (486)
|+.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99999999999999986543211 112234579999999999876 45667899999999999999998
Q ss_pred CCCCCCCCCCcch-hHHh-h--hhhcccccc--cccccCCccCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 339 RSMDKNRPNGEHN-LVEW-A--RPHLGERRR--FYRLIDPRLEGH--FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 339 ~pf~~~~~~~~~~-~~~~-~--~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.||.......... .... . .+...+... ......+.+... .....+..+.+||.+||+.||.+||++.|+++.
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 7775433221111 0000 0 000000000 000011111111 112356689999999999999999999999999
Q ss_pred hcCCC
Q 011412 411 LKPLP 415 (486)
Q Consensus 411 L~~~~ 415 (486)
|+.+.
T Consensus 313 L~~ll 317 (336)
T 3g2f_A 313 MAELM 317 (336)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=359.55 Aligned_cols=256 Identities=28% Similarity=0.385 Sum_probs=198.9
Q ss_pred HHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEE
Q 011412 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIG 202 (486)
Q Consensus 124 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 202 (486)
+....++|++.+.||+|+||.||+|.+.. +|+.||||++..... ....+.+|+.++.++ +||||+++++
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECC---------CCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeee
Confidence 33456789999999999999999999865 577999999975432 346788999999999 7999999999
Q ss_pred EEEe------CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011412 203 YCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 203 ~~~~------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 275 (486)
++.. .+..+|||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.+
T Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTEN 165 (326)
T ss_dssp EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTT
T ss_pred EEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCC
Confidence 9987 46889999999999999999754 357899999999999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011412 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~ 350 (486)
+.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-- 241 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-- 241 (326)
T ss_dssp CCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--
T ss_pred CCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--
Confidence 9999999999987543221 123457999999999986 5678999999999999999999999996543211
Q ss_pred hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..... ... ...... .. ..+..+.+||.+||..||.+||++.+++++
T Consensus 242 -~~~~~---~~~--~~~~~~----~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 242 -ALFLI---PRN--PAPRLK----SK----KWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -HHHHH---HHS--CCCCCS----CS----CSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHHh---hcC--ccccCC----cc----ccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 000 000000 11 123578999999999999999999999984
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=361.57 Aligned_cols=265 Identities=23% Similarity=0.283 Sum_probs=194.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEECC---------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 3689999999999999999998865 677999999975432 22356889999999999999999999997
Q ss_pred eCC------eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 206 ~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
..+ ..|||||||++ +|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cccccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEE
Confidence 765 78999999964 7888874 35889999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH-Hh---
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW--- 355 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~-~~--- 355 (486)
|+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+ ..
T Consensus 168 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 168 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999998754321 233467999999999999999999999999999999999999999764321110000 00
Q ss_pred -----h-------hhhccccc-----ccccccCCccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 356 -----A-------RPHLGERR-----RFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 356 -----~-------~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. ........ .+...+...... ......+..+.+||.+||+.||.+|||+.|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0 00000000 000000000000 01122356789999999999999999999999854
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=355.53 Aligned_cols=265 Identities=26% Similarity=0.387 Sum_probs=205.8
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCCceEEEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIG 202 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~ 202 (486)
....++|.+.+.||+|+||.||+|.+ +|+.||||++... ....+.+|++++.. ++||||+++++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 34556899999999999999999987 3678999999754 24567888888887 78999999999
Q ss_pred EEEeCC----eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCcE
Q 011412 203 YCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAERPVIYRDFKTSNI 270 (486)
Q Consensus 203 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~~~~~iiHrDLKp~NI 270 (486)
++.... ..++||||+++|+|.+++.+. .+++..++.++.|++.||.||| +.+ |+||||||+||
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 998876 789999999999999999653 5899999999999999999999 666 99999999999
Q ss_pred EEcCCCcEEEeecCCCCCCCCCCcce--eeeeccccccccCccccccCC------CCchhhHHHHHHHHHHHHhC-----
Q 011412 271 LLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGH------LTSRSDVYSFGVVLLEMLTG----- 337 (486)
Q Consensus 271 ll~~~~~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltG----- 337 (486)
||+.++.+||+|||+++......... ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999997654332211 123457999999999987652 33689999999999999999
Q ss_pred -----CCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 338 -----RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 338 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..||......... ...+...... ....+.+... ........+.+|+.+||+.||.+||++.+|+++|
T Consensus 259 ~~~~~~~p~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPS-VEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp BCCCCCCTTTTTSCSSCC-HHHHHHHHTT------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccCccccCcCccc-HHHHHHHHHH------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 6777654332211 1111110000 0111111111 1235567899999999999999999999999999
Q ss_pred cCCC
Q 011412 412 KPLP 415 (486)
Q Consensus 412 ~~~~ 415 (486)
+.+.
T Consensus 332 ~~i~ 335 (342)
T 1b6c_B 332 SQLS 335 (342)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.69 Aligned_cols=253 Identities=22% Similarity=0.279 Sum_probs=199.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC----cccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
.++|++.+.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.+++.++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT---------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEECC---------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 4689999999999999999998765 67799999997542 2234678899999999999999999999
Q ss_pred EE--eCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 204 CI--EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 204 ~~--~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
+. +....+|||||++++ |.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl 150 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKI 150 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEe
Confidence 84 456789999999876 77777543 457999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
+|||++................||+.|+|||++.+.. ++.++|||||||++|||++|..||...... ......
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i-- 225 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFENI-- 225 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH--
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHH--
Confidence 9999998764433332334567999999999987644 378999999999999999999999754211 111100
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.... ..+.. ..+..+.+||.+||+.||.+||++.+++++.
T Consensus 226 -~~~~--------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 226 -GKGS--------YAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp -HHCC--------CCCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred -hcCC--------CCCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 0000 01111 2235788999999999999999999999853
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=345.83 Aligned_cols=250 Identities=27% Similarity=0.354 Sum_probs=197.4
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
..++|.+.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.+++.++||||++++++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 79 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQL---------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECC---------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 34689999999999999999998865 57799999986432 2334578899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 80 ISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCC
T ss_pred EecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeec
Confidence 99999999999999999999999655 36899999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
|++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... .+..... ..
T Consensus 156 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~---~~ 226 (276)
T 2h6d_A 156 GLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIR---GG 226 (276)
T ss_dssp CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HC
T ss_pred ccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhh---cC
Confidence 99987654322 234579999999999987765 68999999999999999999999653211 1111100 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. ..+... .+..+.+|+.+||+.||.+||++.+++++
T Consensus 227 ~--------~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 V--------FYIPEY----LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp C--------CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c--------ccCchh----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 001111 23568899999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=351.19 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=187.7
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-H-HHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-H-KEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+.. +|+.||||++....... . ..+..+...++.+.||||+++++++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~ 75 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL 75 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC---------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee
Confidence 34689999999999999999999865 67799999997653221 2 2244555568888999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
.+.+..++||||++ |+|.+++.. ....+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 76 FREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp ECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEB
T ss_pred eccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999999996 588877753 456799999999999999999999997 8 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
+|||+++....... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||....... ..+...
T Consensus 152 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~- 226 (290)
T 3fme_A 152 CDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQLKQV- 226 (290)
T ss_dssp CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHHHHH-
T ss_pred eecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHHHHH-
Confidence 99999987544322 2334799999999996 56678999999999999999999999997532211 001100
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... ..+... ....+..+.+|+.+||+.||.+||++.|++++
T Consensus 227 ---~~~-------~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 227 ---VEE-------PSPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---HHS-------CCCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---hcc-------CCCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 000 000000 11224578999999999999999999999873
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=350.85 Aligned_cols=257 Identities=23% Similarity=0.367 Sum_probs=196.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..++|++++.||+|+||.||+|.+.. +|+.||||++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL---------DSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLE 73 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccccchhhheeccCCcEEEEEEEEcC---------CCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence 34679999999999999999998865 57799999996432 234568899999999999999999998865
Q ss_pred -------------CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 207 -------------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 207 -------------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
....++||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~ 150 (303)
T 1zy4_A 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFID 150 (303)
T ss_dssp CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEc
Confidence 35679999999999999999877767889999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCc------------ceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCC
Q 011412 274 ADYNAKLSDFGLAKDGPEGDK------------THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 340 (486)
Q Consensus 274 ~~~~vkl~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~p 340 (486)
.++.+||+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++ |
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence 999999999999987543210 1112345799999999998754 78999999999999999998 4
Q ss_pred CCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 341 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
|.... ........ +. .....+...+....+..+.+|+.+||+.||.+||++.+++++-.
T Consensus 228 ~~~~~-----~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 228 FSTGM-----ERVNILKK-LR-------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp CSSHH-----HHHHHHHH-HH-------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred cCCch-----hHHHHHHh-cc-------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 43210 00011000 00 00111122233333467899999999999999999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.62 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=199.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhcCCCCCce
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLVHLNLV 198 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv 198 (486)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+|+.++||||+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 78 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC---------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence 34679999999999999999998865 677999999975432 1123478999999999999999
Q ss_pred EEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc-
Q 011412 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN- 277 (486)
Q Consensus 199 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~- 277 (486)
++++++..++ .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 79 ~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 79 KIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp CEEEEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSS
T ss_pred eEeeEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCC
Confidence 9999987655 8999999999999998854 457999999999999999999999988 999999999999987654
Q ss_pred --EEEeecCCCCCCCCCCcceeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011412 278 --AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352 (486)
Q Consensus 278 --vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~ 352 (486)
+||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........ +
T Consensus 154 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~ 228 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L 228 (322)
T ss_dssp CCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--H
T ss_pred CeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--H
Confidence 9999999998764321 123457999999999874 56789999999999999999999999976543221 1
Q ss_pred HHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
...... .... ..+..... .+..+.+||.+||+.||.+||++.+++++-
T Consensus 229 ~~~~~~---~~~~----~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 229 KDQITS---GKYN----FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp HHHHHH---TCCC----CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHHh---Cccc----cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 111100 0000 00001111 235788999999999999999999998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=369.71 Aligned_cols=199 Identities=22% Similarity=0.338 Sum_probs=173.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC------CCCCceEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL------VHLNLVKLI 201 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~~~ 201 (486)
..+|++++.||+|+||.||+|.+.. +++.||||++.... .....+.+|++++..+ .|+||++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~---------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHK---------VHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECC---------CCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 4579999999999999999998865 67899999997542 2235677888888877 577999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--E
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--A 278 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--v 278 (486)
+++.....++|||||+. ++|.+++.... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++. +
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcce
Confidence 99999999999999995 69999887654 45999999999999999999999988 999999999999999887 9
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~ 345 (486)
||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||+||||++|.+||....
T Consensus 242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999764332 223579999999999999999999999999999999999999997654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=387.75 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=197.9
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 212 (486)
+.||+|+||.||+|.+... .+++.||||+++.... ...+++.+|+++|..++|||||++++++. .+..+|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred CEeccCCCEEEEEEEEcCC-------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEE
Confidence 3799999999999977542 2567899999986432 33577999999999999999999999986 456899
Q ss_pred EEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011412 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~ 292 (486)
|||||++|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 447 v~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 99999999999999654 57999999999999999999999988 999999999999999999999999999865443
Q ss_pred Ccc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 293 DKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 293 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
... .......||+.|+|||++.+..++.++|||||||+||||++ |+.||....... +..... .. .
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~----~~------~ 589 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLE----KG------E 589 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TT------C
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cC------C
Confidence 221 22333567899999999999999999999999999999998 999997643221 111111 00 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
.. ..+..++..+.+||.+||+.||.+||++.+|++.|+.
T Consensus 590 ~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 590 RM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 01 1112234678999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=364.09 Aligned_cols=274 Identities=23% Similarity=0.310 Sum_probs=199.7
Q ss_pred hhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-----------cHHHHHHHHHHH
Q 011412 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVNFL 189 (486)
Q Consensus 121 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l 189 (486)
+.++....++|++.+.||+|+||.||+|.+. +|..||||++...... ..+.+.+|+++|
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 83 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHH
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHH
Confidence 4566677899999999999999999999864 3678999998643221 126789999999
Q ss_pred hcCCCCCceEEEEEEEeC-----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 011412 190 GDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 264 (486)
Q Consensus 190 ~~l~h~nIv~~~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrD 264 (486)
+.++||||+++++++... ...|+||||+. |+|.+++......+++..+..++.||+.||.|||+.+ |+|||
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 159 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecC
Confidence 999999999999998542 36799999996 6899888777778999999999999999999999988 99999
Q ss_pred CCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011412 265 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDK 343 (486)
Q Consensus 265 LKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~ 343 (486)
|||+||||+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 160 LHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998643322 2334679999999999876 6799999999999999999999999976
Q ss_pred CCCCCcchhH-Hhhh-hhcc--------cccccc-ccc---CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011412 344 NRPNGEHNLV-EWAR-PHLG--------ERRRFY-RLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409 (486)
Q Consensus 344 ~~~~~~~~~~-~~~~-~~~~--------~~~~~~-~~~---~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 409 (486)
.........+ .... +... ...... ... ............+..+.+||.+||+.||.+||++.|+++
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 4321111100 0000 0000 000000 000 000000001112356889999999999999999999997
Q ss_pred Hh
Q 011412 410 AL 411 (486)
Q Consensus 410 ~L 411 (486)
+-
T Consensus 317 hp 318 (362)
T 3pg1_A 317 HP 318 (362)
T ss_dssp SG
T ss_pred Cc
Confidence 53
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.73 Aligned_cols=254 Identities=26% Similarity=0.343 Sum_probs=204.5
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---------ccHHHHHHHHHHHhcCC-CCC
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHKEWLAEVNFLGDLV-HLN 196 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~n 196 (486)
..++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+.+|+++. |||
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 85 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred hhhccceeeeecCCCceEEEEEEEcC---------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 34689999999999999999999865 678999999975531 11345789999999995 999
Q ss_pred ceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011412 197 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276 (486)
Q Consensus 197 Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 276 (486)
|+++++++......++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDM 161 (298)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCC
Confidence 999999999999999999999999999999654 46899999999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011412 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350 (486)
Q Consensus 277 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~ 350 (486)
.+||+|||++........ .....||+.|+|||++. ...++.++|||||||++|||++|..||......
T Consensus 162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--- 235 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--- 235 (298)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred cEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---
Confidence 999999999987644322 23457999999999885 457889999999999999999999999654221
Q ss_pred hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..... ....... ...+ .....+..+.+|+.+||+.||.+||++.+++++
T Consensus 236 ~~~~~---~~~~~~~---~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 236 LMLRM---IMSGNYQ---FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHH---HHHTCCC---CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHH---HhcCCcc---cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11110 0000000 0000 001224678999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=362.14 Aligned_cols=271 Identities=18% Similarity=0.226 Sum_probs=204.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceE--------
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVK-------- 199 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-------- 199 (486)
.++|++.+.||+|+||.||+|.+...... .....++.||||++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 36899999999999999999998752110 00013678999999754 35789999999999999887
Q ss_pred -------EEEEEEe-CCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 011412 200 -------LIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 270 (486)
Q Consensus 200 -------~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NI 270 (486)
+++++.. +...+|||||+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 77889999999 99999999765 357999999999999999999999988 99999999999
Q ss_pred EEcCCC--cEEEeecCCCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011412 271 LLDADY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 343 (486)
Q Consensus 271 ll~~~~--~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~ 343 (486)
||+.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999865432211 012335799999999999999999999999999999999999999976
Q ss_pred CCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 344 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
...... .+............ .+.+.... ....+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 271 ~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 271 CLPNTE-DIMKQKQKFVDKPG---PFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GTTCHH-HHHHHHHHHHHSCC---CEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCcCHH-HHHHHHHhccCChh---hhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 532211 11111111111111 11111000 0011367899999999999999999999999997653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=356.12 Aligned_cols=269 Identities=23% Similarity=0.291 Sum_probs=202.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
..+|++++.||+|+||.||+|.+.. ++..||||++...... ....+.+|+++|..++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNL---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEEEECC---------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 3589999999999999999998865 6779999999754322 23568899999999999999999999976
Q ss_pred C-----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 207 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 207 ~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
. ...|+||||+. |+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEE
Confidence 5 36899999996 5999988653 5899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 282 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 282 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
|||+++........ ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...........+......
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999865432211 1123458999999999875 455899999999999999999999999765433221111100000
Q ss_pred c-cc---------cccc-ccccCCcc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 360 L-GE---------RRRF-YRLIDPRL--EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 360 ~-~~---------~~~~-~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. .+ ...+ .....+.. ...+....+..+.+||.+||+.||.+||++.|++++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0 00 0000 00000000 0000011235688999999999999999999999854
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=365.89 Aligned_cols=264 Identities=25% Similarity=0.348 Sum_probs=185.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETT---------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3689999999999999999998865 678999999975432 23456889999999999999999999987
Q ss_pred eC------CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 206 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 206 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
.. ...|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEE
Confidence 54 5679999999 7899998854 46999999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
|+|||+++..... .+...||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.....
T Consensus 173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999875432 234679999999999876 6899999999999999999999999976543211111100000
Q ss_pred --------hccc--ccccccccCCccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 359 --------HLGE--RRRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 359 --------~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.+.. ...+.+.+.......+ ....+..+.+||.+||..||.+||++.+++++-
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 0000 0000000000000000 001235688999999999999999999999854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=367.17 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=192.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
.+|++.+.||+|+||+||+|.+.. ++ .||+|++...... ..+|+++|+.++||||+++++++....
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~---------~~-~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVE---------SD-EVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---------TE-EEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred ceEEEeEEEeeCCCeEEEEEEECC---------CC-eEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 478999999999999999998864 23 4888888654322 237999999999999999999996543
Q ss_pred e------eEEEEeecCCCChhHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCcEE
Q 011412 209 Q------RLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAK 279 (486)
Q Consensus 209 ~------~~lv~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~~~vk 279 (486)
. ++||||||+++.+..... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+ .++.+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEE
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEE
Confidence 3 789999997644333221 33567999999999999999999999988 99999999999998 799999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh-
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA- 356 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~-~~~- 356 (486)
|+|||+++....... .....||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.........+ ...
T Consensus 183 L~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 259 (394)
T 4e7w_A 183 LIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259 (394)
T ss_dssp ECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999987644332 2345789999999998764 5999999999999999999999999765322111100 000
Q ss_pred ----------hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 357 ----------RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 357 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+...+ ..+.......+...+....+..+.+||.+||+.||.+||++.|++++
T Consensus 260 ~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 260 TPSREQIKTMNPNYME-HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCCHHHHHHHCGGGSS-SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHhhChhhhh-hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000 00000000000011111234678999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=354.20 Aligned_cols=267 Identities=27% Similarity=0.359 Sum_probs=190.2
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
...++|++.+.||+|+||.||+|.+.. +|..||||++...... ...+.+|++.+..++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp HHHTTEEEC----------CEEEEETT---------TCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 445789999999999999999999865 6779999998654322 245678888899999999999999997
Q ss_pred eCCe-------eEEEEeecCCCChhHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCcEEEc
Q 011412 206 EDDQ-------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLH--EEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 206 ~~~~-------~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~yLH--~~~~~~iiHrDLKp~NIll~ 273 (486)
..+. .++||||+++ +|...+. .....+++..+..++.|++.||.||| +.+ |+||||||+||||+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVN 165 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEE
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEe
Confidence 6443 7899999976 5555443 34567899999999999999999999 777 99999999999999
Q ss_pred C-CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011412 274 A-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351 (486)
Q Consensus 274 ~-~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~ 351 (486)
. ++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..........
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 6 89999999999987654332 2346789999999998654 48999999999999999999999997653221111
Q ss_pred hHHhhhhhcccccccccccCC----------------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 352 LVEWARPHLGERRRFYRLIDP----------------RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
................+++ ..........+..+.+||.+||+.||.+||++.|++++-
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 243 --EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp --HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred --HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 1100000000000000000 000111122456899999999999999999999998753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=350.71 Aligned_cols=255 Identities=27% Similarity=0.352 Sum_probs=180.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHH-HHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVN-FLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ...++..|+. +++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 4689999999999999999998865 6779999999765322 2344566666 777889999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
..+..+|||||+++ +|.+++.. ....+++..+..++.|++.||.|||+. + |+||||||+||||+.++.+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEE
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEE
Confidence 99999999999975 88877752 256789999999999999999999998 8 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
+|||+++....... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||........ ..
T Consensus 168 ~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~ 239 (327)
T 3aln_A 168 CDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL 239 (327)
T ss_dssp CCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------
T ss_pred ccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH
Confidence 99999987643321 2334799999999998 466789999999999999999999999975322110 00
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.... ....+.+........+..+.+|+.+||+.||.+||++.+++++
T Consensus 240 ~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 240 TQVV-------KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCC-------CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHh-------cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000 0001111111111224678999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=358.30 Aligned_cols=261 Identities=20% Similarity=0.332 Sum_probs=201.8
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEE
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~ 202 (486)
.+..++|++.+.||+|+||.||+|.+.. .||||++..... ...+.+.+|+.+++.++||||+++++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 96 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence 3456789999999999999999998743 499999875432 22345778999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
++...+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|
T Consensus 97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~D 172 (319)
T 2y4i_B 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITD 172 (319)
T ss_dssp EEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECC
T ss_pred EEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEee
Confidence 999999999999999999999999776667999999999999999999999988 99999999999998 67999999
Q ss_pred cCCCCCCCCCCc---ceeeeeccccccccCcccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011412 283 FGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMT---------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350 (486)
Q Consensus 283 FGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~ 350 (486)
||+++....... ........||+.|+|||++.. ..++.++|||||||++|||++|..||.......
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-- 250 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-- 250 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 999876432111 111223569999999999864 457899999999999999999999997543211
Q ss_pred hhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011412 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 417 (486)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 417 (486)
...... . ...+.... ...+..+.+|+.+||..||.+||++.++++.|+.+...
T Consensus 251 -~~~~~~----~------~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 251 -IIWQMG----T------GMKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp -HHHHHH----T------TCCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred -HHHHhc----c------CCCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 110000 0 00111100 01234588999999999999999999999999988654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=353.31 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=198.4
Q ss_pred ChhHHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCC--CC
Q 011412 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV--HL 195 (486)
Q Consensus 120 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~ 195 (486)
.+..+....++|++++.||+|+||.||+|.+. ++..||||++..... .....+.+|+.+|..+. |+
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~ 88 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCT
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCC
Confidence 33334455678999999999999999999864 366899999975433 23456889999999997 59
Q ss_pred CceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011412 196 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 196 nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 275 (486)
||+++++++...+..++||| +.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ +
T Consensus 89 ~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~ 162 (313)
T 3cek_A 89 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-D 162 (313)
T ss_dssp TBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-T
T ss_pred ceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-C
Confidence 99999999999999999999 5588999999654 47899999999999999999999988 99999999999996 4
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 011412 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltG~~pf~~~ 344 (486)
+.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 8999999999987654333222344679999999999865 47889999999999999999999999653
Q ss_pred CCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.... .... ..+++.....++...+..+.+||.+||+.||.+||++.+++++.
T Consensus 243 ~~~~-----~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 243 INQI-----SKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CSHH-----HHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHH-----HHHH----------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 2210 0000 01111111111112245789999999999999999999999754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=384.68 Aligned_cols=261 Identities=24% Similarity=0.369 Sum_probs=207.9
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
...++|++.+.||+|+||.||+|.+...+. .+..||||++...... ..+.+.+|+.+|+.++||||+++++++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPEN------PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSS------CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCC------ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 445678999999999999999999865322 4668999998764332 235688999999999999999999998
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
. ++..+||||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 5 56789999999999999999877778999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||...... ....... ..
T Consensus 537 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~----~~ 608 (656)
T 2j0j_A 537 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE----NG 608 (656)
T ss_dssp CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----HT
T ss_pred CCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH----cC
Confidence 99876443222 2233567889999999999999999999999999999997 99999754321 1111111 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.... ++..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 609 ------~~~~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 609 ------ERLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCC----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0011 1112346789999999999999999999999998754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=361.56 Aligned_cols=271 Identities=22% Similarity=0.323 Sum_probs=186.2
Q ss_pred cCCCC-CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe-
Q 011412 129 RNFRP-ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (486)
Q Consensus 129 ~~y~~-~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 206 (486)
+.|++ .++||+|+||.||+|.+.+. .++..||||++...... ..+.+|+.+|+.|+|||||++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~-------~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS-------SCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC-------CCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 34666 45899999999999997642 25678999999765432 568899999999999999999999965
Q ss_pred -CCeeEEEEeecCCCChhHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----c
Q 011412 207 -DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----D 273 (486)
Q Consensus 207 -~~~~~lv~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll----~ 273 (486)
....||||||+. ++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||| +
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP 166 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSST
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCC
Confidence 678999999996 5888877522 224899999999999999999999988 9999999999999 6
Q ss_pred CCCcEEEeecCCCCCCCCCCcc-eeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc--
Q 011412 274 ADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-- 349 (486)
Q Consensus 274 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~-- 349 (486)
.++.+||+|||+++........ ......+||+.|+|||++.+ ..|+.++||||||||||||++|+.||........
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 246 (405)
T 3rgf_A 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246 (405)
T ss_dssp TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence 7789999999999876432211 12334689999999999887 4599999999999999999999999975443210
Q ss_pred ----chhHHhhhhhcc-----ccccc---------ccccCCccCCCCC---------HHHHHHHHHHHHHhcccCCCCCC
Q 011412 350 ----HNLVEWARPHLG-----ERRRF---------YRLIDPRLEGHFS---------IKGAQKAAQLAAHCLSRDPKARP 402 (486)
Q Consensus 350 ----~~~~~~~~~~~~-----~~~~~---------~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~dP~~RP 402 (486)
...+......+. ....+ ...+......... ...+..+.+||.+||+.||.+||
T Consensus 247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ 326 (405)
T 3rgf_A 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 326 (405)
T ss_dssp CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence 011000000000 00000 0000000000000 00134678999999999999999
Q ss_pred CHHHHHHHhc
Q 011412 403 LMSEVVEALK 412 (486)
Q Consensus 403 s~~eil~~L~ 412 (486)
|+.|++++-.
T Consensus 327 ta~e~L~hp~ 336 (405)
T 3rgf_A 327 TSEQAMQDPY 336 (405)
T ss_dssp CHHHHHTSGG
T ss_pred CHHHHhcChh
Confidence 9999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=358.13 Aligned_cols=264 Identities=19% Similarity=0.272 Sum_probs=204.4
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----------------HHHHHHHHHHHh
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------------HKEWLAEVNFLG 190 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~ 190 (486)
.++|++.+.||+|+||.||+|.+ +|..||||++....... ...+.+|+.++.
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 46899999999999999999987 36799999987432211 167899999999
Q ss_pred cCCCCCceEEEEEEEeCCeeEEEEeecCCCChhHH------Hhhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEe
Q 011412 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH------LFRR-SLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIY 262 (486)
Q Consensus 191 ~l~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiH 262 (486)
.++||||+++++++.+.+..++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ .+ |+|
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H 175 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICH 175 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---Eee
Confidence 99999999999999999999999999999999998 5432 5679999999999999999999998 88 999
Q ss_pred cCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccC-CCCc-hhhHHHHHHHHHHHHhCCCC
Q 011412 263 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTS-RSDVYSFGVVLLEMLTGRRS 340 (486)
Q Consensus 263 rDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslGvil~elltG~~p 340 (486)
|||||+|||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|..|
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999875432 23446799999999999877 6766 99999999999999999999
Q ss_pred CCCCCCCCcchhHHhhhhhccc----ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 341 MDKNRPNGEHNLVEWARPHLGE----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
|...... ..+.......... ...+.....+..........+..+.+|+.+||+.||.+||++.+++++-
T Consensus 252 f~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 252 FSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp SCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 9765431 1111111100000 0000000000000000122346789999999999999999999999853
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=349.83 Aligned_cols=266 Identities=23% Similarity=0.308 Sum_probs=204.3
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC------CceEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL------NLVKL 200 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~~ 200 (486)
..++|++.+.||+|+||.||+|.+.. .+|..||||+++... .....+.+|+.++..++|+ +|+++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHK--------AGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecC--------CCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 45689999999999999999998733 157799999997542 2345678899999988765 49999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-----
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----- 274 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~----- 274 (486)
++++...+..+|||||+ +++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEE
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecccccc
Confidence 99999999999999999 889999997654 46899999999999999999999988 999999999999987
Q ss_pred --------------CCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 011412 275 --------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 340 (486)
Q Consensus 275 --------------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~p 340 (486)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 668999999999865432 2335799999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHHhhhhhccc-------cccc------------------ccccCCc-cCCCCCHHHHHHHHHHHHHhc
Q 011412 341 MDKNRPNGEHNLVEWARPHLGE-------RRRF------------------YRLIDPR-LEGHFSIKGAQKAAQLAAHCL 394 (486)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~-------~~~~------------------~~~~~~~-~~~~~~~~~~~~~~~li~~cl 394 (486)
|...........+......... .... .....+. .........+..+.+||.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 9764332211111110000000 0000 0000000 001112345678999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 011412 395 SRDPKARPLMSEVVEA 410 (486)
Q Consensus 395 ~~dP~~RPs~~eil~~ 410 (486)
+.||.+||++.|++++
T Consensus 314 ~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 314 EYDPAKRITLREALKH 329 (339)
T ss_dssp CSSTTTSCCHHHHTTS
T ss_pred CcCcccccCHHHHhcC
Confidence 9999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=355.49 Aligned_cols=269 Identities=24% Similarity=0.292 Sum_probs=199.9
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP---------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC---------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 4689999999999999999998865 678999999975432 223567899999999999999999998876
Q ss_pred C-----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 207 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 207 ~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
. ...++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred cccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence 4 67899999996 699998865 36899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcce--------eeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011412 282 DFGLAKDGPEGDKTH--------VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352 (486)
Q Consensus 282 DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~ 352 (486)
|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999998654322110 1223578999999998764 7899999999999999999999999976432111000
Q ss_pred HHhhhhhc--cc------c---cccccccCCccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 353 VEWARPHL--GE------R---RRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 353 ~~~~~~~~--~~------~---~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
+....... .. . ......+...... ......+..+.+||.+||+.||.+||++.+++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00000000 00 0 0000000000000 00012246788999999999999999999999853
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=347.56 Aligned_cols=268 Identities=24% Similarity=0.311 Sum_probs=195.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE--
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-- 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-- 205 (486)
.++|++++.||+|+||.||+|.+.. +|+.||||++........+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND---------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT---------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEECC---------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 4689999999999999999999865 67899999998766555677899999999999999999999873
Q ss_pred ------------eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 206 ------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 206 ------------~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
.....++||||++ |+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN 154 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence 3467899999997 699998854 46899999999999999999999988 99999999999997
Q ss_pred -CCCcEEEeecCCCCCCCCCCcc-eeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 011412 274 -ADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350 (486)
Q Consensus 274 -~~~~vkl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~ 350 (486)
.++.+||+|||+++........ .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5679999999999875432111 11233568999999998865 78999999999999999999999999765321111
Q ss_pred hhHHhhhhhcc--cccccccc--------c-CCcc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 351 NLVEWARPHLG--ERRRFYRL--------I-DPRL-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 351 ~~~~~~~~~~~--~~~~~~~~--------~-~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+....+... ....+... . .+.. ...+....+..+.+||.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 10000000000 00000000 0 0000 000001124678999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=355.77 Aligned_cols=204 Identities=24% Similarity=0.284 Sum_probs=172.9
Q ss_pred HHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CC-----Cce
Q 011412 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL-----NLV 198 (486)
Q Consensus 125 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv 198 (486)
....++|++.+.||+|+||+||+|.+.. +++.||||+++... ....++..|++++..+. |+ +|+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv 119 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRV---------EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIV 119 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcC---------CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEE
Confidence 3456789999999999999999998865 67799999997542 22356778888888885 44 499
Q ss_pred EEEEEEEeCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc--CC
Q 011412 199 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--AD 275 (486)
Q Consensus 199 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~--~~ 275 (486)
++++++...+..||||||+. ++|.+++.... ..+++..+..++.||+.||.|||.+. .+||||||||+||||+ .+
T Consensus 120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTS
T ss_pred EeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCC
Confidence 99999999999999999995 59999997653 56999999999999999999999532 3399999999999994 57
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 011412 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~ 345 (486)
+.+||+|||+++..... .....||+.|+|||++.+..|+.++|||||||+||||++|+.||....
T Consensus 198 ~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 88999999999876432 234579999999999999999999999999999999999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=348.61 Aligned_cols=269 Identities=24% Similarity=0.325 Sum_probs=200.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcC---CCCCceEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL---VHLNLVKLI 201 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~ 201 (486)
..++|++.+.||+|+||.||+|.+.. .+|+.||||++..... .....+.+|+.+++.+ .||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 45789999999999999999998842 1567899999864321 1123456777777666 899999999
Q ss_pred EEEE-----eCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011412 202 GYCI-----EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 202 ~~~~-----~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 275 (486)
+++. .....++||||++ |+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~ 156 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS 156 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCC
Confidence 9987 5567899999997 69999987653 45999999999999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH-H
Q 011412 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E 354 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~-~ 354 (486)
+.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .
T Consensus 157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 999999999998754322 233467999999999999999999999999999999999999999764321111000 0
Q ss_pred hhh-hhccccc-------ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 355 WAR-PHLGERR-------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 355 ~~~-~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... +...... .............+....+..+.+||.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0000000 0000000000011112234678899999999999999999999964
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=352.34 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=175.2
Q ss_pred HhcCCCCCC-eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..++|.+.+ +||+|+||.||+|.+.. +|+.||||++.... .........+..+.||||+++++++.
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRR---------TGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYE 92 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECC---------CCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHh
Confidence 346888854 69999999999999875 67799999997531 22222333456678999999999987
Q ss_pred e----CCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCc
Q 011412 206 E----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYN 277 (486)
Q Consensus 206 ~----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~ 277 (486)
. ....+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+. ++.
T Consensus 93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCC
T ss_pred hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCce
Confidence 6 456899999999999999997653 46999999999999999999999988 999999999999976 455
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||............. .
T Consensus 170 ~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~ 243 (336)
T 3fhr_A 170 LKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--R 243 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred EEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--H
Confidence 9999999998654322 234578999999999988899999999999999999999999997543322100000 0
Q ss_pred hhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
...... .. ....... ..+..+.+||.+||+.||.+||++.+++++.
T Consensus 244 ~~~~~~---~~-~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 244 RIRLGQ---YG-FPNPEWS----EVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ----------C-CCTTTST----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhhccc---cc-cCchhhc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000000 00 0000111 2246789999999999999999999999854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.61 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=197.6
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|.+.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEECC---------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 4689999999999999999998865 6789999999765332 2356889999999999999999999998
Q ss_pred eCCee------EEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 206 EDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 206 ~~~~~------~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
..+.. ++||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence 87655 99999996 68887763 35899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh-hh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-AR 357 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~-~~ 357 (486)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.. ..
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999865332 234678999999999887 7899999999999999999999999976432111100000 00
Q ss_pred h-------hccc--ccccccccCCccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 358 P-------HLGE--RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 358 ~-------~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
. .+.. ...+...+....... +....+..+.+||.+||+.||.+||++.|++++-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 0 0000 000000000000000 0011246789999999999999999999999754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=337.60 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=202.9
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... ......+.+|++++++++||||+++++++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE
Confidence 34689999999999999999998865 57799999986543 23456789999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CcEEEe
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLS 281 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~---~~vkl~ 281 (486)
...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 91 EDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred eCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEe
Confidence 99999999999999999999886543 6899999999999999999999988 9999999999999654 479999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||+++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .+..... .
T Consensus 167 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~---~ 236 (287)
T 2wei_A 167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVE---T 236 (287)
T ss_dssp STTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---H
T ss_pred ccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---c
Confidence 9999986543322 233568999999998765 5899999999999999999999999764321 1111110 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.... .+...... .+..+.+||.+||+.||.+||++.+++++
T Consensus 237 ~~~~----~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 237 GKYA----FDLPQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCCC----CCSGGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCC----CCchhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0000 00000111 23578899999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=355.19 Aligned_cols=265 Identities=21% Similarity=0.265 Sum_probs=201.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-----------CCC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----------HLN 196 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~n 196 (486)
..+|++.+.||+|+||.||+|.+.. +|+.||||++.... .....+.+|+.++.++. |+|
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---------CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 3589999999999999999998865 67799999997542 22356788999999886 899
Q ss_pred ceEEEEEEEeCC----eeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcE
Q 011412 197 LVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNI 270 (486)
Q Consensus 197 Iv~~~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NI 270 (486)
|+++++++...+ .+++||||+ +++|.+++... ...+++..+..++.||+.||.|||++ + |+||||||+||
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI 163 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV 163 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence 999999988654 789999999 88999999754 34699999999999999999999997 8 99999999999
Q ss_pred EEc------CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 011412 271 LLD------ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 344 (486)
Q Consensus 271 ll~------~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~ 344 (486)
||+ ..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 994 3447999999999875432 23357999999999999999999999999999999999999999765
Q ss_pred CCCCcc---hhHHhhhhhccc-----------------ccccccccCC----------ccCCCCCHHHHHHHHHHHHHhc
Q 011412 345 RPNGEH---NLVEWARPHLGE-----------------RRRFYRLIDP----------RLEGHFSIKGAQKAAQLAAHCL 394 (486)
Q Consensus 345 ~~~~~~---~~~~~~~~~~~~-----------------~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~cl 394 (486)
...... .........+.. .......+.. .....++...+..+.+||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 422111 000000000000 0000000000 0011345677888999999999
Q ss_pred ccCCCCCCCHHHHHHHh
Q 011412 395 SRDPKARPLMSEVVEAL 411 (486)
Q Consensus 395 ~~dP~~RPs~~eil~~L 411 (486)
+.||.+||++.|++++-
T Consensus 319 ~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNHP 335 (373)
T ss_dssp CSSTTTCBCHHHHHTCG
T ss_pred ccCccccCCHHHHhhCh
Confidence 99999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=349.67 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=197.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|.+.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+|+.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEECC---------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 3679999999999999999998865 6789999999764322 2356889999999999999999999998
Q ss_pred eCCe------eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 206 EDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 206 ~~~~------~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
..+. .|+||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEE
T ss_pred cccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEE
Confidence 7654 499999996 58888763 35899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR- 357 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~- 357 (486)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999875332 234578999999999876 688999999999999999999999997643211100000000
Q ss_pred -------hhcccc--ccccccc----CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 358 -------PHLGER--RRFYRLI----DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 358 -------~~~~~~--~~~~~~~----~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..+.+. ..+...+ .+.+ .......+..+.+||.+||+.||.+||++.+++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 000000 0000000 0000 011123356789999999999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=347.19 Aligned_cols=266 Identities=21% Similarity=0.256 Sum_probs=201.7
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC------ceEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN------LVKL 200 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~ 200 (486)
..++|++.+.||+|+||.||+|.+... .+..||||+++... .....+.+|+.+|+.+.|++ ++.+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 456899999999999999999988652 23689999997542 23456788999999987665 9999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE-------
Q 011412 201 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL------- 272 (486)
Q Consensus 201 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll------- 272 (486)
++++...+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEE
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccc
Confidence 99999999999999999 667777776543 57999999999999999999999988 9999999999999
Q ss_pred ------------cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 011412 273 ------------DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 340 (486)
Q Consensus 273 ------------~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~p 340 (486)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence 66789999999999864432 2335799999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHHhhhhhccc-------ccc------------------cccccCCc-cCCCCCHHHHHHHHHHHHHhc
Q 011412 341 MDKNRPNGEHNLVEWARPHLGE-------RRR------------------FYRLIDPR-LEGHFSIKGAQKAAQLAAHCL 394 (486)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~-------~~~------------------~~~~~~~~-~~~~~~~~~~~~~~~li~~cl 394 (486)
|...........+......... ... ......+. .........+..+.+||.+||
T Consensus 239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 318 (355)
T 2eu9_A 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318 (355)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence 9764322111111100000000 000 00000000 000112234567899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 011412 395 SRDPKARPLMSEVVEA 410 (486)
Q Consensus 395 ~~dP~~RPs~~eil~~ 410 (486)
+.||.+||++.|++++
T Consensus 319 ~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 319 EFDPAQRITLAEALLH 334 (355)
T ss_dssp CSSTTTSCCHHHHTTS
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=343.66 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=194.0
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc------HHHHHHHHHHHhcC----CCC
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG------HKEWLAEVNFLGDL----VHL 195 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l----~h~ 195 (486)
...++|++.+.||+|+||.||+|.+.. +|+.||||++....... ...+.+|+.++.++ +|+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~ 98 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLT---------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTT---------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEcc---------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence 345789999999999999999998765 57799999997654321 22356799999888 899
Q ss_pred CceEEEEEEEeCCeeEEEEee-cCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-
Q 011412 196 NLVKLIGYCIEDDQRLLVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD- 273 (486)
Q Consensus 196 nIv~~~~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~- 273 (486)
||+++++++...+..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDL 174 (312)
T ss_dssp SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEET
T ss_pred CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeC
Confidence 999999999999999999999 7899999999664 46999999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011412 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352 (486)
Q Consensus 274 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltG~~pf~~~~~~~~~~~ 352 (486)
.++.+||+|||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||.... ..
T Consensus 175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~ 245 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EI 245 (312)
T ss_dssp TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH
T ss_pred CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HH
Confidence 88999999999998765432 2345699999999998877664 58999999999999999999996321 00
Q ss_pred HHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
. ... ..+.. ..+..+.+||.+||+.||.+||++.+++++..
T Consensus 246 ~-------~~~--------~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 246 L-------EAE--------LHFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp H-------HTC--------CCCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred h-------hhc--------cCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0 000 00111 22357889999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=346.81 Aligned_cols=245 Identities=23% Similarity=0.376 Sum_probs=201.1
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCC--CCCc
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLV--HLNL 197 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nI 197 (486)
...++|++.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+.+++.+. |+||
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETT---------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence 455789999999999999999998865 6779999999754321 1234678999999996 5999
Q ss_pred eEEEEEEEeCCeeEEEEeecCC-CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CC
Q 011412 198 VKLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-AD 275 (486)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~ 275 (486)
+++++++...+..++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+ .+
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 186 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTT
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCC
Confidence 9999999999999999999976 8999998654 46899999999999999999999988 99999999999999 78
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011412 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~ 354 (486)
+.+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ...
T Consensus 187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~- 256 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII- 256 (320)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH-
T ss_pred CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhh-
Confidence 999999999998764332 234579999999999887766 688999999999999999999996421 000
Q ss_pred hhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 355 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.... . +...+ +..+.+||.+||+.||.+||++.+|+++.
T Consensus 257 ------~~~~----~----~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 257 ------RGQV----F----FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp ------HCCC----C----CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred ------cccc----c----ccccC----CHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0000 0 11112 35788999999999999999999999854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=340.24 Aligned_cols=253 Identities=28% Similarity=0.404 Sum_probs=182.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-H-HHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-H-KEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||.||+|.+.. +|+.||||++....... . +.+..+..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT---------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEec---------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 4678899999999999999999875 57799999997654322 2 23444556788889999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
..+..+|||||+ ++.+..++......+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999 5566666655567899999999999999999999985 7 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
+++....... .....||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..... .
T Consensus 171 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~---~ 242 (318)
T 2dyl_A 171 ISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLTK---V 242 (318)
T ss_dssp TC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHH---H
T ss_pred CchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHHH---H
Confidence 9976543221 23457999999999984 5678999999999999999999999997532211 11111 1
Q ss_pred cccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.... .+.+... ...+..+.+||.+||+.||.+||++.+++++
T Consensus 243 ~~~~-------~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 243 LQEE-------PPLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHSC-------CCCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred hccC-------CCCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1110 0101100 0123578899999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.41 Aligned_cols=253 Identities=24% Similarity=0.300 Sum_probs=187.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 207 (486)
+.|.+.+.||+|+||+||.+... +|+.||||++.... ...+.+|+.+|.++ +|||||++++++.+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~----------~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES----------SSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEEEEE----------CCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 34556688999999999865332 57799999987542 35678999999886 899999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC------
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLP------LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD------ 275 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~------l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~------ 275 (486)
+..|||||||. |+|.+++...... ..+..++.++.||+.||+|||+.+ |+||||||+||||+.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccc
Confidence 99999999995 6999999654321 122345789999999999999988 9999999999999654
Q ss_pred -------CcEEEeecCCCCCCCCCCcce--eeeeccccccccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CC
Q 011412 276 -------YNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLT-GR 338 (486)
Q Consensus 276 -------~~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-G~ 338 (486)
+.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |.
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 489999999998765432211 1234679999999999865 678999999999999999999 99
Q ss_pred CCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 339 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 339 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.||....... ..+.. .... .+..........+..+.+||.+||+.||.+||++.+++++-
T Consensus 238 ~Pf~~~~~~~-~~i~~-------~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 238 HPFGDKYSRE-SNIIR-------GIFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp CTTCSTTTHH-HHHHH-------TCCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCCCCchhhH-HHHhc-------CCCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 9996542211 11110 0000 01111122345677899999999999999999999999754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=353.84 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=188.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 206 (486)
..+|.+.++||+|+||+||..... +|+.||||++...... .+.+|+++|+.+ +|||||++++++.+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~----------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~ 89 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKD 89 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEES----------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEe----------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 356888999999999996543221 5779999999765432 356899999999 79999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-----CCcEEEe
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-----DYNAKLS 281 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-----~~~vkl~ 281 (486)
....|||||||. |+|.+++......+....++.++.||+.||.|||+.+ |+||||||+||||+. ...+||+
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred CCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 999999999995 6999999876656666677899999999999999988 999999999999943 3358899
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011412 282 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 282 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 356 (486)
|||+++........ ......+||+.|+|||++. ...++.++|||||||++|||++ |..||....... ....
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~~ 241 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANIL 241 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHHH
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHHH
Confidence 99999876543211 1234467999999999987 4677889999999999999999 999985432110 0000
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
.. .... ... ......+..+.+||.+||+.||.+||++.+++++-
T Consensus 242 ---~~-~~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 242 ---LG-ACSL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp ---TT-CCCC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred ---hc-cCCc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 00 0000 000 01123456688999999999999999999999753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=366.42 Aligned_cols=258 Identities=27% Similarity=0.364 Sum_probs=199.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe-
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 206 (486)
++|++.+.||+|+||.||+|.+.. +|..||||++..... .....+.+|+++|+.++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~---------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD---------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT---------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 689999999999999999998765 677899999876432 234568899999999999999999998765
Q ss_pred -----CCeeEEEEeecCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--
Q 011412 207 -----DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-- 277 (486)
Q Consensus 207 -----~~~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-- 277 (486)
.+..+||||||++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence 677899999999999999997543 36889999999999999999999988 999999999999987665
Q ss_pred -EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 278 -AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 -vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ...|.
T Consensus 162 ~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~ 233 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWH 233 (676)
T ss_dssp EEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSS
T ss_pred eEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhh
Confidence 99999999987654332 2346799999999999999999999999999999999999999965311 11111
Q ss_pred hhh-------------cccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 011412 357 RPH-------------LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 408 (486)
Q Consensus 357 ~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil 408 (486)
... ......+.... .....+....+..+.+||.+||..||.+||++.+++
T Consensus 234 ~~i~~~~~~~~~~~~~l~g~~~~~~~l--p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 234 GKVREKSNEHIVVYDDLTGAVKFSSVL--PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp TTCC------CCSCCCCSSSCCCCSSS--CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhcccchhhhhhhhhcccccccccc--CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000 00000010000 112234445678899999999999999999997744
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=323.69 Aligned_cols=232 Identities=13% Similarity=0.080 Sum_probs=184.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++.+.||+|+||.||+|++.. +|+.||||++....... .+.+.+|+.++..++||||+++++++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETT---------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecC---------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 4679999999999999999999865 67899999998664432 35688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+.+..||||||++|++|.+++... .....+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+++|
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC
T ss_pred EECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc
Confidence 9999999999999999999998432 355678899999999999999988 9999999999999999999998543
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
|++ .++.++|||||||+||||++|+.||............ ........
T Consensus 175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~~~ 222 (286)
T 3uqc_A 175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAGQP 222 (286)
T ss_dssp ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTTSCB
T ss_pred ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhccCC
Confidence 333 3789999999999999999999999865432211000 00000000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.....+ .. ..+..+.+||.+||+.||.+| |+.|+++.|+.+.
T Consensus 223 ~~~~~~----~~----~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 223 IEPADI----DR----DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CCHHHH----CT----TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred CChhhc----cc----CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000000 11 224568999999999999999 9999999997543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.14 Aligned_cols=228 Identities=21% Similarity=0.282 Sum_probs=180.3
Q ss_pred cCCCCC-CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHH-hcCCCCCceEEEEEEEe
Q 011412 129 RNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL-GDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~ 206 (486)
.+|.+. +.||+|+||.||+|.+.. +|+.||||++... ..+.+|+.++ +.+.||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcC---------CCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 567776 789999999999999865 6779999999643 5677899988 55689999999999887
Q ss_pred ----CCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCcE
Q 011412 207 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNA 278 (486)
Q Consensus 207 ----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~v 278 (486)
....+|||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||||+. ++.+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcE
Confidence 678899999999999999997653 46999999999999999999999988 999999999999988 7889
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
||+|||++.... +..++.++|||||||++|||++|..||..........
T Consensus 160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------- 208 (299)
T 3m2w_A 160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------- 208 (299)
T ss_dssp EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------
T ss_pred EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------
Confidence 999999986432 2456789999999999999999999996543221100
Q ss_pred hcccccccccccCCccCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 359 HLGERRRFYRLIDPRLEGHFS----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
..... .... ...++ ...+..+.+|+.+||+.||.+||++.|++++.
T Consensus 209 ~~~~~-----~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 209 GMKTR-----IRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp CSCCS-----SCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHH-----Hhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 00000 0000 00011 11246789999999999999999999999754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.78 Aligned_cols=240 Identities=25% Similarity=0.396 Sum_probs=191.7
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..++|++.+.||+|+||.||+|++... +|+.||||++..... .....+.+|+++|.+++|||||++++++.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 346899999999999999999988641 467899999875432 23456889999999999999999999998
Q ss_pred eCCe-----eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 206 EDDQ-----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 206 ~~~~-----~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
..+. .||||||++|++|.+++.. .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+ .+||
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEE
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEE
Confidence 8765 7999999999999987743 6899999999999999999999988 9999999999999875 8999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
+|||+++..... ....||+.|+|||++.+. ++.++|||||||+||+|++|.+||........
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------- 284 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------- 284 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----------
Confidence 999999875432 335799999999988765 48999999999999999999988864211100
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhc
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 412 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~eil~~L~ 412 (486)
. ........+..+.+||.+||+.||.+||+ +.++...|.
T Consensus 285 ----------~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 ----------P---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ----------C---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ----------c---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 00001122356889999999999999995 555555443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=344.61 Aligned_cols=241 Identities=19% Similarity=0.205 Sum_probs=181.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCC-CCc-------
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVH-LNL------- 197 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-~nI------- 197 (486)
..|...++||+|+||+||+|.+.. +|+.||||++...... ..+.+.+|+.++..+.| .|+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred eeEEEecccccCCCEEEEEEEecC---------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 457778899999999999999875 6779999999844322 24678899999999987 221
Q ss_pred --e------------EEEEEEEe-----CCeeEEEEeecCCCChhHHHh------hcCCCCCHHHHHHHHHHHHHHHHHH
Q 011412 198 --V------------KLIGYCIE-----DDQRLLVYEFMPRGSLENHLF------RRSLPLPWSIRMKIALGAAKGLAFL 252 (486)
Q Consensus 198 --v------------~~~~~~~~-----~~~~~lv~E~~~~gsL~~~l~------~~~~~l~~~~~~~i~~qi~~~l~yL 252 (486)
+ .++.++.. ...++++|+++ +++|.+++. .....+++..++.++.||+.||+||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1 11111111 22457778876 679999884 2244577889999999999999999
Q ss_pred HhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCcccc----------ccCCCCchh
Q 011412 253 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----------MTGHLTSRS 322 (486)
Q Consensus 253 H~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~ 322 (486)
|+++ ||||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....|+.++
T Consensus 228 H~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 228 HHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred HhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 9988 999999999999999999999999998864322 344678 999999998 555688899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 011412 323 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402 (486)
Q Consensus 323 DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 402 (486)
|||||||+||||++|+.||.......... ..+.. ...+ +..+.+||.+||+.||.+||
T Consensus 299 DvwSlGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~--~~~~----~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 299 DTWTLGLAIYWIWCADLPNTDDAALGGSE----------------WIFRS--CKNI----PQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSS--CCCC----CHHHHHHHHHHTCSSGGGSC
T ss_pred hHHHHHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhh--cccC----CHHHHHHHHHHccCChhhCc
Confidence 99999999999999999997543221110 00110 0112 36789999999999999999
Q ss_pred CHHHHHHH
Q 011412 403 LMSEVVEA 410 (486)
Q Consensus 403 s~~eil~~ 410 (486)
++.+++++
T Consensus 357 t~~~~l~~ 364 (413)
T 3dzo_A 357 LPLQAMET 364 (413)
T ss_dssp CHHHHTTS
T ss_pred CHHHHHhC
Confidence 99998763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=328.01 Aligned_cols=244 Identities=16% Similarity=0.152 Sum_probs=186.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhcCC------
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLV------ 193 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~------ 193 (486)
.++|++++.||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.+|+.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 45788999999999999999987 467999999986532 23467889999998885
Q ss_pred ---CCCceEEEEEEE------------------------------eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHH
Q 011412 194 ---HLNLVKLIGYCI------------------------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240 (486)
Q Consensus 194 ---h~nIv~~~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~ 240 (486)
|||||++++++. ..+.+|||||||++|+|.+.+.+ ..+++..+..
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~ 165 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKS 165 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHH
Confidence 888888888753 26789999999999977776643 4689999999
Q ss_pred HHHHHHHHHHHHH-hCCCCCeEecCCCCCcEEEcCCC--------------------cEEEeecCCCCCCCCCCcceeee
Q 011412 241 IALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDADY--------------------NAKLSDFGLAKDGPEGDKTHVST 299 (486)
Q Consensus 241 i~~qi~~~l~yLH-~~~~~~iiHrDLKp~NIll~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~ 299 (486)
|+.||+.||.||| +.+ ||||||||+||||+.++ .+||+|||+++.....
T Consensus 166 i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------- 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred HHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence 9999999999999 888 99999999999999887 8999999999865421
Q ss_pred eccccccccCccccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCccCCCC
Q 011412 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV-LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF 378 (486)
Q Consensus 300 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvi-l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (486)
..+||+.|||||++.+.. +.++||||||++ .+++++|..||... .........+.... ..........
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~----~~~~~~~~~~ 304 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQM----TFKTKCNTPA 304 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTC----CCSSCCCSHH
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhh----ccCcccchhh
Confidence 247999999999988666 899999998777 77889999988421 00000000000000 0001111112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HH
Q 011412 379 SIKGAQKAAQLAAHCLSRDPKARPLMSEVV-EA 410 (486)
Q Consensus 379 ~~~~~~~~~~li~~cl~~dP~~RPs~~eil-~~ 410 (486)
....+..+.+||.+||+.| |+.|++ ++
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 2356788999999999976 999998 64
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=310.56 Aligned_cols=170 Identities=19% Similarity=0.156 Sum_probs=128.3
Q ss_pred CCcEEEEEEecCCCc----------ccHHHHHHHHHHHhcC-CCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcC
Q 011412 162 TGLTVAVKTLNHDGL----------QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 230 (486)
Q Consensus 162 ~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~ 230 (486)
+|+.||||++..... ...++|.+|+++|+++ .|+||+++++++.++...|||||||+|++|.++|.+.
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~- 336 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG- 336 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-
Confidence 677899999975532 1234689999999999 7999999999999999999999999999999999654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCc
Q 011412 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310 (486)
Q Consensus 231 ~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 310 (486)
.+++.. +|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+....... .....+||+.||||
T Consensus 337 ~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAP 408 (569)
T 4azs_A 337 EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVN 408 (569)
T ss_dssp CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHH
T ss_pred CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccH
Confidence 467654 58899999999999999 99999999999999999999999999987654322 23457899999999
Q ss_pred cccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 011412 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 341 (486)
Q Consensus 311 E~~~~~~~~~~~DvwslGvil~elltG~~pf 341 (486)
|++.+ .+..++|+|++|+++++|.++..++
T Consensus 409 E~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 409 ELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHC------------------CCCCTTHHHH
T ss_pred HHhCC-CCCCcccccccccchhhhccccchh
Confidence 98865 5678899999999998887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=272.91 Aligned_cols=185 Identities=18% Similarity=0.233 Sum_probs=145.2
Q ss_pred CCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc--------HHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 132 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
...++||+|+||.||+|.. .+..+++|+........ .+.+.+|+++|++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEEC-----------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEE-----------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 4456899999999999954 35689999875432211 2347899999999999999966555
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+...+..|||||||++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+||
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DF 473 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDF 473 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCC
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEEC
Confidence 5677788999999999999999854 5689999999999999988 999999999999998 9999999
Q ss_pred CCCCCCCCCCcce-----eeeeccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 011412 284 GLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSM 341 (486)
Q Consensus 284 Gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltG~~pf 341 (486)
|+++......... .....+||+.|||||++.. ..|+..+|+|+..+-.++.+.++.+|
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999865432211 1235789999999999986 67888999999999999988877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-26 Score=221.96 Aligned_cols=158 Identities=15% Similarity=0.076 Sum_probs=122.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------------------cHHHHHHHHHHH
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------GHKEWLAEVNFL 189 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------------------~~~~~~~E~~~l 189 (486)
...|.+.+.||+|+||.||+|.+ . +|..||||+++..... ....+.+|+.+|
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~---------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l 158 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-E---------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 158 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-T---------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHH
T ss_pred CeEEEecCEeccCCCceEEEEEe-C---------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHH
Confidence 44577779999999999999988 4 5779999999743211 234588999999
Q ss_pred hcCCCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011412 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (486)
Q Consensus 190 ~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 269 (486)
+.++| +++++++. .+..|+|||||+|++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|
T Consensus 159 ~~l~~---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 159 QKLQG---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp HHTTT---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred HhccC---CCcCeEEe-ccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 99984 55555443 356699999999999988 421 224579999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCcccccc----------CCCCchhhHHH
Q 011412 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----------GHLTSRSDVYS 326 (486)
Q Consensus 270 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvws 326 (486)
|||+ ++.+||+|||+++. +..|+|||++.. ..|+..+|+|.
T Consensus 224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999 99999999999863 345789998753 34455556654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3e-22 Score=192.16 Aligned_cols=137 Identities=18% Similarity=0.049 Sum_probs=105.8
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcE--EEEEEecCCCccc------------------------HHHHHH
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT--VAVKTLNHDGLQG------------------------HKEWLA 184 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~--vavK~~~~~~~~~------------------------~~~~~~ 184 (486)
|.+.+.||+|+||.||+|.+.. +|.. ||||+++...... ...+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 5678899999999999998844 4678 9999975432110 125788
Q ss_pred HHHHHhcCCCCCc--eEEEEEEEeCCeeEEEEeecCC-C----ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCC
Q 011412 185 EVNFLGDLVHLNL--VKLIGYCIEDDQRLLVYEFMPR-G----SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH-EEA 256 (486)
Q Consensus 185 E~~~l~~l~h~nI--v~~~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~~ 256 (486)
|+.+|..|.|++| ..++++ +..+|||||+.+ | +|.+++.. .++..+..++.|++.+|.||| +.+
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999988754 444443 356899999942 3 66665432 224467789999999999999 888
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011412 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289 (486)
Q Consensus 257 ~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~ 289 (486)
||||||||+|||++. .++|+|||+|...
T Consensus 192 ---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 ---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999988 8999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4.7e-19 Score=177.57 Aligned_cols=135 Identities=14% Similarity=0.115 Sum_probs=99.6
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--------------ccHHH--------HHHHHHH
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------------QGHKE--------WLAEVNF 188 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------------~~~~~--------~~~E~~~ 188 (486)
|.+.++||.|+||.||+|... +|+.||||+++.... ..... ..+|...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 889999999999999999864 478999999763210 00111 2357777
Q ss_pred HhcCCCCCc--eEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 011412 189 LGDLVHLNL--VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 266 (486)
Q Consensus 189 l~~l~h~nI--v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK 266 (486)
|.+|.+.++ ...+++ ...+|||||++|+.|.++.. . .....++.||+.+|.|||..+ |||||||
T Consensus 167 L~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~g---IVHrDLK 232 (397)
T 4gyi_A 167 MKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHG---LIHGDFN 232 (397)
T ss_dssp HHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCC
Confidence 777755543 233332 12479999999988876432 1 123567899999999999988 9999999
Q ss_pred CCcEEEcCCC----------cEEEeecCCCCCC
Q 011412 267 TSNILLDADY----------NAKLSDFGLAKDG 289 (486)
Q Consensus 267 p~NIll~~~~----------~vkl~DFGla~~~ 289 (486)
|.||||++++ .+.|+||+-+...
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999998776 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=130.77 Aligned_cols=144 Identities=15% Similarity=-0.003 Sum_probs=110.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 205 (486)
....|.+...++.|+++.||++.. .+..+++|+...........+.+|+.+|+.|. +..+.++++++.
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-----------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~ 80 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-----------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe
Confidence 345688888889899999999864 24589999987532122235789999999884 677889999998
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA----------------------------- 256 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~----------------------------- 256 (486)
..+..|+||||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 81 ~~~~~~lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T 3tm0_A 81 HDGWSNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred cCCceEEEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence 88899999999999999875311 1223477889999999999811
Q ss_pred ---------------------------CCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 257 ---------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 257 ---------------------------~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
...++|+|++|.|||++.+..+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1338999999999999876556799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=4.9e-12 Score=120.10 Aligned_cols=137 Identities=17% Similarity=0.046 Sum_probs=98.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC--ceEEEEEEEeC
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGYCIED 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~ 207 (486)
+|.+..+.+.|..+.||++... +|..++||+..... ...+.+|+.+|+.+.+.+ +.++++++...
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 3443333345556999998642 35579999976542 234678999998886544 56688888888
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------- 256 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------------------------------- 256 (486)
+..++||||++|.+|. ... .. ...++.+++..|..||...
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 8899999999998884 211 11 2356777888888888643
Q ss_pred ------------------------CCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 257 ------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 257 ------------------------~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
...++|+||+|.|||++.++.+.|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.3e-11 Score=121.69 Aligned_cols=142 Identities=15% Similarity=0.195 Sum_probs=105.7
Q ss_pred CCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEec--CCCc-ccHHHHHHHHHHHhcCC--CCCceEEEEEEEeC
Q 011412 133 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGL-QGHKEWLAEVNFLGDLV--HLNLVKLIGYCIED 207 (486)
Q Consensus 133 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~ 207 (486)
.++.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.+|+.|. +..+.+++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 3467899999999998653 3468888876 3321 22346788999999997 45678999988766
Q ss_pred ---CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 011412 208 ---DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA---------------------------- 256 (486)
Q Consensus 208 ---~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~---------------------------- 256 (486)
+..|+||||++|..|.+.. -..++...+..++.+++..|..||...
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK 187 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence 4589999999998885421 124678888899999999999999731
Q ss_pred ---------------------------CCCeEecCCCCCcEEEcCCCc--EEEeecCCCCC
Q 011412 257 ---------------------------ERPVIYRDFKTSNILLDADYN--AKLSDFGLAKD 288 (486)
Q Consensus 257 ---------------------------~~~iiHrDLKp~NIll~~~~~--vkl~DFGla~~ 288 (486)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999987753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.19 E-value=2.2e-11 Score=118.97 Aligned_cols=183 Identities=20% Similarity=0.211 Sum_probs=122.5
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCC--ceEEEEEEEeCC--
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLN--LVKLIGYCIEDD-- 208 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~~~~~~~~~~-- 208 (486)
++.++.|.+..||+.. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v~--------------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN--------------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEEST--------------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEEC--------------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 4679999999999862 25889986533 22356889999998883 333 445555543333
Q ss_pred -eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 011412 209 -QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------- 256 (486)
Q Consensus 209 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------------------------------- 256 (486)
..|+|||+++|..|..... ..++...+..++.+++..|..||...
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp SCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred CcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 3489999999998875432 24667778888889999999888621
Q ss_pred ------------------------CCCeEecCCCCCcEEEcC--CCcEEEeecCCCCCCCCCCcceeeeeccccccc---
Q 011412 257 ------------------------ERPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY--- 307 (486)
Q Consensus 257 ------------------------~~~iiHrDLKp~NIll~~--~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y--- 307 (486)
...++|+|++|.|||++. ...+.|+||+.+........ ......+
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~ 239 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEE 239 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTS
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccc
Confidence 124899999999999988 45678999999865322100 0001111
Q ss_pred cCcccccc-----CCC---------CchhhHHHHHHHHHHHHhCCCCC
Q 011412 308 AAPEYVMT-----GHL---------TSRSDVYSFGVVLLEMLTGRRSM 341 (486)
Q Consensus 308 ~aPE~~~~-----~~~---------~~~~DvwslGvil~elltG~~pf 341 (486)
..|+.... +.. ..-.+.|++|.++|.+.+|..+|
T Consensus 240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 240 YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12221110 011 12368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=2.5e-07 Score=90.26 Aligned_cols=137 Identities=20% Similarity=0.152 Sum_probs=94.7
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC---CceEEEEEEE-eCCe
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL---NLVKLIGYCI-EDDQ 209 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~-~~~~ 209 (486)
++.++.|....||+. |..++||+.... .....+.+|+.+|..|.+. .|.+++.++. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 456888888999987 125888885321 2235688999999999652 3566777664 4556
Q ss_pred eEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 011412 210 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--------------------------------- 256 (486)
Q Consensus 210 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--------------------------------- 256 (486)
.++||||++|..|..... ..++......++.+++..|..||...
T Consensus 88 ~~~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp EEEEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred eEEEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 789999999988876321 12344555555566666666665432
Q ss_pred ------------------------CCCeEecCCCCCcEEEcC---CCcE-EEeecCCCCCC
Q 011412 257 ------------------------ERPVIYRDFKTSNILLDA---DYNA-KLSDFGLAKDG 289 (486)
Q Consensus 257 ------------------------~~~iiHrDLKp~NIll~~---~~~v-kl~DFGla~~~ 289 (486)
...++|+|++|.|||++. ++.+ .|+||+.+...
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 123799999999999987 4554 89999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=1.8e-07 Score=89.23 Aligned_cols=136 Identities=17% Similarity=0.081 Sum_probs=96.6
Q ss_pred eeeecCCe-EEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCceEEEEEEEeCCeeEEE
Q 011412 136 LLGEGGFG-CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 136 ~lg~G~fg-~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv 213 (486)
.+..|..| .||+..... .+..+++|+-... ....+.+|+.+|+.|. +--+.++++++.+.+..++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP---------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp EEECSSSSCEEEEEECCT---------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred EccCCCcCCeEEEEEecC---------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 45556555 689876543 3457889987543 2356788999998884 33467889999999999999
Q ss_pred EeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 011412 214 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------------- 256 (486)
Q Consensus 214 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------------------------------------- 256 (486)
||+++|.++.+..... ......+..+++..|.-||...
T Consensus 99 me~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp EECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 9999998887765321 1223345666667777777421
Q ss_pred ------------------CCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 257 ------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 257 ------------------~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01279999999999999877777999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.5e-07 Score=93.73 Aligned_cols=84 Identities=4% Similarity=-0.084 Sum_probs=54.3
Q ss_pred Cee-eecCCeEEEEEEEcc--CCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCC-C--CCceEEEEEEE
Q 011412 135 SLL-GEGGFGCVFKGWIEE--NGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLV-H--LNLVKLIGYCI 205 (486)
Q Consensus 135 ~~l-g~G~fg~Vy~~~~~~--~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~ 205 (486)
+.| +.|....+|+..... ++. ..+..+++|+..... ......+.+|+.+|+.|. + ..+.+++.++.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~-----~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGR-----SIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTE-----EEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EECCCCCccceEEEEEEecccCCC-----CCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 567 778889999876530 000 014578899875432 111134678888888874 2 35678888776
Q ss_pred eC---CeeEEEEeecCCCChh
Q 011412 206 ED---DQRLLVYEFMPRGSLE 223 (486)
Q Consensus 206 ~~---~~~~lv~E~~~~gsL~ 223 (486)
+. +..|+||||++|..|.
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCCC
T ss_pred CCCccCCceEEEEecCCCChh
Confidence 55 3568999999987764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=8.4e-07 Score=89.68 Aligned_cols=76 Identities=13% Similarity=0.045 Sum_probs=49.2
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-------ccHHHHHHHHHHHhcCCC--C-CceEEEEE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLVH--L-NLVKLIGY 203 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~~~~~ 203 (486)
.+.||.|.++.||++.... .+..|+||....... .....+..|+++|..+.. + .+.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 4579999999999996543 345799998653211 122346778888887742 3 34466654
Q ss_pred EEeCCeeEEEEeecCCC
Q 011412 204 CIEDDQRLLVYEFMPRG 220 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~g 220 (486)
+.+..++||||+++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 355678999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.29 E-value=4.9e-06 Score=81.71 Aligned_cols=139 Identities=15% Similarity=0.194 Sum_probs=78.8
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC--CCceEEEE------EEEe
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIG------YCIE 206 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~------~~~~ 206 (486)
+.|+.|..+.||++... +..+++|+.... ...+..|+.++..|.. -.+.+++. +...
T Consensus 38 ~~l~gG~~n~~~~v~~~-----------~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~ 102 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD-----------SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH 102 (346)
T ss_dssp EECC----CEEEEEEET-----------TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE
T ss_pred eeccccccCcEEEEEeC-----------CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE
Confidence 35666778999998653 235899998752 2344455665555531 12333332 1234
Q ss_pred CCeeEEEEeecCCCChh-----------HH---Hhh--cCC--C---------CCHHH----------------------
Q 011412 207 DDQRLLVYEFMPRGSLE-----------NH---LFR--RSL--P---------LPWSI---------------------- 237 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~-----------~~---l~~--~~~--~---------l~~~~---------------------- 237 (486)
.+..++||||++|..+. .. ++. ... + ..|..
T Consensus 103 ~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 182 (346)
T 2q83_A 103 GSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKED 182 (346)
T ss_dssp TTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSC
T ss_pred CCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCC
Confidence 66789999999986552 11 111 100 0 11211
Q ss_pred ---------HHHHHHHHHHHHHHHHh----------CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 238 ---------RMKIALGAAKGLAFLHE----------EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 238 ---------~~~i~~qi~~~l~yLH~----------~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
...+..++..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 183 PFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01111223445666653 0234599999999999998888899999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.09 E-value=2.5e-05 Score=76.18 Aligned_cols=75 Identities=19% Similarity=0.122 Sum_probs=58.8
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCCceEEEEEEEeCCee
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQR 210 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~ 210 (486)
.+.|+.|.+..+|+... .+..++||+.... ....+..|+..|+.|. ...+.+++.++...+..
T Consensus 41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 35789999999999864 2447889987643 2456788999988884 35688899888888889
Q ss_pred EEEEeecCCCCh
Q 011412 211 LLVYEFMPRGSL 222 (486)
Q Consensus 211 ~lv~E~~~~gsL 222 (486)
++||||+++..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999999865
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.01 E-value=2.4e-05 Score=79.56 Aligned_cols=76 Identities=14% Similarity=0.169 Sum_probs=47.8
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccc--cccccCccccccCC---CCchhhHHHHHHHHH
Q 011412 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG--TYGYAAPEYVMTGH---LTSRSDVYSFGVVLL 332 (486)
Q Consensus 258 ~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwslGvil~ 332 (486)
..++|+||+|.|||++.++ ++|+||+.+......... ..... ...|++|+...... -....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4499999999999998776 999999998764321100 00111 23466766543111 112355668888888
Q ss_pred HHHhC
Q 011412 333 EMLTG 337 (486)
Q Consensus 333 elltG 337 (486)
+++++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00014 Score=69.74 Aligned_cols=79 Identities=18% Similarity=0.120 Sum_probs=56.3
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC---CCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH---LNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~ 206 (486)
...-++.+|.|..+.||+.... +|+.|+||+...........+..|+..|+.|.- --+.+++++.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-- 83 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-- 83 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--
T ss_pred CeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--
Confidence 3444567999999999999875 477899998765544434457889999988842 2355666542
Q ss_pred CCeeEEEEeecCCCCh
Q 011412 207 DDQRLLVYEFMPRGSL 222 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL 222 (486)
.-++||||++++..
T Consensus 84 --~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 --DRTLAMEWVDERPP 97 (288)
T ss_dssp --TTEEEEECCCCCCC
T ss_pred --CceEEEEeecccCC
Confidence 24789999987754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.71 E-value=7.5e-05 Score=72.73 Aligned_cols=140 Identities=13% Similarity=0.101 Sum_probs=76.2
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC--ceEEEEE------EEe
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGY------CIE 206 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~------~~~ 206 (486)
+.|+.|....||+..... | .+++|+...... ...+..|+.++..|...+ +.+++.. ...
T Consensus 28 ~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTK----------D-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp EEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred eccCCCcccceEEEEeCC----------c-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 356678888999986532 2 588998875311 134556777776663212 2333321 123
Q ss_pred CCeeEEEEeecCCCChhH-----------H---Hhhc--C--CC----CC---HHHHHH------------HHHHHHHHH
Q 011412 207 DDQRLLVYEFMPRGSLEN-----------H---LFRR--S--LP----LP---WSIRMK------------IALGAAKGL 249 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~-----------~---l~~~--~--~~----l~---~~~~~~------------i~~qi~~~l 249 (486)
.+..++||+|++|..+.. . ++.. . .+ .. |...+. +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 456789999998865421 0 1111 0 00 11 111000 001133445
Q ss_pred HHHHhC----CCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 250 AFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 250 ~yLH~~----~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
.+++.. .+..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 555532 12359999999999999877656899999775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.64 E-value=7e-05 Score=72.40 Aligned_cols=72 Identities=7% Similarity=0.054 Sum_probs=45.3
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-eEEEEEEEeCCeeEE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLL 212 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~l 212 (486)
++.|+.|....+|+. . .+++|+........ ....+|+.+++.+...++ .+++++ +.+.-++
T Consensus 23 i~~l~gG~tN~~~~~--~-------------~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA--G-------------DLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE--T-------------TEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred eeEcCCcccccccee--e-------------eEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence 678999999999998 1 48889876532111 123467777777643333 455544 3444578
Q ss_pred EEeec-CCCChh
Q 011412 213 VYEFM-PRGSLE 223 (486)
Q Consensus 213 v~E~~-~~gsL~ 223 (486)
|+||+ +|.+|.
T Consensus 85 v~e~i~~g~~l~ 96 (301)
T 3dxq_A 85 VTRYIAGAQTMS 96 (301)
T ss_dssp EEECCTTCEECC
T ss_pred EEeecCCCccCC
Confidence 99999 665553
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00012 Score=74.74 Aligned_cols=81 Identities=19% Similarity=0.108 Sum_probs=51.2
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-eEEEEEEEeCCeeEE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLL 212 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~l 212 (486)
++.|+.|....||++....... ...+.+..|++|+..... ....+.+|+.++..|...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 3568888889999997643110 001124678999884321 12456689999888853334 567776532 38
Q ss_pred EEeecCCCCh
Q 011412 213 VYEFMPRGSL 222 (486)
Q Consensus 213 v~E~~~~gsL 222 (486)
||||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.60 E-value=0.0003 Score=63.86 Aligned_cols=98 Identities=15% Similarity=0.088 Sum_probs=66.9
Q ss_pred ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeee
Q 011412 221 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300 (486)
Q Consensus 221 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 300 (486)
+|.+.|...+.++.+++++.++.|.+..|.-+-.... -..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-------------
Confidence 7999999889999999999999999998877622110 11233457999999999998764 2111
Q ss_pred ccccccccCccccccCCCCchhhHHHHHHHHHHHHh
Q 011412 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336 (486)
Q Consensus 301 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt 336 (486)
.....+.|||... ...+.+.=|||||++||.-+-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888653 455678899999999999884
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00041 Score=67.58 Aligned_cols=140 Identities=16% Similarity=0.111 Sum_probs=79.1
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--CceEEEEE-----EEeC
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGY-----CIED 207 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~-----~~~~ 207 (486)
..|+ |....||+.... .|..+++|+..... .....+..|+.++..|... .+.+++.. ....
T Consensus 32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 4576 888899987542 25578999987432 1345677788888777422 23444432 1234
Q ss_pred CeeEEEEeecCCCChh-----HH---------Hhh--cC------CCCCHHHH----HHH---------------HHHHH
Q 011412 208 DQRLLVYEFMPRGSLE-----NH---------LFR--RS------LPLPWSIR----MKI---------------ALGAA 246 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~-----~~---------l~~--~~------~~l~~~~~----~~i---------------~~qi~ 246 (486)
+..++||+|++|..+. .+ ++. .. ..+.+... ..+ ...+.
T Consensus 100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 179 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 179 (328)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence 5668899999885442 11 110 00 01121110 000 01111
Q ss_pred HHHHHHHhC----CCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 247 KGLAFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 247 ~~l~yLH~~----~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..+..+... ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 122232211 234489999999999998 4 899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00029 Score=72.37 Aligned_cols=74 Identities=14% Similarity=0.026 Sum_probs=46.8
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-eEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv 213 (486)
+.|+.|-...+|++.... .+..|++|+....... .-...+|+.+|..|...++ .++++++. + .+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v 179 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRI 179 (458)
T ss_dssp EEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEE
T ss_pred EEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEE
Confidence 467778889999987642 2357889987543211 1112578888888865555 56777662 2 359
Q ss_pred EeecCCCCh
Q 011412 214 YEFMPRGSL 222 (486)
Q Consensus 214 ~E~~~~gsL 222 (486)
|||++|..|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00059 Score=66.75 Aligned_cols=32 Identities=31% Similarity=0.378 Sum_probs=27.6
Q ss_pred CCeEecCCCCCcEEEcCC----CcEEEeecCCCCCC
Q 011412 258 RPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDG 289 (486)
Q Consensus 258 ~~iiHrDLKp~NIll~~~----~~vkl~DFGla~~~ 289 (486)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 459999999999999874 67999999988754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00039 Score=69.52 Aligned_cols=148 Identities=15% Similarity=0.113 Sum_probs=83.9
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC-ceEEEEEEEeCCeeEE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLL 212 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~l 212 (486)
++.|..|-...+|++....... ...+.+..|++|+.... ......+.+|.++++.|...+ ..++++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 3567778888999987642100 00113468999986432 234456778999998884222 3566766543 39
Q ss_pred EEeecCCCChhHH--------------H---hhcC----CCCC--HHHHHHHHHHHHH-------------------HHH
Q 011412 213 VYEFMPRGSLENH--------------L---FRRS----LPLP--WSIRMKIALGAAK-------------------GLA 250 (486)
Q Consensus 213 v~E~~~~gsL~~~--------------l---~~~~----~~l~--~~~~~~i~~qi~~-------------------~l~ 250 (486)
||||++|..|..- | .... .... +..+.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998665311 1 1111 1111 3444455544322 223
Q ss_pred HHH----hC-CCCCeEecCCCCCcEEEcCC----CcEEEeecCCCCC
Q 011412 251 FLH----EE-AERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 288 (486)
Q Consensus 251 yLH----~~-~~~~iiHrDLKp~NIll~~~----~~vkl~DFGla~~ 288 (486)
.|. .. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 21 12349999999999999876 7899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00036 Score=69.40 Aligned_cols=82 Identities=10% Similarity=0.042 Sum_probs=44.5
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC-ceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv 213 (486)
+.|+.|....||+........ ...+..+..+++|+....... ......|+.++..|...+ +.++++.+ . -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 467788888999987643100 000012357888887543211 112357888887774333 34666554 2 3789
Q ss_pred EeecCCCCh
Q 011412 214 YEFMPRGSL 222 (486)
Q Consensus 214 ~E~~~~gsL 222 (486)
|||++|..|
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0037 Score=61.34 Aligned_cols=31 Identities=13% Similarity=0.153 Sum_probs=27.3
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 258 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 258 ~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0034 Score=63.54 Aligned_cols=81 Identities=12% Similarity=0.050 Sum_probs=47.8
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC-ceEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv 213 (486)
+.|..|-...+|+......... ....+..|++++..... ...-...+|.++++.|...+ ..++++.+ . -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 4677788889999877531110 00125689999875432 11112357888888774323 35566543 2 2789
Q ss_pred EeecCCCCh
Q 011412 214 YEFMPRGSL 222 (486)
Q Consensus 214 ~E~~~~gsL 222 (486)
|||++|..|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.00 E-value=0.11 Score=51.87 Aligned_cols=29 Identities=28% Similarity=0.319 Sum_probs=24.9
Q ss_pred eEecCCCCCcEEE------cCCCcEEEeecCCCCC
Q 011412 260 VIYRDFKTSNILL------DADYNAKLSDFGLAKD 288 (486)
Q Consensus 260 iiHrDLKp~NIll------~~~~~vkl~DFGla~~ 288 (486)
++|+|+.+.|||+ +++..+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4467799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.34 E-value=0.75 Score=41.47 Aligned_cols=122 Identities=9% Similarity=0.093 Sum_probs=82.7
Q ss_pred HHHHHhcCCCCCceEEEEEEEeCCeeEEEEeecCCC-ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 011412 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 263 (486)
Q Consensus 185 E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHr 263 (486)
|+.+| ...||+++.. .+-..++.+.|.++.-+.+ ++.. + ..++...+++++.+|+....+++. =+|-
T Consensus 36 el~LL-~~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf 103 (215)
T 4ann_A 36 LMYLL-EQHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTF 103 (215)
T ss_dssp GGGGG-GSCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGGS-----SEEC
T ss_pred HHHHH-hccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEE
Confidence 44433 3368888866 4666677666666654322 2222 2 346788999999999887766654 4788
Q ss_pred CCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011412 264 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342 (486)
Q Consensus 264 DLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~ 342 (486)
-|.|+||+++.++.++|.-.|+-.. ++|. .++...=+-.+=|++..+++++..|.
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEecceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 8999999999999999987665332 2222 22333445567889999999988774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.85 E-value=1.1 Score=40.48 Aligned_cols=115 Identities=10% Similarity=0.093 Sum_probs=78.2
Q ss_pred CCCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCCcEE
Q 011412 193 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA-FLHEEAERPVIYRDFKTSNIL 271 (486)
Q Consensus 193 ~h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~-yLH~~~~~~iiHrDLKp~NIl 271 (486)
.||++ -..+-.+++.+.|.++.-+++.=...+ ..++...+++++.+|+.... +++. -+|--|.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 57888 444446677777777765443222233 24678889999988887666 5544 578889999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011412 272 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 342 (486)
Q Consensus 272 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~ 342 (486)
++.++.++|.-.|+-.. ++|. .++..-=+-.+=|++..++.++..|+
T Consensus 117 f~~~~~p~i~hRGi~~~-------------------lpP~-----e~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES-------------------LPPD-----EWDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTT-------------------BSSC-----SCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCccc-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987665332 3333 12333334567788888998887764
|
| >2khx_A Ribonuclease 3; drosha, RNA binding domain, hydrolase, gene regulation, NUCL protein, gene regulation,nuclear protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.73 E-value=0.17 Score=38.61 Aligned_cols=26 Identities=12% Similarity=-0.165 Sum_probs=22.9
Q ss_pred ccccccccchhhhhhhcccccccccc
Q 011412 9 KVKKASWDSSKSKAKKKKKKVEDEVE 34 (486)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (486)
+.++.|.|++|++|+|.||+.+.+.+
T Consensus 49 ~~~~~G~G~SKK~AEq~AA~~AL~~L 74 (85)
T 2khx_A 49 ERIGCGKGPSIQQAEMGAAMDALEKY 74 (85)
T ss_dssp EECCCEEESSHHHHHHHHHHHHHTTC
T ss_pred EEEEEEeeCCHHHHHHHHHHHHHHHH
Confidence 56789999999999999999887665
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.27 E-value=0.12 Score=52.87 Aligned_cols=62 Identities=8% Similarity=0.093 Sum_probs=17.8
Q ss_pred CCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEE------EEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV------KTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 132 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
.+.+.|| ||.||+|.+... ...||| |..+.... .....+.+|..++..+.|||+++.+++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~---------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKK---------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred cccccCC---chhhhccccccc---------CCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence 4456776 999999988541 236777 76654322 223457889999999999999999887
Q ss_pred EE
Q 011412 204 CI 205 (486)
Q Consensus 204 ~~ 205 (486)
..
T Consensus 213 ~~ 214 (463)
T 3cxl_A 213 KV 214 (463)
T ss_dssp EE
T ss_pred EE
Confidence 64
|
| >1x49_A Interferon-induced, double-stranded RNA- activated protein kinase; structure genomics, DSRM domain, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=80.19 E-value=0.24 Score=38.81 Aligned_cols=27 Identities=19% Similarity=0.108 Sum_probs=23.8
Q ss_pred ccccccccchhhhhhhccccccccccc
Q 011412 9 KVKKASWDSSKSKAKKKKKKVEDEVEV 35 (486)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (486)
+.++.|.|++|++|+|.||+.+...+.
T Consensus 56 ~~~~~G~G~SKK~Aeq~AA~~AL~~L~ 82 (97)
T 1x49_A 56 KEFPEAKGRSKQEARNAAAKLAVDILD 82 (97)
T ss_dssp CCCCCEEESSHHHHHHHHHHHHHHHHT
T ss_pred EEEEEEeeCCHHHHHHHHHHHHHHHHH
Confidence 567899999999999999999987764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 486 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-76 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-68 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-65 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 7e-76
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 33/290 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+G G FG V+KG VAVK LN Q + + EV
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVG 56
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L H+N++ +GY Q +V ++ SL +HL + IA A+
Sbjct: 57 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 115
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+ +LH + +I+RD K++NI L D K+ DFGLA +H ++ G+ +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 308 AAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
APE + + +SDVY+FG+VL E++TG+ P N + +G
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGY 226
Query: 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
L ++ + + +L A CL + RPL +++ +++ L
Sbjct: 227 LSPDL--SKVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (559), Expect = 1e-68
Identities = 73/309 (23%), Positives = 127/309 (41%), Gaps = 38/309 (12%)
Query: 119 FTFNDLKLATRNFRPE---------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 169
FTF D A R F E ++G G FG V G ++ G + VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60
Query: 170 TLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 228
TL + +++L+E + +G H N++ L G + +++ EFM GSL++ L +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 229 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ + G A G+ +L + ++RD NIL++++ K+SDFGL++
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 289 GPEGDKTHVSTRV---MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
+ T + APE + TS SDV+S+G+V+ E+++ R
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----R 232
Query: 346 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405
P + + I+ + QL C +D RP
Sbjct: 233 PYWDMTNQDV-----------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 406 EVVEALKPL 414
++V L +
Sbjct: 282 QIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 5e-68
Identities = 85/326 (26%), Positives = 136/326 (41%), Gaps = 36/326 (11%)
Query: 104 SKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 163
S L EL A + + L + +F ++G G FGCV+ G + +N G
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIV---HF--NEVIGRGHFGCVYHGTLLDND------GKK 55
Query: 164 LTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR-LLVYEFMPRGS 221
+ AVK+LN G ++L E + D H N++ L+G C+ + L+V +M G
Sbjct: 56 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115
Query: 222 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281
L N + + + L AKG+ FL + ++RD N +LD + K++
Sbjct: 116 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 172
Query: 282 DFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339
DFGLA+D E D H T + A E + T T++SDV+SFGV+L E++T
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
Query: 340 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 399
P + N + L + RL+ P ++ C +
Sbjct: 233 -----PPYPDVNTFDITVYLL----QGRRLLQPEYC-------PDPLYEVMLKCWHPKAE 276
Query: 400 ARPLMSEVVEALKPLPNLKDMASSSY 425
RP SE+V + + Y
Sbjct: 277 MRPSFSELVSRISAI--FSTFIGEHY 300
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-67
Identities = 56/284 (19%), Positives = 107/284 (37%), Gaps = 31/284 (10%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
++ LG G FG V G VA+K + E++ E
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
+ +L H LV+L G C + ++ E+M G L N+L +++ +
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
+ +L + ++RD N L++ K+SDFGL++ + D+ S ++
Sbjct: 113 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWS 168
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368
PE +M +S+SD+++FGV++ E+ + + + N E
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAE 212
Query: 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
I L + ++K + C RP ++ +
Sbjct: 213 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-67
Identities = 77/285 (27%), Positives = 124/285 (43%), Gaps = 31/285 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+G G FG V G+ VA+KT+ ++++ E +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVM 54
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L H LV+L G C+E LV+EFM G L ++L + + + L +G+
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
A+L E VI+RD N L+ + K+SDFG+ + + D+ ST +A+
Sbjct: 115 AYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWAS 170
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
PE +S+SDV+SFGV++ E+ + + +NR N E +VE +RL
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI-------STGFRL 221
Query: 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
PRL + Q+ HC P+ RP S ++ L +
Sbjct: 222 YKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-65
Identities = 67/313 (21%), Positives = 125/313 (39%), Gaps = 43/313 (13%)
Query: 124 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEW 182
++L +F S LG G G VFK +GL +A K ++ + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
+ E+ L + +V G D + + E M GSL+ L + +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVS 110
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
+ KGL +L E+ +++RD K SNIL+++ KL DFG++ + ++ +
Sbjct: 111 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFV 164
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR----------------------- 339
GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 340 ---SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 396
+ + +RP + +++ S + + CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 397 DPKARPLMSEVVE 409
+P R + +++
Sbjct: 285 NPAERADLKQLMV 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 3e-65
Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 33/286 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ LG G FG V+ G+ VAVK+L +LAE N +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLM 62
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKG 248
L H LV+L + ++ E+M GSL + L S + L + + +A A+G
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
+AF+ E R I+RD + +NIL+ + K++DFGLA+ + ++ +
Sbjct: 122 MAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWT 177
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368
APE + G T +SDV+SFG++L E++T R P E + R YR
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGR-----IPYPGMTNPEVIQNL----ERGYR 228
Query: 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
++ P + ++ QL C P+ RP + L+
Sbjct: 229 MVRPD---NCP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (534), Expect = 4e-65
Identities = 69/299 (23%), Positives = 130/299 (43%), Gaps = 31/299 (10%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
++ ++ + + LG G +G V++G V LTVAVKTL D +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTM 55
Query: 177 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPW 235
+ +E+L E + ++ H NLV+L+G C + ++ EFM G+L ++L + +
Sbjct: 56 EV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 114
Query: 236 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 295
+ + +A + + +L + + I+RD N L+ ++ K++DFGL++ GD
Sbjct: 115 VVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 170
Query: 296 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355
+ APE + + +SDV++FGV+L E+ T S +
Sbjct: 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------ 224
Query: 356 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
Y L++ +K +L C +P RP +E+ +A + +
Sbjct: 225 ----------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-64
Identities = 69/310 (22%), Positives = 120/310 (38%), Gaps = 31/310 (10%)
Query: 123 DLKLATRNFRPESL-LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-K 180
L L N + LG G FG V +G + VA+K L + +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTE 54
Query: 181 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
E + E + L + +V+LIG C + + +LV E G L L + +P S +
Sbjct: 55 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVST 299
+ + G+ +L E + ++RD N+LL + AK+SDFGL+K G + +
Sbjct: 114 LLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
+ APE + +SRSDV+S+GV + E L+ + +P + E
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE----- 220
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK-PLPNLK 418
I+ + + L + C + RP V + ++ +L
Sbjct: 221 ------VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 419 DMASSSYYFQ 428
++
Sbjct: 275 SKVEGHHHHH 284
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-64
Identities = 70/307 (22%), Positives = 113/307 (36%), Gaps = 46/307 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
N +LG G FG V K G + VAVK L +E ++E+
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 189 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------- 231
+ L H N+V L+G C L++E+ G L N+L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 232 ------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285
L + + A AKG+ FL + ++RD N+L+ K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 345
A+D V + APE + G T +SDV+S+G++L E+ + +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 346 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 405
P + FY+LI + ++ + C + D + RP
Sbjct: 271 PVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 406 EVVEALK 412
+ L
Sbjct: 316 NLTSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 2e-64
Identities = 68/304 (22%), Positives = 130/304 (42%), Gaps = 30/304 (9%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 183
++ + ++G G FG V+KG ++ + + VA+KTL + + ++L
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFL 57
Query: 184 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
E +G H N+++L G + +++ E+M G+L+ L + + +
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVM 302
G A G+ +L ++RD NIL++++ K+SDFGL++ + + T+ ++
Sbjct: 118 GIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
+ APE + TS SDV+SFG+V+ E++T N E
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------- 221
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL----PNLK 418
+ I+ + QL C ++ RP +++V L L +LK
Sbjct: 222 ---VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
Query: 419 DMAS 422
+A
Sbjct: 279 TLAD 282
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 7e-64
Identities = 77/314 (24%), Positives = 117/314 (37%), Gaps = 46/314 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
LG G FG V + +K +TVAVK L +E ++E+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 189 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-----------------S 230
L L H+N+V L+G C L++ E+ G L N L R+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 231 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 290
L L + + AKG+AFL + I+RD NILL K+ DFGLA+D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 291 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 350
V + APE + T SDV+S+G+ L E+ + S P
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 351 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410
FY++I + + C DP RP ++V+
Sbjct: 257 ---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 411 LKPLPNLKDMASSS 424
++ K ++ S+
Sbjct: 302 IE-----KQISEST 310
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 1e-63
Identities = 71/318 (22%), Positives = 116/318 (36%), Gaps = 47/318 (14%)
Query: 121 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-H 179
L+ N +GEG FG VF+ + VAVK L +
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARA----PGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-------- 231
++ E + + + N+VKL+G C L++E+M G L L S
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 232 ---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
PL + ++ IA A G+A+L E R ++RD T N L+ +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
K++DFGL+++ D + PE + T+ SDV+++GVVL E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 337 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 396
+ E ++ + R G L L C S+
Sbjct: 238 YGLQPYYGMAHEE--VIYYVRD--GNILACPENCPLEL------------YNLMRLCWSK 281
Query: 397 DPKARPLMSEVVEALKPL 414
P RP + L+ +
Sbjct: 282 LPADRPSFCSIHRILQRM 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-63
Identities = 70/313 (22%), Positives = 119/313 (38%), Gaps = 35/313 (11%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
R + +G+G FG V++G G VAVK + + AE+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQ 50
Query: 189 LGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
L H N++ I +D+ Q LV ++ GSL ++L R + +K+AL
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALS 108
Query: 245 AAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HV 297
A GLA LH E + + +RD K+ NIL+ + ++D GLA T
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 298 STRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRR----SMDKNRPN 347
+GT Y APE + R+D+Y+ G+V E+ D P
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
Query: 348 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 407
+ + + + + +L S + + A++ C + AR +
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
Query: 408 VEALKPLPNLKDM 420
+ L L + +
Sbjct: 289 KKTLSQLSQQEGI 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-63
Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 39/286 (13%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 188
+ + +G+G FG V G G VAVK + +D + +LAE +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASV 53
Query: 189 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAA 246
+ L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+ + +L ++RD N+L+ D AK+SDFGL K+ T
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVK 165
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
+ APE + +++SDV+SFG++L E+ + R P L + R
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVV-------PRV 213
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ ++ +C D RP ++ E L+
Sbjct: 214 EKGYKMDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-62
Identities = 76/288 (26%), Positives = 119/288 (41%), Gaps = 29/288 (10%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAE 185
++ R LG+G FG V +G + G ++VAVK L D L + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
VN + L H NL++L G + ++ V E P GSL + L + + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGT 304
A+G+ +L + I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 121 AEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 305 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364
+ + APE + T + SD + FGV L EM T + P N + E
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGE 232
Query: 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
R PR E Q + C + P+ RP + + L
Sbjct: 233 RL-----PRPEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 4e-62
Identities = 70/296 (23%), Positives = 121/296 (40%), Gaps = 33/296 (11%)
Query: 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGD 191
+ LG G FG V KG+ + TVAVK L ++ E LAE N +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 192 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 251
L + +V++IG C E + +LV E G L +L + + +++ + G+ +
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKY 122
Query: 252 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAP 310
L E ++RD N+LL + AK+SDFGL+K + T + AP
Sbjct: 123 LEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370
E + +S+SDV+SFGV++ E + + +P E ++
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE-----------VTAML 223
Query: 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYY 426
+ ++ L C + D + RP + V L+ D+ + ++
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY--YYDVVNEGHH 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-61
Identities = 61/285 (21%), Positives = 116/285 (40%), Gaps = 26/285 (9%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFL 189
F+ +LG G FG V+KG G + VA+K L + +KE L E +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
+ + ++ +L+G C+ +L + + MP G L +++ + + + AKG+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+L + R +++RD N+L+ + K++DFGLAK +K + + + A
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
E ++ T +SDV+S+GV + E++T P E +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSI 225
Query: 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
++ + C D +RP E++ +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-61
Identities = 72/308 (23%), Positives = 123/308 (39%), Gaps = 47/308 (15%)
Query: 128 TRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 181
TR+ PE LG+G FG V+K T + A K ++ + ++
Sbjct: 5 TRDLNPEDFWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELED 55
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
++ E++ L H N+VKL+ ++ ++ EF G+++ + PL S +
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 115
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
L +LH + +I+RD K NIL D + KL+DFG++ +
Sbjct: 116 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSF 170
Query: 302 MGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356
+GT + APE VM ++DV+S G+ L+EM P+ E N +
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVL 224
Query: 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV-------VE 409
+ L P +S CL ++ AR S++ V+
Sbjct: 225 LKIA--KSEPPTLAQPS---RWS----SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
Query: 410 ALKPLPNL 417
+ KP+ L
Sbjct: 276 SNKPIREL 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-61
Identities = 68/296 (22%), Positives = 112/296 (37%), Gaps = 45/296 (15%)
Query: 117 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 176
R++ D F LG+G FG V+ + + +A+K L L
Sbjct: 1 RQWALED-------FEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 44
Query: 177 ---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 233
+ EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 45 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KF 103
Query: 234 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 293
A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 104 DEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160
Query: 294 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
+T + GT Y PE + + D++S GV+ E L G+ P +
Sbjct: 161 RTTL----CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQ 210
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
E + F + A L + L +P RP++ EV+E
Sbjct: 211 ETYKRISRVEFTFPDFVTE------------GARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 6e-61
Identities = 69/318 (21%), Positives = 125/318 (39%), Gaps = 53/318 (16%)
Query: 114 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 173
+ +ND+K + ++GEG FG V K I+++G + A+K +
Sbjct: 2 TIYPVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKE 47
Query: 174 DGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 231
H+++ E+ L L H N++ L+G C L E+ P G+L + L + +
Sbjct: 48 YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 107
Query: 232 ---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 276
L + A A+G+ +L + + I+RD NIL+ +Y
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY 164
Query: 277 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 336
AK++DFGL++ K T + A E + T+ SDV+S+GV+L E+++
Sbjct: 165 VAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221
Query: 337 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 396
+ P E Y + + + L C
Sbjct: 222 LGGT-----PYCGMTCAEL-----------YEKLPQGYRLEKPLNCDDEVYDLMRQCWRE 265
Query: 397 DPKARPLMSEVVEALKPL 414
P RP ++++ +L +
Sbjct: 266 KPYERPSFAQILVSLNRM 283
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-60
Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 33/286 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ R E LG+G FG V+ G VA+KTL + +L E +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPG-TMSPEAFLQEAQVM 66
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKG 248
L H LV+L ++ +V E+M +GSL + L L + +A A G
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
+A++ ++RD + +NIL+ + K++DFGLA+ + ++ +
Sbjct: 126 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWT 181
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368
APE + G T +SDV+SFG++L E+ T R N E
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLD 225
Query: 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
++ + + L C ++P+ RP + L+
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-60
Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 30/282 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNF 188
++ LGEG +G V V T VAVK ++ + + E+
Sbjct: 6 DWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
L H N+VK G+ E + + L E+ G L + + +P + G
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAG 115
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT Y
Sbjct: 116 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 309 APEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE + + DV+S G+VL ML G D+ + + +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YS 217
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ + + K L L +P AR + ++ +
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-59
Identities = 61/289 (21%), Positives = 111/289 (38%), Gaps = 37/289 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
++ +G G +G K + G + K L++ + + ++EVN
Sbjct: 5 DYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSL---PLPWSIRMKIA 242
L +L H N+V+ I+ L V E+ G L + + + + L +++
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 243 LGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
L H + V++RD K +N+ LD N KL DFGLA+ T +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+GT Y +PE + +SD++S G +L E+ P + E A
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIR 227
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ R+ +S + ++ L+ RP + E++E
Sbjct: 228 EGKF-------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 8e-59
Identities = 63/288 (21%), Positives = 107/288 (37%), Gaps = 38/288 (13%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
R + + +G G F V+KG + T + VA L L + + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 187 NFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L L H N+V+ +LV E M G+L+ +L R + +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWC 118
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRV 301
KGL FLH P+I+RD K NI + + K+ D GLA + + V
Sbjct: 119 RQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAV 173
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
+GT + APE + DVY+FG+ +LEM T + + +
Sbjct: 174 IGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------- 221
Query: 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ R+ F + ++ C+ ++ R + +++
Sbjct: 222 ----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-58
Identities = 68/287 (23%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 188
+GEG FG V +G L VA+KT + +E +L E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 248
+ H ++VKLIG ++ ++ E G L + L R L + + A +
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 249 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 308
LA+L + ++RD N+L+ ++ KL DFGL++ + + +++ +
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWM 176
Query: 309 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL-GERRRFY 367
APE + TS SDV+ FGV + E+L +P + GER
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGERLPMP 231
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
P L L C + DP RP +E+ L +
Sbjct: 232 PNCPPTL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 3e-58
Identities = 67/289 (23%), Positives = 116/289 (40%), Gaps = 43/289 (14%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LA 184
+ F +G G FG V+ VA+K +++ G Q +++W +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
EV FL L H N ++ G + + LV E+ + + + PL + G
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHG 123
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 304
A +GLA+LH +I+RD K NILL KL DFG A + +GT
Sbjct: 124 ALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGT 174
Query: 305 YGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLVEWARPHL 360
+ APE ++ G + DV+S G+ +E+ + + + N + +++ + P
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-- 232
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
GH+S + CL + P+ RP +++
Sbjct: 233 -----------ALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 6e-57
Identities = 74/309 (23%), Positives = 129/309 (41%), Gaps = 37/309 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 188
LG+G FG V++G VK VA+KT+N ++ E+L E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVA----KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 189 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---------RRSLPLPWSIRM 239
+ + ++V+L+G + L++ E M RG L+++L P S +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
++A A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
+ + + +PE + G T+ SDV+SFGVVL E+ T + N +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---------- 243
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL--PNL 417
R + +L C +PK RP E++ ++K P
Sbjct: 244 ------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
Query: 418 KDMASSSYY 426
+++ S YY
Sbjct: 298 REV--SFYY 304
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-56
Identities = 63/302 (20%), Positives = 116/302 (38%), Gaps = 36/302 (11%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 187
+ + +G+G G V+ + TG VA++ +N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
+ + + N+V + + D+ +V E++ GSL + + + + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQ 127
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
L FLH VI+RD K+ NILL D + KL+DFG + ++GT +
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYW 182
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE V + D++S G++ +EM+ G P N +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIA--TNGTP 234
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-----ALKPLPNLKDMAS 422
L +P S CL D + R E+++ KPL +L + +
Sbjct: 235 ELQNPE---KLS----AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287
Query: 423 SS 424
++
Sbjct: 288 AA 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (474), Expect = 4e-56
Identities = 82/303 (27%), Positives = 117/303 (38%), Gaps = 40/303 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNF 188
+ LG G FG V + K T TVAVK L H+ ++E+
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 189 LGDLVH-LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR---------------SL 231
L + H LN+V L+G C + L ++ EF G+L +L +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 232 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291
L + + AKG+ FL R I+RD NILL K+ DFGLA+D +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 292 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351
+ APE + T +SDV+SFGV+L E+ + S P
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVK 241
Query: 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411
+ E L E R R + + + Q C +P RP SE+VE L
Sbjct: 242 IDEEFCRRLKEGTR------MRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 412 KPL 414
L
Sbjct: 292 GNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 2e-55
Identities = 75/302 (24%), Positives = 118/302 (39%), Gaps = 38/302 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNF 188
LGEG FG V E G KP VAVK L D + + ++E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 189 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------------- 232
+ + H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 233 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292
L + A A+G+ +L + I+RD N+L+ D K++DFGLA+D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 293 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 352
D +T + APE + T +SDV+SFGV+L E+ T S P E
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245
Query: 353 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
++L+ + + C P RP ++VE L
Sbjct: 246 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 413 PL 414
+
Sbjct: 293 RI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-53
Identities = 59/289 (20%), Positives = 99/289 (34%), Gaps = 34/289 (11%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKE 181
K +F+ +LGEG F V + T A+K L +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPY 54
Query: 182 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
E + + L H VKL +D++ + G L ++ + +
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFY 113
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
L +LH + +I+RD K NILL+ D + +++DFG AK K +
Sbjct: 114 TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
+GT Y +PE + SD+++ G ++ +++ G P N + +
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIK 224
Query: 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410
F P KA L L D R E+
Sbjct: 225 LEYDFPEKFFP------------KARDLVEKLLVLDATKRLGCEEMEGY 261
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (459), Expect = 3e-53
Identities = 61/282 (21%), Positives = 98/282 (34%), Gaps = 31/282 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
++ LG G FG V + + TG A K + + E+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L H LV L +D++ +++YEFM G L + + ++ KGL
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
+H E ++ D K NI+ + KL DFGL V GT +
Sbjct: 138 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEF 191
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
AAPE + +D++S GV+ +L+G P G N E R
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNMD 245
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ ++ L DP R + + +E
Sbjct: 246 DSAFSGI--------SEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 180 bits (458), Expect = 5e-53
Identities = 70/344 (20%), Positives = 126/344 (36%), Gaps = 38/344 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ LG G FG V + V+ TG K +N E++ +
Sbjct: 30 YYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L H L+ L + + +L+ EF+ G L + + + + + A +GL
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
+H E +++ D K NI+ + + K+ DFGLA + T +
Sbjct: 141 KHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEF 194
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
AAPE V + +D+++ GV+ +L+G P + +E + F
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEFD 248
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKP-LPNLKDMASSS 424
+ +A + L ++P+ R + + +E LK NL SS
Sbjct: 249 EDAFSSVS--------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 300
Query: 425 YYFQTMQ--AERIGSSPNTRNGIR--AQGGSLSRNGQRSLSIPN 464
Y + Q E+ P + I A SL ++ + I +
Sbjct: 301 RYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYD 344
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (433), Expect = 2e-50
Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 36/290 (12%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVN 187
+ +LG GG V VAVK L D + + + E
Sbjct: 9 YELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
L H +V + + +V E++ +L + + P+ +++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIA 118
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVM 302
A + L F H+ +I+RD K +NI++ A K+ DFG+A+ G+ + V+
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
GT Y +PE + +RSDVYS G VL E+LTG P + V A H+ E
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVRE 229
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEAL 411
L + + L+++P+ R +E+ L
Sbjct: 230 DPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (425), Expect = 4e-49
Identities = 67/296 (22%), Positives = 110/296 (37%), Gaps = 46/296 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHK 180
N+ P+ +LG G V + + T AVK ++ G + +
Sbjct: 4 NYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 181 EWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
L EV+ L + H N+++L + LV++ M +G L ++L + L
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR 113
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 299
KI + + LH+ +++RD K NILLD D N KL+DFG + G+K
Sbjct: 114 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---R 167
Query: 300 RVMGTYGYAAPEYVMTGHL------TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 353
V GT Y APE + D++S GV++ +L G P +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQM 221
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
R + +F + L + L P+ R E +
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 5e-49
Identities = 57/350 (16%), Positives = 124/350 (35%), Gaps = 45/350 (12%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+ LG G FG V + V+ + T K + G E++ L
Sbjct: 6 KYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
H N++ L ++ ++++EF+ + + + L + + L
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
FLH + + D + NI+ ++ K+ +FG A+ GD + + Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEY 169
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367
APE +++ +D++S G ++ +L+G P + + F
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTFD 223
Query: 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV------EALKPLPN--LKD 419
+ + +A L ++ K+R SE + + ++ + ++
Sbjct: 224 EEAFKEI--------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275
Query: 420 MASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYAS 469
+ YY ++ + R + GG++ Q+ +S+ AS
Sbjct: 276 LKHRRYYHTLIKKDLNMVVSAAR---ISCGGAIRS--QKGVSVAKVKVAS 320
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (430), Expect = 6e-49
Identities = 70/280 (25%), Positives = 107/280 (38%), Gaps = 39/280 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 186
+F ++G GGFG V+ K TG A+K L+ + QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 187 N---FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 243
+ +V + D+ + + M G L HL + + +R A
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAA 114
Query: 244 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 303
GL +H R V+YRD K +NILLD + ++SD GLA D + +G
Sbjct: 115 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 167
Query: 304 TYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
T+GY APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--- 224
Query: 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
L FS + L L RD R
Sbjct: 225 --------AVELPDSFS----PELRSLLEGLLQRDVNRRL 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 1e-48
Identities = 52/298 (17%), Positives = 94/298 (31%), Gaps = 33/298 (11%)
Query: 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 182
+L++ R +R +G G FG ++ G G VA+K H +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVK--TKHPQL 49
Query: 183 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
E + + I +C + ++ + SLE+ S + +A
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 109
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDGPEGD-----K 294
+ ++H + I+RD K N L + DFGLAK +
Sbjct: 110 DQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
Query: 295 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 354
+ + GT YA+ + + R D+ S G VL+ G + + E
Sbjct: 167 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 355 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412
+ L + + A C S +P S + + +
Sbjct: 227 R------ISEKKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (420), Expect = 5e-48
Identities = 55/280 (19%), Positives = 94/280 (33%), Gaps = 28/280 (10%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 189
+ +LG G F V T VA+K + L+G + E+ L
Sbjct: 11 YDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
+ H N+V L L+ + + G L + + + ++ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAV 120
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 309
+LH+ + LD D +SDFGL+K D V + GT GY A
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVA 177
Query: 310 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369
PE + + D +S GV+ +L G P + N + L F
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFDSP 231
Query: 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
+ + A H + +DP+ R + ++
Sbjct: 232 YWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-47
Identities = 70/277 (25%), Positives = 102/277 (36%), Gaps = 37/277 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 186
+F +LG+G FG VF T A+K L D + + + E
Sbjct: 3 DFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 187 NFLG-DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L H L + + V E++ G L H+ S A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEI 112
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
GL FLH + ++YRD K NILLD D + K++DFG+ K+ GD GT
Sbjct: 113 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 167
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
Y APE ++ D +SFGV+L EML G+ P + E +
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPF 221
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
+ R ++ A L R+P+ R
Sbjct: 222 YPRWLEKE------------AKDLLVKLFVREPEKRL 246
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-46
Identities = 67/308 (21%), Positives = 124/308 (40%), Gaps = 32/308 (10%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
NF+ +GEG +G V+K TG VA+K + D + E++
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +L H N+VKL+ +++ LV+EF+ + + +P + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ + V+ +
Sbjct: 114 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYR 169
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWAR 357
A + + ++ D++S G + EM+T R + G + V W
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 358 P-HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV------EA 410
+ + + + + + L + L DP R + +
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289
Query: 411 LKPLPNLK 418
KP+P+L+
Sbjct: 290 TKPVPHLR 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 8e-46
Identities = 67/290 (23%), Positives = 110/290 (37%), Gaps = 31/290 (10%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLG 190
LGEG F V+K T VA+K + K+ L E+ L
Sbjct: 5 FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 191 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
+L H N++ L+ LV++FM LE + SL L S L +GL
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 114
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
+LH+ +++RD K +N+LLD + KL+DFGLAK ++ + T + T Y AP
Sbjct: 115 YLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAP 169
Query: 311 EYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRP----------NGEHNLVEWARPH 359
E + + D+++ G +L E+L + + G +W
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
++ H L +P AR ++ ++
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (402), Expect = 2e-45
Identities = 69/277 (24%), Positives = 108/277 (38%), Gaps = 39/277 (14%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 185
++F+ LG G FG V G A+K L + + K+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 186 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 245
L + H ++++ G + Q ++ +++ G L R+S P + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 246 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
L +LH + +IYRD K NILLD + + K++DFG AK P+ T GT
Sbjct: 114 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTP 165
Query: 306 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365
Y APE V T D +SFG+++ EML G P + N ++ L R
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAELR 219
Query: 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
F + L + ++RD R
Sbjct: 220 FPPFFNE------------DVKDLLSRLITRDLSQRL 244
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 158 bits (400), Expect = 2e-45
Identities = 44/295 (14%), Positives = 86/295 (29%), Gaps = 34/295 (11%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+++ +GEG FG +F+G VA+K + E
Sbjct: 6 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 54
Query: 190 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 249
L + + Y ++ ++ + SLE+ L A +
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYN-----AKLSDFGLAKDGPEGD-----KTHVST 299
+HE + ++YRD K N L+ + + DFG+ K +
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 300 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359
+ GT Y + + + R D+ + G V + L G + E
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI--- 228
Query: 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414
+ L F ++ + + + A P + +
Sbjct: 229 ---GEKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 6e-45
Identities = 68/315 (21%), Positives = 115/315 (36%), Gaps = 37/315 (11%)
Query: 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---- 182
A + + + +GEG +G VFK +NG G VA+K + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 56
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWS 236
+A + L H N+V+L C LV+E + + +P
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116
Query: 237 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 296
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 117 TIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 170
Query: 297 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--- 353
T V+ T Y APE ++ + D++S G + EM + + + +
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
Query: 354 -------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 406
+W R R+ F+ +E + + L CL+ +P R
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYS 289
Query: 407 VVEA--LKPLPNLKD 419
+ + L K+
Sbjct: 290 ALSHPYFQDLERCKE 304
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-45
Identities = 60/300 (20%), Positives = 112/300 (37%), Gaps = 30/300 (10%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEV 186
+ S +GEG +G V + + VA+K ++ Q + + L E+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 187 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALG 244
L H N++ + + ++ + L++ ++ L
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMG 303
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T +
Sbjct: 118 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 304 TYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 362
T Y APE ++ ++S D++S G +L EML+ R + N + +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 363 RRRFYRLIDPRLEGHFSIKGAQK-------------AAQLAAHCLSRDPKARPLMSEVVE 409
+ S+ K A L L+ +P R + + +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-44
Identities = 60/289 (20%), Positives = 100/289 (34%), Gaps = 40/289 (13%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------ 184
+ LG G F V K + TGL A K + + + ++
Sbjct: 12 YDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 185 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 244
EV+ L ++ H N++ L +L+ E + G L + L + L +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQ 121
Query: 245 AAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDGPEGDKTHVSTR 300
G+ +LH + + D K NI+L K+ DFGLA G++
Sbjct: 122 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ GT + APE V L +D++S GV+ +L+G P E
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLANVS 229
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
F + A L +DPK R + + ++
Sbjct: 230 AVNYEFEDEYFSNT--------SALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-43
Identities = 78/281 (27%), Positives = 105/281 (37%), Gaps = 36/281 (12%)
Query: 125 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 182
K+ +F LLG+G FG V + TG A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 183 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
+ E L + H L L D+ V E+ G L HL R
Sbjct: 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFY 110
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 301
L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTF 165
Query: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
GT Y APE + D + GVV+ EM+ GR P + L
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILM 219
Query: 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 402
E RF R + P +A L A L +DPK R
Sbjct: 220 EEIRFPRTLSP------------EAKSLLAGLLKKDPKQRL 248
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-43
Identities = 61/289 (21%), Positives = 99/289 (34%), Gaps = 50/289 (17%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE------WLA 184
++ LLG GGFG V+ G ++ L VA+K + D + E
Sbjct: 6 YQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 185 EVNFLGDL--VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
EV L + +++L+ + D +L+ E L +
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRV 301
+ + H V++RD K NIL+D + KL DFG K V T
Sbjct: 117 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDF 169
Query: 302 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
GT Y+ PE++ RS V+S G++L +M+ G + + ++
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRG----- 219
Query: 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
S + L CL+ P RP E+
Sbjct: 220 ----------QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (381), Expect = 9e-43
Identities = 60/293 (20%), Positives = 110/293 (37%), Gaps = 28/293 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+ +GEG +G V+K G T A+K + + + E++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +L H N+VKL + +LV+E + L+ L L L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
G+A+ H+ R V++RD K N+L++ + K++DFGLA+ + + ++ +
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYR 167
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWAR 357
A + + ++ D++S G + EM+ G G N W
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 358 -PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
L + + + +P F + L + L DP R + +E
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-41
Identities = 68/322 (21%), Positives = 113/322 (35%), Gaps = 47/322 (14%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
++ ++G G FG V++ +G VA+K + D + E+ +
Sbjct: 21 SYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQD----KRFKNRELQIM 67
Query: 190 GDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKI 241
L H N+V+L + ++ LV +++P H R LP
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTR 300
+ LA++H + +RD K N+LLD D KL DFG AK G+ +
Sbjct: 128 MYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SY 182
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360
+ Y A TS DV+S G VL E+L G+ + + +
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 361 GE-----------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR-------- 401
+F ++ F + +A L + L P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 402 -PLMSEVVEALKPLPNLKDMAS 422
E+ + LPN +D +
Sbjct: 303 HSFFDELRDPNVKLPNGRDTPA 324
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-40
Identities = 55/283 (19%), Positives = 93/283 (32%), Gaps = 39/283 (13%)
Query: 136 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 194
+LG G G V + T A+K L + EV
Sbjct: 19 VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64
Query: 195 LNLVKLIGYC----IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGL 249
++V+++ L+V E + G L + + R +I + +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 250 AFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYG 306
+LH + +RD K N+L + KL+DFG AK+ + T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPY 178
Query: 307 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366
Y APE + D++S GV++ +L G H L R
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQ 233
Query: 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
Y +P S ++ L + L +P R ++E +
Sbjct: 234 YEFPNPEWS-EVS----EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 63/307 (20%), Positives = 105/307 (34%), Gaps = 40/307 (13%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVN 187
+ + +G+G FG VFK TG VA+K + + + L E+
Sbjct: 11 KYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 188 FLGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFRRSLPLPWSIRM 239
L L H N+V LI C LV++F S
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIK 120
Query: 240 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS- 298
++ GL ++H +++RD K +N+L+ D KL+DFGLA+ + +
Sbjct: 121 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 299 -TRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--- 353
T + T Y PE ++ D++ G ++ EM T M N + L+
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 354 ----------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ-LAAHCLSRDPKARP 402
L E+ + +++ A L L DP R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 403 LMSEVVE 409
+ +
Sbjct: 298 DSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-38
Identities = 60/294 (20%), Positives = 102/294 (34%), Gaps = 28/294 (9%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 187
+ +GEG +G VFK T VA+K + D L E+
Sbjct: 3 KYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 188 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 247
L +L H N+V+L D + LV+EF + + I K
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLK 112
Query: 248 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 307
GL F H R V++RD K N+L++ + KL++FGLA+ + + S V+ +
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYR 168
Query: 308 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHNLVEWA 356
++ D++S G + E+ R + G +W
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 357 R-PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
L + + + + K L + L +P R E ++
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-37
Identities = 66/323 (20%), Positives = 113/323 (34%), Gaps = 42/323 (13%)
Query: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 188
+R +G G +G V V TG VA+K L K E+
Sbjct: 20 YRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 189 LGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 242
L + H N++ L+ D+ LV FM G+ L + L +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGEDRIQFLV 127
Query: 243 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 302
KGL ++H +I+RD K N+ ++ D K+ DFGLA+ ++ V+
Sbjct: 128 YQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVV 180
Query: 303 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--------- 353
+ A + T D++S G ++ EM+TG+ + + +
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 354 EWARPHLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
E+ + + + Y P LE + A L L D + R E +
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
Query: 410 A--LKPLPNLKDMASSSYYFQTM 430
+ L + +D Y +
Sbjct: 301 HPYFESLHDTEDEPQVQKYDDSF 323
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (344), Expect = 7e-37
Identities = 68/314 (21%), Positives = 108/314 (34%), Gaps = 42/314 (13%)
Query: 95 SNAESNSSTSKLEEELKVASR--LRKFTFNDLKLATRN-FRPESLLGEGGFGCVFKGWIE 151
+ A+ S ++E L A L+K+ A + F LG G FG V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV--- 60
Query: 152 ENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDD 208
+G A+K L+ + K+ L E L + LVKL ++
Sbjct: 61 ------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 268
+V E++ G + +HL R A +LH +IYRD K
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 269 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 328
N+L+D +++DFG AK T + GT APE +++ D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 329 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 388
V++ EM G P ++ + + RF
Sbjct: 226 VLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHFSS------------DLKD 267
Query: 389 LAAHCLSRDPKARP 402
L + L D R
Sbjct: 268 LLRNLLQVDLTKRF 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 7e-36
Identities = 73/326 (22%), Positives = 118/326 (36%), Gaps = 33/326 (10%)
Query: 115 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 174
R T + K+ NF +LG G +G VF TG A+K L
Sbjct: 10 RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVLKKA 63
Query: 175 GL----QGHKEWLAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 229
+ + + E L + LV L + + L+ +++ G L HL +R
Sbjct: 64 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123
Query: 230 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 289
L LH+ +IYRD K NILLD++ + L+DFGL+K+
Sbjct: 124 E-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 290 PEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 347
+ + GT Y AP+ V G D +S GV++ E+LTG
Sbjct: 180 VADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT--VDG 236
Query: 348 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSE 406
+++ E +R L + + + A L L +DPK R
Sbjct: 237 EKNSQAEISRRILKSEPPYPQEMSA------------LAKDLIQRLLMKDPKKRLGCGPR 284
Query: 407 VVEALKPLPNLKDMASSSYYFQTMQA 432
+ +K + + + + A
Sbjct: 285 DADEIKEHLFFQKINWDDLAAKKVPA 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (316), Expect = 4e-33
Identities = 53/305 (17%), Positives = 99/305 (32%), Gaps = 47/305 (15%)
Query: 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 189
+++ LG G + VF+ + V VK L K+ E+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKIL 83
Query: 190 GDL-VHLNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 246
+L N++ L + R LV+E + + L
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEIL 139
Query: 247 KGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 305
K L + H +++RD K N+++D + +L D+GLA+ G + + +
Sbjct: 140 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASR 193
Query: 306 GYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHNLV 353
+ PE ++ D++S G +L M+ + N G +L
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 354 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQK---------AAQLAAHCLSRDPKARPLM 404
++ + E + I R + A L D ++R
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 405 SEVVE 409
E +E
Sbjct: 314 REAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 5e-32
Identities = 60/313 (19%), Positives = 106/313 (33%), Gaps = 51/313 (16%)
Query: 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 186
+ ++ +G G G V + VA+K L+ K E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 187 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ + H N++ L+ E LV E M +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSY 123
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+ G+ LH +I+RD K SNI++ +D K+ DFGLA+ T
Sbjct: 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TP 177
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR----------------RSMDKN 344
+ T Y APE ++ D++S G ++ EM+ + +
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 345 RPNGEHNLVEWARPHLGERRRFYRLIDPRL--------EGHFSIKGAQKAAQLAAHCLSR 396
P L R ++ R ++ L P+L + + A +A L + L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 397 DPKARPLMSEVVE 409
DP R + + ++
Sbjct: 298 DPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 9e-30
Identities = 65/330 (19%), Positives = 120/330 (36%), Gaps = 40/330 (12%)
Query: 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAE 185
++ S +G G +G V + TGL VAVK L+ K E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 186 VNFLGDLVHLNLVKLIGYC-----IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 240
+ L + H N++ L+ +E+ + + + L N + + L
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQF 125
Query: 241 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 300
+ +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
Query: 301 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN----------RPNGEH 350
+ A + H D++S G ++ E+LTGR R G
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238
Query: 351 NLVEWARPHLGERRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEV 407
+ R + + + + +F+ I A L L D R ++
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
Query: 408 VEA--LKPLPNLKDMASSSYYFQTMQAERI 435
+ + D + Y Q+ ++ +
Sbjct: 299 LAHAYFAQYHDPDDEPVADPYDQSFESRDL 328
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 4e-27
Identities = 56/336 (16%), Positives = 103/336 (30%), Gaps = 63/336 (18%)
Query: 120 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 179
+ D + + LG G F V+ N T VA+K + D +
Sbjct: 9 PYKDAR-----YILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKVY-T 53
Query: 180 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY---------------EFMPRGSLEN 224
+ E+ L + + K +LL + E + L
Sbjct: 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 225 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDF 283
+P +I+ GL ++H +I+ D K N+L++ D L
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 343
+A G T + T Y +PE ++ +D++S ++ E++TG +
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
Query: 344 NRPNGEHNLVEWAR------------------------PHLGERRRFYRLIDPRLEG--- 376
+ + + G R +L LE
Sbjct: 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 291
Query: 377 ---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 409
FS A++ + + L DP+ R +V
Sbjct: 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.1 bits (176), Expect = 2e-15
Identities = 25/158 (15%), Positives = 50/158 (31%), Gaps = 16/158 (10%)
Query: 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 194
L+GEG VF + E+ G VK + K + G +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 195 LNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
L KL G + + ++ E + L ++ + +A
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117
Query: 251 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288
+ R +++ D N+L+ + + DF + +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 486 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.79 | |
| d1qu6a2 | 89 | dsRNA-dependent protein kinase pkr {Human (Homo sa | 93.65 | |
| d1x48a1 | 76 | dsRNA-dependent protein kinase pkr {Mouse (Mus mus | 92.78 | |
| d1x49a1 | 85 | dsRNA-dependent protein kinase pkr {Mouse (Mus mus | 84.78 | |
| d1qu6a1 | 90 | dsRNA-dependent protein kinase pkr {Human (Homo sa | 83.03 | |
| d1x47a1 | 85 | Dgcr8 protein {Human (Homo sapiens) [TaxId: 9606]} | 80.62 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=439.95 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=207.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++++.||+|+||+||+|+++. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 3579999999999999999999876 678999999976533 233568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..|||||||++|+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 150 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred CceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhh
Confidence 9999999999999999999854 457999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+...........+..+||+.|||||++.+..+ +.++|||||||+||||++|+.||......... ...+.. ...
T Consensus 151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~-----~~~ 224 (271)
T d1nvra_ 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE-----KKT 224 (271)
T ss_dssp EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHT-----TCT
T ss_pred eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHhc-----CCC
Confidence 87654443334456789999999999988876 57899999999999999999999754432211 111100 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. .. .....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 225 ~---~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 Y---LN------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp T---ST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C---CC------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 00 011224578899999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=438.97 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=205.2
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCceEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGY 203 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 203 (486)
+..++|++.+.||+|+||+||+|++.. .||||+++... ....+.|.+|+.+|++++|||||+++++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 345789999999999999999997642 69999997543 3345678999999999999999999998
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+. ++.++||||||++|+|.++|......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 73 ST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp EC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCC
T ss_pred Ee-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccc
Confidence 75 45689999999999999999877778999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 360 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 360 (486)
|+|+...............||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+...... +.....
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~~--- 223 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMVG--- 223 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHH---
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHHHh---
Confidence 99987655444334456789999999999864 3589999999999999999999999976533211 111110
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 361 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.. ...+. ....+..++..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus 224 -~~-----~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 224 -RG-----YLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp -HT-----SCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cC-----CCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 00 00111 0111222346789999999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-57 Score=438.11 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=210.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|++++.||+|+||+||+|.+.. +|+.||||+++.......+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 579999999999999999998865 67899999998665556678999999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
.+|||||||+||+|.+++.+. .+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhhee
Confidence 999999999999999987553 5899999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 368 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (486)
...... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||....... ..... .....
T Consensus 166 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~---~~~~~---- 233 (293)
T d1yhwa1 166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLI---ATNGT---- 233 (293)
T ss_dssp CCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH---HHHCS----
T ss_pred eccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---HHHHH---HhCCC----
Confidence 644332 2345689999999999999999999999999999999999999997543211 11100 00000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 369 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... ..+...+..+.+||.+||+.||.+|||+.|++++
T Consensus 234 -~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 234 -PEL----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -CCC----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -CCC----CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 1112234678999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-57 Score=431.73 Aligned_cols=247 Identities=25% Similarity=0.394 Sum_probs=207.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++++.||+|+||+||+|+++. +|+.||||++.... ......+.+|+++|+.++|||||++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC---------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 579999999999999999999875 67799999986432 233467889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+++..|||||||++|+|.+++... ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred ECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence 999999999999999999999654 46999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++...... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||....... +... ....
T Consensus 153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~---i~~~--- 219 (263)
T d2j4za1 153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKR---ISRV--- 219 (263)
T ss_dssp CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH---HHTT---
T ss_pred eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHHH---HHcC---
Confidence 98765432 344689999999999999999999999999999999999999997543211 1111 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...+ +...+..+.+||.+||+.||.+|||+.|++++
T Consensus 220 -----~~~~----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 220 -----EFTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----CCCC----CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1111 11234678999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-57 Score=437.44 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=209.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
+.|++++.||+|+||+||+|++.. +|..||||++........+.+.+|+++|++++|||||++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC---------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 468999999999999999999876 67799999998766666677899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
.++||||||++|+|.+++.+....+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhc
Confidence 999999999999999998777778999999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCCcceeeeeccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
..... ......+||+.|||||++. ...|+.++|||||||+||||+||+.||.......... .. ....
T Consensus 160 ~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~--~i----~~~~ 231 (288)
T d2jfla1 160 NTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KI----AKSE 231 (288)
T ss_dssp CHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--HH----HHSC
T ss_pred cCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH--HH----HcCC
Confidence 43211 1223468999999999984 4568999999999999999999999997654322111 00 0000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.+.+ ..+...+..+.+||.+||+.||.+|||+.|++++
T Consensus 232 -------~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 -------PPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -------CCCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -------CCCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0111234678999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-57 Score=437.77 Aligned_cols=264 Identities=25% Similarity=0.363 Sum_probs=216.5
Q ss_pred HHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEE
Q 011412 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 123 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~ 202 (486)
.|++..++|++.+.||+|+||+||+|.+.. +|+.||||+++... ...+++.+|+++|++++|||||++++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~ 80 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG 80 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCc
Confidence 344455789999999999999999999876 67799999997654 34578999999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 281 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~ 281 (486)
+|.+++.++||||||++|+|.+++... ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+
T Consensus 81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred cEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEc
Confidence 999999999999999999999999754 467899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 282 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 282 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|||+++....... .......||+.|||||++.+..|+.++|||||||++|||++|..||...... ..+.....
T Consensus 158 DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i~---- 230 (287)
T d1opja_ 158 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLE---- 230 (287)
T ss_dssp CCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHH----
T ss_pred cccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHHh----
Confidence 9999997654332 2233456899999999999999999999999999999999977766433221 11111111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 416 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 416 (486)
. ...+ .++...+..+.+||.+||+.||.+|||+.||++.|+.+..
T Consensus 231 ~------~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 231 K------DYRM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp T------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred c------CCCC----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0 0111 1222234678999999999999999999999999986643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=430.53 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=195.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++++.||+|+||+||+|+++. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 579999999999999999999876 6789999999765432 23458899999999999999999999865
Q ss_pred --CCeeEEEEeecCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCcEEEcCCCcEE
Q 011412 207 --DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 207 --~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~--~~~iiHrDLKp~NIll~~~~~vk 279 (486)
++.+|||||||++|+|.+++.+ ....+++..++.++.||+.||.|||+.+ ..+||||||||+||||+.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 4568999999999999999863 3567999999999999999999999864 13499999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
|+|||+++....... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||...... .+.....
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~-- 227 (269)
T d2java1 155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIR-- 227 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH--
T ss_pred EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHH--
Confidence 999999987644322 234578999999999999999999999999999999999999999754321 1111110
Q ss_pred cccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. . .+.+.. ..+..+.+||.+||+.||.+|||+.|++++
T Consensus 228 -~~--~-----~~~~~~----~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 228 -EG--K-----FRRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -HT--C-----CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cC--C-----CCCCCc----ccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00 0 011112 234678999999999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=428.21 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=200.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|++++.||+|+||+||+|.+. ++..||||+++... ...+++.+|+++|++++|||||+++++|..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 57889999999999999999875 35679999998654 34578999999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
..+||||||++|+|.+++......+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhee
Confidence 999999999999999999877778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... ......||+.|||||++.+..|+.++|||||||+||||+|+ .+||..... ..+...... . .
T Consensus 151 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~----~---~ 219 (263)
T d1sm2a_ 151 VLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIST----G---F 219 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHHH----T---C
T ss_pred ccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHHh----c---C
Confidence 6543322 22345799999999999999999999999999999999995 444433211 111111111 0 0
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
+... +..++..+.+||.+||+.||.+||+++||+++|+.+
T Consensus 220 ~~~~-------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 220 RLYK-------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC-------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1111 112246789999999999999999999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-56 Score=434.42 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=201.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
++|++.++||+|+||+||+|+++.++. ....||||.+..... ...++|.+|+++|++|+|||||++++++..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 567888999999999999999876432 234689999876533 2345799999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+.++||||||++|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccce
Confidence 9999999999999999999877778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccee---eeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 288 DGPEGDKTHV---STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 288 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
.......... .....||+.|||||++.++.|+.++|||||||+||||+| |+.||...... .+..... ..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~----~~ 249 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIE----QD 249 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----TT
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cC
Confidence 7654322211 122468999999999999999999999999999999998 89999764322 1111111 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
..+ ..+..++..+.+||.+||+.||.+||++.||++.|+.+
T Consensus 250 ------~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 250 ------YRL----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ------CCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCC----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 001 11223356789999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=433.75 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=205.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++++.||+|+||+||+|.+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 579999999999999999999876 67799999987432 233467899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+++.+|||||||++|+|.+++... ..+++..+..++.|++.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccccc
Confidence 999999999999999999988655 47999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
|+..............+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+.. .....
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~---~i~~~--- 225 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQ---KIIKL--- 225 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHTT---
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHHH---HHHcC---
Confidence 98765444333344578999999999999999999999999999999999999999754321 1111 01111
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...+... .+..+.+||.+||+.||.+|||+.|++++
T Consensus 226 -----~~~~p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 226 -----EYDFPEK----FFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -----CCCCCTT----CCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -----CCCCCcc----CCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 0111122 24678999999999999999999997643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=441.89 Aligned_cols=264 Identities=25% Similarity=0.377 Sum_probs=206.8
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..++|++++.||+|+||+||+|++.. +|+.||||+++...... ...+.+|+.+|+.++|||||+++++|.
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT---------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 35689999999999999999999865 68899999997653332 456899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
+++.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||.|||+. + ||||||||+||||+.++.+||+|||
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCC
Confidence 9999999999999999999996554 699999999999999999999974 7 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh-hhhhccc-
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-ARPHLGE- 362 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~-~~~~~~~- 362 (486)
+|+..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.............. .......
T Consensus 151 la~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
T d1s9ja_ 151 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226 (322)
T ss_dssp CCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred CccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence 99864321 23356899999999999999999999999999999999999999976543211000000 0000000
Q ss_pred -----------------c----------cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 363 -----------------R----------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 363 -----------------~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. ..+.....+.+.. ...+.++.+||.+||+.||.+|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccccccccccccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 0000000011100 1123578899999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.7e-55 Score=438.14 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=212.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++++.||+|+||+||+|++.. +|+.||||++........+.+.+|+.+|++|+|||||++++++.++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~---------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3589999999999999999999875 6889999999876655556788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc--CCCcEEEeecCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--ADYNAKLSDFGL 285 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~--~~~~vkl~DFGl 285 (486)
+.+|||||||+||+|.+++.+....+++..+..|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecch
Confidence 9999999999999999999766678999999999999999999999988 99999999999995 467899999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++....... .....||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... .+.... ......
T Consensus 173 a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i---~~~~~~ 243 (350)
T d1koaa2 173 TAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNV---KSCDWN 243 (350)
T ss_dssp CEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHTCCC
T ss_pred heecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHH---HhCCCC
Confidence 987654332 34568999999999999999999999999999999999999999754321 111111 100000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
....... ..+..+.+||.+||+.||.+|||+.|++++
T Consensus 244 ----~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 ----MDDSAFS----GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----SCCGGGG----GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----CCccccc----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111111 223578999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.6e-55 Score=437.62 Aligned_cols=253 Identities=20% Similarity=0.273 Sum_probs=212.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|++++.||+|+||+||+|++.. +|+.||||+++.........+.+|+.+|++|+|||||+++++|.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 479999999999999999999865 67899999998765555567889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc--CCCcEEEeecCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--ADYNAKLSDFGLA 286 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~--~~~~vkl~DFGla 286 (486)
.+|||||||+||+|.+++......+++..+..|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence 999999999999999988777778999999999999999999999988 99999999999997 6789999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
+....... .....||+.|||||++.+..|+.++|||||||+||||+||+.||.+..... +.... ....
T Consensus 177 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i---~~~~--- 244 (352)
T d1koba_ 177 TKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNV---KRCD--- 244 (352)
T ss_dssp EECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH---HHCC---
T ss_pred eecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCC---
Confidence 88654332 345679999999999999999999999999999999999999997543211 11110 0000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+........+..+.+||.+||+.||.+|||+.|++++
T Consensus 245 -----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 -----WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -----CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111111234678999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=436.42 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=211.2
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||+||+|++...+. ......||||.+..... .....+.+|+.+|.++ +|||||++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISK----TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSS----SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCc----ccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 34678999999999999999999875322 12345799999865432 2335688999999998 899999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiH 262 (486)
.+.+.++||||||++|+|.++|..+. ..+++..++.|+.||+.||+|||+++ |||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiH 187 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 187 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 99999999999999999999996543 24889999999999999999999988 999
Q ss_pred cCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 011412 263 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 341 (486)
Q Consensus 263 rDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf 341 (486)
|||||+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |..||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999987655444444455678999999999999999999999999999999998 89999
Q ss_pred CCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 342 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.+...... +..... .. ..+ ..+..++..+.+||.+||+.||++|||+.||+++|.
T Consensus 268 ~~~~~~~~--~~~~~~----~~------~~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDAN--FYKLIQ----NG------FKM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHH--HHHHHH----TT------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHH--HHHHHh----cC------CCC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 76543221 111111 10 011 112223467999999999999999999999999984
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-55 Score=417.37 Aligned_cols=254 Identities=22% Similarity=0.385 Sum_probs=213.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
++|++++.||+|+||+||+|+++ ++..||||+++.... ..+++++|+.++++++|||||+++++|.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 68999999999999999999985 356899999986543 4578999999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
.+++|||||++|+|.+++......+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhee
Confidence 999999999999999998777778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 367 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (486)
....... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||...... .+..... ...
T Consensus 150 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~~i~----~~~--- 218 (258)
T d1k2pa_ 150 VLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIA----QGL--- 218 (258)
T ss_dssp CSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHH----TTC---
T ss_pred ccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHHHHH----hCC---
Confidence 6543322 2334679999999999999999999999999999999998 89999765322 1111111 110
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 368 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
+... . ...+..+.+||.+||+.||.+|||+.+|+++|..+
T Consensus 219 ~~~~---p----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 RLYR---P----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCC---C----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCC---c----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1111 1 12246789999999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-55 Score=430.69 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=192.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.+.|++++.||+|+||+||+|+++. +|+.||||++....... ...+.+|+.+|+.++|||||++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKR---------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETT---------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 4579999999999999999999875 67899999997654322 3457899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCcEEEeec
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDF 283 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~---~~~~vkl~DF 283 (486)
++.+|||||||+||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+|||+. .++.+||+||
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecc
Confidence 99999999999999999999654 57999999999999999999999988 99999999999994 5789999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
|+++...... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+.... ....
T Consensus 155 G~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i---~~~~ 225 (307)
T d1a06a_ 155 GLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQI---LKAE 225 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH---HTTC
T ss_pred ceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHH---hccC
Confidence 9998754432 234468999999999999999999999999999999999999999754321 111111 1110
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. .... .....+..+.+||.+||+.||.+|||+.|++++
T Consensus 226 ~~----~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 YE----FDSP----YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CC----CCTT----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC----CCCc----cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 1111 112234678999999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-55 Score=419.47 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=198.3
Q ss_pred CCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe--
Q 011412 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-- 206 (486)
Q Consensus 131 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-- 206 (486)
|++.+.||+|+||+||+|.+.. ++..||+|++..... ...+.+.+|+++|++++|||||+++++|.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 3566789999999999999875 677999999875432 233568899999999999999999999875
Q ss_pred --CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCcEEEeec
Q 011412 207 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDF 283 (486)
Q Consensus 207 --~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~~~vkl~DF 283 (486)
+..+|||||||++|+|.+++.+. ..+++..+..|+.||+.||+|||+++ .+||||||||+||||+ .++.+||+||
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeec
Confidence 35679999999999999999654 47999999999999999999999865 4599999999999996 5789999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
|+++...... ....+||+.|||||++.+ .|+.++|||||||+||||++|+.||....... .+..... ..
T Consensus 160 Gla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i~----~~ 228 (270)
T d1t4ha_ 160 GLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVT----SG 228 (270)
T ss_dssp TGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHT----TT
T ss_pred CcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHHH----cC
Confidence 9998643322 345689999999998865 69999999999999999999999996543211 1111110 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. ..+.+... .+..+.+||.+||+.||++|||+.|++++
T Consensus 229 ~-----~~~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 229 V-----KPASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp C-----CCGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C-----CCcccCcc----CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0 00111111 23568899999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-55 Score=423.66 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=208.0
Q ss_pred cCCCCCCe-eeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESL-LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~-lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|.+.+. ||+|+||+||+|.++..+ ++..||||+++.... ...++|.+|+++|++++|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecCC-------CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 45666664 999999999999886422 456899999976543 234678999999999999999999999865
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+.+|||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred -CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhh
Confidence 5689999999999999998777778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 287 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 287 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+........ .......||+.|||||++.++.|+.++|||||||+||||+| |+.||...... .+..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~----~~~ 229 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE----QGK 229 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHH----TTC
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCC
Confidence 876543322 22334578999999999999999999999999999999998 99999765432 1111111 100
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
.+. ++..++..+.+||.+||+.||++||++.+|++.|+.
T Consensus 230 ------~~~----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 230 ------RME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ------CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCC----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111 122234678999999999999999999999998863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=424.26 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=205.9
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
+..++|++.+.||+|+||+||+|.++ ++..||||+++... ...+.+.+|+.+|++++|||||++++++.
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 34568899999999999999999875 35689999997654 34577999999999999999999999875
Q ss_pred eCCeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
++..+||||||++|+|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 79 -~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred -cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecccc
Confidence 45679999999999999987533 346899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+|+....... .......||+.|||||++.++.|+.++|||||||+||||+||..|+...... ..+..... .
T Consensus 155 la~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i~----~-- 225 (272)
T d1qpca_ 155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLE----R-- 225 (272)
T ss_dssp TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----T--
T ss_pred ceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHHH----h--
Confidence 9987654332 2233467999999999999999999999999999999999966555432211 11111111 0
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
...+.... ..+..+.+||.+||+.||++|||+.+|++.|+.
T Consensus 226 ----~~~~~~p~----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 226 ----GYRMVRPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----TCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----cCCCCCcc----cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11111122 234678999999999999999999999998864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-55 Score=427.49 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=202.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.|++++.||+|+||+||+|++.. +|+.||||++....... .+.+.+|+++|++|+|||||++++++.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 86 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECC---------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence 48999999999999999999875 67899999998654332 3468899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..|||||||.+|+|..++.. ...+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 87 ~~~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 87 EHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (309)
T ss_dssp TTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred CCEEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccc
Confidence 9999999999999998766644 457999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 363 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 363 (486)
+.... ....+||+.|||||++.+ ..|+.++|||||||++|||++|..||....... .... ....
T Consensus 163 ~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~---~~~~---i~~~- 229 (309)
T d1u5ra_ 163 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH---IAQN- 229 (309)
T ss_dssp BSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH---HHHS-
T ss_pred cccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHhC-
Confidence 87543 234579999999999864 468999999999999999999999997543211 1100 0000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 364 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..+.+. +...+..+.+||.+||+.||.+|||+.|++++
T Consensus 230 ------~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 230 ------ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ------CCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 001111 11224678999999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=421.30 Aligned_cols=262 Identities=24% Similarity=0.401 Sum_probs=203.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
+.|++.++||+|+||.||+|.++..+. .....||||+++..... ...+|.+|+++|++++|||||++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCC-----EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 467888999999999999999875321 12247999999754433 234688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+..++|||||.+++|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999999999998877778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
........ .......||+.|||||++.++.|+.++|||||||+||||++|..||...... ..+.... .+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i----~~~--- 229 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI----NDG--- 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----HTT---
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHH----hcc---
Confidence 76443222 1233457899999999999999999999999999999999976665432211 1111111 110
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
. ....+..++..+.+||.+||+.||++||++.||++.|+.+
T Consensus 230 ---~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 230 ---F----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ---C----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---C----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 1 1112223346789999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=417.71 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=198.5
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEeCCeeEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 212 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 212 (486)
+.||+|+||+||+|.+... .+++.||||+++..... ..+++.+|+++|++++|||||+++++|.. +..+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEccC-------CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 4699999999999987642 25678999999754332 24579999999999999999999999865 46789
Q ss_pred EEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011412 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 292 (486)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~~ 292 (486)
|||||++|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 85 vmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 99999999999998654 57999999999999999999999988 999999999999999999999999999876543
Q ss_pred Ccc-eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 011412 293 DKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370 (486)
Q Consensus 293 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (486)
... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.... .+..... ...
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i~----~~~------ 227 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLE----KGE------ 227 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH----TTC------
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHHH----cCC------
Confidence 332 22334679999999999999999999999999999999998 89999764321 1111111 100
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011412 371 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 412 (486)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 412 (486)
.+. ++..++..+.+||.+||+.||.+||++.+|++.|+
T Consensus 228 ~~~----~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 228 RMG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCC----CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 111 12223467899999999999999999999998875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-54 Score=424.47 Aligned_cols=250 Identities=30% Similarity=0.355 Sum_probs=208.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++++.||+|+||.||+|+++. +|+.||||+++... ......+.+|+.+|+.++|||||+++++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 74 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence 3579999999999999999999876 68899999997532 23356788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+++.+|||||||+||+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||
T Consensus 75 ~~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 75 QTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecc
Confidence 9999999999999999999998655 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+|+....... .....+||+.|||||++.+..|+.++|||||||+||||++|++||.+..... +. .......
T Consensus 151 ~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~---~~i~~~~- 221 (337)
T d1o6la_ 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF---ELILMEE- 221 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCC-
T ss_pred cccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HH---HHHhcCC-
Confidence 9987543222 2345789999999999999999999999999999999999999997653211 11 1111111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 410 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~ 410 (486)
..+.. ..+..+.+||.+||+.||.+||+ +.|++++
T Consensus 222 -------~~~p~----~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 -------IRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------CCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCCc----cCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11122 23467899999999999999995 7788764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=421.16 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=207.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCCceEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGDLVHLNLVKLI 201 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~ 201 (486)
.++|++++.||+|+||+||+|+++. +|+.||||+++.... ...+.+.+|+.+|++|+|||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3579999999999999999999875 678999999975432 2356789999999999999999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----c
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 277 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~----~ 277 (486)
++|.+++.+|||||||++|+|.++|... ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++ .
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCC
T ss_pred EEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccc
Confidence 9999999999999999999999999655 47999999999999999999999988 99999999999998776 5
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
+||+|||+++....... .....||+.|||||++.+..|+.++|||||||+||||++|+.||.+..... .....
T Consensus 156 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i- 228 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANV- 228 (293)
T ss_dssp EEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH-
T ss_pred eEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHHHH-
Confidence 99999999987654332 334679999999999999999999999999999999999999997643211 11110
Q ss_pred hhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
......+ .+.... ..+..+.+||.+||+.||.+|||+.|++++
T Consensus 229 --~~~~~~~----~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 229 --SAVNYEF----EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp --HTTCCCC----CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --HhcCCCC----CchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 000011 123578899999999999999999999984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=417.50 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=201.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
.++|++.+.||+|+||+||+|++...+. .+..||||.++..... ..+.+.+|+.+|++++|||||++++++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCc------eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4679999999999999999999875432 4567999999754433 2456899999999999999999999985
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++.+|||||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhh
Confidence 56789999999999999998877778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
+........ ..+...||+.|+|||++.+..|+.++|||||||+||||+| |.+||....... +..... ...
T Consensus 156 ~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~----~~~- 226 (273)
T d1mp8a_ 156 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIE----NGE- 226 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TTC-
T ss_pred eeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cCC-
Confidence 876443222 2344678999999999999999999999999999999998 899997654322 111111 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.+. ++..++..+.+||.+||+.||.+|||+.||++.|+.+
T Consensus 227 -----~~~----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 227 -----RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCC----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 011 1222346799999999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-53 Score=420.25 Aligned_cols=246 Identities=26% Similarity=0.367 Sum_probs=205.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++++.||+|+||+||+|+++. +|+.||||+++... ....+.+.+|+.+|+.++|||||++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 579999999999999999999876 67899999997432 233567889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+++.+|+|||||+||+|..++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eCCeeeeEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 999999999999999999988544 46889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
|+..... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||....... +. .......
T Consensus 151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~---~~i~~~~-- 217 (316)
T d1fota_ 151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TY---EKILNAE-- 217 (316)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHHCC--
T ss_pred ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HH---HHHHcCC--
Confidence 9876432 234689999999999999999999999999999999999999997643211 11 1111111
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~ 410 (486)
..+.. ..+..+.+++.+||..||.+|+ ++.+++++
T Consensus 218 ------~~~p~----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 ------LRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ------CCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------CCCCC----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11111 2246789999999999999996 88898875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=419.87 Aligned_cols=260 Identities=23% Similarity=0.381 Sum_probs=206.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|++++.||+|+||+||+|.+..++.. ....||||.++.. .....+++.+|+++|++++|||||+++++|.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCE-----EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4799999999999999999998764321 2346999998753 334467899999999999999999999999865
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
..+++|||+.+|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 567889999999999999888888999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 288 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 288 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
...............||+.|||||++.++.|+.++|||||||+||||+| |.+||....... +..... ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~----~~~-- 230 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KGE-- 230 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHH----HTC--
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCC--
Confidence 7655444433445679999999999999999999999999999999998 788887543322 111111 000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.+. .+..++..+.+|+.+||+.||.+|||+.||+++|+.+
T Consensus 231 ----~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 ----RLP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ----CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCC----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 011 1122346789999999999999999999999988654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=411.74 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=201.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++.+.||+|+||+||+|++.. +..||||+++... ...+.|.+|+.+|++++|||||++++++. +
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~ 83 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 83 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence 4679999999999999999998864 3579999997554 34577999999999999999999999985 4
Q ss_pred CeeEEEEeecCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
+..++|||||++|+|..++... ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchh
Confidence 5689999999999999888643 356999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 366 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (486)
+....... .......||+.|+|||++..+.++.++|||||||+||||++|..||...... ..+......
T Consensus 161 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~-------- 229 (285)
T d1fmka3 161 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVER-------- 229 (285)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT--------
T ss_pred hhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHh--------
Confidence 87644332 2234467999999999999999999999999999999999976666443221 111111110
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 367 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
...+.. +..++..+.+||.+||+.||++||++.+|++.|+...
T Consensus 230 --~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 230 --GYRMPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp --TCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred --cCCCCC----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 011111 2223467899999999999999999999999998754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-52 Score=421.54 Aligned_cols=250 Identities=27% Similarity=0.363 Sum_probs=202.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHH---HHHHHHhcCCCCCceEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWL---AEVNFLGDLVHLNLVKLIG 202 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~nIv~~~~ 202 (486)
++|+++++||+|+||.||+|++.. +|+.||||++..... .....+. .|+.+++.++|||||++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECC---------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 589999999999999999999876 678999999864321 1122333 4577788889999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011412 203 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 282 (486)
Q Consensus 203 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~D 282 (486)
+|.+++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECC
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEee
Confidence 999999999999999999999999655 46899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 283 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 283 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
||+|+...... ....+||+.|||||++.. ..|+.++|||||||+||||+||+.||..........+... ...
T Consensus 151 FGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~ 223 (364)
T d1omwa3 151 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT 223 (364)
T ss_dssp CTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SSS
T ss_pred eceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---ccc
Confidence 99998765432 234579999999999874 5789999999999999999999999976544332222111 111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 410 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~ 410 (486)
. ...+... .+..+.+||.+||+.||.+||+ +.|++++
T Consensus 224 ~--------~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 224 M--------AVELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp C--------CCCCCSS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred C--------CCCCCCC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0 1111222 2467899999999999999999 6888764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=416.57 Aligned_cols=269 Identities=28% Similarity=0.377 Sum_probs=203.7
Q ss_pred HHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCceEE
Q 011412 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKL 200 (486)
Q Consensus 123 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~ 200 (486)
.|.+..++|++++.||+|+||.||+|.+...+. ..+++.||||+++.... ...+.+.+|+.++.++ +|+|||.+
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTS----SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 333445789999999999999999999865322 23677899999975433 2345678888888877 68899999
Q ss_pred EEEEEeC-CeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 011412 201 IGYCIED-DQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 264 (486)
Q Consensus 201 ~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrD 264 (486)
++++..+ ..+++|||||++|+|.++|.... ..+++..++.++.||+.||.|||+++ |||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9988764 46899999999999999996432 34889999999999999999999988 99999
Q ss_pred CCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCC
Q 011412 265 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-RSMDK 343 (486)
Q Consensus 265 LKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~-~pf~~ 343 (486)
|||+||||+.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+||. +||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765544433344578999999999999999999999999999999999975 57764
Q ss_pred CCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 344 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
..... .+... +... ..+.... ..+..+.+||.+||+.||.+|||+.||+++|+.+
T Consensus 240 ~~~~~--~~~~~----~~~~------~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 240 VKIDE--EFCRR----LKEG------TRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCCSH--HHHHH----HHHT------CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH--HHHHH----HhcC------CCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 43221 11111 1111 1111111 2245789999999999999999999999999754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=413.48 Aligned_cols=253 Identities=19% Similarity=0.259 Sum_probs=209.0
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.++|++++.||+|+||+||+|.+.. +|+.||||+++..... ...+.+|+++|+.++|||||+++++|.++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~---------~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3579999999999999999999876 6789999999865432 34578999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC--CcEEEeecCC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD--YNAKLSDFGL 285 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~--~~vkl~DFGl 285 (486)
+.+|||||||+||+|.++|...+..+++..+..|+.||+.||+|||+++ |+||||||+||||+.+ ..+||+|||+
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccch
Confidence 9999999999999999999777668999999999999999999999988 9999999999999754 5899999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
++....... .....||+.|+|||.+.+..|+.++|||||||++|+|++|..||....... +... .......
T Consensus 151 ~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~---i~~~~~~ 221 (321)
T d1tkia_ 151 ARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIEN---IMNAEYT 221 (321)
T ss_dssp CEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH---HHHTCCC
T ss_pred hhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhCCCC
Confidence 987654332 344679999999999999999999999999999999999999997643211 1111 1110000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+ +...... .+..+.+||.+||..||.+|||+.|++++
T Consensus 222 ~----~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 F----DEEAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp C----CHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C----ChhhccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000111 23568999999999999999999999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-52 Score=404.99 Aligned_cols=260 Identities=24% Similarity=0.326 Sum_probs=202.2
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++.+.||+|+||+||+|++.. +|+.||||+++...... ...+.+|+++|+.++|||||++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLR---------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 3679999999999999999999875 68899999998654432 34688999999999999999999999
Q ss_pred EeCC----eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 205 IEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 205 ~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
...+ .+|||||||+|++|.+++... ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.++|
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEE
T ss_pred eeccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCcccccee
Confidence 8754 378999999999999988655 47999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCc-ceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 281 SDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 281 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
+|||++........ .......+||+.|||||++.+..|+.++|||||||+||||+||+.||....... .....
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~ 226 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQH 226 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHH
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHH
Confidence 99999876533222 122345689999999999999999999999999999999999999997543211 11111
Q ss_pred cccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCC
Q 011412 360 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPL 414 (486)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~eil~~L~~~ 414 (486)
+.......... ... .+..+.+||.+||+.||.+|| ++.++++.|..+
T Consensus 227 ~~~~~~~~~~~----~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 227 VREDPIPPSAR----HEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHCCCCCGGGT----SSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HhcCCCCCchh----ccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 11111111111 112 246789999999999999999 899998877543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-53 Score=416.02 Aligned_cols=265 Identities=25% Similarity=0.366 Sum_probs=212.1
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
..++|++++.||+|+||+||+|+++... ...++..||||+++..... ..+++.+|+.+|+.++||||++++++|.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCc----cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 4568999999999999999999986421 1235678999999765433 2456899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 262 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiH 262 (486)
..+..++||||+++|+|.++|.... ..+++..++.|+.||+.||+|||+++ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999986432 24889999999999999999999988 999
Q ss_pred cCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 011412 263 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-RSM 341 (486)
Q Consensus 263 rDLKp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~-~pf 341 (486)
|||||+||||+.++.+||+|||+++...........+...||+.|||||++.+..|+.++|||||||+||||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998654433333344577999999999999999999999999999999999986 567
Q ss_pred CCCCCCCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 342 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
...... .+..... +.. .+.... ..+..+.+||.+||+.||++||||.||++.|+.+.
T Consensus 244 ~~~~~~---e~~~~v~----~~~------~~~~p~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHE---EVIYYVR----DGN------ILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHH---HHHHHHH----TTC------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHH---HHHHHHH----cCC------CCCCCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 544221 1111111 110 011122 23457899999999999999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-52 Score=418.66 Aligned_cols=246 Identities=25% Similarity=0.316 Sum_probs=206.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
++|++++.||+|+||.||+|+++. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 579999999999999999999876 67899999986432 233467889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 206 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 206 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
+....++||||+.+|+|..++.+.+ .+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence 9999999999999999999996654 6999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 365 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 365 (486)
|+..... ....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.... .+... .....
T Consensus 188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~---i~~~~-- 254 (350)
T d1rdqe_ 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEK---IVSGK-- 254 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHCC--
T ss_pred eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHHH---HhcCC--
Confidence 9876432 23467999999999999999999999999999999999999999754321 11111 11110
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011412 366 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 410 (486)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~ 410 (486)
+..... .+..+.+||.+||+.||.+|+ ++.+++++
T Consensus 255 ------~~~p~~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 ------VRFPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ------CCCCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------CCCCcc----CCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111122 246789999999999999994 88998864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=416.54 Aligned_cols=253 Identities=21% Similarity=0.227 Sum_probs=201.4
Q ss_pred hcCCCCCC-eeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCceEEEEEEE
Q 011412 128 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 205 (486)
.++|.++. +||+|+||+||+|++.. +|+.||||+++.. ..+.+|+.++.++ +|||||+++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECC---------CCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 35788874 69999999999999875 6789999999743 5678899987655 8999999999987
Q ss_pred e----CCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCc
Q 011412 206 E----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYN 277 (486)
Q Consensus 206 ~----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~ 277 (486)
+ +..+|||||||+||+|.++|.+++ ..+++..+..|+.||+.||+|||+.+ |+||||||+|||++. ++.
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCC
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccc
Confidence 5 467899999999999999997653 57999999999999999999999988 999999999999975 567
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
+||+|||+++....... ....+||+.|||||++.+..|+.++|||||||+||+|+||+.||.+.........+..
T Consensus 153 ~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~-- 227 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-- 227 (335)
T ss_dssp EEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred ccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH--
Confidence 99999999987654332 3346899999999999999999999999999999999999999976543221110000
Q ss_pred hhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.... ....+........+..+.+||.+||+.||.+||++.|++++
T Consensus 228 ~i~~--------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRM--------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCS--------CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhc--------CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 00001111112345679999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=410.06 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=200.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
.++|++++.||+|+||+||+|.+..... ....||||+++.... ...+++.+|+.+|++++|||||++++++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~------~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSG------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTS------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCC------cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3579999999999999999998764321 344799999875432 2345789999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+ +..++|||||++|+|.+++..+...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred ee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccch
Confidence 65 5678999999999999988877778999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcce-eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 011412 285 LAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 362 (486)
Q Consensus 285 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 362 (486)
+++......... ......|+..|+|||++.+..++.++|||||||++|||+| |..||....... ..... ...
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i---~~~ 230 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKI---DKE 230 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---HTS
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHH---HhC
Confidence 999865543332 2334568899999999999999999999999999999998 899997543221 11111 111
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 363 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
. ..+.... ..+..+.+||.+||+.||.+|||+.+|++.|+.
T Consensus 231 ~------~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 231 G------ERLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C------CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C------CCCCCcc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 0111112 234678999999999999999999999998864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-52 Score=404.48 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc---------HHHHHHHHHHHhcCC-CCCc
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGDLV-HLNL 197 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~nI 197 (486)
.++|++++.||+|+||+||+|++.. +|+.||||++....... .+.+.+|+.+|++|. ||||
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI 72 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred cccCEEceEEecCcCeEEEEEEECC---------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence 3689999999999999999999876 67899999997643211 235789999999997 9999
Q ss_pred eEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 198 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 198 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
|++++++.+++..|||||||++|+|.++|..+ ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.
T Consensus 73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 148 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEeecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCC
Confidence 99999999999999999999999999999655 47999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 351 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~ 351 (486)
+||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.....
T Consensus 149 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--- 222 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--- 222 (277)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred eEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---
Confidence 99999999987654332 344689999999999863 357889999999999999999999997653211
Q ss_pred hHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 352 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
..... ...... .........+..+.+|+.+||+.||.+||++.||+++
T Consensus 223 ~~~~i---~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 223 MLRMI---MSGNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHH---HHTCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHH---HhCCCC--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111 111000 0111111234679999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=405.89 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=197.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEe-
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 206 (486)
.++|++++.||+|+||.||+|.++ |..||||+++... ..+.+.+|+++|++++|||||++++++.+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 457888999999999999999873 5689999997653 34679999999999999999999999865
Q ss_pred CCeeEEEEeecCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 285 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGl 285 (486)
.+.++||||||++|+|.++|..+. ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeeccccc
Confidence 466899999999999999996543 35899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 286 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 286 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
++..... .....+|..|+|||++.+..++.++|||||||++|||+| |++||...... ++......
T Consensus 150 s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~------ 215 (262)
T d1byga_ 150 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK------ 215 (262)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTT------
T ss_pred ceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc------
Confidence 9875432 223568999999999999999999999999999999998 68887654322 22221111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...+. ++...+..+.+||.+||+.||.+|||+.+|+++|+.+
T Consensus 216 ----~~~~~----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 216 ----GYKMD----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ----TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCC----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 01111 1222346789999999999999999999999999754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=413.67 Aligned_cols=248 Identities=28% Similarity=0.406 Sum_probs=204.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHh-cCCCCCceEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLG-DLVHLNLVKLIGYC 204 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~ 204 (486)
++|++++.||+|+||+||+|++.. +|+.||||+++... ....+.+..|+.++. .++|||||++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 579999999999999999999875 78899999997432 223456777777765 68999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 284 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFG 284 (486)
.+++.+|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccCCceeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccc
Confidence 9999999999999999999999654 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 364 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 364 (486)
+++....... ..+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..... +.... ...
T Consensus 149 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i---~~~-- 218 (320)
T d1xjda_ 149 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSI---RMD-- 218 (320)
T ss_dssp TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHC--
T ss_pred hhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH---HcC--
Confidence 9987544322 2345689999999999999999999999999999999999999997643221 11111 111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 011412 365 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 409 (486)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~ 409 (486)
.+.+.. ..+..+.+||.+||+.||.+||++. ++++
T Consensus 219 ------~~~~p~----~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 ------NPFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------CCCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CCCCCc----cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111112 2246789999999999999999985 6765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=409.94 Aligned_cols=266 Identities=27% Similarity=0.383 Sum_probs=209.6
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|++++.||+|+||.||+|++...++. ...++..||||+++.+... ...++.+|+..+.++ +|||||+++++|
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 456899999999999999999987653321 1234568999999865542 346788999999888 799999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 269 (486)
.+++..++|||||++|+|.++|..+. ..+++..++.++.||+.||+|||+.+ ||||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence 99999999999999999999996443 35899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 011412 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 348 (486)
Q Consensus 270 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~~~ 348 (486)
||++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||......
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~- 244 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 244 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-
Confidence 9999999999999999997655444434455679999999999999999999999999999999998 68888654321
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.+.... ... ..+..... .+..+.+||.+||+.||.+|||+.||++.|+.+
T Consensus 245 --~~~~~i----~~~------~~~~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 --ELFKLL----KEG------HRMDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp --HHHHHH----HTT------CCCCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHH----HcC------CCCCCCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111111 111 11111222 246789999999999999999999999999754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=410.11 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=214.1
Q ss_pred HhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 127 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 127 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
..++|++.+.||+|+||.||+|++... .+..+++.||||+++..... ...++.+|+.++..+ +|||||++++++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 446888999999999999999987531 12246789999999865432 335688999999999 699999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 267 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp 267 (486)
.+.+.++||||||++|+|.++|.... ..+++..++.++.||+.||+|||+++ ||||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 99999999999999999999986542 25889999999999999999999988 99999999
Q ss_pred CcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 011412 268 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRP 346 (486)
Q Consensus 268 ~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-G~~pf~~~~~ 346 (486)
+|||++.++.+||+|||+++...........+..+||+.|+|||++.+..++.++|||||||++|||+| |.+||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998766555555566789999999999999999999999999999999999 5555544332
Q ss_pred CCcchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011412 347 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 413 (486)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 413 (486)
... +..... .. ..+... ...+..+.+||.+||+.||.+||++.+|++.|+.
T Consensus 254 ~~~--~~~~i~----~~------~~~~~~----~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 254 DSK--FYKMIK----EG------FRMLSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp SHH--HHHHHH----HT------CCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH--HHHHHh----cC------CCCCCc----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 211 111111 00 111111 1234678999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=405.50 Aligned_cols=268 Identities=24% Similarity=0.320 Sum_probs=200.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++++.||+|+||+||+|.+.. +|+.||||+++.... .....+.+|+++|++++|||||+++++|.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 579999999999999999999876 677999999975432 223578899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++.+|||||||.++.+..........+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred ccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcc
Confidence 99999999999664444443455667999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-------- 357 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~-------- 357 (486)
+....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+.......+....
T Consensus 150 ~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 150 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence 76543222 233457999999999877655 5789999999999999999999997543211110000000
Q ss_pred hhcccccccccccCCccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PHLGERRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.................... .....+..+.+|+.+||..||.+|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000000000000000 001123578999999999999999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=408.73 Aligned_cols=262 Identities=24% Similarity=0.276 Sum_probs=195.7
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCccc-----HHHHHHHHHHHhcCCCCCceEEEEEEEeCC
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 208 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 208 (486)
+++||+|+||+||+|++.. +|+.||||+++...... .+.+.+|+.+|++++|||||++++++..++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~ 73 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 73 (299)
T ss_dssp EEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred ceEeccCcCeEEEEEEECC---------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 5689999999999998865 67899999997543221 235889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 209 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 209 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
.+|||||||.++++..++ .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 74 NISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccc
Confidence 999999999887666544 55567999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--hh---ccc
Q 011412 289 GPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PH---LGE 362 (486)
Q Consensus 289 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~--~~---~~~ 362 (486)
....... ....+||+.|||||++.. ..|+.++|||||||++|||++|.+||...........+.... +. ...
T Consensus 150 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 150 FGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 6543322 234679999999998864 468999999999999999999999997643221111110000 00 000
Q ss_pred ccccccccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 363 RRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 363 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.........-......+ ...+..+.+||.+||+.||++|||+.|+|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000000000000000 1124578999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=407.86 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=203.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCc--EEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCceEEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL--TVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 204 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 204 (486)
++|++.+.||+|+||+||+|+++. +|. .||||++.... ....+.+.+|+++|.++ +|||||+++++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---------CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 578889999999999999999876 343 57888876432 23345789999999999 799999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 269 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 269 (486)
.+++.++||||||++|+|.++|... ...+++..++.++.||+.||.|||+.+ ||||||||+|
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~N 157 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 157 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccce
Confidence 9999999999999999999998643 357999999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCC
Q 011412 270 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR-SMDKNRPNG 348 (486)
Q Consensus 270 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~-pf~~~~~~~ 348 (486)
||++.++.+||+|||+++....... .....||..|+|||.+.+..|+.++|||||||++|||++|.. ||.....
T Consensus 158 IL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-- 232 (309)
T d1fvra_ 158 ILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-- 232 (309)
T ss_dssp EEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred EEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999986543222 223569999999999999999999999999999999999765 5654321
Q ss_pred cchhHHhhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 349 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
..+..... .. ..+. .+...+..+.+||.+||+.||++||++.||+++|+.+.
T Consensus 233 -~~~~~~i~----~~------~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 233 -AELYEKLP----QG------YRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp -HHHHHHGG----GT------CCCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHH----hc------CCCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111111 11 1111 12223467999999999999999999999999987653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=403.27 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=204.1
Q ss_pred CCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCceEEEEEEEe-CCeeE
Q 011412 134 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-DDQRL 211 (486)
Q Consensus 134 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~ 211 (486)
.++||+|+||+||+|++..... +...||||+++.. .....++|.+|+++|++++|||||+++|++.. +...+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 4689999999999999865321 3457999999753 33334679999999999999999999999876 46889
Q ss_pred EEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011412 212 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 291 (486)
Q Consensus 212 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~~~~ 291 (486)
+|||||++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999999999999877778889999999999999999999988 99999999999999999999999999987654
Q ss_pred CCcce--eeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 011412 292 GDKTH--VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 369 (486)
Q Consensus 292 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (486)
..... ......||+.|+|||++.+..++.++|||||||+||||+||..||....... .+..+... .. +.
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~----g~---~~ 253 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ----GR---RL 253 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT----TC---CC
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc----CC---CC
Confidence 33221 2233578999999999999999999999999999999999888876533211 11111110 00 01
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 370 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.. . ..++..+.+||.+||+.||.+||++.||+++|+.+.
T Consensus 254 ~~---p----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 254 LQ---P----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp CC---C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---c----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11 1 122467899999999999999999999999997663
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=405.85 Aligned_cols=266 Identities=26% Similarity=0.404 Sum_probs=211.9
Q ss_pred HHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEE
Q 011412 126 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 204 (486)
Q Consensus 126 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 204 (486)
+..++|.+.+.||+|+||+||+|.+.... +..++..||||+++.... .....+.+|+++|++++|||||++++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEE----TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcc----cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 34468889999999999999999885311 112356899999975433 2234588999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011412 205 IEDDQRLLVYEFMPRGSLENHLFRR---------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 275 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 275 (486)
..++..++|||||++|+|.+++... ...+++..+..++.|+++||.|||+++ |+||||||+||||+.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCC
Confidence 9999999999999999999988532 134789999999999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCcchhHH
Q 011412 276 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVE 354 (486)
Q Consensus 276 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~-~pf~~~~~~~~~~~~~ 354 (486)
+.+||+|||+++...............||+.|+|||.+.+..++.++|||||||+||||+||. +||...... ....
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~~ 246 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR 246 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHHH
Confidence 999999999998765444433444567999999999999999999999999999999999985 666543221 1111
Q ss_pred hhhhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011412 355 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 415 (486)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~~ 415 (486)
.. . +.. .+.... .++..+.+||.+||+.||.+|||+.+|+++|+...
T Consensus 247 ~i---~-~~~------~~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 247 FV---M-EGG------LLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HH---H-TTC------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HH---H-hCC------CCCCcc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11 0 100 011111 23467999999999999999999999999998653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-51 Score=399.71 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=201.7
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcC---CCCCceEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL---VHLNLVKLIG 202 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~ 202 (486)
.++|++++.||+|+||+||+|++... +++.||||+++.... .....+.+|+.+|+.| +|||||++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 46899999999999999999988542 356799999864322 1123456777776665 7999999999
Q ss_pred EEEe-----CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011412 203 YCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 203 ~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 277 (486)
+|.. ...++++||||.++.+..........+++..+..++.|++.||+|||+++ ||||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence 9853 34689999999888776666666678999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 357 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~ 357 (486)
+||+|||+++...... ......||+.|||||++.+..|+.++|||||||++|||++|+.||...........+....
T Consensus 155 ~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 155 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 9999999998654322 2345789999999999999999999999999999999999999997654321111110000
Q ss_pred hh-----ccc-----ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PH-----LGE-----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~-----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
.. ... ...+.. ........+....+..+.+||.+||+.||.+|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHS-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCC-CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCchhcccccccchhhhhcc-ccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000 000000 00000111122234678899999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=395.65 Aligned_cols=242 Identities=24% Similarity=0.384 Sum_probs=198.1
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCC--CCCceE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLV--HLNLVK 199 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~ 199 (486)
.++|++.+.||+|+||+||+|++.. +|+.||||++...... ...++.+|+.+|++++ |||||+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 3579999999999999999999875 6789999998754221 1133678999999986 899999
Q ss_pred EEEEEEeCCeeEEEEeecCC-CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-Cc
Q 011412 200 LIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YN 277 (486)
Q Consensus 200 ~~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~ 277 (486)
+++++.+++..++||||+.+ ++|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+ +.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTE
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCe
Confidence 99999999999999999976 5777777544 57999999999999999999999988 9999999999999854 79
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 278 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
+||+|||+++...... .+...||+.|||||++.+..+ +.++|||||||+||||++|+.||.... .+.
T Consensus 150 vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~--- 217 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII--- 217 (273)
T ss_dssp EEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH---
T ss_pred EEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh---
Confidence 9999999998654322 345689999999999987765 577999999999999999999996421 110
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... ..+...+ +..+.+||.+||+.||.+|||+.|++++
T Consensus 218 ----~~~--------~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 ----RGQ--------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----HCC--------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----hcc--------cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000 0111222 3678999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=399.07 Aligned_cols=270 Identities=26% Similarity=0.346 Sum_probs=198.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHH--HHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|.+.+.||+|+||.||+|++ +|+.||||+++... ...+ ..|+..+..++|||||++++++.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~ 68 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK 68 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEe
Confidence 5677888999999999999986 46799999997543 2333 345556667899999999999987
Q ss_pred CC----eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCcEEEcCCCc
Q 011412 207 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYN 277 (486)
Q Consensus 207 ~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-----~~~iiHrDLKp~NIll~~~~~ 277 (486)
++ .+|||||||++|+|.++|.+. .+++..++.++.|++.||+|||... .++||||||||+||||+.++.
T Consensus 69 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred CCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 54 579999999999999999764 5899999999999999999999741 134999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcce--eeeeccccccccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 011412 278 AKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGH------LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 349 (486)
Q Consensus 278 vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltG~~pf~~~~~~~~ 349 (486)
+||+|||+++......... ......||+.|||||++.+.. ++.++|||||||+||||+||..||........
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 9999999998754432221 233468999999999987543 57799999999999999999988854332211
Q ss_pred chhHHh-hhhhcccc--cccccccCCccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 350 HNLVEW-ARPHLGER--RRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 350 ~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
...... ........ ......++|.+.... .......+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 100000 00000000 000111222222221 224556789999999999999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-50 Score=390.49 Aligned_cols=266 Identities=23% Similarity=0.308 Sum_probs=199.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++++.||+|+||+||+|.+. +|+.||||+++.... ...+.+.+|+.+|++++|||||+++++|..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 57999999999999999999874 467999999976532 224678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
++..+++|||+.++.|..+ ......+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 72 ~~~~~i~~e~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp SSCEEEEEECCSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCceeEEEEeehhhhHHHH-HhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccc
Confidence 9999999999977655554 455678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-------- 357 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~-------- 357 (486)
........ ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (286)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence 76543222 1233568999999999875 456899999999999999999999997643211111000000
Q ss_pred hhccccccc---ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 358 PHLGERRRF---YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 358 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
......... .....+.....+....+..+.+|+.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 00000000111111234678899999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=397.03 Aligned_cols=262 Identities=25% Similarity=0.322 Sum_probs=195.3
Q ss_pred CCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCceEEEEEEEeC--
Q 011412 130 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 207 (486)
Q Consensus 130 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 207 (486)
+|+.+++||+|+||+||+|++.. +|+.||||++...... +.+|+++|++++|||||+++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECC---------CCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 57788899999999999999876 6789999999765422 34799999999999999999998543
Q ss_pred ----CeeEEEEeecCCCChhHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEE
Q 011412 208 ----DQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKL 280 (486)
Q Consensus 208 ----~~~~lv~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~vkl 280 (486)
.+++||||||+++.+..+.. .....+++..+..|+.||+.||+|||+++ ||||||||+||||+.++ .+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEE
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeE
Confidence 35789999997654433322 34567999999999999999999999988 99999999999999775 8999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh---
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--- 356 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~--- 356 (486)
+|||+++....... ....+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...........+...
T Consensus 165 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241 (350)
T ss_dssp CCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999987644332 234679999999998765 57899999999999999999999999765322111110000
Q ss_pred ------hhhccc--ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 357 ------RPHLGE--RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 357 ------~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
...... ...+................+..+.+||.+||..||.+|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 000000000000111112234678999999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-49 Score=383.32 Aligned_cols=260 Identities=20% Similarity=0.207 Sum_probs=201.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC-ceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~ 207 (486)
++|++++.||+|+||+||+|++.. +|+.||||++...... .++..|+++++.++|+| |+.+.+++.+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CEEEEeEEEeeCCCcEEEEEEECC---------CCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 579999999999999999999865 6789999998765332 45789999999998766 55566677788
Q ss_pred CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCcEEEeecC
Q 011412 208 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFG 284 (486)
Q Consensus 208 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~---~~~~vkl~DFG 284 (486)
+..++||||| +++|.+.+......+++..+..++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||
T Consensus 76 ~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 76 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred CEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccC
Confidence 8999999999 66787777777778999999999999999999999988 99999999999985 45679999999
Q ss_pred CCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHH-hhhh
Q 011412 285 LAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARP 358 (486)
Q Consensus 285 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~-~~~~ 358 (486)
+|+........ .......||+.|||||++.+..|+.++|||||||++|||+||+.||............. ....
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence 99876443221 12334689999999999999999999999999999999999999997654433222111 1110
Q ss_pred hcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.... ..+.+... ++..+.+|+.+||+.||.+||++.++.+.|+.+
T Consensus 232 ~~~~-------~~~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 232 KMST-------PIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHS-------CHHHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred cCCC-------ChhHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0000 00001111 235688999999999999999999998877654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9e-49 Score=382.16 Aligned_cols=262 Identities=17% Similarity=0.168 Sum_probs=208.8
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC-CCceEEEEEEEe
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIE 206 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~ 206 (486)
.++|++++.||+|+||+||+|++.. +|+.||||++..... ...+.+|++++..|.| +||+.+++++..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 4689999999999999999999875 678999999865432 2346789999999965 899999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-----CCcEEEe
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-----DYNAKLS 281 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-----~~~vkl~ 281 (486)
....++||||| +++|.+++......++...+..++.|++.||+|||+++ ||||||||+||||+. ++.+||+
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEc
Confidence 99999999999 78999999877778999999999999999999999988 999999999999964 5789999
Q ss_pred ecCCCCCCCCCCcc-----eeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011412 282 DFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 356 (486)
Q Consensus 282 DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~ 356 (486)
|||+|+........ ......+||+.|||||++.+..++.++|||||||++|||+||..||...............
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence 99999875432211 1233468999999999999999999999999999999999999999865544332221111
Q ss_pred hhhcccccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011412 357 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 414 (486)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~~ 414 (486)
.... ......+ +... .+..+.+|+..|+..+|++||++..+.+.|+.+
T Consensus 229 ~~~~-~~~~~~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 229 GEKK-QSTPLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHH-HHSCHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred Hhcc-CCCChHH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1000 0000000 1111 235688999999999999999999988877654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=382.81 Aligned_cols=270 Identities=23% Similarity=0.295 Sum_probs=197.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++++.||+|+||+||+|++.. +|+.||||++..... .....+.+|+++|+.++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 689999999999999999999875 678999999865432 234668899999999999999999998865
Q ss_pred --------CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011412 207 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 278 (486)
Q Consensus 207 --------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~v 278 (486)
++..|+|||||.++.+. .+......+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp ----------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred ccccccccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence 34689999999776555 44455567999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcc--eeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011412 279 KLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 355 (486)
Q Consensus 279 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~ 355 (486)
||+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........+..
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 99999999765432221 122235799999999998755 789999999999999999999999976432221111111
Q ss_pred hhhhcccc-------cccccccCCccCCCCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 356 ARPHLGER-------RRFYRLIDPRLEGHFSI-------KGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 356 ~~~~~~~~-------~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
........ ......+.......... .....+.+||.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 11000000 00000000000000000 1134577999999999999999999999854
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=389.27 Aligned_cols=262 Identities=24% Similarity=0.314 Sum_probs=195.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||+||+|.+.. +|+.||||+++..... ..+.+.+|+++|+.++|||||+++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 4689999999999999999999875 6789999999754332 2356889999999999999999999998
Q ss_pred eCC------eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011412 206 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 279 (486)
Q Consensus 206 ~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vk 279 (486)
..+ .+||||||| +.+|..++.. ..+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccc
Confidence 654 569999999 6677776643 36999999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011412 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358 (486)
Q Consensus 280 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 358 (486)
|+|||+++..... .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.................
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence 9999999876442 234679999999999876 4568999999999999999999999976532211110000000
Q ss_pred h--------cc--cc----cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 359 H--------LG--ER----RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 359 ~--------~~--~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. .. .. ..+.......+. ......+..+.+||.+||..||.+|||+.|+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00 00 000000000000 0111223568899999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=390.03 Aligned_cols=268 Identities=21% Similarity=0.282 Sum_probs=197.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCceEEEEEEEeC
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 207 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 207 (486)
.+|++++.||+|+||+||+|++.. +|+.||||++..... ...+.+.+|+.+|+.|+|||||++++++...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNV---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETT---------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred CCeEEEEEEeeccCeEEEEEEECC---------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence 579999999999999999998865 678999999975432 2345688999999999999999999998765
Q ss_pred C----eeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 208 D----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 208 ~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
. ..+++|+|+.+|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 79 ~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 79 TIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp STTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred cccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEccc
Confidence 3 234555666799999999654 6899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcc-eeeeeccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 284 GLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 284 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|+++........ ......+||+.|+|||++. +..|+.++||||+||++|||++|+.||....................
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence 999865432221 1233467999999999985 55778999999999999999999999976543211111100000000
Q ss_pred c----------ccccccccCCccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 E----------RRRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ~----------~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
. .............. ......+..+.+|+.+||+.||.+|||+.|+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000000000000 0000123568899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=375.12 Aligned_cols=265 Identities=23% Similarity=0.277 Sum_probs=204.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|++++.||+|+||+||+|++.. +|+.||||+++.... .....+.+|+.+|+.++|||||+++++|.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 579999999999999999999876 677999999975443 234678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011412 207 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 286 (486)
Q Consensus 207 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla 286 (486)
.+..++|||++.+++|..++ .....+++..+..++.|++.||+|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccceeEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchh
Confidence 99999999999998888776 45567899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc----
Q 011412 287 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---- 361 (486)
Q Consensus 287 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---- 361 (486)
+........ .....++..|+|||++.... ++.++|||||||++|||++|+.||....... ...........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 224 (292)
T d1unla_ 149 RAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTE 224 (292)
T ss_dssp EECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCT
T ss_pred hcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCCh
Confidence 876543322 23346789999999887654 6899999999999999999999975432211 11110000000
Q ss_pred ----------cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 362 ----------ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 362 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+....................+..+.+|+.+||+.||.+|||+.|+|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000111122334678899999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-47 Score=379.02 Aligned_cols=260 Identities=19% Similarity=0.244 Sum_probs=199.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCceEEEEEEEe-
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE- 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~- 206 (486)
++|++++.||+|+||+||+|++.. +|+.||||+++... .+.+.+|+.+|+.+. ||||++++++|..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 579999999999999999999865 67899999997543 467889999999995 9999999999975
Q ss_pred -CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEeecC
Q 011412 207 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG 284 (486)
Q Consensus 207 -~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~vkl~DFG 284 (486)
...+++|||||.+++|..+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGG
T ss_pred CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccc
Confidence 35689999999999997754 46899999999999999999999998 99999999999998655 69999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhH--H-------
Q 011412 285 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--E------- 354 (486)
Q Consensus 285 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~--~------- 354 (486)
+++....... ....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||............ .
T Consensus 176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 9987654332 3446799999999998765 5799999999999999999999999765432111000 0
Q ss_pred --hhh-hhcccccccccccCC--------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 355 --WAR-PHLGERRRFYRLIDP--------RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 355 --~~~-~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
+.. ........+...... ..........+.++.+||.+||..||.+|||+.|+|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000000000000 00001111224578899999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=385.37 Aligned_cols=257 Identities=27% Similarity=0.352 Sum_probs=204.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcCCC-CCceEEEEE
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVH-LNLVKLIGY 203 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~nIv~~~~~ 203 (486)
++|++++.||+|+||+||+|++..+. .+|+.||||+++.... ...+.+.+|+++|++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccC------CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 57999999999999999999885432 3788999999864321 223557899999999976 899999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011412 204 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 283 (486)
Q Consensus 204 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl~DF 283 (486)
+.+...+++|||||.+|+|.+++...+ .+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+||
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred eccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeec
Confidence 999999999999999999999986554 5788999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 011412 284 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361 (486)
Q Consensus 284 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 361 (486)
|+++........ ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+.. ....
T Consensus 174 G~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~--~~~~ 250 (322)
T d1vzoa_ 174 GLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILK 250 (322)
T ss_dssp SEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHH
T ss_pred cchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hccc
Confidence 999875443222 23346799999999998754 468899999999999999999999987654432222111 0110
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011412 362 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 410 (486)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~eil~~ 410 (486)
. .+. ++...+..+.+||.+||+.||.+||+ +.|++++
T Consensus 251 ~--------~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 S--------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp C--------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred C--------CCC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0 111 11223467999999999999999994 7888764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=383.13 Aligned_cols=264 Identities=23% Similarity=0.282 Sum_probs=192.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEEe
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 206 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 206 (486)
++|+++++||+|+||+||+|++.. +|+.||||++...... ....+.+|+.+|++++|||||+++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~---------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT---------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEEECC---------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 679999999999999999999875 7889999999765332 23468899999999999999999999964
Q ss_pred ------CCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 207 ------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 207 ------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
...+|+|||||.++ |.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp CCSTTTCCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred ccccccCceeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence 36789999999665 444442 45899999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHH------
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE------ 354 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~------ 354 (486)
+|||+++...... ..+..+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+.
T Consensus 161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence 9999998765433 2345679999999999999999999999999999999999999997543211110000
Q ss_pred ---hhh---h----hccc-----ccccccccCCccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011412 355 ---WAR---P----HLGE-----RRRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 411 (486)
Q Consensus 355 ---~~~---~----~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 411 (486)
+.. . .... .............. ......+..+.+||.+||..||++|||+.|+|++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 000 0 0000 00000111111111 11234467789999999999999999999999753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=374.38 Aligned_cols=264 Identities=24% Similarity=0.332 Sum_probs=196.3
Q ss_pred hcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCceEEEEEEE
Q 011412 128 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 205 (486)
Q Consensus 128 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 205 (486)
.++|++++.||+|+||+||+|++.. +|+.||||+++..... ..+.+.+|+++|+.|+|||||++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT---------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4689999999999999999999875 6889999999865432 2356889999999999999999999986
Q ss_pred eC-----CeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011412 206 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 280 (486)
Q Consensus 206 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~vkl 280 (486)
.. ...++||+|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccc
Confidence 43 344677788889999998854 36999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011412 281 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 359 (486)
Q Consensus 281 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 359 (486)
+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......
T Consensus 163 ~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 163 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237 (348)
T ss_dssp CCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999765332 2346799999999987765 4688999999999999999999999765322111111000000
Q ss_pred ccc----------ccccccccCCccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011412 360 LGE----------RRRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 410 (486)
Q Consensus 360 ~~~----------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 410 (486)
... .......+.......+ ....+..+.+||.+||..||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000 0000000000000000 00123568899999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-42 Score=346.50 Aligned_cols=264 Identities=21% Similarity=0.238 Sum_probs=193.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-----------CCCc
Q 011412 129 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----------HLNL 197 (486)
Q Consensus 129 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nI 197 (486)
.+|++++.||+|+||+||+|++.. +|+.||||+++.... ..+.+.+|+++|+.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~---------~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 359999999999999999999876 678999999986532 2356778999988875 5789
Q ss_pred eEEEEEEEe--CCeeEEEEeecCCCChhHHH--hhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEE
Q 011412 198 VKLIGYCIE--DDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILL 272 (486)
Q Consensus 198 v~~~~~~~~--~~~~~lv~E~~~~gsL~~~l--~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll 272 (486)
|++++++.. ....+++|+++..+...... ......+++..+..++.||+.||.|||+ .+ |+||||||+||||
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll 159 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM 159 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeee
Confidence 999988764 45667777777665443332 2345678999999999999999999997 66 9999999999999
Q ss_pred cCCCc------EEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 011412 273 DADYN------AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 346 (486)
Q Consensus 273 ~~~~~------vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltG~~pf~~~~~ 346 (486)
+.++. ++|+|||.+...... ....+||+.|+|||++....|+.++|||||||+++||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 76653 999999999865432 2345799999999999999999999999999999999999999976543
Q ss_pred CCcchhHHhhh---hhccc-----------------ccccccccCC----------ccCCCCCHHHHHHHHHHHHHhccc
Q 011412 347 NGEHNLVEWAR---PHLGE-----------------RRRFYRLIDP----------RLEGHFSIKGAQKAAQLAAHCLSR 396 (486)
Q Consensus 347 ~~~~~~~~~~~---~~~~~-----------------~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~ 396 (486)
........... ..+.. .......+.. .....+....+..+.+|+.+||..
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 22111100000 00000 0000000000 012234556778899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 011412 397 DPKARPLMSEVVEA 410 (486)
Q Consensus 397 dP~~RPs~~eil~~ 410 (486)
||.+|||+.|+|++
T Consensus 315 dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 315 DPRKRADAGGLVNH 328 (362)
T ss_dssp STTTCBCHHHHHTC
T ss_pred ChhHCcCHHHHhcC
Confidence 99999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=5.4e-26 Score=206.03 Aligned_cols=170 Identities=16% Similarity=0.117 Sum_probs=119.9
Q ss_pred CCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcc-------------c-----HHHHHHHHHHHhcCC
Q 011412 132 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-------------G-----HKEWLAEVNFLGDLV 193 (486)
Q Consensus 132 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-------------~-----~~~~~~E~~~l~~l~ 193 (486)
.+.+.||+|+||+||+|.+. +|+.||||+++..... . ......|+..|.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 35678999999999999874 4779999987532110 0 122456889999999
Q ss_pred CCCceEEEEEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011412 194 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 273 (486)
Q Consensus 194 h~nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 273 (486)
|.+++..+++. ..+|||||+++..+.+ ++......++.|++.+|.|||+++ |+||||||+|||++
T Consensus 73 ~~~v~~~~~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~ 137 (191)
T d1zara2 73 GLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 137 (191)
T ss_dssp TSSSCCEEEEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCcceEEEec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeee
Confidence 99999988763 2379999998866543 233445678999999999999988 99999999999998
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCccccccCCCCchhhHHHHHHHHH
Q 011412 274 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 332 (486)
Q Consensus 274 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ 332 (486)
++ .++|+|||+|+............+.+.. -.+ +....|+.++|+||+.--++
T Consensus 138 ~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 138 EE-GIWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred CC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHHh
Confidence 65 5899999999775432211100000000 001 12467889999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=2.8e-08 Score=92.11 Aligned_cols=149 Identities=15% Similarity=0.024 Sum_probs=99.6
Q ss_pred HHHHHhcCCCCCCeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCceEEE
Q 011412 123 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLI 201 (486)
Q Consensus 123 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~ 201 (486)
+++.....|+..+..+.++.+.||+... .+..++||+...........+.+|+..|..|. +--+.+++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl 76 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEE
Confidence 3444455666555544455578998753 34568899886544333345678888887774 43467888
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------
Q 011412 202 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------- 256 (486)
Q Consensus 202 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------------------------- 256 (486)
.+...++..++||++++|..+....... .....++.+++..+..||+..
T Consensus 77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T d1j7la_ 77 HFERHDGWSNLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred EEEecCCceEEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHh
Confidence 8888889999999999998886543211 112334555566666666421
Q ss_pred -------------------------------CCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 257 -------------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 257 -------------------------------~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 01279999999999999776667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=1.1e-05 Score=73.49 Aligned_cols=131 Identities=19% Similarity=0.095 Sum_probs=82.9
Q ss_pred eeeecCC-eEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC--CCceEEEEEEEeCCeeEE
Q 011412 136 LLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDDQRLL 212 (486)
Q Consensus 136 ~lg~G~f-g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~l 212 (486)
.+..|.. +.||+.... .|..+++|....... ..+..|+..|+.|.. -.+.+++.+..+++..++
T Consensus 17 ~~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECT----------TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred EcCCcccCCeEEEEEeC----------CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 3444543 678988653 355688898765433 235677777776643 336778888888888999
Q ss_pred EEeecCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 011412 213 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------------------------------------- 253 (486)
Q Consensus 213 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH--------------------------------------- 253 (486)
||+|++|.++.... ... ..++.++...|.-||
T Consensus 84 v~~~i~G~~~~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 154 (255)
T ss_dssp EEECCSSEETTTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEeeecccccccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhh
Confidence 99999887664310 010 011122222233333
Q ss_pred ------------hCC----CCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 254 ------------EEA----ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 254 ------------~~~----~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
... ...+||+|+.|.|||++.+..+-|+||+.+..
T Consensus 155 ~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 155 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 211 11379999999999998876678999997753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.96 E-value=1.7e-05 Score=77.56 Aligned_cols=77 Identities=14% Similarity=0.094 Sum_probs=48.3
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCC------C-cccHHHHHHHHHHHhcCC-C--CCceEEEEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------G-LQGHKEWLAEVNFLGDLV-H--LNLVKLIGYC 204 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~ 204 (486)
+.||.|....||++.... +++.|+||.-... . .....+...|+..|+.+. + ..+.+++.+
T Consensus 32 ~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~- 101 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS- 101 (392)
T ss_dssp EECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-
T ss_pred EEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-
Confidence 468999999999997654 4568999975321 1 112234556888777662 2 345666654
Q ss_pred EeCCeeEEEEeecCCCCh
Q 011412 205 IEDDQRLLVYEFMPRGSL 222 (486)
Q Consensus 205 ~~~~~~~lv~E~~~~gsL 222 (486)
+++..++|||++.+..+
T Consensus 102 -d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 -DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp -ETTTTEEEECCCTTSEE
T ss_pred -cCCCCEEEEeccCCccc
Confidence 45567899999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.44 E-value=0.00023 Score=69.22 Aligned_cols=80 Identities=19% Similarity=0.130 Sum_probs=53.1
Q ss_pred CeeeecCCeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-eEEEEEEEeCCeeEEE
Q 011412 135 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 213 (486)
Q Consensus 135 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv 213 (486)
+.|+.|---.+|++....... +.......|.+++.... .......+|..+++.+.-.++ .++++++.+ .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 578888889999998765322 12223456777776532 233456789999888853344 477777642 689
Q ss_pred EeecCCCCh
Q 011412 214 YEFMPRGSL 222 (486)
Q Consensus 214 ~E~~~~gsL 222 (486)
|||++|..|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.0012 Score=62.12 Aligned_cols=134 Identities=16% Similarity=0.088 Sum_probs=75.7
Q ss_pred CeEEEEEEEccCCCccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc--eEEE-----EEEEeCCeeEEEE
Q 011412 142 FGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL--VKLI-----GYCIEDDQRLLVY 214 (486)
Q Consensus 142 fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~~~-----~~~~~~~~~~lv~ 214 (486)
--.||++... +|..|++|+.+... ....++..|...|..|...+| +..+ ..+...+..+.|+
T Consensus 35 EN~vy~v~~~----------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 35 ENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp SSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred cceeEEEEcC----------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence 3579998764 46789999986542 345678888888887743222 1111 1223466788999
Q ss_pred eecCCCChh-----HH------H---hh--c------CCCCC-------------------HH---HHHHHHHHHHHHHH
Q 011412 215 EFMPRGSLE-----NH------L---FR--R------SLPLP-------------------WS---IRMKIALGAAKGLA 250 (486)
Q Consensus 215 E~~~~gsL~-----~~------l---~~--~------~~~l~-------------------~~---~~~~i~~qi~~~l~ 250 (486)
++++|..+. .+ + .. . ...++ .. .....+..+...+.
T Consensus 104 ~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 183 (325)
T d1zyla1 104 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 183 (325)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred eecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999764431 10 1 00 0 00111 11 11222222332222
Q ss_pred HH-HhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011412 251 FL-HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 288 (486)
Q Consensus 251 yL-H~~~~~~iiHrDLKp~NIll~~~~~vkl~DFGla~~ 288 (486)
-+ ....+..+||+|+.+.|||++++ ..++||+-+..
T Consensus 184 ~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 184 AHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 22 12223458999999999999743 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.79 E-value=0.0057 Score=56.74 Aligned_cols=31 Identities=29% Similarity=0.256 Sum_probs=27.1
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011412 257 ERPVIYRDFKTSNILLDADYNAKLSDFGLAK 287 (486)
Q Consensus 257 ~~~iiHrDLKp~NIll~~~~~vkl~DFGla~ 287 (486)
+.++||+|+.+.|||++.+...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3459999999999999988777899999875
|
| >d1qu6a2 d.50.1.1 (A:91-179) dsRNA-dependent protein kinase pkr {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.65 E-value=0.0037 Score=46.61 Aligned_cols=36 Identities=25% Similarity=0.178 Sum_probs=29.2
Q ss_pred ccccccccccchhhhhhhcccccccccccchhhccc
Q 011412 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETG 42 (486)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 42 (486)
+.+.|+.|.|++|++||+.||+.++..+..++...+
T Consensus 53 ~g~~~~~g~G~sKK~Akq~AA~~Al~~L~~~~~~s~ 88 (89)
T d1qu6a2 53 GQKEYSIGTGSTKQEAKQLAAKLAYLQILSEETGSG 88 (89)
T ss_dssp ETTBCCEEEESSHHHHHHHHHHHHHHHHHHCCCCSC
T ss_pred CCccccccccchHHHHHHHHHHHHHHHHHccCCCCC
Confidence 345788999999999999999999988866554433
|
| >d1x48a1 d.50.1.1 (A:8-83) dsRNA-dependent protein kinase pkr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.78 E-value=0.0057 Score=44.05 Aligned_cols=32 Identities=13% Similarity=0.038 Sum_probs=27.2
Q ss_pred ccccccccccchhhhhhhcccccccccccchh
Q 011412 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVEEE 38 (486)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 38 (486)
+++.|+.|+|++|++|+|.||+.+++.+..+.
T Consensus 38 ~~~~~~~g~G~sKK~Aeq~AA~~Al~~L~~~~ 69 (76)
T d1x48a1 38 GQTMYGTGSGVTKQEAKQLAAKEAYQKLLKSP 69 (76)
T ss_dssp SSCEEEEEEESSHHHHHHHHHHHHHHHHHHSC
T ss_pred CCEEeCCcCccHHHHHHHHHHHHHHHHHHccC
Confidence 34678999999999999999999998886544
|
| >d1x49a1 d.50.1.1 (A:8-92) dsRNA-dependent protein kinase pkr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=84.78 E-value=0.061 Score=39.23 Aligned_cols=30 Identities=20% Similarity=0.139 Sum_probs=25.0
Q ss_pred cccccccccchhhhhhhcccccccccccch
Q 011412 8 GKVKKASWDSSKSKAKKKKKKVEDEVEVEE 37 (486)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 37 (486)
.+.|+.|+|++|++|++.||+.+.+.+..+
T Consensus 48 g~~~~~g~g~sKK~Aeq~AA~~aL~~L~~~ 77 (85)
T d1x49a1 48 EKEFPEAKGRSKQEARNAAAKLAVDILDNE 77 (85)
T ss_dssp SCCCCCEEESSHHHHHHHHHHHHHHHHTTT
T ss_pred ceEeeccccccHHHHHHHHHHHHHHHHHHc
Confidence 356789999999999999999998776443
|
| >d1qu6a1 d.50.1.1 (A:1-90) dsRNA-dependent protein kinase pkr {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.03 E-value=0.068 Score=39.45 Aligned_cols=30 Identities=23% Similarity=0.164 Sum_probs=25.0
Q ss_pred ccccccccchhhhhhhcccccccccccchh
Q 011412 9 KVKKASWDSSKSKAKKKKKKVEDEVEVEEE 38 (486)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 38 (486)
+.++.|+|++|++|++.||+.+.+.+.++.
T Consensus 55 ~~~~~g~G~sKK~Aeq~AA~~aL~~L~~~~ 84 (90)
T d1qu6a1 55 REFPEGEGRSKKEAKNAAAKLAVEILNKEK 84 (90)
T ss_dssp SCCCEEECCSSHHHHHHHHHHHHHHHHSCC
T ss_pred eeeeccCCCcHHHHHHHHHHHHHHHHHhhC
Confidence 467889999999999999999987775433
|
| >d1x47a1 d.50.1.1 (A:8-92) Dgcr8 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: Dgcr8 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.62 E-value=0.096 Score=38.12 Aligned_cols=27 Identities=30% Similarity=0.204 Sum_probs=23.1
Q ss_pred cccccccccchhhhhhhcccccccccc
Q 011412 8 GKVKKASWDSSKSKAKKKKKKVEDEVE 34 (486)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (486)
++.|+.|+|.+|++|++.||+.+.+.+
T Consensus 49 g~~~~~g~G~sKK~Aeq~AA~~AL~~L 75 (85)
T d1x47a1 49 GVTYGSGTASSKKLAKNKAARATLEIL 75 (85)
T ss_dssp TEEEEEEEESSHHHHHHHHHHHHHHHH
T ss_pred CEEEecCCcchHHHHHHHHHHHHHHHH
Confidence 346789999999999999999887655
|